Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type

Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

2168 3974 None 38 Rat Functional pEC50 = 10.2 10.2 12 6
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
2810 3974 None 38 Rat Functional pEC50 = 10.2 10.2 12 6
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
644077 3974 None 38 Rat Functional pEC50 = 10.2 10.2 12 6
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
CHEMBL373742 3974 None 38 Rat Functional pEC50 = 10.2 10.2 12 6
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
DB00067 3974 None 38 Rat Functional pEC50 = 10.2 10.2 12 6
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
2168 3974 None 38 Rat Functional pEC50 = 10.2 10.2 12 6
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
2810 3974 None 38 Rat Functional pEC50 = 10.2 10.2 12 6
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
644077 3974 None 38 Rat Functional pEC50 = 10.2 10.2 12 6
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
CHEMBL373742 3974 None 38 Rat Functional pEC50 = 10.2 10.2 12 6
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
DB00067 3974 None 38 Rat Functional pEC50 = 10.2 10.2 12 6
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
CHEMBL1819441 209012 None 0 Rat Functional pEC50 = 10.2 10.2 1 4
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1819441 209012 None 0 Rat Functional pEC50 = 10.1 10.1 1 4
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1817706 208986 None 0 Rat Functional pEC50 = 10 10.0 2 5
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CCCNCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1817706 208986 None 0 Rat Functional pEC50 = 10.0 10.0 2 5
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CCCNCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1819542 209015 None 9 Rat Functional pEC50 = 9.9 9.9 2 4
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819542 209015 None 9 Rat Functional pEC50 = 9.9 9.9 2 4
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817704 208984 None 0 Rat Functional pEC50 = 9.9 9.9 2 5
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
90285421 114980 None 0 Human Functional pEC50 = 9.9 9.9 9 2
Antagonist activity at human vasopressin 1a receptor expressed in HEK293 cell membranes assessed as inhibition of AVP-induced increase in Ca2+ flux preincubated for 5 mins followed by AVP addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human vasopressin 1a receptor expressed in HEK293 cell membranes assessed as inhibition of AVP-induced increase in Ca2+ flux preincubated for 5 mins followed by AVP addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 334 4 1 5 2.7 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(Cl)cc1 10.1016/j.ejmech.2017.05.013
CHEMBL3342789 114980 None 0 Human Functional pEC50 = 9.9 9.9 9 2
Antagonist activity at human vasopressin 1a receptor expressed in HEK293 cell membranes assessed as inhibition of AVP-induced increase in Ca2+ flux preincubated for 5 mins followed by AVP addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human vasopressin 1a receptor expressed in HEK293 cell membranes assessed as inhibition of AVP-induced increase in Ca2+ flux preincubated for 5 mins followed by AVP addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 334 4 1 5 2.7 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(Cl)cc1 10.1016/j.ejmech.2017.05.013
3601935 162361 None 2 Human Functional pEC50 = 9.9 9.9 -1 2
Antagonist activity at human vasopressin 1a receptor expressed in HEK293 cell membranes assessed as inhibition of AVP-induced increase in Ca2+ flux preincubated for 5 mins followed by AVP addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human vasopressin 1a receptor expressed in HEK293 cell membranes assessed as inhibition of AVP-induced increase in Ca2+ flux preincubated for 5 mins followed by AVP addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 271 3 1 4 1.9 Cn1nccc1NS(=O)(=O)c1ccc(Cl)cc1 10.1016/j.ejmech.2017.05.013
CHEMBL4165132 162361 None 2 Human Functional pEC50 = 9.9 9.9 -1 2
Antagonist activity at human vasopressin 1a receptor expressed in HEK293 cell membranes assessed as inhibition of AVP-induced increase in Ca2+ flux preincubated for 5 mins followed by AVP addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human vasopressin 1a receptor expressed in HEK293 cell membranes assessed as inhibition of AVP-induced increase in Ca2+ flux preincubated for 5 mins followed by AVP addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 271 3 1 4 1.9 Cn1nccc1NS(=O)(=O)c1ccc(Cl)cc1 10.1016/j.ejmech.2017.05.013
CHEMBL1817704 208984 None 0 Rat Functional pEC50 = 9.9 9.9 2 5
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819540 209013 None 0 Human Functional pEC50 = 9.9 9.9 64 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1819540 209013 None 0 Human Functional pEC50 = 9.9 9.9 64 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1819441 209012 None 0 Human Functional pEC50 = 9.8 9.8 -1 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1819441 209012 None 0 Human Functional pEC50 = 9.8 9.8 -1 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
76685194 114981 None 0 Human Functional pEC50 = 9.8 9.8 5 2
Antagonist activity at human vasopressin 1a receptor expressed in HEK293 cell membranes assessed as inhibition of AVP-induced increase in Ca2+ flux preincubated for 5 mins followed by AVP addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human vasopressin 1a receptor expressed in HEK293 cell membranes assessed as inhibition of AVP-induced increase in Ca2+ flux preincubated for 5 mins followed by AVP addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 368 4 1 5 3.1 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(C(F)(F)F)cc1 10.1016/j.ejmech.2017.05.013
CHEMBL3342790 114981 None 0 Human Functional pEC50 = 9.8 9.8 5 2
Antagonist activity at human vasopressin 1a receptor expressed in HEK293 cell membranes assessed as inhibition of AVP-induced increase in Ca2+ flux preincubated for 5 mins followed by AVP addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human vasopressin 1a receptor expressed in HEK293 cell membranes assessed as inhibition of AVP-induced increase in Ca2+ flux preincubated for 5 mins followed by AVP addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 368 4 1 5 3.1 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(C(F)(F)F)cc1 10.1016/j.ejmech.2017.05.013
5014150 162853 None 1 Human Functional pEC50 = 9.8 9.8 -1 2
Antagonist activity at human vasopressin 1a receptor expressed in HEK293 cell membranes assessed as inhibition of AVP-induced increase in Ca2+ flux preincubated for 5 mins followed by AVP addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human vasopressin 1a receptor expressed in HEK293 cell membranes assessed as inhibition of AVP-induced increase in Ca2+ flux preincubated for 5 mins followed by AVP addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 305 3 1 4 2.2 Cn1nccc1NS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.ejmech.2017.05.013
CHEMBL4173036 162853 None 1 Human Functional pEC50 = 9.8 9.8 -1 2
Antagonist activity at human vasopressin 1a receptor expressed in HEK293 cell membranes assessed as inhibition of AVP-induced increase in Ca2+ flux preincubated for 5 mins followed by AVP addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human vasopressin 1a receptor expressed in HEK293 cell membranes assessed as inhibition of AVP-induced increase in Ca2+ flux preincubated for 5 mins followed by AVP addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 305 3 1 4 2.2 Cn1nccc1NS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.ejmech.2017.05.013
CHEMBL1817707 208987 None 0 Rat Functional pEC50 = 9.8 9.8 3 5
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CCNCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1817707 208987 None 0 Rat Functional pEC50 = 9.8 9.8 3 5
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CCNCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
2042 2981 None 58 Human Functional pEC50 = 9.7 9.7 -3 5
Agonist activity at human V1A receptor expressed in HEK293 cells assessed as intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at human V1A receptor expressed in HEK293 cells assessed as intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL None None None None 10.1016/j.bmc.2019.06.018
2174 2981 None 58 Human Functional pEC50 = 9.7 9.7 -3 5
Agonist activity at human V1A receptor expressed in HEK293 cells assessed as intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at human V1A receptor expressed in HEK293 cells assessed as intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL None None None None 10.1016/j.bmc.2019.06.018
2176 2981 None 58 Human Functional pEC50 = 9.7 9.7 -3 5
Agonist activity at human V1A receptor expressed in HEK293 cells assessed as intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at human V1A receptor expressed in HEK293 cells assessed as intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL None None None None 10.1016/j.bmc.2019.06.018
439302 2981 None 58 Human Functional pEC50 = 9.7 9.7 -3 5
Agonist activity at human V1A receptor expressed in HEK293 cells assessed as intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at human V1A receptor expressed in HEK293 cells assessed as intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL None None None None 10.1016/j.bmc.2019.06.018
CHEMBL395429 2981 None 58 Human Functional pEC50 = 9.7 9.7 -3 5
Agonist activity at human V1A receptor expressed in HEK293 cells assessed as intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at human V1A receptor expressed in HEK293 cells assessed as intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL None None None None 10.1016/j.bmc.2019.06.018
DB00107 2981 None 58 Human Functional pEC50 = 9.7 9.7 -3 5
Agonist activity at human V1A receptor expressed in HEK293 cells assessed as intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at human V1A receptor expressed in HEK293 cells assessed as intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL None None None None 10.1016/j.bmc.2019.06.018
CHEMBL1817706 208986 None 0 Human Functional pEC50 = 9.7 9.7 -2 5
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CCCNCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1817706 208986 None 0 Human Functional pEC50 = 9.7 9.7 -2 5
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CCCNCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1819541 209014 None 0 Human Functional pEC50 = 9.6 9.6 14 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
2168 3974 None 38 Human Functional pEC50 = 9.6 9.6 -18 6
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
2810 3974 None 38 Human Functional pEC50 = 9.6 9.6 -18 6
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
644077 3974 None 38 Human Functional pEC50 = 9.6 9.6 -18 6
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
CHEMBL373742 3974 None 38 Human Functional pEC50 = 9.6 9.6 -18 6
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
DB00067 3974 None 38 Human Functional pEC50 = 9.6 9.6 -18 6
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
CHEMBL1819541 209014 None 0 Human Functional pEC50 = 9.6 9.6 14 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
2168 3974 None 38 Human Functional pEC50 = 9.6 9.6 -18 6
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
2810 3974 None 38 Human Functional pEC50 = 9.6 9.6 -18 6
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
644077 3974 None 38 Human Functional pEC50 = 9.6 9.6 -18 6
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
CHEMBL373742 3974 None 38 Human Functional pEC50 = 9.6 9.6 -18 6
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
DB00067 3974 None 38 Human Functional pEC50 = 9.6 9.6 -18 6
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
CHEMBL1819555 209027 None 0 Human Functional pEC50 = 9.6 9.6 8 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819555 209027 None 0 Human Functional pEC50 = 9.6 9.6 8 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817705 208985 None 0 Human Functional pEC50 = 9.6 9.6 1 5
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817705 208985 None 0 Human Functional pEC50 = 9.6 9.6 1 5
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819542 209015 None 9 Human Functional pEC50 = 9.6 9.6 -2 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819542 209015 None 9 Human Functional pEC50 = 9.6 9.6 -2 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817705 208985 None 0 Rat Functional pEC50 = 9.5 9.5 -1 5
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817705 208985 None 0 Rat Functional pEC50 = 9.5 9.5 -1 5
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817761 208999 None 0 Rat Functional pEC50 = 9.5 9.5 2 5
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817761 208999 None 0 Rat Functional pEC50 = 9.5 9.5 2 5
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817702 208982 None 0 Rat Functional pEC50 = 9.5 9.5 2 4
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817702 208982 None 0 Rat Functional pEC50 = 9.5 9.5 2 4
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819440 209011 None 23 Rat Functional pEC50 = 9.5 9.5 1 5
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1819440 209011 None 23 Rat Functional pEC50 = 9.5 9.5 1 5
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1817704 208984 None 0 Human Functional pEC50 = 9.4 9.4 -2 5
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817704 208984 None 0 Human Functional pEC50 = 9.4 9.4 -2 5
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819543 209016 None 0 Human Functional pEC50 = 9.3 9.3 18 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819543 209016 None 0 Human Functional pEC50 = 9.3 9.3 18 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819548 209021 None 0 Human Functional pEC50 = 9.3 9.3 53 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
56672274 64776 None 0 Rat Functional pEC50 = 9.3 9.3 - 1
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1063 20 13 16 -5.1 CCC(N)C(=O)NCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1819439 64776 None 0 Rat Functional pEC50 = 9.3 9.3 - 1
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1063 20 13 16 -5.1 CCC(N)C(=O)NCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1819548 209021 None 0 Human Functional pEC50 = 9.3 9.3 53 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
56672274 64776 None 0 Rat Functional pEC50 = 9.3 9.3 - 1
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1063 20 13 16 -5.1 CCC(N)C(=O)NCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1819439 64776 None 0 Rat Functional pEC50 = 9.3 9.3 - 1
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1063 20 13 16 -5.1 CCC(N)C(=O)NCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
11454 3575 None 11 Rat Functional pEC50 = 9.3 9.3 4 5
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
53330936 3575 None 11 Rat Functional pEC50 = 9.3 9.3 4 5
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
CHEMBL1817709 3575 None 11 Rat Functional pEC50 = 9.3 9.3 4 5
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
DB12495 3575 None 11 Rat Functional pEC50 = 9.3 9.3 4 5
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
11454 3575 None 11 Rat Functional pEC50 = 9.3 9.3 4 5
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
53330936 3575 None 11 Rat Functional pEC50 = 9.3 9.3 4 5
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
CHEMBL1817709 3575 None 11 Rat Functional pEC50 = 9.3 9.3 4 5
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
DB12495 3575 None 11 Rat Functional pEC50 = 9.3 9.3 4 5
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
CHEMBL1817707 208987 None 0 Human Functional pEC50 = 9.2 9.2 -3 5
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CCNCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1817707 208987 None 0 Human Functional pEC50 = 9.2 9.2 -3 5
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CCNCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1819549 209022 None 0 Human Functional pEC50 = 9.2 9.2 47 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccsc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819549 209022 None 0 Human Functional pEC50 = 9.2 9.2 47 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccsc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817756 208994 None 0 Rat Functional pEC50 = 9.2 9.2 4 5
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817756 208994 None 0 Rat Functional pEC50 = 9.2 9.2 4 5
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817761 208999 None 0 Human Functional pEC50 = 9.2 9.2 -2 5
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819440 209011 None 23 Human Functional pEC50 = 9.2 9.2 -1 5
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1817761 208999 None 0 Human Functional pEC50 = 9.2 9.2 -2 5
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819440 209011 None 23 Human Functional pEC50 = 9.2 9.2 -1 5
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1819554 209026 None 0 Human Functional pEC50 = 9.1 9.1 5 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819554 209026 None 0 Human Functional pEC50 = 9.1 9.1 5 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817708 208988 None 0 Human Functional pEC50 = 9.1 9.1 53 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNCCC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817708 208988 None 0 Human Functional pEC50 = 9.1 9.1 53 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNCCC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817702 208982 None 0 Human Functional pEC50 = 9.1 9.1 -2 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817702 208982 None 0 Human Functional pEC50 = 9.1 9.1 -2 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819556 209028 None 0 Human Functional pEC50 = 9.0 9.0 67 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)C2(CCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819556 209028 None 0 Human Functional pEC50 = 9.0 9.0 67 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)C2(CCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817754 208992 None 0 Human Functional pEC50 = 9 9.0 7 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CCNCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1817754 208992 None 0 Human Functional pEC50 = 9 9.0 7 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CCNCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
53362258 64622 None 0 Rat Functional pEC50 = 9 9.0 1 3
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1005 17 11 15 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)N(C)C)NC1=O 10.1021/jm200278m
CHEMBL1817695 64622 None 0 Rat Functional pEC50 = 9 9.0 1 3
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1005 17 11 15 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)N(C)C)NC1=O 10.1021/jm200278m
53362155 64801 None 0 Human Functional pEC50 = 9.0 9.0 25 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1021 19 12 16 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NOC)NC1=O 10.1021/jm200278m
CHEMBL1819560 64801 None 0 Human Functional pEC50 = 9.0 9.0 25 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1021 19 12 16 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NOC)NC1=O 10.1021/jm200278m
53362155 64801 None 0 Human Functional pEC50 = 8.9 8.9 25 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1021 19 12 16 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NOC)NC1=O 10.1021/jm200278m
CHEMBL1819560 64801 None 0 Human Functional pEC50 = 8.9 8.9 25 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1021 19 12 16 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NOC)NC1=O 10.1021/jm200278m
CHEMBL1817752 208990 None 0 Human Functional pEC50 = 8.9 8.9 77 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817692 208981 None 0 Human Functional pEC50 = 8.9 8.9 5 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817752 208990 None 0 Human Functional pEC50 = 8.9 8.9 77 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817770 209008 None 0 Human Functional pEC50 = 8.9 8.9 40 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817770 209008 None 0 Human Functional pEC50 = 8.9 8.9 40 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817692 208981 None 0 Human Functional pEC50 = 8.8 8.8 5 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817755 208993 None 0 Human Functional pEC50 = 8.8 8.8 20 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CCCNCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1817755 208993 None 0 Human Functional pEC50 = 8.8 8.8 20 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CCCNCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1817772 209010 None 0 Human Functional pEC50 = 8.8 8.8 11 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817772 209010 None 0 Human Functional pEC50 = 8.8 8.8 11 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
53362258 64622 None 0 Human Functional pEC50 = 8.8 8.8 -1 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1005 17 11 15 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)N(C)C)NC1=O 10.1021/jm200278m
CHEMBL1817695 64622 None 0 Human Functional pEC50 = 8.8 8.8 -1 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1005 17 11 15 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)N(C)C)NC1=O 10.1021/jm200278m
53362258 64622 None 0 Human Functional pEC50 = 8.8 8.8 -1 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1005 17 11 15 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)N(C)C)NC1=O 10.1021/jm200278m
CHEMBL1817695 64622 None 0 Human Functional pEC50 = 8.8 8.8 -1 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1005 17 11 15 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)N(C)C)NC1=O 10.1021/jm200278m
CHEMBL1817749 208989 None 0 Rat Functional pEC50 = 8.7 8.7 1 3
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817757 208995 None 0 Human Functional pEC50 = 8 8.0 52 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817769 209007 None 0 Human Functional pEC50 = 8.0 8.0 7 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819552 209024 None 0 Human Functional pEC50 = 8.0 8.0 3 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
2369069 179282 None 6 Human Functional pEC50 = 5.0 5.0 -1 3
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 346 3 0 5 4.0 CCN1C(=S)SC(=O)C1=C1C=C(C)N(Cc2ccco2)C(C)=C1 nan
CHEMBL473106 179282 None 6 Human Functional pEC50 = 5.0 5.0 -1 3
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 346 3 0 5 4.0 CCN1C(=S)SC(=O)C1=C1C=C(C)N(Cc2ccco2)C(C)=C1 nan
CHEMBL1817769 209007 None 0 Human Functional pEC50 = 8.0 8.0 7 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819552 209024 None 0 Human Functional pEC50 = 8.0 8.0 3 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817762 209000 None 0 Human Functional pEC50 = 7.9 7.9 43 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
53362202 64619 None 0 Human Functional pEC50 = 7.9 7.9 5 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1007 18 13 16 -4.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NO)NC1=O 10.1021/jm200278m
CHEMBL1817691 64619 None 0 Human Functional pEC50 = 7.9 7.9 5 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1007 18 13 16 -4.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NO)NC1=O 10.1021/jm200278m
25161471 55037 None 15 Human Functional pEC50 = 5.0 5.0 1 2
PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 265 4 2 2 3.5 Oc1ccc(Cl)cc1CNCc1ccc(F)cc1 nan
CHEMBL1356933 55037 None 15 Human Functional pEC50 = 5.0 5.0 1 2
PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 265 4 2 2 3.5 Oc1ccc(Cl)cc1CNCc1ccc(F)cc1 nan
CHEMBL1616435 55037 None 15 Human Functional pEC50 = 5.0 5.0 1 2
PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 265 4 2 2 3.5 Oc1ccc(Cl)cc1CNCc1ccc(F)cc1 nan
53362202 64619 None 0 Human Functional pEC50 = 7.9 7.9 5 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1007 18 13 16 -4.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NO)NC1=O 10.1021/jm200278m
CHEMBL1817691 64619 None 0 Human Functional pEC50 = 7.9 7.9 5 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1007 18 13 16 -4.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NO)NC1=O 10.1021/jm200278m
CHEMBL1817762 209000 None 0 Human Functional pEC50 = 7.9 7.9 43 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817767 209005 None 0 Human Functional pEC50 = 7.9 7.9 10 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)C2(CCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817767 209005 None 0 Human Functional pEC50 = 7.9 7.9 10 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)C2(CCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819553 209025 None 0 Human Functional pEC50 = 7.9 7.9 19 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
5329098 98573 None 79 Human Functional pEC50 = 4.9 4.9 -1 3
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 238 1 2 1 3.1 Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1 nan
CHEMBL276711 98573 None 79 Human Functional pEC50 = 4.9 4.9 -1 3
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 238 1 2 1 3.1 Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1 nan
2919564 30200 None 18 Human Functional pEC50 = 4.9 4.9 1 2
PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 404 9 2 5 4.0 COc1ccc(CCNCC(O)Cn2c3ccccc3c3ccccc32)cc1OC nan
CHEMBL1390471 30200 None 18 Human Functional pEC50 = 4.9 4.9 1 2
PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 404 9 2 5 4.0 COc1ccc(CCNCC(O)Cn2c3ccccc3c3ccccc32)cc1OC nan
CHEMBL1819553 209025 None 0 Human Functional pEC50 = 7.9 7.9 19 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817763 209001 None 0 Human Functional pEC50 = 7.9 7.9 19 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817759 208997 None 0 Human Functional pEC50 = 7.9 7.9 31 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817763 209001 None 0 Human Functional pEC50 = 7.9 7.9 19 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817759 208997 None 0 Human Functional pEC50 = 7.8 7.8 31 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817760 208998 None 0 Human Functional pEC50 = 7.8 7.8 14 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817758 208996 None 0 Human Functional pEC50 = 7.8 7.8 63 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817760 208998 None 0 Human Functional pEC50 = 7.8 7.8 14 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817758 208996 None 0 Human Functional pEC50 = 7.8 7.8 63 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
1112934 56092 None 8 Human Functional pEC50 = 4.8 4.8 -1 3
PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 425 5 1 5 4.7 N=c1n(CC(=O)c2ccc(Br)s2)c2ccccc2n1Cc1ccccc1 nan
CHEMBL1587205 56092 None 8 Human Functional pEC50 = 4.8 4.8 -1 3
PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 425 5 1 5 4.7 N=c1n(CC(=O)c2ccc(Br)s2)c2ccccc2n1Cc1ccccc1 nan
CHEMBL1625302 56092 None 8 Human Functional pEC50 = 4.8 4.8 -1 3
PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 425 5 1 5 4.7 N=c1n(CC(=O)c2ccc(Br)s2)c2ccccc2n1Cc1ccccc1 nan
53362312 64626 None 0 Human Functional pEC50 = 7.8 7.8 3 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1051 20 14 17 -6.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NC(CO)CO)NC1=O 10.1021/jm200278m
CHEMBL1817699 64626 None 0 Human Functional pEC50 = 7.8 7.8 3 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1051 20 14 17 -6.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NC(CO)CO)NC1=O 10.1021/jm200278m
53362312 64626 None 0 Human Functional pEC50 = 7.8 7.8 3 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1051 20 14 17 -6.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NC(CO)CO)NC1=O 10.1021/jm200278m
CHEMBL1817699 64626 None 0 Human Functional pEC50 = 7.8 7.8 3 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1051 20 14 17 -6.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NC(CO)CO)NC1=O 10.1021/jm200278m
42601352 35401 None 0 Human Functional pEC50 = 4.8 4.8 1 2
PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 282 4 2 3 3.4 Oc1ccc(Cl)cc1CNCc1ccc(Cl)nc1 nan
CHEMBL1437791 35401 None 0 Human Functional pEC50 = 4.8 4.8 1 2
PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 282 4 2 3 3.4 Oc1ccc(Cl)cc1CNCc1ccc(Cl)nc1 nan
CHEMBL3211384 35401 None 0 Human Functional pEC50 = 4.8 4.8 1 2
PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 282 4 2 3 3.4 Oc1ccc(Cl)cc1CNCc1ccc(Cl)nc1 nan
CHEMBL1817671 208980 None 0 Human Functional pEC50 = 7.8 7.8 53 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817671 208980 None 0 Human Functional pEC50 = 7.7 7.7 53 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819547 209020 None 0 Human Functional pEC50 = 7.7 7.7 22 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cscn2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
6174589 107584 None 7 Human Functional pEC50 = 4.7 4.7 1 2
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 379 6 2 6 2.0 CCN(CC)c1ccc2cc(C(N)=O)/c(=N\NC(=O)c3ccncc3)oc2c1 nan
CHEMBL3189462 107584 None 7 Human Functional pEC50 = 4.7 4.7 1 2
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 379 6 2 6 2.0 CCN(CC)c1ccc2cc(C(N)=O)/c(=N\NC(=O)c3ccncc3)oc2c1 nan
CHEMBL1819547 209020 None 0 Human Functional pEC50 = 7.7 7.7 22 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cscn2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817749 208989 None 0 Rat Functional pEC50 = 8.7 8.7 1 3
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
53362311 64625 None 0 Human Functional pEC50 = 8.7 8.7 1 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1035 20 13 16 -5.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NCCCO)NC1=O 10.1021/jm200278m
CHEMBL1817698 64625 None 0 Human Functional pEC50 = 8.7 8.7 1 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1035 20 13 16 -5.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NCCCO)NC1=O 10.1021/jm200278m
CHEMBL1819555 209027 None 0 Rat Functional pEC50 = 8.7 8.7 -8 4
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
53362311 64625 None 0 Human Functional pEC50 = 8.7 8.7 1 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1035 20 13 16 -5.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NCCCO)NC1=O 10.1021/jm200278m
CHEMBL1817698 64625 None 0 Human Functional pEC50 = 8.7 8.7 1 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1035 20 13 16 -5.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NCCCO)NC1=O 10.1021/jm200278m
CHEMBL1819555 209027 None 0 Rat Functional pEC50 = 8.7 8.7 -8 4
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819550 209023 None 0 Human Functional pEC50 = 8.7 8.7 47 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819550 209023 None 0 Human Functional pEC50 = 8.7 8.7 47 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
11454 3575 None 11 Human Functional pEC50 = 8.6 8.6 -4 5
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
53330936 3575 None 11 Human Functional pEC50 = 8.6 8.6 -4 5
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
CHEMBL1817709 3575 None 11 Human Functional pEC50 = 8.6 8.6 -4 5
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
DB12495 3575 None 11 Human Functional pEC50 = 8.6 8.6 -4 5
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
CHEMBL1817753 208991 None 0 Human Functional pEC50 = 8.6 8.6 26 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
11454 3575 None 11 Human Functional pEC50 = 8.6 8.6 -4 5
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
53330936 3575 None 11 Human Functional pEC50 = 8.6 8.6 -4 5
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
CHEMBL1817709 3575 None 11 Human Functional pEC50 = 8.6 8.6 -4 5
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
DB12495 3575 None 11 Human Functional pEC50 = 8.6 8.6 -4 5
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
CHEMBL1817753 208991 None 0 Human Functional pEC50 = 8.6 8.6 26 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817756 208994 None 0 Human Functional pEC50 = 8.6 8.6 -4 5
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817756 208994 None 0 Human Functional pEC50 = 8.6 8.6 -4 5
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
53362548 64631 None 0 Human Functional pEC50 = 8.6 8.6 1 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 991 17 12 15 -4.8 CCNC(=O)C[C@@H]1NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817751 64631 None 0 Human Functional pEC50 = 8.6 8.6 1 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 991 17 12 15 -4.8 CCNC(=O)C[C@@H]1NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
53362548 64631 None 0 Human Functional pEC50 = 8.6 8.6 1 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 991 17 12 15 -4.8 CCNC(=O)C[C@@H]1NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817751 64631 None 0 Human Functional pEC50 = 8.6 8.6 1 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 991 17 12 15 -4.8 CCNC(=O)C[C@@H]1NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
53362311 64625 None 0 Rat Functional pEC50 = 8.6 8.6 -1 3
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1035 20 13 16 -5.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NCCCO)NC1=O 10.1021/jm200278m
CHEMBL1817698 64625 None 0 Rat Functional pEC50 = 8.6 8.6 -1 3
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1035 20 13 16 -5.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NCCCO)NC1=O 10.1021/jm200278m
53362311 64625 None 0 Rat Functional pEC50 = 8.6 8.6 -1 3
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1035 20 13 16 -5.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NCCCO)NC1=O 10.1021/jm200278m
CHEMBL1817698 64625 None 0 Rat Functional pEC50 = 8.6 8.6 -1 3
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1035 20 13 16 -5.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NCCCO)NC1=O 10.1021/jm200278m
CHEMBL1817749 208989 None 0 Human Functional pEC50 = 8.5 8.5 -1 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817749 208989 None 0 Human Functional pEC50 = 8.5 8.5 -1 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
53362154 64800 None 0 Human Functional pEC50 = 7.7 7.7 7 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1047 20 12 15 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NCC(C)C)NC1=O 10.1021/jm200278m
CHEMBL1819559 64800 None 0 Human Functional pEC50 = 7.7 7.7 7 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1047 20 12 15 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NCC(C)C)NC1=O 10.1021/jm200278m
3650228 55983 None 6 Human Functional pEC50 = 4.7 4.7 1 2
PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 402 5 2 3 5.1 COc1ccc(C2NCCc3c2[nH]c2ccccc32)cc1COc1ccc(F)cc1 nan
CHEMBL1549574 55983 None 6 Human Functional pEC50 = 4.7 4.7 1 2
PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 402 5 2 3 5.1 COc1ccc(C2NCCc3c2[nH]c2ccccc32)cc1COc1ccc(F)cc1 nan
CHEMBL1624349 55983 None 6 Human Functional pEC50 = 4.7 4.7 1 2
PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 402 5 2 3 5.1 COc1ccc(C2NCCc3c2[nH]c2ccccc32)cc1COc1ccc(F)cc1 nan
53362154 64800 None 0 Human Functional pEC50 = 7.7 7.7 7 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1047 20 12 15 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NCC(C)C)NC1=O 10.1021/jm200278m
CHEMBL1819559 64800 None 0 Human Functional pEC50 = 7.7 7.7 7 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1047 20 12 15 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NCC(C)C)NC1=O 10.1021/jm200278m
215028 55270 None 3 Human Functional pEC50 = 4.7 4.7 1 2
PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 330 1 1 3 4.0 Clc1ccc2c(c1)C(N1CCNCC1)Cc1ccccc1S2 nan
CHEMBL1339676 55270 None 3 Human Functional pEC50 = 4.7 4.7 1 2
PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 330 1 1 3 4.0 Clc1ccc2c(c1)C(N1CCNCC1)Cc1ccccc1S2 nan
CHEMBL1618211 55270 None 3 Human Functional pEC50 = 4.7 4.7 1 2
PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 330 1 1 3 4.0 Clc1ccc2c(c1)C(N1CCNCC1)Cc1ccccc1S2 nan
23983726 48845 None 2 Human Functional pEC50 = 5.6 5.6 1 2
PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 472 1 3 3 6.2 CC1(C)CC[C@@]2(C(=O)O)C(C1)C1=CCC3[C@@]4(C)CC[C@H](O)C(C)(C)C4CC[C@@]3(C)[C@]1(C)C[C@H]2O nan
CHEMBL1559201 48845 None 2 Human Functional pEC50 = 5.6 5.6 1 2
PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput dose response assay to identify agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 472 1 3 3 6.2 CC1(C)CC[C@@]2(C(=O)O)C(C1)C1=CCC3[C@@]4(C)CC[C@H](O)C(C)(C)C4CC[C@@]3(C)[C@]1(C)C[C@H]2O nan
2042 2981 None 58 Human Functional pEC50 = 6.6 6.6 -3 5
Agonist activity at human V1a receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human V1a receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
2174 2981 None 58 Human Functional pEC50 = 6.6 6.6 -3 5
Agonist activity at human V1a receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human V1a receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
2176 2981 None 58 Human Functional pEC50 = 6.6 6.6 -3 5
Agonist activity at human V1a receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human V1a receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
439302 2981 None 58 Human Functional pEC50 = 6.6 6.6 -3 5
Agonist activity at human V1a receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human V1a receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
CHEMBL395429 2981 None 58 Human Functional pEC50 = 6.6 6.6 -3 5
Agonist activity at human V1a receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human V1a receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
DB00107 2981 None 58 Human Functional pEC50 = 6.6 6.6 -3 5
Agonist activity at human V1a receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human V1a receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
CHEMBL1817703 208983 None 0 Human Functional pEC50 = 7.5 7.5 7 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819545 209018 None 0 Human Functional pEC50 = 7.5 7.5 6 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccnc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817771 209009 None 0 Human Functional pEC50 = 8.5 8.5 44 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817771 209009 None 0 Human Functional pEC50 = 8.5 8.5 44 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
53362204 64620 None 0 Human Functional pEC50 = 8.5 8.5 10 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 991 17 12 15 -4.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NC)NC1=O 10.1021/jm200278m
CHEMBL1817693 64620 None 0 Human Functional pEC50 = 8.5 8.5 10 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 991 17 12 15 -4.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NC)NC1=O 10.1021/jm200278m
53362204 64620 None 0 Human Functional pEC50 = 8.4 8.4 10 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 991 17 12 15 -4.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NC)NC1=O 10.1021/jm200278m
CHEMBL1817693 64620 None 0 Human Functional pEC50 = 8.4 8.4 10 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 991 17 12 15 -4.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NC)NC1=O 10.1021/jm200278m
53362547 64630 None 0 Human Functional pEC50 = 8.4 8.4 2 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 977 16 12 15 -5.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NC)NC1=O 10.1021/jm200278m
CHEMBL1817750 64630 None 0 Human Functional pEC50 = 8.4 8.4 2 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 977 16 12 15 -5.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NC)NC1=O 10.1021/jm200278m
53362547 64630 None 0 Human Functional pEC50 = 8.4 8.4 2 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 977 16 12 15 -5.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NC)NC1=O 10.1021/jm200278m
CHEMBL1817750 64630 None 0 Human Functional pEC50 = 8.4 8.4 2 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 977 16 12 15 -5.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NC)NC1=O 10.1021/jm200278m
CHEMBL1817703 208983 None 0 Human Functional pEC50 = 7.5 7.5 7 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819545 209018 None 0 Human Functional pEC50 = 7.5 7.5 6 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccnc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
53363017 64799 None 0 Human Functional pEC50 = 7.4 7.4 2 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1019 19 12 15 -4.0 CCNC(=O)CC[C@@H]1NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819558 64799 None 0 Human Functional pEC50 = 7.4 7.4 2 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1019 19 12 15 -4.0 CCNC(=O)CC[C@@H]1NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
53363017 64799 None 0 Human Functional pEC50 = 7.4 7.4 2 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1019 19 12 15 -4.0 CCNC(=O)CC[C@@H]1NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819558 64799 None 0 Human Functional pEC50 = 7.4 7.4 2 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1019 19 12 15 -4.0 CCNC(=O)CC[C@@H]1NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
53362259 64623 None 0 Human Functional pEC50 = 8.4 8.4 13 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 993 17 13 16 -5.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NO)NC1=O 10.1021/jm200278m
CHEMBL1817696 64623 None 0 Human Functional pEC50 = 8.4 8.4 13 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 993 17 13 16 -5.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NO)NC1=O 10.1021/jm200278m
53362259 64623 None 0 Human Functional pEC50 = 8.4 8.4 13 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 993 17 13 16 -5.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NO)NC1=O 10.1021/jm200278m
CHEMBL1817696 64623 None 0 Human Functional pEC50 = 8.4 8.4 13 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 993 17 13 16 -5.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NO)NC1=O 10.1021/jm200278m
CHEMBL1819554 209026 None 0 Rat Functional pEC50 = 8.4 8.4 -5 4
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819554 209026 None 0 Rat Functional pEC50 = 8.4 8.4 -5 4
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
53362369 64629 None 0 Human Functional pEC50 = 8.3 8.3 8 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1065 22 13 17 -5.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NCCOCCO)NC1=O 10.1021/jm200278m
CHEMBL1817701 64629 None 0 Human Functional pEC50 = 8.3 8.3 8 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1065 22 13 17 -5.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NCCOCCO)NC1=O 10.1021/jm200278m
53362548 64631 None 0 Rat Functional pEC50 = 8.3 8.3 -1 4
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 991 17 12 15 -4.8 CCNC(=O)C[C@@H]1NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817751 64631 None 0 Rat Functional pEC50 = 8.3 8.3 -1 4
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 991 17 12 15 -4.8 CCNC(=O)C[C@@H]1NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
53362369 64629 None 0 Human Functional pEC50 = 8.3 8.3 8 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1065 22 13 17 -5.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NCCOCCO)NC1=O 10.1021/jm200278m
CHEMBL1817701 64629 None 0 Human Functional pEC50 = 8.3 8.3 8 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1065 22 13 17 -5.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NCCOCCO)NC1=O 10.1021/jm200278m
53362548 64631 None 0 Rat Functional pEC50 = 8.3 8.3 -1 4
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 991 17 12 15 -4.8 CCNC(=O)C[C@@H]1NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817751 64631 None 0 Rat Functional pEC50 = 8.3 8.3 -1 4
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 991 17 12 15 -4.8 CCNC(=O)C[C@@H]1NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
449224 168973 None 12 Human Functional pEC50 = 7.4 7.4 -208 4
Agonist activity at vasopressin 1a receptor (unknown origin)Agonist activity at vasopressin 1a receptor (unknown origin)
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL439044 168973 None 12 Human Functional pEC50 = 7.4 7.4 -208 4
Agonist activity at vasopressin 1a receptor (unknown origin)Agonist activity at vasopressin 1a receptor (unknown origin)
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
3385342 40144 None 6 Human Functional pEC50 = 5.3 5.3 - 1
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 384 6 2 5 3.2 CC(NC(=O)Nc1ccc([N+](=O)[O-])cc1)C(c1ccccc1)N1CCOCC1 nan
CHEMBL1479813 40144 None 6 Human Functional pEC50 = 5.3 5.3 - 1
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 384 6 2 5 3.2 CC(NC(=O)Nc1ccc([N+](=O)[O-])cc1)C(c1ccccc1)N1CCOCC1 nan
2871994 41687 None 15 Human Functional pEC50 = 5.3 5.3 - 1
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 324 3 1 4 2.4 O=C1c2cccc3c(N4CCCCC4)ccc(c23)C(=O)N1CCO nan
CHEMBL1492232 41687 None 15 Human Functional pEC50 = 5.3 5.3 - 1
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 324 3 1 4 2.4 O=C1c2cccc3c(N4CCCCC4)ccc(c23)C(=O)N1CCO nan
53362368 64628 None 0 Human Functional pEC50 = 8.3 8.3 5 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1035 19 13 16 -5.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NCC(C)O)NC1=O 10.1021/jm200278m
CHEMBL1817700 64628 None 0 Human Functional pEC50 = 8.3 8.3 5 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1035 19 13 16 -5.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NCC(C)O)NC1=O 10.1021/jm200278m
53362368 64628 None 0 Human Functional pEC50 = 8.3 8.3 5 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1035 19 13 16 -5.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NCC(C)O)NC1=O 10.1021/jm200278m
CHEMBL1817700 64628 None 0 Human Functional pEC50 = 8.3 8.3 5 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1035 19 13 16 -5.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NCC(C)O)NC1=O 10.1021/jm200278m
53362257 64621 None 0 Human Functional pEC50 = 8.2 8.2 5 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1005 18 12 15 -4.4 CCNC(=O)C[C@@H]1NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817694 64621 None 0 Human Functional pEC50 = 8.2 8.2 5 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1005 18 12 15 -4.4 CCNC(=O)C[C@@H]1NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
53362257 64621 None 0 Human Functional pEC50 = 8.2 8.2 5 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1005 18 12 15 -4.4 CCNC(=O)C[C@@H]1NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817694 64621 None 0 Human Functional pEC50 = 8.2 8.2 5 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1005 18 12 15 -4.4 CCNC(=O)C[C@@H]1NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819544 209017 None 0 Human Functional pEC50 = 6.3 6.3 - 1
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819544 209017 None 0 Human Functional pEC50 = 6.3 6.3 - 1
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817770 209008 None 0 Rat Functional pEC50 = 7.2 7.2 -40 4
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817770 209008 None 0 Rat Functional pEC50 = 7.2 7.2 -40 4
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
53363016 64798 None 0 Human Functional pEC50 = 8.2 8.2 9 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1005 18 12 15 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NC)NC1=O 10.1021/jm200278m
CHEMBL1819557 64798 None 0 Human Functional pEC50 = 8.2 8.2 9 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1005 18 12 15 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NC)NC1=O 10.1021/jm200278m
53363016 64798 None 0 Human Functional pEC50 = 8.2 8.2 9 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1005 18 12 15 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NC)NC1=O 10.1021/jm200278m
CHEMBL1819557 64798 None 0 Human Functional pEC50 = 8.2 8.2 9 4
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1005 18 12 15 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NC)NC1=O 10.1021/jm200278m
3484134 51752 None 6 Human Functional pEC50 = 5.2 5.2 - 1
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 407 5 2 3 4.6 CC(NC(=O)Nc1ccc(Cl)c(Cl)c1)C(c1ccccc1)N1CCOCC1 nan
CHEMBL1584768 51752 None 6 Human Functional pEC50 = 5.2 5.2 - 1
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 407 5 2 3 4.6 CC(NC(=O)Nc1ccc(Cl)c(Cl)c1)C(c1ccccc1)N1CCOCC1 nan
1471100 24415 None 15 Human Functional pEC50 = 5.2 5.2 - 1
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 350 1 1 4 3.7 O=c1c2cc(Br)ccc2nc(-c2cccc(Cl)c2)n1O nan
CHEMBL1341433 24415 None 15 Human Functional pEC50 = 5.2 5.2 - 1
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 350 1 1 4 3.7 O=c1c2cc(Br)ccc2nc(-c2cccc(Cl)c2)n1O nan
53362156 64618 None 0 Human Functional pEC50 = 7.2 7.2 7 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1035 19 11 16 -4.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)N(C)OC)NC1=O 10.1021/jm200278m
CHEMBL1817690 64618 None 0 Human Functional pEC50 = 7.2 7.2 7 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1035 19 11 16 -4.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)N(C)OC)NC1=O 10.1021/jm200278m
53362156 64618 None 0 Human Functional pEC50 = 7.2 7.2 7 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1035 19 11 16 -4.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)N(C)OC)NC1=O 10.1021/jm200278m
CHEMBL1817690 64618 None 0 Human Functional pEC50 = 7.2 7.2 7 3
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1035 19 11 16 -4.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)N(C)OC)NC1=O 10.1021/jm200278m
CHEMBL1817764 209002 None 0 Human Functional pEC50 = 8.1 8.1 47 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccsc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817764 209002 None 0 Human Functional pEC50 = 8.1 8.1 47 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccsc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817765 209003 None 0 Human Functional pEC50 = 8.1 8.1 51 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccsc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817765 209003 None 0 Human Functional pEC50 = 8.1 8.1 51 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccsc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817768 209006 None 0 Human Functional pEC50 = 8.1 8.1 15 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
2042 2981 None 58 Human Functional pEC50 = 8.1 8.1 -3 5
Agonist activity at vasopressin 1a receptor (unknown origin)Agonist activity at vasopressin 1a receptor (unknown origin)
ChEMBL None None None None 10.1016/j.bmcl.2017.12.027
2174 2981 None 58 Human Functional pEC50 = 8.1 8.1 -3 5
Agonist activity at vasopressin 1a receptor (unknown origin)Agonist activity at vasopressin 1a receptor (unknown origin)
ChEMBL None None None None 10.1016/j.bmcl.2017.12.027
2176 2981 None 58 Human Functional pEC50 = 8.1 8.1 -3 5
Agonist activity at vasopressin 1a receptor (unknown origin)Agonist activity at vasopressin 1a receptor (unknown origin)
ChEMBL None None None None 10.1016/j.bmcl.2017.12.027
439302 2981 None 58 Human Functional pEC50 = 8.1 8.1 -3 5
Agonist activity at vasopressin 1a receptor (unknown origin)Agonist activity at vasopressin 1a receptor (unknown origin)
ChEMBL None None None None 10.1016/j.bmcl.2017.12.027
CHEMBL395429 2981 None 58 Human Functional pEC50 = 8.1 8.1 -3 5
Agonist activity at vasopressin 1a receptor (unknown origin)Agonist activity at vasopressin 1a receptor (unknown origin)
ChEMBL None None None None 10.1016/j.bmcl.2017.12.027
DB00107 2981 None 58 Human Functional pEC50 = 8.1 8.1 -3 5
Agonist activity at vasopressin 1a receptor (unknown origin)Agonist activity at vasopressin 1a receptor (unknown origin)
ChEMBL None None None None 10.1016/j.bmcl.2017.12.027
CHEMBL1817768 209006 None 0 Human Functional pEC50 = 8.1 8.1 15 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC2CCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817766 209004 None 0 Human Functional pEC50 = 8.1 8.1 13 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)C2(CCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
53362310 64624 None 0 Human Functional pEC50 = 8.1 8.1 3 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1021 19 13 16 -5.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NCCO)NC1=O 10.1021/jm200278m
CHEMBL1817697 64624 None 0 Human Functional pEC50 = 8.1 8.1 3 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1021 19 13 16 -5.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NCCO)NC1=O 10.1021/jm200278m
CHEMBL1817766 209004 None 0 Human Functional pEC50 = 8.1 8.1 13 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)C2(CCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817754 208992 None 0 Rat Functional pEC50 = 8.1 8.1 -7 3
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CCNCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
53362310 64624 None 0 Human Functional pEC50 = 8.1 8.1 3 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1021 19 13 16 -5.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NCCO)NC1=O 10.1021/jm200278m
CHEMBL1817697 64624 None 0 Human Functional pEC50 = 8.1 8.1 3 2
Agonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant human vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL 1021 19 13 16 -5.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)NCCO)NC1=O 10.1021/jm200278m
CHEMBL1817754 208992 None 0 Rat Functional pEC50 = 8.1 8.1 -7 3
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CCNCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1817692 208981 None 0 Rat Functional pEC50 = 8.1 8.1 -5 3
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817692 208981 None 0 Rat Functional pEC50 = 8.1 8.1 -5 3
Agonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assayAgonist activity at recombinant rat vasopressin V1a receptor expressed in HEK293 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
25163004 72915 None 0 Human Functional pEC50 = 5.1 5.1 - 1
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 1317 54 6 22 6.4 C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)CCCCCCCCCCNC(=O)[C@H](CCCCN)n3cc(C[C@@H](C)CC)nn3)CC2)nc(N2CCN(C(=O)CCCCCCCCCCNC(=O)[C@@H](CCC(=O)O)n3cc(CCCCCN)nn3)CC2)n1 nan
CHEMBL2004487 72915 None 0 Human Functional pEC50 = 5.1 5.1 - 1
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response screening assay for agonists of the vasopressin 1 receptor (V1R). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 1317 54 6 22 6.4 C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)CCCCCCCCCCNC(=O)[C@H](CCCCN)n3cc(C[C@@H](C)CC)nn3)CC2)nc(N2CCN(C(=O)CCCCCCCCCCNC(=O)[C@@H](CCC(=O)O)n3cc(CCCCCN)nn3)CC2)n1 nan
2042 2981 None 58 Human Functional pEC50 = 8.1 8.1 -3 5
Agonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
2174 2981 None 58 Human Functional pEC50 = 8.1 8.1 -3 5
Agonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
2176 2981 None 58 Human Functional pEC50 = 8.1 8.1 -3 5
Agonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
439302 2981 None 58 Human Functional pEC50 = 8.1 8.1 -3 5
Agonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
CHEMBL395429 2981 None 58 Human Functional pEC50 = 8.1 8.1 -3 5
Agonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
DB00107 2981 None 58 Human Functional pEC50 = 8.1 8.1 -3 5
Agonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
9935206 66060 None 0 Human Functional pIC50 = 9.3 9.3 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 487 4 0 7 2.8 CN(C)S(=O)(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CCN(c3ccccn3)CC2)C1 10.1016/j.bmcl.2011.08.038
CHEMBL1837039 66060 None 0 Human Functional pIC50 = 9.3 9.3 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 487 4 0 7 2.8 CN(C)S(=O)(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CCN(c3ccccn3)CC2)C1 10.1016/j.bmcl.2011.08.038
162676461 183510 None 0 Human Functional pIC50 = 9 9.0 - 1
Inhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate readerInhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate reader
ChEMBL 394 3 0 5 4.9 Clc1ccc2c(c1)CCCc1nnc([C@H]3CC[C@H](Oc4ccccn4)CC3)n1-2 10.1021/acs.jmedchem.1c00863
CHEMBL4799793 183510 None 0 Human Functional pIC50 = 9 9.0 - 1
Inhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate readerInhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate reader
ChEMBL 394 3 0 5 4.9 Clc1ccc2c(c1)CCCc1nnc([C@H]3CC[C@H](Oc4ccccn4)CC3)n1-2 10.1021/acs.jmedchem.1c00863
162676461 183510 None 0 Human Functional pIC50 = 9 9.0 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 394 3 0 5 4.9 Clc1ccc2c(c1)CCCc1nnc([C@H]3CC[C@H](Oc4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
CHEMBL4799793 183510 None 0 Human Functional pIC50 = 9 9.0 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 394 3 0 5 4.9 Clc1ccc2c(c1)CCCc1nnc([C@H]3CC[C@H](Oc4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
CHEMBL5070261 214227 None 0 Human Functional pIC50 = 9.0 9.0 - 1
Inhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate readerInhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate reader
ChEMBL None None None OC1Cc2cc(Cl)ccc2-n2c(nnc2[C@H]2CC[C@H](Oc3ccccn3)CC2)C1 10.1021/acs.jmedchem.1c00863
CHEMBL5074709 214325 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Inhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate readerInhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate reader
ChEMBL None None None O[C@H]1Cc2cc(Cl)ccc2-n2c(nnc2[C@H]2CC[C@H](Oc3ccccn3)CC2)C1 10.1021/acs.jmedchem.1c00863
10456892 66063 None 0 Human Functional pIC50 = 8.9 8.9 74 2
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 458 3 0 7 3.0 CS(=O)(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CCN(c3ccccn3)CC2)C1 10.1016/j.bmcl.2011.08.038
CHEMBL1837041 66063 None 0 Human Functional pIC50 = 8.9 8.9 74 2
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 458 3 0 7 3.0 CS(=O)(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CCN(c3ccccn3)CC2)C1 10.1016/j.bmcl.2011.08.038
162676448 183481 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 438 3 0 5 5.0 Brc1ccc2c(c1)CCCc1nnc([C@H]3CC[C@H](Oc4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
CHEMBL4799412 183481 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 438 3 0 5 5.0 Brc1ccc2c(c1)CCCc1nnc([C@H]3CC[C@H](Oc4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
162655262 180744 None 0 Human Functional pIC50 = 8.8 8.8 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 426 2 0 5 5.3 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccc(Br)cc3CCC4)CC2)no1 10.1016/j.bmcl.2020.127417
CHEMBL4756031 180744 None 0 Human Functional pIC50 = 8.8 8.8 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 426 2 0 5 5.3 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccc(Br)cc3CCC4)CC2)no1 10.1016/j.bmcl.2020.127417
CHEMBL5070075 214224 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Inhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate readerInhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate reader
ChEMBL None None None O[C@@H]1Cc2cc(Cl)ccc2-n2c(nnc2[C@H]2CC[C@H](Oc3ccccn3)CC2)C1 10.1021/acs.jmedchem.1c00863
CHEMBL5081323 214741 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Inhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate readerInhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate reader
ChEMBL None None None Cc1ccc2c(c1)CC(O)Cc1nnc([C@H]3CC[C@H](Oc4ccccn4)CC3)n1-2 10.1021/acs.jmedchem.1c00863
162669344 182684 None 0 Human Functional pIC50 = 8 8.0 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 438 2 0 3 4.1 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)C3CC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4789306 182684 None 0 Human Functional pIC50 = 8 8.0 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 438 2 0 3 4.1 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)C3CC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
10444 2324 None 14 Human Functional pIC50 = 7 7.0 -61 4
Antagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVPAntagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVP
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
139030525 2324 None 14 Human Functional pIC50 = 7 7.0 -61 4
Antagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVPAntagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVP
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
145711714 2324 None 14 Human Functional pIC50 = 7 7.0 -61 4
Antagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVPAntagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVP
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4204210 2324 None 14 Human Functional pIC50 = 7 7.0 -61 4
Antagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVPAntagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVP
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
162649115 179867 None 0 Human Functional pIC50 = 7 7.0 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 368 2 0 5 4.8 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccc(Cl)cc3CC4)CC2)no1 10.1016/j.bmcl.2020.127417
CHEMBL4745524 179867 None 0 Human Functional pIC50 = 7 7.0 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 368 2 0 5 4.8 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccc(Cl)cc3CC4)CC2)no1 10.1016/j.bmcl.2020.127417
162668040 182516 None 0 Human Functional pIC50 = 6 6.0 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 371 1 1 4 3.3 C[C@H]1CN(C(=O)N2CCNc3cc(Cl)ccc32)CCN1c1ccccn1 10.1016/j.bmcl.2020.127416
CHEMBL4787124 182516 None 0 Human Functional pIC50 = 6 6.0 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 371 1 1 4 3.3 C[C@H]1CN(C(=O)N2CCNc3cc(Cl)ccc32)CCN1c1ccccn1 10.1016/j.bmcl.2020.127416
135192889 174047 None 0 Human Functional pIC50 = 5.0 5.0 -25 2
Antagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assayAntagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assay
ChEMBL 425 5 0 6 4.1 COc1ccc(-n2c(C3CC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
CHEMBL4543809 174047 None 0 Human Functional pIC50 = 5.0 5.0 -25 2
Antagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assayAntagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assay
ChEMBL 425 5 0 6 4.1 COc1ccc(-n2c(C3CC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
162658180 181059 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 466 2 0 3 4.9 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)C3CCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4759676 181059 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 466 2 0 3 4.9 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)C3CCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
162662884 181910 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 440 2 0 3 4.4 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)C(C)C)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4779447 181910 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 440 2 0 3 4.4 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)C(C)C)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
11326488 66056 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 380 2 1 6 3.3 Clc1ccc2c(c1)CNCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2011.08.038
CHEMBL1837035 66056 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 380 2 1 6 3.3 Clc1ccc2c(c1)CNCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2011.08.038
145965794 164371 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVPAntagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVP
ChEMBL 462 5 3 7 2.6 COC(=O)CNC(=O)NCc1ccc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)cc1C 10.1021/acs.jmedchem.8b00697
CHEMBL4212928 164371 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVPAntagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVP
ChEMBL 462 5 3 7 2.6 COC(=O)CNC(=O)NCc1ccc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)cc1C 10.1021/acs.jmedchem.8b00697
137212772 137938 None 0 Human Functional pIC50 = 6.0 6.0 3 2
Antagonist activity at human vasopressin 1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assayAntagonist activity at human vasopressin 1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assay
ChEMBL 609 7 2 8 4.7 COc1cc(CN2CCN(C(=O)NCc3ccc(C(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3C)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
CHEMBL3763951 137938 None 0 Human Functional pIC50 = 6.0 6.0 3 2
Antagonist activity at human vasopressin 1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assayAntagonist activity at human vasopressin 1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assay
ChEMBL 609 7 2 8 4.7 COc1cc(CN2CCN(C(=O)NCc3ccc(C(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3C)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
137212772 137938 None 0 Human Functional pIC50 = 6.0 6.0 3 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin-induced IP1 accumulation preincubated for 30 mins followed by vasopressin addition measured after 1 hr by HTRF assayAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin-induced IP1 accumulation preincubated for 30 mins followed by vasopressin addition measured after 1 hr by HTRF assay
ChEMBL 609 7 2 8 4.7 COc1cc(CN2CCN(C(=O)NCc3ccc(C(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3C)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
CHEMBL3763951 137938 None 0 Human Functional pIC50 = 6.0 6.0 3 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin-induced IP1 accumulation preincubated for 30 mins followed by vasopressin addition measured after 1 hr by HTRF assayAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin-induced IP1 accumulation preincubated for 30 mins followed by vasopressin addition measured after 1 hr by HTRF assay
ChEMBL 609 7 2 8 4.7 COc1cc(CN2CCN(C(=O)NCc3ccc(C(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3C)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
23598597 94095 None 0 Human Functional pIC50 = 4.9 4.9 -91 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 528 5 2 4 5.8 COc1cc(NC(=O)c2cc(F)ccc2C)ccc1C(=O)N1CCC2(C=C(C(=O)O)CC2)Cc2ccccc21 10.1016/j.bmcl.2007.09.059
CHEMBL249133 94095 None 0 Human Functional pIC50 = 4.9 4.9 -91 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 528 5 2 4 5.8 COc1cc(NC(=O)c2cc(F)ccc2C)ccc1C(=O)N1CCC2(C=C(C(=O)O)CC2)Cc2ccccc21 10.1016/j.bmcl.2007.09.059
10359487 66039 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 333 4 0 5 3.4 Cc1nnc(C2CCN(c3ccccn3)CC2)n1Cc1ccccc1 10.1016/j.bmcl.2011.08.038
CHEMBL1837018 66039 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 333 4 0 5 3.4 Cc1nnc(C2CCN(c3ccccn3)CC2)n1Cc1ccccc1 10.1016/j.bmcl.2011.08.038
162661138 181507 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 345 2 0 5 3.5 c1ccc(N2CCC(c3nnc4n3-c3ccccc3CCC4)CC2)nc1 10.1016/j.bmcl.2020.127417
CHEMBL4764976 181507 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 345 2 0 5 3.5 c1ccc(N2CCC(c3nnc4n3-c3ccccc3CCC4)CC2)nc1 10.1016/j.bmcl.2020.127417
9829108 5234 None 1 Human Functional pIC50 = 6.9 6.9 - 1
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 554 7 2 4 5.1 CN(C)CCNC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL106293 5234 None 1 Human Functional pIC50 = 6.9 6.9 - 1
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 554 7 2 4 5.1 CN(C)CCNC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
2200 3309 None 46 Human Functional pIC50 = 7.9 7.9 1548 2
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1016/j.bmcl.2011.08.038
3482 3309 None 46 Human Functional pIC50 = 7.9 7.9 1548 2
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1016/j.bmcl.2011.08.038
60943 3309 None 46 Human Functional pIC50 = 7.9 7.9 1548 2
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1016/j.bmcl.2011.08.038
CHEMBL419667 3309 None 46 Human Functional pIC50 = 7.9 7.9 1548 2
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1016/j.bmcl.2011.08.038
DB13929 3309 None 46 Human Functional pIC50 = 7.9 7.9 1548 2
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1016/j.bmcl.2011.08.038
162648487 179961 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 423 2 0 5 4.3 Brc1ccc2c(c1)CCCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
CHEMBL4746716 179961 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 423 2 0 5 4.3 Brc1ccc2c(c1)CCCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
23598619 94537 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 498 4 1 4 5.6 COC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
CHEMBL251771 94537 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 498 4 1 4 5.6 COC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
11337030 66033 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 349 4 0 6 3.4 COc1ccc(-n2c(C)nnc2C2CCN(c3ccccn3)CC2)cc1 10.1016/j.bmcl.2011.08.038
CHEMBL1837012 66033 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 349 4 0 6 3.4 COc1ccc(-n2c(C)nnc2C2CCN(c3ccccn3)CC2)cc1 10.1016/j.bmcl.2011.08.038
21064040 66051 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 377 3 0 7 3.1 COc1ccc2c(c1)COCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2011.08.038
CHEMBL1837030 66051 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 377 3 0 7 3.1 COc1ccc2c(c1)COCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2011.08.038
162661774 181403 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 439 3 0 3 4.1 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C(C)C)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4763639 181403 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 439 3 0 3 4.1 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C(C)C)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
44336418 108185 None 0 Human Functional pIC50 = 6.9 6.9 2 2
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 569 6 2 5 5.0 COC(=O)CNC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3cc(F)ccc3C)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL319636 108185 None 0 Human Functional pIC50 = 6.9 6.9 2 2
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 569 6 2 5 5.0 COC(=O)CNC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3cc(F)ccc3C)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
145961670 161362 None 0 Human Functional pIC50 = 7.9 7.9 123 4
Antagonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by AVP addition measured for 5 mins by Fluo-4-AM dye based FLIPR assayAntagonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by AVP addition measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1139 19 14 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccccc2CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL4126100 161362 None 0 Human Functional pIC50 = 7.9 7.9 123 4
Antagonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by AVP addition measured for 5 mins by Fluo-4-AM dye based FLIPR assayAntagonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by AVP addition measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1139 19 14 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccccc2CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
162646538 179604 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 412 1 0 3 3.8 CC(=O)N1CCN(C(=O)N2CCN(c3ccccc3C)CC2)c2ccc(Cl)cc21 10.1016/j.bmcl.2020.127416
CHEMBL4742335 179604 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 412 1 0 3 3.8 CC(=O)N1CCN(C(=O)N2CCN(c3ccccc3C)CC2)c2ccc(Cl)cc21 10.1016/j.bmcl.2020.127416
162656367 180888 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 370 1 1 3 3.8 Cc1ccccc1N1CCN(C(=O)N2CCNc3ccc(Cl)cc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4757593 180888 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 370 1 1 3 3.8 Cc1ccccc1N1CCN(C(=O)N2CCNc3ccc(Cl)cc32)CC1 10.1016/j.bmcl.2020.127416
162660975 181855 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 365 2 0 5 3.8 Clc1ccc2c(c1)CCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
CHEMBL4778700 181855 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 365 2 0 5 3.8 Clc1ccc2c(c1)CCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
56672569 66042 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 347 4 0 5 3.7 Cc1ccc(Cn2c(C)nnc2C2CCN(c3ccccn3)CC2)cc1 10.1016/j.bmcl.2011.08.038
CHEMBL1837021 66042 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 347 4 0 5 3.7 Cc1ccc(Cn2c(C)nnc2C2CCN(c3ccccn3)CC2)cc1 10.1016/j.bmcl.2011.08.038
44352783 116779 None 0 Human Functional pIC50 = 6.8 6.8 -4 2
Inhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cellsInhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cells
ChEMBL 508 6 2 4 6.5 O=C(Nc1ccc(C(=O)N2CCC(CCO)Sc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2003.08.051
CHEMBL337725 116779 None 0 Human Functional pIC50 = 6.8 6.8 -4 2
Inhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cellsInhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cells
ChEMBL 508 6 2 4 6.5 O=C(Nc1ccc(C(=O)N2CCC(CCO)Sc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2003.08.051
44336403 5380 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 580 7 2 4 5.6 O=C(NCCN1CCCC1)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL107058 5380 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 580 7 2 4 5.6 O=C(NCCN1CCCC1)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
3537 4002 None 22 Human Functional pIC50 = 5.8 5.8 -57 4
Antagonist activity at V1A receptor (unknown origin) by cAMP accumulation assayAntagonist activity at V1A receptor (unknown origin) by cAMP accumulation assay
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
5311500 4002 None 22 Human Functional pIC50 = 5.8 5.8 -57 4
Antagonist activity at V1A receptor (unknown origin) by cAMP accumulation assayAntagonist activity at V1A receptor (unknown origin) by cAMP accumulation assay
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
CHEMBL363910 4002 None 22 Human Functional pIC50 = 5.8 5.8 -57 4
Antagonist activity at V1A receptor (unknown origin) by cAMP accumulation assayAntagonist activity at V1A receptor (unknown origin) by cAMP accumulation assay
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
11740204 66043 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 375 7 0 5 4.4 CCCCc1nnc(C2CCN(c3ccccn3)CC2)n1Cc1ccccc1 10.1016/j.bmcl.2011.08.038
CHEMBL1837022 66043 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 375 7 0 5 4.4 CCCCc1nnc(C2CCN(c3ccccn3)CC2)n1Cc1ccccc1 10.1016/j.bmcl.2011.08.038
21925639 66052 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 381 2 0 6 3.7 Clc1ccc2c(c1)COCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2011.08.038
CHEMBL1837031 66052 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 381 2 0 6 3.7 Clc1ccc2c(c1)COCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2011.08.038
162647212 179699 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 391 1 1 4 3.6 O=C(N1CCN(c2ncccc2Cl)CC1)N1CCNc2cc(Cl)ccc21 10.1016/j.bmcl.2020.127416
CHEMBL4743785 179699 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 391 1 1 4 3.6 O=C(N1CCN(c2ncccc2Cl)CC1)N1CCNc2cc(Cl)ccc21 10.1016/j.bmcl.2020.127416
135192932 171526 None 0 Human Functional pIC50 = 5.8 5.8 -190 4
Antagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assayAntagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assay
ChEMBL 443 7 0 7 3.8 CCOCc1nnc(N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4464246 171526 None 0 Human Functional pIC50 = 5.8 5.8 -190 4
Antagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assayAntagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assay
ChEMBL 443 7 0 7 3.8 CCOCc1nnc(N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
9828129 116619 None 0 Human Functional pIC50 = 5.8 5.8 -91 2
Inhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cellsInhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cells
ChEMBL 522 6 2 4 6.6 O=C(O)C[C@@H]1CCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc2S1 10.1016/j.bmcl.2003.08.051
CHEMBL336825 116619 None 0 Human Functional pIC50 = 5.8 5.8 -91 2
Inhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cellsInhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cells
ChEMBL 522 6 2 4 6.6 O=C(O)C[C@@H]1CCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc2S1 10.1016/j.bmcl.2003.08.051
10318802 66048 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 400 6 0 8 2.7 c1ccc(Cn2c(Cn3nccn3)nnc2C2CCN(c3ccccn3)CC2)cc1 10.1016/j.bmcl.2011.08.038
CHEMBL1837027 66048 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 400 6 0 8 2.7 c1ccc(Cn2c(Cn3nccn3)nnc2C2CCN(c3ccccn3)CC2)cc1 10.1016/j.bmcl.2011.08.038
162646888 179557 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 437 3 0 3 3.8 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4741743 179557 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 437 3 0 3 3.8 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
142391805 173975 None 0 Human Functional pIC50 = 5.7 5.7 -35 2
Antagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assayAntagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assay
ChEMBL 435 5 0 6 4.2 COc1ccc(-n2c(C(F)F)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
CHEMBL4541860 173975 None 0 Human Functional pIC50 = 5.7 5.7 -35 2
Antagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assayAntagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assay
ChEMBL 435 5 0 6 4.2 COc1ccc(-n2c(C(F)F)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
145976595 163713 None 0 Human Functional pIC50 = 7.7 7.7 -2 3
Antagonist activity at human V1A receptor expressed in human HeLa cells assessed as inhibition of AVP-induced cAMP accumulation incubated for 10 mins by radioimmunoassayAntagonist activity at human V1A receptor expressed in human HeLa cells assessed as inhibition of AVP-induced cAMP accumulation incubated for 10 mins by radioimmunoassay
ChEMBL 408 2 1 4 4.9 Cc1ccn(C(=O)Nc2ccc(C(=O)N3CCCCc4ccccc43)c(Cl)c2)n1 10.1021/acs.jmedchem.8b00697
CHEMBL4205046 163713 None 0 Human Functional pIC50 = 7.7 7.7 -2 3
Antagonist activity at human V1A receptor expressed in human HeLa cells assessed as inhibition of AVP-induced cAMP accumulation incubated for 10 mins by radioimmunoassayAntagonist activity at human V1A receptor expressed in human HeLa cells assessed as inhibition of AVP-induced cAMP accumulation incubated for 10 mins by radioimmunoassay
ChEMBL 408 2 1 4 4.9 Cc1ccn(C(=O)Nc2ccc(C(=O)N3CCCCc4ccccc43)c(Cl)c2)n1 10.1021/acs.jmedchem.8b00697
44444761 94163 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 532 4 1 4 6.2 COC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3cc(F)ccc3Cl)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
CHEMBL249536 94163 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 532 4 1 4 6.2 COC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3cc(F)ccc3Cl)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
135192895 173984 None 0 Human Functional pIC50 = 5.7 5.7 -8 2
Antagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assayAntagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assay
ChEMBL 485 7 0 8 3.5 COc1ccc(-n2c(CO[C@@H]3CCOC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
CHEMBL4542267 173984 None 0 Human Functional pIC50 = 5.7 5.7 -8 2
Antagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assayAntagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assay
ChEMBL 485 7 0 8 3.5 COc1ccc(-n2c(CO[C@@H]3CCOC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
11473073 66034 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 333 3 0 5 3.7 Cc1ccccc1-n1c(C)nnc1C1CCN(c2ccccn2)CC1 10.1016/j.bmcl.2011.08.038
CHEMBL1837013 66034 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 333 3 0 5 3.7 Cc1ccccc1-n1c(C)nnc1C1CCN(c2ccccn2)CC1 10.1016/j.bmcl.2011.08.038
59657596 118664 None 31 Human Functional pIC50 = 8.7 8.7 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 437 4 0 4 4.5 CN(C)CCn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1016/j.bmcl.2020.127416
CHEMBL3416885 118664 None 31 Human Functional pIC50 = 8.7 8.7 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 437 4 0 4 4.5 CN(C)CCn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1016/j.bmcl.2020.127416
59657596 118664 None 31 Human Functional pIC50 = 8.7 8.7 - 1
Inhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate readerInhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate reader
ChEMBL 437 4 0 4 4.5 CN(C)CCn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1021/acs.jmedchem.1c00863
CHEMBL3416885 118664 None 31 Human Functional pIC50 = 8.7 8.7 - 1
Inhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate readerInhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate reader
ChEMBL 437 4 0 4 4.5 CN(C)CCn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1021/acs.jmedchem.1c00863
162655215 180807 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 382 2 0 5 5.1 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccc(Cl)cc3CCC4)CC2)no1 10.1016/j.bmcl.2020.127417
CHEMBL4756737 180807 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 382 2 0 5 5.1 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccc(Cl)cc3CCC4)CC2)no1 10.1016/j.bmcl.2020.127417
162655954 180765 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 465 3 0 3 5.3 Cc1ccccc1N1CCN(C(=O)N2C[C@@H](C(=O)C3CCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4756212 180765 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 465 3 0 3 5.3 Cc1ccccc1N1CCN(C(=O)N2C[C@@H](C(=O)C3CCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
162643927 181805 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 466 2 0 3 4.2 Cc1ccccc1N1CCN(C(=O)N2C[C@@H](C(=O)N3CCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127417
CHEMBL4778087 181805 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 466 2 0 3 4.2 Cc1ccccc1N1CCN(C(=O)N2C[C@@H](C(=O)N3CCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127417
162658238 181004 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 369 2 0 5 3.5 C#Cc1ccc2c(c1)CCCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
CHEMBL4759005 181004 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 369 2 0 5 3.5 C#Cc1ccc2c(c1)CCCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
10411308 201232 None 0 Human Functional pIC50 = 8.6 8.6 -2 3
Antagonist activity at V1A receptor (unknown origin)Antagonist activity at V1A receptor (unknown origin)
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/acs.jmedchem.8b00697
CHEMBL603708 201232 None 0 Human Functional pIC50 = 8.6 8.6 -2 3
Antagonist activity at V1A receptor (unknown origin)Antagonist activity at V1A receptor (unknown origin)
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/acs.jmedchem.8b00697
17989455 65616 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 361 2 0 6 3.4 Cc1ccc2c(c1)COCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2011.08.038
CHEMBL1834004 65616 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 361 2 0 6 3.4 Cc1ccc2c(c1)COCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2011.08.038
22017591 66044 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 377 7 0 6 3.6 CCOCc1nnc(C2CCN(c3ccccn3)CC2)n1Cc1ccccc1 10.1016/j.bmcl.2011.08.038
CHEMBL1837023 66044 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 377 7 0 6 3.6 CCOCc1nnc(C2CCN(c3ccccn3)CC2)n1Cc1ccccc1 10.1016/j.bmcl.2011.08.038
162664826 182096 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 448 2 0 4 3.1 Cc1ccccc1N1CCN(C(=O)N2CN(S(C)(=O)=O)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4781783 182096 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 448 2 0 4 3.1 Cc1ccccc1N1CCN(C(=O)N2CN(S(C)(=O)=O)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
23598595 154801 None 0 Human Functional pIC50 = 7.7 7.7 2 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 542 5 2 3 7.0 O=C(O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
CHEMBL400266 154801 None 0 Human Functional pIC50 = 7.7 7.7 2 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 542 5 2 3 7.0 O=C(O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
162645320 179504 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 360 3 0 5 4.3 c1ccc(O[C@H]2CC[C@H](c3nnc4n3-c3ccccc3CCC4)CC2)nc1 10.1016/j.bmcl.2020.127417
CHEMBL4741178 179504 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 360 3 0 5 4.3 c1ccc(O[C@H]2CC[C@H](c3nnc4n3-c3ccccc3CCC4)CC2)nc1 10.1016/j.bmcl.2020.127417
4391207 57222 None 1 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 311 3 0 3 4.9 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1 10.1016/j.bmcl.2011.08.038
CHEMBL1649949 57222 None 1 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 311 3 0 3 4.9 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1 10.1016/j.bmcl.2011.08.038
162658540 181101 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 369 1 0 2 4.3 Cc1ccccc1N1CCN(C(=O)N2CCCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4760164 181101 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 369 1 0 2 4.3 Cc1ccccc1N1CCN(C(=O)N2CCCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
44352804 18957 None 0 Human Functional pIC50 = 5.7 5.7 -24 2
Inhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cellsInhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cells
ChEMBL 536 7 2 4 7.0 O=C(O)CC[C@H]1CCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc2S1 10.1016/j.bmcl.2003.08.051
CHEMBL128688 18957 None 0 Human Functional pIC50 = 5.7 5.7 -24 2
Inhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cellsInhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cells
ChEMBL 536 7 2 4 7.0 O=C(O)CC[C@H]1CCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc2S1 10.1016/j.bmcl.2003.08.051
162648022 179972 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 479 3 0 3 5.0 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CCCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4746818 179972 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 479 3 0 3 5.0 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CCCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
44352757 118452 None 0 Human Functional pIC50 = 5.7 5.7 -58 2
Inhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cellsInhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cells
ChEMBL 522 6 2 4 6.6 O=C(O)C[C@H]1CCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc2S1 10.1016/j.bmcl.2003.08.051
CHEMBL341173 118452 None 0 Human Functional pIC50 = 5.7 5.7 -58 2
Inhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cellsInhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cells
ChEMBL 522 6 2 4 6.6 O=C(O)C[C@H]1CCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc2S1 10.1016/j.bmcl.2003.08.051
162655687 180780 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 452 5 0 7 4.6 COC(=O)CC1Cc2cc(Cl)ccc2-n2c1nnc2[C@H]1CC[C@H](Oc2ccccn2)CC1 10.1016/j.bmcl.2020.127417
CHEMBL4756354 180780 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 452 5 0 7 4.6 COC(=O)CC1Cc2cc(Cl)ccc2-n2c1nnc2[C@H]1CC[C@H](Oc2ccccn2)CC1 10.1016/j.bmcl.2020.127417
10444 2324 None 14 Human Functional pIC50 = 5.7 5.7 -61 4
Antagonist activity at human V1a receptor expressed in HEK293FT cells assessed as inhibition of AVP-induced response incubated for 30 mins by beta-arrestin recruitment assayAntagonist activity at human V1a receptor expressed in HEK293FT cells assessed as inhibition of AVP-induced response incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
139030525 2324 None 14 Human Functional pIC50 = 5.7 5.7 -61 4
Antagonist activity at human V1a receptor expressed in HEK293FT cells assessed as inhibition of AVP-induced response incubated for 30 mins by beta-arrestin recruitment assayAntagonist activity at human V1a receptor expressed in HEK293FT cells assessed as inhibition of AVP-induced response incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
145711714 2324 None 14 Human Functional pIC50 = 5.7 5.7 -61 4
Antagonist activity at human V1a receptor expressed in HEK293FT cells assessed as inhibition of AVP-induced response incubated for 30 mins by beta-arrestin recruitment assayAntagonist activity at human V1a receptor expressed in HEK293FT cells assessed as inhibition of AVP-induced response incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4204210 2324 None 14 Human Functional pIC50 = 5.7 5.7 -61 4
Antagonist activity at human V1a receptor expressed in HEK293FT cells assessed as inhibition of AVP-induced response incubated for 30 mins by beta-arrestin recruitment assayAntagonist activity at human V1a receptor expressed in HEK293FT cells assessed as inhibition of AVP-induced response incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
44336799 107229 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 596 7 2 5 4.8 O=C(NCCN1CCOCC1)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL316736 107229 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 596 7 2 5 4.8 O=C(NCCN1CCOCC1)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
56672567 66036 None 0 Human Functional pIC50 = 5.6 5.6 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 344 3 0 6 3.2 Cc1nnc(C2CCN(c3ccccn3)CC2)n1-c1ccc(C#N)cc1 10.1016/j.bmcl.2011.08.038
CHEMBL1837015 66036 None 0 Human Functional pIC50 = 5.6 5.6 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 344 3 0 6 3.2 Cc1nnc(C2CCN(c3ccccn3)CC2)n1-c1ccc(C#N)cc1 10.1016/j.bmcl.2011.08.038
22017582 66047 None 0 Human Functional pIC50 = 5.6 5.6 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 407 8 1 7 2.7 O=C(O)COCc1nnc(C2CCN(c3ccccn3)CC2)n1Cc1ccccc1 10.1016/j.bmcl.2011.08.038
CHEMBL1837026 66047 None 0 Human Functional pIC50 = 5.6 5.6 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 407 8 1 7 2.7 O=C(O)COCc1nnc(C2CCN(c3ccccn3)CC2)n1Cc1ccccc1 10.1016/j.bmcl.2011.08.038
22017577 66045 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 418 6 0 7 2.9 c1ccc(Cn2c(CN3CCOCC3)nnc2C2CCN(c3ccccn3)CC2)cc1 10.1016/j.bmcl.2011.08.038
CHEMBL1837024 66045 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 418 6 0 7 2.9 c1ccc(Cn2c(CN3CCOCC3)nnc2C2CCN(c3ccccn3)CC2)cc1 10.1016/j.bmcl.2011.08.038
162670181 182751 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 465 3 0 3 5.3 Cc1ccccc1N1CCN(C(=O)N2C[C@H](C(=O)C3CCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4790089 182751 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 465 3 0 3 5.3 Cc1ccccc1N1CCN(C(=O)N2C[C@H](C(=O)C3CCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
162667087 182437 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 348 2 0 5 4.5 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccccc3CCC4)CC2)no1 10.1016/j.bmcl.2020.127417
CHEMBL4786172 182437 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 348 2 0 5 4.5 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccccc3CCC4)CC2)no1 10.1016/j.bmcl.2020.127417
162676230 183323 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 373 3 0 5 4.1 CCc1ccc2c(c1)CCCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
CHEMBL4797387 183323 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 373 3 0 5 4.1 CCc1ccc2c(c1)CCCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
162657843 181143 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 370 2 0 4 3.4 CN1CCN(C(=O)C2CCN(c3ccccn3)CC2)c2ccc(Cl)cc21 10.1016/j.bmcl.2020.127416
CHEMBL4760698 181143 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 370 2 0 4 3.4 CN1CCN(C(=O)C2CCN(c3ccccn3)CC2)c2ccc(Cl)cc21 10.1016/j.bmcl.2020.127416
162652318 180320 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 356 2 1 4 3.4 O=C(C1CCN(c2ccccn2)CC1)N1CCNc2cc(Cl)ccc21 10.1016/j.bmcl.2020.127417
CHEMBL4751140 180320 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 356 2 1 4 3.4 O=C(C1CCN(c2ccccn2)CC1)N1CCNc2cc(Cl)ccc21 10.1016/j.bmcl.2020.127417
25133000 94192 None 0 Human Functional pIC50 = 7.6 7.6 -2 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 626 6 3 6 4.4 COc1cc(C(=O)N2CC[C@]3(C=C(C(=O)NS(N)(=O)=O)CC3)Cc3ccccc32)ccc1NC(=O)c1cc(F)ccc1Cl 10.1016/j.bmcl.2007.09.059
CHEMBL249740 94192 None 0 Human Functional pIC50 = 7.6 7.6 -2 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 626 6 3 6 4.4 COc1cc(C(=O)N2CC[C@]3(C=C(C(=O)NS(N)(=O)=O)CC3)Cc3ccccc32)ccc1NC(=O)c1cc(F)ccc1Cl 10.1016/j.bmcl.2007.09.059
21925586 66057 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 360 2 0 6 3.0 CN1Cc2ccccc2-n2c(nnc2C2CCN(c3ccccn3)CC2)C1 10.1016/j.bmcl.2011.08.038
CHEMBL1837036 66057 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 360 2 0 6 3.0 CN1Cc2ccccc2-n2c(nnc2C2CCN(c3ccccn3)CC2)C1 10.1016/j.bmcl.2011.08.038
162648022 179972 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 479 3 0 3 5.0 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CCCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4746818 179972 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 479 3 0 3 5.0 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CCCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
162665294 182371 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 383 0 1 3 4.2 O=C(N1CCC2(CC1)OCc1ccccc12)N1CCNc2cc(Cl)ccc21 10.1016/j.bmcl.2020.127416
CHEMBL4785083 182371 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 383 0 1 3 4.2 O=C(N1CCC2(CC1)OCc1ccccc12)N1CCNc2cc(Cl)ccc21 10.1016/j.bmcl.2020.127416
162661801 181453 None 0 Human Functional pIC50 = 5.6 5.6 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 336 1 1 3 3.2 Cc1ccccc1N1CCN(C(=O)N2CCNc3ccccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4764410 181453 None 0 Human Functional pIC50 = 5.6 5.6 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 336 1 1 3 3.2 Cc1ccccc1N1CCN(C(=O)N2CCNc3ccccc32)CC1 10.1016/j.bmcl.2020.127416
135192983 176116 None 14 Human Functional pIC50 = 5.5 5.5 -190 4
Antagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assayAntagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assay
ChEMBL 429 6 0 7 3.4 COCc1nnc(N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4591825 176116 None 14 Human Functional pIC50 = 5.5 5.5 -190 4
Antagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assayAntagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assay
ChEMBL 429 6 0 7 3.4 COCc1nnc(N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
10474163 66041 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 367 4 0 5 4.1 Cc1nnc(C2CCN(c3ccccn3)CC2)n1Cc1cccc(Cl)c1 10.1016/j.bmcl.2011.08.038
CHEMBL1837020 66041 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 367 4 0 5 4.1 Cc1nnc(C2CCN(c3ccccn3)CC2)n1Cc1cccc(Cl)c1 10.1016/j.bmcl.2011.08.038
23598600 5365 None 0 Human Functional pIC50 = 7.5 7.5 1 2
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 594 7 2 4 5.9 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=C(C(=O)NCCN4CCCC4)CC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.04.016
CHEMBL106938 5365 None 0 Human Functional pIC50 = 7.5 7.5 1 2
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 594 7 2 4 5.9 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=C(C(=O)NCCN4CCCC4)CC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.04.016
44336784 109206 None 0 Human Functional pIC50 = 7.5 7.5 1 2
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 626 9 2 4 7.0 CN(C)CCCNC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL321656 109206 None 0 Human Functional pIC50 = 7.5 7.5 1 2
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 626 9 2 4 7.0 CN(C)CCCNC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
56682562 66049 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 434 6 0 8 3.4 Clc1cccc(Cn2c(Cn3nccn3)nnc2C2CCN(c3ccccn3)CC2)c1 10.1016/j.bmcl.2011.08.038
CHEMBL1837028 66049 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 434 6 0 8 3.4 Clc1cccc(Cn2c(Cn3nccn3)nnc2C2CCN(c3ccccn3)CC2)c1 10.1016/j.bmcl.2011.08.038
10615 572 None 32 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1016/j.bmcl.2020.127416
46200932 572 None 32 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1016/j.bmcl.2020.127416
CHEMBL4297183 572 None 32 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1016/j.bmcl.2020.127416
DB14823 572 None 32 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1016/j.bmcl.2020.127416
151171 1163 None 50 Human Functional pIC50 = 8.5 8.5 3 2
Antagonist activity at human Vasopressin V1a receptor assessed as inhibition of intracellular calcium mobilization by FLIPR assayAntagonist activity at human Vasopressin V1a receptor assessed as inhibition of intracellular calcium mobilization by FLIPR assay
ChEMBL 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 10.1016/j.bmcl.2010.04.068
216322 1163 None 50 Human Functional pIC50 = 8.5 8.5 3 2
Antagonist activity at human Vasopressin V1a receptor assessed as inhibition of intracellular calcium mobilization by FLIPR assayAntagonist activity at human Vasopressin V1a receptor assessed as inhibition of intracellular calcium mobilization by FLIPR assay
ChEMBL 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 10.1016/j.bmcl.2010.04.068
2203 1163 None 50 Human Functional pIC50 = 8.5 8.5 3 2
Antagonist activity at human Vasopressin V1a receptor assessed as inhibition of intracellular calcium mobilization by FLIPR assayAntagonist activity at human Vasopressin V1a receptor assessed as inhibition of intracellular calcium mobilization by FLIPR assay
ChEMBL 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 10.1016/j.bmcl.2010.04.068
732 1163 None 50 Human Functional pIC50 = 8.5 8.5 3 2
Antagonist activity at human Vasopressin V1a receptor assessed as inhibition of intracellular calcium mobilization by FLIPR assayAntagonist activity at human Vasopressin V1a receptor assessed as inhibition of intracellular calcium mobilization by FLIPR assay
ChEMBL 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 10.1016/j.bmcl.2010.04.068
CHEMBL1755 1163 None 50 Human Functional pIC50 = 8.5 8.5 3 2
Antagonist activity at human Vasopressin V1a receptor assessed as inhibition of intracellular calcium mobilization by FLIPR assayAntagonist activity at human Vasopressin V1a receptor assessed as inhibition of intracellular calcium mobilization by FLIPR assay
ChEMBL 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 10.1016/j.bmcl.2010.04.068
DB00872 1163 None 50 Human Functional pIC50 = 8.5 8.5 3 2
Antagonist activity at human Vasopressin V1a receptor assessed as inhibition of intracellular calcium mobilization by FLIPR assayAntagonist activity at human Vasopressin V1a receptor assessed as inhibition of intracellular calcium mobilization by FLIPR assay
ChEMBL 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 10.1016/j.bmcl.2010.04.068
10615 572 None 32 Human Functional pIC50 = 8.5 8.5 - 1
Inhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate readerInhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate reader
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1021/acs.jmedchem.1c00863
46200932 572 None 32 Human Functional pIC50 = 8.5 8.5 - 1
Inhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate readerInhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate reader
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1021/acs.jmedchem.1c00863
CHEMBL4297183 572 None 32 Human Functional pIC50 = 8.5 8.5 - 1
Inhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate readerInhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate reader
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1021/acs.jmedchem.1c00863
DB14823 572 None 32 Human Functional pIC50 = 8.5 8.5 - 1
Inhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate readerInhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate reader
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1021/acs.jmedchem.1c00863
10615 572 None 32 Human Functional pIC50 = 8.5 8.5 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1016/j.bmcl.2020.127417
46200932 572 None 32 Human Functional pIC50 = 8.5 8.5 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1016/j.bmcl.2020.127417
CHEMBL4297183 572 None 32 Human Functional pIC50 = 8.5 8.5 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1016/j.bmcl.2020.127417
DB14823 572 None 32 Human Functional pIC50 = 8.5 8.5 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1016/j.bmcl.2020.127417
56672570 66059 None 0 Human Functional pIC50 = 8.5 8.5 9 2
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 438 2 0 7 3.8 COC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CCN(c3ccccn3)CC2)C1 10.1016/j.bmcl.2011.08.038
CHEMBL1837038 66059 None 0 Human Functional pIC50 = 8.5 8.5 9 2
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 438 2 0 7 3.8 COC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CCN(c3ccccn3)CC2)C1 10.1016/j.bmcl.2011.08.038
162660856 181867 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 379 2 0 5 4.2 Clc1ccc2c(c1)CCCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
CHEMBL4778839 181867 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 379 2 0 5 4.2 Clc1ccc2c(c1)CCCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
162672471 183039 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 384 1 0 3 3.8 Cc1ccccc1N1CCN(C(=O)N2CCN(C)c3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4794001 183039 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 384 1 0 3 3.8 Cc1ccccc1N1CCN(C(=O)N2CCN(C)c3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
11237434 66058 None 10 Human Functional pIC50 = 7.5 7.5 102 2
Inhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate readerInhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate reader
ChEMBL 394 2 0 6 3.6 CN1Cc2cc(Cl)ccc2-n2c(nnc2C2CCN(c3ccccn3)CC2)C1 10.1021/acs.jmedchem.1c00863
CHEMBL1837037 66058 None 10 Human Functional pIC50 = 7.5 7.5 102 2
Inhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate readerInhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate reader
ChEMBL 394 2 0 6 3.6 CN1Cc2cc(Cl)ccc2-n2c(nnc2C2CCN(c3ccccn3)CC2)C1 10.1021/acs.jmedchem.1c00863
25132999 154901 None 0 Human Functional pIC50 = 6.5 6.5 3 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 572 5 2 5 6.0 COc1cc(C(=O)N2CC[C@]3(C=C(C4=NCCN4)CC3)Cc3ccccc32)ccc1NC(=O)c1cc(F)ccc1Cl 10.1016/j.bmcl.2007.09.059
CHEMBL400860 154901 None 0 Human Functional pIC50 = 6.5 6.5 3 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 572 5 2 5 6.0 COc1cc(C(=O)N2CC[C@]3(C=C(C4=NCCN4)CC3)Cc3ccccc32)ccc1NC(=O)c1cc(F)ccc1Cl 10.1016/j.bmcl.2007.09.059
11278622 66032 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 319 3 0 5 3.4 Cc1nnc(C2CCN(c3ccccn3)CC2)n1-c1ccccc1 10.1016/j.bmcl.2011.08.038
CHEMBL1837011 66032 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 319 3 0 5 3.4 Cc1nnc(C2CCN(c3ccccn3)CC2)n1-c1ccccc1 10.1016/j.bmcl.2011.08.038
21925546 66050 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 347 2 0 6 3.1 c1ccc(N2CCC(c3nnc4n3-c3ccccc3COC4)CC2)nc1 10.1016/j.bmcl.2011.08.038
CHEMBL1837029 66050 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 347 2 0 6 3.1 c1ccc(N2CCC(c3nnc4n3-c3ccccc3COC4)CC2)nc1 10.1016/j.bmcl.2011.08.038
162647523 179775 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 428 2 1 4 2.7 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)CO)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4744606 179775 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 428 2 1 4 2.7 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)CO)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
162653495 180492 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 465 3 0 3 4.6 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4753130 180492 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 465 3 0 3 4.6 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
162656299 180949 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 474 2 0 3 5.0 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)c3ccccc3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4758331 180949 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 474 2 0 3 5.0 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)c3ccccc3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
145963213 161479 None 0 Human Functional pIC50 = 7.5 7.5 8 4
Antagonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by AVP addition measured for 5 mins by Fluo-4-AM dye based FLIPR assayAntagonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by AVP addition measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1095 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccccc2CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL4127791 161479 None 0 Human Functional pIC50 = 7.5 7.5 8 4
Antagonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by AVP addition measured for 5 mins by Fluo-4-AM dye based FLIPR assayAntagonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by AVP addition measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1095 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccccc2CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
54586172 61909 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium releaseAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release
ChEMBL 485 7 3 3 4.2 O=C(N[C@@H]1C[C@@H]2CC[C@H](C1)N2)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C1(c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.02.096
CHEMBL1774024 61909 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium releaseAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release
ChEMBL 485 7 3 3 4.2 O=C(N[C@@H]1C[C@@H]2CC[C@H](C1)N2)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C1(c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.02.096
11157078 94193 None 7 Human Functional pIC50 = 7.4 7.4 2 4
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 548 5 2 4 6.1 COc1cc(C(=O)N2CC[C@]3(C=C(C(=O)O)CC3)Cc3ccccc32)ccc1NC(=O)c1cc(F)ccc1Cl 10.1016/j.bmcl.2007.09.059
CHEMBL249741 94193 None 7 Human Functional pIC50 = 7.4 7.4 2 4
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 548 5 2 4 6.1 COc1cc(C(=O)N2CC[C@]3(C=C(C(=O)O)CC3)Cc3ccccc32)ccc1NC(=O)c1cc(F)ccc1Cl 10.1016/j.bmcl.2007.09.059
162643184 181676 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 369 1 1 2 4.9 Cc1ccccc1C1CCN(C(=O)N2CCNc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4776471 181676 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 369 1 1 2 4.9 Cc1ccccc1C1CCN(C(=O)N2CCNc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
11432362 94135 None 0 Human Functional pIC50 = 6.4 6.4 1 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 518 4 2 3 6.1 O=C(O)C1=C[C@@]2(CC1)CCN(C(=O)c1ccc(NC(=O)c3cc(F)ccc3Cl)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
CHEMBL249340 94135 None 0 Human Functional pIC50 = 6.4 6.4 1 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 518 4 2 3 6.1 O=C(O)C1=C[C@@]2(CC1)CCN(C(=O)c1ccc(NC(=O)c3cc(F)ccc3Cl)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
135192928 174902 None 0 Human Functional pIC50 = 5.4 5.4 -125 4
Antagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assayAntagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assay
ChEMBL 429 6 0 7 3.4 COCc1nnc(N2C[C@@H]3C[C@]3(c3cccc(F)c3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4564411 174902 None 0 Human Functional pIC50 = 5.4 5.4 -125 4
Antagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assayAntagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assay
ChEMBL 429 6 0 7 3.4 COCc1nnc(N2C[C@@H]3C[C@]3(c3cccc(F)c3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
162651435 180203 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 383 1 0 2 4.7 Cc1ccccc1N1CCN(C(=O)N2CCCCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4749660 180203 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 383 1 0 2 4.7 Cc1ccccc1N1CCN(C(=O)N2CCCCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL5085869 214994 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Inhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate readerInhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate reader
ChEMBL None None None Cc1ccc2c(c1)-n1c(nnc1[C@H]1CC[C@H](Oc3ccccn3)CC1)CC(O)C2 10.1021/acs.jmedchem.1c00863
10461417 107299 None 0 Human Functional pIC50 = 8.4 8.4 7 2
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 612 8 2 4 6.6 CN(C)CCNC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL317243 107299 None 0 Human Functional pIC50 = 8.4 8.4 7 2
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 612 8 2 4 6.6 CN(C)CCNC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
44336379 107415 None 0 Human Functional pIC50 = 8.4 8.4 6 2
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 582 8 2 4 5.8 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=C(C(=O)NCCCN(C)C)CC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.04.016
CHEMBL318083 107415 None 0 Human Functional pIC50 = 8.4 8.4 6 2
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 582 8 2 4 5.8 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=C(C(=O)NCCCN(C)C)CC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.04.016
10345610 66062 None 0 Human Functional pIC50 = 8.3 8.3 204 2
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 422 2 0 6 3.6 CC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CCN(c3ccccn3)CC2)C1 10.1016/j.bmcl.2011.08.038
CHEMBL1837040 66062 None 0 Human Functional pIC50 = 8.3 8.3 204 2
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 422 2 0 6 3.6 CC(=O)N1Cc2cc(Cl)ccc2-n2c(nnc2C2CCN(c3ccccn3)CC2)C1 10.1016/j.bmcl.2011.08.038
162648022 179972 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 479 3 0 3 5.0 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CCCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4746818 179972 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 479 3 0 3 5.0 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CCCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
162658817 180989 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 370 1 1 3 3.5 Cc1ccccc1N1CCN(C(=O)N2CNCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4758799 180989 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 370 1 1 3 3.5 Cc1ccccc1N1CCN(C(=O)N2CNCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
162671049 182818 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 703 11 1 6 5.6 C[C@H](NC(=O)[C@@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1)c1ccccc1 10.1016/j.bmcl.2020.127416
CHEMBL4790970 182818 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 703 11 1 6 5.6 C[C@H](NC(=O)[C@@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1)c1ccccc1 10.1016/j.bmcl.2020.127416
46890707 6725 None 0 Human Functional pIC50 = 7.4 7.4 20 2
Antagonist activity at human Vasopressin V1a receptor assessed as inhibition of intracellular calcium mobilization by FLIPR assayAntagonist activity at human Vasopressin V1a receptor assessed as inhibition of intracellular calcium mobilization by FLIPR assay
ChEMBL 419 3 0 3 6.6 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1csc2ccccc12 10.1016/j.bmcl.2010.04.068
CHEMBL1083703 6725 None 0 Human Functional pIC50 = 7.4 7.4 20 2
Antagonist activity at human Vasopressin V1a receptor assessed as inhibition of intracellular calcium mobilization by FLIPR assayAntagonist activity at human Vasopressin V1a receptor assessed as inhibition of intracellular calcium mobilization by FLIPR assay
ChEMBL 419 3 0 3 6.6 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1csc2ccccc12 10.1016/j.bmcl.2010.04.068
145962220 161575 None 0 Human Functional pIC50 = 5.4 5.4 -128 4
Antagonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by AVP addition measured for 5 mins by Fluo-4-AM dye based FLIPR assayAntagonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by AVP addition measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1095 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2cccc(c2)CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL4129142 161575 None 0 Human Functional pIC50 = 5.4 5.4 -128 4
Antagonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by AVP addition measured for 5 mins by Fluo-4-AM dye based FLIPR assayAntagonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by AVP addition measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1095 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2cccc(c2)CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
11961325 66055 None 0 Human Functional pIC50 = 5.4 5.4 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 346 2 1 6 2.7 c1ccc(N2CCC(c3nnc4n3-c3ccccc3CNC4)CC2)nc1 10.1016/j.bmcl.2011.08.038
CHEMBL1837034 66055 None 0 Human Functional pIC50 = 5.4 5.4 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 346 2 1 6 2.7 c1ccc(N2CCC(c3nnc4n3-c3ccccc3CNC4)CC2)nc1 10.1016/j.bmcl.2011.08.038
14306032 151505 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human Vasopressin V1a receptorAntagonist activity at human Vasopressin V1a receptor
ChEMBL 568 9 0 7 4.3 CC1(C(C(=O)OCc2ccccc2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)OCCO1 10.1016/j.ejmech.2010.09.035
CHEMBL396270 151505 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human Vasopressin V1a receptorAntagonist activity at human Vasopressin V1a receptor
ChEMBL 568 9 0 7 4.3 CC1(C(C(=O)OCc2ccccc2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)OCCO1 10.1016/j.ejmech.2010.09.035
44444762 154727 None 0 Human Functional pIC50 = 7.4 7.4 1 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 612 8 2 4 6.6 CN(C)CCNC(=O)C1=C[C@@]2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
CHEMBL399888 154727 None 0 Human Functional pIC50 = 7.4 7.4 1 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 612 8 2 4 6.6 CN(C)CCNC(=O)C1=C[C@@]2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
54582950 63035 None 0 Human Functional pIC50 = 7.4 7.4 -1 4
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 612 8 2 4 6.6 CN(C)CCNC(=O)C1=C[C@]2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL1788220 63035 None 0 Human Functional pIC50 = 7.4 7.4 -1 4
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 612 8 2 4 6.6 CN(C)CCNC(=O)C1=C[C@]2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
162674253 183223 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 371 1 1 4 3.2 Cc1cccnc1N1CCN(C(=O)N2CCNc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4796133 183223 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 371 1 1 4 3.2 Cc1cccnc1N1CCN(C(=O)N2CCNc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
44352768 115254 None 0 Human Functional pIC50 = 5.3 5.3 -47 2
Inhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cellsInhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cells
ChEMBL 536 7 2 4 7.0 O=C(O)CC[C@@H]1CCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc2S1 10.1016/j.bmcl.2003.08.051
CHEMBL334777 115254 None 0 Human Functional pIC50 = 5.3 5.3 -47 2
Inhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cellsInhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cells
ChEMBL 536 7 2 4 7.0 O=C(O)CC[C@@H]1CCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc2S1 10.1016/j.bmcl.2003.08.051
137212776 137931 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at human vasopressin 1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assayAntagonist activity at human vasopressin 1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assay
ChEMBL 532 10 3 8 4.6 Cn1ncc2c1Nc1ccccc1N(C(=O)CCCCCCCN1CCN(Cc3cc(O)cc(O)c3)CC1)C2 10.1016/j.ejmech.2015.11.050
CHEMBL3763823 137931 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at human vasopressin 1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assayAntagonist activity at human vasopressin 1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assay
ChEMBL 532 10 3 8 4.6 Cn1ncc2c1Nc1ccccc1N(C(=O)CCCCCCCN1CCN(Cc3cc(O)cc(O)c3)CC1)C2 10.1016/j.ejmech.2015.11.050
137212776 137931 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin-induced IP1 accumulation preincubated for 30 mins followed by vasopressin addition measured after 1 hr by HTRF assayAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin-induced IP1 accumulation preincubated for 30 mins followed by vasopressin addition measured after 1 hr by HTRF assay
ChEMBL 532 10 3 8 4.6 Cn1ncc2c1Nc1ccccc1N(C(=O)CCCCCCCN1CCN(Cc3cc(O)cc(O)c3)CC1)C2 10.1016/j.ejmech.2017.10.059
CHEMBL3763823 137931 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin-induced IP1 accumulation preincubated for 30 mins followed by vasopressin addition measured after 1 hr by HTRF assayAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin-induced IP1 accumulation preincubated for 30 mins followed by vasopressin addition measured after 1 hr by HTRF assay
ChEMBL 532 10 3 8 4.6 Cn1ncc2c1Nc1ccccc1N(C(=O)CCCCCCCN1CCN(Cc3cc(O)cc(O)c3)CC1)C2 10.1016/j.ejmech.2017.10.059
135192948 175613 None 0 Human Functional pIC50 = 5.3 5.3 -5 2
Antagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assayAntagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assay
ChEMBL 499 7 0 8 3.9 COc1ccc(-n2c(COC3CCOCC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
CHEMBL4580413 175613 None 0 Human Functional pIC50 = 5.3 5.3 -5 2
Antagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assayAntagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assay
ChEMBL 499 7 0 8 3.9 COc1ccc(-n2c(COC3CCOCC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
216237 3841 None 89 Human Functional pIC50 = 6.3 6.3 -41 7
Inhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate readerInhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate reader
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1021/acs.jmedchem.1c00863
2226 3841 None 89 Human Functional pIC50 = 6.3 6.3 -41 7
Inhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate readerInhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate reader
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1021/acs.jmedchem.1c00863
4110 3841 None 89 Human Functional pIC50 = 6.3 6.3 -41 7
Inhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate readerInhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate reader
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1021/acs.jmedchem.1c00863
443894 3841 None 89 Human Functional pIC50 = 6.3 6.3 -41 7
Inhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate readerInhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate reader
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1021/acs.jmedchem.1c00863
CHEMBL344159 3841 None 89 Human Functional pIC50 = 6.3 6.3 -41 7
Inhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate readerInhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate reader
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1021/acs.jmedchem.1c00863
DB06212 3841 None 89 Human Functional pIC50 = 6.3 6.3 -41 7
Inhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate readerInhibition of human V1A receptor expressed in human 1321N1 cells assessed as calcium mobilization by fluorescent plate reader
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1021/acs.jmedchem.1c00863
23598598 4965 None 0 Human Functional pIC50 = 7.3 7.3 -1 2
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 608 7 2 4 6.3 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=C(C(=O)NCCN4CCCCC4)CC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.04.016
CHEMBL104839 4965 None 0 Human Functional pIC50 = 7.3 7.3 -1 2
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 608 7 2 4 6.3 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=C(C(=O)NCCN4CCCCC4)CC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.04.016
44336636 164163 None 0 Human Functional pIC50 = 8.3 8.3 7 2
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 585 7 3 4 6.0 O=C(NCCO)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL421039 164163 None 0 Human Functional pIC50 = 8.3 8.3 7 2
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 585 7 3 4 6.0 O=C(NCCO)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
145970269 163580 None 0 Human Functional pIC50 = 7.3 7.3 15 2
Antagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVPAntagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVP
ChEMBL 475 5 3 6 2.5 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)NCC(=O)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4203314 163580 None 0 Human Functional pIC50 = 7.3 7.3 15 2
Antagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVPAntagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVP
ChEMBL 475 5 3 6 2.5 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)NCC(=O)N(C)C 10.1021/acs.jmedchem.8b00697
162663957 182151 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 412 1 0 3 3.7 CC(=O)N1Cc2cc(Cl)ccc2N(C(=O)N2CCN(c3ccccc3C)CC2)C1 10.1016/j.bmcl.2020.127416
CHEMBL4782389 182151 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 412 1 0 3 3.7 CC(=O)N1Cc2cc(Cl)ccc2N(C(=O)N2CCN(c3ccccc3C)CC2)C1 10.1016/j.bmcl.2020.127416
11238362 168906 None 0 Human Functional pIC50 = 7.3 7.3 5 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 562 6 2 4 6.5 CCOc1cc(C(=O)N2CC[C@]3(C=C(C(=O)O)CC3)Cc3ccccc32)ccc1NC(=O)c1cc(F)ccc1Cl 10.1016/j.bmcl.2007.09.059
CHEMBL438523 168906 None 0 Human Functional pIC50 = 7.3 7.3 5 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 562 6 2 4 6.5 CCOc1cc(C(=O)N2CC[C@]3(C=C(C(=O)O)CC3)Cc3ccccc32)ccc1NC(=O)c1cc(F)ccc1Cl 10.1016/j.bmcl.2007.09.059
162670083 182747 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 380 2 0 5 5.2 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccc(Cl)cc3C3CC43)CC2)no1 10.1016/j.bmcl.2020.127417
CHEMBL4790066 182747 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 380 2 0 5 5.2 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccc(Cl)cc3C3CC43)CC2)no1 10.1016/j.bmcl.2020.127417
21064021 66053 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 381 2 0 6 3.7 Clc1ccc2c(c1)-n1c(nnc1C1CCN(c3ccccn3)CC1)COC2 10.1016/j.bmcl.2011.08.038
CHEMBL1837032 66053 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 381 2 0 6 3.7 Clc1ccc2c(c1)-n1c(nnc1C1CCN(c3ccccn3)CC1)COC2 10.1016/j.bmcl.2011.08.038
54584254 61908 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium releaseAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release
ChEMBL 459 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@@H]1C[C@@H]2CC[C@H](C1)N2 10.1016/j.bmcl.2011.02.096
CHEMBL1774023 61908 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium releaseAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release
ChEMBL 459 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@@H]1C[C@@H]2CC[C@H](C1)N2 10.1016/j.bmcl.2011.02.096
162676406 183418 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 405 1 0 4 3.6 CN1CCN(C(=O)N2CCN(c3ncccc3Cl)CC2)c2ccc(Cl)cc21 10.1016/j.bmcl.2020.127416
CHEMBL4798542 183418 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 405 1 0 4 3.6 CN1CCN(C(=O)N2CCN(c3ncccc3Cl)CC2)c2ccc(Cl)cc21 10.1016/j.bmcl.2020.127416
56672568 66037 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 387 3 0 5 4.4 Cc1nnc(C2CCN(c3ccccn3)CC2)n1-c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2011.08.038
CHEMBL1837016 66037 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 387 3 0 5 4.4 Cc1nnc(C2CCN(c3ccccn3)CC2)n1-c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2011.08.038
10444 2324 None 14 Human Functional pIC50 = 5.2 5.2 -61 4
Antagonist activity at human V1a receptor expressed in HEK293FT cells assessed as inhibition of AVP-induced calcium release by Aequorin based assayAntagonist activity at human V1a receptor expressed in HEK293FT cells assessed as inhibition of AVP-induced calcium release by Aequorin based assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
139030525 2324 None 14 Human Functional pIC50 = 5.2 5.2 -61 4
Antagonist activity at human V1a receptor expressed in HEK293FT cells assessed as inhibition of AVP-induced calcium release by Aequorin based assayAntagonist activity at human V1a receptor expressed in HEK293FT cells assessed as inhibition of AVP-induced calcium release by Aequorin based assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
145711714 2324 None 14 Human Functional pIC50 = 5.2 5.2 -61 4
Antagonist activity at human V1a receptor expressed in HEK293FT cells assessed as inhibition of AVP-induced calcium release by Aequorin based assayAntagonist activity at human V1a receptor expressed in HEK293FT cells assessed as inhibition of AVP-induced calcium release by Aequorin based assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4204210 2324 None 14 Human Functional pIC50 = 5.2 5.2 -61 4
Antagonist activity at human V1a receptor expressed in HEK293FT cells assessed as inhibition of AVP-induced calcium release by Aequorin based assayAntagonist activity at human V1a receptor expressed in HEK293FT cells assessed as inhibition of AVP-induced calcium release by Aequorin based assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
11237434 66058 None 10 Human Functional pIC50 = 8.2 8.2 102 2
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 394 2 0 6 3.6 CN1Cc2cc(Cl)ccc2-n2c(nnc2C2CCN(c3ccccn3)CC2)C1 10.1016/j.bmcl.2011.08.038
CHEMBL1837037 66058 None 10 Human Functional pIC50 = 8.2 8.2 102 2
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 394 2 0 6 3.6 CN1Cc2cc(Cl)ccc2-n2c(nnc2C2CCN(c3ccccn3)CC2)C1 10.1016/j.bmcl.2011.08.038
56679250 66046 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 431 6 0 7 2.9 CN1CCN(Cc2nnc(C3CCN(c4ccccn4)CC3)n2Cc2ccccc2)CC1 10.1016/j.bmcl.2011.08.038
CHEMBL1837025 66046 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 431 6 0 7 2.9 CN1CCN(Cc2nnc(C3CCN(c4ccccn4)CC3)n2Cc2ccccc2)CC1 10.1016/j.bmcl.2011.08.038
135506374 137898 None 23 Human Functional pIC50 = 6.2 6.2 -1 4
Antagonist activity at human vasopressin 1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assayAntagonist activity at human vasopressin 1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2015.11.050
CHEMBL3763342 137898 None 23 Human Functional pIC50 = 6.2 6.2 -1 4
Antagonist activity at human vasopressin 1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assayAntagonist activity at human vasopressin 1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2015.11.050
135506374 137898 None 23 Human Functional pIC50 = 6.2 6.2 -1 4
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin-induced IP1 accumulation preincubated for 30 mins followed by vasopressin addition measured after 1 hr by HTRF assayAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin-induced IP1 accumulation preincubated for 30 mins followed by vasopressin addition measured after 1 hr by HTRF assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2017.10.059
CHEMBL3763342 137898 None 23 Human Functional pIC50 = 6.2 6.2 -1 4
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin-induced IP1 accumulation preincubated for 30 mins followed by vasopressin addition measured after 1 hr by HTRF assayAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin-induced IP1 accumulation preincubated for 30 mins followed by vasopressin addition measured after 1 hr by HTRF assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2017.10.059
25132666 94527 None 0 Human Functional pIC50 = 7.2 7.2 -1 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 572 5 2 6 5.7 COc1cc(C(=O)N2CC[C@]3(C=C(c4nnn[nH]4)CC3)Cc3ccccc32)ccc1NC(=O)c1cc(F)ccc1Cl 10.1016/j.bmcl.2007.09.059
CHEMBL251715 94527 None 0 Human Functional pIC50 = 7.2 7.2 -1 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 572 5 2 6 5.7 COc1cc(C(=O)N2CC[C@]3(C=C(c4nnn[nH]4)CC3)Cc3ccccc32)ccc1NC(=O)c1cc(F)ccc1Cl 10.1016/j.bmcl.2007.09.059
23598642 154802 None 0 Human Functional pIC50 = 6.2 6.2 2 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 541 6 2 3 7.1 CNCC1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
CHEMBL400267 154802 None 0 Human Functional pIC50 = 6.2 6.2 2 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 541 6 2 3 7.1 CNCC1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
162645988 179690 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 380 2 0 5 5.2 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccc(Cl)cc3[C@H]3C[C@@H]43)CC2)no1 10.1016/j.bmcl.2020.127417
CHEMBL4743652 179690 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 380 2 0 5 5.2 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccc(Cl)cc3[C@H]3C[C@@H]43)CC2)no1 10.1016/j.bmcl.2020.127417
11157078 94193 None 7 Rat Functional pIC50 = 6.2 6.2 -46 4
Antagonist activity at rat vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at rat vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 548 5 2 4 6.1 COc1cc(C(=O)N2CC[C@]3(C=C(C(=O)O)CC3)Cc3ccccc32)ccc1NC(=O)c1cc(F)ccc1Cl 10.1016/j.bmcl.2007.09.059
CHEMBL249741 94193 None 7 Rat Functional pIC50 = 6.2 6.2 -46 4
Antagonist activity at rat vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at rat vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 548 5 2 4 6.1 COc1cc(C(=O)N2CC[C@]3(C=C(C(=O)O)CC3)Cc3ccccc32)ccc1NC(=O)c1cc(F)ccc1Cl 10.1016/j.bmcl.2007.09.059
44336404 110957 None 0 Human Functional pIC50 = 7.2 7.2 2 2
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 568 7 2 4 5.4 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=C(C(=O)NCCN(C)C)CC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.04.016
CHEMBL326225 110957 None 0 Human Functional pIC50 = 7.2 7.2 2 2
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 568 7 2 4 5.4 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=C(C(=O)NCCN(C)C)CC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.04.016
162646537 179603 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 357 1 1 4 2.9 O=C(N1CCN(c2ccccn2)CC1)N1CCNc2cc(Cl)ccc21 10.1016/j.bmcl.2020.127416
CHEMBL4742334 179603 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 357 1 1 4 2.9 O=C(N1CCN(c2ccccn2)CC1)N1CCNc2cc(Cl)ccc21 10.1016/j.bmcl.2020.127416
135506374 137898 None 23 Human Functional pIC50 = 8.2 8.2 -1 4
Antagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVPAntagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVP
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL3763342 137898 None 23 Human Functional pIC50 = 8.2 8.2 -1 4
Antagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVPAntagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVP
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
162664620 182145 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 380 3 0 5 4.5 Clc1ccc2c(c1)CCc1nnc([C@H]3CC[C@H](Oc4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
CHEMBL4782340 182145 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Inhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayInhibition of human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 380 3 0 5 4.5 Clc1ccc2c(c1)CCc1nnc([C@H]3CC[C@H](Oc4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
11461755 66035 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 333 3 0 5 3.7 Cc1ccc(-n2c(C)nnc2C2CCN(c3ccccn3)CC2)cc1 10.1016/j.bmcl.2011.08.038
CHEMBL1837014 66035 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 333 3 0 5 3.7 Cc1ccc(-n2c(C)nnc2C2CCN(c3ccccn3)CC2)cc1 10.1016/j.bmcl.2011.08.038
23598598 4965 None 0 Human Functional pIC50 = 7.2 7.2 -1 2
Evaluated for intracellular calcium mobilization in HEK- 293 cells transfected to express human vasopressin V1a receptor (Compound 7o)Evaluated for intracellular calcium mobilization in HEK- 293 cells transfected to express human vasopressin V1a receptor (Compound 7o)
ChEMBL 608 7 2 4 6.3 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=C(C(=O)NCCN4CCCCC4)CC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.04.016
CHEMBL104839 4965 None 0 Human Functional pIC50 = 7.2 7.2 -1 2
Evaluated for intracellular calcium mobilization in HEK- 293 cells transfected to express human vasopressin V1a receptor (Compound 7o)Evaluated for intracellular calcium mobilization in HEK- 293 cells transfected to express human vasopressin V1a receptor (Compound 7o)
ChEMBL 608 7 2 4 6.3 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=C(C(=O)NCCN4CCCCC4)CC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.04.016
9871426 117009 None 0 Human Functional pIC50 = 6.1 6.1 -44 2
Inhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cellsInhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cells
ChEMBL 522 6 2 4 6.6 O=C(O)CC1CCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc2S1 10.1016/j.bmcl.2003.08.051
CHEMBL338901 117009 None 0 Human Functional pIC50 = 6.1 6.1 -44 2
Inhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cellsInhibition of vasopressin induced calcium immobilization in human V1a receptor expressing cells
ChEMBL 522 6 2 4 6.6 O=C(O)CC1CCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc2S1 10.1016/j.bmcl.2003.08.051
162645370 179592 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 385 1 1 4 3.6 Cc1cccnc1N1CCN(C(=O)N2CCNc3cc(Cl)ccc32)[C@H](C)C1 10.1016/j.bmcl.2020.127416
CHEMBL4742173 179592 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 385 1 1 4 3.6 Cc1cccnc1N1CCN(C(=O)N2CCNc3cc(Cl)ccc32)[C@H](C)C1 10.1016/j.bmcl.2020.127416
135192979 175836 None 0 Human Functional pIC50 = 5.1 5.1 -41 4
Antagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assayAntagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assay
ChEMBL 485 7 0 8 3.5 COc1ccc(-n2c(CO[C@H]3CCOC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
CHEMBL4585239 175836 None 0 Human Functional pIC50 = 5.1 5.1 -41 4
Antagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assayAntagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assay
ChEMBL 485 7 0 8 3.5 COc1ccc(-n2c(CO[C@H]3CCOC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
137189941 138076 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at human vasopressin 1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assayAntagonist activity at human vasopressin 1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assay
ChEMBL 560 12 1 8 5.2 COc1cc(CN2CCN(CCCCCCCC(=O)N3Cc4cnn(C)c4Nc4ccccc43)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
CHEMBL3765689 138076 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at human vasopressin 1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assayAntagonist activity at human vasopressin 1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assay
ChEMBL 560 12 1 8 5.2 COc1cc(CN2CCN(CCCCCCCC(=O)N3Cc4cnn(C)c4Nc4ccccc43)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
135193003 175382 None 0 Human Functional pIC50 = 6.1 6.1 -3 3
Antagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assayAntagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assay
ChEMBL 424 5 0 7 3.3 COc1ccc(-n2c(CC#N)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
CHEMBL4575160 175382 None 0 Human Functional pIC50 = 6.1 6.1 -3 3
Antagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assayAntagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assay
ChEMBL 424 5 0 7 3.3 COc1ccc(-n2c(CC#N)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
9937535 63036 None 1 Human Functional pIC50 = 7.1 7.1 25 4
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 554 7 2 4 5.1 CN(C)CCNC(=O)C1=C[C@@]2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL1788221 63036 None 1 Human Functional pIC50 = 7.1 7.1 25 4
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 554 7 2 4 5.1 CN(C)CCNC(=O)C1=C[C@@]2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
44336768 163350 None 0 Human Functional pIC50 = 7.1 7.1 1 2
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 599 7 3 4 6.1 O=C(O)CNC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL419183 163350 None 0 Human Functional pIC50 = 7.1 7.1 1 2
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 599 7 3 4 6.1 O=C(O)CNC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
44444760 154617 None 0 Human Functional pIC50 = 6.1 6.1 1 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 518 4 2 3 6.1 O=C(O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3cc(F)ccc3Cl)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
CHEMBL399288 154617 None 0 Human Functional pIC50 = 6.1 6.1 1 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 518 4 2 3 6.1 O=C(O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3cc(F)ccc3Cl)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
145960494 161559 None 0 Human Functional pIC50 = 5.1 5.1 -72 4
Antagonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by AVP addition measured for 5 mins by Fluo-4-AM dye based FLIPR assayAntagonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by AVP addition measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1081 17 11 14 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccc(cc2)SC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL4128839 161559 None 0 Human Functional pIC50 = 5.1 5.1 -72 4
Antagonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by AVP addition measured for 5 mins by Fluo-4-AM dye based FLIPR assayAntagonist activity at human liver vasopressin V1a receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by AVP addition measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1081 17 11 14 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccc(cc2)SC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
135413563 122928 None 25 Human Functional pIC50 = 8.1 8.1 3 3
Antagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVPAntagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVP
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL360648 122928 None 25 Human Functional pIC50 = 8.1 8.1 3 3
Antagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVPAntagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVP
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/acs.jmedchem.8b00697
162667594 182525 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 370 1 1 3 3.8 Cc1ccccc1N1CCN(C(=O)N2CCNc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4787242 182525 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 370 1 1 3 3.8 Cc1ccccc1N1CCN(C(=O)N2CCNc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
31112441 180336 None 1 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 439 4 1 4 4.9 Cc1ccccc1N1CCN(C(=O)c2ccc(Cl)c(NC(=O)c3cccs3)c2)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4751260 180336 None 1 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 439 4 1 4 4.9 Cc1ccccc1N1CCN(C(=O)c2ccc(Cl)c(NC(=O)c3cccs3)c2)CC1 10.1016/j.bmcl.2020.127416
142391767 169640 None 0 Human Functional pIC50 = 6.1 6.1 -6 2
Antagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assayAntagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assay
ChEMBL 442 5 0 7 3.7 COCc1nnc(N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc2c(c1)OCO2 10.1021/acsmedchemlett.9b00186
CHEMBL4437214 169640 None 0 Human Functional pIC50 = 6.1 6.1 -6 2
Antagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assayAntagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assay
ChEMBL 442 5 0 7 3.7 COCc1nnc(N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc2c(c1)OCO2 10.1021/acsmedchemlett.9b00186
135192997 173828 None 0 Human Functional pIC50 = 6.1 6.1 -18 4
Antagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assayAntagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assay
ChEMBL 461 8 0 7 3.7 COc1ccc(-n2c(COCCF)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
CHEMBL4538696 173828 None 0 Human Functional pIC50 = 6.1 6.1 -18 4
Antagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assayAntagonist activity at human vasopressin V1A receptor expressed in HEK293 cells assessed as decrease in vasopressin-stimulated calcium flux measured after 10 mins by Fluo-4 dye based microplate reader based assay
ChEMBL 461 8 0 7 3.7 COc1ccc(-n2c(COCCF)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
137212770 138052 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at human vasopressin 1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assayAntagonist activity at human vasopressin 1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assay
ChEMBL 532 10 1 8 4.4 COc1cc(CN2CCN(CCCCCC(=O)N3Cc4cnn(C)c4Nc4ccccc43)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
CHEMBL3765356 138052 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at human vasopressin 1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assayAntagonist activity at human vasopressin 1a receptor expressed in HEK293 cells assessed as inhibition of vasopressin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assay
ChEMBL 532 10 1 8 4.4 COc1cc(CN2CCN(CCCCCC(=O)N3Cc4cnn(C)c4Nc4ccccc43)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
10383074 66040 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 347 4 0 5 3.7 Cc1cccc(Cn2c(C)nnc2C2CCN(c3ccccn3)CC2)c1 10.1016/j.bmcl.2011.08.038
CHEMBL1837019 66040 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 347 4 0 5 3.7 Cc1cccc(Cn2c(C)nnc2C2CCN(c3ccccn3)CC2)c1 10.1016/j.bmcl.2011.08.038
162675154 183422 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 370 2 1 3 3.5 O=C(N1CCN(Cc2ccccc2)CC1)N1CCNc2cc(Cl)ccc21 10.1016/j.bmcl.2020.127416
CHEMBL4798616 183422 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 370 2 1 3 3.5 O=C(N1CCN(Cc2ccccc2)CC1)N1CCNc2cc(Cl)ccc21 10.1016/j.bmcl.2020.127416
162658968 181280 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 384 1 0 3 3.8 Cc1ccccc1N1CCN(C(=O)N2CN(C)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4762200 181280 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 384 1 0 3 3.8 Cc1ccccc1N1CCN(C(=O)N2CN(C)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
162676890 183488 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 355 1 0 2 4.0 Cc1ccccc1N1CCN(C(=O)N2CCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4799501 183488 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assayAntagonist activity at human V1a receptor expressed in human 1321N1 cells assessed as decrease in Arg8-vasopressin-stimulated calcium flux by fluorometric calcium assay
ChEMBL 355 1 0 2 4.0 Cc1ccccc1N1CCN(C(=O)N2CCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
11261339 154618 None 0 Human Functional pIC50 = 7.1 7.1 2 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 548 5 2 4 6.1 COc1cc(C(=O)N2CCC3(C=C(C(=O)O)CC3)Cc3ccccc32)ccc1NC(=O)c1cc(F)ccc1Cl 10.1016/j.bmcl.2007.09.059
CHEMBL399289 154618 None 0 Human Functional pIC50 = 7.1 7.1 2 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 548 5 2 4 6.1 COc1cc(C(=O)N2CCC3(C=C(C(=O)O)CC3)Cc3ccccc32)ccc1NC(=O)c1cc(F)ccc1Cl 10.1016/j.bmcl.2007.09.059
11451056 66038 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 353 3 0 5 4.0 Cc1nnc(C2CCN(c3ccccn3)CC2)n1-c1ccc(Cl)cc1 10.1016/j.bmcl.2011.08.038
CHEMBL1837017 66038 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 353 3 0 5 4.0 Cc1nnc(C2CCN(c3ccccn3)CC2)n1-c1ccc(Cl)cc1 10.1016/j.bmcl.2011.08.038
145974527 164758 None 0 Human Functional pIC50 = 8.1 8.1 67 2
Antagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVPAntagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVP
ChEMBL 491 5 3 6 3.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)NCC(=S)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4217872 164758 None 0 Human Functional pIC50 = 8.1 8.1 67 2
Antagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVPAntagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVP
ChEMBL 491 5 3 6 3.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)NCC(=S)N(C)C 10.1021/acs.jmedchem.8b00697
23598641 94275 None 0 Human Functional pIC50 = 8.1 8.1 6 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 528 5 2 3 6.9 O=C(Nc1ccc(C(=O)N2CCC3(C=C(CO)CC3)Cc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2007.09.059
CHEMBL250346 94275 None 0 Human Functional pIC50 = 8.1 8.1 6 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 528 5 2 3 6.9 O=C(Nc1ccc(C(=O)N2CCC3(C=C(CO)CC3)Cc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2007.09.059
21925559 66054 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 381 2 0 6 3.7 Clc1cccc2c1COCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2011.08.038
CHEMBL1837033 66054 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Antagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assayAntagonist activity at human V1A receptor expressed in CHO cells assessed as inhibition of AVP-induced intracellular calcium release after 30 seconds by FLIPR assay
ChEMBL 381 2 0 6 3.7 Clc1cccc2c1COCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2011.08.038
145972114 164625 None 0 Human Functional pIC50 = 7.0 7.0 3 2
Antagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVPAntagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVP
ChEMBL 515 4 2 6 3.4 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=O)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4216174 164625 None 0 Human Functional pIC50 = 7.0 7.0 3 2
Antagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVPAntagonist activity at human V1A receptor expressed in HEK cells assessed as inhibition of AVP-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay relative to AVP
ChEMBL 515 4 2 6 3.4 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=O)N(C)C 10.1021/acs.jmedchem.8b00697
25133001 94496 None 0 Human Functional pIC50 = 7.0 7.0 7 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 570 5 2 4 6.9 COc1cc(C(=O)N2CC[C@]3(C=C(c4ncc[nH]4)CC3)Cc3ccccc32)ccc1NC(=O)c1cc(F)ccc1Cl 10.1016/j.bmcl.2007.09.059
CHEMBL251561 94496 None 0 Human Functional pIC50 = 7.0 7.0 7 2
Antagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium levelAntagonist activity at human vasopressin V1a receptor expressed in HEK293 cells assessed as inhibition of Arg-vasopressin-induced intracellular calcium level
ChEMBL 570 5 2 4 6.9 COc1cc(C(=O)N2CC[C@]3(C=C(c4ncc[nH]4)CC3)Cc3ccccc32)ccc1NC(=O)c1cc(F)ccc1Cl 10.1016/j.bmcl.2007.09.059
44336402 168129 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 594 7 2 4 6.0 O=C(NCCN1CCCCC1)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL432973 168129 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 594 7 2 4 6.0 O=C(NCCN1CCCCC1)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
44336791 8122 None 0 Human Functional pIC50 = 7 7.0 - 1
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 527 6 3 4 4.5 O=C(NCCO)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL109166 8122 None 0 Human Functional pIC50 = 7 7.0 - 1
Evaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptorEvaluated for intracellular calcium mobilization in HEK293 cells transfected to express human vasopressin V1a receptor
ChEMBL 527 6 3 4 4.5 O=C(NCCO)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
42645362 194912 None 0 Rat Functional pKd = 5.8 5.8 - 0
Antagonist activity at vasopressin V1a receptor in phenoxybenzamine-treated Wistar rat uterus assessed as inhibition of vasopressin-induced arterial vasopressor activity treated 1 min prior to vasopressin challengeAntagonist activity at vasopressin V1a receptor in phenoxybenzamine-treated Wistar rat uterus assessed as inhibition of vasopressin-induced arterial vasopressor activity treated 1 min prior to vasopressin challenge
ChEMBL 1128 20 13 14 -2.2 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
CHEMBL541246 194912 None 0 Rat Functional pKd = 5.8 5.8 - 0
Antagonist activity at vasopressin V1a receptor in phenoxybenzamine-treated Wistar rat uterus assessed as inhibition of vasopressin-induced arterial vasopressor activity treated 1 min prior to vasopressin challengeAntagonist activity at vasopressin V1a receptor in phenoxybenzamine-treated Wistar rat uterus assessed as inhibition of vasopressin-induced arterial vasopressor activity treated 1 min prior to vasopressin challenge
ChEMBL 1128 20 13 14 -2.2 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
45270786 195888 None 0 Rat Functional pKd = 7.4 7.4 - 0
Antagonist activity at vasopressin V1a receptor in phenoxybenzamine-treated Wistar rat uterus assessed as inhibition of vasopressin-induced arterial vasopressor activity treated 1 min prior to vasopressin challengeAntagonist activity at vasopressin V1a receptor in phenoxybenzamine-treated Wistar rat uterus assessed as inhibition of vasopressin-induced arterial vasopressor activity treated 1 min prior to vasopressin challenge
ChEMBL 1168 18 12 13 0.8 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](C(c2ccccc2)c2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1016/j.ejmech.2008.12.010
CHEMBL558950 195888 None 0 Rat Functional pKd = 7.4 7.4 - 0
Antagonist activity at vasopressin V1a receptor in phenoxybenzamine-treated Wistar rat uterus assessed as inhibition of vasopressin-induced arterial vasopressor activity treated 1 min prior to vasopressin challengeAntagonist activity at vasopressin V1a receptor in phenoxybenzamine-treated Wistar rat uterus assessed as inhibition of vasopressin-induced arterial vasopressor activity treated 1 min prior to vasopressin challenge
ChEMBL 1168 18 12 13 0.8 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](C(c2ccccc2)c2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1016/j.ejmech.2008.12.010
45267363 195515 None 0 Rat Functional pKd = 8.4 8.4 - 0
Antagonist activity at vasopressin V1a receptor in phenoxybenzamine-treated Wistar rat uterus assessed as inhibition of vasopressin-induced arterial vasopressor activity treated 1 min prior to vasopressin challengeAntagonist activity at vasopressin V1a receptor in phenoxybenzamine-treated Wistar rat uterus assessed as inhibition of vasopressin-induced arterial vasopressor activity treated 1 min prior to vasopressin challenge
ChEMBL 1107 17 12 14 -1.2 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1016/j.ejmech.2008.12.010
CHEMBL553710 195515 None 0 Rat Functional pKd = 8.4 8.4 - 0
Antagonist activity at vasopressin V1a receptor in phenoxybenzamine-treated Wistar rat uterus assessed as inhibition of vasopressin-induced arterial vasopressor activity treated 1 min prior to vasopressin challengeAntagonist activity at vasopressin V1a receptor in phenoxybenzamine-treated Wistar rat uterus assessed as inhibition of vasopressin-induced arterial vasopressor activity treated 1 min prior to vasopressin challenge
ChEMBL 1107 17 12 14 -1.2 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1016/j.ejmech.2008.12.010
42645836 194804 None 0 Rat Functional pKd = 6.2 6.2 - 0
Antagonist activity at vasopressin V1a receptor in phenoxybenzamine-treated Wistar rat uterus assessed as inhibition of vasopressin-induced arterial vasopressor activity treated 1 min prior to vasopressin challengeAntagonist activity at vasopressin V1a receptor in phenoxybenzamine-treated Wistar rat uterus assessed as inhibition of vasopressin-induced arterial vasopressor activity treated 1 min prior to vasopressin challenge
ChEMBL 1128 20 13 14 -2.2 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
CHEMBL538934 194804 None 0 Rat Functional pKd = 6.2 6.2 - 0
Antagonist activity at vasopressin V1a receptor in phenoxybenzamine-treated Wistar rat uterus assessed as inhibition of vasopressin-induced arterial vasopressor activity treated 1 min prior to vasopressin challengeAntagonist activity at vasopressin V1a receptor in phenoxybenzamine-treated Wistar rat uterus assessed as inhibition of vasopressin-induced arterial vasopressor activity treated 1 min prior to vasopressin challenge
ChEMBL 1128 20 13 14 -2.2 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
46225081 202227 None 0 Human Functional pKi = 6 6.0 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 431 7 0 8 3.1 COCc1nnc(N2CC[C@@H](Oc3cc(F)cc(F)c3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL609848 202227 None 0 Human Functional pKi = 6 6.0 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 431 7 0 8 3.1 COCc1nnc(N2CC[C@@H](Oc3cc(F)cc(F)c3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
53316694 56764 None 0 Human Functional pKi = 6 6.0 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 513 11 1 6 5.7 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCC(C)C)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643585 56764 None 0 Human Functional pKi = 6 6.0 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 513 11 1 6 5.7 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCC(C)C)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
44571530 179914 None 0 Human Functional pKi = 5 5.0 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 379 7 0 3 4.7 COc1ccc(C)cc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL474609 179914 None 0 Human Functional pKi = 5 5.0 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 379 7 0 3 4.7 COc1ccc(C)cc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
46884414 7836 None 0 Human Functional pKi = 6.0 6.0 - 0
Antagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assay
ChEMBL 334 4 0 5 3.1 COc1ccc(N(C)C(=O)c2cnc(-c3ccccc3C)cn2)cn1 10.1016/j.bmcl.2010.02.018
CHEMBL1089682 7836 None 0 Human Functional pKi = 6.0 6.0 - 0
Antagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assay
ChEMBL 334 4 0 5 3.1 COc1ccc(N(C)C(=O)c2cnc(-c3ccccc3C)cn2)cn1 10.1016/j.bmcl.2010.02.018
11538526 199571 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 397 5 0 7 3.5 COc1ccc(-n2c(C)nnc2N2CCC(Oc3ccc(F)cc3C)CC2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL592494 199571 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 397 5 0 7 3.5 COc1ccc(-n2c(C)nnc2N2CCC(Oc3ccc(F)cc3C)CC2)cn1 10.1016/j.bmcl.2009.11.097
11683187 199930 None 44 Human Functional pKi = 6.0 6.0 - 2
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL594828 199930 None 44 Human Functional pKi = 6.0 6.0 - 2
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
44571387 184062 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 401 7 0 3 5.2 COc1ccccc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL482321 184062 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 401 7 0 3 5.2 COc1ccccc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
46884479 8259 None 0 Human Functional pKi = 4.9 4.9 - 0
Antagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assay
ChEMBL 403 7 0 7 3.0 COCCN(C(=O)c1cnc(-c2ccc(C#N)cc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1092457 8259 None 0 Human Functional pKi = 4.9 4.9 - 0
Antagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assay
ChEMBL 403 7 0 7 3.0 COCCN(C(=O)c1cnc(-c2ccc(C#N)cc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
44577939 189188 None 0 Human Functional pKi = 5.9 5.9 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 406 6 0 8 3.4 COCc1nnc(-c2cnc(-c3ccc(F)c(C)c3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
CHEMBL511265 189188 None 0 Human Functional pKi = 5.9 5.9 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 406 6 0 8 3.4 COCc1nnc(-c2cnc(-c3ccc(F)c(C)c3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
46225023 199541 None 1 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 365 5 0 7 3.0 COc1ccc(-n2c(C)nnc2N2CCC(Oc3ccccc3)CC2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL592250 199541 None 1 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 365 5 0 7 3.0 COc1ccc(-n2c(C)nnc2N2CCC(Oc3ccccc3)CC2)cn1 10.1016/j.bmcl.2009.11.097
46881861 8270 None 0 Human Functional pKi = 5.9 5.9 - 0
Antagonist activity at human vasopressin V1A receptorAntagonist activity at human vasopressin V1A receptor
ChEMBL 345 4 0 4 2.9 COc1ccc(N(C)C(=O)N2CC(Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2010.01.143
CHEMBL1092499 8270 None 0 Human Functional pKi = 5.9 5.9 - 0
Antagonist activity at human vasopressin V1A receptorAntagonist activity at human vasopressin V1A receptor
ChEMBL 345 4 0 4 2.9 COc1ccc(N(C)C(=O)N2CC(Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2010.01.143
11384094 178581 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 402 6 0 8 3.6 COCc1nnc(-c2cnc(-c3cccc(C)c3C)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
CHEMBL467186 178581 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 402 6 0 8 3.6 COCc1nnc(-c2cnc(-c3cccc(C)c3C)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
46225117 199291 None 0 Human Functional pKi = 5.9 5.9 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 401 7 0 8 2.7 COCc1nnc(N2CC(Oc3ccccc3Cl)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL590349 199291 None 0 Human Functional pKi = 5.9 5.9 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 401 7 0 8 2.7 COCc1nnc(N2CC(Oc3ccccc3Cl)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
44581242 175885 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human recombinant vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 475 8 0 6 4.9 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3C)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL458635 175885 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human recombinant vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 475 8 0 6 4.9 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3C)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
44571488 183820 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 396 6 0 3 5.0 N#Cc1ccccc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL480584 183820 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 396 6 0 3 5.0 N#Cc1ccccc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
44571490 183944 None 0 Human Functional pKi = 5.8 5.8 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 415 7 0 3 5.5 COc1ccc(C)cc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL481568 183944 None 0 Human Functional pKi = 5.8 5.8 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 415 7 0 3 5.5 COc1ccc(C)cc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
46225118 201050 None 0 Human Functional pKi = 5.8 5.8 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 369 5 0 7 2.7 COc1ccc(-n2c(C)nnc2N2CC(Oc3cc(F)ccc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL602641 201050 None 0 Human Functional pKi = 5.8 5.8 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 369 5 0 7 2.7 COc1ccc(-n2c(C)nnc2N2CC(Oc3cc(F)ccc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
11486351 192975 None 0 Human Functional pKi = 5.8 5.8 - 0
Antagonist activity at human vasopressin V1a receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human vasopressin V1a receptor by cell based beta-lactamase reporter gene assay
ChEMBL 398 10 0 8 3.2 CCOc1ccc(-c2nnc(COCCOC)n2-c2ccc(OC)nc2)cc1C 10.1016/j.bmcl.2008.08.066
CHEMBL522255 192975 None 0 Human Functional pKi = 5.8 5.8 - 0
Antagonist activity at human vasopressin V1a receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human vasopressin V1a receptor by cell based beta-lactamase reporter gene assay
ChEMBL 398 10 0 8 3.2 CCOc1ccc(-c2nnc(COCCOC)n2-c2ccc(OC)nc2)cc1C 10.1016/j.bmcl.2008.08.066
46225048 201811 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 415 5 0 7 3.6 COc1ccc(-n2c(C)nnc2N2CCC(Oc3cc(F)cc(F)c3C)CC2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL606976 201811 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 415 5 0 7 3.6 COc1ccc(-n2c(C)nnc2N2CCC(Oc3cc(F)cc(F)c3C)CC2)cn1 10.1016/j.bmcl.2009.11.097
46225049 201142 None 0 Human Functional pKi = 5.7 5.7 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 351 5 0 7 2.6 COc1ccc(-n2c(C)nnc2N2CC[C@@H](Oc3ccccc3)C2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL603205 201142 None 0 Human Functional pKi = 5.7 5.7 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 351 5 0 7 2.6 COc1ccc(-n2c(C)nnc2N2CC[C@@H](Oc3ccccc3)C2)cn1 10.1016/j.bmcl.2009.11.097
46225116 199251 None 0 Human Functional pKi = 5.7 5.7 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 371 5 0 7 2.9 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccccc3Cl)C2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL590099 199251 None 0 Human Functional pKi = 5.7 5.7 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 371 5 0 7 2.9 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccccc3Cl)C2)cn1 10.1016/j.bmcl.2009.11.097
44572048 189512 None 0 Human Functional pKi = 5.7 5.7 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 349 6 0 2 4.7 Cc1cc(-c2ccccc2)ccc1C(=O)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL514031 189512 None 0 Human Functional pKi = 5.7 5.7 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 349 6 0 2 4.7 Cc1cc(-c2ccccc2)ccc1C(=O)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
53317994 56765 None 0 Human Functional pKi = 5.7 5.7 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 513 11 0 6 5.8 CCN(CC)Cc1ccc(-c2nc(CN(C3CCCC3)S(=O)(=O)c3ccc(OC)cc3)cs2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643586 56765 None 0 Human Functional pKi = 5.7 5.7 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 513 11 0 6 5.8 CCN(CC)Cc1ccc(-c2nc(CN(C3CCCC3)S(=O)(=O)c3ccc(OC)cc3)cs2)cc1 10.1016/j.bmcl.2010.11.061
53323297 56767 None 0 Human Functional pKi = 5.7 5.7 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 499 11 1 6 5.5 CCCNCc1ccc(-c2nc(CN(C3CCCC3)S(=O)(=O)c3ccc(OC)cc3)cs2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643588 56767 None 0 Human Functional pKi = 5.7 5.7 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 499 11 1 6 5.5 CCCNCc1ccc(-c2nc(CN(C3CCCC3)S(=O)(=O)c3ccc(OC)cc3)cs2)cc1 10.1016/j.bmcl.2010.11.061
44571386 184064 None 0 Human Functional pKi = 8.6 8.6 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 403 6 0 2 5.6 Cc1cc(F)ccc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL482323 184064 None 0 Human Functional pKi = 8.6 8.6 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 403 6 0 2 5.6 Cc1cc(F)ccc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
46884440 8402 None 0 Human Functional pKi = 5.7 5.7 - 0
Antagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assay
ChEMBL 352 4 0 5 3.3 COc1ccc(N(C)C(=O)c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2010.02.018
CHEMBL1093366 8402 None 0 Human Functional pKi = 5.7 5.7 - 0
Antagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assay
ChEMBL 352 4 0 5 3.3 COc1ccc(N(C)C(=O)c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2010.02.018
44577982 178636 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 378 4 0 7 3.8 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccccc3Cl)cn2)cn1 10.1016/j.bmcl.2008.06.098
CHEMBL467545 178636 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 378 4 0 7 3.8 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccccc3Cl)cn2)cn1 10.1016/j.bmcl.2008.06.098
11625088 199570 None 0 Human Functional pKi = 7.7 7.7 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 379 5 0 7 3.3 COc1ccc(-n2c(C)nnc2N2CCC(Oc3ccccc3C)CC2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL592493 199570 None 0 Human Functional pKi = 7.7 7.7 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 379 5 0 7 3.3 COc1ccc(-n2c(C)nnc2N2CCC(Oc3ccccc3C)CC2)cn1 10.1016/j.bmcl.2009.11.097
44579442 186826 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human vasopressin V1a receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human vasopressin V1a receptor by cell based beta-lactamase reporter gene assay
ChEMBL 391 7 0 9 2.7 CCOc1ccc(-c2nnc(Cn3nccn3)n2-c2ccc(OC)nc2)cc1C 10.1016/j.bmcl.2008.08.066
CHEMBL489387 186826 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human vasopressin V1a receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human vasopressin V1a receptor by cell based beta-lactamase reporter gene assay
ChEMBL 391 7 0 9 2.7 CCOc1ccc(-c2nnc(Cn3nccn3)n2-c2ccc(OC)nc2)cc1C 10.1016/j.bmcl.2008.08.066
46884437 7737 None 0 Human Functional pKi = 5.6 5.6 - 0
Antagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assay
ChEMBL 348 5 0 5 3.5 CCN(C(=O)c1cnc(-c2ccccc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1089025 7737 None 0 Human Functional pKi = 5.6 5.6 - 0
Antagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assay
ChEMBL 348 5 0 5 3.5 CCN(C(=O)c1cnc(-c2ccccc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
16062053 194837 None 0 Human Functional pKi = 5.6 5.6 - 0
Antagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase assayAntagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase assay
ChEMBL 360 5 0 8 3.2 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL539665 194837 None 0 Human Functional pKi = 5.6 5.6 - 0
Antagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase assayAntagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase assay
ChEMBL 360 5 0 8 3.2 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3)cn2)cn1 10.1016/j.bmcl.2009.03.160
11502419 199572 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 409 7 0 8 3.2 COCc1nnc(N2CCC(Oc3ccccc3C)CC2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL592495 199572 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 409 7 0 8 3.2 COCc1nnc(N2CCC(Oc3ccccc3C)CC2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
11574636 199108 None 0 Human Functional pKi = 5.6 5.6 - 0
Antagonist activity at human vasopressin V1A receptorAntagonist activity at human vasopressin V1A receptor
ChEMBL 389 5 0 7 3.0 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1016/j.bmcl.2010.01.143
CHEMBL589125 199108 None 0 Human Functional pKi = 5.6 5.6 - 0
Antagonist activity at human vasopressin V1A receptorAntagonist activity at human vasopressin V1A receptor
ChEMBL 389 5 0 7 3.0 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1016/j.bmcl.2010.01.143
44577984 189273 None 0 Human Functional pKi = 5.6 5.6 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 418 7 0 9 3.3 COCc1nnc(-c2cnc(-c3ccc(OC)c(C)c3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
CHEMBL511917 189273 None 0 Human Functional pKi = 5.6 5.6 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 418 7 0 9 3.3 COCc1nnc(-c2cnc(-c3ccc(OC)c(C)c3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
11574636 199108 None 0 Human Functional pKi = 5.6 5.6 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 389 5 0 7 3.0 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL589125 199108 None 0 Human Functional pKi = 5.6 5.6 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 389 5 0 7 3.0 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1016/j.bmcl.2009.11.097
44581241 175884 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at human recombinant vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 495 8 0 6 5.2 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3Cl)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL458634 175884 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at human recombinant vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 495 8 0 6 5.2 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3Cl)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
44571491 183945 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 367 6 0 2 4.8 Cc1cc(F)ccc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL481569 183945 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 367 6 0 2 4.8 Cc1cc(F)ccc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
50941635 56763 None 0 Human Functional pKi = 5.6 5.6 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 513 12 1 6 5.8 CCCCNCc1ccc(-c2nc(CN(C3CCCC3)S(=O)(=O)c3ccc(OC)cc3)cs2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643584 56763 None 0 Human Functional pKi = 5.6 5.6 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 513 12 1 6 5.8 CCCCNCc1ccc(-c2nc(CN(C3CCCC3)S(=O)(=O)c3ccc(OC)cc3)cs2)cc1 10.1016/j.bmcl.2010.11.061
46225079 199250 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 395 7 0 8 2.8 COCc1nnc(N2CC[C@@H](Oc3ccccc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL590097 199250 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 395 7 0 8 2.8 COCc1nnc(N2CC[C@@H](Oc3ccccc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
44577937 178580 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 402 7 0 7 4.2 COCc1nnc(-c2ccc(-c3ccccc3OC)cc2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
CHEMBL467185 178580 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 402 7 0 7 4.2 COCc1nnc(-c2ccc(-c3ccccc3OC)cc2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
44215484 178578 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 440 7 0 6 4.6 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCN1CCOCC1 10.1016/j.bmcl.2008.06.098
CHEMBL467154 178578 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 440 7 0 6 4.6 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCN1CCOCC1 10.1016/j.bmcl.2008.06.098
44579441 186825 None 0 Human Functional pKi = 5.5 5.5 - 0
Antagonist activity at human vasopressin V1a receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human vasopressin V1a receptor by cell based beta-lactamase reporter gene assay
ChEMBL 374 7 0 7 3.5 CCOc1ccc(-c2nnc(COC)n2-c2ccc(OC)nc2)cc1Cl 10.1016/j.bmcl.2008.08.066
CHEMBL489386 186825 None 0 Human Functional pKi = 5.5 5.5 - 0
Antagonist activity at human vasopressin V1a receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human vasopressin V1a receptor by cell based beta-lactamase reporter gene assay
ChEMBL 374 7 0 7 3.5 CCOc1ccc(-c2nnc(COC)n2-c2ccc(OC)nc2)cc1Cl 10.1016/j.bmcl.2008.08.066
44572107 179928 None 0 Human Functional pKi = 8.5 8.5 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 385 6 0 2 5.5 Cc1cc(C(=O)N(Cc2ccccc2)CC2CCCO2)ccc1-c1ccccc1 10.1016/j.bmcl.2008.11.064
CHEMBL474621 179928 None 0 Human Functional pKi = 8.5 8.5 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 385 6 0 2 5.5 Cc1cc(C(=O)N(Cc2ccccc2)CC2CCCO2)ccc1-c1ccccc1 10.1016/j.bmcl.2008.11.064
44571429 183813 None 0 Human Functional pKi = 8.4 8.4 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 440 6 0 3 5.6 O=C(c1ccc(-c2ccccc2C(F)(F)F)nc1)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL480546 183813 None 0 Human Functional pKi = 8.4 8.4 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 440 6 0 3 5.6 O=C(c1ccc(-c2ccccc2C(F)(F)F)nc1)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
53323298 56768 None 0 Human Functional pKi = 5.5 5.5 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 553 11 1 6 6.6 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCC4CCCCC4)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643589 56768 None 0 Human Functional pKi = 5.5 5.5 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 553 11 1 6 6.6 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCC4CCCCC4)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
44577981 189289 None 0 Human Functional pKi = 5.5 5.5 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 369 5 0 8 2.8 COCc1nnc(-c2cnc(-c3cccc(C#N)c3)cn2)n1-c1cccnc1 10.1016/j.bmcl.2008.06.098
CHEMBL512105 189289 None 0 Human Functional pKi = 5.5 5.5 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 369 5 0 8 2.8 COCc1nnc(-c2cnc(-c3cccc(C#N)c3)cn2)n1-c1cccnc1 10.1016/j.bmcl.2008.06.098
46884439 8401 None 0 Human Functional pKi = 5.5 5.5 - 0
Antagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assay
ChEMBL 378 7 0 6 3.1 COCCN(C(=O)c1cnc(-c2ccccc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1093365 8401 None 0 Human Functional pKi = 5.5 5.5 - 0
Antagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assay
ChEMBL 378 7 0 6 3.1 COCCN(C(=O)c1cnc(-c2ccccc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
44579401 187095 None 0 Human Functional pKi = 5.4 5.4 - 0
Antagonist activity at human vasopressin V1a receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human vasopressin V1a receptor by cell based beta-lactamase reporter gene assay
ChEMBL 354 7 0 7 3.2 CCOc1ccc(-c2nnc(COC)n2-c2ccc(OC)nc2)cc1C 10.1016/j.bmcl.2008.08.066
CHEMBL491422 187095 None 0 Human Functional pKi = 5.4 5.4 - 0
Antagonist activity at human vasopressin V1a receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human vasopressin V1a receptor by cell based beta-lactamase reporter gene assay
ChEMBL 354 7 0 7 3.2 CCOc1ccc(-c2nnc(COC)n2-c2ccc(OC)nc2)cc1C 10.1016/j.bmcl.2008.08.066
11257380 178612 None 0 Human Functional pKi = 6.4 6.4 - 0
Antagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase assayAntagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase assay
ChEMBL 376 4 0 7 3.6 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL467378 178612 None 0 Human Functional pKi = 6.4 6.4 - 0
Antagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase assayAntagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase assay
ChEMBL 376 4 0 7 3.6 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2009.03.160
11257380 178612 None 0 Human Functional pKi = 6.4 6.4 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 376 4 0 7 3.6 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL467378 178612 None 0 Human Functional pKi = 6.4 6.4 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 376 4 0 7 3.6 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2009.11.097
11257380 178612 None 0 Human Functional pKi = 6.4 6.4 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 376 4 0 7 3.6 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2008.06.098
CHEMBL467378 178612 None 0 Human Functional pKi = 6.4 6.4 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 376 4 0 7 3.6 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2008.06.098
44572105 172445 None 0 Human Functional pKi = 5.4 5.4 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 336 6 0 3 3.8 O=C(c1ccc(-c2ccccc2)nc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL447916 172445 None 0 Human Functional pKi = 5.4 5.4 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 336 6 0 3 3.8 O=C(c1ccc(-c2ccccc2)nc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
44572047 180705 None 0 Human Functional pKi = 5.4 5.4 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 360 6 0 3 4.3 N#Cc1ccccc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL475561 180705 None 0 Human Functional pKi = 5.4 5.4 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 360 6 0 3 4.3 N#Cc1ccccc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
44571529 189698 None 0 Human Functional pKi = 5.4 5.4 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 404 6 0 3 4.8 O=C(c1ccc(-c2ccccc2C(F)(F)F)nc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL515447 189698 None 0 Human Functional pKi = 5.4 5.4 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 404 6 0 3 4.8 O=C(c1ccc(-c2ccccc2C(F)(F)F)nc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
53324622 56770 None 0 Human Functional pKi = 4.4 4.4 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 577 12 1 7 6.3 COc1ccc(CNCc2ccc(-c3nc(CN(C4CCCC4)S(=O)(=O)c4ccc(OC)cc4)cs3)cc2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643591 56770 None 0 Human Functional pKi = 4.4 4.4 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 577 12 1 7 6.3 COc1ccc(CNCc2ccc(-c3nc(CN(C4CCCC4)S(=O)(=O)c4ccc(OC)cc4)cs3)cc2)cc1 10.1016/j.bmcl.2010.11.061
11475469 178792 None 0 Human Functional pKi = 5.4 5.4 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 413 6 0 9 3.1 COCc1nnc(-c2cnc(-c3ccc(C#N)cc3C)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
CHEMBL469005 178792 None 0 Human Functional pKi = 5.4 5.4 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 413 6 0 9 3.1 COCc1nnc(-c2cnc(-c3ccc(C#N)cc3C)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
44578010 189177 None 0 Human Functional pKi = 6.4 6.4 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 402 6 0 8 3.6 COCc1nnc(-c2cnc(-c3ccc(C)c(C)c3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
CHEMBL511215 189177 None 0 Human Functional pKi = 6.4 6.4 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 402 6 0 8 3.6 COCc1nnc(-c2cnc(-c3ccc(C)c(C)c3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
44577938 189304 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 374 6 0 8 2.9 COCc1nnc(-c2cnc(-c3ccccc3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
CHEMBL512257 189304 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 374 6 0 8 2.9 COCc1nnc(-c2cnc(-c3ccccc3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
44581266 175393 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human recombinant vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 479 8 0 6 4.7 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3F)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL457544 175393 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human recombinant vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 479 8 0 6 4.7 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3F)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
44581240 189722 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human recombinant vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 486 8 0 7 4.4 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3C#N)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL515660 189722 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human recombinant vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 486 8 0 7 4.4 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3C#N)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
44571388 192587 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 385 6 0 2 5.5 Cc1cc(-c2ccccc2)ccc1C(=O)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL521444 192587 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 385 6 0 2 5.5 Cc1cc(-c2ccccc2)ccc1C(=O)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
44571489 192282 None 0 Human Functional pKi = 6.3 6.3 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 372 6 0 3 4.6 O=C(c1ccc(-c2ccccc2)nc1)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL520595 192282 None 0 Human Functional pKi = 6.3 6.3 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 372 6 0 3 4.6 O=C(c1ccc(-c2ccccc2)nc1)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
46225082 199613 None 0 Human Functional pKi = 6.3 6.3 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 395 7 0 8 2.8 COCc1nnc(N2CC[C@H](Oc3ccccc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL592733 199613 None 0 Human Functional pKi = 6.3 6.3 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 395 7 0 8 2.8 COCc1nnc(N2CC[C@H](Oc3ccccc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
16062053 194837 None 0 Human Functional pKi = 6.3 6.3 - 0
Antagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase assayAntagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase assay
ChEMBL 360 5 0 8 3.2 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL539665 194837 None 0 Human Functional pKi = 6.3 6.3 - 0
Antagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase assayAntagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase assay
ChEMBL 360 5 0 8 3.2 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3)cn2)cn1 10.1016/j.bmcl.2009.03.160
44577936 178579 None 0 Human Functional pKi = 6.3 6.3 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 371 5 0 5 4.9 COc1ccc(-n2c(C)nnc2-c2ccc(-c3ccccc3OC)cc2)cc1 10.1016/j.bmcl.2008.06.098
CHEMBL467184 178579 None 0 Human Functional pKi = 6.3 6.3 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 371 5 0 5 4.9 COc1ccc(-n2c(C)nnc2-c2ccc(-c3ccccc3OC)cc2)cc1 10.1016/j.bmcl.2008.06.098
45483204 197885 None 0 Human Functional pKi = 5.3 5.3 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2010.11.061
CHEMBL1204126 197885 None 0 Human Functional pKi = 5.3 5.3 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2010.11.061
CHEMBL1204403 197885 None 0 Human Functional pKi = 5.3 5.3 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2010.11.061
CHEMBL572709 197885 None 0 Human Functional pKi = 5.3 5.3 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2010.11.061
2202 2759 None 33 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2010.11.061
9895468 2759 None 33 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2010.11.061
CHEMBL582857 2759 None 33 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2010.11.061
DB12643 2759 None 33 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2010.11.061
46225080 199612 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 413 7 0 8 2.9 COCc1nnc(N2CC[C@@H](Oc3ccc(F)cc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL592732 199612 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 413 7 0 8 2.9 COCc1nnc(N2CC[C@@H](Oc3ccc(F)cc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
46884480 8260 None 0 Human Functional pKi = 5.2 5.2 - 0
Antagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assay
ChEMBL 366 5 0 5 3.7 CCN(C(=O)c1cnc(-c2cccc(F)c2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1092458 8260 None 0 Human Functional pKi = 5.2 5.2 - 0
Antagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assay
ChEMBL 366 5 0 5 3.7 CCN(C(=O)c1cnc(-c2cccc(F)c2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
44579399 187160 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity at human vasopressin V1a receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human vasopressin V1a receptor by cell based beta-lactamase reporter gene assay
ChEMBL 368 8 0 7 3.6 CCOCc1nnc(-c2ccc(OCC)c(C)c2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.08.066
CHEMBL492029 187160 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity at human vasopressin V1a receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human vasopressin V1a receptor by cell based beta-lactamase reporter gene assay
ChEMBL 368 8 0 7 3.6 CCOCc1nnc(-c2ccc(OCC)c(C)c2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.08.066
11667812 199885 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 369 5 0 7 2.7 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL594591 199885 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 369 5 0 7 2.7 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
11667812 199885 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity at human vasopressin V1A receptorAntagonist activity at human vasopressin V1A receptor
ChEMBL 369 5 0 7 2.7 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2010.01.143
CHEMBL594591 199885 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity at human vasopressin V1A receptorAntagonist activity at human vasopressin V1A receptor
ChEMBL 369 5 0 7 2.7 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2010.01.143
53325929 56769 None 0 Human Functional pKi = 5.2 5.2 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 537 11 1 7 5.8 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCc4ccoc4)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643590 56769 None 0 Human Functional pKi = 5.2 5.2 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 537 11 1 7 5.8 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCc4ccoc4)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
46225153 199109 None 0 Human Functional pKi = 6.1 6.1 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 399 7 0 8 2.5 COCc1nnc(N2CC(Oc3ccc(F)cc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL589128 199109 None 0 Human Functional pKi = 6.1 6.1 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 399 7 0 8 2.5 COCc1nnc(N2CC(Oc3ccc(F)cc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
46884478 8488 None 0 Human Functional pKi = 5.1 5.1 - 0
Antagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assay
ChEMBL 373 5 0 6 3.4 CCN(C(=O)c1cnc(-c2ccc(C#N)cc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1094002 8488 None 0 Human Functional pKi = 5.1 5.1 - 0
Antagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned vasopressin V1A receptor by cell based beta-lactamase reporter gene assay
ChEMBL 373 5 0 6 3.4 CCN(C(=O)c1cnc(-c2ccc(C#N)cc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
11848692 178528 None 1 Human Functional pKi = 6.1 6.1 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 396 4 0 7 3.9 COc1ccc(-n2c(C)nnc2-c2cnc(-c3cccc(F)c3Cl)cn2)cn1 10.1016/j.bmcl.2008.06.098
CHEMBL466762 178528 None 1 Human Functional pKi = 6.1 6.1 - 0
Antagonist activity at vasopressin V1a receptorAntagonist activity at vasopressin V1a receptor
ChEMBL 396 4 0 7 3.9 COc1ccc(-n2c(C)nnc2-c2cnc(-c3cccc(F)c3Cl)cn2)cn1 10.1016/j.bmcl.2008.06.098
46225050 199611 None 0 Human Functional pKi = 6.1 6.1 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 365 5 0 7 2.9 COc1ccc(-n2c(C)nnc2N2CC[C@@H](Oc3ccccc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL592731 199611 None 0 Human Functional pKi = 6.1 6.1 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 365 5 0 7 2.9 COc1ccc(-n2c(C)nnc2N2CC[C@@H](Oc3ccccc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
46881862 7936 None 0 Human Functional pKi = 6.1 6.1 - 0
Antagonist activity at human vasopressin V1A receptorAntagonist activity at human vasopressin V1A receptor
ChEMBL 365 4 0 4 3.2 COc1ccc(N(C)C(=O)N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1016/j.bmcl.2010.01.143
CHEMBL1090417 7936 None 0 Human Functional pKi = 6.1 6.1 - 0
Antagonist activity at human vasopressin V1A receptorAntagonist activity at human vasopressin V1A receptor
ChEMBL 365 4 0 4 3.2 COc1ccc(N(C)C(=O)N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1016/j.bmcl.2010.01.143
42611262 180557 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 349 6 0 2 4.7 Cc1cc(C(=O)N(CC2CC2)CC2CCCO2)ccc1-c1ccccc1 10.1016/j.bmcl.2008.11.064
CHEMBL475395 180557 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 349 6 0 2 4.7 Cc1cc(C(=O)N(CC2CC2)CC2CCCO2)ccc1-c1ccccc1 10.1016/j.bmcl.2008.11.064
44571389 184063 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 440 6 0 3 5.6 O=C(c1ccc(-c2ncccc2C(F)(F)F)cc1)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL482322 184063 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 440 6 0 3 5.6 O=C(c1ccc(-c2ncccc2C(F)(F)F)cc1)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
44572045 189649 None 0 Human Functional pKi = 6.1 6.1 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 365 7 0 3 4.4 COc1ccccc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL515111 189649 None 0 Human Functional pKi = 6.1 6.1 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 365 7 0 3 4.4 COc1ccccc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
44571492 183966 None 0 Human Functional pKi = 5.1 5.1 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 404 6 0 3 4.8 O=C(c1ccc(-c2ncccc2C(F)(F)F)cc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL481730 183966 None 0 Human Functional pKi = 5.1 5.1 - 0
Antagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assayAntagonist activity at human vasopressin V1a receptor expressed in CHO cells by FLIPR assay
ChEMBL 404 6 0 3 4.8 O=C(c1ccc(-c2ncccc2C(F)(F)F)cc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
53316695 56766 None 0 Human Functional pKi = 5.1 5.1 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 527 10 1 6 6.1 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCC(C)(C)C)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643587 56766 None 0 Human Functional pKi = 5.1 5.1 - 0
Antagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant V1a receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 527 10 1 6 6.1 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCC(C)(C)C)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
46225051 199434 None 0 Human Functional pKi = 6.0 6.0 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 383 5 0 7 3.1 COc1ccc(-n2c(C)nnc2N2CC[C@@H](Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL591310 199434 None 0 Human Functional pKi = 6.0 6.0 - 0
Antagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assayAntagonist activity at human cloned vasopressin V1a receptor by cell based beta lactamase assay
ChEMBL 383 5 0 7 3.1 COc1ccc(-n2c(C)nnc2N2CC[C@@H](Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
2042 2981 None 58 Human Functional pEC50 = 8.2 8.2 -3 5
NoneNone
Drug Central None None None None None
2174 2981 None 58 Human Functional pEC50 = 8.2 8.2 -3 5
NoneNone
Drug Central None None None None None
2176 2981 None 58 Human Functional pEC50 = 8.2 8.2 -3 5
NoneNone
Drug Central None None None None None
439302 2981 None 58 Human Functional pEC50 = 8.2 8.2 -3 5
NoneNone
Drug Central None None None None None
CHEMBL395429 2981 None 58 Human Functional pEC50 = 8.2 8.2 -3 5
NoneNone
Drug Central None None None None None
DB00107 2981 None 58 Human Functional pEC50 = 8.2 8.2 -3 5
NoneNone
Drug Central None None None None None
11169 796 None 37 Human Functional pEC50 = 8.1 8.1 -1 5
NoneNone
Drug Central None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C None
131676677 796 None 37 Human Functional pEC50 = 8.1 8.1 -1 5
NoneNone
Drug Central None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C None
165708555 796 None 37 Human Functional pEC50 = 8.1 8.1 -1 5
NoneNone
Drug Central None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C None
16681432 796 None 37 Human Functional pEC50 = 8.1 8.1 -1 5
NoneNone
Drug Central None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C None
495 796 None 37 Human Functional pEC50 = 8.1 8.1 -1 5
NoneNone
Drug Central None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C None
CHEMBL3301668 796 None 37 Human Functional pEC50 = 8.1 8.1 -1 5
NoneNone
Drug Central None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C None
DB01282 796 None 37 Human Functional pEC50 = 8.1 8.1 -1 5
NoneNone
Drug Central None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C None
11454 3575 None 11 Human Functional pEC50 = 8.6 8.6 -4 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 21411496
53330936 3575 None 11 Human Functional pEC50 = 8.6 8.6 -4 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 21411496
CHEMBL1817709 3575 None 11 Human Functional pEC50 = 8.6 8.6 -4 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 21411496
DB12495 3575 None 11 Human Functional pEC50 = 8.6 8.6 -4 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 21411496




Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type
Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

16362 3123 None 71 Human Binding pAC50 = 5.0 5.0 - 30
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2172 3123 None 71 Human Binding pAC50 = 5.0 5.0 - 30
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
90 3123 None 71 Human Binding pAC50 = 5.0 5.0 - 30
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1423 3123 None 71 Human Binding pAC50 = 5.0 5.0 - 30
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01100 3123 None 71 Human Binding pAC50 = 5.0 5.0 - 30
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
3149 12612 None 15 Human Binding pAC50 = 5.0 5.0 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 334 15 0 1 6.1 CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1187011 12612 None 15 Human Binding pAC50 = 5.0 5.0 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 334 15 0 1 6.1 CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1 10.1038/s41467-023-40064-9
448537 160248 None 89 Human Binding pAC50 = 5.0 5.0 -45 25
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL411 160248 None 89 Human Binding pAC50 = 5.0 5.0 -45 25
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 10.1038/s41467-023-40064-9
11980903 14490 None 19 Human Binding pAC50 = 4.9 4.9 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
22526 14490 None 19 Human Binding pAC50 = 4.9 4.9 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
5281035 14490 None 19 Human Binding pAC50 = 4.9 4.9 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1201303 14490 None 19 Human Binding pAC50 = 4.9 4.9 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
1222 1662 None 49 Human Binding pAC50 = 4.9 4.9 - 33
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
3396 1662 None 49 Human Binding pAC50 = 4.9 4.9 - 33
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
85 1662 None 49 Human Binding pAC50 = 4.9 4.9 - 33
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL46516 1662 None 49 Human Binding pAC50 = 4.9 4.9 - 33
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
DB04842 1662 None 49 Human Binding pAC50 = 4.9 4.9 - 33
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
72093 35059 None 9 Human Binding pAC50 = 4.9 4.9 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 483 16 1 4 6.3 CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1 10.1038/s41467-023-40064-9
CHEMBL1433361 35059 None 9 Human Binding pAC50 = 4.9 4.9 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 483 16 1 4 6.3 CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1 10.1038/s41467-023-40064-9
CHEMBL2103773 35059 None 9 Human Binding pAC50 = 4.9 4.9 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 483 16 1 4 6.3 CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1 10.1038/s41467-023-40064-9
6436173 55114 None 45 Human Binding pAC50 = 4.9 4.9 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 785 2 5 13 6.2 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
CHEMBL1617 55114 None 45 Human Binding pAC50 = 4.9 4.9 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 785 2 5 13 6.2 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
2713 205269 None 82 Human Binding pAC50 = 4.8 4.8 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
5353524 205269 None 82 Human Binding pAC50 = 4.8 4.8 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
5360566 205269 None 82 Human Binding pAC50 = 4.8 4.8 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
88536661 205269 None 82 Human Binding pAC50 = 4.8 4.8 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
9552079 205269 None 82 Human Binding pAC50 = 4.8 4.8 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL1330113 205269 None 82 Human Binding pAC50 = 4.8 4.8 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL790 205269 None 82 Human Binding pAC50 = 4.8 4.8 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
103 4151 None 61 Human Binding pAC50 = 4.8 4.8 - 54
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2875 4151 None 61 Human Binding pAC50 = 4.8 4.8 - 54
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
5736 4151 None 61 Human Binding pAC50 = 4.8 4.8 - 54
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL285802 4151 None 61 Human Binding pAC50 = 4.8 4.8 - 54
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB09225 4151 None 61 Human Binding pAC50 = 4.8 4.8 - 54
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2335 11846 None 22 Human Binding pAC50 = 4.8 4.8 - 12
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
8478 11846 None 22 Human Binding pAC50 = 4.8 4.8 - 12
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1182210 11846 None 22 Human Binding pAC50 = 4.8 4.8 - 12
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL221753 11846 None 22 Human Binding pAC50 = 4.8 4.8 - 12
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
41684 31219 None 105 Human Binding pAC50 = 4.8 4.8 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 307 4 1 7 2.2 CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1 10.1038/s41467-023-40064-9
CHEMBL1401 31219 None 105 Human Binding pAC50 = 4.8 4.8 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 307 4 1 7 2.2 CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1 10.1038/s41467-023-40064-9
2213 518 None 46 Human Binding pAC50 = 7.7 7.7 28 5
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
3008 518 None 46 Human Binding pAC50 = 7.7 7.7 28 5
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
5311010 518 None 46 Human Binding pAC50 = 7.7 7.7 28 5
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
68613 518 None 46 Human Binding pAC50 = 7.7 7.7 28 5
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
CHEMBL378642 518 None 46 Human Binding pAC50 = 7.7 7.7 28 5
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
CHEMBL382301 518 None 46 Human Binding pAC50 = 7.7 7.7 28 5
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
DB09059 518 None 46 Human Binding pAC50 = 7.7 7.7 28 5
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
72081 209274 None 55 Human Binding pAC50 = 4.7 4.7 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL None None None NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1038/s41467-023-40064-9
CHEMBL2135460 209274 None 55 Human Binding pAC50 = 4.7 4.7 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL None None None NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1038/s41467-023-40064-9
DB02638 209274 None 55 Human Binding pAC50 = 4.7 4.7 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL None None None NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1038/s41467-023-40064-9
135409453 3771 None 41 Human Binding pAC50 = 4.7 4.7 - 2
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
226 3771 None 41 Human Binding pAC50 = 4.7 4.7 - 2
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
CHEMBL76370 3771 None 41 Human Binding pAC50 = 4.7 4.7 - 2
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
1385580 29274 None 76 Human Binding pAC50 = 4.7 4.7 - 5
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 426 7 1 4 4.1 O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
4615 29274 None 76 Human Binding pAC50 = 4.7 4.7 - 5
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 426 7 1 4 4.1 O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL13828 29274 None 76 Human Binding pAC50 = 4.7 4.7 - 5
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 426 7 1 4 4.1 O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
DB12877 29274 None 76 Human Binding pAC50 = 4.7 4.7 - 5
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 426 7 1 4 4.1 O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
24826799 10796 None 104 Human Binding pAC50 = 4.6 4.6 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 532 4 1 6 4.5 Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12 10.1038/s41467-023-40064-9
CHEMBL1171837 10796 None 104 Human Binding pAC50 = 4.6 4.6 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 532 4 1 6 4.5 Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12 10.1038/s41467-023-40064-9
242 470 None 124 Human Binding pAC50 = 5.6 5.6 - 52
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
34 470 None 124 Human Binding pAC50 = 5.6 5.6 - 52
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
60795 470 None 124 Human Binding pAC50 = 5.6 5.6 - 52
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL1112 470 None 124 Human Binding pAC50 = 5.6 5.6 - 52
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
DB01238 470 None 124 Human Binding pAC50 = 5.6 5.6 - 52
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
26248 161537 None 102 Human Binding pAC50 = 4.6 4.6 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 368 3 1 7 2.0 CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O 10.1038/s41467-023-40064-9
CHEMBL41286 161537 None 102 Human Binding pAC50 = 4.6 4.6 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 368 3 1 7 2.0 CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O 10.1038/s41467-023-40064-9
135398735 136966 None 32 Human Binding pAC50 = 4.6 4.6 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
136262914 136966 None 32 Human Binding pAC50 = 4.6 4.6 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
CHEMBL374478 136966 None 32 Human Binding pAC50 = 4.6 4.6 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
1549120 196484 None 85 Human Binding pAC50 = 4.6 4.6 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 319 4 1 4 2.9 CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL56337 196484 None 85 Human Binding pAC50 = 4.6 4.6 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 319 4 1 4 2.9 CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1 10.1038/s41467-023-40064-9
104850 3328 None 96 Human Binding pAC50 = 4.5 4.5 - 6
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
4150 3328 None 96 Human Binding pAC50 = 4.5 4.5 - 6
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
743 3328 None 96 Human Binding pAC50 = 4.5 4.5 - 6
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
CHEMBL111 3328 None 96 Human Binding pAC50 = 4.5 4.5 - 6
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
DB06155 3328 None 96 Human Binding pAC50 = 4.5 4.5 - 6
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
54585 14500 None 85 Human Binding pAC50 = 4.5 4.5 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 357 7 4 6 2.7 O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1201346 14500 None 85 Human Binding pAC50 = 4.5 4.5 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 357 7 4 6 2.7 O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1 10.1038/s41467-023-40064-9
30323 62483 None 57 Human Binding pAC50 = 5.4 5.4 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 527 4 5 11 1.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL1563 62483 None 57 Human Binding pAC50 = 5.4 5.4 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 527 4 5 11 1.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL178 62483 None 57 Human Binding pAC50 = 5.4 5.4 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 527 4 5 11 1.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
5328940 100214 None 107 Human Binding pAC50 = 5.3 5.3 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 529 9 1 8 5.2 COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl 10.1038/s41467-023-40064-9
CHEMBL288441 100214 None 107 Human Binding pAC50 = 5.3 5.3 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 529 9 1 8 5.2 COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl 10.1038/s41467-023-40064-9
392622 56310 None 95 Human Binding pAC50 = 5.2 5.2 -2 4
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 10.1038/s41467-023-40064-9
CHEMBL163 56310 None 95 Human Binding pAC50 = 5.2 5.2 -2 4
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 10.1038/s41467-023-40064-9
135564886 14491 None 5 Human Binding pAC50 = 5.1 5.1 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
135673376 14491 None 5 Human Binding pAC50 = 5.1 5.1 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
137157436 14491 None 5 Human Binding pAC50 = 5.1 5.1 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
145948239 14491 None 5 Human Binding pAC50 = 5.1 5.1 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
71587099 14491 None 5 Human Binding pAC50 = 5.1 5.1 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
CHEMBL1201304 14491 None 5 Human Binding pAC50 = 5.1 5.1 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
2194 63081 None 101 Human Binding pAC50 = 5.1 5.1 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 240 2 0 4 4.2 COc1ccc(-c2cc(=S)ss2)cc1 10.1038/s41467-023-40064-9
CHEMBL178862 63081 None 101 Human Binding pAC50 = 5.1 5.1 - 0
Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 240 2 0 4 4.2 COc1ccc(-c2cc(=S)ss2)cc1 10.1038/s41467-023-40064-9
2168 3974 None 38 Human Binding pEC50 = 9.6 9.6 -5 9
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
2810 3974 None 38 Human Binding pEC50 = 9.6 9.6 -5 9
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
644077 3974 None 38 Human Binding pEC50 = 9.6 9.6 -5 9
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
CHEMBL373742 3974 None 38 Human Binding pEC50 = 9.6 9.6 -5 9
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
DB00067 3974 None 38 Human Binding pEC50 = 9.6 9.6 -5 9
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
2042 2981 None 58 Human Binding pEC50 = 8 8.0 -29 8
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
2174 2981 None 58 Human Binding pEC50 = 8 8.0 -29 8
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
2176 2981 None 58 Human Binding pEC50 = 8 8.0 -29 8
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
439302 2981 None 58 Human Binding pEC50 = 8 8.0 -29 8
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
CHEMBL395429 2981 None 58 Human Binding pEC50 = 8 8.0 -29 8
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
DB00107 2981 None 58 Human Binding pEC50 = 8 8.0 -29 8
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
118719829 115751 None 0 Human Binding pEC50 = 7.9 7.9 - 0
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1035 23 11 14 -1.1 CCCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3353940 115751 None 0 Human Binding pEC50 = 7.9 7.9 - 0
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1035 23 11 14 -1.1 CCCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
10411308 201232 None 0 Human Binding pEC50 = 7.9 7.9 -2 3
Activity at human vasopressin V1a receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human vasopressin V1a receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/jm901084f
CHEMBL603708 201232 None 0 Human Binding pEC50 = 7.9 7.9 -2 3
Activity at human vasopressin V1a receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human vasopressin V1a receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/jm901084f
118719827 115749 None 0 Human Binding pEC50 = 7.7 7.7 - 0
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1021 22 11 14 -1.5 CCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3353938 115749 None 0 Human Binding pEC50 = 7.7 7.7 - 0
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1021 22 11 14 -1.5 CCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
449224 168973 None 12 Human Binding pEC50 = 7.7 7.7 - 1
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL439044 168973 None 12 Human Binding pEC50 = 7.7 7.7 - 1
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
2168 3974 None 38 Human Binding pEC50 = 7.5 7.5 -5 9
Activation of human 3X-HA N-tagged AVP1a expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged AVP1a expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL None None None None 10.1021/acsmedchemlett.2c00455
2810 3974 None 38 Human Binding pEC50 = 7.5 7.5 -5 9
Activation of human 3X-HA N-tagged AVP1a expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged AVP1a expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL None None None None 10.1021/acsmedchemlett.2c00455
644077 3974 None 38 Human Binding pEC50 = 7.5 7.5 -5 9
Activation of human 3X-HA N-tagged AVP1a expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged AVP1a expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL None None None None 10.1021/acsmedchemlett.2c00455
CHEMBL373742 3974 None 38 Human Binding pEC50 = 7.5 7.5 -5 9
Activation of human 3X-HA N-tagged AVP1a expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged AVP1a expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL None None None None 10.1021/acsmedchemlett.2c00455
DB00067 3974 None 38 Human Binding pEC50 = 7.5 7.5 -5 9
Activation of human 3X-HA N-tagged AVP1a expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged AVP1a expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL None None None None 10.1021/acsmedchemlett.2c00455
2252 2228 None 48 Human Binding pEC50 = 5.5 5.5 -851 5
Activity at human vasopressin V1a receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human vasopressin V1a receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm901084f
6918320 2228 None 48 Human Binding pEC50 = 5.5 5.5 -851 5
Activity at human vasopressin V1a receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human vasopressin V1a receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm901084f
CHEMBL24781 2228 None 48 Human Binding pEC50 = 5.5 5.5 -851 5
Activity at human vasopressin V1a receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human vasopressin V1a receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm901084f
11169 796 None 37 Human Binding pEC50 = 7.4 7.4 - 2
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/jm500365s
131676677 796 None 37 Human Binding pEC50 = 7.4 7.4 - 2
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/jm500365s
165708555 796 None 37 Human Binding pEC50 = 7.4 7.4 - 2
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/jm500365s
16681432 796 None 37 Human Binding pEC50 = 7.4 7.4 - 2
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/jm500365s
495 796 None 37 Human Binding pEC50 = 7.4 7.4 - 2
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/jm500365s
CHEMBL3301668 796 None 37 Human Binding pEC50 = 7.4 7.4 - 2
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/jm500365s
DB01282 796 None 37 Human Binding pEC50 = 7.4 7.4 - 2
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/jm500365s
3537 4002 None 22 Human Binding pEC50 = 6.3 6.3 -9 3
Activity at human vasopressin V1a receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human vasopressin V1a receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/jm901084f
5311500 4002 None 22 Human Binding pEC50 = 6.3 6.3 -9 3
Activity at human vasopressin V1a receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human vasopressin V1a receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/jm901084f
CHEMBL363910 4002 None 22 Human Binding pEC50 = 6.3 6.3 -9 3
Activity at human vasopressin V1a receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human vasopressin V1a receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/jm901084f
118720282 115852 None 0 Human Binding pEC50 = 7.2 7.2 - 0
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1038 20 11 13 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccc(C)c2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354592 115852 None 0 Human Binding pEC50 = 7.2 7.2 - 0
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1038 20 11 13 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccc(C)c2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719821 115743 None 0 Human Binding pEC50 = 7.1 7.1 - 0
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1005 19 11 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C2CCC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353932 115743 None 0 Human Binding pEC50 = 7.1 7.1 - 0
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1005 19 11 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C2CCC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720275 115845 None 0 Human Binding pEC50 = 7.1 7.1 - 0
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1004 22 11 13 -1.8 CCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3354585 115845 None 0 Human Binding pEC50 = 7.1 7.1 - 0
Agonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human vasopressin V1a expressed in HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1004 22 11 13 -1.8 CCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL2370569 209869 None 23 Human Binding pIC50 = 9.2 9.2 - 1
Binding affinity to human vasopressin V1a receptor by radioligand displacement assayBinding affinity to human vasopressin V1a receptor by radioligand displacement assay
ChEMBL None None None COc1ccc(C[C@@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1016/j.ejmech.2013.01.044
CHEMBL2370569 209869 None 23 Human Binding pIC50 = 9 9.0 - 1
Displacement of [3H]AVP from human recombinant V1a receptor expressed in CHO cells measured after 60 mins by scintillation counting methodDisplacement of [3H]AVP from human recombinant V1a receptor expressed in CHO cells measured after 60 mins by scintillation counting method
ChEMBL None None None COc1ccc(C[C@@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1016/j.bmc.2016.11.014
CHEMBL2370569 209869 None 23 Human Binding pIC50 = 9 9.0 - 1
Displacement of [3H]AVP from human recombinant arginine vasopressin receptor 1a expressed in CHO cellsDisplacement of [3H]AVP from human recombinant arginine vasopressin receptor 1a expressed in CHO cells
ChEMBL None None None COc1ccc(C[C@@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1016/j.bmc.2016.03.006
56849411 153176 None 0 Human Binding pIC50 = 9 9.0 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 609 10 3 8 3.3 NC(=O)OCC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1ccccc1C(F)(F)F nan
CHEMBL3976964 153176 None 0 Human Binding pIC50 = 9 9.0 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 609 10 3 8 3.3 NC(=O)OCC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1ccccc1C(F)(F)F nan
72548703 161565 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement of [3H]AVP from human recombinant V1a receptor after 60 mins by scintillation counting analysisDisplacement of [3H]AVP from human recombinant V1a receptor after 60 mins by scintillation counting analysis
ChEMBL 583 8 3 6 5.8 CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12 10.1016/j.bmcl.2018.03.093
CHEMBL4128926 161565 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement of [3H]AVP from human recombinant V1a receptor after 60 mins by scintillation counting analysisDisplacement of [3H]AVP from human recombinant V1a receptor after 60 mins by scintillation counting analysis
ChEMBL 583 8 3 6 5.8 CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12 10.1016/j.bmcl.2018.03.093
CHEMBL2370569 209869 None 23 Human Binding pIC50 = 8.7 8.7 - 1
Binding affinity to human vasopressin V1a receptor by radioligand displacement assayBinding affinity to human vasopressin V1a receptor by radioligand displacement assay
ChEMBL None None None COc1ccc(C[C@@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1016/j.bmc.2013.03.016
44428419 152585 None 0 Human Binding pIC50 = 8 8.0 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 568 9 1 6 5.0 CC(C)(C)C(O)C(C(=O)OCc1ccccc1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL397187 152585 None 0 Human Binding pIC50 = 8 8.0 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 568 9 1 6 5.0 CC(C)(C)C(O)C(C(=O)OCc1ccccc1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
23598598 4965 None 0 Human Binding pIC50 = 8 8.0 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 608 7 2 4 6.3 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=C(C(=O)NCCN4CCCCC4)CC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.04.016
CHEMBL104839 4965 None 0 Human Binding pIC50 = 8 8.0 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 608 7 2 4 6.3 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=C(C(=O)NCCN4CCCCC4)CC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.04.016
56848626 143716 None 0 Human Binding pIC50 = 8 8.0 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 557 9 2 7 4.2 NC(=O)OC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(Cc2ccccc2F)c1=O)c1ccccc1Cl nan
CHEMBL3900528 143716 None 0 Human Binding pIC50 = 8 8.0 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 557 9 2 7 4.2 NC(=O)OC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(Cc2ccccc2F)c1=O)c1ccccc1Cl nan
10527151 102171 None 0 Rat Binding pIC50 = 8 8.0 - 0
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 441 3 1 3 5.6 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccccc1Cl 10.1021/jm980179c
CHEMBL302709 102171 None 0 Rat Binding pIC50 = 8 8.0 - 0
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 441 3 1 3 5.6 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccccc1Cl 10.1021/jm980179c
44332181 4234 None 0 Human Binding pIC50 = 8 8.0 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 451 3 2 3 5.8 Nc1ccc(C(=O)Nc2ccc(C(=O)N3CCC4(C=CCCC4)Cc4ccccc43)cc2)cc1 10.1016/j.bmcl.2004.02.103
CHEMBL100402 4234 None 0 Human Binding pIC50 = 8 8.0 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 451 3 2 3 5.8 Nc1ccc(C(=O)Nc2ccc(C(=O)N3CCC4(C=CCCC4)Cc4ccccc43)cc2)cc1 10.1016/j.bmcl.2004.02.103
23598556 4364 None 0 Human Binding pIC50 = 8 8.0 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 454 3 1 2 6.4 O=C(Nc1ccc(C(=O)N2CCC3(C=CCCC3)Cc3ccccc32)cc1)c1ccccc1F 10.1016/j.bmcl.2004.02.103
CHEMBL101157 4364 None 0 Human Binding pIC50 = 8 8.0 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 454 3 1 2 6.4 O=C(Nc1ccc(C(=O)N2CCC3(C=CCCC3)Cc3ccccc32)cc1)c1ccccc1F 10.1016/j.bmcl.2004.02.103
44332273 169115 None 0 Human Binding pIC50 = 8 8.0 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 450 3 1 2 6.6 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC3(C=CCCC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.02.103
CHEMBL440147 169115 None 0 Human Binding pIC50 = 8 8.0 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 450 3 1 2 6.6 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC3(C=CCCC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.02.103
10527151 102171 None 0 Rat Binding pIC50 = 8 8.0 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 441 3 1 3 5.6 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccccc1Cl 10.1016/s0960-894x(03)00388-3
CHEMBL302709 102171 None 0 Rat Binding pIC50 = 8 8.0 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 441 3 1 3 5.6 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccccc1Cl 10.1016/s0960-894x(03)00388-3
14969547 100913 None 0 Rat Binding pIC50 = 7 7.0 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 449 9 1 4 4.2 NCCCCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL293905 100913 None 0 Rat Binding pIC50 = 7 7.0 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 449 9 1 4 4.2 NCCCCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
44428417 93288 None 0 Human Binding pIC50 = 7 7.0 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 586 10 0 6 5.5 O=C(OCc1ccccc1)C(C(=O)c1ccccc1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL245086 93288 None 0 Human Binding pIC50 = 7 7.0 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 586 10 0 6 5.5 O=C(OCc1ccccc1)C(C(=O)c1ccccc1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
44293778 101618 None 0 Rat Binding pIC50 = 7 7.0 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 476 3 1 4 5.7 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1)c1cc(Cl)ccc1Cl 10.1016/s0960-894x(99)00279-6
CHEMBL298911 101618 None 0 Rat Binding pIC50 = 7 7.0 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 476 3 1 4 5.7 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1)c1cc(Cl)ccc1Cl 10.1016/s0960-894x(99)00279-6
23598638 94016 None 0 Human Binding pIC50 = 7 7.0 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 518 4 2 3 6.3 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=C(CO)CC3)Cc3ccccc32)c(Cl)c1 10.1016/j.bmcl.2007.09.059
CHEMBL248733 94016 None 0 Human Binding pIC50 = 7 7.0 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 518 4 2 3 6.3 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=C(CO)CC3)Cc3ccccc32)c(Cl)c1 10.1016/j.bmcl.2007.09.059
44444759 154750 None 0 Human Binding pIC50 = 7 7.0 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 484 4 2 3 5.5 O=C(O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
CHEMBL400048 154750 None 0 Human Binding pIC50 = 7 7.0 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 484 4 2 3 5.5 O=C(O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
44428428 142546 None 0 Human Binding pIC50 = 6 6.0 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 571 10 1 4 5.9 CC(C)C[C@@H](C(=O)NCc1ccccc1Cl)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL389091 142546 None 0 Human Binding pIC50 = 6 6.0 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 571 10 1 4 5.9 CC(C)C[C@@H](C(=O)NCc1ccccc1Cl)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
10599369 114810 None 0 Rat Binding pIC50 = 6 6.0 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 443 5 1 4 5.0 COc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(N(C)C)c3ccccc32)cc1 10.1021/jm960133o
CHEMBL334082 114810 None 0 Rat Binding pIC50 = 6 6.0 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 443 5 1 4 5.0 COc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(N(C)C)c3ccccc32)cc1 10.1021/jm960133o
44433367 89845 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 489 3 1 3 5.0 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CC3C=CC(=O)N3Cc3ccccc32)c(Cl)c1 10.1016/j.bmcl.2007.08.053
CHEMBL237772 89845 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 489 3 1 3 5.0 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CC3C=CC(=O)N3Cc3ccccc32)c(Cl)c1 10.1016/j.bmcl.2007.08.053
44433372 89924 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 426 5 3 3 5.0 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)Nc2ccccc2C(=O)O)c(Cl)c1 10.1016/j.bmcl.2007.08.053
CHEMBL237987 89924 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 426 5 3 3 5.0 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)Nc2ccccc2C(=O)O)c(Cl)c1 10.1016/j.bmcl.2007.08.053
44433375 90185 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 505 7 3 4 5.8 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)Nc2ccccc2Cn2cccc2C(=O)O)c(Cl)c1 10.1016/j.bmcl.2007.08.053
CHEMBL238206 90185 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 505 7 3 4 5.8 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)Nc2ccccc2Cn2cccc2C(=O)O)c(Cl)c1 10.1016/j.bmcl.2007.08.053
44433363 146650 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 489 3 1 3 5.7 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2C=C3CCC(=O)N3Cc3ccccc32)c(Cl)c1 10.1016/j.bmcl.2007.08.053
CHEMBL392363 146650 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 489 3 1 3 5.7 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2C=C3CCC(=O)N3Cc3ccccc32)c(Cl)c1 10.1016/j.bmcl.2007.08.053
10690528 113509 None 0 Rat Binding pIC50 = 5 5.0 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 370 3 1 2 4.8 Cc1ccc(C(=O)Nc2ccc(C(=O)N3CCCc4ccccc43)cc2)cc1 10.1021/jm960133o
CHEMBL332090 113509 None 0 Rat Binding pIC50 = 5 5.0 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 370 3 1 2 4.8 Cc1ccc(C(=O)Nc2ccc(C(=O)N3CCCc4ccccc43)cc2)cc1 10.1021/jm960133o
44213444 101912 None 0 Rat Binding pIC50 = 8.0 8.0 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 442 3 1 4 5.0 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1)c1ccccc1Cl 10.1016/s0960-894x(99)00279-6
CHEMBL300963 101912 None 0 Rat Binding pIC50 = 8.0 8.0 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 442 3 1 4 5.0 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1)c1ccccc1Cl 10.1016/s0960-894x(99)00279-6
44374802 120001 None 0 Human Binding pIC50 = 7.0 7.0 - 0
In vitro binding affinity to human V1a receptorIn vitro binding affinity to human V1a receptor
ChEMBL 442 3 1 3 6.1 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCCCc3sccc32)c(Cl)c1 10.1016/s0960-894x(00)00084-6
CHEMBL350089 120001 None 0 Human Binding pIC50 = 7.0 7.0 - 0
In vitro binding affinity to human V1a receptorIn vitro binding affinity to human V1a receptor
ChEMBL 442 3 1 3 6.1 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCCCc3sccc32)c(Cl)c1 10.1016/s0960-894x(00)00084-6
44273355 74945 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 587 8 0 6 3.9 CN(C)CCSC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL20319 74945 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 587 8 0 6 3.9 CN(C)CCSC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL2112655 209242 None 0 Rat Binding pIC50 = 6.0 6.0 - 0
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CCCCN)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
14969508 100986 None 0 Rat Binding pIC50 = 5.0 5.0 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 324 2 0 3 2.9 O=C(c1ccco1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
CHEMBL294293 100986 None 0 Rat Binding pIC50 = 5.0 5.0 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 324 2 0 3 2.9 O=C(c1ccco1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
14969530 199787 None 0 Rat Binding pIC50 = 5.0 5.0 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 377 3 1 3 2.4 NC(=O)c1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL59397 199787 None 0 Rat Binding pIC50 = 5.0 5.0 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 377 3 1 3 2.4 NC(=O)c1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
10713341 12953 None 0 Rat Binding pIC50 = 5.0 5.0 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 357 3 1 3 3.9 O=C(Nc1ccc(C(=O)N2CCCc3ccccc32)cc1)c1cccnc1 10.1021/jm960133o
CHEMBL118933 12953 None 0 Rat Binding pIC50 = 5.0 5.0 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 357 3 1 3 3.9 O=C(Nc1ccc(C(=O)N2CCCc3ccccc32)cc1)c1cccnc1 10.1021/jm960133o
9828129 116619 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Ability to displace [3H]arginine vasopressin in cloned human V1a receptorAbility to displace [3H]arginine vasopressin in cloned human V1a receptor
ChEMBL 522 6 2 4 6.6 O=C(O)C[C@@H]1CCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc2S1 10.1016/j.bmcl.2003.08.051
CHEMBL336825 116619 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Ability to displace [3H]arginine vasopressin in cloned human V1a receptorAbility to displace [3H]arginine vasopressin in cloned human V1a receptor
ChEMBL 522 6 2 4 6.6 O=C(O)C[C@@H]1CCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc2S1 10.1016/j.bmcl.2003.08.051
44352777 21380 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Ability to displace [3H]arginine vasopressin in cloned human V1a receptorAbility to displace [3H]arginine vasopressin in cloned human V1a receptor
ChEMBL 572 7 2 5 6.4 O=C(Nc1ccc(C(=O)N2CCC(CCS(=O)(=O)O)Sc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2003.08.051
CHEMBL131439 21380 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Ability to displace [3H]arginine vasopressin in cloned human V1a receptorAbility to displace [3H]arginine vasopressin in cloned human V1a receptor
ChEMBL 572 7 2 5 6.4 O=C(Nc1ccc(C(=O)N2CCC(CCS(=O)(=O)O)Sc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2003.08.051
86690917 150409 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 555 8 2 9 2.7 NC(=O)Cn1nc(Cn2nc(-c3ccc(Cl)cc3)n(C[C@H](O)C(F)(F)F)c2=O)nc1-c1ccccc1Cl nan
CHEMBL3953766 150409 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 555 8 2 9 2.7 NC(=O)Cn1nc(Cn2nc(-c3ccc(Cl)cc3)n(C[C@H](O)C(F)(F)F)c2=O)nc1-c1ccccc1Cl nan
56848490 146750 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 575 10 3 8 2.9 NC(=O)OCC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1ccccc1Cl nan
CHEMBL3924331 146750 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 575 10 3 8 2.9 NC(=O)OCC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1ccccc1Cl nan
44332209 4319 None 0 Human Binding pIC50 = 7.9 7.9 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 470 3 1 2 6.9 O=C(Nc1ccc(C(=O)N2CCC3(C=CCCC3)Cc3ccccc32)cc1)c1ccccc1Cl 10.1016/j.bmcl.2004.02.103
CHEMBL100893 4319 None 0 Human Binding pIC50 = 7.9 7.9 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 470 3 1 2 6.9 O=C(Nc1ccc(C(=O)N2CCC3(C=CCCC3)Cc3ccccc32)cc1)c1ccccc1Cl 10.1016/j.bmcl.2004.02.103
22405322 71780 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 406 4 0 2 6.3 CCCc1ccc(-c2ccc(C(=O)N3Cc4cccn4Cc4ccccc43)cc2)cc1 10.1016/j.bmcl.2005.08.007
CHEMBL196737 71780 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 406 4 0 2 6.3 CCCc1ccc(-c2ccc(C(=O)N3Cc4cccn4Cc4ccccc43)cc2)cc1 10.1016/j.bmcl.2005.08.007
14969554 102245 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 491 10 1 4 4.3 CC(=O)NCCCCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL303134 102245 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 491 10 1 4 4.3 CC(=O)NCCCCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
86690931 149027 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 543 6 1 7 5.1 O=c1n(Cc2cc(-c3cccc(Cl)c3Cl)ncn2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
CHEMBL3942564 149027 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 543 6 1 7 5.1 O=c1n(Cc2cc(-c3cccc(Cl)c3Cl)ncn2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
67412781 154270 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 499 6 1 8 4.0 O=c1n(Cc2nnc(-c3ccccc3Cl)o2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
CHEMBL3986461 154270 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 499 6 1 8 4.0 O=c1n(Cc2nnc(-c3ccccc3Cl)o2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
10503858 205555 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 453 3 1 3 5.7 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(C)c1 10.1021/jm980179c
CHEMBL81133 205555 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 453 3 1 3 5.7 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(C)c1 10.1021/jm980179c
21837107 203898 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 475 3 1 3 6.3 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1cc(Cl)ccc1Cl 10.1016/s0960-894x(03)00388-3
CHEMBL68948 203898 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 475 3 1 3 6.3 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1cc(Cl)ccc1Cl 10.1016/s0960-894x(03)00388-3
14969514 203310 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 368 2 0 2 3.9 O=C(c1ccc(Cl)cc1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
CHEMBL64811 203310 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 368 2 0 2 3.9 O=C(c1ccc(Cl)cc1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
44352302 18956 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Ability to displace [3H]arginine vasopressin in cloned human V1a receptorAbility to displace [3H]arginine vasopressin in cloned human V1a receptor
ChEMBL 521 6 1 4 6.7 CN(C)CC1CCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc2S1 10.1016/j.bmcl.2003.08.051
CHEMBL128687 18956 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Ability to displace [3H]arginine vasopressin in cloned human V1a receptorAbility to displace [3H]arginine vasopressin in cloned human V1a receptor
ChEMBL 521 6 1 4 6.7 CN(C)CC1CCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc2S1 10.1016/j.bmcl.2003.08.051
118719845 115767 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1047 20 11 15 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353956 115767 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1047 20 11 15 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
76073634 115854 None 3 Human Binding pIC50 = 5.9 5.9 - 1
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1041 20 11 13 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354594 115854 None 3 Human Binding pIC50 = 5.9 5.9 - 1
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1041 20 11 13 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720290 115862 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1013 20 10 13 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354602 115862 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1013 20 10 13 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
10766187 12853 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 455 6 1 3 6.1 CCCN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc21 10.1021/jm960133o
CHEMBL118863 12853 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 455 6 1 3 6.1 CCCN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc21 10.1021/jm960133o
10620180 113502 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 386 3 1 3 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCOc3ccccc32)cc1 10.1021/jm960133o
CHEMBL332060 113502 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 386 3 1 3 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCOc3ccccc32)cc1 10.1021/jm960133o
14969509 201939 None 0 Rat Binding pIC50 = 4.9 4.9 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 348 3 0 2 3.2 O=C(Cc1ccccc1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
CHEMBL60773 201939 None 0 Rat Binding pIC50 = 4.9 4.9 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 348 3 0 2 3.2 O=C(Cc1ccccc1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
CHEMBL2112651 209240 None 0 Rat Binding pIC50 = 4.9 4.9 - 0
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
172997 2330 None 57 Human Binding pIC50 = 6.9 6.9 -64 2
Displacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2007.08.053
2238 2330 None 57 Human Binding pIC50 = 6.9 6.9 -64 2
Displacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2007.08.053
CHEMBL49429 2330 None 57 Human Binding pIC50 = 6.9 6.9 -64 2
Displacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2007.08.053
DB06666 2330 None 57 Human Binding pIC50 = 6.9 6.9 -64 2
Displacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2007.08.053
9805201 56255 None 0 Rat Binding pIC50 = 4.9 4.9 - 0
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 480 3 2 4 5.7 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCc3c[nH]nc3-c3sccc32)c(Cl)c1 10.1016/s0960-894x(00)00084-6
CHEMBL162748 56255 None 0 Rat Binding pIC50 = 4.9 4.9 - 0
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 480 3 2 4 5.7 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCc3c[nH]nc3-c3sccc32)c(Cl)c1 10.1016/s0960-894x(00)00084-6
392622 56310 None 95 Human Binding pIC50 = 4.9 4.9 -2 4
DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 nan
CHEMBL163 56310 None 95 Human Binding pIC50 = 4.9 4.9 -2 4
DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 nan
44428427 161733 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 537 10 1 4 5.2 CC(C)C[C@@H](C(=O)NCc1ccccc1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL413711 161733 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 537 10 1 4 5.2 CC(C)C[C@@H](C(=O)NCc1ccccc1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
56848553 145615 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 651 9 3 8 5.0 CC(C)(C)OC(=O)NC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1cccc(Cl)c1Cl nan
CHEMBL3915616 145615 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 651 9 3 8 5.0 CC(C)(C)OC(=O)NC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1cccc(Cl)c1Cl nan
11432362 94135 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 518 4 2 3 6.1 O=C(O)C1=C[C@@]2(CC1)CCN(C(=O)c1ccc(NC(=O)c3cc(F)ccc3Cl)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
CHEMBL249340 94135 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 518 4 2 3 6.1 O=C(O)C1=C[C@@]2(CC1)CCN(C(=O)c1ccc(NC(=O)c3cc(F)ccc3Cl)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
15298022 72038 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 370 2 0 3 5.4 O=C(c1ccc(-c2cccs2)cc1)N1Cc2cccn2Cc2ccccc21 10.1016/j.bmcl.2005.08.007
CHEMBL197616 72038 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 370 2 0 3 5.4 O=C(c1ccc(-c2cccs2)cc1)N1Cc2cccn2Cc2ccccc21 10.1016/j.bmcl.2005.08.007
22861321 134337 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 421 4 0 3 5.4 CN(C)Cc1ccc2n1Cc1ccccc1N(C(=O)c1ccc(-c3ccccc3)cc1)C2 10.1016/j.bmcl.2005.08.007
CHEMBL371721 134337 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 421 4 0 3 5.4 CN(C)Cc1ccc2n1Cc1ccccc1N(C(=O)c1ccc(-c3ccccc3)cc1)C2 10.1016/j.bmcl.2005.08.007
56848687 150479 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 581 11 2 9 2.5 COCCn1c(-c2ccc(Cl)s2)nn(CC(=O)NCC(NS(C)(=O)=O)c2ccccc2C(F)(F)F)c1=O nan
CHEMBL3954357 150479 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 581 11 2 9 2.5 COCCn1c(-c2ccc(Cl)s2)nn(CC(=O)NCC(NS(C)(=O)=O)c2ccccc2C(F)(F)F)c1=O nan
14969526 200772 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 350 2 1 3 3.0 O=C(c1ccc(O)cc1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
CHEMBL60054 200772 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 350 2 1 3 3.0 O=C(c1ccc(O)cc1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
14969516 201049 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 348 2 0 2 3.6 Cc1cccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)c1 10.1021/jm00066a010
CHEMBL60262 201049 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 348 2 0 2 3.6 Cc1cccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)c1 10.1021/jm00066a010
118719822 115744 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1017 19 10 14 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2C[C@H](OC)C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353933 115744 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1017 19 10 14 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2C[C@H](OC)C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719840 115762 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1042 20 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccnc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353951 115762 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1042 20 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccnc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720262 115833 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1048 21 12 15 -2.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCC2CCCN2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354573 115833 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1048 21 12 15 -2.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCC2CCCN2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720285 115856 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1025 20 10 12 -1.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354596 115856 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1025 20 10 12 -1.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
2241 2216 None 1 Rat Binding pIC50 = 5.9 5.9 -117 4
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None None 10.1021/jm00099a019
9810632 2216 None 1 Rat Binding pIC50 = 5.9 5.9 -117 4
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None None 10.1021/jm00099a019
CHEMBL127686 2216 None 1 Rat Binding pIC50 = 5.9 5.9 -117 4
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None None 10.1021/jm00099a019
CHEMBL338018 211600 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CCCCN)NC(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
CHEMBL405289 212552 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None CCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10838493 13912 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 481 4 1 3 6.3 CN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3ccc(Cl)cc3Cl)cc2)c2ccccc21 10.1021/jm960133o
CHEMBL119638 13912 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 481 4 1 3 6.3 CN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3ccc(Cl)cc3Cl)cc2)c2ccccc21 10.1021/jm960133o
14981576 78868 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Displacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liverDisplacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liver
ChEMBL 610 12 1 7 2.9 CCN(CC)[C@@H](CCS(C)(=O)=O)C(=O)N[C@H]1CC2CC[C@]1(CS(=O)(=O)N1CCN(c3ccccc3C)CC1)C2(C)C 10.1021/jm00031a004
CHEMBL2112894 78868 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Displacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liverDisplacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liver
ChEMBL 610 12 1 7 2.9 CCN(CC)[C@@H](CCS(C)(=O)=O)C(=O)N[C@H]1CC2CC[C@]1(CS(=O)(=O)N1CCN(c3ccccc3C)CC1)C2(C)C 10.1021/jm00031a004
44273473 72782 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 542 5 0 6 3.2 CC(=O)OC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL20002 72782 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 542 5 0 6 3.2 CC(=O)OC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
44273259 73518 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 557 7 1 6 2.5 CN(CCO)C1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL20171 73518 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 557 7 1 6 2.5 CN(CCO)C1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
56848684 148410 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 545 9 2 7 3.9 NC(=O)OC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(CCC(F)(F)F)c1=O)c1ccccc1Cl nan
CHEMBL3937650 148410 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 545 9 2 7 3.9 NC(=O)OC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(CCC(F)(F)F)c1=O)c1ccccc1Cl nan
44352804 18957 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Ability to displace [3H]arginine vasopressin in cloned human V1a receptorAbility to displace [3H]arginine vasopressin in cloned human V1a receptor
ChEMBL 536 7 2 4 7.0 O=C(O)CC[C@H]1CCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc2S1 10.1016/j.bmcl.2003.08.051
CHEMBL128688 18957 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Ability to displace [3H]arginine vasopressin in cloned human V1a receptorAbility to displace [3H]arginine vasopressin in cloned human V1a receptor
ChEMBL 536 7 2 4 7.0 O=C(O)CC[C@H]1CCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc2S1 10.1016/j.bmcl.2003.08.051
10715974 11920 None 0 Rat Binding pIC50 = 6.9 6.9 - 2
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 400 3 2 3 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3ccccc32)cc1 10.1021/jm960133o
CHEMBL118271 11920 None 0 Rat Binding pIC50 = 6.9 6.9 - 2
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 400 3 2 3 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3ccccc32)cc1 10.1021/jm960133o
44332238 107393 None 0 Human Binding pIC50 = 6.9 6.9 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 464 3 1 2 6.9 Cc1ccc(C(=O)Nc2ccc(C(=O)N3CCC4(C=CCCC4)Cc4ccccc43)cc2)cc1C 10.1016/j.bmcl.2004.02.103
CHEMBL317919 107393 None 0 Human Binding pIC50 = 6.9 6.9 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 464 3 1 2 6.9 Cc1ccc(C(=O)Nc2ccc(C(=O)N3CCC4(C=CCCC4)Cc4ccccc43)cc2)cc1C 10.1016/j.bmcl.2004.02.103
14969533 201465 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 352 2 0 2 3.4 O=C(c1ccc(F)cc1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
CHEMBL60502 201465 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 352 2 0 2 3.4 O=C(c1ccc(F)cc1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
14969521 203196 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 392 3 0 4 3.2 CC(=O)Oc1ccccc1C(=O)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
CHEMBL64332 203196 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 392 3 0 4 3.2 CC(=O)Oc1ccccc1C(=O)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
118719826 115748 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 947 19 11 13 -3.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353937 115748 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 947 19 11 13 -3.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719836 115758 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1055 20 11 14 -1.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(C)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353947 115758 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1055 20 11 14 -1.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(C)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720268 115839 None 0 Human Binding pIC50 = 5.9 5.9 - 1
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 21 12 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354579 115839 None 0 Human Binding pIC50 = 5.9 5.9 - 1
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 21 12 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720278 115848 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1023 20 11 13 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354588 115848 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1023 20 11 13 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
119369 2604 None 74 Rat Binding pIC50 = 5.9 5.9 -31 8
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1021/jm960133o
2197 2604 None 74 Rat Binding pIC50 = 5.9 5.9 -31 8
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1021/jm960133o
4004 2604 None 74 Rat Binding pIC50 = 5.9 5.9 -31 8
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1021/jm960133o
CHEMBL420762 2604 None 74 Rat Binding pIC50 = 5.9 5.9 -31 8
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1021/jm960133o
10666852 113062 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 370 3 1 2 4.8 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCc3ccccc32)cc1 10.1021/jm960133o
CHEMBL331164 113062 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 370 3 1 2 4.8 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCc3ccccc32)cc1 10.1021/jm960133o
CHEMBL1790938 208905 None 0 Rat Binding pIC50 = 4.9 4.9 - 0
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10573075 114443 None 0 Rat Binding pIC50 = 4.9 4.9 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 400 5 1 3 4.9 CCOc1ccc(C(=O)Nc2ccc(C(=O)N3CCCc4ccccc43)cc2)cc1 10.1021/jm960133o
CHEMBL333340 114443 None 0 Rat Binding pIC50 = 4.9 4.9 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 400 5 1 3 4.9 CCOc1ccc(C(=O)Nc2ccc(C(=O)N3CCCc4ccccc43)cc2)cc1 10.1021/jm960133o
10766720 105448 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 469 4 1 4 5.4 COc1cc(NC(=O)c2cc(F)ccc2C)ccc1C(=O)N1Cc2cccn2Cc2ccccc21 10.1021/jm980179c
CHEMBL312036 105448 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 469 4 1 4 5.4 COc1cc(NC(=O)c2cc(F)ccc2C)ccc1C(=O)N1Cc2cccn2Cc2ccccc21 10.1021/jm980179c
9826254 163307 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 475 3 1 3 6.3 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccc(Cl)cc1Cl 10.1021/jm980179c
CHEMBL418890 163307 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 475 3 1 3 6.3 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccc(Cl)cc1Cl 10.1021/jm980179c
23598619 94537 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 498 4 1 4 5.6 COC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
CHEMBL251771 94537 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 498 4 1 4 5.6 COC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
9826254 163307 None 0 Human Binding pIC50 = 7.8 7.8 - 0
In vitro binding affinity to human V1a receptorIn vitro binding affinity to human V1a receptor
ChEMBL 475 3 1 3 6.3 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccc(Cl)cc1Cl 10.1016/s0960-894x(00)00084-6
CHEMBL418890 163307 None 0 Human Binding pIC50 = 7.8 7.8 - 0
In vitro binding affinity to human V1a receptorIn vitro binding affinity to human V1a receptor
ChEMBL 475 3 1 3 6.3 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccc(Cl)cc1Cl 10.1016/s0960-894x(00)00084-6
44332226 4368 None 0 Human Binding pIC50 = 7.8 7.8 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 482 4 1 3 7.0 CSc1ccc(C(=O)Nc2ccc(C(=O)N3CCC4(C=CCCC4)Cc4ccccc43)cc2)cc1 10.1016/j.bmcl.2004.02.103
CHEMBL101187 4368 None 0 Human Binding pIC50 = 7.8 7.8 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 482 4 1 3 7.0 CSc1ccc(C(=O)Nc2ccc(C(=O)N3CCC4(C=CCCC4)Cc4ccccc43)cc2)cc1 10.1016/j.bmcl.2004.02.103
172997 2330 None 57 Human Binding pIC50 = 6.8 6.8 -64 2
Binding affinity towards human V1a receptorsBinding affinity towards human V1a receptors
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(02)01059-4
2238 2330 None 57 Human Binding pIC50 = 6.8 6.8 -64 2
Binding affinity towards human V1a receptorsBinding affinity towards human V1a receptors
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(02)01059-4
CHEMBL49429 2330 None 57 Human Binding pIC50 = 6.8 6.8 -64 2
Binding affinity towards human V1a receptorsBinding affinity towards human V1a receptors
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(02)01059-4
DB06666 2330 None 57 Human Binding pIC50 = 6.8 6.8 -64 2
Binding affinity towards human V1a receptorsBinding affinity towards human V1a receptors
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(02)01059-4
172997 2330 None 57 Human Binding pIC50 = 6.8 6.8 -64 2
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2007.09.059
2238 2330 None 57 Human Binding pIC50 = 6.8 6.8 -64 2
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2007.09.059
CHEMBL49429 2330 None 57 Human Binding pIC50 = 6.8 6.8 -64 2
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2007.09.059
DB06666 2330 None 57 Human Binding pIC50 = 6.8 6.8 -64 2
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2007.09.059
15307968 103053 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 432 3 1 2 6.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3ccccc3Cc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
CHEMBL307271 103053 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 432 3 1 2 6.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3ccccc3Cc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
172997 2330 None 57 Human Binding pIC50 = 6.8 6.8 -64 2
Inhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptorInhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(02)00649-2
2238 2330 None 57 Human Binding pIC50 = 6.8 6.8 -64 2
Inhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptorInhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(02)00649-2
CHEMBL49429 2330 None 57 Human Binding pIC50 = 6.8 6.8 -64 2
Inhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptorInhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(02)00649-2
DB06666 2330 None 57 Human Binding pIC50 = 6.8 6.8 -64 2
Inhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptorInhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(02)00649-2
14969524 102845 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 350 2 1 3 3.0 O=C(c1ccccc1O)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
CHEMBL305588 102845 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 350 2 1 3 3.0 O=C(c1ccccc1O)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
14969539 167959 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 434 8 0 3 5.2 CCCCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL431723 167959 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 434 8 0 3 5.2 CCCCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
118720261 115832 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1035 20 11 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)CC2CCCO2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354572 115832 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1035 20 11 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)CC2CCCO2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
44309805 204280 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 434 3 1 3 6.2 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3ccccc3Oc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
CHEMBL71283 204280 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 434 3 1 3 6.2 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3ccccc3Oc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
44273369 99542 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 500 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](O)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL283524 99542 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 500 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](O)C1=O)C2 10.1016/0960-894X(94)00469-V
23598598 4965 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor (Compound 7o)Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor (Compound 7o)
ChEMBL 608 7 2 4 6.3 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=C(C(=O)NCCN4CCCCC4)CC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.04.016
CHEMBL104839 4965 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor (Compound 7o)Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor (Compound 7o)
ChEMBL 608 7 2 4 6.3 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=C(C(=O)NCCN4CCCCC4)CC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.04.016
10459252 52649 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 517 4 1 3 7.3 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/s0960-894x(00)00084-6
CHEMBL159359 52649 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 517 4 1 3 7.3 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/s0960-894x(00)00084-6
44332207 107260 None 0 Human Binding pIC50 = 7.8 7.8 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 504 3 1 2 7.6 O=C(Nc1ccc(C(=O)N2CCC3(C=CCCC3)Cc3ccccc32)cc1)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2004.02.103
CHEMBL316958 107260 None 0 Human Binding pIC50 = 7.8 7.8 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 504 3 1 2 7.6 O=C(Nc1ccc(C(=O)N2CCC3(C=CCCC3)Cc3ccccc32)cc1)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2004.02.103
14969553 102043 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 477 9 1 4 4.0 CC(=O)NCCCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL301850 102043 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 477 9 1 4 4.0 CC(=O)NCCCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
44352767 115119 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Ability to displace [3H]arginine vasopressin in cloned human V1a receptorAbility to displace [3H]arginine vasopressin in cloned human V1a receptor
ChEMBL 528 6 1 3 7.8 O=C(Nc1ccc(C(=O)N2CCC(CC(F)F)Sc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2003.08.051
CHEMBL334363 115119 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Ability to displace [3H]arginine vasopressin in cloned human V1a receptorAbility to displace [3H]arginine vasopressin in cloned human V1a receptor
ChEMBL 528 6 1 3 7.8 O=C(Nc1ccc(C(=O)N2CCC(CC(F)F)Sc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2003.08.051
44273346 162945 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 570 8 1 6 2.8 CN(C)CCNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL417458 162945 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 570 8 1 6 2.8 CN(C)CCNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
118720280 115850 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1007 20 10 12 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354590 115850 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1007 20 10 12 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL126765 208666 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CCCN)NC(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00099a019
CHEMBL419793 213239 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CCCCN)NC(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
2981363 12521 None 7 Rat Binding pIC50 = 5.8 5.8 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 390 3 1 2 5.2 O=C(Nc1ccc(C(=O)N2CCCc3ccccc32)cc1)c1ccccc1Cl 10.1021/jm960133o
CHEMBL118660 12521 None 7 Rat Binding pIC50 = 5.8 5.8 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 390 3 1 2 5.2 O=C(Nc1ccc(C(=O)N2CCCc3ccccc32)cc1)c1ccccc1Cl 10.1021/jm960133o
10598596 12939 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 427 5 2 3 5.3 CCNC1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc21 10.1021/jm960133o
CHEMBL118922 12939 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 427 5 2 3 5.3 CCNC1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc21 10.1021/jm960133o
10642000 114390 None 9 Rat Binding pIC50 = 5.8 5.8 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 356 3 1 2 4.5 O=C(Nc1ccc(C(=O)N2CCCc3ccccc32)cc1)c1ccccc1 10.1021/jm960133o
CHEMBL333139 114390 None 9 Rat Binding pIC50 = 5.8 5.8 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 356 3 1 2 4.5 O=C(Nc1ccc(C(=O)N2CCCc3ccccc32)cc1)c1ccccc1 10.1021/jm960133o
10790546 110645 None 0 Rat Binding pIC50 = 4.8 4.8 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 470 5 2 4 4.9 CC(=O)Nc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(N(C)C)c3ccccc32)cc1 10.1021/jm960133o
CHEMBL325819 110645 None 0 Rat Binding pIC50 = 4.8 4.8 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 470 5 2 4 4.9 CC(=O)Nc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(N(C)C)c3ccccc32)cc1 10.1021/jm960133o
10501216 113131 None 0 Rat Binding pIC50 = 4.8 4.8 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 401 4 1 4 4.4 O=C(Nc1ccc(C(=O)N2CCCc3ccccc32)cc1)c1cccc([N+](=O)[O-])c1 10.1021/jm960133o
CHEMBL331424 113131 None 0 Rat Binding pIC50 = 4.8 4.8 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 401 4 1 4 4.4 O=C(Nc1ccc(C(=O)N2CCCc3ccccc32)cc1)c1cccc([N+](=O)[O-])c1 10.1021/jm960133o
118719824 115746 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1017 19 11 14 -3.1 CCOc1ccc(C[C@@H]2NC(=O)CCCSC[C@@H](C(=O)N3C[C@@H](O)C[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1021/jm500365s
CHEMBL3353935 115746 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1017 19 11 14 -3.1 CCOc1ccc(C[C@@H]2NC(=O)CCCSC[C@@H](C(=O)N3C[C@@H](O)C[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1021/jm500365s
86690920 145540 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 548 6 1 7 5.5 O=c1n(Cc2cnc(-c3ccccc3C(F)(F)F)s2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
CHEMBL3915055 145540 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 548 6 1 7 5.5 O=c1n(Cc2cnc(-c3ccccc3C(F)(F)F)s2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
56848555 151747 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 560 9 4 7 2.5 NC(=O)NC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1ccccc1Cl nan
CHEMBL3964694 151747 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 560 9 4 7 2.5 NC(=O)NC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1ccccc1Cl nan
15340668 203767 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 407 3 1 3 5.2 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3-c3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
CHEMBL68033 203767 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 407 3 1 3 5.2 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3-c3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
44273368 98792 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 584 9 1 6 3.2 CN(C)CCCNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL278377 98792 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 584 9 1 6 3.2 CN(C)CCCNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
53379068 142369 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 551 7 2 6 5.4 O=C(O)c1ccc(-c2ccccc2Cl)cc1Cn1nc(-c2ccc(Cl)cc2)n(CC(O)C(F)(F)F)c1=O nan
CHEMBL3889504 142369 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 551 7 2 6 5.4 O=C(O)c1ccc(-c2ccccc2Cl)cc1Cn1nc(-c2ccc(Cl)cc2)n(CC(O)C(F)(F)F)c1=O nan
10832492 114797 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 362 3 1 3 4.6 O=C(Nc1ccc(C(=O)N2CCCc3ccccc32)cc1)c1ccsc1 10.1021/jm960133o
CHEMBL334009 114797 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 362 3 1 3 4.6 O=C(Nc1ccc(C(=O)N2CCCc3ccccc32)cc1)c1ccsc1 10.1021/jm960133o
19699097 120002 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 446 3 2 4 5.0 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCc3c[nH]nc3-c3sccc32)cc1 10.1016/s0960-894x(00)00084-6
CHEMBL350090 120002 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 446 3 2 4 5.0 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCc3c[nH]nc3-c3sccc32)cc1 10.1016/s0960-894x(00)00084-6
44374839 120167 None 0 Human Binding pIC50 = 5.8 5.8 - 0
In vitro binding affinity to human V1a receptorIn vitro binding affinity to human V1a receptor
ChEMBL 442 3 1 5 4.9 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCc3cn(C)nc3-c3sccc32)cc1 10.1016/s0960-894x(00)00084-6
CHEMBL351587 120167 None 0 Human Binding pIC50 = 5.8 5.8 - 0
In vitro binding affinity to human V1a receptorIn vitro binding affinity to human V1a receptor
ChEMBL 442 3 1 5 4.9 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCc3cn(C)nc3-c3sccc32)cc1 10.1016/s0960-894x(00)00084-6
441243 9834 None 58 Human Binding pIC50 = 4.8 4.8 -33 8
DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)
ChEMBL 670 12 5 7 3.1 CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1 nan
CHEMBL114 9834 None 58 Human Binding pIC50 = 4.8 4.8 -33 8
DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)
ChEMBL 670 12 5 7 3.1 CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1 nan
9931699 75049 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of [3H]AVP from human V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1a receptor expressed in CHO cells
ChEMBL 415 2 1 5 5.0 Cn1ccc(-c2ccc(C(=O)N3Cc4cccnc4Nc4ccccc43)c(Cl)c2)n1 10.1016/j.bmcl.2005.10.107
CHEMBL203513 75049 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of [3H]AVP from human V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1a receptor expressed in CHO cells
ChEMBL 415 2 1 5 5.0 Cn1ccc(-c2ccc(C(=O)N3Cc4cccnc4Nc4ccccc43)c(Cl)c2)n1 10.1016/j.bmcl.2005.10.107
56848686 144536 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 653 9 2 8 6.0 CC(C)(C)OC(=O)NC(CNC(=O)Cn1nc(-c2ccc(Cl)s2)n(Cc2ccccc2F)c1=O)c1ccccc1C(F)(F)F nan
CHEMBL3907257 144536 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 653 9 2 8 6.0 CC(C)(C)OC(=O)NC(CNC(=O)Cn1nc(-c2ccc(Cl)s2)n(Cc2ccccc2F)c1=O)c1ccccc1C(F)(F)F nan
23598642 154802 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 541 6 2 3 7.1 CNCC1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
CHEMBL400267 154802 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 541 6 2 3 7.1 CNCC1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
44352796 21474 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Ability to displace [3H]arginine vasopressin in cloned human V1a receptorAbility to displace [3H]arginine vasopressin in cloned human V1a receptor
ChEMBL 510 6 1 3 7.5 O=C(Nc1ccc(C(=O)N2CCC(CCF)Sc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2003.08.051
CHEMBL131566 21474 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Ability to displace [3H]arginine vasopressin in cloned human V1a receptorAbility to displace [3H]arginine vasopressin in cloned human V1a receptor
ChEMBL 510 6 1 3 7.5 O=C(Nc1ccc(C(=O)N2CCC(CCF)Sc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2003.08.051
172997 2330 None 57 Human Binding pIC50 = 6.8 6.8 -64 2
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2005.08.007
2238 2330 None 57 Human Binding pIC50 = 6.8 6.8 -64 2
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2005.08.007
CHEMBL49429 2330 None 57 Human Binding pIC50 = 6.8 6.8 -64 2
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2005.08.007
DB06666 2330 None 57 Human Binding pIC50 = 6.8 6.8 -64 2
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2005.08.007
118719831 115753 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1009 21 11 15 -3.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353942 115753 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1009 21 11 15 -3.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720269 115840 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 21 12 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354580 115840 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 21 12 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
10834761 114536 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 399 3 1 3 4.3 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCN(C)Cc3ccccc32)cc1 10.1021/jm960133o
CHEMBL333652 114536 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 399 3 1 3 4.3 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCN(C)Cc3ccccc32)cc1 10.1021/jm960133o
44273080 98617 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 571 7 1 7 2.4 COC(=O)CNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL277022 98617 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 571 7 1 7 2.4 COC(=O)CNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
23598600 5365 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 594 7 2 4 5.9 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=C(C(=O)NCCN4CCCC4)CC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.04.016
CHEMBL106938 5365 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 594 7 2 4 5.9 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=C(C(=O)NCCN4CCCC4)CC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.04.016
69940391 148547 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 512 7 2 7 3.7 O=c1n(Cc2nnc(Cc3ccccc3Cl)[nH]2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
CHEMBL3938717 148547 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 512 7 2 7 3.7 O=c1n(Cc2nnc(Cc3ccccc3Cl)[nH]2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
56848556 147035 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 579 10 3 7 2.9 O=CNC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1cccc(C(F)(F)F)c1 nan
CHEMBL3926829 147035 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 579 10 3 7 2.9 O=CNC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1cccc(C(F)(F)F)c1 nan
11261339 154618 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 548 5 2 4 6.1 COc1cc(C(=O)N2CCC3(C=C(C(=O)O)CC3)Cc3ccccc32)ccc1NC(=O)c1cc(F)ccc1Cl 10.1016/j.bmcl.2007.09.059
CHEMBL399289 154618 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 548 5 2 4 6.1 COc1cc(C(=O)N2CCC3(C=C(C(=O)O)CC3)Cc3ccccc32)ccc1NC(=O)c1cc(F)ccc1Cl 10.1016/j.bmcl.2007.09.059
44309820 204226 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 433 3 2 3 6.2 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3ccccc3Nc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
CHEMBL70949 204226 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 433 3 2 3 6.2 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3ccccc3Nc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
14969510 200635 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 334 2 0 2 3.3 O=C(c1ccccc1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
CHEMBL59947 200635 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 334 2 0 2 3.3 O=C(c1ccccc1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
118719834 115756 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1055 20 11 14 -1.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353945 115756 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1055 20 11 14 -1.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
10550481 12873 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 428 4 2 4 4.6 CN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3N)cc2)c2ccccc21 10.1021/jm960133o
CHEMBL118878 12873 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 428 4 2 4 4.6 CN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3N)cc2)c2ccccc21 10.1021/jm960133o
10527137 12785 None 0 Rat Binding pIC50 = 4.7 4.7 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 441 4 0 3 5.3 Cc1ccccc1C(=O)N(C)c1ccc(C(=O)N2CCCC(N(C)C)c3ccccc32)cc1 10.1021/jm960133o
CHEMBL118805 12785 None 0 Rat Binding pIC50 = 4.7 4.7 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 441 4 0 3 5.3 Cc1ccccc1C(=O)N(C)c1ccc(C(=O)N2CCCC(N(C)C)c3ccccc32)cc1 10.1021/jm960133o
10834036 13633 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 386 4 1 3 4.5 COc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCc3ccccc32)cc1 10.1021/jm960133o
CHEMBL119442 13633 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 386 4 1 3 4.5 COc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCc3ccccc32)cc1 10.1021/jm960133o
44428412 143139 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 556 9 0 7 4.8 CC(C)(C)C(=O)C(C(=O)OCc1ccccc1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccco1 10.1016/j.bmc.2006.12.031
CHEMBL389581 143139 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 556 9 0 7 4.8 CC(C)(C)C(=O)C(C(=O)OCc1ccccc1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccco1 10.1016/j.bmc.2006.12.031
54582950 63035 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 612 8 2 4 6.6 CN(C)CCNC(=O)C1=C[C@]2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL1788220 63035 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 612 8 2 4 6.6 CN(C)CCNC(=O)C1=C[C@]2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
44444762 154727 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 612 8 2 4 6.6 CN(C)CCNC(=O)C1=C[C@@]2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
CHEMBL399888 154727 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 612 8 2 4 6.6 CN(C)CCNC(=O)C1=C[C@@]2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
18917534 204292 None 0 Rat Binding pIC50 = 8.7 8.7 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 485 3 1 3 5.7 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccccc1Br 10.1016/s0960-894x(03)00388-3
CHEMBL71355 204292 None 0 Rat Binding pIC50 = 8.7 8.7 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 485 3 1 3 5.7 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccccc1Br 10.1016/s0960-894x(03)00388-3
44404614 165748 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 378 2 0 2 5.7 Cc1ccc(-c2ccc(C(=O)N3Cc4cccn4Cc4ccccc43)cc2)cc1 10.1016/j.bmcl.2005.08.007
CHEMBL424663 165748 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 378 2 0 2 5.7 Cc1ccc(-c2ccc(C(=O)N3Cc4cccn4Cc4ccccc43)cc2)cc1 10.1016/j.bmcl.2005.08.007
10003306 203771 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 439 3 1 3 5.4 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1021/jm980179c
CHEMBL68085 203771 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 439 3 1 3 5.4 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1021/jm980179c
44332168 4483 None 0 Human Binding pIC50 = 7.7 7.7 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 436 3 1 2 6.3 O=C(Nc1ccc(C(=O)N2CCC3(C=CCCC3)Cc3ccccc32)cc1)c1ccccc1 10.1016/j.bmcl.2004.02.103
CHEMBL101935 4483 None 0 Human Binding pIC50 = 7.7 7.7 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 436 3 1 2 6.3 O=C(Nc1ccc(C(=O)N2CCC3(C=CCCC3)Cc3ccccc32)cc1)c1ccccc1 10.1016/j.bmcl.2004.02.103
10003306 203771 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 439 3 1 3 5.4 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
CHEMBL68085 203771 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 439 3 1 3 5.4 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
14969520 202705 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 379 3 0 4 3.2 O=C(c1ccc([N+](=O)[O-])cc1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
CHEMBL61688 202705 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 379 3 0 4 3.2 O=C(c1ccc([N+](=O)[O-])cc1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
14969543 202746 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 393 5 1 4 2.6 NCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL61947 202746 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 393 5 1 4 2.6 NCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
118719830 115752 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1033 19 11 14 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C2CCCCC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353941 115752 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1033 19 11 14 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C2CCCCC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL338294 211604 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CCCCN)NC(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
19699060 56145 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 466 3 2 4 5.4 O=C(Nc1ccc(C(=O)N2CCc3c[nH]nc3-c3sccc32)cc1)c1ccc(F)cc1Cl 10.1016/s0960-894x(00)00084-6
CHEMBL162588 56145 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 466 3 2 4 5.4 O=C(Nc1ccc(C(=O)N2CCc3c[nH]nc3-c3sccc32)cc1)c1ccc(F)cc1Cl 10.1016/s0960-894x(00)00084-6
44374839 120167 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 442 3 1 5 4.9 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCc3cn(C)nc3-c3sccc32)cc1 10.1016/s0960-894x(00)00084-6
CHEMBL351587 120167 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 442 3 1 5 4.9 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCc3cn(C)nc3-c3sccc32)cc1 10.1016/s0960-894x(00)00084-6
6734379 163708 None 1 Human Binding pIC50 = 5.7 5.7 - 0
Inhibition of human V1A vasopressin receptorInhibition of human V1A vasopressin receptor
ChEMBL 409 3 1 6 2.5 O=C(OCc1ccc2c(c1)OCO2)N1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm010878g
CHEMBL420500 163708 None 1 Human Binding pIC50 = 5.7 5.7 - 0
Inhibition of human V1A vasopressin receptorInhibition of human V1A vasopressin receptor
ChEMBL 409 3 1 6 2.5 O=C(OCc1ccc2c(c1)OCO2)N1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm010878g
44293763 101506 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
In vitro inhibition of (Phe-3,4,5 [3H]-) AVP binding towards isolated rat hepatic Vasopressin V1a receptorIn vitro inhibition of (Phe-3,4,5 [3H]-) AVP binding towards isolated rat hepatic Vasopressin V1a receptor
ChEMBL 422 3 1 4 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1 10.1016/s0960-894x(99)00279-6
CHEMBL297990 101506 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
In vitro inhibition of (Phe-3,4,5 [3H]-) AVP binding towards isolated rat hepatic Vasopressin V1a receptorIn vitro inhibition of (Phe-3,4,5 [3H]-) AVP binding towards isolated rat hepatic Vasopressin V1a receptor
ChEMBL 422 3 1 4 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1 10.1016/s0960-894x(99)00279-6
22405324 70594 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 442 3 0 4 4.8 Cc1ccc(S(=O)(=O)c2ccc(C(=O)N3Cc4cccn4Cc4ccccc43)cc2)cc1 10.1016/j.bmcl.2005.08.007
CHEMBL194970 70594 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 442 3 0 4 4.8 Cc1ccc(S(=O)(=O)c2ccc(C(=O)N3Cc4cccn4Cc4ccccc43)cc2)cc1 10.1016/j.bmcl.2005.08.007
14969552 200825 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 463 8 1 4 3.6 CC(=O)NCCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL60096 200825 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 463 8 1 4 3.6 CC(=O)NCCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
14969536 201886 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 378 4 0 3 3.7 CCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL60736 201886 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 378 4 0 3 3.7 CCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
118720288 115860 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1029 20 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354600 115860 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1029 20 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
19699133 119929 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 496 3 1 5 5.9 Cn1cc2c(n1)-c1sccc1N(C(=O)c1ccc(NC(=O)c3ccc(Cl)cc3Cl)cc1)CC2 10.1016/s0960-894x(00)00084-6
CHEMBL349506 119929 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 496 3 1 5 5.9 Cn1cc2c(n1)-c1sccc1N(C(=O)c1ccc(NC(=O)c3ccc(Cl)cc3Cl)cc1)CC2 10.1016/s0960-894x(00)00084-6
19699093 120036 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 428 3 2 4 4.9 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCc3c[nH]nc3-c3sccc32)cc1 10.1016/s0960-894x(00)00084-6
CHEMBL350383 120036 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 428 3 2 4 4.9 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCc3c[nH]nc3-c3sccc32)cc1 10.1016/s0960-894x(00)00084-6
14981580 78869 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Displacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liverDisplacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liver
ChEMBL 637 11 3 8 1.9 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCNCC2)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112895 78869 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Displacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liverDisplacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liver
ChEMBL 637 11 3 8 1.9 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCNCC2)C3(C)C)CC1 10.1021/jm00031a004
118719839 115761 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1042 20 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccn2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353950 115761 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1042 20 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccn2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
10524202 13760 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 386 4 1 3 4.5 COc1ccc(C(=O)Nc2ccc(C(=O)N3CCCc4ccccc43)cc2)cc1 10.1021/jm960133o
CHEMBL119534 13760 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 386 4 1 3 4.5 COc1ccc(C(=O)Nc2ccc(C(=O)N3CCCc4ccccc43)cc2)cc1 10.1021/jm960133o
11059058 10089 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Inhibition of human V1A vasopressin receptorInhibition of human V1A vasopressin receptor
ChEMBL 429 3 1 7 4.1 O=C(OCc1cc2c(cc1Cl)OCO2)N1CCC(n2c(O)nc3ccccc32)CC1 10.1021/jm010878g
CHEMBL115444 10089 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Inhibition of human V1A vasopressin receptorInhibition of human V1A vasopressin receptor
ChEMBL 429 3 1 7 4.1 O=C(OCc1cc2c(cc1Cl)OCO2)N1CCC(n2c(O)nc3ccccc32)CC1 10.1021/jm010878g
53378730 152941 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 548 7 1 7 5.4 O=c1n(Cc2nnc(Cc3ccccc3C(F)(F)F)[nH]2)nc(-c2ccc(Cl)s2)n1Cc1ccccc1F nan
CHEMBL3975038 152941 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 548 7 1 7 5.4 O=c1n(Cc2nnc(Cc3ccccc3C(F)(F)F)[nH]2)nc(-c2ccc(Cl)s2)n1Cc1ccccc1F nan
9826254 163307 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 475 3 1 3 6.3 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccc(Cl)cc1Cl 10.1021/jm980179c
CHEMBL418890 163307 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 475 3 1 3 6.3 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccc(Cl)cc1Cl 10.1021/jm980179c
9826254 163307 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 475 3 1 3 6.3 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccc(Cl)cc1Cl 10.1016/s0960-894x(00)00084-6
CHEMBL418890 163307 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 475 3 1 3 6.3 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccc(Cl)cc1Cl 10.1016/s0960-894x(00)00084-6
9826254 163307 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 475 3 1 3 6.3 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccc(Cl)cc1Cl 10.1016/s0960-894x(03)00388-3
CHEMBL418890 163307 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 475 3 1 3 6.3 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccc(Cl)cc1Cl 10.1016/s0960-894x(03)00388-3
53378840 149713 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 532 6 1 7 5.3 O=c1n(Cc2cnc(-c3cccc(Cl)c3Cl)o2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
CHEMBL3947893 149713 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 532 6 1 7 5.3 O=c1n(Cc2cnc(-c3cccc(Cl)c3Cl)o2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
172997 2330 None 57 Human Binding pIC50 = 6.6 6.6 -64 2
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1021/jm980179c
2238 2330 None 57 Human Binding pIC50 = 6.6 6.6 -64 2
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1021/jm980179c
CHEMBL49429 2330 None 57 Human Binding pIC50 = 6.6 6.6 -64 2
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1021/jm980179c
DB06666 2330 None 57 Human Binding pIC50 = 6.6 6.6 -64 2
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1021/jm980179c
21467152 53155 None 0 Rat Binding pIC50 = 6.6 6.6 - 0
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 478 3 1 3 6.9 O=C(Nc1ccc(C(=O)N2CCCCc3sc(Cl)cc32)cc1)c1ccc(Cl)cc1Cl 10.1016/s0960-894x(00)00084-6
CHEMBL159831 53155 None 0 Rat Binding pIC50 = 6.6 6.6 - 0
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 478 3 1 3 6.9 O=C(Nc1ccc(C(=O)N2CCCCc3sc(Cl)cc32)cc1)c1ccc(Cl)cc1Cl 10.1016/s0960-894x(00)00084-6
172997 2330 None 57 Human Binding pIC50 = 6.6 6.6 -64 2
In vitro binding affinity to human V1a receptorIn vitro binding affinity to human V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(00)00084-6
2238 2330 None 57 Human Binding pIC50 = 6.6 6.6 -64 2
In vitro binding affinity to human V1a receptorIn vitro binding affinity to human V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(00)00084-6
CHEMBL49429 2330 None 57 Human Binding pIC50 = 6.6 6.6 -64 2
In vitro binding affinity to human V1a receptorIn vitro binding affinity to human V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(00)00084-6
DB06666 2330 None 57 Human Binding pIC50 = 6.6 6.6 -64 2
In vitro binding affinity to human V1a receptorIn vitro binding affinity to human V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(00)00084-6
172997 2330 None 57 Human Binding pIC50 = 6.6 6.6 -64 2
In vitro inhibition of [3H]- AVP binding to V1a receptor from human platelet membraneIn vitro inhibition of [3H]- AVP binding to V1a receptor from human platelet membrane
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(99)00278-4
2238 2330 None 57 Human Binding pIC50 = 6.6 6.6 -64 2
In vitro inhibition of [3H]- AVP binding to V1a receptor from human platelet membraneIn vitro inhibition of [3H]- AVP binding to V1a receptor from human platelet membrane
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(99)00278-4
CHEMBL49429 2330 None 57 Human Binding pIC50 = 6.6 6.6 -64 2
In vitro inhibition of [3H]- AVP binding to V1a receptor from human platelet membraneIn vitro inhibition of [3H]- AVP binding to V1a receptor from human platelet membrane
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(99)00278-4
DB06666 2330 None 57 Human Binding pIC50 = 6.6 6.6 -64 2
In vitro inhibition of [3H]- AVP binding to V1a receptor from human platelet membraneIn vitro inhibition of [3H]- AVP binding to V1a receptor from human platelet membrane
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(99)00278-4
10789935 11814 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Compound was tested for its ability to displace [3H]AVP from its specific binding sites in Rat liver (AVP-V1a receptor).Compound was tested for its ability to displace [3H]AVP from its specific binding sites in Rat liver (AVP-V1a receptor).
ChEMBL 455 4 1 5 5.0 CC(=O)O/N=C1\CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc21 10.1021/jm960133o
CHEMBL118204 11814 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Compound was tested for its ability to displace [3H]AVP from its specific binding sites in Rat liver (AVP-V1a receptor).Compound was tested for its ability to displace [3H]AVP from its specific binding sites in Rat liver (AVP-V1a receptor).
ChEMBL 455 4 1 5 5.0 CC(=O)O/N=C1\CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc21 10.1021/jm960133o
10620049 114104 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 384 5 1 2 4.9 O=C(CCc1ccccc1)Nc1ccc(C(=O)N2CCCc3ccccc32)cc1 10.1021/jm960133o
CHEMBL332757 114104 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 384 5 1 2 4.9 O=C(CCc1ccccc1)Nc1ccc(C(=O)N2CCCc3ccccc32)cc1 10.1021/jm960133o
71458039 78873 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Displacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liverDisplacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liver
ChEMBL 530 8 3 5 2.2 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)C2 10.1021/jm00031a004
CHEMBL2112899 78873 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Displacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liverDisplacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liver
ChEMBL 530 8 3 5 2.2 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)C2 10.1021/jm00031a004
44273077 99182 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 589 7 1 5 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@H](NCc3ccccc3)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL281361 99182 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 589 7 1 5 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@H](NCc3ccccc3)C1=O)C2 10.1016/0960-894X(94)00469-V
44273173 99023 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 555 7 0 5 4.0 CCN(CC)[C@@H]1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL280202 99023 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 555 7 0 5 4.0 CCN(CC)[C@@H]1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
44336768 163350 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 599 7 3 4 6.1 O=C(O)CNC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL419183 163350 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 599 7 3 4 6.1 O=C(O)CNC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
56848489 144880 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 637 11 3 8 4.0 CCNC(=O)OCC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1cccc(C(F)(F)F)c1 nan
CHEMBL3909988 144880 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 637 11 3 8 4.0 CCNC(=O)OCC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1cccc(C(F)(F)F)c1 nan
44335329 167836 None 0 Human Binding pIC50 = 7.6 7.6 -1 2
Inhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptorInhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptor
ChEMBL 561 4 1 3 7.6 Cc1ccc(-c2ccccc2C(=O)Nc2ccc(C(=O)N3C[C@@H]4C5CCC(C5)N4Cc4cc(Cl)ccc43)cc2)cc1 10.1016/s0960-894x(02)00649-2
CHEMBL430841 167836 None 0 Human Binding pIC50 = 7.6 7.6 -1 2
Inhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptorInhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptor
ChEMBL 561 4 1 3 7.6 Cc1ccc(-c2ccccc2C(=O)Nc2ccc(C(=O)N3C[C@@H]4C5CCC(C5)N4Cc4cc(Cl)ccc43)cc2)cc1 10.1016/s0960-894x(02)00649-2
9915472 169521 None 0 Human Binding pIC50 = 7.6 7.6 -14 2
Inhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptorInhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptor
ChEMBL 547 4 1 3 7.3 O=C(Nc1ccc(C(=O)N2C[C@@H]3C4CCC(C4)N3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/s0960-894x(02)00649-2
CHEMBL443498 169521 None 0 Human Binding pIC50 = 7.6 7.6 -14 2
Inhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptorInhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptor
ChEMBL 547 4 1 3 7.3 O=C(Nc1ccc(C(=O)N2C[C@@H]3C4CCC(C4)N3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/s0960-894x(02)00649-2
14969549 201766 None 0 Rat Binding pIC50 = 6.6 6.6 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 435 8 1 4 2.8 O=CNCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL60672 201766 None 0 Rat Binding pIC50 = 6.6 6.6 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 435 8 1 4 2.8 O=CNCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
19699093 120036 None 0 Human Binding pIC50 = 6.6 6.6 - 0
In vitro binding affinity to human V1a receptorIn vitro binding affinity to human V1a receptor
ChEMBL 428 3 2 4 4.9 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCc3c[nH]nc3-c3sccc32)cc1 10.1016/s0960-894x(00)00084-6
CHEMBL350383 120036 None 0 Human Binding pIC50 = 6.6 6.6 - 0
In vitro binding affinity to human V1a receptorIn vitro binding affinity to human V1a receptor
ChEMBL 428 3 2 4 4.9 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCc3c[nH]nc3-c3sccc32)cc1 10.1016/s0960-894x(00)00084-6
10503021 102734 None 0 Rat Binding pIC50 = 6.6 6.6 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 435 3 1 3 5.6 Cc1cccc(C(=O)Nc2ccc(C(=O)N3Cc4cccn4Cc4ccccc43)cc2)c1C 10.1016/s0960-894x(03)00388-3
CHEMBL304956 102734 None 0 Rat Binding pIC50 = 6.6 6.6 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 435 3 1 3 5.6 Cc1cccc(C(=O)Nc2ccc(C(=O)N3Cc4cccn4Cc4ccccc43)cc2)c1C 10.1016/s0960-894x(03)00388-3
5099582 110504 None 9 Rat Binding pIC50 = 5.6 5.6 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 322 3 1 2 3.9 CC(C)C(=O)Nc1ccc(C(=O)N2CCCc3ccccc32)cc1 10.1021/jm960133o
CHEMBL324935 110504 None 9 Rat Binding pIC50 = 5.6 5.6 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 322 3 1 2 3.9 CC(C)C(=O)Nc1ccc(C(=O)N2CCCc3ccccc32)cc1 10.1021/jm960133o
10574499 112986 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 427 4 1 3 5.3 Cc1cccc(C(=O)Nc2ccc(C(=O)N3CCCC(N(C)C)c4ccccc43)cc2)c1 10.1021/jm960133o
CHEMBL331098 112986 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 427 4 1 3 5.3 Cc1cccc(C(=O)Nc2ccc(C(=O)N3CCCC(N(C)C)c4ccccc43)cc2)c1 10.1021/jm960133o
56848557 146671 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 607 9 3 7 3.5 CC(=O)NC(C)(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1cccc(C(F)(F)F)c1 nan
CHEMBL3923775 146671 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 607 9 3 7 3.5 CC(=O)NC(C)(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1cccc(C(F)(F)F)c1 nan
10719289 205630 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 473 3 1 3 6.1 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1Cl 10.1021/jm980179c
CHEMBL81755 205630 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 473 3 1 3 6.1 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1Cl 10.1021/jm980179c
14969550 200246 None 0 Rat Binding pIC50 = 6.6 6.6 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 449 9 1 4 3.2 O=CNCCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL59699 200246 None 0 Rat Binding pIC50 = 6.6 6.6 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 449 9 1 4 3.2 O=CNCCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
44335356 5223 None 0 Human Binding pIC50 = 6.6 6.6 -5 2
Inhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptorInhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptor
ChEMBL 385 3 2 3 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCNc3ccccc32)cc1 10.1016/s0960-894x(02)00649-2
CHEMBL106229 5223 None 0 Human Binding pIC50 = 6.6 6.6 -5 2
Inhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptorInhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptor
ChEMBL 385 3 2 3 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCNc3ccccc32)cc1 10.1016/s0960-894x(02)00649-2
14969505 102649 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 340 2 0 3 3.3 O=C(c1cccs1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
CHEMBL304430 102649 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 340 2 0 3 3.3 O=C(c1cccs1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
118720267 115838 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 975 21 10 13 -3.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354578 115838 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 975 21 10 13 -3.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
10763869 11873 None 1 Rat Binding pIC50 = 5.6 5.6 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 406 4 1 3 4.5 O=C(c1ccc(NS(=O)(=O)c2ccccc2)cc1)N1CCCCc2ccccc21 10.1021/jm960133o
CHEMBL118244 11873 None 1 Rat Binding pIC50 = 5.6 5.6 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 406 4 1 3 4.5 O=C(c1ccc(NS(=O)(=O)c2ccccc2)cc1)N1CCCCc2ccccc21 10.1021/jm960133o
15307967 102289 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 432 3 1 2 6.3 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2c3ccccc3CCc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
CHEMBL303376 102289 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 432 3 1 2 6.3 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2c3ccccc3CCc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
448537 160248 None 89 Human Binding pIC50 = 4.6 4.6 -45 25
DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
CHEMBL411 160248 None 89 Human Binding pIC50 = 4.6 4.6 -45 25
DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
10551037 204232 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 439 3 1 3 5.4 Cc1c(F)cccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1021/jm980179c
CHEMBL70981 204232 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 439 3 1 3 5.4 Cc1c(F)cccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1021/jm980179c
11798757 204286 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 475 3 1 3 6.0 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccccc1C(F)(F)F 10.1021/jm980179c
CHEMBL71305 204286 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 475 3 1 3 6.0 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccccc1C(F)(F)F 10.1021/jm980179c
23598560 4449 None 0 Human Binding pIC50 = 7.6 7.6 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 512 4 1 2 7.9 O=C(Nc1ccc(C(=O)N2CCC3(C=CCCC3)Cc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.02.103
CHEMBL101678 4449 None 0 Human Binding pIC50 = 7.6 7.6 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 512 4 1 2 7.9 O=C(Nc1ccc(C(=O)N2CCC3(C=CCCC3)Cc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.02.103
10551037 204232 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 439 3 1 3 5.4 Cc1c(F)cccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
CHEMBL70981 204232 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 439 3 1 3 5.4 Cc1c(F)cccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
11798757 204286 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 475 3 1 3 6.0 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccccc1C(F)(F)F 10.1016/s0960-894x(03)00388-3
CHEMBL71305 204286 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 475 3 1 3 6.0 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccccc1C(F)(F)F 10.1016/s0960-894x(03)00388-3
53378841 145895 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 508 6 1 6 5.1 O=c1n(Cc2cncc(-c3ccccc3Cl)c2)nc(-c2ccc(Cl)cc2)n1CC(O)C(F)(F)F nan
CHEMBL3917760 145895 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 508 6 1 6 5.1 O=c1n(Cc2cncc(-c3ccccc3Cl)c2)nc(-c2ccc(Cl)cc2)n1CC(O)C(F)(F)F nan
86690918 151818 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 547 6 1 6 6.4 O=c1n(Cc2ccc(-c3cccc(Cl)c3Cl)s2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
CHEMBL3965329 151818 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 547 6 1 6 6.4 O=c1n(Cc2ccc(-c3cccc(Cl)c3Cl)s2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
44294195 101313 None 1 Rat Binding pIC50 = 6.6 6.6 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 519 4 1 5 6.1 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1)c1cc(-c2ccccn2)ccc1Cl 10.1016/s0960-894x(99)00279-6
CHEMBL296619 101313 None 1 Rat Binding pIC50 = 6.6 6.6 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 519 4 1 5 6.1 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1)c1cc(-c2ccccn2)ccc1Cl 10.1016/s0960-894x(99)00279-6
CHEMBL2112249 209234 None 1 Rat Binding pIC50 = 5.6 5.6 - 2
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10838492 13462 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 481 4 1 3 6.3 CN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3cc(Cl)cc(Cl)c3)cc2)c2ccccc21 10.1021/jm960133o
CHEMBL119318 13462 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 481 4 1 3 6.3 CN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3cc(Cl)cc(Cl)c3)cc2)c2ccccc21 10.1021/jm960133o
11798122 114530 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 458 5 1 5 4.9 CN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3[N+](=O)[O-])cc2)c2ccccc21 10.1021/jm960133o
CHEMBL333597 114530 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 458 5 1 5 4.9 CN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3[N+](=O)[O-])cc2)c2ccccc21 10.1021/jm960133o
14969506 203192 None 0 Rat Binding pIC50 = 4.6 4.6 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 336 2 0 4 2.1 O=C(c1cnccn1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
CHEMBL64319 203192 None 0 Rat Binding pIC50 = 4.6 4.6 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 336 2 0 4 2.1 O=C(c1cnccn1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
10693776 10159 None 0 Rat Binding pIC50 = 4.6 4.6 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 427 4 1 3 5.3 Cc1ccc(C(=O)Nc2ccc(C(=O)N3CCCC(N(C)C)c4ccccc43)cc2)cc1 10.1021/jm960133o
CHEMBL115853 10159 None 0 Rat Binding pIC50 = 4.6 4.6 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 427 4 1 3 5.3 Cc1ccc(C(=O)Nc2ccc(C(=O)N3CCCC(N(C)C)c4ccccc43)cc2)cc1 10.1021/jm960133o
44428431 167254 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 571 10 1 4 5.9 CC(C)C[C@@H](C(=O)NCc1ccc(Cl)cc1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL429281 167254 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 571 10 1 4 5.9 CC(C)C[C@@H](C(=O)NCc1ccc(Cl)cc1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
69939726 145027 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 498 6 1 8 3.6 O=c1n(Cc2cn(-c3ccccc3Cl)nn2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
CHEMBL3911148 145027 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 498 6 1 8 3.6 O=c1n(Cc2cn(-c3ccccc3Cl)nn2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
44309960 204279 None 1 Rat Binding pIC50 = 7.6 7.6 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 475 3 1 3 6.3 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1cccc(Cl)c1Cl 10.1016/s0960-894x(03)00388-3
CHEMBL71282 204279 None 1 Rat Binding pIC50 = 7.6 7.6 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 475 3 1 3 6.3 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1cccc(Cl)c1Cl 10.1016/s0960-894x(03)00388-3
118719842 115764 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1055 21 11 14 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353953 115764 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1055 21 11 14 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
21837085 102254 None 0 Rat Binding pIC50 = 6.6 6.6 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 421 3 1 3 5.2 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCc3cccn3-c3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
CHEMBL303176 102254 None 0 Rat Binding pIC50 = 6.6 6.6 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 421 3 1 3 5.2 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCc3cccn3-c3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
10621059 114260 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 401 4 1 4 4.4 O=C(Nc1ccc(C(=O)N2CCCc3ccccc32)cc1)c1ccccc1[N+](=O)[O-] 10.1021/jm960133o
CHEMBL333055 114260 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 401 4 1 4 4.4 O=C(Nc1ccc(C(=O)N2CCCc3ccccc32)cc1)c1ccccc1[N+](=O)[O-] 10.1021/jm960133o
44273321 167500 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 542 7 2 6 2.2 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(NCCN)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL429971 167500 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 542 7 2 6 2.2 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(NCCN)C1=O)C2 10.1016/0960-894X(94)00469-V
14969546 163278 None 0 Rat Binding pIC50 = 6.6 6.6 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 435 8 1 4 3.8 NCCCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL418692 163278 None 0 Rat Binding pIC50 = 6.6 6.6 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 435 8 1 4 3.8 NCCCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
118720260 115831 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1061 21 11 15 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2cccs2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354571 115831 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1061 21 11 15 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2cccs2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
22405326 72334 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 394 3 0 3 5.8 Cc1ccc(Oc2ccc(C(=O)N3Cc4cccn4Cc4ccccc43)cc2)cc1 10.1016/j.bmcl.2005.08.007
CHEMBL198446 72334 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 394 3 0 3 5.8 Cc1ccc(Oc2ccc(C(=O)N3Cc4cccn4Cc4ccccc43)cc2)cc1 10.1016/j.bmcl.2005.08.007
14969531 102099 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 391 3 1 3 3.2 CC(=O)Nc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL302233 102099 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 391 3 1 3 3.2 CC(=O)Nc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
10548204 12382 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 386 4 1 3 4.5 COc1cccc(C(=O)Nc2ccc(C(=O)N3CCCc4ccccc43)cc2)c1 10.1021/jm960133o
CHEMBL118562 12382 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 386 4 1 3 4.5 COc1cccc(C(=O)Nc2ccc(C(=O)N3CCCc4ccccc43)cc2)c1 10.1021/jm960133o
10601045 13959 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 487 4 1 3 6.6 O=C(Nc1ccc(C(=O)N2CCCC(N3CCCCC3)c3ccccc32)cc1)c1ccccc1Cl 10.1021/jm960133o
CHEMBL119671 13959 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 487 4 1 3 6.6 O=C(Nc1ccc(C(=O)N2CCCC(N3CCCCC3)c3ccccc32)cc1)c1ccccc1Cl 10.1021/jm960133o
10599903 14568 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 456 4 3 3 4.7 CNC(=O)NC1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc21 10.1021/jm960133o
CHEMBL120449 14568 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 456 4 3 3 4.7 CNC(=O)NC1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc21 10.1021/jm960133o
69940395 149076 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 514 6 1 7 5.1 O=c1n(Cc2ncc(-c3ccccc3Cl)s2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
CHEMBL3943019 149076 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 514 6 1 7 5.1 O=c1n(Cc2ncc(-c3ccccc3Cl)s2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
10742994 110377 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 470 6 2 4 4.1 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(N(C)CC(N)=O)c3ccccc32)cc1 10.1021/jm960133o
CHEMBL324251 110377 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 470 6 2 4 4.1 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(N(C)CC(N)=O)c3ccccc32)cc1 10.1021/jm960133o
44273316 98869 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 589 7 1 5 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](NCc3ccccc3)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL279022 98869 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 589 7 1 5 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](NCc3ccccc3)C1=O)C2 10.1016/0960-894X(94)00469-V
44273417 99505 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 555 7 0 5 4.0 CCN(CC)[C@H]1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL283317 99505 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 555 7 0 5 4.0 CCN(CC)[C@H]1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
9799174 140571 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 364 2 0 2 5.4 O=C(c1ccc(-c2ccccc2)cc1)N1Cc2cccn2Cc2ccccc21 10.1016/j.bmcl.2005.08.007
CHEMBL381248 140571 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 364 2 0 2 5.4 O=C(c1ccc(-c2ccccc2)cc1)N1Cc2cccn2Cc2ccccc21 10.1016/j.bmcl.2005.08.007
9935001 53148 None 0 Rat Binding pIC50 = 8.5 8.5 - 0
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 483 4 1 3 6.6 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/s0960-894x(00)00084-6
CHEMBL159823 53148 None 0 Rat Binding pIC50 = 8.5 8.5 - 0
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 483 4 1 3 6.6 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/s0960-894x(00)00084-6
25109291 191384 None 10 Human Binding pIC50 = 8.4 8.4 -56 8
Displacement of radiolabeled [d(CH2)51,Tyr(Me)2]-AVP from human vasopressin V1a receptorDisplacement of radiolabeled [d(CH2)51,Tyr(Me)2]-AVP from human vasopressin V1a receptor
ChEMBL 327 1 2 6 1.7 Nc1nc2c(c(N3CCNCC3)n1)CCC1=C2[C@@H]2CCCC[C@@H]2O1 10.1021/jm8007618
CHEMBL519240 191384 None 10 Human Binding pIC50 = 8.4 8.4 -56 8
Displacement of radiolabeled [d(CH2)51,Tyr(Me)2]-AVP from human vasopressin V1a receptorDisplacement of radiolabeled [d(CH2)51,Tyr(Me)2]-AVP from human vasopressin V1a receptor
ChEMBL 327 1 2 6 1.7 Nc1nc2c(c(N3CCNCC3)n1)CCC1=C2[C@@H]2CCCC[C@@H]2O1 10.1021/jm8007618
18917553 101460 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 484 4 1 4 6.0 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1)c1ccccc1-c1ccccc1 10.1016/s0960-894x(99)00279-6
CHEMBL297705 101460 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 484 4 1 4 6.0 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1)c1ccccc1-c1ccccc1 10.1016/s0960-894x(99)00279-6
44332239 4531 None 0 Human Binding pIC50 = 7.5 7.5 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 466 4 1 3 6.3 COc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC3(C=CCCC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.02.103
CHEMBL102311 4531 None 0 Human Binding pIC50 = 7.5 7.5 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 466 4 1 3 6.3 COc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC3(C=CCCC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.02.103
14969555 200331 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 519 12 1 4 5.1 CC(=O)NCCCCCCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL59754 200331 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 519 12 1 4 5.1 CC(=O)NCCCCCCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
118720273 115843 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 974 21 10 12 -1.9 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3354583 115843 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 974 21 10 12 -1.9 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL338020 211601 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None CC(C)C[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10837161 11918 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 447 4 1 3 5.6 CN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3Cl)cc2)c2ccccc21 10.1021/jm960133o
CHEMBL118270 11918 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 447 4 1 3 5.6 CN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3Cl)cc2)c2ccccc21 10.1021/jm960133o
10716675 114913 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 413 4 1 3 5.0 CN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3)cc2)c2ccccc21 10.1021/jm960133o
CHEMBL334225 114913 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 413 4 1 3 5.0 CN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3)cc2)c2ccccc21 10.1021/jm960133o
67409800 146896 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 497 6 1 7 4.2 O=c1n(Cc2cnn(-c3ccccc3Cl)c2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
CHEMBL3925572 146896 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 497 6 1 7 4.2 O=c1n(Cc2cnn(-c3ccccc3Cl)c2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
10503021 102734 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 435 3 1 3 5.6 Cc1cccc(C(=O)Nc2ccc(C(=O)N3Cc4cccn4Cc4ccccc43)cc2)c1C 10.1021/jm980179c
CHEMBL304956 102734 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 435 3 1 3 5.6 Cc1cccc(C(=O)Nc2ccc(C(=O)N3Cc4cccn4Cc4ccccc43)cc2)c1C 10.1021/jm980179c
10789117 204610 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 437 4 1 4 5.0 COc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1021/jm980179c
CHEMBL73286 204610 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 437 4 1 4 5.0 COc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1021/jm980179c
10789117 204610 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 437 4 1 4 5.0 COc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
CHEMBL73286 204610 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 437 4 1 4 5.0 COc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
44293784 187895 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 444 3 1 4 4.6 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1)c1cc(F)ccc1F 10.1016/s0960-894x(99)00279-6
CHEMBL49657 187895 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 444 3 1 4 4.6 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1)c1cc(F)ccc1F 10.1016/s0960-894x(99)00279-6
14969532 100918 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 359 2 0 3 3.1 N#Cc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL293922 100918 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 359 2 0 3 3.1 N#Cc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
14969519 201866 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 379 3 0 4 3.2 O=C(c1cccc([N+](=O)[O-])c1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
CHEMBL60726 201866 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 379 3 0 4 3.2 O=C(c1cccc([N+](=O)[O-])c1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
9826033 57460 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Binding affinity towards VIa receptorBinding affinity towards VIa receptor
ChEMBL 471 4 2 2 6.7 O=C(Nc1ccc(C(=O)N2CCCc3c[nH]c4cccc2c34)cc1)c1ccccc1-c1ccccc1 10.1016/s0960-894x(02)01059-4
CHEMBL165670 57460 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Binding affinity towards VIa receptorBinding affinity towards VIa receptor
ChEMBL 471 4 2 2 6.7 O=C(Nc1ccc(C(=O)N2CCCc3c[nH]c4cccc2c34)cc1)c1ccccc1-c1ccccc1 10.1016/s0960-894x(02)01059-4
10619160 11843 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 370 3 1 2 4.8 Cc1cccc(C(=O)Nc2ccc(C(=O)N3CCCc4ccccc43)cc2)c1 10.1021/jm960133o
CHEMBL118220 11843 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 370 3 1 2 4.8 Cc1cccc(C(=O)Nc2ccc(C(=O)N3CCCc4ccccc43)cc2)c1 10.1021/jm960133o
44352768 115254 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Ability to displace [3H]arginine vasopressin in cloned human V1a receptorAbility to displace [3H]arginine vasopressin in cloned human V1a receptor
ChEMBL 536 7 2 4 7.0 O=C(O)CC[C@@H]1CCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc2S1 10.1016/j.bmcl.2003.08.051
CHEMBL334777 115254 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Ability to displace [3H]arginine vasopressin in cloned human V1a receptorAbility to displace [3H]arginine vasopressin in cloned human V1a receptor
ChEMBL 536 7 2 4 7.0 O=C(O)CC[C@@H]1CCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc2S1 10.1016/j.bmcl.2003.08.051
10696913 205567 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 505 4 1 4 6.3 COc1cc(C(=O)N2Cc3cccn3Cc3ccccc32)ccc1NC(=O)c1ccc(Cl)cc1Cl 10.1021/jm980179c
CHEMBL81269 205567 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 505 4 1 4 6.3 COc1cc(C(=O)N2Cc3cccn3Cc3ccccc32)ccc1NC(=O)c1ccc(Cl)cc1Cl 10.1021/jm980179c
44444760 154617 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 518 4 2 3 6.1 O=C(O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3cc(F)ccc3Cl)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
CHEMBL399288 154617 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 518 4 2 3 6.1 O=C(O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3cc(F)ccc3Cl)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
14969537 200305 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 392 5 0 3 4.1 CCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL59740 200305 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 392 5 0 3 4.1 CCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
14981574 78872 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Displacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liverDisplacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liver
ChEMBL 568 10 2 7 1.8 CN[C@@H](CCS(C)(=O)=O)C(=O)N[C@H]1CC2CC[C@]1(CS(=O)(=O)N1CCN(c3ccccc3C)CC1)C2(C)C 10.1021/jm00031a004
CHEMBL2112898 78872 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Displacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liverDisplacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liver
ChEMBL 568 10 2 7 1.8 CN[C@@H](CCS(C)(=O)=O)C(=O)N[C@H]1CC2CC[C@]1(CS(=O)(=O)N1CCN(c3ccccc3C)CC1)C2(C)C 10.1021/jm00031a004
10483105 90678 None 1 Rat Binding pIC50 = 6.5 6.5 - 4
Inhibition of rat liver V1a receptorInhibition of rat liver V1a receptor
ChEMBL 568 10 2 7 1.8 CN[C@@H](CCS(C)(=O)=O)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCN(c3ccccc3C)CC1)C2(C)C 10.1016/j.bmcl.2012.10.116
CHEMBL2391300 90678 None 1 Rat Binding pIC50 = 6.5 6.5 - 4
Inhibition of rat liver V1a receptorInhibition of rat liver V1a receptor
ChEMBL 568 10 2 7 1.8 CN[C@@H](CCS(C)(=O)=O)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCN(c3ccccc3C)CC1)C2(C)C 10.1016/j.bmcl.2012.10.116
118719841 115763 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1042 20 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccncc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353952 115763 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1042 20 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccncc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL339118 211615 None 0 Rat Binding pIC50 = 5.5 5.5 - 2
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10527129 13847 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 441 4 2 3 4.9 CC(=O)NC1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc21 10.1021/jm960133o
CHEMBL119591 13847 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 441 4 2 3 4.9 CC(=O)NC1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc21 10.1021/jm960133o
10499401 14030 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 370 4 1 2 4.5 O=C(Cc1ccccc1)Nc1ccc(C(=O)N2CCCc3ccccc32)cc1 10.1021/jm960133o
CHEMBL119730 14030 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 370 4 1 2 4.5 O=C(Cc1ccccc1)Nc1ccc(C(=O)N2CCCc3ccccc32)cc1 10.1021/jm960133o
10647295 110272 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 452 5 1 4 5.2 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(N(C)CC#N)c3ccccc32)cc1 10.1021/jm960133o
CHEMBL323802 110272 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 452 5 1 4 5.2 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(N(C)CC#N)c3ccccc32)cc1 10.1021/jm960133o
CHEMBL435021 213659 None 2 Rat Binding pIC50 = 4.5 4.5 - 2
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CNCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
9954905 101910 None 4 Rat Binding pIC50 = 7.5 7.5 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 440 3 1 4 4.8 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1 10.1016/s0960-894x(99)00279-6
CHEMBL300946 101910 None 4 Rat Binding pIC50 = 7.5 7.5 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 440 3 1 4 4.8 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1 10.1016/s0960-894x(99)00279-6
10528416 104727 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 471 4 1 4 5.6 COc1cc(Cl)ccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1021/jm980179c
CHEMBL310581 104727 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 471 4 1 4 5.6 COc1cc(Cl)ccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1021/jm980179c
10743659 205700 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 489 3 1 3 6.6 Cc1cc(C(=O)N2Cc3cccn3Cc3ccccc32)ccc1NC(=O)c1ccc(Cl)cc1Cl 10.1021/jm980179c
CHEMBL82376 205700 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 489 3 1 3 6.6 Cc1cc(C(=O)N2Cc3cccn3Cc3ccccc32)ccc1NC(=O)c1ccc(Cl)cc1Cl 10.1021/jm980179c
54582950 63035 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Evaluated for binding affinity towards vasopressin V1a receptor in ratEvaluated for binding affinity towards vasopressin V1a receptor in rat
ChEMBL 612 8 2 4 6.6 CN(C)CCNC(=O)C1=C[C@]2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL1788220 63035 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Evaluated for binding affinity towards vasopressin V1a receptor in ratEvaluated for binding affinity towards vasopressin V1a receptor in rat
ChEMBL 612 8 2 4 6.6 CN(C)CCNC(=O)C1=C[C@]2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
14969541 100906 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 376 4 0 2 4.2 CCCc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL293863 100906 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 376 4 0 2 4.2 CCCc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
14969545 102659 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 421 7 1 4 3.4 NCCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL304485 102659 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 421 7 1 4 3.4 NCCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
118720287 115859 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1022 21 10 12 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354599 115859 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1022 21 10 12 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL52813 215703 None 0 Rat Binding pIC50 = 5.5 5.5 - 2
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C1=O 10.1021/jm00099a019
10667727 11031 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 384 3 1 2 5.1 Cc1ccc(C(=O)Nc2ccc(C(=O)N3CCCc4ccccc43)cc2)c(C)c1 10.1021/jm960133o
CHEMBL117566 11031 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 384 3 1 2 5.1 Cc1ccc(C(=O)Nc2ccc(C(=O)N3CCCc4ccccc43)cc2)c(C)c1 10.1021/jm960133o
89701036 151801 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 496 7 2 7 3.2 O=c1n(Cc2nnc(Cc3ccccc3F)[nH]2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
CHEMBL3965167 151801 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 496 7 2 7 3.2 O=c1n(Cc2nnc(Cc3ccccc3F)[nH]2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
172997 2330 None 57 Rat Binding pIC50 = 6.5 6.5 - 2
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1021/jm980179c
2238 2330 None 57 Rat Binding pIC50 = 6.5 6.5 - 2
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1021/jm980179c
CHEMBL49429 2330 None 57 Rat Binding pIC50 = 6.5 6.5 - 2
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1021/jm980179c
DB06666 2330 None 57 Rat Binding pIC50 = 6.5 6.5 - 2
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1021/jm980179c
10814200 163502 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 469 3 1 3 6.2 Cc1ccc(C)c(C(=O)Nc2ccc(C(=O)N3Cc4cccn4Cc4ccccc43)c(Cl)c2)c1 10.1021/jm980179c
CHEMBL420216 163502 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 469 3 1 3 6.2 Cc1ccc(C)c(C(=O)Nc2ccc(C(=O)N3Cc4cccn4Cc4ccccc43)c(Cl)c2)c1 10.1021/jm980179c
172997 2330 None 57 Rat Binding pIC50 = 6.5 6.5 - 2
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(00)00084-6
2238 2330 None 57 Rat Binding pIC50 = 6.5 6.5 - 2
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(00)00084-6
CHEMBL49429 2330 None 57 Rat Binding pIC50 = 6.5 6.5 - 2
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(00)00084-6
DB06666 2330 None 57 Rat Binding pIC50 = 6.5 6.5 - 2
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(00)00084-6
118719832 115754 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1009 21 12 15 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353943 115754 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1009 21 12 15 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
44335343 107468 None 0 Human Binding pIC50 = 7.5 7.5 -1 2
Inhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptorInhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptor
ChEMBL 519 3 1 3 6.6 O=C(Nc1ccc(C(=O)N2C[C@@H]3C4CCC(CC4)N3Cc3cc(Cl)ccc32)cc1)c1ccccc1Cl 10.1016/s0960-894x(02)00649-2
CHEMBL318392 107468 None 0 Human Binding pIC50 = 7.5 7.5 -1 2
Inhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptorInhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptor
ChEMBL 519 3 1 3 6.6 O=C(Nc1ccc(C(=O)N2C[C@@H]3C4CCC(CC4)N3Cc3cc(Cl)ccc32)cc1)c1ccccc1Cl 10.1016/s0960-894x(02)00649-2
20825285 109195 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptorInhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptor
ChEMBL 595 4 1 3 8.2 Cc1ccc(-c2ccccc2C(=O)Nc2ccc(C(=O)N3C[C@@H]4C5CCC(C5)N4Cc4cc(Cl)ccc43)c(Cl)c2)cc1 10.1016/s0960-894x(02)00649-2
CHEMBL321561 109195 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptorInhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptor
ChEMBL 595 4 1 3 8.2 Cc1ccc(-c2ccccc2C(=O)Nc2ccc(C(=O)N3C[C@@H]4C5CCC(C5)N4Cc4cc(Cl)ccc43)c(Cl)c2)cc1 10.1016/s0960-894x(02)00649-2
14969542 200550 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 390 5 0 2 4.6 CCCCc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL59900 200550 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 390 5 0 2 4.6 CCCCc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
118719844 115766 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1056 21 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2ccncc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353955 115766 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1056 21 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2ccncc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
14969528 202812 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 392 3 0 4 3.1 COC(=O)c1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL62344 202812 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 392 3 0 4 3.1 COC(=O)c1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL2370623 209889 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00099a019
15307998 101095 None 0 Human Binding pIC50 = 7.4 7.4 - 0
In vitro inhibition of [3H]- AVP binding to V1a receptor from human platelet membraneIn vitro inhibition of [3H]- AVP binding to V1a receptor from human platelet membrane
ChEMBL 438 3 1 3 6.1 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3ccsc3Cc3ccccc32)cc1 10.1016/s0960-894x(99)00278-4
CHEMBL295014 101095 None 0 Human Binding pIC50 = 7.4 7.4 - 0
In vitro inhibition of [3H]- AVP binding to V1a receptor from human platelet membraneIn vitro inhibition of [3H]- AVP binding to V1a receptor from human platelet membrane
ChEMBL 438 3 1 3 6.1 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3ccsc3Cc3ccccc32)cc1 10.1016/s0960-894x(99)00278-4
14969557 202522 None 0 Rat Binding pIC50 = 6.4 6.4 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 465 7 1 5 3.4 COC(=O)NCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL61154 202522 None 0 Rat Binding pIC50 = 6.4 6.4 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 465 7 1 5 3.4 COC(=O)NCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
14981575 78870 None 0 Rat Binding pIC50 = 6.4 6.4 - 1
Displacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liverDisplacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liver
ChEMBL 582 10 1 7 2.1 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)N(C)C)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112896 78870 None 0 Rat Binding pIC50 = 6.4 6.4 - 1
Displacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liverDisplacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liver
ChEMBL 582 10 1 7 2.1 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)N(C)C)C3(C)C)CC1 10.1021/jm00031a004
11005810 10464 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Inhibition of human V1A vasopressin receptorInhibition of human V1A vasopressin receptor
ChEMBL 517 10 1 4 6.2 N#Cc1ccc(CCOC(=O)NC2CCN(CCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1 10.1021/jm010878g
CHEMBL116463 10464 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Inhibition of human V1A vasopressin receptorInhibition of human V1A vasopressin receptor
ChEMBL 517 10 1 4 6.2 N#Cc1ccc(CCOC(=O)NC2CCN(CCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1 10.1021/jm010878g
10743786 163477 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 493 3 1 3 6.4 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1)c1ccc(F)cc1Cl 10.1021/jm980179c
CHEMBL420031 163477 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 493 3 1 3 6.4 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1)c1ccc(F)cc1Cl 10.1021/jm980179c
23598595 154801 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 542 5 2 3 7.0 O=C(O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
CHEMBL400266 154801 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 542 5 2 3 7.0 O=C(O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
10437668 78878 None 1 Rat Binding pIC50 = 6.4 6.4 - 2
Displacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liverDisplacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liver
ChEMBL 554 9 2 7 1.5 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@@H](N)CCS(C)(=O)=O)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112903 78878 None 1 Rat Binding pIC50 = 6.4 6.4 - 2
Displacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liverDisplacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liver
ChEMBL 554 9 2 7 1.5 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@@H](N)CCS(C)(=O)=O)C3(C)C)CC1 10.1021/jm00031a004
10459252 52649 None 0 Human Binding pIC50 = 6.4 6.4 - 0
In vitro binding affinity to human V1a receptorIn vitro binding affinity to human V1a receptor
ChEMBL 517 4 1 3 7.3 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/s0960-894x(00)00084-6
CHEMBL159359 52649 None 0 Human Binding pIC50 = 6.4 6.4 - 0
In vitro binding affinity to human V1a receptorIn vitro binding affinity to human V1a receptor
ChEMBL 517 4 1 3 7.3 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/s0960-894x(00)00084-6
2249 2225 None 18 Rat Binding pIC50 = 6.4 6.4 -30 6
Inhibition of rat liver V1a receptorInhibition of rat liver V1a receptor
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1016/j.bmcl.2012.10.116
9872389 2225 None 18 Rat Binding pIC50 = 6.4 6.4 -30 6
Inhibition of rat liver V1a receptorInhibition of rat liver V1a receptor
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1016/j.bmcl.2012.10.116
CHEMBL1253853 2225 None 18 Rat Binding pIC50 = 6.4 6.4 -30 6
Inhibition of rat liver V1a receptorInhibition of rat liver V1a receptor
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1016/j.bmcl.2012.10.116
14969527 203236 None 0 Rat Binding pIC50 = 5.4 5.4 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 349 2 1 3 2.9 Nc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL64520 203236 None 0 Rat Binding pIC50 = 5.4 5.4 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 349 2 1 3 2.9 Nc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
14969522 203314 None 0 Rat Binding pIC50 = 5.4 5.4 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 392 3 0 4 3.2 CC(=O)Oc1cccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)c1 10.1021/jm00066a010
CHEMBL64836 203314 None 0 Rat Binding pIC50 = 5.4 5.4 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 392 3 0 4 3.2 CC(=O)Oc1cccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)c1 10.1021/jm00066a010
CHEMBL2112247 209232 None 0 Rat Binding pIC50 = 5.4 5.4 - 0
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cn(C)c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
14969507 162354 None 0 Rat Binding pIC50 = 4.4 4.4 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 335 2 0 3 2.7 O=C(c1ccncc1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
CHEMBL416505 162354 None 0 Rat Binding pIC50 = 4.4 4.4 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 335 2 0 3 2.7 O=C(c1ccncc1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
10764664 204377 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 421 3 1 3 5.3 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1021/jm980179c
CHEMBL71797 204377 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 421 3 1 3 5.3 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1021/jm980179c
10764664 204377 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 421 3 1 3 5.3 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
CHEMBL71797 204377 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 421 3 1 3 5.3 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
118720289 115861 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1029 20 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354601 115861 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1029 20 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
10524974 114058 None 0 Rat Binding pIC50 = 6.4 6.4 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 399 3 1 3 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCN(C)c3ccccc32)cc1 10.1021/jm960133o
CHEMBL332685 114058 None 0 Rat Binding pIC50 = 6.4 6.4 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 399 3 1 3 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCN(C)c3ccccc32)cc1 10.1021/jm960133o
44428420 92190 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 538 10 0 5 5.6 CC(C)C[C@@H](C(=O)OCc1ccccc1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL242517 92190 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 538 10 0 5 5.6 CC(C)C[C@@H](C(=O)OCc1ccccc1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
86690936 149125 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 596 7 1 10 3.2 O=c1n(S(=O)(=O)c2ncnn2Cc2ccccc2C(F)(F)F)nc(-c2ccc(Cl)cc2)n1CC(O)C(F)(F)F nan
CHEMBL3943296 149125 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 596 7 1 10 3.2 O=c1n(S(=O)(=O)c2ncnn2Cc2ccccc2C(F)(F)F)nc(-c2ccc(Cl)cc2)n1CC(O)C(F)(F)F nan
118720259 115830 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1031 20 11 15 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccco2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354570 115830 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1031 20 11 15 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccco2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
10692311 164036 None 0 Rat Binding pIC50 = 6.4 6.4 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 399 3 2 3 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(N)c3ccccc32)cc1 10.1021/jm960133o
CHEMBL420880 164036 None 0 Rat Binding pIC50 = 6.4 6.4 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 399 3 2 3 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(N)c3ccccc32)cc1 10.1021/jm960133o
44336791 8122 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 527 6 3 4 4.5 O=C(NCCO)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL109166 8122 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 527 6 3 4 4.5 O=C(NCCO)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
9937535 63036 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 554 7 2 4 5.1 CN(C)CCNC(=O)C1=C[C@@]2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL1788221 63036 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 554 7 2 4 5.1 CN(C)CCNC(=O)C1=C[C@@]2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
44336799 107229 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 596 7 2 5 4.8 O=C(NCCN1CCOCC1)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL316736 107229 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 596 7 2 5 4.8 O=C(NCCN1CCOCC1)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
67409933 150063 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 554 8 1 7 5.5 COc1ccc(Cn2c(-c3ccc(Cl)cc3)nn(Cc3nnc(Cc4c(Cl)cccc4Cl)[nH]3)c2=O)cc1 nan
CHEMBL3950716 150063 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 554 8 1 7 5.5 COc1ccc(Cn2c(-c3ccc(Cl)cc3)nn(Cc3nnc(Cc4c(Cl)cccc4Cl)[nH]3)c2=O)cc1 nan
56848491 152417 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 651 9 3 8 4.7 CC(C)(C)OC(=O)NC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1ccccc1C(F)(F)F nan
CHEMBL3970631 152417 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 651 9 3 8 4.7 CC(C)(C)OC(=O)NC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1ccccc1C(F)(F)F nan
56848624 160765 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 566 9 3 7 3.0 O=C(Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)N[C@@H](CO)Cc1cccc(C(F)(F)F)c1 nan
CHEMBL4114132 160765 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 566 9 3 7 3.0 O=C(Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)N[C@@H](CO)Cc1cccc(C(F)(F)F)c1 nan
10392505 108590 None 0 Human Binding pIC50 = 8.4 8.4 -4 2
Inhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptorInhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptor
ChEMBL 539 3 1 3 6.6 O=C(Nc1ccc(C(=O)N2C[C@@H]3C4CCC(C4)N3Cc3cc(Cl)ccc32)cc1)c1ccccc1C(F)(F)F 10.1016/s0960-894x(02)00649-2
CHEMBL320416 108590 None 0 Human Binding pIC50 = 8.4 8.4 -4 2
Inhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptorInhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptor
ChEMBL 539 3 1 3 6.6 O=C(Nc1ccc(C(=O)N2C[C@@H]3C4CCC(C4)N3Cc3cc(Cl)ccc32)cc1)c1ccccc1C(F)(F)F 10.1016/s0960-894x(02)00649-2
88064173 151624 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 530 7 1 6 5.4 O=c1n(Cc2nnc(Cc3c(Cl)cccc3Cl)[nH]2)nc(-c2ccc(Cl)cc2)n1CCC(F)(F)F nan
CHEMBL3963751 151624 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 530 7 1 6 5.4 O=c1n(Cc2nnc(Cc3c(Cl)cccc3Cl)[nH]2)nc(-c2ccc(Cl)cc2)n1CCC(F)(F)F nan
44428429 92192 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 571 10 1 4 5.9 CC(C)C[C@@H](C(=O)NCc1cccc(Cl)c1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL242534 92192 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 571 10 1 4 5.9 CC(C)C[C@@H](C(=O)NCc1cccc(Cl)c1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
44293777 188107 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 460 3 1 4 5.1 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1)c1c(F)cccc1Cl 10.1016/s0960-894x(99)00279-6
CHEMBL49824 188107 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 460 3 1 4 5.1 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1)c1c(F)cccc1Cl 10.1016/s0960-894x(99)00279-6
44444761 94163 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 532 4 1 4 6.2 COC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3cc(F)ccc3Cl)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
CHEMBL249536 94163 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 532 4 1 4 6.2 COC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3cc(F)ccc3Cl)cc1)c1ccccc1C2 10.1016/j.bmcl.2007.09.059
44428418 92189 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 482 8 0 5 4.2 O=C(CN1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1)OCc1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL242516 92189 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 482 8 0 5 4.2 O=C(CN1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1)OCc1ccccc1 10.1016/j.bmc.2006.12.031
15307988 204360 None 0 Rat Binding pIC50 = 6.4 6.4 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 450 3 1 3 6.6 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3ccccc3Sc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
CHEMBL71712 204360 None 0 Rat Binding pIC50 = 6.4 6.4 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 450 3 1 3 6.6 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3ccccc3Sc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
CHEMBL2112248 209233 None 0 Rat Binding pIC50 = 5.4 5.4 - 2
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00099a019
2984025 12889 None 6 Rat Binding pIC50 = 5.4 5.4 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 346 3 1 3 4.1 O=C(Nc1ccc(C(=O)N2CCCc3ccccc32)cc1)c1ccco1 10.1021/jm960133o
CHEMBL118892 12889 None 6 Rat Binding pIC50 = 5.4 5.4 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 346 3 1 3 4.1 O=C(Nc1ccc(C(=O)N2CCCc3ccccc32)cc1)c1ccco1 10.1021/jm960133o
44428423 92295 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 578 10 0 7 4.5 CC1(C(C(=O)OCC[Si](C)(C)C)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)OCCO1 10.1016/j.bmc.2006.12.031
CHEMBL242733 92295 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 578 10 0 7 4.5 CC1(C(C(=O)OCC[Si](C)(C)C)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)OCCO1 10.1016/j.bmc.2006.12.031
44428430 93254 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 605 10 1 4 6.2 CC(C)C[C@@H](C(=O)NCc1cccc(C(F)(F)F)c1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL244865 93254 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 605 10 1 4 6.2 CC(C)C[C@@H](C(=O)NCc1cccc(C(F)(F)F)c1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
44332269 167817 None 0 Human Binding pIC50 = 7.4 7.4 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 496 5 1 4 6.3 COc1cccc(OC)c1C(=O)Nc1ccc(C(=O)N2CCC3(C=CCCC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.02.103
CHEMBL430676 167817 None 0 Human Binding pIC50 = 7.4 7.4 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 496 5 1 4 6.3 COc1cccc(OC)c1C(=O)Nc1ccc(C(=O)N2CCC3(C=CCCC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.02.103
10692266 14128 None 0 Rat Binding pIC50 = 6.4 6.4 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 398 3 1 2 5.6 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCCCc3ccccc32)cc1 10.1021/jm960133o
CHEMBL119806 14128 None 0 Rat Binding pIC50 = 6.4 6.4 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 398 3 1 2 5.6 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCCCc3ccccc32)cc1 10.1021/jm960133o
172997 2330 None 57 Rat Binding pIC50 = 6.4 6.4 - 2
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(03)00388-3
2238 2330 None 57 Rat Binding pIC50 = 6.4 6.4 - 2
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(03)00388-3
CHEMBL49429 2330 None 57 Rat Binding pIC50 = 6.4 6.4 - 2
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(03)00388-3
DB06666 2330 None 57 Rat Binding pIC50 = 6.4 6.4 - 2
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(03)00388-3
19699133 119929 None 0 Human Binding pIC50 = 5.4 5.4 - 0
In vitro binding affinity to human V1a receptorIn vitro binding affinity to human V1a receptor
ChEMBL 496 3 1 5 5.9 Cn1cc2c(n1)-c1sccc1N(C(=O)c1ccc(NC(=O)c3ccc(Cl)cc3Cl)cc1)CC2 10.1016/s0960-894x(00)00084-6
CHEMBL349506 119929 None 0 Human Binding pIC50 = 5.4 5.4 - 0
In vitro binding affinity to human V1a receptorIn vitro binding affinity to human V1a receptor
ChEMBL 496 3 1 5 5.9 Cn1cc2c(n1)-c1sccc1N(C(=O)c1ccc(NC(=O)c3ccc(Cl)cc3Cl)cc1)CC2 10.1016/s0960-894x(00)00084-6
44273034 99046 None 0 Rat Binding pIC50 = 5.4 5.4 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 557 7 2 6 2.3 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(NCC(=O)O)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL280356 99046 None 0 Rat Binding pIC50 = 5.4 5.4 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 557 7 2 6 2.3 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(NCC(=O)O)C1=O)C2 10.1016/0960-894X(94)00469-V
44273459 73925 None 0 Rat Binding pIC50 = 5.4 5.4 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 482 4 0 4 3.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C=CC1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL20205 73925 None 0 Rat Binding pIC50 = 5.4 5.4 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 482 4 0 4 3.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C=CC1=O)C2 10.1016/0960-894X(94)00469-V
14969551 202180 None 0 Rat Binding pIC50 = 6.4 6.4 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 435 6 1 4 2.8 CC(=O)NCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL60954 202180 None 0 Rat Binding pIC50 = 6.4 6.4 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 435 6 1 4 2.8 CC(=O)NCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
14969538 203281 None 0 Rat Binding pIC50 = 6.4 6.4 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 406 6 0 3 4.5 CCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL64695 203281 None 0 Rat Binding pIC50 = 6.4 6.4 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 406 6 0 3 4.5 CCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
44428424 152586 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 567 9 1 6 3.9 CC1(C(C(=O)NCc2ccccc2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)OCCO1 10.1016/j.bmc.2006.12.031
CHEMBL397188 152586 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 567 9 1 6 3.9 CC1(C(C(=O)NCc2ccccc2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)OCCO1 10.1016/j.bmc.2006.12.031
15307999 101404 None 0 Human Binding pIC50 = 7.4 7.4 - 0
In vitro inhibition of [3H]- AVP binding to V1a receptor from human platelet membraneIn vitro inhibition of [3H]- AVP binding to V1a receptor from human platelet membrane
ChEMBL 492 3 1 3 7.1 O=C(Nc1ccc(C(=O)N2Cc3sccc3Cc3ccccc32)cc1)c1ccc(Cl)cc1Cl 10.1016/s0960-894x(99)00278-4
CHEMBL297293 101404 None 0 Human Binding pIC50 = 7.4 7.4 - 0
In vitro inhibition of [3H]- AVP binding to V1a receptor from human platelet membraneIn vitro inhibition of [3H]- AVP binding to V1a receptor from human platelet membrane
ChEMBL 492 3 1 3 7.1 O=C(Nc1ccc(C(=O)N2Cc3sccc3Cc3ccccc32)cc1)c1ccc(Cl)cc1Cl 10.1016/s0960-894x(99)00278-4
10648029 105418 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 469 3 1 3 6.2 Cc1cccc(C(=O)Nc2ccc(C(=O)N3Cc4cccn4Cc4ccccc43)c(Cl)c2)c1C 10.1021/jm980179c
CHEMBL311931 105418 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 469 3 1 3 6.2 Cc1cccc(C(=O)Nc2ccc(C(=O)N3Cc4cccn4Cc4ccccc43)c(Cl)c2)c1C 10.1021/jm980179c
977621 10087 None 12 Rat Binding pIC50 = 5.4 5.4 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 322 4 1 2 4.0 CCCC(=O)Nc1ccc(C(=O)N2CCCc3ccccc32)cc1 10.1021/jm960133o
CHEMBL115434 10087 None 12 Rat Binding pIC50 = 5.4 5.4 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 322 4 1 2 4.0 CCCC(=O)Nc1ccc(C(=O)N2CCCc3ccccc32)cc1 10.1021/jm960133o
9937535 63036 None 1 Rat Binding pIC50 = 6.4 6.4 - 0
Evaluated for binding affinity towards vasopressin receptor V1a in ratEvaluated for binding affinity towards vasopressin receptor V1a in rat
ChEMBL 554 7 2 4 5.1 CN(C)CCNC(=O)C1=C[C@@]2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL1788221 63036 None 1 Rat Binding pIC50 = 6.4 6.4 - 0
Evaluated for binding affinity towards vasopressin receptor V1a in ratEvaluated for binding affinity towards vasopressin receptor V1a in rat
ChEMBL 554 7 2 4 5.1 CN(C)CCNC(=O)C1=C[C@@]2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
114904 2952 None 56 Rat Binding pIC50 = 6.4 6.4 7 7
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm00066a010
2196 2952 None 56 Rat Binding pIC50 = 6.4 6.4 7 7
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm00066a010
CHEMBL296908 2952 None 56 Rat Binding pIC50 = 6.4 6.4 7 7
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm00066a010
44352757 118452 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Ability to displace [3H]arginine vasopressin in cloned human V1a receptorAbility to displace [3H]arginine vasopressin in cloned human V1a receptor
ChEMBL 522 6 2 4 6.6 O=C(O)C[C@H]1CCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc2S1 10.1016/j.bmcl.2003.08.051
CHEMBL341173 118452 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Ability to displace [3H]arginine vasopressin in cloned human V1a receptorAbility to displace [3H]arginine vasopressin in cloned human V1a receptor
ChEMBL 522 6 2 4 6.6 O=C(O)C[C@H]1CCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc2S1 10.1016/j.bmcl.2003.08.051
14981581 78867 None 0 Rat Binding pIC50 = 6.4 6.4 - 0
Displacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liverDisplacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liver
ChEMBL 686 11 2 9 1.7 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCS(=O)(=O)CC2)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112893 78867 None 0 Rat Binding pIC50 = 6.4 6.4 - 0
Displacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liverDisplacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liver
ChEMBL 686 11 2 9 1.7 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCS(=O)(=O)CC2)C3(C)C)CC1 10.1021/jm00031a004
14969513 203218 None 0 Rat Binding pIC50 = 5.4 5.4 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 368 2 0 2 3.9 O=C(c1cccc(Cl)c1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
CHEMBL64434 203218 None 0 Rat Binding pIC50 = 5.4 5.4 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 368 2 0 2 3.9 O=C(c1cccc(Cl)c1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
10673699 106682 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 527 3 1 3 6.8 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1)c1cccc(C(F)(F)F)c1F 10.1021/jm980179c
CHEMBL314344 106682 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 527 3 1 3 6.8 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1)c1cccc(C(F)(F)F)c1F 10.1021/jm980179c
14306032 151505 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 568 9 0 7 4.3 CC1(C(C(=O)OCc2ccccc2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)OCCO1 10.1016/j.bmc.2006.12.031
CHEMBL396270 151505 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 568 9 0 7 4.3 CC1(C(C(=O)OCc2ccccc2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)OCCO1 10.1016/j.bmc.2006.12.031
10673295 104894 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 509 3 1 3 6.9 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1)c1ccc(Cl)cc1Cl 10.1021/jm980179c
CHEMBL311230 104894 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 509 3 1 3 6.9 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1)c1ccc(Cl)cc1Cl 10.1021/jm980179c
10835094 12084 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 404 3 1 2 5.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1Cl 10.1021/jm960133o
CHEMBL118387 12084 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 404 3 1 2 5.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1Cl 10.1021/jm960133o
21837089 103808 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 451 5 1 4 5.3 CCOc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
CHEMBL309096 103808 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 451 5 1 4 5.3 CCOc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
86690916 150923 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 549 6 1 8 4.9 O=c1n(Cc2nnc(-c3ccccc3C(F)(F)F)s2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
CHEMBL3957738 150923 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 549 6 1 8 4.9 O=c1n(Cc2nnc(-c3ccccc3C(F)(F)F)s2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
44332208 4243 None 0 Human Binding pIC50 = 7.3 7.3 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 504 3 1 2 7.6 O=C(Nc1ccc(C(=O)N2CCC3(C=CCCC3)Cc3ccccc32)cc1)c1c(Cl)cccc1Cl 10.1016/j.bmcl.2004.02.103
CHEMBL100447 4243 None 0 Human Binding pIC50 = 7.3 7.3 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 504 3 1 2 7.6 O=C(Nc1ccc(C(=O)N2CCC3(C=CCCC3)Cc3ccccc32)cc1)c1c(Cl)cccc1Cl 10.1016/j.bmcl.2004.02.103
9951649 202737 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 377 3 0 3 3.3 CN(C)c1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL61906 202737 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 377 3 0 3 3.3 CN(C)c1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
19699114 53374 None 0 Rat Binding pIC50 = 5.3 5.3 - 0
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 434 3 1 5 4.9 Cn1cc2c(n1)-c1sccc1N(C(=O)c1ccc(NC(=O)C3CCCCC3)cc1)CC2 10.1016/s0960-894x(00)00084-6
CHEMBL160029 53374 None 0 Rat Binding pIC50 = 5.3 5.3 - 0
In vitro binding affinity for rat V1a receptorIn vitro binding affinity for rat V1a receptor
ChEMBL 434 3 1 5 4.9 Cn1cc2c(n1)-c1sccc1N(C(=O)c1ccc(NC(=O)C3CCCCC3)cc1)CC2 10.1016/s0960-894x(00)00084-6
118720283 115853 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1022 20 10 12 -1.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccc(C)c2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354593 115853 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1022 20 10 12 -1.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccc(C)c2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
14969523 203117 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 392 3 0 4 3.2 CC(=O)Oc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL64046 203117 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 392 3 0 4 3.2 CC(=O)Oc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
44232512 115857 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1038 21 11 13 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354597 115857 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1038 21 11 13 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
67408780 152127 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 550 7 2 6 4.8 NC(=O)c1ccc(-c2ccccc2Cl)cc1Cn1nc(-c2ccc(Cl)cc2)n(CC(O)C(F)(F)F)c1=O nan
CHEMBL3967902 152127 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 550 7 2 6 4.8 NC(=O)c1ccc(-c2ccccc2Cl)cc1Cn1nc(-c2ccc(Cl)cc2)n(CC(O)C(F)(F)F)c1=O nan
44273013 99468 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 543 7 2 6 2.2 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(NCCO)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL283126 99468 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 543 7 2 6 2.2 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(NCCO)C1=O)C2 10.1016/0960-894X(94)00469-V
44428416 142890 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 566 9 0 6 5.2 CC(C)(C)C(=O)C(C(=O)OCc1ccccc1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL389363 142890 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 566 9 0 6 5.2 CC(C)(C)C(=O)C(C(=O)OCc1ccccc1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
10461417 107299 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 612 8 2 4 6.6 CN(C)CCNC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL317243 107299 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 612 8 2 4 6.6 CN(C)CCNC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
44336379 107415 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 582 8 2 4 5.8 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=C(C(=O)NCCCN(C)C)CC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.04.016
CHEMBL318083 107415 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 582 8 2 4 5.8 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=C(C(=O)NCCCN(C)C)CC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.04.016
44336784 109206 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 626 9 2 4 7.0 CN(C)CCCNC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL321656 109206 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 626 9 2 4 7.0 CN(C)CCCNC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
44336404 110957 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 568 7 2 4 5.4 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=C(C(=O)NCCN(C)C)CC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.04.016
CHEMBL326225 110957 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 568 7 2 4 5.4 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=C(C(=O)NCCN(C)C)CC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.04.016
56848623 151679 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 561 9 3 8 2.9 NC(=O)OC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1ccccc1Cl nan
CHEMBL3964135 151679 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 561 9 3 8 2.9 NC(=O)OC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1ccccc1Cl nan
11157078 94193 None 7 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 548 5 2 4 6.1 COc1cc(C(=O)N2CC[C@]3(C=C(C(=O)O)CC3)Cc3ccccc32)ccc1NC(=O)c1cc(F)ccc1Cl 10.1016/j.bmcl.2007.09.059
CHEMBL249741 94193 None 7 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 548 5 2 4 6.1 COc1cc(C(=O)N2CC[C@]3(C=C(C(=O)O)CC3)Cc3ccccc32)ccc1NC(=O)c1cc(F)ccc1Cl 10.1016/j.bmcl.2007.09.059
44335345 5169 None 0 Human Binding pIC50 = 8.3 8.3 -4 2
Inhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptorInhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptor
ChEMBL 505 3 1 3 6.3 O=C(Nc1ccc(C(=O)N2C[C@@H]3C4CCC(C4)N3Cc3cc(Cl)ccc32)cc1)c1ccccc1Cl 10.1016/s0960-894x(02)00649-2
CHEMBL105961 5169 None 0 Human Binding pIC50 = 8.3 8.3 -4 2
Inhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptorInhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptor
ChEMBL 505 3 1 3 6.3 O=C(Nc1ccc(C(=O)N2C[C@@H]3C4CCC(C4)N3Cc3cc(Cl)ccc32)cc1)c1ccccc1Cl 10.1016/s0960-894x(02)00649-2
53378731 153726 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 556 8 2 9 3.3 O=C(O)Cn1nc(Cn2nc(-c3ccc(Cl)cc3)n(C[C@H](O)C(F)(F)F)c2=O)nc1-c1ccccc1Cl nan
CHEMBL3981686 153726 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 556 8 2 9 3.3 O=C(O)Cn1nc(Cn2nc(-c3ccc(Cl)cc3)n(C[C@H](O)C(F)(F)F)c2=O)nc1-c1ccccc1Cl nan
44332272 107237 None 0 Human Binding pIC50 = 7.3 7.3 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 450 3 1 2 6.6 Cc1cccc(C(=O)Nc2ccc(C(=O)N3CCC4(C=CCCC4)Cc4ccccc43)cc2)c1 10.1016/j.bmcl.2004.02.103
CHEMBL316849 107237 None 0 Human Binding pIC50 = 7.3 7.3 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 450 3 1 2 6.6 Cc1cccc(C(=O)Nc2ccc(C(=O)N3CCC4(C=CCCC4)Cc4ccccc43)cc2)c1 10.1016/j.bmcl.2004.02.103
14969540 100806 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 362 3 0 2 3.8 CCc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL293184 100806 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 362 3 0 2 3.8 CCc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
14969534 167882 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 412 2 0 2 4.0 O=C(c1ccc(Br)cc1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
CHEMBL431159 167882 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 412 2 0 2 4.0 O=C(c1ccc(Br)cc1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
14969517 200540 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 348 2 0 2 3.6 Cc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL59896 200540 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 348 2 0 2 3.6 Cc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
15307972 204347 None 0 Rat Binding pIC50 = 4.3 4.3 - 0
Compound was tested for the inhibition of [3H]AVP binding to Dawley rat kidney medullary Vasopressin V1a receptorCompound was tested for the inhibition of [3H]AVP binding to Dawley rat kidney medullary Vasopressin V1a receptor
ChEMBL 446 3 1 2 6.2 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3ccccc3CCc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
CHEMBL71626 204347 None 0 Rat Binding pIC50 = 4.3 4.3 - 0
Compound was tested for the inhibition of [3H]AVP binding to Dawley rat kidney medullary Vasopressin V1a receptorCompound was tested for the inhibition of [3H]AVP binding to Dawley rat kidney medullary Vasopressin V1a receptor
ChEMBL 446 3 1 2 6.2 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3ccccc3CCc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
56848685 151793 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 603 10 2 9 4.5 COCCn1c(-c2ccc(Cl)s2)nn(CC(=O)NCC(NC(=O)OC(C)(C)C)c2ccccc2C(F)(F)F)c1=O nan
CHEMBL3965109 151793 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 603 10 2 9 4.5 COCCn1c(-c2ccc(Cl)s2)nn(CC(=O)NCC(NC(=O)OC(C)(C)C)c2ccccc2C(F)(F)F)c1=O nan
CHEMBL340204 211630 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cccc3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CCCCN)NC(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
44357890 168391 None 0 Rat Binding pIC50 = 5.3 5.3 - 0
Binding affinity towards rat Vasopressin V1a receptor after peroral administration of the compoundBinding affinity towards rat Vasopressin V1a receptor after peroral administration of the compound
ChEMBL 462 5 1 3 6.0 Cc1ccccc1OCC(=O)Nc1ccc(C(=O)N2CCCCc3cc(Cl)ccc32)c(C)c1 10.1021/jm000108p
CHEMBL434654 168391 None 0 Rat Binding pIC50 = 5.3 5.3 - 0
Binding affinity towards rat Vasopressin V1a receptor after peroral administration of the compoundBinding affinity towards rat Vasopressin V1a receptor after peroral administration of the compound
ChEMBL 462 5 1 3 6.0 Cc1ccccc1OCC(=O)Nc1ccc(C(=O)N2CCCCc3cc(Cl)ccc32)c(C)c1 10.1021/jm000108p
10762667 12814 None 0 Rat Binding pIC50 = 5.3 5.3 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 385 3 1 3 4.3 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCN(C)c3ccccc32)cc1 10.1021/jm960133o
CHEMBL118829 12814 None 0 Rat Binding pIC50 = 5.3 5.3 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 385 3 1 3 4.3 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCN(C)c3ccccc32)cc1 10.1021/jm960133o
10668163 13789 None 0 Rat Binding pIC50 = 5.3 5.3 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 390 3 1 2 5.2 O=C(Nc1ccc(C(=O)N2CCCc3ccccc32)cc1)c1ccc(Cl)cc1 10.1021/jm960133o
CHEMBL119551 13789 None 0 Rat Binding pIC50 = 5.3 5.3 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 390 3 1 2 5.2 O=C(Nc1ccc(C(=O)N2CCCc3ccccc32)cc1)c1ccc(Cl)cc1 10.1021/jm960133o
10927276 110619 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Inhibition of human V1A vasopressin receptorInhibition of human V1A vasopressin receptor
ChEMBL 391 2 1 4 3.2 O=C(OC1CCc2ccccc21)N1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm010878g
CHEMBL325674 110619 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Inhibition of human V1A vasopressin receptorInhibition of human V1A vasopressin receptor
ChEMBL 391 2 1 4 3.2 O=C(OC1CCc2ccccc21)N1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm010878g
44273425 98901 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 557 7 2 6 2.6 C[C@@H](O)CNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL279281 98901 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 557 7 2 6 2.6 C[C@@H](O)CNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
44428426 152590 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 598 9 0 5 5.4 CC(C)C[C@@H](C(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL397189 152590 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 598 9 0 5 5.4 CC(C)C[C@@H](C(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
10742418 104484 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 455 3 1 3 5.9 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1 10.1021/jm980179c
CHEMBL310416 104484 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.Displacement of (Phe-3,4,5-H) Vasopressin from V1a receptor from rat liver membranes.
ChEMBL 455 3 1 3 5.9 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1 10.1021/jm980179c
44303524 102163 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 463 7 0 4 3.5 CC(=O)N(C)CCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL302624 102163 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 463 7 0 4 3.5 CC(=O)N(C)CCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
10672170 205394 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 473 3 1 3 6.1 Cc1c(F)cccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1 10.1021/jm980179c
CHEMBL80029 205394 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 473 3 1 3 6.1 Cc1c(F)cccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1 10.1021/jm980179c
118719825 115747 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1032 20 10 14 -2.5 CCOc1ccc(C[C@@H]2NC(=O)CCCSC[C@@H](C(=O)N3C[C@@H](OC)C[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1021/jm500365s
CHEMBL3353936 115747 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1032 20 10 14 -2.5 CCOc1ccc(C[C@@H]2NC(=O)CCCSC[C@@H](C(=O)N3C[C@@H](OC)C[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1021/jm500365s
11740743 14106 None 0 Rat Binding pIC50 = 7.3 7.3 - 3
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 384 3 1 2 5.2 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/jm960133o
CHEMBL119793 14106 None 0 Rat Binding pIC50 = 7.3 7.3 - 3
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 384 3 1 2 5.2 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/jm960133o
21837086 169448 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 425 3 1 3 5.1 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccccc1F 10.1016/s0960-894x(03)00388-3
CHEMBL442743 169448 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 425 3 1 3 5.1 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccccc1F 10.1016/s0960-894x(03)00388-3
15307971 204555 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 418 3 1 2 6.1 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3ccccc3-c3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
CHEMBL72945 204555 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 418 3 1 2 6.1 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3ccccc3-c3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
10436379 74177 None 0 Rat Binding pIC50 = 5.3 5.3 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 510 6 2 4 3.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1c[nH]cn1)C2 10.1016/0960-894X(94)00469-V
CHEMBL20230 74177 None 0 Rat Binding pIC50 = 5.3 5.3 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 510 6 2 4 3.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1c[nH]cn1)C2 10.1016/0960-894X(94)00469-V
53378951 144778 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 507 6 1 5 5.7 O=c1n(Cc2cccc(-c3ccccc3Cl)c2)nc(-c2ccc(Cl)cc2)n1CC(O)C(F)(F)F nan
CHEMBL3909196 144778 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 507 6 1 5 5.7 O=c1n(Cc2cccc(-c3ccccc3Cl)c2)nc(-c2ccc(Cl)cc2)n1CC(O)C(F)(F)F nan
CHEMBL129733 208680 None 0 Rat Binding pIC50 = 5.2 5.2 - 0
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10742418 104484 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 455 3 1 3 5.9 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1 10.1021/jm980179c
CHEMBL310416 104484 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 455 3 1 3 5.9 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1 10.1021/jm980179c
22099567 101337 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
In vitro inhibition of [3H]- AVP binding to rat V1a receptorIn vitro inhibition of [3H]- AVP binding to rat V1a receptor
ChEMBL 457 3 1 4 5.6 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3sccc3Cc3ccccc32)cn1 10.1016/s0960-894x(99)00278-4
CHEMBL296814 101337 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
In vitro inhibition of [3H]- AVP binding to rat V1a receptorIn vitro inhibition of [3H]- AVP binding to rat V1a receptor
ChEMBL 457 3 1 4 5.6 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3sccc3Cc3ccccc32)cn1 10.1016/s0960-894x(99)00278-4
44335241 167996 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptorInhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptor
ChEMBL 575 4 1 3 8.0 Cc1ccc(-c2ccccc2C(=O)Nc2ccc(C(=O)N3C[C@@H]4C5CCC(CC5)N4Cc4cc(Cl)ccc43)cc2)cc1 10.1016/s0960-894x(02)00649-2
CHEMBL432009 167996 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptorInhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptor
ChEMBL 575 4 1 3 8.0 Cc1ccc(-c2ccccc2C(=O)Nc2ccc(C(=O)N3C[C@@H]4C5CCC(CC5)N4Cc4cc(Cl)ccc43)cc2)cc1 10.1016/s0960-894x(02)00649-2
9824954 73858 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Displacement of [3H]AVP from human V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1a receptor expressed in CHO cells
ChEMBL 449 2 1 5 5.5 Cc1ccn(-c2ccc(C(=O)N3Cc4cccnc4Nc4ccccc43)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2005.10.107
CHEMBL201889 73858 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Displacement of [3H]AVP from human V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1a receptor expressed in CHO cells
ChEMBL 449 2 1 5 5.5 Cc1ccn(-c2ccc(C(=O)N3Cc4cccnc4Nc4ccccc43)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2005.10.107
44336636 164163 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 585 7 3 4 6.0 O=C(NCCO)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL421039 164163 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 585 7 3 4 6.0 O=C(NCCO)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
44213442 102028 None 0 Rat Binding pIC50 = 8.2 8.2 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 460 3 1 4 5.1 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1)c1ccc(F)cc1Cl 10.1016/s0960-894x(99)00279-6
CHEMBL301788 102028 None 0 Rat Binding pIC50 = 8.2 8.2 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 460 3 1 4 5.1 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1)c1ccc(F)cc1Cl 10.1016/s0960-894x(99)00279-6
10837633 103022 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 459 3 1 3 5.7 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccc(F)cc1Cl 10.1021/jm980179c
CHEMBL306970 103022 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 459 3 1 3 5.7 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccc(F)cc1Cl 10.1021/jm980179c
69940338 150627 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 497 6 1 7 4.2 O=c1n(Cc2cn(-c3ccccc3Cl)cn2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
CHEMBL3955416 150627 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 497 6 1 7 4.2 O=c1n(Cc2cn(-c3ccccc3Cl)cn2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
71146879 146133 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 498 6 2 7 3.8 O=c1n(Cc2nnc(-c3ccccc3Cl)[nH]2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
CHEMBL3919631 146133 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 498 6 2 7 3.8 O=c1n(Cc2nnc(-c3ccccc3Cl)[nH]2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
87388676 151864 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 533 6 1 8 4.4 O=c1n(Cc2nc(-c3ccccc3C(F)(F)F)no2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
CHEMBL3965602 151864 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 533 6 1 8 4.4 O=c1n(Cc2nc(-c3ccccc3C(F)(F)F)no2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
14981577 78875 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Displacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liverDisplacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liver
ChEMBL 636 11 2 7 3.5 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCCCC2)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112900 78875 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Displacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liverDisplacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liver
ChEMBL 636 11 2 7 3.5 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCCCC2)C3(C)C)CC1 10.1021/jm00031a004
9805972 98613 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 499 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](N)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL276990 98613 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 499 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](N)C1=O)C2 10.1016/0960-894X(94)00469-V
14306046 151506 None 0 Human Binding pIC50 = 4.2 4.2 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 552 8 0 7 3.5 CC1(C(C(=O)OCc2ccccc2)N2C(=O)[C@@H](N3C(=O)c4ccccc4C3=O)[C@H]2/C=C/c2ccccc2)OCCO1 10.1016/j.bmc.2006.12.031
CHEMBL396271 151506 None 0 Human Binding pIC50 = 4.2 4.2 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 552 8 0 7 3.5 CC1(C(C(=O)OCc2ccccc2)N2C(=O)[C@@H](N3C(=O)c4ccccc4C3=O)[C@H]2/C=C/c2ccccc2)OCCO1 10.1016/j.bmc.2006.12.031
14969535 201147 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 364 3 0 3 3.3 COc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL60323 201147 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 364 3 0 3 3.3 COc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
56848488 149553 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 609 10 3 8 3.3 NC(=O)OCC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1cccc(C(F)(F)F)c1 nan
CHEMBL3946734 149553 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 609 10 3 8 3.3 NC(=O)OCC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1cccc(C(F)(F)F)c1 nan
22405325 133558 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 427 4 0 4 5.5 CN(C)Cc1ccc2n1Cc1ccccc1N(C(=O)c1ccc(-c3cccs3)cc1)C2 10.1016/j.bmcl.2005.08.007
CHEMBL371055 133558 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 427 4 0 4 5.5 CN(C)Cc1ccc2n1Cc1ccccc1N(C(=O)c1ccc(-c3cccs3)cc1)C2 10.1016/j.bmcl.2005.08.007
10762739 114381 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 386 3 1 3 4.4 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCOCc3ccccc32)cc1 10.1021/jm960133o
CHEMBL333135 114381 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 386 3 1 3 4.4 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCOCc3ccccc32)cc1 10.1021/jm960133o
14969525 201125 None 0 Rat Binding pIC50 = 5.2 5.2 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 350 2 1 3 3.0 O=C(c1cccc(O)c1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
CHEMBL60312 201125 None 0 Rat Binding pIC50 = 5.2 5.2 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 350 2 1 3 3.0 O=C(c1cccc(O)c1)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
22405327 140274 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 409 3 0 4 5.3 O=C(c1ccc(-c2ccccc2[N+](=O)[O-])cc1)N1Cc2cccn2Cc2ccccc21 10.1016/j.bmcl.2005.08.007
CHEMBL380579 140274 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 409 3 0 4 5.3 O=C(c1ccc(-c2ccccc2[N+](=O)[O-])cc1)N1Cc2cccn2Cc2ccccc21 10.1016/j.bmcl.2005.08.007
118720286 115858 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1038 21 11 13 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354598 115858 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1038 21 11 13 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
10673295 104894 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 509 3 1 3 6.9 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1)c1ccc(Cl)cc1Cl 10.1021/jm980179c
CHEMBL311230 104894 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.Displacement of [3H]AVP from vasopressin receptor (V1a) from human platelet membranes.
ChEMBL 509 3 1 3 6.9 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)c(Cl)c1)c1ccc(Cl)cc1Cl 10.1021/jm980179c
10548464 15380 None 0 Rat Binding pIC50 = 5.2 5.2 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 390 3 1 2 5.2 O=C(Nc1ccc(C(=O)N2CCCc3ccccc32)cc1)c1cccc(Cl)c1 10.1021/jm960133o
CHEMBL121455 15380 None 0 Rat Binding pIC50 = 5.2 5.2 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 390 3 1 2 5.2 O=C(Nc1ccc(C(=O)N2CCCc3ccccc32)cc1)c1cccc(Cl)c1 10.1021/jm960133o
71450903 78876 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Displacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liverDisplacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liver
ChEMBL 614 12 3 9 0.8 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)N(CO)CO)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112901 78876 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Displacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liverDisplacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liver
ChEMBL 614 12 3 9 0.8 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)N(CO)CO)C3(C)C)CC1 10.1021/jm00031a004
10939174 10027 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Inhibition of human V1A vasopressin receptorInhibition of human V1A vasopressin receptor
ChEMBL 443 3 1 6 3.1 O=C(OCc1cc2c(cc1Cl)OCO2)N1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm010878g
CHEMBL115076 10027 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Inhibition of human V1A vasopressin receptorInhibition of human V1A vasopressin receptor
ChEMBL 443 3 1 6 3.1 O=C(OCc1cc2c(cc1Cl)OCO2)N1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm010878g
118719823 115745 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1033 19 10 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2C[C@H](SC)C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353934 115745 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1033 19 10 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2C[C@H](SC)C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
14969548 202129 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 477 11 1 4 4.9 NCCCCCCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL60905 202129 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 477 11 1 4 4.9 NCCCCCCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
44335386 108008 None 0 Human Binding pIC50 = 7.2 7.2 -14 2
Inhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptorInhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptor
ChEMBL 489 3 1 3 5.7 O=C(Nc1ccc(C(=O)N2C[C@@H]3C4CCC(C4)N3Cc3cc(Cl)ccc32)cc1)c1ccccc1F 10.1016/s0960-894x(02)00649-2
CHEMBL319433 108008 None 0 Human Binding pIC50 = 7.2 7.2 -14 2
Inhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptorInhibition of [3H]Arg-vasopressin binding to recombinant human vasopressin V1a receptor
ChEMBL 489 3 1 3 5.7 O=C(Nc1ccc(C(=O)N2C[C@@H]3C4CCC(C4)N3Cc3cc(Cl)ccc32)cc1)c1ccccc1F 10.1016/s0960-894x(02)00649-2
14981578 78871 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Displacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liverDisplacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liver
ChEMBL 638 11 2 8 2.3 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCOCC2)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112897 78871 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Displacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liverDisplacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liver
ChEMBL 638 11 2 8 2.3 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCOCC2)C3(C)C)CC1 10.1021/jm00031a004
44336418 108185 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 569 6 2 5 5.0 COC(=O)CNC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3cc(F)ccc3C)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL319636 108185 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 569 6 2 5 5.0 COC(=O)CNC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3cc(F)ccc3C)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
44336402 168129 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 594 7 2 4 6.0 O=C(NCCN1CCCCC1)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL432973 168129 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 594 7 2 4 6.0 O=C(NCCN1CCCCC1)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
56848625 145191 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 595 9 3 8 3.5 NC(=O)OC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1cccc(Cl)c1Cl nan
CHEMBL3912406 145191 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 595 9 3 8 3.5 NC(=O)OC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1cccc(Cl)c1Cl nan
18917497 101718 None 0 Rat Binding pIC50 = 8.2 8.2 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 486 3 1 4 5.1 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1)c1ccccc1Br 10.1016/s0960-894x(99)00279-6
CHEMBL299532 101718 None 0 Rat Binding pIC50 = 8.2 8.2 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 486 3 1 4 5.1 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1)c1ccccc1Br 10.1016/s0960-894x(99)00279-6
10837633 103022 None 0 Rat Binding pIC50 = 8.2 8.2 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 459 3 1 3 5.7 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccc(F)cc1Cl 10.1016/s0960-894x(03)00388-3
CHEMBL306970 103022 None 0 Rat Binding pIC50 = 8.2 8.2 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 459 3 1 3 5.7 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccc(F)cc1Cl 10.1016/s0960-894x(03)00388-3
11282041 88563 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Activity at vasopressin V1A receptorActivity at vasopressin V1A receptor
ChEMBL 437 4 2 4 2.8 Cc1ccc(C(=O)N2CC3CNCC(C2)O3)cc1C(=O)NCC12CC3CC(CC(C3)C1)C2 10.1021/jm700949w
CHEMBL235393 88563 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Activity at vasopressin V1A receptorActivity at vasopressin V1A receptor
ChEMBL 437 4 2 4 2.8 Cc1ccc(C(=O)N2CC3CNCC(C2)O3)cc1C(=O)NCC12CC3CC(CC(C3)C1)C2 10.1021/jm700949w
44434716 148391 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Activity at vasopressin V1A receptorActivity at vasopressin V1A receptor
ChEMBL 457 4 2 4 3.1 O=C(NCC12CC3CC(CC(C3)C1)C2)c1cc(C(=O)N2CC3CNCC(C2)O3)ccc1Cl 10.1021/jm700949w
CHEMBL393754 148391 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Activity at vasopressin V1A receptorActivity at vasopressin V1A receptor
ChEMBL 457 4 2 4 3.1 O=C(NCC12CC3CC(CC(C3)C1)C2)c1cc(C(=O)N2CC3CNCC(C2)O3)ccc1Cl 10.1021/jm700949w
10716676 110416 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 413 4 2 3 4.9 CNC1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc21 10.1021/jm960133o
CHEMBL324488 110416 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 413 4 2 3 4.9 CNC1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc21 10.1021/jm960133o
9871426 117009 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Ability to displace [3H]arginine vasopressin in cloned human V1a receptorAbility to displace [3H]arginine vasopressin in cloned human V1a receptor
ChEMBL 522 6 2 4 6.6 O=C(O)CC1CCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc2S1 10.1016/j.bmcl.2003.08.051
CHEMBL338901 117009 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Ability to displace [3H]arginine vasopressin in cloned human V1a receptorAbility to displace [3H]arginine vasopressin in cloned human V1a receptor
ChEMBL 522 6 2 4 6.6 O=C(O)CC1CCN(C(=O)c2ccc(NC(=O)c3ccccc3-c3ccccc3)cc2)c2ccccc2S1 10.1016/j.bmcl.2003.08.051
118719843 115765 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1056 21 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2ccccn2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353954 115765 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1056 21 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2ccccn2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL2112654 209241 None 0 Rat Binding pIC50 = 5.1 5.1 - 0
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
44332237 108597 None 0 Human Binding pIC50 = 7.1 7.1 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 450 3 1 2 6.6 Cc1ccc(C(=O)Nc2ccc(C(=O)N3CCC4(C=CCCC4)Cc4ccccc43)cc2)cc1 10.1016/j.bmcl.2004.02.103
CHEMBL320462 108597 None 0 Human Binding pIC50 = 7.1 7.1 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 450 3 1 2 6.6 Cc1ccc(C(=O)Nc2ccc(C(=O)N3CCC4(C=CCCC4)Cc4ccccc43)cc2)cc1 10.1016/j.bmcl.2004.02.103
118720274 115844 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 974 21 10 12 -1.9 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CCSCCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3354584 115844 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 974 21 10 12 -1.9 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CCSCCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
579 3142 None 18 Human Binding pIC50 = 6.1 6.1 - 0
Binding affinity to V1a receptorBinding affinity to V1a receptor
ChEMBL None None None None 10.1016/j.bmcl.2006.07.036
6918468 3142 None 18 Human Binding pIC50 = 6.1 6.1 - 0
Binding affinity to V1a receptorBinding affinity to V1a receptor
ChEMBL None None None None 10.1016/j.bmcl.2006.07.036
CHEMBL41547 3142 None 18 Human Binding pIC50 = 6.1 6.1 - 0
Binding affinity to V1a receptorBinding affinity to V1a receptor
ChEMBL None None None None 10.1016/j.bmcl.2006.07.036
CHEMBL2371928 210152 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Binding affinity to V1a receptorBinding affinity to V1a receptor
ChEMBL None None None CC(C)CC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CC(=O)NC(=O)N1)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)N[C@H](Cc1ccccc1)C(N)=O 10.1016/j.bmcl.2006.07.036
CHEMBL1790937 208904 None 0 Rat Binding pIC50 = 5.1 5.1 - 2
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
669479 113483 None 13 Rat Binding pIC50 = 4.1 4.1 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 294 2 1 2 3.2 CC(=O)Nc1ccc(C(=O)N2CCCc3ccccc32)cc1 10.1021/jm960133o
CHEMBL331956 113483 None 13 Rat Binding pIC50 = 4.1 4.1 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 294 2 1 2 3.2 CC(=O)Nc1ccc(C(=O)N2CCCc3ccccc32)cc1 10.1021/jm960133o
14969544 102660 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 407 6 1 4 3.0 NCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL304486 102660 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 407 6 1 4 3.0 NCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL2112250 209235 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cccc3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10810133 113801 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 385 3 2 2 5.3 O=C(Nc1ccccc1)Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/jm960133o
CHEMBL332450 113801 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 385 3 2 2 5.3 O=C(Nc1ccccc1)Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/jm960133o
10595449 10514 None 0 Rat Binding pIC50 = 5.1 5.1 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 372 3 1 3 4.3 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCOc3ccccc32)cc1 10.1021/jm960133o
CHEMBL116820 10514 None 0 Rat Binding pIC50 = 5.1 5.1 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 372 3 1 3 4.3 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCOc3ccccc32)cc1 10.1021/jm960133o
3537 4002 None 22 Human Binding pIC50 = 6.1 6.1 -9 3
Displacement of [3H]AVP from human V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1a receptor expressed in CHO cells
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1016/j.bmcl.2005.10.107
5311500 4002 None 22 Human Binding pIC50 = 6.1 6.1 -9 3
Displacement of [3H]AVP from human V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1a receptor expressed in CHO cells
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1016/j.bmcl.2005.10.107
CHEMBL363910 4002 None 22 Human Binding pIC50 = 6.1 6.1 -9 3
Displacement of [3H]AVP from human V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1a receptor expressed in CHO cells
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1016/j.bmcl.2005.10.107
3537 4002 None 22 Human Binding pIC50 = 6.1 6.1 -9 3
Displacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1016/j.bmcl.2007.08.053
5311500 4002 None 22 Human Binding pIC50 = 6.1 6.1 -9 3
Displacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1016/j.bmcl.2007.08.053
CHEMBL363910 4002 None 22 Human Binding pIC50 = 6.1 6.1 -9 3
Displacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]manning ligand from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1016/j.bmcl.2007.08.053
44428425 142105 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 626 11 0 5 6.0 CC(C)C[C@@H](C(=O)N1CCC(CCN2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL388253 142105 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 626 11 0 5 6.0 CC(C)C[C@@H](C(=O)N1CCC(CCN2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
14969556 203219 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 463 8 1 4 3.6 CCC(=O)NCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
CHEMBL64436 203219 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 463 8 1 4 3.6 CCC(=O)NCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1 10.1021/jm00066a010
10548205 12706 None 0 Rat Binding pIC50 = 5.1 5.1 - 0
Compound was tested for its ability to displace [3H]AVP from its specific binding sites in Rat liver (AVP-V1a receptor).Compound was tested for its ability to displace [3H]AVP from its specific binding sites in Rat liver (AVP-V1a receptor).
ChEMBL 386 3 1 3 5.3 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)Oc1ccccc1 10.1021/jm960133o
CHEMBL118760 12706 None 0 Rat Binding pIC50 = 5.1 5.1 - 0
Compound was tested for its ability to displace [3H]AVP from its specific binding sites in Rat liver (AVP-V1a receptor).Compound was tested for its ability to displace [3H]AVP from its specific binding sites in Rat liver (AVP-V1a receptor).
ChEMBL 386 3 1 3 5.3 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)Oc1ccccc1 10.1021/jm960133o
9829108 5234 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 554 7 2 4 5.1 CN(C)CCNC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL106293 5234 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 554 7 2 4 5.1 CN(C)CCNC(=O)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
44336403 5380 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 580 7 2 4 5.6 O=C(NCCN1CCCC1)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
CHEMBL107058 5380 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Binding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptorBinding affinity measured by inhibition of 3[H] AVP binding to cloned human vasopressin V1a receptor
ChEMBL 580 7 2 4 5.6 O=C(NCCN1CCCC1)C1=CC2(CC1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3F)cc1)c1ccccc1C2 10.1016/j.bmcl.2004.04.016
56848622 147938 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 595 9 3 8 3.3 NC(=O)OC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1ccccc1C(F)(F)F nan
CHEMBL3933782 147938 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 595 9 3 8 3.3 NC(=O)OC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1ccccc1C(F)(F)F nan
56848554 151843 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 595 10 3 8 2.3 CS(=O)(=O)NC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1ccccc1Cl nan
CHEMBL3965460 151843 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular in Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtitre plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtitre plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtitre plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 595 10 3 8 2.3 CS(=O)(=O)NC(CNC(=O)Cn1nc(-c2ccc(Cl)cc2)n(C[C@H](O)C(F)(F)F)c1=O)c1ccccc1Cl nan
11238362 168906 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 562 6 2 4 6.5 CCOc1cc(C(=O)N2CC[C@]3(C=C(C(=O)O)CC3)Cc3ccccc32)ccc1NC(=O)c1cc(F)ccc1Cl 10.1016/j.bmcl.2007.09.059
CHEMBL438523 168906 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 562 6 2 4 6.5 CCOc1cc(C(=O)N2CC[C@]3(C=C(C(=O)O)CC3)Cc3ccccc32)ccc1NC(=O)c1cc(F)ccc1Cl 10.1016/j.bmcl.2007.09.059
10322392 4689 None 0 Human Binding pIC50 = 8.1 8.1 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 468 3 1 2 6.7 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=CCCC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.02.103
CHEMBL103406 4689 None 0 Human Binding pIC50 = 8.1 8.1 - 0
In vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptorIn vitro inhibitory concentration against [3H]AVP binding to cloned human vasopressin V1a receptor
ChEMBL 468 3 1 2 6.7 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CCC3(C=CCCC3)Cc3ccccc32)cc1 10.1016/j.bmcl.2004.02.103
15308000 187342 None 0 Human Binding pIC50 = 8.1 8.1 - 0
In vitro inhibition of [3H]- AVP binding to V1a receptor from human platelet membraneIn vitro inhibition of [3H]- AVP binding to V1a receptor from human platelet membrane
ChEMBL 438 3 1 3 6.1 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3sccc3Cc3ccccc32)cc1 10.1016/s0960-894x(99)00278-4
CHEMBL49322 187342 None 0 Human Binding pIC50 = 8.1 8.1 - 0
In vitro inhibition of [3H]- AVP binding to V1a receptor from human platelet membraneIn vitro inhibition of [3H]- AVP binding to V1a receptor from human platelet membrane
ChEMBL 438 3 1 3 6.1 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3sccc3Cc3ccccc32)cc1 10.1016/s0960-894x(99)00278-4
69940428 149869 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 568 8 2 7 5.2 O=C(O)c1cccc(Cn2c(-c3ccc(Cl)cc3)nn(Cc3nnc(Cc4c(Cl)cccc4Cl)[nH]3)c2=O)c1 nan
CHEMBL3949118 149869 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 568 8 2 7 5.2 O=C(O)c1cccc(Cn2c(-c3ccc(Cl)cc3)nn(Cc3nnc(Cc4c(Cl)cccc4Cl)[nH]3)c2=O)c1 nan
CHEMBL338308 211606 None 0 Rat Binding pIC50 = 6.1 6.1 - 2
Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.Concentration required to displace 50% of [3H]arginine vasopressin from rat liver arginine vasopressin 1A (AVP-V1a) site.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CCCN)NC(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00099a019
172997 2330 None 57 Rat Binding pIC50 = 7.1 7.1 - 2
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(99)00279-6
2238 2330 None 57 Rat Binding pIC50 = 7.1 7.1 - 2
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(99)00279-6
CHEMBL49429 2330 None 57 Rat Binding pIC50 = 7.1 7.1 - 2
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(99)00279-6
DB06666 2330 None 57 Rat Binding pIC50 = 7.1 7.1 - 2
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/s0960-894x(99)00279-6
44294175 101837 None 0 Rat Binding pIC50 = 7.1 7.1 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 520 3 1 4 5.8 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1)c1cc(Br)ccc1Cl 10.1016/s0960-894x(99)00279-6
CHEMBL300433 101837 None 0 Rat Binding pIC50 = 7.1 7.1 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 520 3 1 4 5.8 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1)c1cc(Br)ccc1Cl 10.1016/s0960-894x(99)00279-6
44374781 53179 None 0 Human Binding pIC50 = 7.1 7.1 - 0
In vitro binding affinity to human V1a receptorIn vitro binding affinity to human V1a receptor
ChEMBL 486 4 1 3 7.3 O=C(Nc1ccc(C(=O)N2CCCCc3sc(Cl)cc32)cc1)c1ccccc1-c1ccccc1 10.1016/s0960-894x(00)00084-6
CHEMBL159856 53179 None 0 Human Binding pIC50 = 7.1 7.1 - 0
In vitro binding affinity to human V1a receptorIn vitro binding affinity to human V1a receptor
ChEMBL 486 4 1 3 7.3 O=C(Nc1ccc(C(=O)N2CCCCc3sc(Cl)cc32)cc1)c1ccccc1-c1ccccc1 10.1016/s0960-894x(00)00084-6
53378729 142453 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 473 7 0 6 5.2 C=CCn1c(-c2ccc(Cl)cc2)nn(Cc2cncn2Cc2c(Cl)cccc2Cl)c1=O nan
CHEMBL3890193 142453 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 473 7 0 6 5.2 C=CCn1c(-c2ccc(Cl)cc2)nn(Cc2cncn2Cc2c(Cl)cccc2Cl)c1=O nan
14969518 202683 None 0 Rat Binding pIC50 = 5.1 5.1 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 379 3 0 4 3.2 O=C(c1ccccc1[N+](=O)[O-])N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
CHEMBL61578 202683 None 0 Rat Binding pIC50 = 5.1 5.1 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 379 3 0 4 3.2 O=C(c1ccccc1[N+](=O)[O-])N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
14969515 203204 None 0 Rat Binding pIC50 = 5.1 5.1 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 348 2 0 2 3.6 Cc1ccccc1C(=O)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
CHEMBL64375 203204 None 0 Rat Binding pIC50 = 5.1 5.1 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 348 2 0 2 3.6 Cc1ccccc1C(=O)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
44428432 92037 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 654 10 0 6 5.6 CC(C)(C)C(=O)[C@@H](C(=O)N1CCC(CCN2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@H]2c2ccccc2)C1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL241859 92037 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 654 10 0 6 5.6 CC(C)(C)C(=O)[C@@H](C(=O)N1CCC(CCN2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@H]2c2ccccc2)C1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
44310140 204465 None 0 Rat Binding pIC50 = 7.1 7.1 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 423 3 2 4 4.7 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccccc1O 10.1016/s0960-894x(03)00388-3
CHEMBL72342 204465 None 0 Rat Binding pIC50 = 7.1 7.1 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 423 3 2 4 4.7 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1ccccc1O 10.1016/s0960-894x(03)00388-3
22405331 135337 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 400 2 0 2 5.6 O=C(c1ccc(-c2cc(F)cc(F)c2)cc1)N1Cc2cccn2Cc2ccccc21 10.1016/j.bmcl.2005.08.007
CHEMBL372766 135337 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 400 2 0 2 5.6 O=C(c1ccc(-c2cc(F)cc(F)c2)cc1)N1Cc2cccn2Cc2ccccc21 10.1016/j.bmcl.2005.08.007
21467141 119665 None 0 Human Binding pIC50 = 7.1 7.1 - 0
In vitro binding affinity to human V1a receptorIn vitro binding affinity to human V1a receptor
ChEMBL 486 4 1 3 7.3 O=C(Nc1ccc(C(=O)N2CCCCc3sccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/s0960-894x(00)00084-6
CHEMBL347020 119665 None 0 Human Binding pIC50 = 7.1 7.1 - 0
In vitro binding affinity to human V1a receptorIn vitro binding affinity to human V1a receptor
ChEMBL 486 4 1 3 7.3 O=C(Nc1ccc(C(=O)N2CCCCc3sccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/s0960-894x(00)00084-6
44272960 73263 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 527 6 1 5 3.2 CCNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL20126 73263 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 527 6 1 5 3.2 CCNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
69940091 147915 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 508 6 1 6 5.1 O=c1n(Cc2ccnc(-c3ccccc3Cl)c2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
CHEMBL3933604 147915 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 508 6 1 6 5.1 O=c1n(Cc2ccnc(-c3ccccc3Cl)c2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
10156521 72473 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 378 2 0 2 5.7 Cc1ccccc1-c1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1016/j.bmcl.2005.08.007
CHEMBL198931 72473 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor Inhibitory concentration against [3H]AVP binding to human vasopressin V1a receptor
ChEMBL 378 2 0 2 5.7 Cc1ccccc1-c1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1016/j.bmcl.2005.08.007
118719837 115759 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1059 20 11 14 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353948 115759 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1059 20 11 14 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
8105663 13427 None 5 Rat Binding pIC50 = 4.1 4.1 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 356 3 1 2 4.5 O=C(Nc1ccccc1C(=O)N1CCCc2ccccc21)c1ccccc1 10.1021/jm960133o
CHEMBL119291 13427 None 5 Rat Binding pIC50 = 4.1 4.1 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 356 3 1 2 4.5 O=C(Nc1ccccc1C(=O)N1CCCc2ccccc21)c1ccccc1 10.1021/jm960133o
69940642 151777 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 509 6 1 7 4.4 O=c1n(Cc2ccnc(-c3ccccc3Cl)n2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
CHEMBL3964983 151777 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 509 6 1 7 4.4 O=c1n(Cc2ccnc(-c3ccccc3Cl)n2)nc(-c2ccc(Cl)cc2)n1C[C@H](O)C(F)(F)F nan
10765617 12451 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 441 6 2 3 5.7 CCCNC1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc21 10.1021/jm960133o
CHEMBL118609 12451 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 441 6 2 3 5.7 CCCNC1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc21 10.1021/jm960133o
71449109 78877 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Displacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liverDisplacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liver
ChEMBL 565 8 2 6 2.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@@H](N)CCS(C)(=O)=O)C2 10.1021/jm00031a004
CHEMBL2112902 78877 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Displacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liverDisplacement of [3H]AVP from binding to arginine vasopressin 1a (V1a) column of rat liver
ChEMBL 565 8 2 6 2.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@@H](N)CCS(C)(=O)=O)C2 10.1021/jm00031a004
44213443 177016 None 0 Rat Binding pIC50 = 8.1 8.1 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 440 3 1 4 4.8 Cc1c(F)cccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1 10.1016/s0960-894x(99)00279-6
CHEMBL46295 177016 None 0 Rat Binding pIC50 = 8.1 8.1 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 440 3 1 4 4.8 Cc1c(F)cccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1 10.1016/s0960-894x(99)00279-6
23598641 94275 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 528 5 2 3 6.9 O=C(Nc1ccc(C(=O)N2CCC3(C=C(CO)CC3)Cc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2007.09.059
CHEMBL250346 94275 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cellsDisplacement of [3H]Arg-vasopressin from human recombinant vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 528 5 2 3 6.9 O=C(Nc1ccc(C(=O)N2CCC3(C=C(CO)CC3)Cc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2007.09.059
21837162 102531 None 0 Rat Binding pIC50 = 8.1 8.1 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 453 4 1 4 5.7 CSc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
CHEMBL304060 102531 None 0 Rat Binding pIC50 = 8.1 8.1 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 453 4 1 4 5.7 CSc1ccccc1C(=O)Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
18917508 188081 None 0 Rat Binding pIC50 = 6.0 6.0 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 453 4 1 6 4.3 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1)c1ccccc1[N+](=O)[O-] 10.1016/s0960-894x(99)00279-6
CHEMBL49796 188081 None 0 Rat Binding pIC50 = 6.0 6.0 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 453 4 1 6 4.3 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cn1)c1ccccc1[N+](=O)[O-] 10.1016/s0960-894x(99)00279-6
69940703 146197 None 0 Human Binding pIC50 = 5.0 5.0 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 490 6 0 6 5.8 O=c1n(Cc2ncc(Cc3cccc(C(F)(F)F)c3)s2)nc(-c2ccc(Cl)cc2)n1C1CC1 nan
CHEMBL3920097 146197 None 0 Human Binding pIC50 = 5.0 5.0 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 490 6 0 6 5.8 O=c1n(Cc2ncc(Cc3cccc(C(F)(F)F)c3)s2)nc(-c2ccc(Cl)cc2)n1C1CC1 nan
67412584 150775 None 0 Human Binding pIC50 = 5.0 5.0 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 473 6 1 5 5.1 O=c1n(Cc2ncc(Cc3cccc(C(F)(F)F)c3)[nH]2)nc(-c2ccc(Cl)cc2)n1C1CC1 nan
CHEMBL3956553 150775 None 0 Human Binding pIC50 = 5.0 5.0 - 0
Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.Cellular In Vitro Assay: On the day before the assay, the cells are plated out in culture medium (DMEM, 10% FCS, 2 mM glutamine, 10 mM HEPES) in 384-well microtiter plates and kept in a cell incubator (96% humidity, 5% v/v CO2, 37° C.). On the day of the assay, the culture medium is replaced by a Tyrode solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, 20 mM HEPES), which additionally contains the cofactor coelenterazine (50 μM), and the microtiter plate is then incubated for a further 3-4 hours. The test substances in various concentrations are placed for 10 to 20 minutes in the wells of the microtiter plate before the agonist [Arg8]-vasopressin is added, and the resulting light signal is measured immediately in the luminometer.
ChEMBL 473 6 1 5 5.1 O=c1n(Cc2ncc(Cc3cccc(C(F)(F)F)c3)[nH]2)nc(-c2ccc(Cl)cc2)n1C1CC1 nan
44310163 102221 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 475 3 1 3 6.3 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1c(Cl)cccc1Cl 10.1016/s0960-894x(03)00388-3
CHEMBL302955 102221 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 475 3 1 3 6.3 O=C(Nc1ccc(C(=O)N2Cc3cccn3Cc3ccccc32)cc1)c1c(Cl)cccc1Cl 10.1016/s0960-894x(03)00388-3
10741034 13934 None 0 Rat Binding pIC50 = 5.0 5.0 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 424 3 1 2 5.8 O=C(Nc1ccc(C(=O)N2CCCc3ccccc32)cc1)c1cc(Cl)cc(Cl)c1 10.1021/jm960133o
CHEMBL119651 13934 None 0 Rat Binding pIC50 = 5.0 5.0 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 424 3 1 2 5.8 O=C(Nc1ccc(C(=O)N2CCCc3ccccc32)cc1)c1cc(Cl)cc(Cl)c1 10.1021/jm960133o
44272990 99604 None 0 Rat Binding pIC50 = 6.0 6.0 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 500 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@H](O)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL283994 99604 None 0 Rat Binding pIC50 = 6.0 6.0 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 500 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@H](O)C1=O)C2 10.1016/0960-894X(94)00469-V
10595343 114423 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 370 3 1 2 4.9 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1 10.1021/jm960133o
CHEMBL333201 114423 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 370 3 1 2 4.9 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1 10.1021/jm960133o
44352783 116779 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Ability to displace [3H]arginine vasopressin in cloned human V1a receptorAbility to displace [3H]arginine vasopressin in cloned human V1a receptor
ChEMBL 508 6 2 4 6.5 O=C(Nc1ccc(C(=O)N2CCC(CCO)Sc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2003.08.051
CHEMBL337725 116779 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Ability to displace [3H]arginine vasopressin in cloned human V1a receptorAbility to displace [3H]arginine vasopressin in cloned human V1a receptor
ChEMBL 508 6 2 4 6.5 O=C(Nc1ccc(C(=O)N2CCC(CCO)Sc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2003.08.051
118719838 115760 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1071 21 11 15 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(OC)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353949 115760 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1071 21 11 15 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(OC)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
44272997 71719 None 0 Rat Binding pIC50 = 6.0 6.0 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 499 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@H](N)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL19658 71719 None 0 Rat Binding pIC50 = 6.0 6.0 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 499 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@H](N)C1=O)C2 10.1016/0960-894X(94)00469-V
44212554 103673 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 432 3 1 2 6.1 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCc3ccccc3-c3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
CHEMBL308741 103673 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.Inhibition of [3H]AVP binding to Dawley rat hepatic vasopressin V1a receptor.
ChEMBL 432 3 1 2 6.1 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCc3ccccc3-c3ccccc32)cc1 10.1016/s0960-894x(03)00388-3
10743970 113063 None 0 Rat Binding pIC50 = 6.0 6.0 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 499 7 1 5 5.2 CCOC(=O)CN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc21 10.1021/jm960133o
CHEMBL331173 113063 None 0 Rat Binding pIC50 = 6.0 6.0 - 0
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
ChEMBL 499 7 1 5 5.2 CCOC(=O)CN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc21 10.1021/jm960133o
18917554 189819 None 0 Rat Binding pIC50 = 7 7.0 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 497 5 1 5 4.9 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3ccc(CN(C)C)n3Cc3ccccc32)cn1 10.1016/s0960-894x(99)00279-6
CHEMBL51645 189819 None 0 Rat Binding pIC50 = 7 7.0 - 0
Displacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptorDisplacement of (Phe-3,4,5 [3H]-) AVP from isolated rat hepatic V1a receptor
ChEMBL 497 5 1 5 4.9 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2Cc3ccc(CN(C)C)n3Cc3ccccc32)cn1 10.1016/s0960-894x(99)00279-6
118720265 115836 None 0 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 21 11 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354576 115836 None 0 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assayAntagonist activity at human vasopressin V1a expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 21 11 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
44273426 77104 None 0 Rat Binding pIC50 = 6 6.0 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 557 7 2 6 2.6 C[C@H](CO)NC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL20757 77104 None 0 Rat Binding pIC50 = 6 6.0 - 0
Inhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptorInhibition of binding of [3H]vasopressin to rat liver vasopressin V1a receptor
ChEMBL 557 7 2 6 2.6 C[C@H](CO)NC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
14969512 100804 None 0 Rat Binding pIC50 = 5 5.0 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 368 2 0 2 3.9 O=C(c1ccccc1Cl)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
CHEMBL293177 100804 None 0 Rat Binding pIC50 = 5 5.0 - 0
Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor)
ChEMBL 368 2 0 2 3.9 O=C(c1ccccc1Cl)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1021/jm00066a010
44297517 155724 None 0 Rat Binding pKd = 10.4 10.4 28 3
Tested for dissociation constant at V1a receptor of rat liver membraneTested for dissociation constant at V1a receptor of rat liver membrane
ChEMBL 1343 39 15 16 -1.4 CN(C(=O)CCCc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL405440 155724 None 0 Rat Binding pKd = 10.4 10.4 28 3
Tested for dissociation constant at V1a receptor of rat liver membraneTested for dissociation constant at V1a receptor of rat liver membrane
ChEMBL 1343 39 15 16 -1.4 CN(C(=O)CCCc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
44297525 96807 None 0 Rat Binding pKd = 10.3 10.3 10 3
Tested for dissociation constant at V1a receptor of rat liver membraneTested for dissociation constant at V1a receptor of rat liver membrane
ChEMBL 1329 38 15 16 -1.8 CN(C(=O)CCc1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL265048 96807 None 0 Rat Binding pKd = 10.3 10.3 10 3
Tested for dissociation constant at V1a receptor of rat liver membraneTested for dissociation constant at V1a receptor of rat liver membrane
ChEMBL 1329 38 15 16 -1.8 CN(C(=O)CCc1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
44297516 161289 None 0 Rat Binding pKd = 9.8 9.8 22 3
Tested for dissociation constant at V1a receptor of rat liver membraneTested for dissociation constant at V1a receptor of rat liver membrane
ChEMBL 1315 37 15 16 -2.2 CN(C(=O)Cc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL412192 161289 None 0 Rat Binding pKd = 9.8 9.8 22 3
Tested for dissociation constant at V1a receptor of rat liver membraneTested for dissociation constant at V1a receptor of rat liver membrane
ChEMBL 1315 37 15 16 -2.2 CN(C(=O)Cc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
71461726 79690 None 0 Rat Binding pKd = 9.7 9.7 257 2
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL 1186 20 11 15 0.9 COc1ccc(C[C@@H]2NC(=O)C3(CCCC3)CSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00079a020
CHEMBL2115369 79690 None 0 Rat Binding pKd = 9.7 9.7 257 2
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL 1186 20 11 15 0.9 COc1ccc(C[C@@H]2NC(=O)C3(CCCC3)CSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00079a020
71461726 79690 None 0 Rat Binding pKd = 9.7 9.7 257 2
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL 1186 20 11 15 0.9 COc1ccc(C[C@@H]2NC(=O)C3(CCCC3)CSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00079a020
CHEMBL2115369 79690 None 0 Rat Binding pKd = 9.7 9.7 257 2
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL 1186 20 11 15 0.9 COc1ccc(C[C@@H]2NC(=O)C3(CCCC3)CSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00079a020
71449189 79688 None 0 Rat Binding pKd = 9.7 9.7 - 1
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL 1203 22 11 16 1.1 CCC1(CC)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC1=O 10.1021/jm00079a020
CHEMBL2115365 79688 None 0 Rat Binding pKd = 9.7 9.7 - 1
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL 1203 22 11 16 1.1 CCC1(CC)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC1=O 10.1021/jm00079a020
44297505 165855 None 0 Rat Binding pKd = 9.7 9.7 7 3
Tested for dissociation constant at V1a receptor of rat liver membraneTested for dissociation constant at V1a receptor of rat liver membrane
ChEMBL 1329 38 15 16 -1.8 CN(C(=O)CCc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL424905 165855 None 0 Rat Binding pKd = 9.7 9.7 7 3
Tested for dissociation constant at V1a receptor of rat liver membraneTested for dissociation constant at V1a receptor of rat liver membrane
ChEMBL 1329 38 15 16 -1.8 CN(C(=O)CCc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
71449189 79688 None 0 Rat Binding pKd = 9.7 9.7 - 1
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL 1203 22 11 16 1.1 CCC1(CC)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC1=O 10.1021/jm00079a020
CHEMBL2115365 79688 None 0 Rat Binding pKd = 9.7 9.7 - 1
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL 1203 22 11 16 1.1 CCC1(CC)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC1=O 10.1021/jm00079a020
71461726 79690 None 0 Rat Binding pKd = 9.6 9.6 257 2
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL 1186 20 11 15 0.9 COc1ccc(C[C@@H]2NC(=O)C3(CCCC3)CSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00079a020
CHEMBL2115369 79690 None 0 Rat Binding pKd = 9.6 9.6 257 2
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL 1186 20 11 15 0.9 COc1ccc(C[C@@H]2NC(=O)C3(CCCC3)CSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00079a020
71461726 79690 None 0 Rat Binding pKd = 9.6 9.6 257 2
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL 1186 20 11 15 0.9 COc1ccc(C[C@@H]2NC(=O)C3(CCCC3)CSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00079a020
CHEMBL2115369 79690 None 0 Rat Binding pKd = 9.6 9.6 257 2
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL 1186 20 11 15 0.9 COc1ccc(C[C@@H]2NC(=O)C3(CCCC3)CSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00079a020
145981637 166491 None 0 Human Binding pKd = 9.5 9.5 - 1
Binding affinity to human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisBinding affinity to human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 1206 34 16 14 -4.3 COc1ccc(C[C@@H](NC(=O)C[Se]c2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)cc1 10.1021/acs.jmedchem.8b01320
CHEMBL4278500 166491 None 0 Human Binding pKd = 9.5 9.5 - 1
Binding affinity to human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisBinding affinity to human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 1206 34 16 14 -4.3 COc1ccc(C[C@@H](NC(=O)C[Se]c2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)cc1 10.1021/acs.jmedchem.8b01320
70689895 74517 None 0 Rat Binding pKd = 9.5 9.5 - 1
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL 1326 27 14 17 -0.4 C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCC/N=C(/N)c1ccc(N=[N+]=[N-])cc1)C(N)=O)N(C)C(=O)[C@H]1CSSCC2(CCCC2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm00079a020
CHEMBL2028983 74517 None 0 Rat Binding pKd = 9.5 9.5 - 1
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL 1326 27 14 17 -0.4 C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCC/N=C(/N)c1ccc(N=[N+]=[N-])cc1)C(N)=O)N(C)C(=O)[C@H]1CSSCC2(CCCC2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm00079a020
70689895 74517 None 0 Rat Binding pKd = 9.5 9.5 - 1
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL 1326 27 14 17 -0.4 C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCC/N=C(/N)c1ccc(N=[N+]=[N-])cc1)C(N)=O)N(C)C(=O)[C@H]1CSSCC2(CCCC2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm00079a020
CHEMBL2028983 74517 None 0 Rat Binding pKd = 9.5 9.5 - 1
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL 1326 27 14 17 -0.4 C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCC/N=C(/N)c1ccc(N=[N+]=[N-])cc1)C(N)=O)N(C)C(=O)[C@H]1CSSCC2(CCCC2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm00079a020
145986380 167091 None 0 Human Binding pKd = 9.4 9.4 - 1
Binding affinity to human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisBinding affinity to human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 1206 34 16 14 -3.8 COc1ccc(C[C@@H](NC(=O)CCc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2C[Se]C[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)cc1 10.1021/acs.jmedchem.8b01320
CHEMBL4289837 167091 None 0 Human Binding pKd = 9.4 9.4 - 1
Binding affinity to human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisBinding affinity to human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 1206 34 16 14 -3.8 COc1ccc(C[C@@H](NC(=O)CCc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2C[Se]C[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)cc1 10.1021/acs.jmedchem.8b01320
71458135 79687 None 0 Rat Binding pKd = 9.3 9.3 123 2
Negative log of Kd.Negative log of Kd.
ChEMBL 1171 20 11 15 1.3 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)C(C)(C)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
CHEMBL2115364 79687 None 0 Rat Binding pKd = 9.3 9.3 123 2
Negative log of Kd.Negative log of Kd.
ChEMBL 1171 20 11 15 1.3 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)C(C)(C)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
71458135 79687 None 0 Rat Binding pKd = 9.3 9.3 123 2
Binding potency against V1 receptor in rat liver cellsBinding potency against V1 receptor in rat liver cells
ChEMBL 1171 20 11 15 1.3 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)C(C)(C)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
CHEMBL2115364 79687 None 0 Rat Binding pKd = 9.3 9.3 123 2
Binding potency against V1 receptor in rat liver cellsBinding potency against V1 receptor in rat liver cells
ChEMBL 1171 20 11 15 1.3 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)C(C)(C)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
145993846 167378 None 0 Human Binding pKd = 9.2 9.2 - 1
Binding affinity to human V1A receptor expressed in CHO cell membranesBinding affinity to human V1A receptor expressed in CHO cell membranes
ChEMBL 1179 19 15 14 -6.4 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1C[Se][Se]C[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.8b01320
CHEMBL4294901 167378 None 0 Human Binding pKd = 9.2 9.2 - 1
Binding affinity to human V1A receptor expressed in CHO cell membranesBinding affinity to human V1A receptor expressed in CHO cell membranes
ChEMBL 1179 19 15 14 -6.4 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1C[Se][Se]C[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.8b01320
71458135 79687 None 0 Rat Binding pKd = 9.2 9.2 123 2
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL 1171 20 11 15 1.3 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)C(C)(C)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
CHEMBL2115364 79687 None 0 Rat Binding pKd = 9.2 9.2 123 2
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL 1171 20 11 15 1.3 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)C(C)(C)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
71458135 79687 None 0 Rat Binding pKd = 9.2 9.2 123 2
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL 1171 20 11 15 1.3 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)C(C)(C)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
CHEMBL2115364 79687 None 0 Rat Binding pKd = 9.2 9.2 123 2
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL 1171 20 11 15 1.3 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)C(C)(C)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
2168 3974 None 38 Rat Binding pKd = 9.2 9.2 -8 9
Binding potency against V1 receptor in rat liver cellsBinding potency against V1 receptor in rat liver cells
ChEMBL None None None None 10.1021/jm00079a020
2810 3974 None 38 Rat Binding pKd = 9.2 9.2 -8 9
Binding potency against V1 receptor in rat liver cellsBinding potency against V1 receptor in rat liver cells
ChEMBL None None None None 10.1021/jm00079a020
644077 3974 None 38 Rat Binding pKd = 9.2 9.2 -8 9
Binding potency against V1 receptor in rat liver cellsBinding potency against V1 receptor in rat liver cells
ChEMBL None None None None 10.1021/jm00079a020
CHEMBL373742 3974 None 38 Rat Binding pKd = 9.2 9.2 -8 9
Binding potency against V1 receptor in rat liver cellsBinding potency against V1 receptor in rat liver cells
ChEMBL None None None None 10.1021/jm00079a020
DB00067 3974 None 38 Rat Binding pKd = 9.2 9.2 -8 9
Binding potency against V1 receptor in rat liver cellsBinding potency against V1 receptor in rat liver cells
ChEMBL None None None None 10.1021/jm00079a020
2168 3974 None 38 Rat Binding pKd = 9.2 9.2 -8 9
Negative log of Kd.Negative log of Kd.
ChEMBL None None None None 10.1021/jm00079a020
2810 3974 None 38 Rat Binding pKd = 9.2 9.2 -8 9
Negative log of Kd.Negative log of Kd.
ChEMBL None None None None 10.1021/jm00079a020
644077 3974 None 38 Rat Binding pKd = 9.2 9.2 -8 9
Negative log of Kd.Negative log of Kd.
ChEMBL None None None None 10.1021/jm00079a020
CHEMBL373742 3974 None 38 Rat Binding pKd = 9.2 9.2 -8 9
Negative log of Kd.Negative log of Kd.
ChEMBL None None None None 10.1021/jm00079a020
DB00067 3974 None 38 Rat Binding pKd = 9.2 9.2 -8 9
Negative log of Kd.Negative log of Kd.
ChEMBL None None None None 10.1021/jm00079a020
70689895 74517 None 0 Rat Binding pKd = 9.0 9.0 - 1
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL 1326 27 14 17 -0.4 C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCC/N=C(/N)c1ccc(N=[N+]=[N-])cc1)C(N)=O)N(C)C(=O)[C@H]1CSSCC2(CCCC2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm00079a020
CHEMBL2028983 74517 None 0 Rat Binding pKd = 9.0 9.0 - 1
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL 1326 27 14 17 -0.4 C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCC/N=C(/N)c1ccc(N=[N+]=[N-])cc1)C(N)=O)N(C)C(=O)[C@H]1CSSCC2(CCCC2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm00079a020
70689895 74517 None 0 Rat Binding pKd = 9.0 9.0 - 1
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL 1326 27 14 17 -0.4 C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCC/N=C(/N)c1ccc(N=[N+]=[N-])cc1)C(N)=O)N(C)C(=O)[C@H]1CSSCC2(CCCC2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm00079a020
CHEMBL2028983 74517 None 0 Rat Binding pKd = 9.0 9.0 - 1
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL 1326 27 14 17 -0.4 C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCC/N=C(/N)c1ccc(N=[N+]=[N-])cc1)C(N)=O)N(C)C(=O)[C@H]1CSSCC2(CCCC2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm00079a020
145993846 167378 None 0 Human Binding pKd = 9 9.0 - 1
Binding affinity to human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisBinding affinity to human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 1179 19 15 14 -6.4 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1C[Se][Se]C[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.8b01320
CHEMBL4294901 167378 None 0 Human Binding pKd = 9 9.0 - 1
Binding affinity to human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisBinding affinity to human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 1179 19 15 14 -6.4 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1C[Se][Se]C[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.8b01320
71454576 79689 None 0 Rat Binding pKd = 8.8 8.8 - 1
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL 1174 20 11 16 0.3 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)C(C)(C)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
CHEMBL2115368 79689 None 0 Rat Binding pKd = 8.8 8.8 - 1
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL 1174 20 11 16 0.3 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)C(C)(C)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
71454576 79689 None 0 Rat Binding pKd = 8.8 8.8 - 1
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL 1174 20 11 16 0.3 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)C(C)(C)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
CHEMBL2115368 79689 None 0 Rat Binding pKd = 8.8 8.8 - 1
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL 1174 20 11 16 0.3 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)C(C)(C)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
71454576 79689 None 0 Rat Binding pKd = 8.7 8.7 - 1
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL 1174 20 11 16 0.3 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)C(C)(C)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
CHEMBL2115368 79689 None 0 Rat Binding pKd = 8.7 8.7 - 1
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL 1174 20 11 16 0.3 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)C(C)(C)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
71454576 79689 None 0 Rat Binding pKd = 8.7 8.7 - 1
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL 1174 20 11 16 0.3 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)C(C)(C)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
CHEMBL2115368 79689 None 0 Rat Binding pKd = 8.7 8.7 - 1
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL 1174 20 11 16 0.3 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)C(C)(C)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
71312201 115385 None 12 Rat Binding pKd = 8.0 8.0 -1 2
Anti-vasopressor activity at V1a receptorAnti-vasopressor activity at V1a receptor
ChEMBL 1074 19 11 15 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350118 115385 None 12 Rat Binding pKd = 8.0 8.0 -1 2
Anti-vasopressor activity at V1a receptorAnti-vasopressor activity at V1a receptor
ChEMBL 1074 19 11 15 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
118718751 115388 None 0 Rat Binding pKd = 7.9 7.9 1 3
Anti-vasopressor activity at V1a receptor Anti-vasopressor activity at V1a receptor
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350123 115388 None 0 Rat Binding pKd = 7.9 7.9 1 3
Anti-vasopressor activity at V1a receptor Anti-vasopressor activity at V1a receptor
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
118718384 115344 None 0 Rat Binding pKd = 6.8 6.8 -7 3
Anti-vasopressor activity at V1a receptorAnti-vasopressor activity at V1a receptor
ChEMBL 1154 18 12 16 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349465 115344 None 0 Rat Binding pKd = 6.8 6.8 -7 3
Anti-vasopressor activity at V1a receptorAnti-vasopressor activity at V1a receptor
ChEMBL 1154 18 12 16 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL2372422 210242 None 0 Rat Binding pKd = 7.8 7.8 - 1
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL None None None [N-]=[N+]=Nc1ccc(C[C@@H]2NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC2=O)cc1 10.1021/jm00079a020
CHEMBL2372422 210242 None 0 Rat Binding pKd = 7.8 7.8 - 1
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL None None None [N-]=[N+]=Nc1ccc(C[C@@H]2NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC2=O)cc1 10.1021/jm00079a020
136961688 118591 None 0 Human Binding pKd = 7.7 7.7 -14 3
Binding affinity to V1aR (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to V1aR (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1206 23 5 13 7.4 CCN1/C(=C\C=C\C=C\C2=[N+](CC)c3cc(S(=O)(=O)[O-])ccc3C2(C)C)C(C)(CCCC(=O)NCCNC(=O)CCc2ccc(S(=O)(=O)N(CC(=O)N/N=C3\C(=O)Nc4ccccc43)c3ccc(Cl)cc3)cc2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm501395b
CHEMBL3416750 118591 None 0 Human Binding pKd = 7.7 7.7 -14 3
Binding affinity to V1aR (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to V1aR (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1206 23 5 13 7.4 CCN1/C(=C\C=C\C=C\C2=[N+](CC)c3cc(S(=O)(=O)[O-])ccc3C2(C)C)C(C)(CCCC(=O)NCCNC(=O)CCc2ccc(S(=O)(=O)N(CC(=O)N/N=C3\C(=O)Nc4ccccc43)c3ccc(Cl)cc3)cc2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm501395b
118718750 115387 None 0 Rat Binding pKd = 8.6 8.6 8 2
Compound was evaluated for the anti-vasopressor activity at V1a receptor.. Compound was evaluated for the anti-vasopressor activity at V1a receptor..
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350120 115387 None 0 Rat Binding pKd = 8.6 8.6 8 2
Compound was evaluated for the anti-vasopressor activity at V1a receptor.. Compound was evaluated for the anti-vasopressor activity at V1a receptor..
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL2372416 210236 None 0 Rat Binding pKd = 8.6 8.6 - 1
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL None None None CCC1(CC)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC1=O 10.1021/jm00079a020
CHEMBL2372416 210236 None 0 Rat Binding pKd = 8.6 8.6 - 1
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL None None None CCC1(CC)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC1=O 10.1021/jm00079a020
71449189 79688 None 0 Rat Binding pKd = 8.6 8.6 - 1
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL 1203 22 11 16 1.1 CCC1(CC)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC1=O 10.1021/jm00079a020
CHEMBL2115365 79688 None 0 Rat Binding pKd = 8.6 8.6 - 1
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL 1203 22 11 16 1.1 CCC1(CC)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC1=O 10.1021/jm00079a020
71449189 79688 None 0 Rat Binding pKd = 8.6 8.6 - 1
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL 1203 22 11 16 1.1 CCC1(CC)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC1=O 10.1021/jm00079a020
CHEMBL2115365 79688 None 0 Rat Binding pKd = 8.6 8.6 - 1
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL 1203 22 11 16 1.1 CCC1(CC)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC1=O 10.1021/jm00079a020
CHEMBL2372420 210240 None 0 Rat Binding pKd = 7.6 7.6 - 1
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL None None None CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
CHEMBL2372420 210240 None 0 Rat Binding pKd = 7.6 7.6 - 1
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL None None None CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
118718748 115384 None 0 Rat Binding pKd = 7.6 7.6 -1 2
Anti-vasopressor activity at V1a receptorAnti-vasopressor activity at V1a receptor
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350116 115384 None 0 Rat Binding pKd = 7.6 7.6 -1 2
Anti-vasopressor activity at V1a receptorAnti-vasopressor activity at V1a receptor
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
10011419 115390 None 0 Rat Binding pKd = 7.6 7.6 -1 3
Anti-vasopressor activity at V1a receptor Anti-vasopressor activity at V1a receptor
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350125 115390 None 0 Rat Binding pKd = 7.6 7.6 -1 3
Anti-vasopressor activity at V1a receptor Anti-vasopressor activity at V1a receptor
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00010a020
118718386 115346 None 0 Rat Binding pKd = 6.6 6.6 -12 3
Anti-vasopressor activity at V1a receptorAnti-vasopressor activity at V1a receptor
ChEMBL 991 14 10 14 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349467 115346 None 0 Rat Binding pKd = 6.6 6.6 -12 3
Anti-vasopressor activity at V1a receptorAnti-vasopressor activity at V1a receptor
ChEMBL 991 14 10 14 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
118718747 115383 None 0 Rat Binding pKd = 7.5 7.5 -2 2
Anti-vasopressor activity at V1a receptorAnti-vasopressor activity at V1a receptor
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350115 115383 None 0 Rat Binding pKd = 7.5 7.5 -2 2
Anti-vasopressor activity at V1a receptorAnti-vasopressor activity at V1a receptor
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL2372415 210235 None 0 Rat Binding pKd = 8.5 8.5 - 1
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL None None None CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)C2(CCCC2)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
CHEMBL2372415 210235 None 0 Rat Binding pKd = 8.5 8.5 - 1
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL None None None CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)C2(CCCC2)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
118718383 115343 None 0 Rat Binding pKd = 6.5 6.5 -16 3
Anti-vasopressor activity at V1a receptorAnti-vasopressor activity at V1a receptor
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349464 115343 None 0 Rat Binding pKd = 6.5 6.5 -16 3
Anti-vasopressor activity at V1a receptorAnti-vasopressor activity at V1a receptor
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL2372421 210241 None 0 Rat Binding pKd = 7.5 7.5 - 1
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL None None None [N-]=[N+]=Nc1ccc(C[C@@H]2NC(=O)[C@@H](Cc3ccc(O)cc3)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC2=O)cc1 10.1021/jm00079a020
CHEMBL2372421 210241 None 0 Rat Binding pKd = 7.5 7.5 - 1
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL None None None [N-]=[N+]=Nc1ccc(C[C@@H]2NC(=O)[C@@H](Cc3ccc(O)cc3)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC2=O)cc1 10.1021/jm00079a020
10463677 115347 None 1 Rat Binding pKd = 6.5 6.5 -38 3
Anti-vasopressor activity at V1a receptorAnti-vasopressor activity at V1a receptor
ChEMBL 991 15 10 14 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349468 115347 None 1 Rat Binding pKd = 6.5 6.5 -38 3
Anti-vasopressor activity at V1a receptorAnti-vasopressor activity at V1a receptor
ChEMBL 991 15 10 14 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL2372414 210234 None 0 Rat Binding pKd = 7.5 7.5 - 1
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL None None None CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)C2(CCCC2)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
CHEMBL2372414 210234 None 0 Rat Binding pKd = 7.5 7.5 - 1
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL None None None CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)C2(CCCC2)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
118718385 115345 None 0 Rat Binding pKd = 5.4 5.4 -251 2
Anti-vasopressor activity at V1a receptorAnti-vasopressor activity at V1a receptor
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349466 115345 None 0 Rat Binding pKd = 5.4 5.4 -251 2
Anti-vasopressor activity at V1a receptorAnti-vasopressor activity at V1a receptor
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL2372419 210239 None 0 Rat Binding pKd = 8.3 8.3 - 1
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL None None None CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
CHEMBL2372417 210237 None 0 Rat Binding pKd = 7.4 7.4 - 1
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL None None None NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
CHEMBL2372417 210237 None 0 Rat Binding pKd = 7.4 7.4 - 1
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL None None None NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
CHEMBL2372419 210239 None 0 Rat Binding pKd = 8.3 8.3 - 1
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL None None None CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
CHEMBL2372418 210238 None 0 Rat Binding pKd = 7.3 7.3 - 1
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL None None None NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
CHEMBL2372418 210238 None 0 Rat Binding pKd = 7.3 7.3 - 1
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL None None None NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
118718753 115391 None 0 Rat Binding pKd = 7.3 7.3 -1 3
Anti-vasopressor activity at V1a receptorAnti-vasopressor activity at V1a receptor
ChEMBL 1074 18 11 15 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350126 115391 None 0 Rat Binding pKd = 7.3 7.3 -1 3
Anti-vasopressor activity at V1a receptorAnti-vasopressor activity at V1a receptor
ChEMBL 1074 18 11 15 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL2370617 209885 None 0 Rat Binding pKd = 8.2 8.2 -1 3
Anti-vasopressor activity at V1a receptor Anti-vasopressor activity at V1a receptor
ChEMBL None None None CCOc1ccc(C[C@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00010a020
CHEMBL2370976 209970 None 10 Rat Binding pKd = 8.2 8.2 2 3
Anti-vasopressor activity at V1a receptor Anti-vasopressor activity at V1a receptor
ChEMBL None None None CCOc1ccc(C[C@@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00010a020
136961687 118590 None 0 Human Binding pKd = 7.2 7.2 -35 3
Binding affinity to V1aR (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to V1aR (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1053 21 7 12 6.4 O=C(CCCCCNC(=O)c1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)NCCNC(=O)CCc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm501395b
CHEMBL3416749 118590 None 0 Human Binding pKd = 7.2 7.2 -35 3
Binding affinity to V1aR (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to V1aR (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1053 21 7 12 6.4 O=C(CCCCCNC(=O)c1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)NCCNC(=O)CCc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm501395b
118718752 115389 None 0 Rat Binding pKd = 7.2 7.2 -1 3
Anti-vasopressor activity at V1a receptor Anti-vasopressor activity at V1a receptor
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350124 115389 None 0 Rat Binding pKd = 7.2 7.2 -1 3
Anti-vasopressor activity at V1a receptor Anti-vasopressor activity at V1a receptor
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
70681483 74518 None 0 Rat Binding pKd = 7.1 7.1 - 1
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL 1183 35 13 14 -2.0 CCOc1ccc(C[C@@H](NC(=O)Cc2ccncc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C(C)C)cc1 10.1021/jm00079a020
CHEMBL2028984 74518 None 0 Rat Binding pKd = 7.1 7.1 - 1
Binding potency against Vasopressin V1 receptor in rat liver cells.Binding potency against Vasopressin V1 receptor in rat liver cells.
ChEMBL 1183 35 13 14 -2.0 CCOc1ccc(C[C@@H](NC(=O)Cc2ccncc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C(C)C)cc1 10.1021/jm00079a020
70681483 74518 None 0 Rat Binding pKd = 7.1 7.1 - 1
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL 1183 35 13 14 -2.0 CCOc1ccc(C[C@@H](NC(=O)Cc2ccncc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C(C)C)cc1 10.1021/jm00079a020
CHEMBL2028984 74518 None 0 Rat Binding pKd = 7.1 7.1 - 1
Negative log of Kd for Vasopressin V1 receptorNegative log of Kd for Vasopressin V1 receptor
ChEMBL 1183 35 13 14 -2.0 CCOc1ccc(C[C@@H](NC(=O)Cc2ccncc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C(C)C)cc1 10.1021/jm00079a020
44294474 97010 None 0 Rat Binding pKd = 8.1 8.1 -1 3
Anti-vasopressor activity at V1a receptor Anti-vasopressor activity at V1a receptor
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL266643 97010 None 0 Rat Binding pKd = 8.1 8.1 -1 3
Anti-vasopressor activity at V1a receptor Anti-vasopressor activity at V1a receptor
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm00010a020
118718749 115386 None 0 Rat Binding pKd = 8.1 8.1 1 3
Anti-vasopressor activity at V1a receptor Anti-vasopressor activity at V1a receptor
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350119 115386 None 0 Rat Binding pKd = 8.1 8.1 1 3
Anti-vasopressor activity at V1a receptor Anti-vasopressor activity at V1a receptor
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
10396464 115348 None 1 Rat Binding pKd = 7.0 7.0 -8 2
Anti-vasopressor activity at V1a receptorAnti-vasopressor activity at V1a receptor
ChEMBL 1154 19 12 16 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349469 115348 None 1 Rat Binding pKd = 7.0 7.0 -8 2
Anti-vasopressor activity at V1a receptorAnti-vasopressor activity at V1a receptor
ChEMBL 1154 19 12 16 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
44428111 149451 None 0 Human Binding pKi = 10.5 10.5 - 1
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranes
ChEMBL 1127 32 16 14 -3.6 CN(C(=O)Cc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CC[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C1 10.1021/jm061404q
CHEMBL394602 149451 None 0 Human Binding pKi = 10.5 10.5 - 1
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranes
ChEMBL 1127 32 16 14 -3.6 CN(C(=O)Cc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CC[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C1 10.1021/jm061404q
44428111 149451 None 0 Human Binding pKi = 10.4 10.4 - 1
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranes
ChEMBL 1127 32 16 14 -3.6 CN(C(=O)Cc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CC[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C1 10.1021/jm061404q
CHEMBL394602 149451 None 0 Human Binding pKi = 10.4 10.4 - 1
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranes
ChEMBL 1127 32 16 14 -3.6 CN(C(=O)Cc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CC[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C1 10.1021/jm061404q
56680285 64054 None 0 Human Binding pKi = 10.4 10.4 37 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 513 8 2 3 5.0 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)C2(c3ccc(F)cc3)CCCC2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807272 64054 None 0 Human Binding pKi = 10.4 10.4 37 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 513 8 2 3 5.0 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)C2(c3ccc(F)cc3)CCCC2)CC1 10.1016/j.bmcl.2011.05.092
56676958 64049 None 0 Human Binding pKi = 10.4 10.4 42 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 501 8 2 3 4.7 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)C2(c3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807267 64049 None 0 Human Binding pKi = 10.4 10.4 42 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 501 8 2 3 4.7 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)C2(c3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2011.05.092
44297517 155724 None 0 Rat Binding pKi = 10.4 10.4 28 3
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1343 39 15 16 -1.4 CN(C(=O)CCCc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL405440 155724 None 0 Rat Binding pKi = 10.4 10.4 28 3
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1343 39 15 16 -1.4 CN(C(=O)CCCc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
46890438 6584 None 0 Human Binding pKi = 10.3 10.3 4073 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 347 2 0 1 5.7 Cc1ccccc1-c1ccc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)cc1 10.1016/j.bmcl.2010.04.068
CHEMBL1083094 6584 None 0 Human Binding pKi = 10.3 10.3 4073 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 347 2 0 1 5.7 Cc1ccccc1-c1ccc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)cc1 10.1016/j.bmcl.2010.04.068
46890485 7028 None 0 Human Binding pKi = 10.2 10.2 7943 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 361 2 0 1 6.0 Cc1ccccc1-c1ccc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)cc1C 10.1016/j.bmcl.2010.04.068
CHEMBL1084823 7028 None 0 Human Binding pKi = 10.2 10.2 7943 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 361 2 0 1 6.0 Cc1ccccc1-c1ccc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)cc1C 10.1016/j.bmcl.2010.04.068
44275525 194864 None 0 Human Binding pKi = 10.2 10.2 16 4
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1525 36 12 20 1.8 CN(C)c1ccc2c(c1)Oc1cc(N(C)C)ccc1C21OC(=O)c2cc(C(=O)N(C(=O)[C@@H]3CCCN3C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccc(O)cc3)N(C)C(=O)CCc3ccc(O)cc3)[C@@H](CCCCN)C(N)=O)ccc21 10.1021/jm9804782
91931055 194864 None 0 Human Binding pKi = 10.2 10.2 16 4
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1525 36 12 20 1.8 CN(C)c1ccc2c(c1)Oc1cc(N(C)C)ccc1C21OC(=O)c2cc(C(=O)N(C(=O)[C@@H]3CCCN3C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccc(O)cc3)N(C)C(=O)CCc3ccc(O)cc3)[C@@H](CCCCN)C(N)=O)ccc21 10.1021/jm9804782
CHEMBL540192 194864 None 0 Human Binding pKi = 10.2 10.2 16 4
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1525 36 12 20 1.8 CN(C)c1ccc2c(c1)Oc1cc(N(C)C)ccc1C21OC(=O)c2cc(C(=O)N(C(=O)[C@@H]3CCCN3C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccc(O)cc3)N(C)C(=O)CCc3ccc(O)cc3)[C@@H](CCCCN)C(N)=O)ccc21 10.1021/jm9804782
44275104 97285 None 0 Human Binding pKi = 10.1 10.1 33 4
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1127 32 14 14 -3.9 CN(C(=O)Cc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(N)=O 10.1021/jm9804782
CHEMBL269012 97285 None 0 Human Binding pKi = 10.1 10.1 33 4
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1127 32 14 14 -3.9 CN(C(=O)Cc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(N)=O 10.1021/jm9804782
44428107 10315 None 0 Human Binding pKi = 10.1 10.1 11 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 2058 46 18 25 6.0 CC1CC(C)(C)Nc2c1cc1c(c2S(=O)(=O)O)OC2C(=C1c1c(Cl)c(SCC(=O)NCCCCCC(=O)N(C(=O)[C@H]3CCN(C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](Cc4ccc(O)cc4)N(C)C(=O)CCc4ccc(O)cc4)C3)[C@@H](CCCCN)C(N)=O)c(Cl)c(Cl)c1C(=O)O)CC1C(=NC(C)(C)CC1C)C2S(=O)(=O)O 10.1021/jm061404q
91935616 10315 None 0 Human Binding pKi = 10.1 10.1 11 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 2058 46 18 25 6.0 CC1CC(C)(C)Nc2c1cc1c(c2S(=O)(=O)O)OC2C(=C1c1c(Cl)c(SCC(=O)NCCCCCC(=O)N(C(=O)[C@H]3CCN(C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](Cc4ccc(O)cc4)N(C)C(=O)CCc4ccc(O)cc4)C3)[C@@H](CCCCN)C(N)=O)c(Cl)c(Cl)c1C(=O)O)CC1C(=NC(C)(C)CC1C)C2S(=O)(=O)O 10.1021/jm061404q
CHEMBL1161978 10315 None 0 Human Binding pKi = 10.1 10.1 11 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 2058 46 18 25 6.0 CC1CC(C)(C)Nc2c1cc1c(c2S(=O)(=O)O)OC2C(=C1c1c(Cl)c(SCC(=O)NCCCCCC(=O)N(C(=O)[C@H]3CCN(C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](Cc4ccc(O)cc4)N(C)C(=O)CCc4ccc(O)cc4)C3)[C@@H](CCCCN)C(N)=O)c(Cl)c(Cl)c1C(=O)O)CC1C(=NC(C)(C)CC1C)C2S(=O)(=O)O 10.1021/jm061404q
56680284 64052 None 0 Human Binding pKi = 10.0 10.0 21 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 515 8 2 3 5.1 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)C2(c3ccc(Cl)cc3)CCC2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807270 64052 None 0 Human Binding pKi = 10.0 10.0 21 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 515 8 2 3 5.1 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)C2(c3ccc(Cl)cc3)CCC2)CC1 10.1016/j.bmcl.2011.05.092
46890709 6835 None 0 Human Binding pKi = 10 10.0 6025 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 402 3 1 2 5.9 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1c[nH]c2ccccc12 10.1016/j.bmcl.2010.04.068
CHEMBL1084008 6835 None 0 Human Binding pKi = 10 10.0 6025 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 402 3 1 2 5.9 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1c[nH]c2ccccc12 10.1016/j.bmcl.2010.04.068
44314134 104790 None 0 Rat Binding pKi = 10.0 10.0 331 2
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 576 5 1 5 5.5 Cc1occc1C(=O)Nc1ccc(C(=O)N2CCC(F)(F)/C(=C/C(=O)N3CCC(N(C)C)CC3)c3ccccc32)cc1 10.1016/s0960-894x(01)00723-5
CHEMBL310921 104790 None 0 Rat Binding pKi = 10.0 10.0 331 2
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 576 5 1 5 5.5 Cc1occc1C(=O)Nc1ccc(C(=O)N2CCC(F)(F)/C(=C/C(=O)N3CCC(N(C)C)CC3)c3ccccc32)cc1 10.1016/s0960-894x(01)00723-5
44297505 165855 None 0 Rat Binding pKi = 10.0 10.0 7 3
Tested for inhibition constant determined from vasopressin induced inositol phosphates accumulation performed on WRK1 cell line of V1a receptor subtypeTested for inhibition constant determined from vasopressin induced inositol phosphates accumulation performed on WRK1 cell line of V1a receptor subtype
ChEMBL 1329 38 15 16 -1.8 CN(C(=O)CCc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL424905 165855 None 0 Rat Binding pKi = 10.0 10.0 7 3
Tested for inhibition constant determined from vasopressin induced inositol phosphates accumulation performed on WRK1 cell line of V1a receptor subtypeTested for inhibition constant determined from vasopressin induced inositol phosphates accumulation performed on WRK1 cell line of V1a receptor subtype
ChEMBL 1329 38 15 16 -1.8 CN(C(=O)CCc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
44297516 161289 None 0 Rat Binding pKi = 9.9 9.9 22 3
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1315 37 15 16 -2.2 CN(C(=O)Cc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL412192 161289 None 0 Rat Binding pKi = 9.9 9.9 22 3
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1315 37 15 16 -2.2 CN(C(=O)Cc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
44297525 96807 None 0 Rat Binding pKi = 9.9 9.9 10 3
Tested for inhibition constant determined from vasopressin induced inositol phosphates accumulation performed on WRK1 cell line of V1a receptor subtypeTested for inhibition constant determined from vasopressin induced inositol phosphates accumulation performed on WRK1 cell line of V1a receptor subtype
ChEMBL 1329 38 15 16 -1.8 CN(C(=O)CCc1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL265048 96807 None 0 Rat Binding pKi = 9.9 9.9 10 3
Tested for inhibition constant determined from vasopressin induced inositol phosphates accumulation performed on WRK1 cell line of V1a receptor subtypeTested for inhibition constant determined from vasopressin induced inositol phosphates accumulation performed on WRK1 cell line of V1a receptor subtype
ChEMBL 1329 38 15 16 -1.8 CN(C(=O)CCc1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
2213 518 None 46 Human Binding pKi = 9.8 9.8 28 5
Binding affinity to human vasopressin V1a receptorBinding affinity to human vasopressin V1a receptor
ChEMBL None None None None 10.1016/j.bmcl.2007.11.008
3008 518 None 46 Human Binding pKi = 9.8 9.8 28 5
Binding affinity to human vasopressin V1a receptorBinding affinity to human vasopressin V1a receptor
ChEMBL None None None None 10.1016/j.bmcl.2007.11.008
5311010 518 None 46 Human Binding pKi = 9.8 9.8 28 5
Binding affinity to human vasopressin V1a receptorBinding affinity to human vasopressin V1a receptor
ChEMBL None None None None 10.1016/j.bmcl.2007.11.008
68613 518 None 46 Human Binding pKi = 9.8 9.8 28 5
Binding affinity to human vasopressin V1a receptorBinding affinity to human vasopressin V1a receptor
ChEMBL None None None None 10.1016/j.bmcl.2007.11.008
CHEMBL378642 518 None 46 Human Binding pKi = 9.8 9.8 28 5
Binding affinity to human vasopressin V1a receptorBinding affinity to human vasopressin V1a receptor
ChEMBL None None None None 10.1016/j.bmcl.2007.11.008
CHEMBL382301 518 None 46 Human Binding pKi = 9.8 9.8 28 5
Binding affinity to human vasopressin V1a receptorBinding affinity to human vasopressin V1a receptor
ChEMBL None None None None 10.1016/j.bmcl.2007.11.008
DB09059 518 None 46 Human Binding pKi = 9.8 9.8 28 5
Binding affinity to human vasopressin V1a receptorBinding affinity to human vasopressin V1a receptor
ChEMBL None None None None 10.1016/j.bmcl.2007.11.008
2205 4121 None 6 Rat Binding pKi = 9.8 9.8 1 5
Binding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liverBinding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liver
ChEMBL 648 6 1 4 7.2 CN(C1CCN(CC1)C(=O)/C=C\1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1)C 10.1021/jm010544r
9810140 4121 None 6 Rat Binding pKi = 9.8 9.8 1 5
Binding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liverBinding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liver
ChEMBL 648 6 1 4 7.2 CN(C1CCN(CC1)C(=O)/C=C\1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1)C 10.1021/jm010544r
CHEMBL307483 4121 None 6 Rat Binding pKi = 9.8 9.8 1 5
Binding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liverBinding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liver
ChEMBL 648 6 1 4 7.2 CN(C1CCN(CC1)C(=O)/C=C\1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1)C 10.1021/jm010544r
44297525 96807 None 0 Rat Binding pKi = 9.8 9.8 10 3
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1329 38 15 16 -1.8 CN(C(=O)CCc1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL265048 96807 None 0 Rat Binding pKi = 9.8 9.8 10 3
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1329 38 15 16 -1.8 CN(C(=O)CCc1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
44275524 161291 None 0 Human Binding pKi = 9.8 9.8 9 4
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1471 34 14 20 1.1 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N(C(=O)c1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21)[C@@H](CCCCN)C(N)=O 10.1021/jm9804782
91931053 161291 None 0 Human Binding pKi = 9.8 9.8 9 4
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1471 34 14 20 1.1 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N(C(=O)c1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21)[C@@H](CCCCN)C(N)=O 10.1021/jm9804782
CHEMBL412210 161291 None 0 Human Binding pKi = 9.8 9.8 9 4
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1471 34 14 20 1.1 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N(C(=O)c1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21)[C@@H](CCCCN)C(N)=O 10.1021/jm9804782
44275467 167726 None 0 Human Binding pKi = 9.8 9.8 - 1
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1525 36 12 20 1.8 CN(C)c1ccc2c(c1)Oc1cc(N(C)C)ccc1C21OC(=O)c2ccc(C(=O)N(C(=O)[C@@H]3CCCN3C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccc(O)cc3)N(C)C(=O)CCc3ccc(O)cc3)[C@@H](CCCCN)C(N)=O)cc21 10.1021/jm9804782
91931056 167726 None 0 Human Binding pKi = 9.8 9.8 - 1
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1525 36 12 20 1.8 CN(C)c1ccc2c(c1)Oc1cc(N(C)C)ccc1C21OC(=O)c2ccc(C(=O)N(C(=O)[C@@H]3CCCN3C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccc(O)cc3)N(C)C(=O)CCc3ccc(O)cc3)[C@@H](CCCCN)C(N)=O)cc21 10.1021/jm9804782
CHEMBL430272 167726 None 0 Human Binding pKi = 9.8 9.8 - 1
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1525 36 12 20 1.8 CN(C)c1ccc2c(c1)Oc1cc(N(C)C)ccc1C21OC(=O)c2ccc(C(=O)N(C(=O)[C@@H]3CCCN3C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccc(O)cc3)N(C)C(=O)CCc3ccc(O)cc3)[C@@H](CCCCN)C(N)=O)cc21 10.1021/jm9804782
44400427 159807 None 0 Rat Binding pKi = 9.7 9.7 - 1
Binding affinity against rat vasopressin V1a receptorBinding affinity against rat vasopressin V1a receptor
ChEMBL 1469 40 15 16 -0.9 COc1ccc(C[C@@H](NC(=O)CCCc2ccc(N=[N+]=[N-])cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc(O)c(I)c2)C(N)=O)cc1 10.1021/jm040871+
CHEMBL410567 159807 None 0 Rat Binding pKi = 9.7 9.7 - 1
Binding affinity against rat vasopressin V1a receptorBinding affinity against rat vasopressin V1a receptor
ChEMBL 1469 40 15 16 -0.9 COc1ccc(C[C@@H](NC(=O)CCCc2ccc(N=[N+]=[N-])cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc(O)c(I)c2)C(N)=O)cc1 10.1021/jm040871+
44297517 155724 None 0 Rat Binding pKi = 9.7 9.7 28 3
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1343 39 15 16 -1.4 CN(C(=O)CCCc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL405440 155724 None 0 Rat Binding pKi = 9.7 9.7 28 3
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1343 39 15 16 -1.4 CN(C(=O)CCCc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
56680283 64048 None 0 Human Binding pKi = 9.7 9.7 44 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 475 8 2 3 4.3 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)Cc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807266 64048 None 0 Human Binding pKi = 9.7 9.7 44 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 475 8 2 3 4.3 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)Cc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.05.092
2200 3309 None 46 Human Binding pKi = 9.7 9.7 1 6
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranes
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
3482 3309 None 46 Human Binding pKi = 9.7 9.7 1 6
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranes
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
60943 3309 None 46 Human Binding pKi = 9.7 9.7 1 6
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranes
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
CHEMBL419667 3309 None 46 Human Binding pKi = 9.7 9.7 1 6
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranes
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
DB13929 3309 None 46 Human Binding pKi = 9.7 9.7 1 6
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranes
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
44428537 152568 None 0 Human Binding pKi = 9.7 9.7 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 789 12 1 6 6.6 O=C(NCc1cccc(C(F)(F)F)c1F)[C@H](CCC(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL397179 152568 None 0 Human Binding pKi = 9.7 9.7 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 789 12 1 6 6.6 O=C(NCc1cccc(C(F)(F)F)c1F)[C@H](CCC(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
145981307 166675 None 0 Human Binding pKi = 9.7 9.7 - 1
Displacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisDisplacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 1141 34 16 14 -3.1 COc1ccc(C[C@@H](NC(=O)CCc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)cc1 10.1021/acs.jmedchem.8b01320
CHEMBL4281963 166675 None 0 Human Binding pKi = 9.7 9.7 - 1
Displacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisDisplacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 1141 34 16 14 -3.1 COc1ccc(C[C@@H](NC(=O)CCc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)cc1 10.1021/acs.jmedchem.8b01320
44297505 165855 None 0 Rat Binding pKi = 9.7 9.7 7 3
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1329 38 15 16 -1.8 CN(C(=O)CCc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL424905 165855 None 0 Rat Binding pKi = 9.7 9.7 7 3
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1329 38 15 16 -1.8 CN(C(=O)CCc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
44297516 161289 None 0 Rat Binding pKi = 9.7 9.7 22 3
Tested for inhibition constant determined from vasopressin induced inositol phosphates accumulation performed on WRK1 cell line of V1a receptor subtypeTested for inhibition constant determined from vasopressin induced inositol phosphates accumulation performed on WRK1 cell line of V1a receptor subtype
ChEMBL 1315 37 15 16 -2.2 CN(C(=O)Cc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL412192 161289 None 0 Rat Binding pKi = 9.7 9.7 22 3
Tested for inhibition constant determined from vasopressin induced inositol phosphates accumulation performed on WRK1 cell line of V1a receptor subtypeTested for inhibition constant determined from vasopressin induced inositol phosphates accumulation performed on WRK1 cell line of V1a receptor subtype
ChEMBL 1315 37 15 16 -2.2 CN(C(=O)Cc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
56663273 64064 None 0 Human Binding pKi = 9.7 9.7 28 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 448 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)NC1CCCCC1O 10.1016/j.bmcl.2011.05.092
CHEMBL1807281 64064 None 0 Human Binding pKi = 9.7 9.7 28 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 448 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)NC1CCCCC1O 10.1016/j.bmcl.2011.05.092
44428111 149451 None 0 Human Binding pKi = 9.7 9.7 - 1
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranes
ChEMBL 1127 32 16 14 -3.6 CN(C(=O)Cc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CC[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C1 10.1021/jm061404q
CHEMBL394602 149451 None 0 Human Binding pKi = 9.7 9.7 - 1
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranes
ChEMBL 1127 32 16 14 -3.6 CN(C(=O)Cc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CC[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C1 10.1021/jm061404q
44428111 149451 None 0 Human Binding pKi = 9.7 9.7 - 1
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranes
ChEMBL 1127 32 16 14 -3.6 CN(C(=O)Cc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CC[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C1 10.1021/jm061404q
CHEMBL394602 149451 None 0 Human Binding pKi = 9.7 9.7 - 1
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranes
ChEMBL 1127 32 16 14 -3.6 CN(C(=O)Cc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CC[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C1 10.1021/jm061404q
44274848 167433 None 0 Human Binding pKi = 9.6 9.6 - 1
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1471 34 14 20 1.1 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N(C(=O)c1ccc2c(c1)C1(OC2=O)c2ccc(O)cc2Oc2cc(O)ccc21)[C@@H](CCCCN)C(N)=O 10.1021/jm9804782
91931059 167433 None 0 Human Binding pKi = 9.6 9.6 - 1
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1471 34 14 20 1.1 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N(C(=O)c1ccc2c(c1)C1(OC2=O)c2ccc(O)cc2Oc2cc(O)ccc21)[C@@H](CCCCN)C(N)=O 10.1021/jm9804782
CHEMBL429725 167433 None 0 Human Binding pKi = 9.6 9.6 - 1
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1471 34 14 20 1.1 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N(C(=O)c1ccc2c(c1)C1(OC2=O)c2ccc(O)cc2Oc2cc(O)ccc21)[C@@H](CCCCN)C(N)=O 10.1021/jm9804782
54584254 61908 None 0 Human Binding pKi = 9.6 9.6 93 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 459 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@@H]1C[C@@H]2CC[C@H](C1)N2 10.1016/j.bmcl.2011.02.096
54584254 61908 None 0 Human Binding pKi = 9.6 9.6 93 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 459 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@@H]1C[C@@H]2CC[C@H](C1)N2 10.1016/j.bmcl.2011.05.092
CHEMBL1774023 61908 None 0 Human Binding pKi = 9.6 9.6 93 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 459 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@@H]1C[C@@H]2CC[C@H](C1)N2 10.1016/j.bmcl.2011.02.096
CHEMBL1774023 61908 None 0 Human Binding pKi = 9.6 9.6 93 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 459 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@@H]1C[C@@H]2CC[C@H](C1)N2 10.1016/j.bmcl.2011.05.092
53364234 64055 None 0 Human Binding pKi = 9.6 9.6 9 3
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 485 8 2 3 4.2 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)C2(c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807273 64055 None 0 Human Binding pKi = 9.6 9.6 9 3
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 485 8 2 3 4.2 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)C2(c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2011.05.092
44297449 169258 None 0 Rat Binding pKi = 9.6 9.6 1 3
Tested for inhibition constant determined from vasopressin induced inositol phosphates accumulation performed on WRK1 cell line of V1a receptor subtypeTested for inhibition constant determined from vasopressin induced inositol phosphates accumulation performed on WRK1 cell line of V1a receptor subtype
ChEMBL 1315 37 15 16 -2.2 CN(C(=O)Cc1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL441195 169258 None 0 Rat Binding pKi = 9.6 9.6 1 3
Tested for inhibition constant determined from vasopressin induced inositol phosphates accumulation performed on WRK1 cell line of V1a receptor subtypeTested for inhibition constant determined from vasopressin induced inositol phosphates accumulation performed on WRK1 cell line of V1a receptor subtype
ChEMBL 1315 37 15 16 -2.2 CN(C(=O)Cc1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
56683606 64053 None 0 Human Binding pKi = 9.6 9.6 19 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 499 8 2 3 4.6 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)C2(c3ccc(F)cc3)CCC2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807271 64053 None 0 Human Binding pKi = 9.6 9.6 19 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 499 8 2 3 4.6 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)C2(c3ccc(F)cc3)CCC2)CC1 10.1016/j.bmcl.2011.05.092
2168 3974 None 38 Human Binding pKi = 9.6 9.6 -5 9
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
2810 3974 None 38 Human Binding pKi = 9.6 9.6 -5 9
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
644077 3974 None 38 Human Binding pKi = 9.6 9.6 -5 9
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
CHEMBL373742 3974 None 38 Human Binding pKi = 9.6 9.6 -5 9
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
DB00067 3974 None 38 Human Binding pKi = 9.6 9.6 -5 9
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
44428516 161167 None 0 Human Binding pKi = 9.6 9.6 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 771 12 1 6 6.4 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CCC(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL411757 161167 None 0 Human Binding pKi = 9.6 9.6 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 771 12 1 6 6.4 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CCC(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
44297525 96807 None 0 Rat Binding pKi = 9.6 9.6 10 3
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1329 38 15 16 -1.8 CN(C(=O)CCc1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL265048 96807 None 0 Rat Binding pKi = 9.6 9.6 10 3
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1329 38 15 16 -1.8 CN(C(=O)CCc1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
44428111 149451 None 0 Human Binding pKi = 9.6 9.6 - 1
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cellsInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cells
ChEMBL 1127 32 16 14 -3.6 CN(C(=O)Cc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CC[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C1 10.1021/jm061404q
CHEMBL394602 149451 None 0 Human Binding pKi = 9.6 9.6 - 1
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cellsInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cells
ChEMBL 1127 32 16 14 -3.6 CN(C(=O)Cc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CC[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C1 10.1021/jm061404q
44428550 150960 None 18 Human Binding pKi = 9.5 9.5 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 703 11 1 6 5.6 C[C@@H](NC(=O)[C@@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1)c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL395817 150960 None 18 Human Binding pKi = 9.5 9.5 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 703 11 1 6 5.6 C[C@@H](NC(=O)[C@@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1)c1ccccc1 10.1016/j.bmc.2006.12.031
2204 4115 None 5 Human Binding pKi = 9.5 9.5 229 4
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranesDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes
ChEMBL 616 5 1 5 6.4 O=C(N1CCC(CC1)N1CCCCC1)/C=C\1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccoc1C 10.1021/acs.jmedchem.8b00697
9917025 4115 None 5 Human Binding pKi = 9.5 9.5 229 4
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranesDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes
ChEMBL 616 5 1 5 6.4 O=C(N1CCC(CC1)N1CCCCC1)/C=C\1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccoc1C 10.1021/acs.jmedchem.8b00697
CHEMBL3307200 4115 None 5 Human Binding pKi = 9.5 9.5 229 4
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranesDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes
ChEMBL 616 5 1 5 6.4 O=C(N1CCC(CC1)N1CCCCC1)/C=C\1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccoc1C 10.1021/acs.jmedchem.8b00697
CHEMBL5070075 214224 None 0 Human Binding pKi = 9.5 9.5 660 2
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL None None None O[C@@H]1Cc2cc(Cl)ccc2-n2c(nnc2[C@H]2CC[C@H](Oc3ccccn3)CC2)C1 10.1021/acs.jmedchem.1c00863
CHEMBL5070261 214227 None 0 Human Binding pKi = 9.5 9.5 1548 2
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL None None None OC1Cc2cc(Cl)ccc2-n2c(nnc2[C@H]2CC[C@H](Oc3ccccn3)CC2)C1 10.1021/acs.jmedchem.1c00863
CHEMBL5074709 214325 None 0 Human Binding pKi = 9.5 9.5 2951 2
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL None None None O[C@H]1Cc2cc(Cl)ccc2-n2c(nnc2[C@H]2CC[C@H](Oc3ccccn3)CC2)C1 10.1021/acs.jmedchem.1c00863
46890440 7349 None 0 Human Binding pKi = 9.5 9.5 173 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 381 2 0 1 6.4 Cc1ccccc1-c1ccc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)c(Cl)c1 10.1016/j.bmcl.2010.04.068
CHEMBL1086272 7349 None 0 Human Binding pKi = 9.5 9.5 173 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 381 2 0 1 6.4 Cc1ccccc1-c1ccc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)c(Cl)c1 10.1016/j.bmcl.2010.04.068
44297449 169258 None 0 Rat Binding pKi = 9.5 9.5 1 3
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1315 37 15 16 -2.2 CN(C(=O)Cc1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL441195 169258 None 0 Rat Binding pKi = 9.5 9.5 1 3
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1315 37 15 16 -2.2 CN(C(=O)Cc1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
2168 3974 None 38 Human Binding pKi = 9.5 9.5 -5 9
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
2810 3974 None 38 Human Binding pKi = 9.5 9.5 -5 9
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
644077 3974 None 38 Human Binding pKi = 9.5 9.5 -5 9
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
CHEMBL373742 3974 None 38 Human Binding pKi = 9.5 9.5 -5 9
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
DB00067 3974 None 38 Human Binding pKi = 9.5 9.5 -5 9
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
46890612 6902 None 0 Human Binding pKi = 9.4 9.4 81 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 420 4 1 3 5.4 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1cccc(NC(C)=O)c1 10.1016/j.bmcl.2010.04.068
CHEMBL1084325 6902 None 0 Human Binding pKi = 9.4 9.4 81 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 420 4 1 3 5.4 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1cccc(NC(C)=O)c1 10.1016/j.bmcl.2010.04.068
56670128 64060 None 0 Human Binding pKi = 9.4 9.4 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 422 9 3 3 3.2 CC(CCO)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1 10.1016/j.bmcl.2011.05.092
CHEMBL1807278 64060 None 0 Human Binding pKi = 9.4 9.4 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 422 9 3 3 3.2 CC(CCO)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1 10.1016/j.bmcl.2011.05.092
44428538 160466 None 0 Human Binding pKi = 9.4 9.4 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 771 12 1 6 6.7 O=C(NCc1cccc(Cl)c1Cl)[C@H](CCC(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL411179 160466 None 0 Human Binding pKi = 9.4 9.4 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 771 12 1 6 6.7 O=C(NCc1cccc(Cl)c1Cl)[C@H](CCC(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL2370569 209869 None 23 Human Binding pKi = 9.4 9.4 - 1
Binding affinity to human vasopressin V1a receptor by radioligand displacement assayBinding affinity to human vasopressin V1a receptor by radioligand displacement assay
ChEMBL None None None COc1ccc(C[C@@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1016/j.ejmech.2013.01.044
CHEMBL5081323 214741 None 0 Human Binding pKi = 9.4 9.4 2691 2
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL None None None Cc1ccc2c(c1)CC(O)Cc1nnc([C@H]3CC[C@H](Oc4ccccn4)CC3)n1-2 10.1021/acs.jmedchem.1c00863
145986380 167091 None 0 Human Binding pKi = 9.4 9.4 - 1
Displacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisDisplacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 1206 34 16 14 -3.8 COc1ccc(C[C@@H](NC(=O)CCc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2C[Se]C[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)cc1 10.1021/acs.jmedchem.8b01320
CHEMBL4289837 167091 None 0 Human Binding pKi = 9.4 9.4 - 1
Displacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisDisplacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 1206 34 16 14 -3.8 COc1ccc(C[C@@H](NC(=O)CCc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2C[Se]C[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)cc1 10.1021/acs.jmedchem.8b01320
44428540 152578 None 0 Human Binding pKi = 9.4 9.4 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 789 12 1 6 6.6 O=C(NCc1cc(C(F)(F)F)ccc1F)[C@H](CCC(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL397185 152578 None 0 Human Binding pKi = 9.4 9.4 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 789 12 1 6 6.6 O=C(NCc1cc(C(F)(F)F)ccc1F)[C@H](CCC(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
151171 1163 None 50 Human Binding pKi = 9.4 9.4 -3 6
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 10.1016/j.bmcl.2010.04.068
216322 1163 None 50 Human Binding pKi = 9.4 9.4 -3 6
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 10.1016/j.bmcl.2010.04.068
2203 1163 None 50 Human Binding pKi = 9.4 9.4 -3 6
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 10.1016/j.bmcl.2010.04.068
732 1163 None 50 Human Binding pKi = 9.4 9.4 -3 6
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 10.1016/j.bmcl.2010.04.068
CHEMBL1755 1163 None 50 Human Binding pKi = 9.4 9.4 -3 6
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 10.1016/j.bmcl.2010.04.068
DB00872 1163 None 50 Human Binding pKi = 9.4 9.4 -3 6
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 10.1016/j.bmcl.2010.04.068
162658238 181004 None 0 Human Binding pKi = 9.4 9.4 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 369 2 0 5 3.5 C#Cc1ccc2c(c1)CCCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
CHEMBL4759005 181004 None 0 Human Binding pKi = 9.4 9.4 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 369 2 0 5 3.5 C#Cc1ccc2c(c1)CCCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
44428518 152299 None 0 Human Binding pKi = 9.3 9.3 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 785 13 1 6 6.7 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CCC(=O)N1CCN(CC2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL396954 152299 None 0 Human Binding pKi = 9.3 9.3 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 785 13 1 6 6.7 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CCC(=O)N1CCN(CC2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
44297517 155724 None 0 Rat Binding pKi = 9.3 9.3 28 3
Tested for inhibition constant determined from vasopressin induced inositol phosphates accumulation performed on WRK1 cell line of V1a receptor subtypeTested for inhibition constant determined from vasopressin induced inositol phosphates accumulation performed on WRK1 cell line of V1a receptor subtype
ChEMBL 1343 39 15 16 -1.4 CN(C(=O)CCCc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL405440 155724 None 0 Rat Binding pKi = 9.3 9.3 28 3
Tested for inhibition constant determined from vasopressin induced inositol phosphates accumulation performed on WRK1 cell line of V1a receptor subtypeTested for inhibition constant determined from vasopressin induced inositol phosphates accumulation performed on WRK1 cell line of V1a receptor subtype
ChEMBL 1343 39 15 16 -1.4 CN(C(=O)CCCc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
44297505 165855 None 0 Rat Binding pKi = 9.3 9.3 7 3
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1329 38 15 16 -1.8 CN(C(=O)CCc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL424905 165855 None 0 Rat Binding pKi = 9.3 9.3 7 3
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1329 38 15 16 -1.8 CN(C(=O)CCc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
151171 1163 None 50 Rat Binding pKi = 9.3 9.3 1 6
Displacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting methodDisplacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting method
ChEMBL 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 10.1021/acs.jmedchem.8b00697
216322 1163 None 50 Rat Binding pKi = 9.3 9.3 1 6
Displacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting methodDisplacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting method
ChEMBL 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 10.1021/acs.jmedchem.8b00697
2203 1163 None 50 Rat Binding pKi = 9.3 9.3 1 6
Displacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting methodDisplacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting method
ChEMBL 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 10.1021/acs.jmedchem.8b00697
732 1163 None 50 Rat Binding pKi = 9.3 9.3 1 6
Displacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting methodDisplacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting method
ChEMBL 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 10.1021/acs.jmedchem.8b00697
CHEMBL1755 1163 None 50 Rat Binding pKi = 9.3 9.3 1 6
Displacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting methodDisplacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting method
ChEMBL 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 10.1021/acs.jmedchem.8b00697
DB00872 1163 None 50 Rat Binding pKi = 9.3 9.3 1 6
Displacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting methodDisplacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting method
ChEMBL 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 10.1021/acs.jmedchem.8b00697
59657523 118660 None 0 Human Binding pKi = 9.3 9.3 28 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 451 3 0 4 4.0 CN(C)C(=O)Cn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1021/jm501745f
CHEMBL3416881 118660 None 0 Human Binding pKi = 9.3 9.3 28 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 451 3 0 4 4.0 CN(C)C(=O)Cn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1021/jm501745f
44428541 149808 None 0 Human Binding pKi = 9.3 9.3 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 789 12 1 6 6.6 O=C(NCc1cc(F)cc(C(F)(F)F)c1)[C@H](CCC(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL394866 149808 None 0 Human Binding pKi = 9.3 9.3 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 789 12 1 6 6.6 O=C(NCc1cc(F)cc(C(F)(F)F)c1)[C@H](CCC(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
2200 3309 None 46 Human Binding pKi = 9.3 9.3 1 6
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranes
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
3482 3309 None 46 Human Binding pKi = 9.3 9.3 1 6
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranes
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
60943 3309 None 46 Human Binding pKi = 9.3 9.3 1 6
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranes
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
CHEMBL419667 3309 None 46 Human Binding pKi = 9.3 9.3 1 6
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranes
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
DB13929 3309 None 46 Human Binding pKi = 9.3 9.3 1 6
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranes
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
56666701 64050 None 0 Human Binding pKi = 9.3 9.3 26 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 497 9 2 4 4.1 COc1ccc(C[C@@H](NC(=O)C2(c3ccc(Cl)cc3)CC2)C(=O)N[C@H]2CC[C@H](N(C)C)CC2)cc1 10.1016/j.bmcl.2011.05.092
CHEMBL1807268 64050 None 0 Human Binding pKi = 9.3 9.3 26 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 497 9 2 4 4.1 COc1ccc(C[C@@H](NC(=O)C2(c3ccc(Cl)cc3)CC2)C(=O)N[C@H]2CC[C@H](N(C)C)CC2)cc1 10.1016/j.bmcl.2011.05.092
2200 3309 None 46 Human Binding pKi = 9.3 9.3 1 6
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm010544r
3482 3309 None 46 Human Binding pKi = 9.3 9.3 1 6
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm010544r
60943 3309 None 46 Human Binding pKi = 9.3 9.3 1 6
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm010544r
CHEMBL419667 3309 None 46 Human Binding pKi = 9.3 9.3 1 6
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm010544r
DB13929 3309 None 46 Human Binding pKi = 9.3 9.3 1 6
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm010544r
2200 3309 None 46 Human Binding pKi = 9.3 9.3 1 6
Displacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysisDisplacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysis
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/acs.jmedchem.8b01320
3482 3309 None 46 Human Binding pKi = 9.3 9.3 1 6
Displacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysisDisplacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysis
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/acs.jmedchem.8b01320
60943 3309 None 46 Human Binding pKi = 9.3 9.3 1 6
Displacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysisDisplacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysis
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/acs.jmedchem.8b01320
CHEMBL419667 3309 None 46 Human Binding pKi = 9.3 9.3 1 6
Displacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysisDisplacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysis
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/acs.jmedchem.8b01320
DB13929 3309 None 46 Human Binding pKi = 9.3 9.3 1 6
Displacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysisDisplacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysis
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/acs.jmedchem.8b01320
46890528 7030 None 0 Human Binding pKi = 9.3 9.3 199 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 411 3 0 2 6.4 COc1cc(-c2ccccc2C)c(Cl)cc1C(=O)N1C[C@]2(C)C[C@H]1CC(C)(C)C2 10.1016/j.bmcl.2010.04.068
CHEMBL1084825 7030 None 0 Human Binding pKi = 9.3 9.3 199 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 411 3 0 2 6.4 COc1cc(-c2ccccc2C)c(Cl)cc1C(=O)N1C[C@]2(C)C[C@H]1CC(C)(C)C2 10.1016/j.bmcl.2010.04.068
56680282 64041 None 0 Human Binding pKi = 9.3 9.3 21 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 490 10 2 4 3.0 CN1CCN(CCCNC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)Cc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807259 64041 None 0 Human Binding pKi = 9.3 9.3 21 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 490 10 2 4 3.0 CN1CCN(CCCNC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)Cc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.05.092
2168 3974 None 38 Human Binding pKi = 9.3 9.3 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 96-well plate cellsInhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 96-well plate cells
ChEMBL None None None None 10.1021/jm061404q
2810 3974 None 38 Human Binding pKi = 9.3 9.3 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 96-well plate cellsInhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 96-well plate cells
ChEMBL None None None None 10.1021/jm061404q
644077 3974 None 38 Human Binding pKi = 9.3 9.3 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 96-well plate cellsInhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 96-well plate cells
ChEMBL None None None None 10.1021/jm061404q
CHEMBL373742 3974 None 38 Human Binding pKi = 9.3 9.3 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 96-well plate cellsInhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 96-well plate cells
ChEMBL None None None None 10.1021/jm061404q
DB00067 3974 None 38 Human Binding pKi = 9.3 9.3 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 96-well plate cellsInhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 96-well plate cells
ChEMBL None None None None 10.1021/jm061404q
54586172 61909 None 0 Human Binding pKi = 9.3 9.3 7 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 485 7 3 3 4.2 O=C(N[C@@H]1C[C@@H]2CC[C@H](C1)N2)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C1(c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.02.096
CHEMBL1774024 61909 None 0 Human Binding pKi = 9.3 9.3 7 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 485 7 3 3 4.2 O=C(N[C@@H]1C[C@@H]2CC[C@H](C1)N2)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C1(c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.02.096
44297516 161289 None 0 Rat Binding pKi = 9.2 9.2 22 3
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1315 37 15 16 -2.2 CN(C(=O)Cc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL412192 161289 None 0 Rat Binding pKi = 9.2 9.2 22 3
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1315 37 15 16 -2.2 CN(C(=O)Cc1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
46890530 6734 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 391 3 0 2 6.0 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1c(C)cccc1C 10.1016/j.bmcl.2010.04.068
CHEMBL1083731 6734 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 391 3 0 2 6.0 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1c(C)cccc1C 10.1016/j.bmcl.2010.04.068
162655262 180744 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 426 2 0 5 5.3 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccc(Br)cc3CCC4)CC2)no1 10.1016/j.bmcl.2020.127417
CHEMBL4756031 180744 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 426 2 0 5 5.3 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccc(Br)cc3CCC4)CC2)no1 10.1016/j.bmcl.2020.127417
162655954 180765 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 465 3 0 3 5.3 Cc1ccccc1N1CCN(C(=O)N2C[C@@H](C(=O)C3CCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4756212 180765 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 465 3 0 3 5.3 Cc1ccccc1N1CCN(C(=O)N2C[C@@H](C(=O)C3CCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
162643927 181805 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 466 2 0 3 4.2 Cc1ccccc1N1CCN(C(=O)N2C[C@@H](C(=O)N3CCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127417
CHEMBL4778087 181805 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 466 2 0 3 4.2 Cc1ccccc1N1CCN(C(=O)N2C[C@@H](C(=O)N3CCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127417
162676448 183481 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 438 3 0 5 5.0 Brc1ccc2c(c1)CCCc1nnc([C@H]3CC[C@H](Oc4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
CHEMBL4799412 183481 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 438 3 0 5 5.0 Brc1ccc2c(c1)CCCc1nnc([C@H]3CC[C@H](Oc4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
57391220 70196 None 0 Human Binding pKi = 9.2 9.2 1862 2
Displacement of [3H]arginine-vasopressin from human Vasopressin V1a receptor after 30 mins by liquid scintillation counterDisplacement of [3H]arginine-vasopressin from human Vasopressin V1a receptor after 30 mins by liquid scintillation counter
ChEMBL 721 11 1 6 5.7 C[C@@H](NC(=O)[C@@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1cccc(F)c1)c1ccccc1 10.1016/j.bmc.2011.12.013
CHEMBL1940587 70196 None 0 Human Binding pKi = 9.2 9.2 1862 2
Displacement of [3H]arginine-vasopressin from human Vasopressin V1a receptor after 30 mins by liquid scintillation counterDisplacement of [3H]arginine-vasopressin from human Vasopressin V1a receptor after 30 mins by liquid scintillation counter
ChEMBL 721 11 1 6 5.7 C[C@@H](NC(=O)[C@@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1cccc(F)c1)c1ccccc1 10.1016/j.bmc.2011.12.013
56663268 64038 None 0 Human Binding pKi = 9.2 9.2 95 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 447 7 3 3 3.5 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)NC1CCCNCC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807256 64038 None 0 Human Binding pKi = 9.2 9.2 95 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 447 7 3 3 3.5 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)NC1CCCNCC1 10.1016/j.bmcl.2011.05.092
2205 4121 None 6 Human Binding pKi = 9.2 9.2 -1 5
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 648 6 1 4 7.2 CN(C1CCN(CC1)C(=O)/C=C\1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1)C 10.1021/jm010544r
9810140 4121 None 6 Human Binding pKi = 9.2 9.2 -1 5
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 648 6 1 4 7.2 CN(C1CCN(CC1)C(=O)/C=C\1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1)C 10.1021/jm010544r
CHEMBL307483 4121 None 6 Human Binding pKi = 9.2 9.2 -1 5
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 648 6 1 4 7.2 CN(C1CCN(CC1)C(=O)/C=C\1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1)C 10.1021/jm010544r
2205 4121 None 6 Rat Binding pKi = 9.2 9.2 1 5
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 648 6 1 4 7.2 CN(C1CCN(CC1)C(=O)/C=C\1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1)C 10.1016/s0960-894x(01)00723-5
9810140 4121 None 6 Rat Binding pKi = 9.2 9.2 1 5
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 648 6 1 4 7.2 CN(C1CCN(CC1)C(=O)/C=C\1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1)C 10.1016/s0960-894x(01)00723-5
CHEMBL307483 4121 None 6 Rat Binding pKi = 9.2 9.2 1 5
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 648 6 1 4 7.2 CN(C1CCN(CC1)C(=O)/C=C\1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1)C 10.1016/s0960-894x(01)00723-5
2213 518 None 46 Human Binding pKi = 9.2 9.2 28 5
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL None None None None 10.1021/jm050645f
3008 518 None 46 Human Binding pKi = 9.2 9.2 28 5
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL None None None None 10.1021/jm050645f
5311010 518 None 46 Human Binding pKi = 9.2 9.2 28 5
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL None None None None 10.1021/jm050645f
68613 518 None 46 Human Binding pKi = 9.2 9.2 28 5
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL None None None None 10.1021/jm050645f
CHEMBL378642 518 None 46 Human Binding pKi = 9.2 9.2 28 5
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL None None None None 10.1021/jm050645f
CHEMBL382301 518 None 46 Human Binding pKi = 9.2 9.2 28 5
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL None None None None 10.1021/jm050645f
DB09059 518 None 46 Human Binding pKi = 9.2 9.2 28 5
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL None None None None 10.1021/jm050645f
57394727 70197 None 0 Human Binding pKi = 9.2 9.2 2041 2
Displacement of [3H]arginine-vasopressin from human Vasopressin V1a receptor after 30 mins by liquid scintillation counterDisplacement of [3H]arginine-vasopressin from human Vasopressin V1a receptor after 30 mins by liquid scintillation counter
ChEMBL 717 11 1 6 5.9 Cc1cccc(/C=C/[C@@H]2[C@H](N3C(=O)OC[C@@H]3c3ccccc3)C(=O)N2[C@H](CC(=O)N2CCC(N3CCCCC3)CC2)C(=O)N[C@H](C)c2ccccc2)c1 10.1016/j.bmc.2011.12.013
CHEMBL1940588 70197 None 0 Human Binding pKi = 9.2 9.2 2041 2
Displacement of [3H]arginine-vasopressin from human Vasopressin V1a receptor after 30 mins by liquid scintillation counterDisplacement of [3H]arginine-vasopressin from human Vasopressin V1a receptor after 30 mins by liquid scintillation counter
ChEMBL 717 11 1 6 5.9 Cc1cccc(/C=C/[C@@H]2[C@H](N3C(=O)OC[C@@H]3c3ccccc3)C(=O)N2[C@H](CC(=O)N2CCC(N3CCCCC3)CC2)C(=O)N[C@H](C)c2ccccc2)c1 10.1016/j.bmc.2011.12.013
135413562 2203 None 15 Human Binding pKi = 9.2 9.2 -16 5
Displacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissue
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm901812z
2194 2203 None 15 Human Binding pKi = 9.2 9.2 -16 5
Displacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissue
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm901812z
CHEMBL445816 2203 None 15 Human Binding pKi = 9.2 9.2 -16 5
Displacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissue
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm901812z
11686429 98908 None 7 Human Binding pKi = 9.2 9.2 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 771 11 0 6 6.4 CN(Cc1cccc(C(F)(F)F)c1)C(=O)[C@@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL279328 98908 None 7 Human Binding pKi = 9.2 9.2 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 771 11 0 6 6.4 CN(Cc1cccc(C(F)(F)F)c1)C(=O)[C@@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
44428542 171733 None 0 Human Binding pKi = 9.2 9.2 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 737 12 1 6 6.1 O=C(NCc1cccc(Cl)c1)[C@H](CCC(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL446720 171733 None 0 Human Binding pKi = 9.2 9.2 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 737 12 1 6 6.1 O=C(NCc1cccc(Cl)c1)[C@H](CCC(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
56676960 64061 None 0 Human Binding pKi = 9.2 9.2 75 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 448 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)NC1CCCC(O)C1 10.1016/j.bmcl.2011.05.092
CHEMBL1807279 64061 None 0 Human Binding pKi = 9.2 9.2 75 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 448 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)NC1CCCC(O)C1 10.1016/j.bmcl.2011.05.092
145993846 167378 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysisDisplacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysis
ChEMBL 1179 19 15 14 -6.4 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1C[Se][Se]C[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.8b01320
CHEMBL4294901 167378 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysisDisplacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysis
ChEMBL 1179 19 15 14 -6.4 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1C[Se][Se]C[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.8b01320
2168 3974 None 38 Human Binding pKi = 9.2 9.2 -5 9
Displacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 mins
ChEMBL None None None None 10.1021/jm3006146
2810 3974 None 38 Human Binding pKi = 9.2 9.2 -5 9
Displacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 mins
ChEMBL None None None None 10.1021/jm3006146
644077 3974 None 38 Human Binding pKi = 9.2 9.2 -5 9
Displacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 mins
ChEMBL None None None None 10.1021/jm3006146
CHEMBL373742 3974 None 38 Human Binding pKi = 9.2 9.2 -5 9
Displacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 mins
ChEMBL None None None None 10.1021/jm3006146
DB00067 3974 None 38 Human Binding pKi = 9.2 9.2 -5 9
Displacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 mins
ChEMBL None None None None 10.1021/jm3006146
10615 572 None 32 Human Binding pKi = 9.2 9.2 -501 4
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1021/acs.jmedchem.1c00863
46200932 572 None 32 Human Binding pKi = 9.2 9.2 -501 4
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1021/acs.jmedchem.1c00863
CHEMBL4297183 572 None 32 Human Binding pKi = 9.2 9.2 -501 4
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1021/acs.jmedchem.1c00863
DB14823 572 None 32 Human Binding pKi = 9.2 9.2 -501 4
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1021/acs.jmedchem.1c00863
10615 572 None 32 Human Binding pKi = 9.2 9.2 -501 4
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1016/j.bmcl.2020.127416
10615 572 None 32 Human Binding pKi = 9.2 9.2 -501 4
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1016/j.bmcl.2020.127417
46200932 572 None 32 Human Binding pKi = 9.2 9.2 -501 4
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1016/j.bmcl.2020.127416
46200932 572 None 32 Human Binding pKi = 9.2 9.2 -501 4
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1016/j.bmcl.2020.127417
CHEMBL4297183 572 None 32 Human Binding pKi = 9.2 9.2 -501 4
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1016/j.bmcl.2020.127416
CHEMBL4297183 572 None 32 Human Binding pKi = 9.2 9.2 -501 4
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1016/j.bmcl.2020.127417
DB14823 572 None 32 Human Binding pKi = 9.2 9.2 -501 4
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1016/j.bmcl.2020.127416
DB14823 572 None 32 Human Binding pKi = 9.2 9.2 -501 4
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 10.1016/j.bmcl.2020.127417
162648487 179961 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 423 2 0 5 4.3 Brc1ccc2c(c1)CCCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
CHEMBL4746716 179961 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 423 2 0 5 4.3 Brc1ccc2c(c1)CCCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
162655215 180807 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 382 2 0 5 5.1 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccc(Cl)cc3CCC4)CC2)no1 10.1016/j.bmcl.2020.127417
CHEMBL4756737 180807 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 382 2 0 5 5.1 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccc(Cl)cc3CCC4)CC2)no1 10.1016/j.bmcl.2020.127417
2200 3309 None 46 Human Binding pKi = 9.2 9.2 1 6
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranes
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
3482 3309 None 46 Human Binding pKi = 9.2 9.2 1 6
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranes
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
60943 3309 None 46 Human Binding pKi = 9.2 9.2 1 6
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranes
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
CHEMBL419667 3309 None 46 Human Binding pKi = 9.2 9.2 1 6
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranes
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
DB13929 3309 None 46 Human Binding pKi = 9.2 9.2 1 6
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranes
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
46890101 7301 None 0 Human Binding pKi = 9.2 9.2 181 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 414 3 0 3 6.0 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1cccc2cccnc12 10.1016/j.bmcl.2010.04.068
CHEMBL1086070 7301 None 0 Human Binding pKi = 9.2 9.2 181 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 414 3 0 3 6.0 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1cccc2cccnc12 10.1016/j.bmcl.2010.04.068
2253 2229 None 20 Rat Binding pKi = 9.1 9.1 5 6
Displacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissue
ChEMBL 586 7 0 7 4.4 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)Cc1ccc[n+](c1C)[O-] 10.1021/jm901812z
5311202 2229 None 20 Rat Binding pKi = 9.1 9.1 5 6
Displacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissue
ChEMBL 586 7 0 7 4.4 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)Cc1ccc[n+](c1C)[O-] 10.1021/jm901812z
CHEMBL306645 2229 None 20 Rat Binding pKi = 9.1 9.1 5 6
Displacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissue
ChEMBL 586 7 0 7 4.4 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)Cc1ccc[n+](c1C)[O-] 10.1021/jm901812z
46890707 6725 None 0 Human Binding pKi = 9.1 9.1 19 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 419 3 0 3 6.6 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1csc2ccccc12 10.1016/j.bmcl.2010.04.068
CHEMBL1083703 6725 None 0 Human Binding pKi = 9.1 9.1 19 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 419 3 0 3 6.6 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1csc2ccccc12 10.1016/j.bmcl.2010.04.068
162676461 183510 None 0 Human Binding pKi = 9.1 9.1 707 2
Antagonist activity against human V1A receptor expressed in human 1321N1 cellsAntagonist activity against human V1A receptor expressed in human 1321N1 cells
ChEMBL 394 3 0 5 4.9 Clc1ccc2c(c1)CCCc1nnc([C@H]3CC[C@H](Oc4ccccn4)CC3)n1-2 10.1021/acs.jmedchem.1c01215
CHEMBL4799793 183510 None 0 Human Binding pKi = 9.1 9.1 707 2
Antagonist activity against human V1A receptor expressed in human 1321N1 cellsAntagonist activity against human V1A receptor expressed in human 1321N1 cells
ChEMBL 394 3 0 5 4.9 Clc1ccc2c(c1)CCCc1nnc([C@H]3CC[C@H](Oc4ccccn4)CC3)n1-2 10.1021/acs.jmedchem.1c01215
44400408 96701 None 0 Human Binding pKi = 9.1 9.1 - 1
Binding affinity against human vasopressin V1a receptor expressed in CHO cellsBinding affinity against human vasopressin V1a receptor expressed in CHO cells
ChEMBL 1474 38 15 15 -1.4 NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](Cc1ccc(C(=O)c2ccccc2)cc1)NC(=O)Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)c(I)c1)C(N)=O 10.1021/jm040871+
91936749 96701 None 0 Human Binding pKi = 9.1 9.1 - 1
Binding affinity against human vasopressin V1a receptor expressed in CHO cellsBinding affinity against human vasopressin V1a receptor expressed in CHO cells
ChEMBL 1474 38 15 15 -1.4 NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](Cc1ccc(C(=O)c2ccccc2)cc1)NC(=O)Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)c(I)c1)C(N)=O 10.1021/jm040871+
CHEMBL264101 96701 None 0 Human Binding pKi = 9.1 9.1 - 1
Binding affinity against human vasopressin V1a receptor expressed in CHO cellsBinding affinity against human vasopressin V1a receptor expressed in CHO cells
ChEMBL 1474 38 15 15 -1.4 NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](Cc1ccc(C(=O)c2ccccc2)cc1)NC(=O)Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)c(I)c1)C(N)=O 10.1021/jm040871+
46890654 7129 None 0 Human Binding pKi = 9.1 9.1 707 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 377 3 0 2 5.7 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1ccc(C)cc1 10.1016/j.bmcl.2010.04.068
CHEMBL1085299 7129 None 0 Human Binding pKi = 9.1 9.1 707 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 377 3 0 2 5.7 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1ccc(C)cc1 10.1016/j.bmcl.2010.04.068
44275447 96421 None 0 Human Binding pKi = 9.1 9.1 1 4
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1111 32 13 13 -3.6 CN(C(=O)Cc1ccccc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(N)=O 10.1021/jm9804782
CHEMBL262035 96421 None 0 Human Binding pKi = 9.1 9.1 1 4
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1111 32 13 13 -3.6 CN(C(=O)Cc1ccccc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(N)=O 10.1021/jm9804782
145981307 166675 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysisDisplacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysis
ChEMBL 1141 34 16 14 -3.1 COc1ccc(C[C@@H](NC(=O)CCc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)cc1 10.1021/acs.jmedchem.8b01320
CHEMBL4281963 166675 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysisDisplacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysis
ChEMBL 1141 34 16 14 -3.1 COc1ccc(C[C@@H](NC(=O)CCc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)cc1 10.1021/acs.jmedchem.8b01320
162676461 183510 None 0 Human Binding pKi = 9.1 9.1 707 2
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL 394 3 0 5 4.9 Clc1ccc2c(c1)CCCc1nnc([C@H]3CC[C@H](Oc4ccccn4)CC3)n1-2 10.1021/acs.jmedchem.1c00863
CHEMBL4799793 183510 None 0 Human Binding pKi = 9.1 9.1 707 2
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL 394 3 0 5 4.9 Clc1ccc2c(c1)CCCc1nnc([C@H]3CC[C@H](Oc4ccccn4)CC3)n1-2 10.1021/acs.jmedchem.1c00863
162676461 183510 None 0 Human Binding pKi = 9.1 9.1 707 2
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 394 3 0 5 4.9 Clc1ccc2c(c1)CCCc1nnc([C@H]3CC[C@H](Oc4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
CHEMBL4799793 183510 None 0 Human Binding pKi = 9.1 9.1 707 2
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 394 3 0 5 4.9 Clc1ccc2c(c1)CCCc1nnc([C@H]3CC[C@H](Oc4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
44428543 168884 None 0 Human Binding pKi = 9.1 9.1 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 739 12 1 6 5.7 O=C(NCc1cc(F)cc(F)c1)[C@H](CCC(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL438319 168884 None 0 Human Binding pKi = 9.1 9.1 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 739 12 1 6 5.7 O=C(NCc1cc(F)cc(F)c1)[C@H](CCC(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
2200 3309 None 46 Human Binding pKi = 9.1 9.1 1 6
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cellsInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cells
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
3482 3309 None 46 Human Binding pKi = 9.1 9.1 1 6
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cellsInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cells
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
60943 3309 None 46 Human Binding pKi = 9.1 9.1 1 6
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cellsInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cells
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
CHEMBL419667 3309 None 46 Human Binding pKi = 9.1 9.1 1 6
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cellsInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cells
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
DB13929 3309 None 46 Human Binding pKi = 9.1 9.1 1 6
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cellsInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cells
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
145981637 166491 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysisDisplacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysis
ChEMBL 1206 34 16 14 -4.3 COc1ccc(C[C@@H](NC(=O)C[Se]c2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)cc1 10.1021/acs.jmedchem.8b01320
CHEMBL4278500 166491 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysisDisplacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysis
ChEMBL 1206 34 16 14 -4.3 COc1ccc(C[C@@H](NC(=O)C[Se]c2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)cc1 10.1021/acs.jmedchem.8b01320
145986380 167091 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysisDisplacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysis
ChEMBL 1206 34 16 14 -3.8 COc1ccc(C[C@@H](NC(=O)CCc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2C[Se]C[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)cc1 10.1021/acs.jmedchem.8b01320
CHEMBL4289837 167091 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysisDisplacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysis
ChEMBL 1206 34 16 14 -3.8 COc1ccc(C[C@@H](NC(=O)CCc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2C[Se]C[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)cc1 10.1021/acs.jmedchem.8b01320
162671049 182818 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 703 11 1 6 5.6 C[C@H](NC(=O)[C@@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1)c1ccccc1 10.1016/j.bmcl.2020.127416
CHEMBL4790970 182818 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 703 11 1 6 5.6 C[C@H](NC(=O)[C@@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1)c1ccccc1 10.1016/j.bmcl.2020.127416
2200 3309 None 46 Human Binding pKi = 9.1 9.1 1 6
Displacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisDisplacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/acs.jmedchem.8b01320
3482 3309 None 46 Human Binding pKi = 9.1 9.1 1 6
Displacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisDisplacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/acs.jmedchem.8b01320
60943 3309 None 46 Human Binding pKi = 9.1 9.1 1 6
Displacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisDisplacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/acs.jmedchem.8b01320
CHEMBL419667 3309 None 46 Human Binding pKi = 9.1 9.1 1 6
Displacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisDisplacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/acs.jmedchem.8b01320
DB13929 3309 None 46 Human Binding pKi = 9.1 9.1 1 6
Displacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisDisplacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/acs.jmedchem.8b01320
44428544 149809 None 0 Human Binding pKi = 9.0 9.0 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 771 12 1 6 6.4 O=C(NCc1ccccc1C(F)(F)F)[C@H](CCC(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL394867 149809 None 0 Human Binding pKi = 9.0 9.0 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 771 12 1 6 6.4 O=C(NCc1ccccc1C(F)(F)F)[C@H](CCC(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
59657596 118664 None 31 Human Binding pKi = 9 9.0 16 2
Antagonist activity at human vasopressin 1a receptorAntagonist activity at human vasopressin 1a receptor
ChEMBL 437 4 0 4 4.5 CN(C)CCn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1021/acs.jmedchem.6b01437
CHEMBL3416885 118664 None 31 Human Binding pKi = 9 9.0 16 2
Antagonist activity at human vasopressin 1a receptorAntagonist activity at human vasopressin 1a receptor
ChEMBL 437 4 0 4 4.5 CN(C)CCn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1021/acs.jmedchem.6b01437
59657616 118647 None 0 Human Binding pKi = 9 9.0 40 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 506 3 0 5 3.7 CN1CCN(C(=O)Cn2cc(C(=O)N3CCC4(CC3)OCc3ccccc34)c3ccc(Cl)cc32)CC1 10.1021/jm501745f
CHEMBL3416868 118647 None 0 Human Binding pKi = 9 9.0 40 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 506 3 0 5 3.7 CN1CCN(C(=O)Cn2cc(C(=O)N3CCC4(CC3)OCc3ccccc34)c3ccc(Cl)cc32)CC1 10.1021/jm501745f
11993729 118662 None 0 Human Binding pKi = 9 9.0 12 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 463 3 0 4 5.1 CN1CCC[C@H]1Cn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1021/jm501745f
CHEMBL3416883 118662 None 0 Human Binding pKi = 9 9.0 12 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 463 3 0 4 5.1 CN1CCC[C@H]1Cn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1021/jm501745f
59657596 118664 None 31 Human Binding pKi = 9 9.0 16 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 437 4 0 4 4.5 CN(C)CCn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1021/jm501745f
CHEMBL3416885 118664 None 31 Human Binding pKi = 9 9.0 16 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 437 4 0 4 4.5 CN(C)CCn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1021/jm501745f
162658180 181059 None 0 Human Binding pKi = 9 9.0 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 466 2 0 3 4.9 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)C3CCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4759676 181059 None 0 Human Binding pKi = 9 9.0 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 466 2 0 3 4.9 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)C3CCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
10304617 206225 None 0 Human Binding pKi = 9 9.0 32 4
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 625 8 0 6 7.9 Cc1cccc(OCc2ccc(C(=O)N3CCC(N4CCCCC4)CC3)cc2)c1-n1c(C)nnc1-c1ccc(-c2ccccc2)cc1 10.1021/jm010544r
CHEMBL86667 206225 None 0 Human Binding pKi = 9 9.0 32 4
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 625 8 0 6 7.9 Cc1cccc(OCc2ccc(C(=O)N3CCC(N4CCCCC4)CC3)cc2)c1-n1c(C)nnc1-c1ccc(-c2ccccc2)cc1 10.1021/jm010544r
46890572 7356 None 0 Human Binding pKi = 9.0 9.0 1148 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 420 4 1 3 4.8 CNC(=O)c1cccc(-c2ccc(C(=O)N3C[C@]4(C)C[C@H]3CC(C)(C)C4)cc2OC)c1 10.1016/j.bmcl.2010.04.068
CHEMBL1086294 7356 None 0 Human Binding pKi = 9.0 9.0 1148 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 420 4 1 3 4.8 CNC(=O)c1cccc(-c2ccc(C(=O)N3C[C@]4(C)C[C@H]3CC(C)(C)C4)cc2OC)c1 10.1016/j.bmcl.2010.04.068
15416418 157137 None 0 Human Binding pKi = 9.0 9.0 8 2
Displacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting methodDisplacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting method
ChEMBL 400 3 2 3 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC[C@@H](O)c3ccccc32)cc1 10.1021/acs.jmedchem.7b00422
CHEMBL4075127 157137 None 0 Human Binding pKi = 9.0 9.0 8 2
Displacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting methodDisplacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting method
ChEMBL 400 3 2 3 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC[C@@H](O)c3ccccc32)cc1 10.1021/acs.jmedchem.7b00422
10164478 206683 None 0 Human Binding pKi = 9.0 9.0 16 4
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 509 11 0 6 6.1 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCCCN1CCN(C)CC1 10.1021/jm010544r
CHEMBL89552 206683 None 0 Human Binding pKi = 9.0 9.0 16 4
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 509 11 0 6 6.1 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCCCN1CCN(C)CC1 10.1021/jm010544r
10303620 206274 None 0 Human Binding pKi = 9.0 9.0 9 4
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 577 12 0 6 7.8 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCCCN1CCC(N2CCCCC2)CC1 10.1021/jm010544r
CHEMBL86949 206274 None 0 Human Binding pKi = 9.0 9.0 9 4
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 577 12 0 6 7.8 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCCCN1CCC(N2CCCCC2)CC1 10.1021/jm010544r
46890055 6449 None 0 Human Binding pKi = 9.0 9.0 2290 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 398 3 0 3 5.5 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1cccnc1Cl 10.1016/j.bmcl.2010.04.068
CHEMBL1082493 6449 None 0 Human Binding pKi = 9.0 9.0 2290 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 398 3 0 3 5.5 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1cccnc1Cl 10.1016/j.bmcl.2010.04.068
2168 3974 None 38 Human Binding pKi = 9.0 9.0 -5 9
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL None None None None 10.1021/jm1016208
2810 3974 None 38 Human Binding pKi = 9.0 9.0 -5 9
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL None None None None 10.1021/jm1016208
644077 3974 None 38 Human Binding pKi = 9.0 9.0 -5 9
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL None None None None 10.1021/jm1016208
CHEMBL373742 3974 None 38 Human Binding pKi = 9.0 9.0 -5 9
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL None None None None 10.1021/jm1016208
DB00067 3974 None 38 Human Binding pKi = 9.0 9.0 -5 9
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL None None None None 10.1021/jm1016208
57399933 70195 None 0 Human Binding pKi = 9.0 9.0 - 1
Displacement of [3H]arginine-vasopressin from human Vasopressin V1a receptor after 30 mins by liquid scintillation counterDisplacement of [3H]arginine-vasopressin from human Vasopressin V1a receptor after 30 mins by liquid scintillation counter
ChEMBL 829 11 1 6 6.2 C[C@@H](NC(=O)[C@@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1cccc(I)c1)c1ccccc1 10.1016/j.bmc.2011.12.013
CHEMBL1940586 70195 None 0 Human Binding pKi = 9.0 9.0 - 1
Displacement of [3H]arginine-vasopressin from human Vasopressin V1a receptor after 30 mins by liquid scintillation counterDisplacement of [3H]arginine-vasopressin from human Vasopressin V1a receptor after 30 mins by liquid scintillation counter
ChEMBL 829 11 1 6 6.2 C[C@@H](NC(=O)[C@@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1cccc(I)c1)c1ccccc1 10.1016/j.bmc.2011.12.013
44297449 169258 None 0 Rat Binding pKi = 9.0 9.0 1 3
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1315 37 15 16 -2.2 CN(C(=O)Cc1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL441195 169258 None 0 Rat Binding pKi = 9.0 9.0 1 3
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1315 37 15 16 -2.2 CN(C(=O)Cc1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
56683607 64056 None 0 Human Binding pKi = 9.0 9.0 61 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 459 8 2 3 3.7 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)Cc2ccc(F)cc2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807274 64056 None 0 Human Binding pKi = 9.0 9.0 61 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 459 8 2 3 3.7 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)Cc2ccc(F)cc2)CC1 10.1016/j.bmcl.2011.05.092
44428492 149764 None 0 Human Binding pKi = 9.0 9.0 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 780 12 2 6 6.2 NC1CC[N+](Cc2ccccc2)(C(=O)C[C@@H](C(=O)NCc2cccc(C(F)(F)F)c2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)CC1 10.1016/j.bmc.2006.12.031
CHEMBL394829 149764 None 0 Human Binding pKi = 9.0 9.0 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 780 12 2 6 6.2 NC1CC[N+](Cc2ccccc2)(C(=O)C[C@@H](C(=O)NCc2cccc(C(F)(F)F)c2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)CC1 10.1016/j.bmc.2006.12.031
44428569 152374 None 0 Human Binding pKi = 9.0 9.0 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 775 11 1 6 6.2 O=C(NCc1cccc(C(F)(F)F)c1F)[C@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL397025 152374 None 0 Human Binding pKi = 9.0 9.0 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 775 11 1 6 6.2 O=C(NCc1cccc(C(F)(F)F)c1F)[C@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
2168 3974 None 38 Human Binding pKi = 9.0 9.0 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 96-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
2810 3974 None 38 Human Binding pKi = 9.0 9.0 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 96-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
644077 3974 None 38 Human Binding pKi = 9.0 9.0 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 96-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
CHEMBL373742 3974 None 38 Human Binding pKi = 9.0 9.0 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 96-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
DB00067 3974 None 38 Human Binding pKi = 9.0 9.0 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 96-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
24896178 92017 None 0 Human Binding pKi = 8.9 8.9 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 771 12 1 6 6.3 O=C(NCc1cccc(C(F)(F)F)c1)C(C(=O)N1CCC(CCN2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL241826 92017 None 0 Human Binding pKi = 8.9 8.9 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 771 12 1 6 6.3 O=C(NCc1cccc(C(F)(F)F)c1)C(C(=O)N1CCC(CCN2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
44428520 166465 None 0 Human Binding pKi = 8.9 8.9 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 793 14 1 6 6.3 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CCC(=O)N1CCN(CCc2ccccc2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL427810 166465 None 0 Human Binding pKi = 8.9 8.9 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 793 14 1 6 6.3 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CCC(=O)N1CCN(CCc2ccccc2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
44428529 152300 None 0 Human Binding pKi = 8.9 8.9 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 731 13 1 6 5.5 CCCN1CCN(C(=O)CC[C@@H](C(=O)NCc2cccc(C(F)(F)F)c2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)CC1 10.1016/j.bmc.2006.12.031
CHEMBL396955 152300 None 0 Human Binding pKi = 8.9 8.9 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 731 13 1 6 5.5 CCCN1CCN(C(=O)CC[C@@H](C(=O)NCc2cccc(C(F)(F)F)c2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)CC1 10.1016/j.bmc.2006.12.031
44428551 93064 None 0 Human Binding pKi = 8.9 8.9 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 771 11 1 6 6.6 C[C@@H](NC(=O)[C@@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1)c1cccc(C(F)(F)F)c1 10.1016/j.bmc.2006.12.031
CHEMBL244243 93064 None 0 Human Binding pKi = 8.9 8.9 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 771 11 1 6 6.6 C[C@@H](NC(=O)[C@@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1)c1cccc(C(F)(F)F)c1 10.1016/j.bmc.2006.12.031
44275137 157239 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1525 36 12 20 1.8 CN(C)c1ccc2c(c1)Oc1cc(N(C)C)ccc1C21OC(=O)c2cc(C(=O)N(C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccc(O)cc3)N(C)C(=O)CCc3ccc(O)cc3)[C@@H](CCCCN)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)ccc21 10.1021/jm9804782
91931058 157239 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1525 36 12 20 1.8 CN(C)c1ccc2c(c1)Oc1cc(N(C)C)ccc1C21OC(=O)c2cc(C(=O)N(C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccc(O)cc3)N(C)C(=O)CCc3ccc(O)cc3)[C@@H](CCCCN)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)ccc21 10.1021/jm9804782
CHEMBL407644 157239 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1525 36 12 20 1.8 CN(C)c1ccc2c(c1)Oc1cc(N(C)C)ccc1C21OC(=O)c2cc(C(=O)N(C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccc(O)cc3)N(C)C(=O)CCc3ccc(O)cc3)[C@@H](CCCCN)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)ccc21 10.1021/jm9804782
2168 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 384-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
2810 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 384-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
644077 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 384-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
CHEMBL373742 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 384-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
DB00067 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by fluorescent binding assay using 384-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
2168 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cellsInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cells
ChEMBL None None None None 10.1021/jm061404q
2810 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cellsInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cells
ChEMBL None None None None 10.1021/jm061404q
644077 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cellsInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cells
ChEMBL None None None None 10.1021/jm061404q
CHEMBL373742 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cellsInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cells
ChEMBL None None None None 10.1021/jm061404q
DB00067 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cellsInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate cells
ChEMBL None None None None 10.1021/jm061404q
56680285 64054 None 0 Rat Binding pKi = 8.9 8.9 -37 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 513 8 2 3 5.0 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)C2(c3ccc(F)cc3)CCCC2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807272 64054 None 0 Rat Binding pKi = 8.9 8.9 -37 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 513 8 2 3 5.0 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)C2(c3ccc(F)cc3)CCCC2)CC1 10.1016/j.bmcl.2011.05.092
162660856 181867 None 0 Human Binding pKi = 8.9 8.9 - 1
Antagonist activity against human V1A receptor expressed in human 1321N1 cellsAntagonist activity against human V1A receptor expressed in human 1321N1 cells
ChEMBL 379 2 0 5 4.2 Clc1ccc2c(c1)CCCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1021/acs.jmedchem.1c01215
CHEMBL4778839 181867 None 0 Human Binding pKi = 8.9 8.9 - 1
Antagonist activity against human V1A receptor expressed in human 1321N1 cellsAntagonist activity against human V1A receptor expressed in human 1321N1 cells
ChEMBL 379 2 0 5 4.2 Clc1ccc2c(c1)CCCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1021/acs.jmedchem.1c01215
57978135 118661 None 0 Human Binding pKi = 8.9 8.9 89 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 449 3 1 4 4.7 O=C(c1cn(C[C@@H]2CCCN2)c2cc(Cl)ccc12)N1CCC2(CC1)OCc1ccccc12 10.1021/jm501745f
CHEMBL3416882 118661 None 0 Human Binding pKi = 8.9 8.9 89 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 449 3 1 4 4.7 O=C(c1cn(C[C@@H]2CCCN2)c2cc(Cl)ccc12)N1CCC2(CC1)OCc1ccccc12 10.1021/jm501745f
162652318 180320 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 356 2 1 4 3.4 O=C(C1CCN(c2ccccn2)CC1)N1CCNc2cc(Cl)ccc21 10.1016/j.bmcl.2020.127417
CHEMBL4751140 180320 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 356 2 1 4 3.4 O=C(C1CCN(c2ccccn2)CC1)N1CCNc2cc(Cl)ccc21 10.1016/j.bmcl.2020.127417
162660856 181867 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 379 2 0 5 4.2 Clc1ccc2c(c1)CCCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
CHEMBL4778839 181867 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 379 2 0 5 4.2 Clc1ccc2c(c1)CCCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
71461726 79690 None 0 Rat Binding pKi = 8.9 8.9 257 2
Inhibition of the 3 nM VP stimulation of phospholipase-C in cultured WRK cells was used as a V1-mediated assay (Vasopressin V1 receptor)Inhibition of the 3 nM VP stimulation of phospholipase-C in cultured WRK cells was used as a V1-mediated assay (Vasopressin V1 receptor)
ChEMBL 1186 20 11 15 0.9 COc1ccc(C[C@@H]2NC(=O)C3(CCCC3)CSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00079a020
CHEMBL2115369 79690 None 0 Rat Binding pKi = 8.9 8.9 257 2
Inhibition of the 3 nM VP stimulation of phospholipase-C in cultured WRK cells was used as a V1-mediated assay (Vasopressin V1 receptor)Inhibition of the 3 nM VP stimulation of phospholipase-C in cultured WRK cells was used as a V1-mediated assay (Vasopressin V1 receptor)
ChEMBL 1186 20 11 15 0.9 COc1ccc(C[C@@H]2NC(=O)C3(CCCC3)CSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00079a020
2200 3309 None 46 Rat Binding pKi = 8.9 8.9 -1 6
Binding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liverBinding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liver
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm010544r
3482 3309 None 46 Rat Binding pKi = 8.9 8.9 -1 6
Binding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liverBinding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liver
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm010544r
60943 3309 None 46 Rat Binding pKi = 8.9 8.9 -1 6
Binding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liverBinding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liver
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm010544r
CHEMBL419667 3309 None 46 Rat Binding pKi = 8.9 8.9 -1 6
Binding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liverBinding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liver
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm010544r
DB13929 3309 None 46 Rat Binding pKi = 8.9 8.9 -1 6
Binding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liverBinding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liver
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm010544r
44428522 161011 None 0 Human Binding pKi = 8.8 8.8 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 771 12 1 6 6.4 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CCC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL411629 161011 None 0 Human Binding pKi = 8.8 8.8 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 771 12 1 6 6.4 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CCC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
10208389 78629 None 0 Human Binding pKi = 8.8 8.8 70 4
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 523 11 0 6 6.4 Cc1cccc(OCCCCCCN2CCN(C)CC2)c1-n1c(C)nnc1-c1ccc(-c2ccccc2)cc1 10.1021/jm010544r
CHEMBL2112339 78629 None 0 Human Binding pKi = 8.8 8.8 70 4
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 523 11 0 6 6.4 Cc1cccc(OCCCCCCN2CCN(C)CC2)c1-n1c(C)nnc1-c1ccc(-c2ccccc2)cc1 10.1021/jm010544r
2200 3309 None 46 Human Binding pKi = 8.8 8.8 1 6
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranes
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
3482 3309 None 46 Human Binding pKi = 8.8 8.8 1 6
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranes
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
60943 3309 None 46 Human Binding pKi = 8.8 8.8 1 6
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranes
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
CHEMBL419667 3309 None 46 Human Binding pKi = 8.8 8.8 1 6
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranes
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
DB13929 3309 None 46 Human Binding pKi = 8.8 8.8 1 6
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 384-well plate membranes
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/jm061404q
11513323 142886 None 0 Human Binding pKi = 8.8 8.8 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 757 11 1 6 6.0 O=C(NCc1cccc(C(F)(F)F)c1)[C@@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL389359 142886 None 0 Human Binding pKi = 8.8 8.8 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 757 11 1 6 6.0 O=C(NCc1cccc(C(F)(F)F)c1)[C@@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL2369839 209702 None 0 Human Binding pKi = 8.8 8.8 1 4
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL None None None NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
2168 3974 None 38 Human Binding pKi = 8.8 8.8 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
2810 3974 None 38 Human Binding pKi = 8.8 8.8 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
644077 3974 None 38 Human Binding pKi = 8.8 8.8 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
CHEMBL373742 3974 None 38 Human Binding pKi = 8.8 8.8 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
DB00067 3974 None 38 Human Binding pKi = 8.8 8.8 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 96-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
2168 3974 None 38 Rat Binding pKi = 8.8 8.8 -8 9
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL None None None None 10.1021/jm060928n
2810 3974 None 38 Rat Binding pKi = 8.8 8.8 -8 9
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL None None None None 10.1021/jm060928n
644077 3974 None 38 Rat Binding pKi = 8.8 8.8 -8 9
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL None None None None 10.1021/jm060928n
CHEMBL373742 3974 None 38 Rat Binding pKi = 8.8 8.8 -8 9
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL None None None None 10.1021/jm060928n
DB00067 3974 None 38 Rat Binding pKi = 8.8 8.8 -8 9
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL None None None None 10.1021/jm060928n
10715974 11920 None 0 Human Binding pKi = 8.8 8.8 4 2
Displacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting methodDisplacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting method
ChEMBL 400 3 2 3 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3ccccc32)cc1 10.1021/acs.jmedchem.7b00422
CHEMBL118271 11920 None 0 Human Binding pKi = 8.8 8.8 4 2
Displacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting methodDisplacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting method
ChEMBL 400 3 2 3 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3ccccc32)cc1 10.1021/acs.jmedchem.7b00422
162667087 182437 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 348 2 0 5 4.5 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccccc3CCC4)CC2)no1 10.1016/j.bmcl.2020.127417
CHEMBL4786172 182437 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 348 2 0 5 4.5 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccccc3CCC4)CC2)no1 10.1016/j.bmcl.2020.127417
54587189 61907 None 0 Human Binding pKi = 8.8 8.8 33 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 499 7 2 3 4.5 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C1(c3ccc(Cl)cc3)CC1)C2 10.1016/j.bmcl.2011.02.096
CHEMBL1774022 61907 None 0 Human Binding pKi = 8.8 8.8 33 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 499 7 2 3 4.5 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C1(c3ccc(Cl)cc3)CC1)C2 10.1016/j.bmcl.2011.02.096
56676958 64049 None 0 Rat Binding pKi = 8.8 8.8 -42 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 501 8 2 3 4.7 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)C2(c3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807267 64049 None 0 Rat Binding pKi = 8.8 8.8 -42 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 501 8 2 3 4.7 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)C2(c3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2011.05.092
70685417 73647 None 0 Prairie vole Binding pKi = 8.8 8.8 5 4
Displacement of [125I]-LVA from prairie vole vasopressin V1A receptor after 72 hrsDisplacement of [125I]-LVA from prairie vole vasopressin V1A receptor after 72 hrs
ChEMBL 707 9 0 6 4.3 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OC/C=C/I)c2)CC1 10.1016/j.bmc.2012.02.019
CHEMBL2017867 73647 None 0 Prairie vole Binding pKi = 8.8 8.8 5 4
Displacement of [125I]-LVA from prairie vole vasopressin V1A receptor after 72 hrsDisplacement of [125I]-LVA from prairie vole vasopressin V1A receptor after 72 hrs
ChEMBL 707 9 0 6 4.3 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OC/C=C/I)c2)CC1 10.1016/j.bmc.2012.02.019
145993846 167378 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisDisplacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 1179 19 15 14 -6.4 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1C[Se][Se]C[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.8b01320
CHEMBL4294901 167378 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisDisplacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 1179 19 15 14 -6.4 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1C[Se][Se]C[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.8b01320
56666703 64063 None 0 Human Binding pKi = 8.8 8.8 72 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 448 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H]1CC[C@@H](O)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807280 64063 None 0 Human Binding pKi = 8.8 8.8 72 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 448 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H]1CC[C@@H](O)CC1 10.1016/j.bmcl.2011.05.092
15416417 159741 None 0 Human Binding pKi = 8.7 8.7 2 2
Displacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting methodDisplacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting method
ChEMBL 400 3 2 3 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC[C@H](O)c3ccccc32)cc1 10.1021/acs.jmedchem.7b00422
CHEMBL4104877 159741 None 0 Human Binding pKi = 8.7 8.7 2 2
Displacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting methodDisplacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting method
ChEMBL 400 3 2 3 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC[C@H](O)c3ccccc32)cc1 10.1021/acs.jmedchem.7b00422
15976308 149766 None 0 Human Binding pKi = 8.7 8.7 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 757 11 1 6 6.0 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL394830 149766 None 0 Human Binding pKi = 8.7 8.7 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 757 11 1 6 6.0 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
71458135 79687 None 0 Rat Binding pKi = 8.7 8.7 123 2
Inhibition of the 3 nM VP stimulation of phospholipase-C in cultured WRK cells was used as a V1-mediated assayInhibition of the 3 nM VP stimulation of phospholipase-C in cultured WRK cells was used as a V1-mediated assay
ChEMBL 1171 20 11 15 1.3 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)C(C)(C)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
CHEMBL2115364 79687 None 0 Rat Binding pKi = 8.7 8.7 123 2
Inhibition of the 3 nM VP stimulation of phospholipase-C in cultured WRK cells was used as a V1-mediated assayInhibition of the 3 nM VP stimulation of phospholipase-C in cultured WRK cells was used as a V1-mediated assay
ChEMBL 1171 20 11 15 1.3 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)C(C)(C)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00079a020
44428531 169034 None 0 Human Binding pKi = 8.7 8.7 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 785 13 1 6 6.7 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CCC(=O)N1CCC(CN2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL439462 169034 None 0 Human Binding pKi = 8.7 8.7 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 785 13 1 6 6.7 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CCC(=O)N1CCC(CN2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
54581530 62379 None 0 Human Binding pKi = 8 8.0 -331 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 666 9 0 8 4.5 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN4CCCC4)ccc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
CHEMBL1779409 62379 None 0 Human Binding pKi = 8 8.0 -331 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 666 9 0 8 4.5 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN4CCCC4)ccc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
24894462 152581 None 0 Human Binding pKi = 8.0 8.0 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 745 14 1 6 5.9 CCCCN1CCN(C(=O)CC[C@H](C(=O)NCc2cccc(C(F)(F)F)c2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)CC1 10.1016/j.bmc.2006.12.031
CHEMBL397186 152581 None 0 Human Binding pKi = 8.0 8.0 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 745 14 1 6 5.9 CCCCN1CCN(C(=O)CC[C@H](C(=O)NCc2cccc(C(F)(F)F)c2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)CC1 10.1016/j.bmc.2006.12.031
16051933 138128 None 4 Rat Binding pKi = 8.0 8.0 -53 8
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1068 19 14 15 -4.1 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL376685 138128 None 4 Rat Binding pKi = 8.0 8.0 -53 8
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1068 19 14 15 -4.1 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
DB00035 138128 None 4 Rat Binding pKi = 8.0 8.0 -53 8
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1068 19 14 15 -4.1 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
56673645 64040 None 0 Human Binding pKi = 8.0 8.0 17 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 447 7 2 3 3.5 CN1CCC(NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)Cc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807258 64040 None 0 Human Binding pKi = 8.0 8.0 17 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 447 7 2 3 3.5 CN1CCC(NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)Cc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.05.092
162670083 182747 None 0 Human Binding pKi = 7 7.0 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 380 2 0 5 5.2 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccc(Cl)cc3C3CC43)CC2)no1 10.1016/j.bmcl.2020.127417
CHEMBL4790066 182747 None 0 Human Binding pKi = 7 7.0 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 380 2 0 5 5.2 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccc(Cl)cc3C3CC43)CC2)no1 10.1016/j.bmcl.2020.127417
2181 1330 None 42 Rat Binding pKi = 7 7.0 -645 7
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL None None None None 10.1021/jm060928n
2182 1330 None 42 Rat Binding pKi = 7 7.0 -645 7
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL None None None None 10.1021/jm060928n
27991 1330 None 42 Rat Binding pKi = 7 7.0 -645 7
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL None None None None 10.1021/jm060928n
CHEMBL1429 1330 None 42 Rat Binding pKi = 7 7.0 -645 7
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL None None None None 10.1021/jm060928n
CHEMBL264448 1330 None 42 Rat Binding pKi = 7 7.0 -645 7
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL None None None None 10.1021/jm060928n
DB00035 1330 None 42 Rat Binding pKi = 7 7.0 -645 7
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL None None None None 10.1021/jm060928n
44325345 111560 None 0 Human Binding pKi = 7 7.0 -75 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 493 3 1 4 4.9 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2C[C@H]3COCCN3Cc3ccccc32)c(Cl)c1 10.1016/j.bmcl.2004.03.083
CHEMBL328079 111560 None 0 Human Binding pKi = 7 7.0 -75 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 493 3 1 4 4.9 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2C[C@H]3COCCN3Cc3ccccc32)c(Cl)c1 10.1016/j.bmcl.2004.03.083
16109440 161614 None 0 Rat Binding pKi = 6 6.0 -3981 4
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 997 16 11 14 -2.3 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL412973 161614 None 0 Rat Binding pKi = 6 6.0 -3981 4
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 997 16 11 14 -2.3 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
54584478 62376 None 0 Human Binding pKi = 7 7.0 -1258 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 666 9 0 8 4.5 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3ccc(CN4CCCC4)cc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
CHEMBL1779406 62376 None 0 Human Binding pKi = 7 7.0 -1258 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 666 9 0 8 4.5 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3ccc(CN4CCCC4)cc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
15951937 118641 None 0 Mouse Binding pKi = 6 6.0 -251 3
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 366 1 1 2 4.5 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)OCc1ccccc12 10.1021/jm501745f
CHEMBL3416861 118641 None 0 Mouse Binding pKi = 6 6.0 -251 3
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 366 1 1 2 4.5 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)OCc1ccccc12 10.1021/jm501745f
24997177 118649 None 0 Mouse Binding pKi = 6.0 6.0 -204 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 367 1 1 3 3.9 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)OCc1cccnc12 10.1021/jm501745f
CHEMBL3416870 118649 None 0 Mouse Binding pKi = 6.0 6.0 -204 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 367 1 1 3 3.9 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)OCc1cccnc12 10.1021/jm501745f
10208389 78629 None 0 Rat Binding pKi = 7.0 7.0 -70 4
Binding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liverBinding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liver
ChEMBL 523 11 0 6 6.4 Cc1cccc(OCCCCCCN2CCN(C)CC2)c1-n1c(C)nnc1-c1ccc(-c2ccccc2)cc1 10.1021/jm010544r
CHEMBL2112339 78629 None 0 Rat Binding pKi = 7.0 7.0 -70 4
Binding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liverBinding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liver
ChEMBL 523 11 0 6 6.4 Cc1cccc(OCCCCCCN2CCN(C)CC2)c1-n1c(C)nnc1-c1ccc(-c2ccccc2)cc1 10.1021/jm010544r
448537 160248 None 89 Human Binding pKi = 5.0 5.0 -45 25
DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
CHEMBL411 160248 None 89 Human Binding pKi = 5.0 5.0 -45 25
DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
46890054 6917 None 0 Human Binding pKi = 7.0 7.0 19 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 443 4 0 3 6.6 COc1ccc2cc(-c3ccc(C(=O)N4C[C@]5(C)C[C@H]4CC(C)(C)C5)cc3OC)ccc2c1 10.1016/j.bmcl.2010.04.068
CHEMBL1084386 6917 None 0 Human Binding pKi = 7.0 7.0 19 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 443 4 0 3 6.6 COc1ccc2cc(-c3ccc(C(=O)N4C[C@]5(C)C[C@H]4CC(C)(C)C5)cc3OC)ccc2c1 10.1016/j.bmcl.2010.04.068
145959348 161983 None 0 Human Binding pKi = 6.0 6.0 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 566 8 1 8 5.0 COc1cc(CN2CCN(c3ccccc3CCC(=O)N3Cc4cnn(C)c4Nc4ccccc43)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
CHEMBL4159182 161983 None 0 Human Binding pKi = 6.0 6.0 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 566 8 1 8 5.0 COc1cc(CN2CCN(c3ccccc3CCC(=O)N3Cc4cnn(C)c4Nc4ccccc43)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
56664849 63222 None 0 Human Binding pKi = 7.0 7.0 -426 3
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1308 18 14 20 0.2 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
CHEMBL1790721 63222 None 0 Human Binding pKi = 7.0 7.0 -426 3
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1308 18 14 20 0.2 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
145977918 163894 None 1 Human Binding pKi = 6.0 6.0 - 1
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 308 2 1 2 3.6 CC(=O)Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/acs.jmedchem.8b00697
CHEMBL4207120 163894 None 1 Human Binding pKi = 6.0 6.0 - 1
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 308 2 1 2 3.6 CC(=O)Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/acs.jmedchem.8b00697
54581266 61887 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 481 10 2 5 2.8 COc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)NCCN(C)C)c(C)c1C 10.1016/j.bmcl.2011.02.096
CHEMBL1774002 61887 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 481 10 2 5 2.8 COc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)NCCN(C)C)c(C)c1C 10.1016/j.bmcl.2011.02.096
46890484 7027 None 0 Human Binding pKi = 8.0 8.0 93 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 381 2 0 1 6.4 Cc1ccccc1-c1ccc(C(=O)N2C[C@@]3(C)C[C@@H]2CC(C)(C)C3)c(Cl)c1 10.1016/j.bmcl.2010.04.068
CHEMBL1084822 7027 None 0 Human Binding pKi = 8.0 8.0 93 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 381 2 0 1 6.4 Cc1ccccc1-c1ccc(C(=O)N2C[C@@]3(C)C[C@@H]2CC(C)(C)C3)c(Cl)c1 10.1016/j.bmcl.2010.04.068
CHEMBL5071635 214263 None 0 Human Binding pKi = 8.0 8.0 - 1
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL None None None Cc1cccc2c1-n1c(nnc1[C@H]1CC[C@H](Oc3ccccn3)CC1)C[C@H](O)C2 10.1021/acs.jmedchem.1c00863
118734429 118663 None 0 Mouse Binding pKi = 8.0 8.0 -2 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 463 2 0 4 5.2 CN1CCC(n2cc(C(=O)N3CCC4(CC3)OCc3ccccc34)c3ccc(Cl)cc32)CC1 10.1021/jm501745f
CHEMBL3416884 118663 None 0 Mouse Binding pKi = 8.0 8.0 -2 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 463 2 0 4 5.2 CN1CCC(n2cc(C(=O)N3CCC4(CC3)OCc3ccccc34)c3ccc(Cl)cc32)CC1 10.1021/jm501745f
44419025 84294 None 0 Human Binding pKi = 7.9 7.9 -45 8
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
CHEMBL221436 84294 None 0 Human Binding pKi = 7.9 7.9 -45 8
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
56657868 63219 None 0 Human Binding pKi = 7.9 7.9 -69 3
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1297 16 15 21 -0.8 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
CHEMBL1790719 63219 None 0 Human Binding pKi = 7.9 7.9 -69 3
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1297 16 15 21 -0.8 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
2249 2225 None 18 Rat Binding pKi = 7.0 7.0 -30 6
Displacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissue
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1021/jm901812z
9872389 2225 None 18 Rat Binding pKi = 7.0 7.0 -30 6
Displacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissue
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1021/jm901812z
CHEMBL1253853 2225 None 18 Rat Binding pKi = 7.0 7.0 -30 6
Displacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissue
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1021/jm901812z
44325579 111925 None 0 Human Binding pKi = 7.0 7.0 -33 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 535 4 2 5 5.9 O=C(Nc1ccc(C(=O)N2CC3CSCCN3Cc3ccccc32)c(O)c1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL328791 111925 None 0 Human Binding pKi = 7.0 7.0 -33 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 535 4 2 5 5.9 O=C(Nc1ccc(C(=O)N2CC3CSCCN3Cc3ccccc32)c(O)c1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
44325558 112567 None 0 Human Binding pKi = 5.0 5.0 -1096 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 553 4 2 5 5.8 O=C(Nc1ccc(C(=O)N2C[C@H]3COCCN3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1cccc(O)c1 10.1016/j.bmcl.2004.03.083
CHEMBL330094 112567 None 0 Human Binding pKi = 5.0 5.0 -1096 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 553 4 2 5 5.8 O=C(Nc1ccc(C(=O)N2C[C@H]3COCCN3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1cccc(O)c1 10.1016/j.bmcl.2004.03.083
135461396 79063 None 0 Human Binding pKi = 6.0 6.0 -3 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 626 13 2 8 2.2 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)N(CC(N)=O)c3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113196 79063 None 0 Human Binding pKi = 6.0 6.0 -3 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 626 13 2 8 2.2 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)N(CC(N)=O)c3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
46890185 7201 None 0 Human Binding pKi = 7.0 7.0 -5 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 549 3 0 2 10.1 CC1(C)C[C@@H]2C[C@@](C)(CN2C(=O)c2ccc(-c3ccc(-c4csc5ccccc45)c4ccccc34)cc2Cl)C1 10.1016/j.bmcl.2010.04.068
CHEMBL1085624 7201 None 0 Human Binding pKi = 7.0 7.0 -5 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 549 3 0 2 10.1 CC1(C)C[C@@H]2C[C@@](C)(CN2C(=O)c2ccc(-c3ccc(-c4csc5ccccc45)c4ccccc34)cc2Cl)C1 10.1016/j.bmcl.2010.04.068
54581267 61889 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 507 8 2 5 3.4 COc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)NC2CCN(C)CC2)c(C)c1C 10.1016/j.bmcl.2011.02.096
CHEMBL1774004 61889 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 507 8 2 5 3.4 COc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)NC2CCN(C)CC2)c(C)c1C 10.1016/j.bmcl.2011.02.096
11683187 199930 None 44 Human Binding pKi = 6.0 6.0 -117 5
Displacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uMDisplacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uM
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/jm901812z
CHEMBL594828 199930 None 44 Human Binding pKi = 6.0 6.0 -117 5
Displacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uMDisplacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uM
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/jm901812z
45483204 197885 None 0 Human Binding pKi = 6.0 6.0 -11 5
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL1204126 197885 None 0 Human Binding pKi = 6.0 6.0 -11 5
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL1204403 197885 None 0 Human Binding pKi = 6.0 6.0 -11 5
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL572709 197885 None 0 Human Binding pKi = 6.0 6.0 -11 5
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
135506374 137898 None 23 Human Binding pKi = 7.0 7.0 1 3
Binding affinity to vasopressin 1a receptor (unknown origin)Binding affinity to vasopressin 1a receptor (unknown origin)
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2015.11.050
CHEMBL3763342 137898 None 23 Human Binding pKi = 7.0 7.0 1 3
Binding affinity to vasopressin 1a receptor (unknown origin)Binding affinity to vasopressin 1a receptor (unknown origin)
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2015.11.050
135506374 137898 None 23 Human Binding pKi = 7.0 7.0 1 3
Displacement of [3H]-vasopressin from V1A receptor (unknown origin) expressed in HEK293 cell membranes incubated for 60 minsDisplacement of [3H]-vasopressin from V1A receptor (unknown origin) expressed in HEK293 cell membranes incubated for 60 mins
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL3763342 137898 None 23 Human Binding pKi = 7.0 7.0 1 3
Displacement of [3H]-vasopressin from V1A receptor (unknown origin) expressed in HEK293 cell membranes incubated for 60 minsDisplacement of [3H]-vasopressin from V1A receptor (unknown origin) expressed in HEK293 cell membranes incubated for 60 mins
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
56666702 64059 None 0 Rat Binding pKi = 6.9 6.9 -57 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 422 9 3 3 3.2 CC(O)CCNC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1 10.1016/j.bmcl.2011.05.092
CHEMBL1807277 64059 None 0 Rat Binding pKi = 6.9 6.9 -57 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 422 9 3 3 3.2 CC(O)CCNC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1 10.1016/j.bmcl.2011.05.092
44314536 204998 None 0 Rat Binding pKi = 5.9 5.9 1 2
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 620 8 1 6 7.0 Cc1occc1C(=O)Nc1ccc(C(=O)N(C)c2ccccc2Oc2ccccc2C(=O)N2CCC(N3CCCCC3)CC2)cc1 10.1016/s0960-894x(01)00723-5
CHEMBL76763 204998 None 0 Rat Binding pKi = 5.9 5.9 1 2
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 620 8 1 6 7.0 Cc1occc1C(=O)Nc1ccc(C(=O)N(C)c2ccccc2Oc2ccccc2C(=O)N2CCC(N3CCCCC3)CC2)cc1 10.1016/s0960-894x(01)00723-5
44400360 169030 None 0 Human Binding pKi = 6.9 6.9 - 1
Binding affinity against human vasopressin V1a receptor expressed in CHO cellsBinding affinity against human vasopressin V1a receptor expressed in CHO cells
ChEMBL 1519 40 15 17 -1.1 COc1ccc(C[C@@H](NC(=O)CNC(=O)c2ccc(C(=O)c3ccccc3)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc(O)c(I)c2)C(N)=O)cc1 10.1021/jm040871+
91936754 169030 None 0 Human Binding pKi = 6.9 6.9 - 1
Binding affinity against human vasopressin V1a receptor expressed in CHO cellsBinding affinity against human vasopressin V1a receptor expressed in CHO cells
ChEMBL 1519 40 15 17 -1.1 COc1ccc(C[C@@H](NC(=O)CNC(=O)c2ccc(C(=O)c3ccccc3)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc(O)c(I)c2)C(N)=O)cc1 10.1021/jm040871+
CHEMBL439430 169030 None 0 Human Binding pKi = 6.9 6.9 - 1
Binding affinity against human vasopressin V1a receptor expressed in CHO cellsBinding affinity against human vasopressin V1a receptor expressed in CHO cells
ChEMBL 1519 40 15 17 -1.1 COc1ccc(C[C@@H](NC(=O)CNC(=O)c2ccc(C(=O)c3ccccc3)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc(O)c(I)c2)C(N)=O)cc1 10.1021/jm040871+
1135733 135997 None 9 Human Binding pKi = 6.9 6.9 1 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 436 6 0 4 3.5 COc1ccc(N(CC(=O)N2CCc3ccccc3C2)S(=O)(=O)c2ccccc2)cc1 10.1021/jm050645f
CHEMBL373167 135997 None 9 Human Binding pKi = 6.9 6.9 1 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 436 6 0 4 3.5 COc1ccc(N(CC(=O)N2CCc3ccccc3C2)S(=O)(=O)c2ccccc2)cc1 10.1021/jm050645f
46890258 6933 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 424 3 1 2 6.0 CC(=O)Nc1cccc(-c2ccc(C(=O)N3C[C@]4(C)C[C@H]3CC(C)(C)C4)c(Cl)c2)c1 10.1016/j.bmcl.2010.04.068
CHEMBL1084455 6933 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 424 3 1 2 6.0 CC(=O)Nc1cccc(-c2ccc(C(=O)N3C[C@]4(C)C[C@H]3CC(C)(C)C4)c(Cl)c2)c1 10.1016/j.bmcl.2010.04.068
16063234 118659 None 3 Human Binding pKi = 6.9 6.9 16 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 373 2 1 2 4.4 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCN(c2ccccc2Cl)CC1 10.1021/jm501745f
CHEMBL3416880 118659 None 3 Human Binding pKi = 6.9 6.9 16 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 373 2 1 2 4.4 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCN(c2ccccc2Cl)CC1 10.1021/jm501745f
135469685 79077 None 0 Human Binding pKi = 5.9 5.9 -165 3
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 542 10 2 7 3.0 COCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113211 79077 None 0 Human Binding pKi = 5.9 5.9 -165 3
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 542 10 2 7 3.0 COCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL5074961 214341 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL None None None OC1Cc2c(Cl)cccc2-n2c(nnc2[C@H]2CC[C@H](Oc3ccccn3)CC2)C1 10.1021/acs.jmedchem.1c00863
56680282 64041 None 0 Rat Binding pKi = 7.9 7.9 -21 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 490 10 2 4 3.0 CN1CCN(CCCNC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)Cc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807259 64041 None 0 Rat Binding pKi = 7.9 7.9 -21 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 490 10 2 4 3.0 CN1CCN(CCCNC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)Cc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.05.092
56671720 63221 None 0 Human Binding pKi = 7.9 7.9 -67 3
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1324 18 15 21 -0.9 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
CHEMBL1790720 63221 None 0 Human Binding pKi = 7.9 7.9 -67 3
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1324 18 15 21 -0.9 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
135506374 137898 None 23 Human Binding pKi = 7.9 7.9 1 3
Displacement of DY647 from SNAP-tagged V1A receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayDisplacement of DY647 from SNAP-tagged V1A receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL3763342 137898 None 23 Human Binding pKi = 7.9 7.9 1 3
Displacement of DY647 from SNAP-tagged V1A receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayDisplacement of DY647 from SNAP-tagged V1A receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
54580270 61886 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 536 10 2 6 2.5 COc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)NCCN2CCN(C)CC2)c(C)c1C 10.1016/j.bmcl.2011.02.096
CHEMBL1774001 61886 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 536 10 2 6 2.5 COc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)NCCN2CCN(C)CC2)c(C)c1C 10.1016/j.bmcl.2011.02.096
42611262 180557 None 0 Human Binding pKi = 7.9 7.9 -31 4
Displacement of [3H]oxytocin from human vasopressin V1a receptor expressed in CHO cells by filtration binding assayDisplacement of [3H]oxytocin from human vasopressin V1a receptor expressed in CHO cells by filtration binding assay
ChEMBL 349 6 0 2 4.7 Cc1cc(C(=O)N(CC2CC2)CC2CCCO2)ccc1-c1ccccc1 10.1016/j.bmcl.2008.11.064
CHEMBL475395 180557 None 0 Human Binding pKi = 7.9 7.9 -31 4
Displacement of [3H]oxytocin from human vasopressin V1a receptor expressed in CHO cells by filtration binding assayDisplacement of [3H]oxytocin from human vasopressin V1a receptor expressed in CHO cells by filtration binding assay
ChEMBL 349 6 0 2 4.7 Cc1cc(C(=O)N(CC2CC2)CC2CCCO2)ccc1-c1ccccc1 10.1016/j.bmcl.2008.11.064
44419039 137394 None 0 Rat Binding pKi = 7.9 7.9 -100 8
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1096 20 14 15 -4.6 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm060928n
CHEMBL375324 137394 None 0 Rat Binding pKi = 7.9 7.9 -100 8
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1096 20 14 15 -4.6 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm060928n
145981637 166491 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [Ph-Se-acetyl]-LVA from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisDisplacement of [Ph-Se-acetyl]-LVA from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 1206 34 16 14 -4.3 COc1ccc(C[C@@H](NC(=O)C[Se]c2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)cc1 10.1021/acs.jmedchem.8b01320
CHEMBL4278500 166491 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [Ph-Se-acetyl]-LVA from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisDisplacement of [Ph-Se-acetyl]-LVA from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 1206 34 16 14 -4.3 COc1ccc(C[C@@H](NC(=O)C[Se]c2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)cc1 10.1021/acs.jmedchem.8b01320
5034737 206341 None 12 Human Binding pKi = 6.9 6.9 20 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 341 4 0 4 4.9 COc1ccccc1-n1c(C)nnc1-c1ccc(-c2ccccc2)cc1 10.1021/jm010544r
CHEMBL87351 206341 None 12 Human Binding pKi = 6.9 6.9 20 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 341 4 0 4 4.9 COc1ccccc1-n1c(C)nnc1-c1ccc(-c2ccccc2)cc1 10.1021/jm010544r
2042 2981 None 58 Human Binding pKi = 6.9 6.9 -29 8
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL None None None None 10.1021/jm010526+
2174 2981 None 58 Human Binding pKi = 6.9 6.9 -29 8
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL None None None None 10.1021/jm010526+
2176 2981 None 58 Human Binding pKi = 6.9 6.9 -29 8
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL None None None None 10.1021/jm010526+
439302 2981 None 58 Human Binding pKi = 6.9 6.9 -29 8
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL None None None None 10.1021/jm010526+
CHEMBL395429 2981 None 58 Human Binding pKi = 6.9 6.9 -29 8
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL None None None None 10.1021/jm010526+
DB00107 2981 None 58 Human Binding pKi = 6.9 6.9 -29 8
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL None None None None 10.1021/jm010526+
2042 2981 None 58 Human Binding pKi = 6.9 6.9 -29 8
Binding affinity to V1aR (unknown origin)Binding affinity to V1aR (unknown origin)
ChEMBL None None None None 10.1021/jm501395b
2174 2981 None 58 Human Binding pKi = 6.9 6.9 -29 8
Binding affinity to V1aR (unknown origin)Binding affinity to V1aR (unknown origin)
ChEMBL None None None None 10.1021/jm501395b
2176 2981 None 58 Human Binding pKi = 6.9 6.9 -29 8
Binding affinity to V1aR (unknown origin)Binding affinity to V1aR (unknown origin)
ChEMBL None None None None 10.1021/jm501395b
439302 2981 None 58 Human Binding pKi = 6.9 6.9 -29 8
Binding affinity to V1aR (unknown origin)Binding affinity to V1aR (unknown origin)
ChEMBL None None None None 10.1021/jm501395b
CHEMBL395429 2981 None 58 Human Binding pKi = 6.9 6.9 -29 8
Binding affinity to V1aR (unknown origin)Binding affinity to V1aR (unknown origin)
ChEMBL None None None None 10.1021/jm501395b
DB00107 2981 None 58 Human Binding pKi = 6.9 6.9 -29 8
Binding affinity to V1aR (unknown origin)Binding affinity to V1aR (unknown origin)
ChEMBL None None None None 10.1021/jm501395b
44361522 121693 None 0 Human Binding pKi = 4.9 4.9 -2137 5
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human plateletsBinding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets
ChEMBL 477 4 0 5 3.8 CC(=O)N1CCC(Oc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2)CC1 10.1021/jm00023a002
CHEMBL358793 121693 None 0 Human Binding pKi = 4.9 4.9 -2137 5
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human plateletsBinding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets
ChEMBL 477 4 0 5 3.8 CC(=O)N1CCC(Oc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2)CC1 10.1021/jm00023a002
57978135 118661 None 0 Mouse Binding pKi = 6.9 6.9 -89 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 449 3 1 4 4.7 O=C(c1cn(C[C@@H]2CCCN2)c2cc(Cl)ccc12)N1CCC2(CC1)OCc1ccccc12 10.1021/jm501745f
CHEMBL3416882 118661 None 0 Mouse Binding pKi = 6.9 6.9 -89 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 449 3 1 4 4.7 O=C(c1cn(C[C@@H]2CCCN2)c2cc(Cl)ccc12)N1CCC2(CC1)OCc1ccccc12 10.1021/jm501745f
44419029 96908 None 0 Rat Binding pKi = 5.9 5.9 -31622 4
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1053 18 13 14 -2.4 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL265859 96908 None 0 Rat Binding pKi = 5.9 5.9 -31622 4
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1053 18 13 14 -2.4 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
10444 2324 None 14 Human Binding pKi = 5.9 5.9 -5 3
Displacement of DY647 from SNAP-tagged V1A receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayDisplacement of DY647 from SNAP-tagged V1A receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
139030525 2324 None 14 Human Binding pKi = 5.9 5.9 -5 3
Displacement of DY647 from SNAP-tagged V1A receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayDisplacement of DY647 from SNAP-tagged V1A receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
145711714 2324 None 14 Human Binding pKi = 5.9 5.9 -5 3
Displacement of DY647 from SNAP-tagged V1A receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayDisplacement of DY647 from SNAP-tagged V1A receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4204210 2324 None 14 Human Binding pKi = 5.9 5.9 -5 3
Displacement of DY647 from SNAP-tagged V1A receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayDisplacement of DY647 from SNAP-tagged V1A receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
45483325 198269 None 0 Human Binding pKi = 5.9 5.9 -20 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 577 11 1 7 3.4 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL575797 198269 None 0 Human Binding pKi = 5.9 5.9 -20 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 577 11 1 7 3.4 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
10416272 104737 None 6 Human Binding pKi = 5.9 5.9 -630 2
Compound was tested for its ability to displace vasopressin from human Vasopressin V1a receptorCompound was tested for its ability to displace vasopressin from human Vasopressin V1a receptor
ChEMBL 608 6 1 7 4.7 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL31065 104737 None 6 Human Binding pKi = 5.9 5.9 -630 2
Compound was tested for its ability to displace vasopressin from human Vasopressin V1a receptorCompound was tested for its ability to displace vasopressin from human Vasopressin V1a receptor
ChEMBL 608 6 1 7 4.7 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
10416272 104737 None 6 Human Binding pKi = 5.9 5.9 -630 2
Displacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 608 6 1 7 4.7 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1021/jm901812z
CHEMBL31065 104737 None 6 Human Binding pKi = 5.9 5.9 -630 2
Displacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 608 6 1 7 4.7 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1021/jm901812z
45483256 198296 None 0 Human Binding pKi = 5.9 5.9 -8 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 565 11 1 7 3.4 CCCNC1CCN(S(=O)(=O)CCC2CCc3ccccc3N2S(=O)(=O)c2ccc(OC)cc2OC)CC1 10.1016/j.bmcl.2009.09.050
CHEMBL575987 198296 None 0 Human Binding pKi = 5.9 5.9 -8 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 565 11 1 7 3.4 CCCNC1CCN(S(=O)(=O)CCC2CCc3ccccc3N2S(=O)(=O)c2ccc(OC)cc2OC)CC1 10.1016/j.bmcl.2009.09.050
54581268 61891 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 533 8 2 5 3.9 COc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)N[C@H]2C[C@@H]3CC[C@H](C2)N3C)c(C)c1C 10.1016/j.bmcl.2011.02.096
CHEMBL1774006 61891 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 533 8 2 5 3.9 COc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)N[C@H]2C[C@@H]3CC[C@H](C2)N3C)c(C)c1C 10.1016/j.bmcl.2011.02.096
54582311 61901 None 0 Human Binding pKi = 6.9 6.9 1 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 493 7 3 3 4.3 O=C(Cc1ccc(Cl)c(Cl)c1)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@@H]1C[C@@H]2CC[C@H](C1)N2 10.1016/j.bmcl.2011.02.096
CHEMBL1774016 61901 None 0 Human Binding pKi = 6.9 6.9 1 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 493 7 3 3 4.3 O=C(Cc1ccc(Cl)c(Cl)c1)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@@H]1C[C@@H]2CC[C@H](C1)N2 10.1016/j.bmcl.2011.02.096
56683608 64058 None 0 Rat Binding pKi = 6.9 6.9 -18 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 446 9 3 3 3.5 O=C(NCCCO)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C1(c2ccc(F)cc2)CCCC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807276 64058 None 0 Rat Binding pKi = 6.9 6.9 -18 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 446 9 3 3 3.5 O=C(NCCCO)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C1(c2ccc(F)cc2)CCCC1 10.1016/j.bmcl.2011.05.092
56676960 64061 None 0 Rat Binding pKi = 6.9 6.9 -75 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 448 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)NC1CCCC(O)C1 10.1016/j.bmcl.2011.05.092
CHEMBL1807279 64061 None 0 Rat Binding pKi = 6.9 6.9 -75 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 448 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)NC1CCCC(O)C1 10.1016/j.bmcl.2011.05.092
56666703 64063 None 0 Rat Binding pKi = 6.9 6.9 -72 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 448 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H]1CC[C@@H](O)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807280 64063 None 0 Rat Binding pKi = 6.9 6.9 -72 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 448 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H]1CC[C@@H](O)CC1 10.1016/j.bmcl.2011.05.092
145990668 166937 None 0 Human Binding pKi = 5.9 5.9 - 1
Displacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysisDisplacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysis
ChEMBL 1099 19 15 14 -6.0 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1C[Se]C[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.8b01320
CHEMBL4286989 166937 None 0 Human Binding pKi = 5.9 5.9 - 1
Displacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysisDisplacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysis
ChEMBL 1099 19 15 14 -6.0 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1C[Se]C[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.8b01320
135489430 79062 None 0 Human Binding pKi = 5.9 5.9 -11 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 627 12 2 9 3.1 COC(=O)c1cccc2c1NC(=O)/C2=N\NC(=O)CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(OCCCN(C)C)cc1 10.1021/jm050645f
CHEMBL2113195 79062 None 0 Human Binding pKi = 5.9 5.9 -11 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 627 12 2 9 3.1 COC(=O)c1cccc2c1NC(=O)/C2=N\NC(=O)CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(OCCCN(C)C)cc1 10.1021/jm050645f
CHEMBL2369838 209701 None 0 Human Binding pKi = 7.9 7.9 -6 4
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL None None None NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
44428547 93175 None 0 Human Binding pKi = 7.9 7.9 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 731 12 1 6 5.5 CC(C)N1CCN(C(=O)CC[C@H](C(=O)NCc2cccc(C(F)(F)F)c2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)CC1 10.1016/j.bmc.2006.12.031
CHEMBL244389 93175 None 0 Human Binding pKi = 7.9 7.9 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 731 12 1 6 5.5 CC(C)N1CCN(C(=O)CC[C@H](C(=O)NCc2cccc(C(F)(F)F)c2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)CC1 10.1016/j.bmc.2006.12.031
53349471 118601 None 0 Human Binding pKi = 7.9 7.9 22 2
Binding affinity to human V1a assessed as inhibition constantBinding affinity to human V1a assessed as inhibition constant
ChEMBL 413 3 1 3 5.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCN(C)c3cccc(C)c32)cc1 10.1016/j.bmcl.2017.11.050
CHEMBL3416774 118601 None 0 Human Binding pKi = 7.9 7.9 22 2
Binding affinity to human V1a assessed as inhibition constantBinding affinity to human V1a assessed as inhibition constant
ChEMBL 413 3 1 3 5.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCN(C)c3cccc(C)c32)cc1 10.1016/j.bmcl.2017.11.050
53349471 118601 None 0 Human Binding pKi = 7.9 7.9 22 2
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 413 3 1 3 5.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCN(C)c3cccc(C)c32)cc1 10.1021/acs.jmedchem.5b00289
CHEMBL3416774 118601 None 0 Human Binding pKi = 7.9 7.9 22 2
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 413 3 1 3 5.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCN(C)c3cccc(C)c32)cc1 10.1021/acs.jmedchem.5b00289
11993729 118662 None 0 Mouse Binding pKi = 7.9 7.9 -12 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 463 3 0 4 5.1 CN1CCC[C@H]1Cn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1021/jm501745f
CHEMBL3416883 118662 None 0 Mouse Binding pKi = 7.9 7.9 -12 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 463 3 0 4 5.1 CN1CCC[C@H]1Cn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1021/jm501745f
162646538 179604 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 412 1 0 3 3.8 CC(=O)N1CCN(C(=O)N2CCN(c3ccccc3C)CC2)c2ccc(Cl)cc21 10.1016/j.bmcl.2020.127416
CHEMBL4742335 179604 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 412 1 0 3 3.8 CC(=O)N1CCN(C(=O)N2CCN(c3ccccc3C)CC2)c2ccc(Cl)cc21 10.1016/j.bmcl.2020.127416
162649115 179867 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 368 2 0 5 4.8 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccc(Cl)cc3CC4)CC2)no1 10.1016/j.bmcl.2020.127417
CHEMBL4745524 179867 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 368 2 0 5 4.8 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccc(Cl)cc3CC4)CC2)no1 10.1016/j.bmcl.2020.127417
54580516 62380 None 0 Human Binding pKi = 7.9 7.9 -426 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 695 9 0 9 3.6 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN4CCN(C)CC4)ccc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
CHEMBL1779410 62380 None 0 Human Binding pKi = 7.9 7.9 -426 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 695 9 0 9 3.6 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN4CCN(C)CC4)ccc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
44520868 182026 None 0 Human Binding pKi = 7.9 7.9 1 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 498 5 1 4 5.4 CCCNC(=O)/C=C1/c2ccccc2N(C(=O)c2ccc(-n3ccc(C)n3)cc2Cl)CCC1(F)F 10.1016/j.bmc.2009.03.001
CHEMBL478083 182026 None 0 Human Binding pKi = 7.9 7.9 1 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 498 5 1 4 5.4 CCCNC(=O)/C=C1/c2ccccc2N(C(=O)c2ccc(-n3ccc(C)n3)cc2Cl)CCC1(F)F 10.1016/j.bmc.2009.03.001
44520849 201711 None 0 Human Binding pKi = 7.9 7.9 1 2
Displacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation countingDisplacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation counting
ChEMBL 503 5 2 4 4.4 C[C@@H]1CCN(c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCCO)c4ccccc43)c(Cl)c2)C1 10.1016/j.bmc.2009.10.038
CHEMBL606464 201711 None 0 Human Binding pKi = 7.9 7.9 1 2
Displacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation countingDisplacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation counting
ChEMBL 503 5 2 4 4.4 C[C@@H]1CCN(c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCCO)c4ccccc43)c(Cl)c2)C1 10.1016/j.bmc.2009.10.038
10165683 106124 None 0 Human Binding pKi = 7.9 7.9 676 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 537 13 0 6 6.9 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCCCCCN1CCN(C)CC1 10.1021/jm010544r
CHEMBL313451 106124 None 0 Human Binding pKi = 7.9 7.9 676 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 537 13 0 6 6.9 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCCCCCN1CCN(C)CC1 10.1021/jm010544r
44428488 142601 None 0 Human Binding pKi = 7.9 7.9 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 766 11 2 6 5.8 NC1CC[N+](Cc2ccccc2)(C(=O)C(C(=O)NCc2cccc(C(F)(F)F)c2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)CC1 10.1016/j.bmc.2006.12.031
CHEMBL389139 142601 None 0 Human Binding pKi = 7.9 7.9 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 766 11 2 6 5.8 NC1CC[N+](Cc2ccccc2)(C(=O)C(C(=O)NCc2cccc(C(F)(F)F)c2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)CC1 10.1016/j.bmc.2006.12.031
46890613 6903 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 439 4 0 2 7.1 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1cccc(-c2ccccc2)c1 10.1016/j.bmcl.2010.04.068
CHEMBL1084326 6903 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 439 4 0 2 7.1 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1cccc(-c2ccccc2)c1 10.1016/j.bmcl.2010.04.068
56657867 63217 None 0 Human Binding pKi = 7.9 7.9 -40 3
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1338 19 15 21 -0.5 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
CHEMBL1790717 63217 None 0 Human Binding pKi = 7.9 7.9 -40 3
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1338 19 15 21 -0.5 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
56666701 64050 None 0 Rat Binding pKi = 7.9 7.9 -26 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 497 9 2 4 4.1 COc1ccc(C[C@@H](NC(=O)C2(c3ccc(Cl)cc3)CC2)C(=O)N[C@H]2CC[C@H](N(C)C)CC2)cc1 10.1016/j.bmcl.2011.05.092
CHEMBL1807268 64050 None 0 Rat Binding pKi = 7.9 7.9 -26 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 497 9 2 4 4.1 COc1ccc(C[C@@H](NC(=O)C2(c3ccc(Cl)cc3)CC2)C(=O)N[C@H]2CC[C@H](N(C)C)CC2)cc1 10.1016/j.bmcl.2011.05.092
10206901 206355 None 0 Human Binding pKi = 7.9 7.9 501 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 494 11 0 5 7.3 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCCCN1CCCCC1 10.1021/jm010544r
CHEMBL87455 206355 None 0 Human Binding pKi = 7.9 7.9 501 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 494 11 0 5 7.3 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCCCN1CCCCC1 10.1021/jm010544r
137212775 137890 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader methodDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader method
ChEMBL 518 9 3 8 4.2 Cn1ncc2c1Nc1ccccc1N(C(=O)CCCCCCN1CCN(Cc3cc(O)cc(O)c3)CC1)C2 10.1016/j.ejmech.2015.11.050
CHEMBL3763217 137890 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader methodDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader method
ChEMBL 518 9 3 8 4.2 Cn1ncc2c1Nc1ccccc1N(C(=O)CCCCCCN1CCN(Cc3cc(O)cc(O)c3)CC1)C2 10.1016/j.ejmech.2015.11.050
16109442 137395 None 0 Rat Binding pKi = 6.9 6.9 -213 4
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1068 20 14 15 -3.3 N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL375325 137395 None 0 Rat Binding pKi = 6.9 6.9 -213 4
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1068 20 14 15 -3.3 N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
44335345 5169 None 0 Human Binding pKi = 6.9 6.9 -4 2
Inhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cellsInhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 505 3 1 3 6.3 O=C(Nc1ccc(C(=O)N2C[C@@H]3C4CCC(C4)N3Cc3cc(Cl)ccc32)cc1)c1ccccc1Cl 10.1016/s0960-894x(02)00649-2
CHEMBL105961 5169 None 0 Human Binding pKi = 6.9 6.9 -4 2
Inhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cellsInhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 505 3 1 3 6.3 O=C(Nc1ccc(C(=O)N2C[C@@H]3C4CCC(C4)N3Cc3cc(Cl)ccc32)cc1)c1ccccc1Cl 10.1016/s0960-894x(02)00649-2
9915472 169521 None 0 Human Binding pKi = 6.9 6.9 -14 2
Inhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cellsInhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 547 4 1 3 7.3 O=C(Nc1ccc(C(=O)N2C[C@@H]3C4CCC(C4)N3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/s0960-894x(02)00649-2
CHEMBL443498 169521 None 0 Human Binding pKi = 6.9 6.9 -14 2
Inhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cellsInhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 547 4 1 3 7.3 O=C(Nc1ccc(C(=O)N2C[C@@H]3C4CCC(C4)N3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/s0960-894x(02)00649-2
16109447 83349 None 0 Rat Binding pKi = 5.9 5.9 -1412 4
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1012 18 12 15 -3.2 NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL219272 83349 None 0 Rat Binding pKi = 5.9 5.9 -1412 4
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1012 18 12 15 -3.2 NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
44325363 106608 None 0 Human Binding pKi = 5.9 5.9 -281 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 567 5 1 5 6.1 COc1ccc(C(=O)Nc2ccc(C(=O)N3C[C@H]4COCCN4Cc4ccccc43)c(Cl)c2)c(-c2ccccc2)c1 10.1016/j.bmcl.2004.03.083
CHEMBL314290 106608 None 0 Human Binding pKi = 5.9 5.9 -281 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 567 5 1 5 6.1 COc1ccc(C(=O)Nc2ccc(C(=O)N3C[C@H]4COCCN4Cc4ccccc43)c(Cl)c2)c(-c2ccccc2)c1 10.1016/j.bmcl.2004.03.083
44325895 207906 None 0 Human Binding pKi = 5.9 5.9 -19 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 519 4 1 4 6.2 O=C(Nc1ccc(C(=O)N2C[C@@H]3CSCCN3Cc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL96731 207906 None 0 Human Binding pKi = 5.9 5.9 -19 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 519 4 1 4 6.2 O=C(Nc1ccc(C(=O)N2C[C@@H]3CSCCN3Cc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
54581300 61906 None 0 Rat Binding pKi = 6.9 6.9 -41 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 501 7 2 3 4.7 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C(C)(C)c1ccc(Cl)cc1)C2 10.1016/j.bmcl.2011.02.096
CHEMBL1774021 61906 None 0 Rat Binding pKi = 6.9 6.9 -41 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 501 7 2 3 4.7 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C(C)(C)c1ccc(Cl)cc1)C2 10.1016/j.bmcl.2011.02.096
135476004 79059 None 0 Human Binding pKi = 6.9 6.9 -147 3
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 597 10 2 8 2.7 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(OCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
CHEMBL2113185 79059 None 0 Human Binding pKi = 6.9 6.9 -147 3
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 597 10 2 8 2.7 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(OCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
135520376 79075 None 0 Human Binding pKi = 5.9 5.9 -138 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 526 9 2 6 3.8 CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113209 79075 None 0 Human Binding pKi = 5.9 5.9 -138 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 526 9 2 6 3.8 CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL5283016 194180 None 0 Human Binding pKi = 7.9 7.9 - 1
Antagonist activity against human V1A receptor expressed in human 1321N1 cellsAntagonist activity against human V1A receptor expressed in human 1321N1 cells
ChEMBL 384 3 0 7 3.6 Clc1cnc2n1CCCc1nnc([C@H]3CC[C@H](Oc4ccccn4)CC3)n1-2 10.1021/acs.jmedchem.1c01215
59657523 118660 None 0 Mouse Binding pKi = 7.9 7.9 -28 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 451 3 0 4 4.0 CN(C)C(=O)Cn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1021/jm501745f
CHEMBL3416881 118660 None 0 Mouse Binding pKi = 7.9 7.9 -28 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 451 3 0 4 4.0 CN(C)C(=O)Cn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1021/jm501745f
162657843 181143 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 370 2 0 4 3.4 CN1CCN(C(=O)C2CCN(c3ccccn3)CC2)c2ccc(Cl)cc21 10.1016/j.bmcl.2020.127416
CHEMBL4760698 181143 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 370 2 0 4 3.4 CN1CCN(C(=O)C2CCN(c3ccccn3)CC2)c2ccc(Cl)cc21 10.1016/j.bmcl.2020.127416
10411308 201232 None 0 Human Binding pKi = 7.9 7.9 -2 3
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/jm3006146
CHEMBL603708 201232 None 0 Human Binding pKi = 7.9 7.9 -2 3
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/jm3006146
56670128 64060 None 0 Human Binding pKi = 7.8 7.8 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 422 9 3 3 3.2 CC(CCO)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1 10.1016/j.bmcl.2011.05.092
CHEMBL1807278 64060 None 0 Human Binding pKi = 7.8 7.8 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 422 9 3 3 3.2 CC(CCO)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1 10.1016/j.bmcl.2011.05.092
CHEMBL5283584 194217 None 0 Human Binding pKi = 6.9 6.9 - 1
Antagonist activity against human V1A receptor expressed in human 1321N1 cellsAntagonist activity against human V1A receptor expressed in human 1321N1 cells
ChEMBL 369 2 0 7 2.8 Clc1cnc2n1CCCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1021/acs.jmedchem.1c01215
16109445 137242 None 0 Rat Binding pKi = 5.9 5.9 -5495 4
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1011 17 11 14 -1.9 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL375188 137242 None 0 Rat Binding pKi = 5.9 5.9 -5495 4
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1011 17 11 14 -1.9 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
10414302 112518 None 0 Human Binding pKi = 5.9 5.9 -50 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 519 4 1 4 6.2 O=C(Nc1ccc(C(=O)N2C[C@H]3CSCCN3Cc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL329903 112518 None 0 Human Binding pKi = 5.9 5.9 -50 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 519 4 1 4 6.2 O=C(Nc1ccc(C(=O)N2C[C@H]3CSCCN3Cc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
44325896 207809 None 0 Human Binding pKi = 5.9 5.9 -27 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 551 4 1 5 4.9 O=C(Nc1ccc(C(=O)N2CC3CS(=O)(=O)CCN3Cc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL96255 207809 None 0 Human Binding pKi = 5.9 5.9 -27 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 551 4 1 5 4.9 O=C(Nc1ccc(C(=O)N2CC3CS(=O)(=O)CCN3Cc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
114904 2952 None 56 Human Binding pKi = 4.9 4.9 -301 7
Binding affinity towards Vasopressin V1a receptor in human liverBinding affinity towards Vasopressin V1a receptor in human liver
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm000108p
2196 2952 None 56 Human Binding pKi = 4.9 4.9 -301 7
Binding affinity towards Vasopressin V1a receptor in human liverBinding affinity towards Vasopressin V1a receptor in human liver
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm000108p
CHEMBL296908 2952 None 56 Human Binding pKi = 4.9 4.9 -301 7
Binding affinity towards Vasopressin V1a receptor in human liverBinding affinity towards Vasopressin V1a receptor in human liver
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm000108p
44325691 12996 None 0 Human Binding pKi = 4.9 4.9 -239 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 553 4 1 4 6.8 O=C(Nc1ccc(C(=O)N2C[C@H]3CSCCN3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL1189693 12996 None 0 Human Binding pKi = 4.9 4.9 -239 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 553 4 1 4 6.8 O=C(Nc1ccc(C(=O)N2C[C@H]3CSCCN3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL539285 12996 None 0 Human Binding pKi = 4.9 4.9 -239 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 553 4 1 4 6.8 O=C(Nc1ccc(C(=O)N2C[C@H]3CSCCN3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
9807250 78345 None 0 Human Binding pKi = 4.9 4.9 -58 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 537 4 1 4 6.1 O=C(Nc1ccc(C(=O)N2C[C@@H]3COCCN3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL2093899 78345 None 0 Human Binding pKi = 4.9 4.9 -58 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 537 4 1 4 6.1 O=C(Nc1ccc(C(=O)N2C[C@@H]3COCCN3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL2110044 78345 None 0 Human Binding pKi = 4.9 4.9 -58 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 537 4 1 4 6.1 O=C(Nc1ccc(C(=O)N2C[C@@H]3COCCN3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
44325915 112736 None 0 Human Binding pKi = 4.9 4.9 -104 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 509 3 1 4 5.6 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CC3CSCCN3Cc3ccccc32)c(Cl)c1 10.1016/j.bmcl.2004.03.083
CHEMBL330494 112736 None 0 Human Binding pKi = 4.9 4.9 -104 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 509 3 1 4 5.6 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CC3CSCCN3Cc3ccccc32)c(Cl)c1 10.1016/j.bmcl.2004.03.083
44325905 164275 None 0 Human Binding pKi = 4.9 4.9 -275 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 571 4 1 4 7.0 O=C(Nc1ccc(C(=O)N2CC3CSCCN3Cc3ccccc32)c(Cl)c1)c1cc(F)ccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL421180 164275 None 0 Human Binding pKi = 4.9 4.9 -275 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 571 4 1 4 7.0 O=C(Nc1ccc(C(=O)N2CC3CSCCN3Cc3ccccc32)c(Cl)c1)c1cc(F)ccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
44325804 207308 None 0 Human Binding pKi = 4.9 4.9 -37 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 533 4 1 4 6.5 Cc1ccc2c(c1)N(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)CC1CSCCN1C2 10.1016/j.bmcl.2004.03.083
CHEMBL93366 207308 None 0 Human Binding pKi = 4.9 4.9 -37 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 533 4 1 4 6.5 Cc1ccc2c(c1)N(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)CC1CSCCN1C2 10.1016/j.bmcl.2004.03.083
1103817 17002 None 13 Human Binding pKi = 5.9 5.9 -338 4
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 492 8 2 6 3.1 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm050645f
CHEMBL1254117 17002 None 13 Human Binding pKi = 5.9 5.9 -338 4
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 492 8 2 6 3.1 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm050645f
1103817 17002 None 13 Human Binding pKi = 5.9 5.9 -338 4
Displacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissue
ChEMBL 492 8 2 6 3.1 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm901812z
CHEMBL1254117 17002 None 13 Human Binding pKi = 5.9 5.9 -338 4
Displacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissue
ChEMBL 492 8 2 6 3.1 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm901812z
10461270 3676 None 7 Human Binding pKi = 6.8 6.8 -199 5
Displacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
2201 3676 None 7 Human Binding pKi = 6.8 6.8 -199 5
Displacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
CHEMBL1615640 3676 None 7 Human Binding pKi = 6.8 6.8 -199 5
Displacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
CHEMBL5071635 214263 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL None None None Cc1cccc2c1-n1c(nnc1[C@H]1CC[C@H](Oc3ccccn3)CC1)C[C@H](O)C2 10.1021/acs.jmedchem.1c00863
118734334 118595 None 0 Human Binding pKi = 6.8 6.8 10 2
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 416 3 1 3 5.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCSc3cccc(C)c32)cc1 10.1021/acs.jmedchem.5b00289
CHEMBL3416767 118595 None 0 Human Binding pKi = 6.8 6.8 10 2
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 416 3 1 3 5.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCSc3cccc(C)c32)cc1 10.1021/acs.jmedchem.5b00289
168294720 192467 None 0 Human Binding pKi = 6.8 6.8 -16 2
Displacement of [3H]-vasopressin from human V1A receptor expressed in CHO cells membrane by microbeta scintillation counter analysisDisplacement of [3H]-vasopressin from human V1A receptor expressed in CHO cells membrane by microbeta scintillation counter analysis
ChEMBL 601 9 1 5 6.5 CCN1CCN(CCCN2CCCN(C(=O)c3ccc(NC(=O)c4ccccc4-c4ccccc4)cc3)c3ccccc32)CC1 10.1021/acs.jmedchem.2c00567
CHEMBL5208751 192467 None 0 Human Binding pKi = 6.8 6.8 -16 2
Displacement of [3H]-vasopressin from human V1A receptor expressed in CHO cells membrane by microbeta scintillation counter analysisDisplacement of [3H]-vasopressin from human V1A receptor expressed in CHO cells membrane by microbeta scintillation counter analysis
ChEMBL 601 9 1 5 6.5 CCN1CCN(CCCN2CCCN(C(=O)c3ccc(NC(=O)c4ccccc4-c4ccccc4)cc3)c3ccccc32)CC1 10.1021/acs.jmedchem.2c00567
54585160 61851 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 612 13 1 6 4.9 COc1cc(C)c(S(=O)(=O)N[C@@H](CC2CCCCC2)C(=O)N(CCCN2CCN(C)CC2)Cc2ccccc2)c(C)c1C 10.1016/j.bmcl.2011.02.096
CHEMBL1773860 61851 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 612 13 1 6 4.9 COc1cc(C)c(S(=O)(=O)N[C@@H](CC2CCCCC2)C(=O)N(CCCN2CCN(C)CC2)Cc2ccccc2)c(C)c1C 10.1016/j.bmcl.2011.02.096
CHEMBL1161780 208509 None 0 Human Binding pKi = 6.8 6.8 - 1
Binding affinity against human vasopressin V1a receptor expressed in CHO cellsBinding affinity against human vasopressin V1a receptor expressed in CHO cells
ChEMBL None None None NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccc(C(=O)c2ccccc2)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)c(I)c1)C(N)=O 10.1021/jm040871+
59429617 118658 None 0 Mouse Binding pKi = 5.8 5.8 -64 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 338 2 1 1 4.8 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC(c2ccccc2)CC1 10.1021/jm501745f
CHEMBL3416879 118658 None 0 Mouse Binding pKi = 5.8 5.8 -64 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 338 2 1 1 4.8 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC(c2ccccc2)CC1 10.1021/jm501745f
CHEMBL408657 212725 None 0 Human Binding pKi = 5.8 5.8 - 1
Binding affinity against human vasopressin V1a receptor expressed in CHO cellsBinding affinity against human vasopressin V1a receptor expressed in CHO cells
ChEMBL None None None CC(=O)N[C@@H](Cc1ccc(C(=O)c2ccccc2)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)c(I)c1)C(N)=O 10.1021/jm040871+
44361387 119412 None 0 Rat Binding pKi = 7.8 7.8 8 5
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liverBinding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver
ChEMBL 505 6 0 5 4.6 CC(=O)N1CCCCC1CCOc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)cc1 10.1021/jm00023a002
CHEMBL344752 119412 None 0 Rat Binding pKi = 7.8 7.8 8 5
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liverBinding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver
ChEMBL 505 6 0 5 4.6 CC(=O)N1CCCCC1CCOc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)cc1 10.1021/jm00023a002
162661138 181507 None 0 Human Binding pKi = 7.8 7.8 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 345 2 0 5 3.5 c1ccc(N2CCC(c3nnc4n3-c3ccccc3CCC4)CC2)nc1 10.1016/j.bmcl.2020.127417
CHEMBL4764976 181507 None 0 Human Binding pKi = 7.8 7.8 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 345 2 0 5 3.5 c1ccc(N2CCC(c3nnc4n3-c3ccccc3CCC4)CC2)nc1 10.1016/j.bmcl.2020.127417
162676230 183323 None 0 Human Binding pKi = 7.8 7.8 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 373 3 0 5 4.1 CCc1ccc2c(c1)CCCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
CHEMBL4797387 183323 None 0 Human Binding pKi = 7.8 7.8 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 373 3 0 5 4.1 CCc1ccc2c(c1)CCCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
162676890 183488 None 0 Human Binding pKi = 7.8 7.8 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 355 1 0 2 4.0 Cc1ccccc1N1CCN(C(=O)N2CCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4799501 183488 None 0 Human Binding pKi = 7.8 7.8 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 355 1 0 2 4.0 Cc1ccccc1N1CCN(C(=O)N2CCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
54586392 62377 None 0 Human Binding pKi = 7.8 7.8 -380 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 695 9 0 9 3.6 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3ccc(CN4CCN(C)CC4)cc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
CHEMBL1779407 62377 None 0 Human Binding pKi = 7.8 7.8 -380 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 695 9 0 9 3.6 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3ccc(CN4CCN(C)CC4)cc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
44520853 185517 None 0 Human Binding pKi = 7.8 7.8 1 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 547 5 1 5 5.6 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4ccncc4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
CHEMBL486268 185517 None 0 Human Binding pKi = 7.8 7.8 1 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 547 5 1 5 5.6 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4ccncc4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
54580268 61880 None 0 Human Binding pKi = 7.8 7.8 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 592 12 1 6 4.0 COc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)N(CCCN2CCN(C)CC2)C(C)C)c(C)c1C 10.1016/j.bmcl.2011.02.096
CHEMBL1773998 61880 None 0 Human Binding pKi = 7.8 7.8 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 592 12 1 6 4.0 COc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)N(CCCN2CCN(C)CC2)C(C)C)c(C)c1C 10.1016/j.bmcl.2011.02.096
46890215 7151 None 0 Human Binding pKi = 6.8 6.8 -3 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 447 3 0 2 7.2 COc1cc(-c2cccc3ccccc23)c(Cl)cc1C(=O)N1C[C@]2(C)C[C@H]1CC(C)(C)C2 10.1016/j.bmcl.2010.04.068
CHEMBL1085378 7151 None 0 Human Binding pKi = 6.8 6.8 -3 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 447 3 0 2 7.2 COc1cc(-c2cccc3ccccc23)c(Cl)cc1C(=O)N1C[C@]2(C)C[C@H]1CC(C)(C)C2 10.1016/j.bmcl.2010.04.068
44419028 96907 None 17 Human Binding pKi = 6.8 6.8 -125 8
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1093 18 12 14 -1.6 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
CHEMBL265858 96907 None 17 Human Binding pKi = 6.8 6.8 -125 8
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1093 18 12 14 -1.6 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
44279910 99164 None 0 Human Binding pKi = 5.8 5.8 -630 2
Compound was tested for its ability to displace vasopressin from human Vasopressin V1a receptorCompound was tested for its ability to displace vasopressin from human Vasopressin V1a receptor
ChEMBL 570 7 1 8 3.7 COc1cccn(CC(=O)NCc2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)c1=O 10.1016/s0960-894x(02)00160-9
CHEMBL281243 99164 None 0 Human Binding pKi = 5.8 5.8 -630 2
Compound was tested for its ability to displace vasopressin from human Vasopressin V1a receptorCompound was tested for its ability to displace vasopressin from human Vasopressin V1a receptor
ChEMBL 570 7 1 8 3.7 COc1cccn(CC(=O)NCc2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)c1=O 10.1016/s0960-894x(02)00160-9
44279908 99583 None 0 Human Binding pKi = 5.8 5.8 -794 2
Compound was tested for its ability to displace vasopressin from human Vasopressin V1a receptorCompound was tested for its ability to displace vasopressin from human Vasopressin V1a receptor
ChEMBL 585 8 1 9 3.5 CCOc1ccn(CC(=O)NCc2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)c(=O)n1 10.1016/s0960-894x(02)00160-9
CHEMBL283894 99583 None 0 Human Binding pKi = 5.8 5.8 -794 2
Compound was tested for its ability to displace vasopressin from human Vasopressin V1a receptorCompound was tested for its ability to displace vasopressin from human Vasopressin V1a receptor
ChEMBL 585 8 1 9 3.5 CCOc1ccn(CC(=O)NCc2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)c(=O)n1 10.1016/s0960-894x(02)00160-9
57519947 73648 None 0 Prairie vole Binding pKi = 7.8 7.8 -2 5
Displacement of [125I]-LVA from prairie vole vasopressin V1A receptor after 72 hrsDisplacement of [125I]-LVA from prairie vole vasopressin V1A receptor after 72 hrs
ChEMBL 707 9 0 6 4.3 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OC/C=C\I)c2)CC1 10.1016/j.bmc.2012.02.019
CHEMBL2017868 73648 None 0 Prairie vole Binding pKi = 7.8 7.8 -2 5
Displacement of [125I]-LVA from prairie vole vasopressin V1A receptor after 72 hrsDisplacement of [125I]-LVA from prairie vole vasopressin V1A receptor after 72 hrs
ChEMBL 707 9 0 6 4.3 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OC/C=C\I)c2)CC1 10.1016/j.bmc.2012.02.019
15952129 118653 None 0 Human Binding pKi = 7.8 7.8 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 366 1 1 2 4.4 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)COc1ccccc12 10.1021/jm501745f
CHEMBL3416874 118653 None 0 Human Binding pKi = 7.8 7.8 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 366 1 1 2 4.4 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)COc1ccccc12 10.1021/jm501745f
54583238 61849 None 0 Human Binding pKi = 7.8 7.8 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 606 13 1 6 4.2 COc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)N(CCCN2CCN(C)CC2)Cc2ccccc2)c(C)c1C 10.1016/j.bmcl.2011.02.096
CHEMBL1773859 61849 None 0 Human Binding pKi = 7.8 7.8 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 606 13 1 6 4.2 COc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)N(CCCN2CCN(C)CC2)Cc2ccccc2)c(C)c1C 10.1016/j.bmcl.2011.02.096
56682530 63208 None 0 Human Binding pKi = 7.8 7.8 -39 4
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1053 18 12 14 -2.6 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm030611c
CHEMBL1790575 63208 None 0 Human Binding pKi = 7.8 7.8 -39 4
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1053 18 12 14 -2.6 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm030611c
162646537 179603 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 357 1 1 4 2.9 O=C(N1CCN(c2ccccn2)CC1)N1CCNc2cc(Cl)ccc21 10.1016/j.bmcl.2020.127416
CHEMBL4742334 179603 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 357 1 1 4 2.9 O=C(N1CCN(c2ccccn2)CC1)N1CCNc2cc(Cl)ccc21 10.1016/j.bmcl.2020.127416
11692335 71982 None 0 Human Binding pKi = 5.8 5.8 -3 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 537 10 1 6 3.1 CCOc1ccc(S(=O)(=O)N(CC(=O)N2Cc3ccccc3CC2CC(N)=O)c2ccc(OC)cc2)cc1 10.1021/jm050645f
CHEMBL197378 71982 None 0 Human Binding pKi = 5.8 5.8 -3 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 537 10 1 6 3.1 CCOc1ccc(S(=O)(=O)N(CC(=O)N2Cc3ccccc3CC2CC(N)=O)c2ccc(OC)cc2)cc1 10.1021/jm050645f
11620428 141271 None 0 Human Binding pKi = 5.8 5.8 -2 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 509 9 1 6 2.9 CCOc1ccc(S(=O)(=O)N(CC(=O)N2Cc3ccccc3C2C(N)=O)c2ccc(OC)cc2)cc1 10.1021/jm050645f
CHEMBL383149 141271 None 0 Human Binding pKi = 5.8 5.8 -2 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 509 9 1 6 2.9 CCOc1ccc(S(=O)(=O)N(CC(=O)N2Cc3ccccc3C2C(N)=O)c2ccc(OC)cc2)cc1 10.1021/jm050645f
9981665 118475 None 4 Human Binding pKi = 5.8 5.8 -4 6
Displacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissue
ChEMBL 459 5 2 4 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC(=O)O)C2 10.1021/jm901812z
CHEMBL341339 118475 None 4 Human Binding pKi = 5.8 5.8 -4 6
Displacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissue
ChEMBL 459 5 2 4 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC(=O)O)C2 10.1021/jm901812z
44325703 111401 None 0 Human Binding pKi = 5.8 5.8 -75 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 553 4 2 5 5.8 O=C(Nc1ccc(C(=O)N2C[C@H]3COCCN3Cc3ccccc32)c(Cl)c1)c1ccc(O)cc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL327242 111401 None 0 Human Binding pKi = 5.8 5.8 -75 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 553 4 2 5 5.8 O=C(Nc1ccc(C(=O)N2C[C@H]3COCCN3Cc3ccccc32)c(Cl)c1)c1ccc(O)cc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
145974638 164592 None 0 Human Binding pKi = 6.8 6.8 4 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 347 2 1 4 3.7 Cc1ccn(-c2ccc(C(=O)N3CCCC(O)c4ccccc43)cc2)n1 10.1021/acs.jmedchem.8b00697
CHEMBL4215696 164592 None 0 Human Binding pKi = 6.8 6.8 4 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 347 2 1 4 3.7 Cc1ccn(-c2ccc(C(=O)N3CCCC(O)c4ccccc43)cc2)n1 10.1021/acs.jmedchem.8b00697
162675154 183422 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 370 2 1 3 3.5 O=C(N1CCN(Cc2ccccc2)CC1)N1CCNc2cc(Cl)ccc21 10.1016/j.bmcl.2020.127416
CHEMBL4798616 183422 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 370 2 1 3 3.5 O=C(N1CCN(Cc2ccccc2)CC1)N1CCNc2cc(Cl)ccc21 10.1016/j.bmcl.2020.127416
135916060 201086 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 444 3 2 5 3.9 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCCC1 10.1021/jm901084f
CHEMBL602871 201086 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 444 3 2 5 3.9 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCCC1 10.1021/jm901084f
145962220 161575 None 0 Human Binding pKi = 5.8 5.8 -33 2
Displacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1095 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2cccc(c2)CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL4129142 161575 None 0 Human Binding pKi = 5.8 5.8 -33 2
Displacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1095 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2cccc(c2)CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
54584224 61876 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 546 12 1 4 4.3 CN1CCN(CCCN(Cc2ccccc2)C(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)Cc2ccccc2)CC1 10.1016/j.bmcl.2011.02.096
CHEMBL1773994 61876 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 546 12 1 4 4.3 CN1CCN(CCCN(Cc2ccccc2)C(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)Cc2ccccc2)CC1 10.1016/j.bmcl.2011.02.096
56673646 64043 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 435 10 2 3 3.3 CN(C)CCCNC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1 10.1016/j.bmcl.2011.05.092
CHEMBL1807261 64043 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 435 10 2 3 3.3 CN(C)CCCNC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1 10.1016/j.bmcl.2011.05.092
56666702 64059 None 0 Rat Binding pKi = 6.8 6.8 -57 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 422 9 3 3 3.2 CC(O)CCNC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1 10.1016/j.bmcl.2011.05.092
CHEMBL1807277 64059 None 0 Rat Binding pKi = 6.8 6.8 -57 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 422 9 3 3 3.2 CC(O)CCNC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1 10.1016/j.bmcl.2011.05.092
46890053 6854 None 0 Human Binding pKi = 7.8 7.8 141 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 413 3 0 2 6.6 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1ccc2ccccc2c1 10.1016/j.bmcl.2010.04.068
CHEMBL1084112 6854 None 0 Human Binding pKi = 7.8 7.8 141 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 413 3 0 2 6.6 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1ccc2ccccc2c1 10.1016/j.bmcl.2010.04.068
44520851 199797 None 0 Human Binding pKi = 7.8 7.8 -1 2
Displacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation countingDisplacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation counting
ChEMBL 503 5 2 4 4.4 C[C@H]1CCN(c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCCO)c4ccccc43)c(Cl)c2)C1 10.1016/j.bmc.2009.10.038
CHEMBL594026 199797 None 0 Human Binding pKi = 7.8 7.8 -1 2
Displacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation countingDisplacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation counting
ChEMBL 503 5 2 4 4.4 C[C@H]1CCN(c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCCO)c4ccccc43)c(Cl)c2)C1 10.1016/j.bmc.2009.10.038
10164478 206683 None 0 Rat Binding pKi = 7.8 7.8 -16 4
Binding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liverBinding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liver
ChEMBL 509 11 0 6 6.1 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCCCN1CCN(C)CC1 10.1021/jm010544r
CHEMBL89552 206683 None 0 Rat Binding pKi = 7.8 7.8 -16 4
Binding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liverBinding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liver
ChEMBL 509 11 0 6 6.1 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCCCN1CCN(C)CC1 10.1021/jm010544r
56671723 63226 None 0 Human Binding pKi = 7.8 7.8 -53 3
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1311 17 15 21 -0.4 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
CHEMBL1790729 63226 None 0 Human Binding pKi = 7.8 7.8 -53 3
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1311 17 15 21 -0.4 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
54587188 61905 None 0 Human Binding pKi = 7.8 7.8 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 469 8 2 4 3.4 COc1ccc(CC(=O)N[C@H](Cc2ccc(Cl)cc2)C(=O)N[C@@H]2C[C@@H]3CC[C@H](C2)N3C)cc1 10.1016/j.bmcl.2011.02.096
CHEMBL1774020 61905 None 0 Human Binding pKi = 7.8 7.8 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 469 8 2 4 3.4 COc1ccc(CC(=O)N[C@H](Cc2ccc(Cl)cc2)C(=O)N[C@@H]2C[C@@H]3CC[C@H](C2)N3C)cc1 10.1016/j.bmcl.2011.02.096
44297641 167750 None 0 Rat Binding pKi = 7.8 7.8 - 1
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1301 36 15 16 -2.2 CN(C(=O)c1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL430301 167750 None 0 Rat Binding pKi = 7.8 7.8 - 1
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1301 36 15 16 -2.2 CN(C(=O)c1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
31112441 180336 None 1 Human Binding pKi = 6.8 6.8 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 439 4 1 4 4.9 Cc1ccccc1N1CCN(C(=O)c2ccc(Cl)c(NC(=O)c3cccs3)c2)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4751260 180336 None 1 Human Binding pKi = 6.8 6.8 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 439 4 1 4 4.9 Cc1ccccc1N1CCN(C(=O)c2ccc(Cl)c(NC(=O)c3cccs3)c2)CC1 10.1016/j.bmcl.2020.127416
135916061 201114 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 418 3 2 5 3.4 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N(C)C 10.1021/jm901084f
CHEMBL603075 201114 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 418 3 2 5 3.4 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N(C)C 10.1021/jm901084f
44520848 199942 None 0 Human Binding pKi = 6.8 6.8 -2 2
Displacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation countingDisplacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation counting
ChEMBL 534 5 2 5 4.4 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCCO)c4ccccc43)c(C(F)(F)F)c2)n1 10.1016/j.bmc.2009.10.038
CHEMBL594953 199942 None 0 Human Binding pKi = 6.8 6.8 -2 2
Displacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation countingDisplacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation counting
ChEMBL 534 5 2 5 4.4 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCCO)c4ccccc43)c(C(F)(F)F)c2)n1 10.1016/j.bmc.2009.10.038
2192 2356 None 28 Human Binding pKi = 6.8 6.8 -7 3
Displacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 10.1021/jm901812z
9690136 2356 None 28 Human Binding pKi = 6.8 6.8 -7 3
Displacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 10.1021/jm901812z
CHEMBL1254024 2356 None 28 Human Binding pKi = 6.8 6.8 -7 3
Displacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 10.1021/jm901812z
54585429 62374 None 0 Human Binding pKi = 6.8 6.8 -30 4
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 661 9 1 12 1.7 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cnc(OC)nc3OC)(N3C[C@H](O)C[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
CHEMBL1779404 62374 None 0 Human Binding pKi = 6.8 6.8 -30 4
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 661 9 1 12 1.7 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cnc(OC)nc3OC)(N3C[C@H](O)C[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
71455302 82374 None 0 Human Binding pKi = 5.8 5.8 -501 3
Displacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 mins
ChEMBL 1441 33 5 17 10.3 CCN1/C(=C/C=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)[O-])cc3C2(C)C)C(C)(CCCC(=O)NCCOCCOCCOCCn2cc(CNC(=O)CCC(=O)NC3CCCN(C(=O)c4ccc(NC(=O)c5ccccc5-c5ccccc5)cc4)c4ccccc43)nn2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm3006146
71482380 82374 None 0 Human Binding pKi = 5.8 5.8 -501 3
Displacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 mins
ChEMBL 1441 33 5 17 10.3 CCN1/C(=C/C=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)[O-])cc3C2(C)C)C(C)(CCCC(=O)NCCOCCOCCOCCn2cc(CNC(=O)CCC(=O)NC3CCCN(C(=O)c4ccc(NC(=O)c5ccccc5-c5ccccc5)cc4)c4ccccc43)nn2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm3006146
CHEMBL2172290 82374 None 0 Human Binding pKi = 5.8 5.8 -501 3
Displacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 mins
ChEMBL 1441 33 5 17 10.3 CCN1/C(=C/C=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)[O-])cc3C2(C)C)C(C)(CCCC(=O)NCCOCCOCCOCCn2cc(CNC(=O)CCC(=O)NC3CCCN(C(=O)c4ccc(NC(=O)c5ccccc5-c5ccccc5)cc4)c4ccccc43)nn2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm3006146
145956003 162620 None 0 Human Binding pKi = 5.8 5.8 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 538 6 3 8 4.4 Cn1ncc2c1Nc1ccccc1N(C(=O)CCc1ccc(N3CCN(Cc4cc(O)cc(O)c4)CC3)cc1)C2 10.1016/j.ejmech.2017.10.059
CHEMBL4169435 162620 None 0 Human Binding pKi = 5.8 5.8 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 538 6 3 8 4.4 Cn1ncc2c1Nc1ccccc1N(C(=O)CCc1ccc(N3CCN(Cc4cc(O)cc(O)c4)CC3)cc1)C2 10.1016/j.ejmech.2017.10.059
135469700 79069 None 0 Human Binding pKi = 6.8 6.8 -85 3
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 555 10 2 7 2.9 CN(C)CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113203 79069 None 0 Human Binding pKi = 6.8 6.8 -85 3
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 555 10 2 7 2.9 CN(C)CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
59657559 118648 None 0 Mouse Binding pKi = 6.8 6.8 -89 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 494 6 1 5 3.6 CN(C)CCNC(=O)Cn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1021/jm501745f
CHEMBL3416869 118648 None 0 Mouse Binding pKi = 6.8 6.8 -89 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 494 6 1 5 3.6 CN(C)CCNC(=O)Cn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1021/jm501745f
46890259 6912 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 454 4 1 3 6.0 COc1cc(-c2cccc(NC(C)=O)c2)c(Cl)cc1C(=O)N1C[C@]2(C)C[C@H]1CC(C)(C)C2 10.1016/j.bmcl.2010.04.068
CHEMBL1084362 6912 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 454 4 1 3 6.0 COc1cc(-c2cccc(NC(C)=O)c2)c(Cl)cc1C(=O)N1C[C@]2(C)C[C@H]1CC(C)(C)C2 10.1016/j.bmcl.2010.04.068
44428579 92055 None 0 Human Binding pKi = 6.8 6.8 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 731 13 1 6 6.2 C[C@@H](NC(=O)[C@H](CC(=O)N1CCC(CCN2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1)c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL241886 92055 None 0 Human Binding pKi = 6.8 6.8 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 731 13 1 6 6.2 C[C@@H](NC(=O)[C@H](CC(=O)N1CCC(CCN2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1)c1ccccc1 10.1016/j.bmc.2006.12.031
44400361 96822 None 0 Human Binding pKi = 7.8 7.8 - 1
Binding affinity against human vasopressin V1a receptor expressed in CHO cellsBinding affinity against human vasopressin V1a receptor expressed in CHO cells
ChEMBL 1490 38 15 16 -1.3 COc1ccc(C[C@@H](NC(=O)c2ccc(C(=O)c3ccccc3)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc(O)c(I)c2)C(N)=O)cc1 10.1021/jm040871+
91936750 96822 None 0 Human Binding pKi = 7.8 7.8 - 1
Binding affinity against human vasopressin V1a receptor expressed in CHO cellsBinding affinity against human vasopressin V1a receptor expressed in CHO cells
ChEMBL 1490 38 15 16 -1.3 COc1ccc(C[C@@H](NC(=O)c2ccc(C(=O)c3ccccc3)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc(O)c(I)c2)C(N)=O)cc1 10.1021/jm040871+
CHEMBL265137 96822 None 0 Human Binding pKi = 7.8 7.8 - 1
Binding affinity against human vasopressin V1a receptor expressed in CHO cellsBinding affinity against human vasopressin V1a receptor expressed in CHO cells
ChEMBL 1490 38 15 16 -1.3 COc1ccc(C[C@@H](NC(=O)c2ccc(C(=O)c3ccccc3)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc(O)c(I)c2)C(N)=O)cc1 10.1021/jm040871+
136961690 118592 None 0 Human Binding pKi = 7.8 7.8 -1 3
Binding affinity to V1aR (unknown origin)Binding affinity to V1aR (unknown origin)
ChEMBL 412 3 1 6 4.2 Cc1ccn(Cc2ccc(C(=O)N3Cc4cnn(C)c4Nc4ccccc43)cc2C)n1 10.1021/jm501395b
CHEMBL3416757 118592 None 0 Human Binding pKi = 7.8 7.8 -1 3
Binding affinity to V1aR (unknown origin)Binding affinity to V1aR (unknown origin)
ChEMBL 412 3 1 6 4.2 Cc1ccn(Cc2ccc(C(=O)N3Cc4cnn(C)c4Nc4ccccc43)cc2C)n1 10.1021/jm501395b
135916069 201541 None 0 Human Binding pKi = 7.8 7.8 1 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 398 2 1 6 4.1 Cc1ccn(-c2ccc(C(=O)N3Cc4cnn(C)c4Nc4ccccc43)cc2C)n1 10.1021/jm901084f
CHEMBL605373 201541 None 0 Human Binding pKi = 7.8 7.8 1 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 398 2 1 6 4.1 Cc1ccn(-c2ccc(C(=O)N3Cc4cnn(C)c4Nc4ccccc43)cc2C)n1 10.1021/jm901084f
44325804 207308 None 0 Human Binding pKi = 7.8 7.8 -37 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 533 4 1 4 6.5 Cc1ccc2c(c1)N(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)CC1CSCCN1C2 10.1016/j.bmcl.2004.03.083
CHEMBL93366 207308 None 0 Human Binding pKi = 7.8 7.8 -37 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 533 4 1 4 6.5 Cc1ccc2c(c1)N(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)CC1CSCCN1C2 10.1016/j.bmcl.2004.03.083
44428489 152079 None 0 Human Binding pKi = 7.7 7.7 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 703 10 1 6 4.7 CC(C)N1CCN(C(=O)C(C(=O)NCc2cccc(C(F)(F)F)c2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)CC1 10.1016/j.bmc.2006.12.031
CHEMBL396756 152079 None 0 Human Binding pKi = 7.7 7.7 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 703 10 1 6 4.7 CC(C)N1CCN(C(=O)C(C(=O)NCc2cccc(C(F)(F)F)c2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)CC1 10.1016/j.bmc.2006.12.031
56666700 64047 None 0 Human Binding pKi = 7.7 7.7 5 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 434 9 3 3 3.3 O=C(NCCCO)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C1(c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807265 64047 None 0 Human Binding pKi = 7.7 7.7 5 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 434 9 3 3 3.3 O=C(NCCCO)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C1(c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.05.092
2249 2225 None 18 Human Binding pKi = 6.8 6.8 -48 6
Binding affinity to human liver V1A receptorBinding affinity to human liver V1A receptor
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1016/j.bmcl.2012.10.116
9872389 2225 None 18 Human Binding pKi = 6.8 6.8 -48 6
Binding affinity to human liver V1A receptorBinding affinity to human liver V1A receptor
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1016/j.bmcl.2012.10.116
CHEMBL1253853 2225 None 18 Human Binding pKi = 6.8 6.8 -48 6
Binding affinity to human liver V1A receptorBinding affinity to human liver V1A receptor
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1016/j.bmcl.2012.10.116
162650665 180148 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 392 3 0 5 5.0 Clc1ccc2c(c1)C1CC1c1nnc([C@H]3CC[C@@H](Oc4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
CHEMBL4748895 180148 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 392 3 0 5 5.0 Clc1ccc2c(c1)C1CC1c1nnc([C@H]3CC[C@@H](Oc4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
2249 2225 None 18 Human Binding pKi = 6.8 6.8 -48 6
Displacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissue
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1021/jm901812z
9872389 2225 None 18 Human Binding pKi = 6.8 6.8 -48 6
Displacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissue
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1021/jm901812z
CHEMBL1253853 2225 None 18 Human Binding pKi = 6.8 6.8 -48 6
Displacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissue
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1021/jm901812z
11519251 166312 None 0 Human Binding pKi = 5.8 5.8 -3 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 521 9 1 5 3.4 CCOc1ccc(S(=O)(=O)N(CC(=O)N2Cc3ccccc3CC2CC(N)=O)c2ccc(C)cc2)cc1 10.1021/jm050645f
CHEMBL427190 166312 None 0 Human Binding pKi = 5.8 5.8 -3 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 521 9 1 5 3.4 CCOc1ccc(S(=O)(=O)N(CC(=O)N2Cc3ccccc3CC2CC(N)=O)c2ccc(C)cc2)cc1 10.1021/jm050645f
16109439 137240 None 0 Rat Binding pKi = 5.8 5.8 -177 5
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1023 15 11 14 -1.7 NC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL375187 137240 None 0 Rat Binding pKi = 5.8 5.8 -177 5
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1023 15 11 14 -1.7 NC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
54582291 61888 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 493 7 1 5 2.9 COc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)N2CCN(C)CC2)c(C)c1C 10.1016/j.bmcl.2011.02.096
CHEMBL1774003 61888 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 493 7 1 5 2.9 COc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)N2CCN(C)CC2)c(C)c1C 10.1016/j.bmcl.2011.02.096
11619807 72888 None 0 Human Binding pKi = 5.7 5.7 1 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 472 9 1 6 3.5 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C/c2ccccn2)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL200368 72888 None 0 Human Binding pKi = 5.7 5.7 1 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 472 9 1 6 3.5 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C/c2ccccn2)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
46890216 6851 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 458 3 1 2 6.7 CC(=O)Nc1cccc(-c2ccc(C(=O)N3C[C@]4(C)C[C@H]3CC(C)(C)C4)c(Cl)c2Cl)c1 10.1016/j.bmcl.2010.04.068
CHEMBL1084085 6851 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 458 3 1 2 6.7 CC(=O)Nc1cccc(-c2ccc(C(=O)N3C[C@]4(C)C[C@H]3CC(C)(C)C4)c(Cl)c2Cl)c1 10.1016/j.bmcl.2010.04.068
45483204 197885 None 0 Human Binding pKi = 6.7 6.7 -11 5
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL1204126 197885 None 0 Human Binding pKi = 6.7 6.7 -11 5
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL1204403 197885 None 0 Human Binding pKi = 6.7 6.7 -11 5
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL572709 197885 None 0 Human Binding pKi = 6.7 6.7 -11 5
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
118734334 118595 None 0 Human Binding pKi = 7.7 7.7 10 2
Binding affinity to human V1a assessed as inhibition constantBinding affinity to human V1a assessed as inhibition constant
ChEMBL 416 3 1 3 5.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCSc3cccc(C)c32)cc1 10.1016/j.bmcl.2017.11.050
CHEMBL3416767 118595 None 0 Human Binding pKi = 7.7 7.7 10 2
Binding affinity to human V1a assessed as inhibition constantBinding affinity to human V1a assessed as inhibition constant
ChEMBL 416 3 1 3 5.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCSc3cccc(C)c32)cc1 10.1016/j.bmcl.2017.11.050
118734334 118595 None 0 Human Binding pKi = 7.7 7.7 10 2
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 416 3 1 3 5.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCSc3cccc(C)c32)cc1 10.1021/acs.jmedchem.5b00289
CHEMBL3416767 118595 None 0 Human Binding pKi = 7.7 7.7 10 2
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 416 3 1 3 5.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCSc3cccc(C)c32)cc1 10.1021/acs.jmedchem.5b00289
CHEMBL2369829 209694 None 0 Human Binding pKi = 7.7 7.7 -16 4
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL None None None CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
CHEMBL2369841 209704 None 0 Human Binding pKi = 7.7 7.7 -5 4
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL None None None NC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
44520867 182024 None 0 Human Binding pKi = 6.7 6.7 -5 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 456 3 1 4 4.4 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(N)=O)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
CHEMBL478082 182024 None 0 Human Binding pKi = 6.7 6.7 -5 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 456 3 1 4 4.4 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(N)=O)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
56673645 64040 None 0 Rat Binding pKi = 6.7 6.7 -17 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 447 7 2 3 3.5 CN1CCC(NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)Cc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807258 64040 None 0 Rat Binding pKi = 6.7 6.7 -17 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 447 7 2 3 3.5 CN1CCC(NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)Cc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.05.092
44325607 112154 None 0 Human Binding pKi = 5.7 5.7 -660 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 567 5 1 5 6.1 COc1ccc(-c2ccccc2C(=O)Nc2ccc(C(=O)N3C[C@H]4COCCN4Cc4ccccc43)c(Cl)c2)cc1 10.1016/j.bmcl.2004.03.083
CHEMBL329026 112154 None 0 Human Binding pKi = 5.7 5.7 -660 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 567 5 1 5 6.1 COc1ccc(-c2ccccc2C(=O)Nc2ccc(C(=O)N3C[C@H]4COCCN4Cc4ccccc43)c(Cl)c2)cc1 10.1016/j.bmcl.2004.03.083
44325704 112305 None 0 Human Binding pKi = 5.7 5.7 -64 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 553 4 2 5 5.8 O=C(Nc1ccc(C(=O)N2C[C@H]3COCCN3Cc3ccccc32)c(Cl)c1)c1cc(O)ccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL329141 112305 None 0 Human Binding pKi = 5.7 5.7 -64 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 553 4 2 5 5.8 O=C(Nc1ccc(C(=O)N2C[C@H]3COCCN3Cc3ccccc32)c(Cl)c1)c1cc(O)ccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
145953063 162650 None 0 Human Binding pKi = 5.7 5.7 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 552 7 1 8 4.6 COc1cc(CN2CCN(c3ccc(CC(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
CHEMBL4169830 162650 None 0 Human Binding pKi = 5.7 5.7 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 552 7 1 8 4.6 COc1cc(CN2CCN(c3ccc(CC(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
45483204 197885 None 0 Rat Binding pKi = 5.7 5.7 -40 5
Displacement of [3H]Arg8-vasopressin from rat vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from rat vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL1204126 197885 None 0 Rat Binding pKi = 5.7 5.7 -40 5
Displacement of [3H]Arg8-vasopressin from rat vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from rat vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL1204403 197885 None 0 Rat Binding pKi = 5.7 5.7 -40 5
Displacement of [3H]Arg8-vasopressin from rat vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from rat vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL572709 197885 None 0 Rat Binding pKi = 5.7 5.7 -40 5
Displacement of [3H]Arg8-vasopressin from rat vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from rat vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
45483238 198762 None 0 Human Binding pKi = 6.7 6.7 -2 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 613 11 1 7 4.2 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCc3ccccc3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL583083 198762 None 0 Human Binding pKi = 6.7 6.7 -2 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 613 11 1 7 4.2 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCc3ccccc3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
54585431 62385 None 0 Human Binding pKi = 6.7 6.7 -162 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 662 9 0 9 5.8 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN4CCCC4)ccc3OC)(N3CCC[C@H]3c3ncco3)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
CHEMBL1779417 62385 None 0 Human Binding pKi = 6.7 6.7 -162 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 662 9 0 9 5.8 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN4CCCC4)ccc3OC)(N3CCC[C@H]3c3ncco3)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
145953061 162647 None 0 Human Binding pKi = 5.7 5.7 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 524 5 3 8 4.0 Cn1ncc2c1Nc1ccccc1N(C(=O)Cc1ccccc1N1CCN(Cc3cc(O)cc(O)c3)CC1)C2 10.1016/j.ejmech.2017.10.059
CHEMBL4169825 162647 None 0 Human Binding pKi = 5.7 5.7 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 524 5 3 8 4.0 Cn1ncc2c1Nc1ccccc1N(C(=O)Cc1ccccc1N1CCN(Cc3cc(O)cc(O)c3)CC1)C2 10.1016/j.ejmech.2017.10.059
137212771 137886 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 546 11 1 8 4.8 COc1cc(CN2CCN(CCCCCCC(=O)N3Cc4cnn(C)c4Nc4ccccc43)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
CHEMBL3763174 137886 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 546 11 1 8 4.8 COc1cc(CN2CCN(CCCCCCC(=O)N3Cc4cnn(C)c4Nc4ccccc43)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
54582311 61901 None 0 Rat Binding pKi = 6.7 6.7 -1 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 493 7 3 3 4.3 O=C(Cc1ccc(Cl)c(Cl)c1)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@@H]1C[C@@H]2CC[C@H](C1)N2 10.1016/j.bmcl.2011.02.096
CHEMBL1774016 61901 None 0 Rat Binding pKi = 6.7 6.7 -1 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 493 7 3 3 4.3 O=C(Cc1ccc(Cl)c(Cl)c1)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@@H]1C[C@@H]2CC[C@H](C1)N2 10.1016/j.bmcl.2011.02.096
119369 2604 None 74 Human Binding pKi = 6.7 6.7 -6 8
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1021/jm3006146
2197 2604 None 74 Human Binding pKi = 6.7 6.7 -6 8
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1021/jm3006146
4004 2604 None 74 Human Binding pKi = 6.7 6.7 -6 8
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1021/jm3006146
CHEMBL420762 2604 None 74 Human Binding pKi = 6.7 6.7 -6 8
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1021/jm3006146
137212771 137886 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader methodDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader method
ChEMBL 546 11 1 8 4.8 COc1cc(CN2CCN(CCCCCCC(=O)N3Cc4cnn(C)c4Nc4ccccc43)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
CHEMBL3763174 137886 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader methodDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader method
ChEMBL 546 11 1 8 4.8 COc1cc(CN2CCN(CCCCCCC(=O)N3Cc4cnn(C)c4Nc4ccccc43)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
145960494 161559 None 0 Human Binding pKi = 5.7 5.7 -13 2
Displacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1081 17 11 14 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccc(cc2)SC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL4128839 161559 None 0 Human Binding pKi = 5.7 5.7 -13 2
Displacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1081 17 11 14 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccc(cc2)SC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
135413563 122928 None 25 Human Binding pKi = 6.7 6.7 -1 2
Displacement of DY647 from SNAP-tagged V1A receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayDisplacement of DY647 from SNAP-tagged V1A receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL360648 122928 None 25 Human Binding pKi = 6.7 6.7 -1 2
Displacement of DY647 from SNAP-tagged V1A receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayDisplacement of DY647 from SNAP-tagged V1A receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/acs.jmedchem.8b00697
16063234 118659 None 3 Mouse Binding pKi = 5.7 5.7 -16 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 373 2 1 2 4.4 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCN(c2ccccc2Cl)CC1 10.1021/jm501745f
CHEMBL3416880 118659 None 3 Mouse Binding pKi = 5.7 5.7 -16 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 373 2 1 2 4.4 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCN(c2ccccc2Cl)CC1 10.1021/jm501745f
15953022 118640 None 0 Human Binding pKi = 8.7 8.7 104 3
Antagonist activity at human vasopressin 1a receptorAntagonist activity at human vasopressin 1a receptor
ChEMBL 436 3 0 3 5.7 Cc1c(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccccc2n1Cc1ccccc1 10.1021/acs.jmedchem.6b01437
CHEMBL3416860 118640 None 0 Human Binding pKi = 8.7 8.7 104 3
Antagonist activity at human vasopressin 1a receptorAntagonist activity at human vasopressin 1a receptor
ChEMBL 436 3 0 3 5.7 Cc1c(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccccc2n1Cc1ccccc1 10.1021/acs.jmedchem.6b01437
2200 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/np50112a001
3482 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/np50112a001
60943 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/np50112a001
CHEMBL419667 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/np50112a001
DB13929 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10.1021/np50112a001
9938406 93315 None 1 Rat Binding pKi = 8.7 8.7 -2 6
Binding affinity towards rat liver Vasopressin V1a receptor by using functional assayBinding affinity towards rat liver Vasopressin V1a receptor by using functional assay
ChEMBL 589 7 0 6 4.7 CC(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)c(OCC(F)(F)F)c2)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL24526 93315 None 1 Rat Binding pKi = 8.7 8.7 -2 6
Binding affinity towards rat liver Vasopressin V1a receptor by using functional assayBinding affinity towards rat liver Vasopressin V1a receptor by using functional assay
ChEMBL 589 7 0 6 4.7 CC(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)c(OCC(F)(F)F)c2)CC1 10.1016/s0960-894x(99)00181-x
15953022 118640 None 0 Human Binding pKi = 8.7 8.7 104 3
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 436 3 0 3 5.7 Cc1c(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccccc2n1Cc1ccccc1 10.1021/jm501745f
CHEMBL3416860 118640 None 0 Human Binding pKi = 8.7 8.7 104 3
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 436 3 0 3 5.7 Cc1c(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccccc2n1Cc1ccccc1 10.1021/jm501745f
59657559 118648 None 0 Human Binding pKi = 8.7 8.7 89 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 494 6 1 5 3.6 CN(C)CCNC(=O)Cn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1021/jm501745f
CHEMBL3416869 118648 None 0 Human Binding pKi = 8.7 8.7 89 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 494 6 1 5 3.6 CN(C)CCNC(=O)Cn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1021/jm501745f
162674253 183223 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 371 1 1 4 3.2 Cc1cccnc1N1CCN(C(=O)N2CCNc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4796133 183223 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 371 1 1 4 3.2 Cc1cccnc1N1CCN(C(=O)N2CCNc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
162676406 183418 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 405 1 0 4 3.6 CN1CCN(C(=O)N2CCN(c3ncccc3Cl)CC2)c2ccc(Cl)cc21 10.1016/j.bmcl.2020.127416
CHEMBL4798542 183418 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 405 1 0 4 3.6 CN1CCN(C(=O)N2CCN(c3ncccc3Cl)CC2)c2ccc(Cl)cc21 10.1016/j.bmcl.2020.127416
2168 3974 None 38 Human Binding pKi = 8.7 8.7 -5 9
Displacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
2810 3974 None 38 Human Binding pKi = 8.7 8.7 -5 9
Displacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
644077 3974 None 38 Human Binding pKi = 8.7 8.7 -5 9
Displacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
CHEMBL373742 3974 None 38 Human Binding pKi = 8.7 8.7 -5 9
Displacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
DB00067 3974 None 38 Human Binding pKi = 8.7 8.7 -5 9
Displacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
137652605 158832 None 0 Human Binding pKi = 8.7 8.7 22 2
Displacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting methodDisplacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting method
ChEMBL 414 3 2 3 5.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC[C@H](O)c3c(C)cccc32)cc1 10.1021/acs.jmedchem.7b00422
CHEMBL4094707 158832 None 0 Human Binding pKi = 8.7 8.7 22 2
Displacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting methodDisplacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting method
ChEMBL 414 3 2 3 5.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC[C@H](O)c3c(C)cccc32)cc1 10.1021/acs.jmedchem.7b00422
54581299 61902 None 0 Human Binding pKi = 8.7 8.7 97 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 473 7 2 3 4.0 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1)C2 10.1016/j.bmcl.2011.02.096
CHEMBL1774017 61902 None 0 Human Binding pKi = 8.7 8.7 97 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 473 7 2 3 4.0 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1)C2 10.1016/j.bmcl.2011.02.096
56666702 64059 None 0 Human Binding pKi = 8.7 8.7 57 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 422 9 3 3 3.2 CC(O)CCNC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1 10.1016/j.bmcl.2011.05.092
CHEMBL1807277 64059 None 0 Human Binding pKi = 8.7 8.7 57 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 422 9 3 3 3.2 CC(O)CCNC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1 10.1016/j.bmcl.2011.05.092
56680284 64052 None 0 Rat Binding pKi = 8.7 8.7 -21 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 515 8 2 3 5.1 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)C2(c3ccc(Cl)cc3)CCC2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807270 64052 None 0 Rat Binding pKi = 8.7 8.7 -21 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 515 8 2 3 5.1 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)C2(c3ccc(Cl)cc3)CCC2)CC1 10.1016/j.bmcl.2011.05.092
44428109 10316 None 0 Human Binding pKi = 8.7 8.7 -1 2
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 1629 38 18 23 -0.0 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CC[C@H](C(=O)N(C(=O)c2ccc(-c3c4ccc(=N)c(S(=O)(=O)O)c-4oc4c(S(=O)(=O)O)c(N)ccc34)c(C(=O)O)c2)[C@@H](CCCCN)C(N)=O)C1 10.1021/jm061404q
91935618 10316 None 0 Human Binding pKi = 8.7 8.7 -1 2
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 1629 38 18 23 -0.0 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CC[C@H](C(=O)N(C(=O)c2ccc(-c3c4ccc(=N)c(S(=O)(=O)O)c-4oc4c(S(=O)(=O)O)c(N)ccc34)c(C(=O)O)c2)[C@@H](CCCCN)C(N)=O)C1 10.1021/jm061404q
CHEMBL1161979 10316 None 0 Human Binding pKi = 8.7 8.7 -1 2
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 1629 38 18 23 -0.0 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CC[C@H](C(=O)N(C(=O)c2ccc(-c3c4ccc(=N)c(S(=O)(=O)O)c-4oc4c(S(=O)(=O)O)c(N)ccc34)c(C(=O)O)c2)[C@@H](CCCCN)C(N)=O)C1 10.1021/jm061404q
11016093 168053 None 0 Human Binding pKi = 8.7 8.7 2089 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 466 9 1 5 6.5 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCC1CCNCC1 10.1021/jm010544r
CHEMBL432375 168053 None 0 Human Binding pKi = 8.7 8.7 2089 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 466 9 1 5 6.5 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCC1CCNCC1 10.1021/jm010544r
46890615 6672 None 0 Human Binding pKi = 8.7 8.7 128 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 411 3 0 2 6.4 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1ccc(Cl)cc1C 10.1016/j.bmcl.2010.04.068
CHEMBL1083444 6672 None 0 Human Binding pKi = 8.7 8.7 128 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 411 3 0 2 6.4 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1ccc(Cl)cc1C 10.1016/j.bmcl.2010.04.068
67839485 164199 None 0 Human Binding pKi = 8.6 8.6 4 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 327 2 0 1 5.3 O=C(c1ccc(-c2ccccc2)cc1)N1CCCCc2ccccc21 10.1021/acs.jmedchem.8b00697
CHEMBL4210854 164199 None 0 Human Binding pKi = 8.6 8.6 4 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 327 2 0 1 5.3 O=C(c1ccc(-c2ccccc2)cc1)N1CCCCc2ccccc21 10.1021/acs.jmedchem.8b00697
53364234 64055 None 0 Rat Binding pKi = 8.6 8.6 -9 3
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 485 8 2 3 4.2 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)C2(c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807273 64055 None 0 Rat Binding pKi = 8.6 8.6 -9 3
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 485 8 2 3 4.2 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)C2(c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2011.05.092
162645320 179504 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 360 3 0 5 4.3 c1ccc(O[C@H]2CC[C@H](c3nnc4n3-c3ccccc3CCC4)CC2)nc1 10.1016/j.bmcl.2020.127417
CHEMBL4741178 179504 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 360 3 0 5 4.3 c1ccc(O[C@H]2CC[C@H](c3nnc4n3-c3ccccc3CCC4)CC2)nc1 10.1016/j.bmcl.2020.127417
162670181 182751 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 465 3 0 3 5.3 Cc1ccccc1N1CCN(C(=O)N2C[C@H](C(=O)C3CCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4790089 182751 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 465 3 0 3 5.3 Cc1ccccc1N1CCN(C(=O)N2C[C@H](C(=O)C3CCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
25109291 191384 None 10 Human Binding pKi = 8.6 8.6 -56 8
Displacement of radiolabeled [d(CH2)51,Tyr(Me)2]-AVP from human vasopressin V1a receptorDisplacement of radiolabeled [d(CH2)51,Tyr(Me)2]-AVP from human vasopressin V1a receptor
ChEMBL 327 1 2 6 1.7 Nc1nc2c(c(N3CCNCC3)n1)CCC1=C2[C@@H]2CCCC[C@@H]2O1 10.1021/jm8007618
CHEMBL519240 191384 None 10 Human Binding pKi = 8.6 8.6 -56 8
Displacement of radiolabeled [d(CH2)51,Tyr(Me)2]-AVP from human vasopressin V1a receptorDisplacement of radiolabeled [d(CH2)51,Tyr(Me)2]-AVP from human vasopressin V1a receptor
ChEMBL 327 1 2 6 1.7 Nc1nc2c(c(N3CCNCC3)n1)CCC1=C2[C@@H]2CCCC[C@@H]2O1 10.1021/jm8007618
44400328 159671 None 0 Human Binding pKi = 8.6 8.6 - 1
Binding affinity against human vasopressin V1a receptor expressed in CHO cellsBinding affinity against human vasopressin V1a receptor expressed in CHO cells
ChEMBL 1474 38 15 15 -1.4 NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(C(=O)c2ccccc2)cc1)NC(=O)Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)c(I)c1)C(N)=O 10.1021/jm040871+
91936751 159671 None 0 Human Binding pKi = 8.6 8.6 - 1
Binding affinity against human vasopressin V1a receptor expressed in CHO cellsBinding affinity against human vasopressin V1a receptor expressed in CHO cells
ChEMBL 1474 38 15 15 -1.4 NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(C(=O)c2ccccc2)cc1)NC(=O)Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)c(I)c1)C(N)=O 10.1021/jm040871+
CHEMBL410401 159671 None 0 Human Binding pKi = 8.6 8.6 - 1
Binding affinity against human vasopressin V1a receptor expressed in CHO cellsBinding affinity against human vasopressin V1a receptor expressed in CHO cells
ChEMBL 1474 38 15 15 -1.4 NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(C(=O)c2ccccc2)cc1)NC(=O)Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)c(I)c1)C(N)=O 10.1021/jm040871+
46890569 7295 None 0 Human Binding pKi = 8.6 8.6 74 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 439 4 0 2 7.1 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1ccccc1-c1ccccc1 10.1016/j.bmcl.2010.04.068
CHEMBL1086052 7295 None 0 Human Binding pKi = 8.6 8.6 74 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 439 4 0 2 7.1 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1ccccc1-c1ccccc1 10.1016/j.bmcl.2010.04.068
162662884 181910 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 440 2 0 3 4.4 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)C(C)C)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4779447 181910 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 440 2 0 3 4.4 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)C(C)C)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
10411308 201232 None 0 Human Binding pKi = 8.6 8.6 -2 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/acs.jmedchem.8b00697
CHEMBL603708 201232 None 0 Human Binding pKi = 8.6 8.6 -2 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/acs.jmedchem.8b00697
10411308 201232 None 0 Human Binding pKi = 8.6 8.6 -2 3
Displacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 mins
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/jm3006146
CHEMBL603708 201232 None 0 Human Binding pKi = 8.6 8.6 -2 3
Displacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 mins
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/jm3006146
10411308 201232 None 0 Human Binding pKi = 8.6 8.6 -2 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/jm901084f
CHEMBL603708 201232 None 0 Human Binding pKi = 8.6 8.6 -2 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/jm901084f
46890570 7296 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 411 3 0 2 6.4 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1cc(Cl)ccc1C 10.1016/j.bmcl.2010.04.068
CHEMBL1086053 7296 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 411 3 0 2 6.4 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1cc(Cl)ccc1C 10.1016/j.bmcl.2010.04.068
56666702 64059 None 0 Human Binding pKi = 8.6 8.6 57 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 422 9 3 3 3.2 CC(O)CCNC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1 10.1016/j.bmcl.2011.05.092
CHEMBL1807277 64059 None 0 Human Binding pKi = 8.6 8.6 57 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 422 9 3 3 3.2 CC(O)CCNC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1 10.1016/j.bmcl.2011.05.092
137637867 156219 None 0 Human Binding pKi = 8.6 8.6 50 2
Displacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting methodDisplacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting method
ChEMBL 414 3 2 3 5.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC[C@@H](O)c3cccc(C)c32)cc1 10.1021/acs.jmedchem.7b00422
CHEMBL4064556 156219 None 0 Human Binding pKi = 8.6 8.6 50 2
Displacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting methodDisplacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting method
ChEMBL 414 3 2 3 5.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC[C@@H](O)c3cccc(C)c32)cc1 10.1021/acs.jmedchem.7b00422
CHEMBL2369831 209696 None 1 Human Binding pKi = 8.5 8.5 -2 4
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL None None None C[C@@H](O)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
44314382 102992 None 0 Rat Binding pKi = 8.5 8.5 14 2
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 648 9 1 6 7.1 Cc1ccc(N(C)C(=O)c2ccc(NC(=O)c3ccoc3C)cc2)c(OCc2ccc(C(=O)N3CCC(N4CCCCC4)CC3)cc2)c1 10.1016/s0960-894x(01)00723-5
CHEMBL306718 102992 None 0 Rat Binding pKi = 8.5 8.5 14 2
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 648 9 1 6 7.1 Cc1ccc(N(C)C(=O)c2ccc(NC(=O)c3ccoc3C)cc2)c(OCc2ccc(C(=O)N3CCC(N4CCCCC4)CC3)cc2)c1 10.1016/s0960-894x(01)00723-5
54584201 61847 None 0 Human Binding pKi = 8.5 8.5 426 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 640 13 1 6 4.8 COc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)N(CCCN2CCN(C)CC2)Cc2ccccc2)c(C)c1C 10.1016/j.bmcl.2011.02.096
CHEMBL1773857 61847 None 0 Human Binding pKi = 8.5 8.5 426 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 640 13 1 6 4.8 COc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)N(CCCN2CCN(C)CC2)Cc2ccccc2)c(C)c1C 10.1016/j.bmcl.2011.02.096
CHEMBL1161783 208510 None 0 Human Binding pKi = 7.7 7.7 - 1
Binding affinity against human vasopressin V1a receptor expressed in CHO cellsBinding affinity against human vasopressin V1a receptor expressed in CHO cells
ChEMBL None None None NC(=O)CC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](N)Cc1ccc(C(=O)c2ccccc2)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)c(I)c1)C(N)=O 10.1021/jm040871+
46890487 6896 None 0 Human Binding pKi = 7.7 7.7 4 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 377 3 0 2 5.7 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1ccccc1C 10.1016/j.bmcl.2010.04.068
CHEMBL1084307 6896 None 0 Human Binding pKi = 7.7 7.7 4 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 377 3 0 2 5.7 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1ccccc1C 10.1016/j.bmcl.2010.04.068
2042 2981 None 58 Human Binding pKi = 7.7 7.7 -29 8
Displacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
2174 2981 None 58 Human Binding pKi = 7.7 7.7 -29 8
Displacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
2176 2981 None 58 Human Binding pKi = 7.7 7.7 -29 8
Displacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
439302 2981 None 58 Human Binding pKi = 7.7 7.7 -29 8
Displacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
CHEMBL395429 2981 None 58 Human Binding pKi = 7.7 7.7 -29 8
Displacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
DB00107 2981 None 58 Human Binding pKi = 7.7 7.7 -29 8
Displacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
44297506 96958 None 0 Rat Binding pKi = 7.7 7.7 - 1
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1301 36 15 16 -2.2 CN(C(=O)c1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL266264 96958 None 0 Rat Binding pKi = 7.7 7.7 - 1
Inhibition constant for V1a receptor of rat liver membraneInhibition constant for V1a receptor of rat liver membrane
ChEMBL 1301 36 15 16 -2.2 CN(C(=O)c1ccc(N=[N+]=[N-])cc1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
44325345 111560 None 0 Human Binding pKi = 5.7 5.7 -75 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 493 3 1 4 4.9 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2C[C@H]3COCCN3Cc3ccccc32)c(Cl)c1 10.1016/j.bmcl.2004.03.083
CHEMBL328079 111560 None 0 Human Binding pKi = 5.7 5.7 -75 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 493 3 1 4 4.9 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2C[C@H]3COCCN3Cc3ccccc32)c(Cl)c1 10.1016/j.bmcl.2004.03.083
54581299 61902 None 0 Rat Binding pKi = 6.7 6.7 -97 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 473 7 2 3 4.0 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1)C2 10.1016/j.bmcl.2011.02.096
CHEMBL1774017 61902 None 0 Rat Binding pKi = 6.7 6.7 -97 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 473 7 2 3 4.0 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1)C2 10.1016/j.bmcl.2011.02.096
56663272 64045 None 0 Rat Binding pKi = 6.7 6.7 -67 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 392 8 2 2 3.8 CCCNC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1 10.1016/j.bmcl.2011.05.092
CHEMBL1807263 64045 None 0 Rat Binding pKi = 6.7 6.7 -67 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 392 8 2 2 3.8 CCCNC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1 10.1016/j.bmcl.2011.05.092
145959208 162187 None 0 Human Binding pKi = 5.7 5.7 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 552 7 1 8 4.6 COc1cc(CN2CCN(c3cccc(CC(=O)N4Cc5cnn(C)c5Nc5ccccc54)c3)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
CHEMBL4162568 162187 None 0 Human Binding pKi = 5.7 5.7 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 552 7 1 8 4.6 COc1cc(CN2CCN(c3cccc(CC(=O)N4Cc5cnn(C)c5Nc5ccccc54)c3)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
54584254 61908 None 0 Rat Binding pKi = 7.7 7.7 -93 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 459 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@@H]1C[C@@H]2CC[C@H](C1)N2 10.1016/j.bmcl.2011.02.096
54584254 61908 None 0 Rat Binding pKi = 7.7 7.7 -93 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 459 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@@H]1C[C@@H]2CC[C@H](C1)N2 10.1016/j.bmcl.2011.05.092
CHEMBL1774023 61908 None 0 Rat Binding pKi = 7.7 7.7 -93 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 459 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@@H]1C[C@@H]2CC[C@H](C1)N2 10.1016/j.bmcl.2011.02.096
CHEMBL1774023 61908 None 0 Rat Binding pKi = 7.7 7.7 -93 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 459 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@@H]1C[C@@H]2CC[C@H](C1)N2 10.1016/j.bmcl.2011.05.092
15953022 118640 None 0 Mouse Binding pKi = 6.7 6.7 -104 3
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 436 3 0 3 5.7 Cc1c(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccccc2n1Cc1ccccc1 10.1021/jm501745f
CHEMBL3416860 118640 None 0 Mouse Binding pKi = 6.7 6.7 -104 3
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 436 3 0 3 5.7 Cc1c(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccccc2n1Cc1ccccc1 10.1021/jm501745f
135438380 79078 None 0 Human Binding pKi = 5.7 5.7 -58 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 510 8 2 5 4.0 CCCc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113212 79078 None 0 Human Binding pKi = 5.7 5.7 -58 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 510 8 2 5 4.0 CCCc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
10984025 112745 None 0 Human Binding pKi = 6.7 6.7 - 1
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 509 11 0 6 6.1 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1cccc(OCCCCCCN2CCN(C)CC2)c1 10.1021/jm010544r
CHEMBL330510 112745 None 0 Human Binding pKi = 6.7 6.7 - 1
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 509 11 0 6 6.1 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1cccc(OCCCCCCN2CCN(C)CC2)c1 10.1021/jm010544r
54581307 61182 None 0 Human Binding pKi = 6.7 6.7 -165 4
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL 1097 21 12 15 -1.4 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
CHEMBL1765666 61182 None 0 Human Binding pKi = 6.7 6.7 -165 4
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL 1097 21 12 15 -1.4 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
56668257 63213 None 0 Human Binding pKi = 6.7 6.7 -35 2
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1484 18 15 21 3.2 CC[C@@H](C)[C@H]1NC(=O)[C@@](C)(c2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)N[C@H](C(N)=O)c2ccc(O)cc2)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H]([C@@H](C)O)NC1=O 10.1021/jm010526+
CHEMBL1790713 63213 None 0 Human Binding pKi = 6.7 6.7 -35 2
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1484 18 15 21 3.2 CC[C@@H](C)[C@H]1NC(=O)[C@@](C)(c2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)N[C@H](C(N)=O)c2ccc(O)cc2)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H]([C@@H](C)O)NC1=O 10.1021/jm010526+
54581528 62371 None 0 Human Binding pKi = 6.7 6.7 -57 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 614 8 0 9 3.3 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cccnc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
CHEMBL1779401 62371 None 0 Human Binding pKi = 6.7 6.7 -57 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 614 8 0 9 3.3 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cccnc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
2202 2759 None 33 Human Binding pKi = 7.7 7.7 -58 5
Displacement of [3H]AVP from human vasopressin V1a receptor at 5 uMDisplacement of [3H]AVP from human vasopressin V1a receptor at 5 uM
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2010.12.081
9895468 2759 None 33 Human Binding pKi = 7.7 7.7 -58 5
Displacement of [3H]AVP from human vasopressin V1a receptor at 5 uMDisplacement of [3H]AVP from human vasopressin V1a receptor at 5 uM
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2010.12.081
CHEMBL582857 2759 None 33 Human Binding pKi = 7.7 7.7 -58 5
Displacement of [3H]AVP from human vasopressin V1a receptor at 5 uMDisplacement of [3H]AVP from human vasopressin V1a receptor at 5 uM
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2010.12.081
DB12643 2759 None 33 Human Binding pKi = 7.7 7.7 -58 5
Displacement of [3H]AVP from human vasopressin V1a receptor at 5 uMDisplacement of [3H]AVP from human vasopressin V1a receptor at 5 uM
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2010.12.081
2202 2759 None 33 Human Binding pKi = 7.7 7.7 -58 5
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2009.09.050
9895468 2759 None 33 Human Binding pKi = 7.7 7.7 -58 5
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2009.09.050
CHEMBL582857 2759 None 33 Human Binding pKi = 7.7 7.7 -58 5
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2009.09.050
DB12643 2759 None 33 Human Binding pKi = 7.7 7.7 -58 5
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2009.09.050
44520859 171627 None 0 Human Binding pKi = 7.7 7.7 -2 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 572 5 1 6 5.5 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4cccc(C#N)n4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
CHEMBL446566 171627 None 0 Human Binding pKi = 7.7 7.7 -2 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 572 5 1 6 5.5 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4cccc(C#N)n4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
54584252 61896 None 0 Human Binding pKi = 7.7 7.7 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 473 7 2 3 4.0 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)C(Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1)C2 10.1016/j.bmcl.2011.02.096
CHEMBL1774010 61896 None 0 Human Binding pKi = 7.7 7.7 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 473 7 2 3 4.0 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)C(Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1)C2 10.1016/j.bmcl.2011.02.096
46890531 6735 None 0 Human Binding pKi = 7.7 7.7 38 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 455 5 0 3 7.2 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1ccccc1Oc1ccccc1 10.1016/j.bmcl.2010.04.068
CHEMBL1083732 6735 None 0 Human Binding pKi = 7.7 7.7 38 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 455 5 0 3 7.2 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1ccccc1Oc1ccccc1 10.1016/j.bmcl.2010.04.068
CHEMBL2369845 209706 None 0 Human Binding pKi = 7.7 7.7 -28 4
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL None None None CCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
44361387 119412 None 0 Human Binding pKi = 4.7 4.7 -1445 5
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human plateletsBinding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets
ChEMBL 505 6 0 5 4.6 CC(=O)N1CCCCC1CCOc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)cc1 10.1021/jm00023a002
CHEMBL344752 119412 None 0 Human Binding pKi = 4.7 4.7 -1445 5
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human plateletsBinding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets
ChEMBL 505 6 0 5 4.6 CC(=O)N1CCCCC1CCOc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)cc1 10.1021/jm00023a002
44428495 142107 None 0 Human Binding pKi = 7.6 7.6 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 785 13 1 6 6.7 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CC(=O)N1CCC(CCN2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL388259 142107 None 0 Human Binding pKi = 7.6 7.6 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 785 13 1 6 6.7 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CC(=O)N1CCC(CCN2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
59429617 118658 None 0 Human Binding pKi = 7.6 7.6 64 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 338 2 1 1 4.8 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC(c2ccccc2)CC1 10.1021/jm501745f
CHEMBL3416879 118658 None 0 Human Binding pKi = 7.6 7.6 64 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 338 2 1 1 4.8 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC(c2ccccc2)CC1 10.1021/jm501745f
162668903 182698 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 532 3 0 3 5.6 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)C3(c4ccc(F)cc4)CC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4789445 182698 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 532 3 0 3 5.6 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)C3(c4ccc(F)cc4)CC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
44335329 167836 None 0 Human Binding pKi = 7.6 7.6 -1 2
Inhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cellsInhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 561 4 1 3 7.6 Cc1ccc(-c2ccccc2C(=O)Nc2ccc(C(=O)N3C[C@@H]4C5CCC(C5)N4Cc4cc(Cl)ccc43)cc2)cc1 10.1016/s0960-894x(02)00649-2
CHEMBL430841 167836 None 0 Human Binding pKi = 7.6 7.6 -1 2
Inhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cellsInhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 561 4 1 3 7.6 Cc1ccc(-c2ccccc2C(=O)Nc2ccc(C(=O)N3C[C@@H]4C5CCC(C5)N4Cc4cc(Cl)ccc43)cc2)cc1 10.1016/s0960-894x(02)00649-2
114904 2952 None 56 Rat Binding pKi = 7.6 7.6 7 7
Binding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liverBinding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liver
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm010544r
2196 2952 None 56 Rat Binding pKi = 7.6 7.6 7 7
Binding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liverBinding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liver
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm010544r
CHEMBL296908 2952 None 56 Rat Binding pKi = 7.6 7.6 7 7
Binding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liverBinding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liver
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm010544r
46890100 7300 None 0 Human Binding pKi = 7.6 7.6 33 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 414 3 0 3 6.0 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1cccc2ncccc12 10.1016/j.bmcl.2010.04.068
CHEMBL1086069 7300 None 0 Human Binding pKi = 7.6 7.6 33 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 414 3 0 3 6.0 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1cccc2ncccc12 10.1016/j.bmcl.2010.04.068
114904 2952 None 56 Rat Binding pKi = 7.6 7.6 7 7
Evaluated for the binding affinity towards Vasopressin V1a receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards Vasopressin V1a receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1016/s0960-894x(01)00723-5
2196 2952 None 56 Rat Binding pKi = 7.6 7.6 7 7
Evaluated for the binding affinity towards Vasopressin V1a receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards Vasopressin V1a receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1016/s0960-894x(01)00723-5
CHEMBL296908 2952 None 56 Rat Binding pKi = 7.6 7.6 7 7
Evaluated for the binding affinity towards Vasopressin V1a receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards Vasopressin V1a receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1016/s0960-894x(01)00723-5
54585191 61879 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 592 13 1 6 4.0 CCCN(CCCN1CCN(C)CC1)C(=O)[C@H](Cc1ccc(Cl)cc1)NS(=O)(=O)c1c(C)cc(OC)c(C)c1C 10.1016/j.bmcl.2011.02.096
CHEMBL1773997 61879 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 592 13 1 6 4.0 CCCN(CCCN1CCN(C)CC1)C(=O)[C@H](Cc1ccc(Cl)cc1)NS(=O)(=O)c1c(C)cc(OC)c(C)c1C 10.1016/j.bmcl.2011.02.096
44520870 186951 None 0 Human Binding pKi = 6.6 6.6 -10 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 514 5 2 5 4.1 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCC(=O)O)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
CHEMBL490249 186951 None 0 Human Binding pKi = 6.6 6.6 -10 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 514 5 2 5 4.1 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCC(=O)O)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
44419028 96907 None 17 Rat Binding pKi = 5.6 5.6 -1905 8
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1093 18 12 14 -1.6 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm060928n
CHEMBL265858 96907 None 17 Rat Binding pKi = 5.6 5.6 -1905 8
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1093 18 12 14 -1.6 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm060928n
54580518 62388 None 0 Human Binding pKi = 6.6 6.6 -177 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 691 9 0 10 4.9 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN4CCN(C)CC4)ccc3OC)(N3CCC[C@H]3c3ncco3)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
CHEMBL1779420 62388 None 0 Human Binding pKi = 6.6 6.6 -177 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 691 9 0 10 4.9 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN4CCN(C)CC4)ccc3OC)(N3CCC[C@H]3c3ncco3)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
54580246 61853 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 568 12 1 5 3.9 CN1CCN(CCCN(Cc2ccccc2)C(=O)[C@H](Cc2ccc(Cl)cc2)NS(=O)(=O)c2ccccc2)CC1 10.1016/j.bmcl.2011.02.096
CHEMBL1773863 61853 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 568 12 1 5 3.9 CN1CCN(CCCN(Cc2ccccc2)C(=O)[C@H](Cc2ccc(Cl)cc2)NS(=O)(=O)c2ccccc2)CC1 10.1016/j.bmcl.2011.02.096
54586150 61874 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 582 13 1 5 4.0 CN1CCN(CCCN(Cc2ccccc2)C(=O)[C@H](Cc2ccc(Cl)cc2)NS(=O)(=O)Cc2ccccc2)CC1 10.1016/j.bmcl.2011.02.096
CHEMBL1773992 61874 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 582 13 1 5 4.0 CN1CCN(CCCN(Cc2ccccc2)C(=O)[C@H](Cc2ccc(Cl)cc2)NS(=O)(=O)Cc2ccccc2)CC1 10.1016/j.bmcl.2011.02.096
145976595 163713 None 0 Human Binding pKi = 6.6 6.6 -6 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 408 2 1 4 4.9 Cc1ccn(C(=O)Nc2ccc(C(=O)N3CCCCc4ccccc43)c(Cl)c2)n1 10.1021/acs.jmedchem.8b00697
CHEMBL4205046 163713 None 0 Human Binding pKi = 6.6 6.6 -6 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 408 2 1 4 4.9 Cc1ccn(C(=O)Nc2ccc(C(=O)N3CCCCc4ccccc43)c(Cl)c2)n1 10.1021/acs.jmedchem.8b00697
54582268 61852 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 516 11 1 6 2.6 COc1cc(C)c(S(=O)(=O)NCC(=O)N(CCCN2CCN(C)CC2)Cc2ccccc2)c(C)c1C 10.1016/j.bmcl.2011.02.096
CHEMBL1773861 61852 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 516 11 1 6 2.6 COc1cc(C)c(S(=O)(=O)NCC(=O)N(CCCN2CCN(C)CC2)Cc2ccccc2)c(C)c1C 10.1016/j.bmcl.2011.02.096
16059348 118657 None 1 Mouse Binding pKi = 5.6 5.6 -301 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 394 2 2 3 3.9 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC(n2c(=O)[nH]c3ccccc32)CC1 10.1021/jm501745f
CHEMBL3416878 118657 None 1 Mouse Binding pKi = 5.6 5.6 -301 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 394 2 2 3 3.9 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC(n2c(=O)[nH]c3ccccc32)CC1 10.1021/jm501745f
CHEMBL410673 212829 None 0 Human Binding pKi = 7.6 7.6 - 1
Binding affinity against human vasopressin V1a receptor expressed in CHO cellsBinding affinity against human vasopressin V1a receptor expressed in CHO cells
ChEMBL None None None CC(=O)N[C@H](Cc1ccc(C(=O)c2ccccc2)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)c(I)c1)C(N)=O 10.1021/jm040871+
44361403 33843 None 1 Rat Binding pKi = 7.6 7.6 8 5
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liverBinding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver
ChEMBL 491 5 0 5 4.1 CC(=O)N1CCCC(COc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2)C1 10.1021/jm00023a002
CHEMBL142324 33843 None 1 Rat Binding pKi = 7.6 7.6 8 5
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liverBinding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver
ChEMBL 491 5 0 5 4.1 CC(=O)N1CCCC(COc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2)C1 10.1021/jm00023a002
118734428 118655 None 0 Human Binding pKi = 7.6 7.6 245 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 414 1 1 3 3.9 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)c1ccccc1CS2(=O)=O 10.1021/jm501745f
CHEMBL3416876 118655 None 0 Human Binding pKi = 7.6 7.6 245 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 414 1 1 3 3.9 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)c1ccccc1CS2(=O)=O 10.1021/jm501745f
2198 3418 None 2 Human Binding pKi = 7.6 7.6 -46 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 537 4 1 4 6.1 Clc1cc(ccc1C(=O)N1C[C@H]2COCCN2Cc2c1cccc2)NC(=O)c1ccccc1c1ccccc1 10.1016/j.bmcl.2004.03.083
9807249 3418 None 2 Human Binding pKi = 7.6 7.6 -46 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 537 4 1 4 6.1 Clc1cc(ccc1C(=O)N1C[C@H]2COCCN2Cc2c1cccc2)NC(=O)c1ccccc1c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL1192593 3418 None 2 Human Binding pKi = 7.6 7.6 -46 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 537 4 1 4 6.1 Clc1cc(ccc1C(=O)N1C[C@H]2COCCN2Cc2c1cccc2)NC(=O)c1ccccc1c1ccccc1 10.1016/j.bmcl.2004.03.083
44316235 160426 None 0 Human Binding pKi = 7.6 7.6 -3 4
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1011 16 12 14 -3.6 C[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm030611c
CHEMBL411148 160426 None 0 Human Binding pKi = 7.6 7.6 -3 4
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1011 16 12 14 -3.6 C[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm030611c
162660009 181303 None 0 Human Binding pKi = 5.6 5.6 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 436 2 0 6 4.3 CC(=O)N1c2cc(Cl)ccc2-n2c(C3CCN(c4ccccn4)CC3)nnc2C1(C)C 10.1016/j.bmcl.2020.127417
CHEMBL4762451 181303 None 0 Human Binding pKi = 5.6 5.6 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 436 2 0 6 4.3 CC(=O)N1c2cc(Cl)ccc2-n2c(C3CCN(c4ccccn4)CC3)nnc2C1(C)C 10.1016/j.bmcl.2020.127417
54582526 62387 None 0 Human Binding pKi = 6.6 6.6 -63 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 622 9 1 9 4.9 CNCc1ccc(OC)c([C@@]2(N3CCC[C@H]3c3ncco3)C(=O)N(S(=O)(=O)c3ccc(OC)cc3)c3ccc(Cl)cc32)c1 10.1016/j.bmcl.2011.03.012
CHEMBL1779419 62387 None 0 Human Binding pKi = 6.6 6.6 -63 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 622 9 1 9 4.9 CNCc1ccc(OC)c([C@@]2(N3CCC[C@H]3c3ncco3)C(=O)N(S(=O)(=O)c3ccc(OC)cc3)c3ccc(Cl)cc32)c1 10.1016/j.bmcl.2011.03.012
56676959 64051 None 0 Rat Binding pKi = 6.6 6.6 -3 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 485 8 2 3 4.2 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(F)cc2)NC(=O)C2(c3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807269 64051 None 0 Rat Binding pKi = 6.6 6.6 -3 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 485 8 2 3 4.2 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(F)cc2)NC(=O)C2(c3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2011.05.092
54584266 61181 None 0 Human Binding pKi = 6.6 6.6 -380 4
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL 1145 20 12 15 0.2 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccccc2N)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
CHEMBL1765664 61181 None 0 Human Binding pKi = 6.6 6.6 -380 4
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL 1145 20 12 15 0.2 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccccc2N)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
137189941 138076 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader methodDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader method
ChEMBL 560 12 1 8 5.2 COc1cc(CN2CCN(CCCCCCCC(=O)N3Cc4cnn(C)c4Nc4ccccc43)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
CHEMBL3765689 138076 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader methodDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader method
ChEMBL 560 12 1 8 5.2 COc1cc(CN2CCN(CCCCCCCC(=O)N3Cc4cnn(C)c4Nc4ccccc43)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
46890529 6733 None 0 Human Binding pKi = 7.6 7.6 47 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 411 3 0 2 6.4 COc1cc(-c2ccccc2C)c(Cl)cc1C(=O)N1C[C@@]2(C)C[C@@H]1CC(C)(C)C2 10.1016/j.bmcl.2010.04.068
CHEMBL1083730 6733 None 0 Human Binding pKi = 7.6 7.6 47 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 411 3 0 2 6.4 COc1cc(-c2ccccc2C)c(Cl)cc1C(=O)N1C[C@@]2(C)C[C@@H]1CC(C)(C)C2 10.1016/j.bmcl.2010.04.068
162646888 179557 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 437 3 0 3 3.8 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4741743 179557 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 437 3 0 3 3.8 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
16109443 141717 None 0 Rat Binding pKi = 7.6 7.6 -131 4
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1040 18 14 15 -4.0 N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL385739 141717 None 0 Rat Binding pKi = 7.6 7.6 -131 4
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1040 18 14 15 -4.0 N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
56675151 63225 None 0 Human Binding pKi = 7.6 7.6 -14 3
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1295 17 14 20 0.7 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
CHEMBL1790728 63225 None 0 Human Binding pKi = 7.6 7.6 -14 3
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1295 17 14 20 0.7 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
44325691 12996 None 0 Human Binding pKi = 6.6 6.6 -239 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 553 4 1 4 6.8 O=C(Nc1ccc(C(=O)N2C[C@H]3CSCCN3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL1189693 12996 None 0 Human Binding pKi = 6.6 6.6 -239 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 553 4 1 4 6.8 O=C(Nc1ccc(C(=O)N2C[C@H]3CSCCN3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL539285 12996 None 0 Human Binding pKi = 6.6 6.6 -239 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 553 4 1 4 6.8 O=C(Nc1ccc(C(=O)N2C[C@H]3CSCCN3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
145955181 162409 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 538 6 3 8 4.4 Cn1ncc2c1Nc1ccccc1N(C(=O)CCc1ccccc1N1CCN(Cc3cc(O)cc(O)c3)CC1)C2 10.1016/j.ejmech.2017.10.059
CHEMBL4166008 162409 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 538 6 3 8 4.4 Cn1ncc2c1Nc1ccccc1N(C(=O)CCc1ccccc1N1CCN(Cc3cc(O)cc(O)c3)CC1)C2 10.1016/j.ejmech.2017.10.059
54583310 63091 None 0 Human Binding pKi = 6.6 6.6 -213 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL 1542 24 16 22 1.4 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc(-c3c4ccc(=N)c(S(=O)(=O)O)c-4oc4c(S(=O)(=O)O)c(N)ccc34)c(C(=O)O)c2)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
CHEMBL1765665 63091 None 0 Human Binding pKi = 6.6 6.6 -213 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL 1542 24 16 22 1.4 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc(-c3c4ccc(=N)c(S(=O)(=O)O)c-4oc4c(S(=O)(=O)O)c(N)ccc34)c(C(=O)O)c2)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
CHEMBL1789128 63091 None 0 Human Binding pKi = 6.6 6.6 -213 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL 1542 24 16 22 1.4 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc(-c3c4ccc(=N)c(S(=O)(=O)O)c-4oc4c(S(=O)(=O)O)c(N)ccc34)c(C(=O)O)c2)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
9959174 194485 None 0 Human Binding pKi = 7.6 7.6 -5 3
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 547 5 1 5 5.6 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4ccccn4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
CHEMBL487164 194485 None 0 Human Binding pKi = 7.6 7.6 -5 3
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 547 5 1 5 5.6 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4ccccn4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
CHEMBL528996 194485 None 0 Human Binding pKi = 7.6 7.6 -5 3
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 547 5 1 5 5.6 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4ccccn4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
44428490 152082 None 0 Human Binding pKi = 7.6 7.6 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 743 10 1 6 5.7 O=C(NCc1cccc(C(F)(F)F)c1)C(C(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL396757 152082 None 0 Human Binding pKi = 7.6 7.6 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 743 10 1 6 5.7 O=C(NCc1cccc(C(F)(F)F)c1)C(C(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
54585220 61903 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 457 7 2 3 3.5 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(F)cc1)C2 10.1016/j.bmcl.2011.02.096
CHEMBL1774018 61903 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 457 7 2 3 3.5 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(F)cc1)C2 10.1016/j.bmcl.2011.02.096
162655579 180682 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 377 2 0 5 4.3 Clc1ccc2c(c1)C1CC1c1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
CHEMBL4755383 180682 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 377 2 0 5 4.3 Clc1ccc2c(c1)C1CC1c1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
45483241 197914 None 0 Human Binding pKi = 5.6 5.6 -9 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 643 12 1 8 4.2 COc1cccc(CNC2CCN(S(=O)(=O)CCC3CCc4ccccc4N3S(=O)(=O)c3ccc(OC)cc3OC)CC2)c1 10.1016/j.bmcl.2009.09.050
CHEMBL572983 197914 None 0 Human Binding pKi = 5.6 5.6 -9 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 643 12 1 8 4.2 COc1cccc(CNC2CCN(S(=O)(=O)CCC3CCc4ccccc4N3S(=O)(=O)c3ccc(OC)cc3OC)CC2)c1 10.1016/j.bmcl.2009.09.050
44335386 108008 None 0 Human Binding pKi = 5.6 5.6 -14 2
Inhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cellsInhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 489 3 1 3 5.7 O=C(Nc1ccc(C(=O)N2C[C@@H]3C4CCC(C4)N3Cc3cc(Cl)ccc32)cc1)c1ccccc1F 10.1016/s0960-894x(02)00649-2
CHEMBL319433 108008 None 0 Human Binding pKi = 5.6 5.6 -14 2
Inhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cellsInhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 489 3 1 3 5.7 O=C(Nc1ccc(C(=O)N2C[C@@H]3C4CCC(C4)N3Cc3cc(Cl)ccc32)cc1)c1ccccc1F 10.1016/s0960-894x(02)00649-2
9981665 118475 None 4 Rat Binding pKi = 4.6 4.6 -70 6
Displacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissue
ChEMBL 459 5 2 4 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC(=O)O)C2 10.1021/jm901812z
CHEMBL341339 118475 None 4 Rat Binding pKi = 4.6 4.6 -70 6
Displacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissue
ChEMBL 459 5 2 4 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC(=O)O)C2 10.1021/jm901812z
CHEMBL5078950 214593 None 0 Human Binding pKi = 5.6 5.6 - 1
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL None None None Cc1cccc2c1-n1c(nnc1[C@H]1CC[C@H](Oc3ccccn3)CC1)C[C@@H](O)C2 10.1021/acs.jmedchem.1c00863
137212770 138052 None 0 Human Binding pKi = 6.6 6.6 28 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader methodDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader method
ChEMBL 532 10 1 8 4.4 COc1cc(CN2CCN(CCCCCC(=O)N3Cc4cnn(C)c4Nc4ccccc43)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
CHEMBL3765356 138052 None 0 Human Binding pKi = 6.6 6.6 28 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader methodDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader method
ChEMBL 532 10 1 8 4.4 COc1cc(CN2CCN(CCCCCC(=O)N3Cc4cnn(C)c4Nc4ccccc43)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
54584267 61183 None 0 Human Binding pKi = 6.6 6.6 -426 4
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL 1154 25 12 15 0.2 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
CHEMBL1765667 61183 None 0 Human Binding pKi = 6.6 6.6 -426 4
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL 1154 25 12 15 0.2 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
135916070 200971 None 0 Human Binding pKi = 7.6 7.6 -1 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 418 2 1 6 4.5 Cc1ccn(-c2ccc(C(=O)N3Cc4cnn(C)c4Nc4ccccc43)c(Cl)c2)n1 10.1021/acs.jmedchem.8b00697
CHEMBL601931 200971 None 0 Human Binding pKi = 7.6 7.6 -1 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 418 2 1 6 4.5 Cc1ccn(-c2ccc(C(=O)N3Cc4cnn(C)c4Nc4ccccc43)c(Cl)c2)n1 10.1021/acs.jmedchem.8b00697
59657691 118654 None 0 Human Binding pKi = 7.6 7.6 218 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 365 1 2 2 4.4 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)CNc1ccccc12 10.1021/jm501745f
CHEMBL3416875 118654 None 0 Human Binding pKi = 7.6 7.6 218 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 365 1 2 2 4.4 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)CNc1ccccc12 10.1021/jm501745f
135506374 137898 None 23 Human Binding pKi = 7.6 7.6 1 3
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader methodDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader method
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2015.11.050
CHEMBL3763342 137898 None 23 Human Binding pKi = 7.6 7.6 1 3
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader methodDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader method
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2015.11.050
135506374 137898 None 23 Human Binding pKi = 7.6 7.6 1 3
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2017.10.059
CHEMBL3763342 137898 None 23 Human Binding pKi = 7.6 7.6 1 3
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2017.10.059
135916070 200971 None 0 Human Binding pKi = 7.6 7.6 -1 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 418 2 1 6 4.5 Cc1ccn(-c2ccc(C(=O)N3Cc4cnn(C)c4Nc4ccccc43)c(Cl)c2)n1 10.1021/jm901084f
CHEMBL601931 200971 None 0 Human Binding pKi = 7.6 7.6 -1 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 418 2 1 6 4.5 Cc1ccn(-c2ccc(C(=O)N3Cc4cnn(C)c4Nc4ccccc43)c(Cl)c2)n1 10.1021/jm901084f
44428512 158923 None 0 Human Binding pKi = 7.6 7.6 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 744 11 1 7 4.7 O=C(NCc1cccc(C(F)(F)F)c1)[C@@H](CC(=O)N1CCN(N2CCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL409562 158923 None 0 Human Binding pKi = 7.6 7.6 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 744 11 1 7 4.7 O=C(NCc1cccc(C(F)(F)F)c1)[C@@H](CC(=O)N1CCN(N2CCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
56663270 64042 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 475 8 1 3 4.1 CN(C)CC1CCN(C(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)Cc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807260 64042 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 475 8 1 3 4.1 CN(C)CC1CCN(C(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)Cc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.05.092
44316236 205523 None 0 Human Binding pKi = 6.6 6.6 -12 4
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 997 16 12 14 -4.0 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]1CCCN1C(=O)[C@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2ccccc2)C(=O)NCC(=O)N[C@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
CHEMBL80877 205523 None 0 Human Binding pKi = 6.6 6.6 -12 4
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 997 16 12 14 -4.0 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]1CCCN1C(=O)[C@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2ccccc2)C(=O)NCC(=O)N[C@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
54584268 61186 None 0 Human Binding pKi = 5.6 5.6 -338 4
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL 1226 29 13 16 0.7 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)C(O)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
CHEMBL1765671 61186 None 0 Human Binding pKi = 5.6 5.6 -338 4
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL 1226 29 13 16 0.7 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)C(O)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
145970757 164783 None 0 Human Binding pKi = 7.6 7.6 1 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 307 4 0 1 5.0 CCCCc1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/acs.jmedchem.8b00697
CHEMBL4218211 164783 None 0 Human Binding pKi = 7.6 7.6 1 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 307 4 0 1 5.0 CCCCc1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/acs.jmedchem.8b00697
162655687 180780 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 452 5 0 7 4.6 COC(=O)CC1Cc2cc(Cl)ccc2-n2c1nnc2[C@H]1CC[C@H](Oc2ccccn2)CC1 10.1016/j.bmcl.2020.127417
CHEMBL4756354 180780 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 452 5 0 7 4.6 COC(=O)CC1Cc2cc(Cl)ccc2-n2c1nnc2[C@H]1CC[C@H](Oc2ccccn2)CC1 10.1016/j.bmcl.2020.127417
42629369 182192 None 0 Human Binding pKi = 7.6 7.6 -2 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 500 5 2 5 4.0 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCCO)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
CHEMBL478283 182192 None 0 Human Binding pKi = 7.6 7.6 -2 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 500 5 2 5 4.0 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCCO)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
42629369 182192 None 0 Human Binding pKi = 7.6 7.6 -2 2
Displacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation countingDisplacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation counting
ChEMBL 500 5 2 5 4.0 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCCO)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.10.038
CHEMBL478283 182192 None 0 Human Binding pKi = 7.6 7.6 -2 2
Displacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation countingDisplacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation counting
ChEMBL 500 5 2 5 4.0 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCCO)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.10.038
44215484 178578 None 0 Human Binding pKi = 7.6 7.6 10 2
Displacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uMDisplacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uM
ChEMBL 440 7 0 6 4.6 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCN1CCOCC1 10.1021/jm901812z
CHEMBL467154 178578 None 0 Human Binding pKi = 7.6 7.6 10 2
Displacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uMDisplacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uM
ChEMBL 440 7 0 6 4.6 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCN1CCOCC1 10.1021/jm901812z
CHEMBL2369830 209695 None 0 Human Binding pKi = 7.6 7.6 -66 4
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL None None None CCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
56670127 64057 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 448 9 3 3 3.6 O=C(NCCCO)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C1(c2ccc(Cl)cc2)CCC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807275 64057 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 448 9 3 3 3.6 O=C(NCCCO)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C1(c2ccc(Cl)cc2)CCC1 10.1016/j.bmcl.2011.05.092
16109441 137393 None 0 Rat Binding pKi = 5.6 5.6 -6309 4
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1026 19 12 15 -2.8 NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL375323 137393 None 0 Rat Binding pKi = 5.6 5.6 -6309 4
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1026 19 12 15 -2.8 NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
118734423 118638 None 0 Human Binding pKi = 5.6 5.6 4 2
Antagonist activity at human vasopressin 1a receptorAntagonist activity at human vasopressin 1a receptor
ChEMBL 389 5 1 3 4.4 CCOc1ccc2ccccc2c1C(=O)N1CCC(O)(Cc2ccccc2)CC1 10.1021/acs.jmedchem.6b01437
CHEMBL3416858 118638 None 0 Human Binding pKi = 5.6 5.6 4 2
Antagonist activity at human vasopressin 1a receptorAntagonist activity at human vasopressin 1a receptor
ChEMBL 389 5 1 3 4.4 CCOc1ccc2ccccc2c1C(=O)N1CCC(O)(Cc2ccccc2)CC1 10.1021/acs.jmedchem.6b01437
118734423 118638 None 0 Human Binding pKi = 5.6 5.6 4 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 389 5 1 3 4.4 CCOc1ccc2ccccc2c1C(=O)N1CCC(O)(Cc2ccccc2)CC1 10.1021/jm501745f
CHEMBL3416858 118638 None 0 Human Binding pKi = 5.6 5.6 4 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 389 5 1 3 4.4 CCOc1ccc2ccccc2c1C(=O)N1CCC(O)(Cc2ccccc2)CC1 10.1021/jm501745f
54580290 61893 None 0 Human Binding pKi = 6.5 6.5 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 473 7 2 3 4.0 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)C(Cc1ccc(Cl)cc1)NC(=O)Cc1ccccc1Cl)C2 10.1016/j.bmcl.2011.02.096
CHEMBL1774008 61893 None 0 Human Binding pKi = 6.5 6.5 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 473 7 2 3 4.0 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)C(Cc1ccc(Cl)cc1)NC(=O)Cc1ccccc1Cl)C2 10.1016/j.bmcl.2011.02.096
54581533 62386 None 0 Human Binding pKi = 6.5 6.5 -144 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 636 9 0 9 5.2 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN(C)C)ccc3OC)(N3CCC[C@H]3c3ncco3)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
CHEMBL1779418 62386 None 0 Human Binding pKi = 6.5 6.5 -144 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 636 9 0 9 5.2 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN(C)C)ccc3OC)(N3CCC[C@H]3c3ncco3)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
11092056 107036 None 0 Human Binding pKi = 7.5 7.5 354 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 481 9 0 6 5.3 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCN1CCN(C)CC1 10.1021/jm010544r
CHEMBL315524 107036 None 0 Human Binding pKi = 7.5 7.5 354 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 481 9 0 6 5.3 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCN1CCN(C)CC1 10.1021/jm010544r
44325895 207906 None 0 Human Binding pKi = 6.5 6.5 -19 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 519 4 1 4 6.2 O=C(Nc1ccc(C(=O)N2C[C@@H]3CSCCN3Cc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL96731 207906 None 0 Human Binding pKi = 6.5 6.5 -19 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 519 4 1 4 6.2 O=C(Nc1ccc(C(=O)N2C[C@@H]3CSCCN3Cc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
16109438 96575 None 0 Rat Binding pKi = 5.5 5.5 -954 5
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1051 17 11 14 -1.0 NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL263090 96575 None 0 Rat Binding pKi = 5.5 5.5 -954 5
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1051 17 11 14 -1.0 NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
158348 3485 None 18 Human Binding pKi = 5.5 5.5 -1318 4
Displacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisDisplacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 643 10 1 9 3.9 CCOc1ccc2c(c1)[C@@]1(CC[C@H](CC1)OCCN1CCOCC1)C(=O)N2S(=O)(=O)c1ccc(cc1OC)C(=O)NC(C)(C)C 10.1021/acs.jmedchem.8b01320
2199 3485 None 18 Human Binding pKi = 5.5 5.5 -1318 4
Displacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisDisplacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 643 10 1 9 3.9 CCOc1ccc2c(c1)[C@@]1(CC[C@H](CC1)OCCN1CCOCC1)C(=O)N2S(=O)(=O)c1ccc(cc1OC)C(=O)NC(C)(C)C 10.1021/acs.jmedchem.8b01320
CHEMBL4283439 3485 None 18 Human Binding pKi = 5.5 5.5 -1318 4
Displacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisDisplacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 643 10 1 9 3.9 CCOc1ccc2c(c1)[C@@]1(CC[C@H](CC1)OCCN1CCOCC1)C(=O)N2S(=O)(=O)c1ccc(cc1OC)C(=O)NC(C)(C)C 10.1021/acs.jmedchem.8b01320
DB14923 3485 None 18 Human Binding pKi = 5.5 5.5 -1318 4
Displacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisDisplacement of [Se-Se]-AVP from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 643 10 1 9 3.9 CCOc1ccc2c(c1)[C@@]1(CC[C@H](CC1)OCCN1CCOCC1)C(=O)N2S(=O)(=O)c1ccc(cc1OC)C(=O)NC(C)(C)C 10.1021/acs.jmedchem.8b01320
59429650 118643 None 0 Human Binding pKi = 6.5 6.5 - 1
Antagonist activity at human vasopressin 1a receptorAntagonist activity at human vasopressin 1a receptor
ChEMBL 438 5 1 3 5.2 Cc1c(C(=O)N2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1Cc1ccccc1 10.1021/acs.jmedchem.6b01437
CHEMBL3416864 118643 None 0 Human Binding pKi = 6.5 6.5 - 1
Antagonist activity at human vasopressin 1a receptorAntagonist activity at human vasopressin 1a receptor
ChEMBL 438 5 1 3 5.2 Cc1c(C(=O)N2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1Cc1ccccc1 10.1021/acs.jmedchem.6b01437
59429650 118643 None 0 Human Binding pKi = 6.5 6.5 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 438 5 1 3 5.2 Cc1c(C(=O)N2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1Cc1ccccc1 10.1021/jm501745f
CHEMBL3416864 118643 None 0 Human Binding pKi = 6.5 6.5 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 438 5 1 3 5.2 Cc1c(C(=O)N2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1Cc1ccccc1 10.1021/jm501745f
216237 3841 None 89 Human Binding pKi = 6.5 6.5 -23 5
Displacement of [3H]-vasopressin from human V1A receptor expressed in CHO cells membrane by microbeta scintillation counter analysisDisplacement of [3H]-vasopressin from human V1A receptor expressed in CHO cells membrane by microbeta scintillation counter analysis
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1021/acs.jmedchem.2c00567
2226 3841 None 89 Human Binding pKi = 6.5 6.5 -23 5
Displacement of [3H]-vasopressin from human V1A receptor expressed in CHO cells membrane by microbeta scintillation counter analysisDisplacement of [3H]-vasopressin from human V1A receptor expressed in CHO cells membrane by microbeta scintillation counter analysis
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1021/acs.jmedchem.2c00567
4110 3841 None 89 Human Binding pKi = 6.5 6.5 -23 5
Displacement of [3H]-vasopressin from human V1A receptor expressed in CHO cells membrane by microbeta scintillation counter analysisDisplacement of [3H]-vasopressin from human V1A receptor expressed in CHO cells membrane by microbeta scintillation counter analysis
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1021/acs.jmedchem.2c00567
443894 3841 None 89 Human Binding pKi = 6.5 6.5 -23 5
Displacement of [3H]-vasopressin from human V1A receptor expressed in CHO cells membrane by microbeta scintillation counter analysisDisplacement of [3H]-vasopressin from human V1A receptor expressed in CHO cells membrane by microbeta scintillation counter analysis
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1021/acs.jmedchem.2c00567
CHEMBL344159 3841 None 89 Human Binding pKi = 6.5 6.5 -23 5
Displacement of [3H]-vasopressin from human V1A receptor expressed in CHO cells membrane by microbeta scintillation counter analysisDisplacement of [3H]-vasopressin from human V1A receptor expressed in CHO cells membrane by microbeta scintillation counter analysis
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1021/acs.jmedchem.2c00567
DB06212 3841 None 89 Human Binding pKi = 6.5 6.5 -23 5
Displacement of [3H]-vasopressin from human V1A receptor expressed in CHO cells membrane by microbeta scintillation counter analysisDisplacement of [3H]-vasopressin from human V1A receptor expressed in CHO cells membrane by microbeta scintillation counter analysis
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1021/acs.jmedchem.2c00567
25001929 118650 None 0 Mouse Binding pKi = 5.5 5.5 -331 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 367 1 1 3 3.9 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)OCc1ccncc12 10.1021/jm501745f
CHEMBL3416871 118650 None 0 Mouse Binding pKi = 5.5 5.5 -331 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 367 1 1 3 3.9 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)OCc1ccncc12 10.1021/jm501745f
162656299 180949 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 474 2 0 3 5.0 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)c3ccccc3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4758331 180949 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 474 2 0 3 5.0 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)c3ccccc3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
162658817 180989 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 370 1 1 3 3.5 Cc1ccccc1N1CCN(C(=O)N2CNCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4758799 180989 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 370 1 1 3 3.5 Cc1ccccc1N1CCN(C(=O)N2CNCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
162658968 181280 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 384 1 0 3 3.8 Cc1ccccc1N1CCN(C(=O)N2CN(C)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4762200 181280 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 384 1 0 3 3.8 Cc1ccccc1N1CCN(C(=O)N2CN(C)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
162643184 181676 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 369 1 1 2 4.9 Cc1ccccc1C1CCN(C(=O)N2CCNc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4776471 181676 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 369 1 1 2 4.9 Cc1ccccc1C1CCN(C(=O)N2CCNc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
56663272 64045 None 0 Human Binding pKi = 8.5 8.5 67 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 392 8 2 2 3.8 CCCNC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1 10.1016/j.bmcl.2011.05.092
CHEMBL1807263 64045 None 0 Human Binding pKi = 8.5 8.5 67 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 392 8 2 2 3.8 CCCNC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1 10.1016/j.bmcl.2011.05.092
10187283 206211 None 0 Human Binding pKi = 8.5 8.5 20 4
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 543 7 0 6 5.9 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCc1ccc(C(=O)N2CCN(C)CC2)cc1 10.1021/jm010544r
CHEMBL86577 206211 None 0 Human Binding pKi = 8.5 8.5 20 4
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 543 7 0 6 5.9 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCc1ccc(C(=O)N2CCN(C)CC2)cc1 10.1021/jm010544r
54581300 61906 None 0 Human Binding pKi = 8.5 8.5 41 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 501 7 2 3 4.7 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C(C)(C)c1ccc(Cl)cc1)C2 10.1016/j.bmcl.2011.02.096
CHEMBL1774021 61906 None 0 Human Binding pKi = 8.5 8.5 41 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 501 7 2 3 4.7 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C(C)(C)c1ccc(Cl)cc1)C2 10.1016/j.bmcl.2011.02.096
44274849 97236 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1525 36 12 20 1.8 CN(C)c1ccc2c(c1)Oc1cc(N(C)C)ccc1C21OC(=O)c2ccc(C(=O)N(C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccc(O)cc3)N(C)C(=O)CCc3ccc(O)cc3)[C@@H](CCCCN)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)cc21 10.1021/jm9804782
91931060 97236 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1525 36 12 20 1.8 CN(C)c1ccc2c(c1)Oc1cc(N(C)C)ccc1C21OC(=O)c2ccc(C(=O)N(C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccc(O)cc3)N(C)C(=O)CCc3ccc(O)cc3)[C@@H](CCCCN)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)cc21 10.1021/jm9804782
CHEMBL268664 97236 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1525 36 12 20 1.8 CN(C)c1ccc2c(c1)Oc1cc(N(C)C)ccc1C21OC(=O)c2ccc(C(=O)N(C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccc(O)cc3)N(C)C(=O)CCc3ccc(O)cc3)[C@@H](CCCCN)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)cc21 10.1021/jm9804782
162669344 182684 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 438 2 0 3 4.1 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)C3CC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4789306 182684 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 438 2 0 3 4.1 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)C3CC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
44428487 169026 None 0 Human Binding pKi = 8.5 8.5 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 743 10 1 6 5.7 O=C(NCc1cccc(C(F)(F)F)c1)C(C(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL439398 169026 None 0 Human Binding pKi = 8.5 8.5 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 743 10 1 6 5.7 O=C(NCc1cccc(C(F)(F)F)c1)C(C(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL562961 215743 None 1 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125I]OH-LVA from human V1A receptor expressed in African green monkey COS7 cell membranes after 60 minsDisplacement of [125I]OH-LVA from human V1A receptor expressed in African green monkey COS7 cell membranes after 60 mins
ChEMBL None None None NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01320
11237434 66058 None 10 Human Binding pKi = 8.5 8.5 - 1
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL 394 2 0 6 3.6 CN1Cc2cc(Cl)ccc2-n2c(nnc2C2CCN(c3ccccn3)CC2)C1 10.1021/acs.jmedchem.1c00863
CHEMBL1837037 66058 None 10 Human Binding pKi = 8.5 8.5 - 1
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL 394 2 0 6 3.6 CN1Cc2cc(Cl)ccc2-n2c(nnc2C2CCN(c3ccccn3)CC2)C1 10.1021/acs.jmedchem.1c00863
44428493 142106 None 0 Human Binding pKi = 8.4 8.4 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 766 12 2 6 5.8 N[C@H]1CC[N+](Cc2ccccc2)(C(=O)C[C@@H](C(=O)NCc2cccc(C(F)(F)F)c2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)C1 10.1016/j.bmc.2006.12.031
CHEMBL388258 142106 None 0 Human Binding pKi = 8.4 8.4 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 766 12 2 6 5.8 N[C@H]1CC[N+](Cc2ccccc2)(C(=O)C[C@@H](C(=O)NCc2cccc(C(F)(F)F)c2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)C1 10.1016/j.bmc.2006.12.031
44428507 158745 None 0 Human Binding pKi = 8.4 8.4 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 771 12 1 6 6.3 O=C(NCc1cccc(C(F)(F)F)c1)[C@@H](CC(=O)N1CCC(CN2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL409370 158745 None 0 Human Binding pKi = 8.4 8.4 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 771 12 1 6 6.3 O=C(NCc1cccc(C(F)(F)F)c1)[C@@H](CC(=O)N1CCC(CN2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
2252 2228 None 48 Rat Binding pKi = 8.4 8.4 1 5
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liverBinding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm00023a002
6918320 2228 None 48 Rat Binding pKi = 8.4 8.4 1 5
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liverBinding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm00023a002
CHEMBL24781 2228 None 48 Rat Binding pKi = 8.4 8.4 1 5
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liverBinding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm00023a002
2252 2228 None 48 Rat Binding pKi = 8.4 8.4 1 5
Displacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissue
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm901812z
6918320 2228 None 48 Rat Binding pKi = 8.4 8.4 1 5
Displacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissue
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm901812z
CHEMBL24781 2228 None 48 Rat Binding pKi = 8.4 8.4 1 5
Displacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissue
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm901812z
46890706 7017 None 0 Human Binding pKi = 8.4 8.4 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 419 3 0 3 6.6 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1cc2ccccc2s1 10.1016/j.bmcl.2010.04.068
CHEMBL1084801 7017 None 0 Human Binding pKi = 8.4 8.4 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 419 3 0 3 6.6 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1cc2ccccc2s1 10.1016/j.bmcl.2010.04.068
16051933 138128 None 4 Human Binding pKi = 8.4 8.4 -19 8
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1068 19 14 15 -4.1 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm030611c
CHEMBL376685 138128 None 4 Human Binding pKi = 8.4 8.4 -19 8
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1068 19 14 15 -4.1 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm030611c
DB00035 138128 None 4 Human Binding pKi = 8.4 8.4 -19 8
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1068 19 14 15 -4.1 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm030611c
46890656 7133 None 0 Human Binding pKi = 8.4 8.4 177 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 403 3 0 3 6.1 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1coc2ccccc12 10.1016/j.bmcl.2010.04.068
CHEMBL1085301 7133 None 0 Human Binding pKi = 8.4 8.4 177 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 403 3 0 3 6.1 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1coc2ccccc12 10.1016/j.bmcl.2010.04.068
CHEMBL562961 215743 None 1 Human Binding pKi = 8.4 8.4 - 1
Displacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysisDisplacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysis
ChEMBL None None None NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01320
145986380 167091 None 0 Human Binding pKi = 8.4 8.4 - 1
Displacement of [Sez6]-HO-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisDisplacement of [Sez6]-HO-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 1206 34 16 14 -3.8 COc1ccc(C[C@@H](NC(=O)CCc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2C[Se]C[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)cc1 10.1021/acs.jmedchem.8b01320
CHEMBL4289837 167091 None 0 Human Binding pKi = 8.4 8.4 - 1
Displacement of [Sez6]-HO-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysisDisplacement of [Sez6]-HO-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by RP-LC-ICPMS analysis
ChEMBL 1206 34 16 14 -3.8 COc1ccc(C[C@@H](NC(=O)CCc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2C[Se]C[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)cc1 10.1021/acs.jmedchem.8b01320
56678446 63212 None 0 Human Binding pKi = 8.4 8.4 -18 3
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1125 16 13 16 -0.3 CC[C@@H](C)[C@H]1NC(=O)[C@@](C)(c2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@H](C(N)=O)c2ccc(O)cc2)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H]([C@@H](C)O)NC1=O 10.1021/jm010526+
CHEMBL1790712 63212 None 0 Human Binding pKi = 8.4 8.4 -18 3
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1125 16 13 16 -0.3 CC[C@@H](C)[C@H]1NC(=O)[C@@](C)(c2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@H](C(N)=O)c2ccc(O)cc2)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H]([C@@H](C)O)NC1=O 10.1021/jm010526+
2168 3974 None 38 Human Binding pKi = 8.4 8.4 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
2810 3974 None 38 Human Binding pKi = 8.4 8.4 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
644077 3974 None 38 Human Binding pKi = 8.4 8.4 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
CHEMBL373742 3974 None 38 Human Binding pKi = 8.4 8.4 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
DB00067 3974 None 38 Human Binding pKi = 8.4 8.4 -5 9
Inhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranesInhibition of human vasopressin V1a receptor expressed in COS7 cells by HTRF-FRET assay using 384-well plate membranes
ChEMBL None None None None 10.1021/jm061404q
46890571 7355 None 0 Human Binding pKi = 8.4 8.4 177 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 377 3 0 2 5.7 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1cccc(C)c1 10.1016/j.bmcl.2010.04.068
CHEMBL1086293 7355 None 0 Human Binding pKi = 8.4 8.4 177 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 377 3 0 2 5.7 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1cccc(C)c1 10.1016/j.bmcl.2010.04.068
56657866 63211 None 0 Human Binding pKi = 7.5 7.5 -75 3
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1281 16 14 20 0.3 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H]([C@H](C)O)NC1=O 10.1021/jm010526+
CHEMBL1790711 63211 None 0 Human Binding pKi = 7.5 7.5 -75 3
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1281 16 14 20 0.3 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H]([C@H](C)O)NC1=O 10.1021/jm010526+
44428497 93055 None 0 Human Binding pKi = 7.5 7.5 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 757 11 1 6 6.0 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CC(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL244227 93055 None 0 Human Binding pKi = 7.5 7.5 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 757 11 1 6 6.0 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CC(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
44428496 143440 None 0 Human Binding pKi = 7.5 7.5 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 744 11 1 7 4.7 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CC(=O)N1CCN(N2CCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL389828 143440 None 0 Human Binding pKi = 7.5 7.5 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 744 11 1 7 4.7 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CC(=O)N1CCN(N2CCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
24894463 150675 None 0 Human Binding pKi = 7.5 7.5 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 771 12 1 6 6.4 O=C(NCc1cccc(C(F)(F)F)c1)[C@@H](CCC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL395579 150675 None 0 Human Binding pKi = 7.5 7.5 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 771 12 1 6 6.4 O=C(NCc1cccc(C(F)(F)F)c1)[C@@H](CCC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL5079921 214651 None 0 Human Binding pKi = 7.5 7.5 - 1
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL None None None Cc1cccc2c1-n1c(nnc1C1CCN(c3ccccc3)CC1)C[C@@H](O)C2 10.1021/acs.jmedchem.1c00863
145961670 161362 None 0 Human Binding pKi = 7.5 7.5 5 2
Displacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1139 19 14 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccccc2CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL4126100 161362 None 0 Human Binding pKi = 7.5 7.5 5 2
Displacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1139 19 14 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccccc2CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
44520855 179372 None 0 Human Binding pKi = 7.5 7.5 -5 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 561 5 1 5 5.9 Cc1cccc(CNC(=O)/C=C2/c3ccccc3N(C(=O)c3ccc(-n4ccc(C)n4)cc3Cl)CCC2(F)F)n1 10.1016/j.bmc.2009.03.001
CHEMBL473872 179372 None 0 Human Binding pKi = 7.5 7.5 -5 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 561 5 1 5 5.9 Cc1cccc(CNC(=O)/C=C2/c3ccccc3N(C(=O)c3ccc(-n4ccc(C)n4)cc3Cl)CCC2(F)F)n1 10.1016/j.bmc.2009.03.001
44325703 111401 None 0 Human Binding pKi = 7.5 7.5 -75 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 553 4 2 5 5.8 O=C(Nc1ccc(C(=O)N2C[C@H]3COCCN3Cc3ccccc32)c(Cl)c1)c1ccc(O)cc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL327242 111401 None 0 Human Binding pKi = 7.5 7.5 -75 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 553 4 2 5 5.8 O=C(Nc1ccc(C(=O)N2C[C@H]3COCCN3Cc3ccccc32)c(Cl)c1)c1ccc(O)cc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
54586924 61780 None 0 Human Binding pKi = 7.5 7.5 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 592 12 1 6 4.3 COc1cc(C)c(S(=O)(=O)N[C@H](C(=O)N(CCCN2CCN(C)CC2)Cc2ccccc2)c2ccccc2)c(C)c1C 10.1016/j.bmcl.2011.02.096
CHEMBL1773080 61780 None 0 Human Binding pKi = 7.5 7.5 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 592 12 1 6 4.3 COc1cc(C)c(S(=O)(=O)N[C@H](C(=O)N(CCCN2CCN(C)CC2)Cc2ccccc2)c2ccccc2)c(C)c1C 10.1016/j.bmcl.2011.02.096
1134581 9892 None 8 Human Binding pKi = 6.5 6.5 -3 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 444 7 1 4 4.5 COc1ccc(N(CC(=O)Nc2cccc(Cl)c2C)S(=O)(=O)c2ccccc2)cc1 10.1021/jm050645f
CHEMBL114302 9892 None 8 Human Binding pKi = 6.5 6.5 -3 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 444 7 1 4 4.5 COc1ccc(N(CC(=O)Nc2cccc(Cl)c2C)S(=O)(=O)c2ccccc2)cc1 10.1021/jm050645f
158348 3485 None 18 Human Binding pKi = 6.5 6.5 -1318 4
Displacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysisDisplacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysis
ChEMBL 643 10 1 9 3.9 CCOc1ccc2c(c1)[C@@]1(CC[C@H](CC1)OCCN1CCOCC1)C(=O)N2S(=O)(=O)c1ccc(cc1OC)C(=O)NC(C)(C)C 10.1021/acs.jmedchem.8b01320
2199 3485 None 18 Human Binding pKi = 6.5 6.5 -1318 4
Displacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysisDisplacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysis
ChEMBL 643 10 1 9 3.9 CCOc1ccc2c(c1)[C@@]1(CC[C@H](CC1)OCCN1CCOCC1)C(=O)N2S(=O)(=O)c1ccc(cc1OC)C(=O)NC(C)(C)C 10.1021/acs.jmedchem.8b01320
CHEMBL4283439 3485 None 18 Human Binding pKi = 6.5 6.5 -1318 4
Displacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysisDisplacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysis
ChEMBL 643 10 1 9 3.9 CCOc1ccc2c(c1)[C@@]1(CC[C@H](CC1)OCCN1CCOCC1)C(=O)N2S(=O)(=O)c1ccc(cc1OC)C(=O)NC(C)(C)C 10.1021/acs.jmedchem.8b01320
DB14923 3485 None 18 Human Binding pKi = 6.5 6.5 -1318 4
Displacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysisDisplacement of [125I]OH-Phpa-LVA from human V1A receptor expressed in CHO cells after 4 hrs by gamma counter analysis
ChEMBL 643 10 1 9 3.9 CCOc1ccc2c(c1)[C@@]1(CC[C@H](CC1)OCCN1CCOCC1)C(=O)N2S(=O)(=O)c1ccc(cc1OC)C(=O)NC(C)(C)C 10.1021/acs.jmedchem.8b01320
44361406 35012 None 0 Rat Binding pKi = 7.5 7.5 4 5
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver.Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver.
ChEMBL 451 7 1 5 3.4 CC(=O)NCCCOc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)cc1 10.1021/jm00023a002
CHEMBL143304 35012 None 0 Rat Binding pKi = 7.5 7.5 4 5
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver.Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver.
ChEMBL 451 7 1 5 3.4 CC(=O)NCCCOc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)cc1 10.1021/jm00023a002
162644579 179465 None 0 Human Binding pKi = 6.5 6.5 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 371 1 1 4 3.3 C[C@@H]1CN(C(=O)N2CCNc3cc(Cl)ccc32)CCN1c1ccccn1 10.1016/j.bmcl.2020.127416
CHEMBL4740795 179465 None 0 Human Binding pKi = 6.5 6.5 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 371 1 1 4 3.3 C[C@@H]1CN(C(=O)N2CCNc3cc(Cl)ccc32)CCN1c1ccccn1 10.1016/j.bmcl.2020.127416
45483204 197885 None 0 Human Binding pKi = 6.5 6.5 -11 5
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL1204126 197885 None 0 Human Binding pKi = 6.5 6.5 -11 5
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL1204403 197885 None 0 Human Binding pKi = 6.5 6.5 -11 5
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL572709 197885 None 0 Human Binding pKi = 6.5 6.5 -11 5
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
46890153 6848 None 0 Human Binding pKi = 6.5 6.5 -1 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 457 2 0 2 7.9 CC1(C)C[C@@H]2C[C@@](C)(CN2C(=O)c2cc(Cl)c(-c3csc4ccccc34)cc2Cl)C1 10.1016/j.bmcl.2010.04.068
CHEMBL1084069 6848 None 0 Human Binding pKi = 6.5 6.5 -1 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 457 2 0 2 7.9 CC1(C)C[C@@H]2C[C@@](C)(CN2C(=O)c2cc(Cl)c(-c3csc4ccccc34)cc2Cl)C1 10.1016/j.bmcl.2010.04.068
44419026 168497 None 17 Rat Binding pKi = 6.5 6.5 -1230 2
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL435323 168497 None 17 Rat Binding pKi = 6.5 6.5 -1230 2
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
56663269 64039 None 0 Rat Binding pKi = 6.5 6.5 -67 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 433 7 3 3 3.1 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)NC1CCNCC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807257 64039 None 0 Rat Binding pKi = 6.5 6.5 -67 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 433 7 3 3 3.1 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)NC1CCNCC1 10.1016/j.bmcl.2011.05.092
114904 2952 None 56 Rat Binding pKi = 7.5 7.5 7 7
Binding affinity towards Vasopressin V1a receptor in rat liverBinding affinity towards Vasopressin V1a receptor in rat liver
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm000108p
2196 2952 None 56 Rat Binding pKi = 7.5 7.5 7 7
Binding affinity towards Vasopressin V1a receptor in rat liverBinding affinity towards Vasopressin V1a receptor in rat liver
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm000108p
CHEMBL296908 2952 None 56 Rat Binding pKi = 7.5 7.5 7 7
Binding affinity towards Vasopressin V1a receptor in rat liverBinding affinity towards Vasopressin V1a receptor in rat liver
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm000108p
114904 2952 None 56 Rat Binding pKi = 7.5 7.5 7 7
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver.Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver.
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm00023a002
2196 2952 None 56 Rat Binding pKi = 7.5 7.5 7 7
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver.Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver.
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm00023a002
CHEMBL296908 2952 None 56 Rat Binding pKi = 7.5 7.5 7 7
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver.Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver.
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm00023a002
216237 3841 None 89 Human Binding pKi = 7.5 7.5 -23 5
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1021/acs.jmedchem.1c00863
2226 3841 None 89 Human Binding pKi = 7.5 7.5 -23 5
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1021/acs.jmedchem.1c00863
4110 3841 None 89 Human Binding pKi = 7.5 7.5 -23 5
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1021/acs.jmedchem.1c00863
443894 3841 None 89 Human Binding pKi = 7.5 7.5 -23 5
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1021/acs.jmedchem.1c00863
CHEMBL344159 3841 None 89 Human Binding pKi = 7.5 7.5 -23 5
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1021/acs.jmedchem.1c00863
DB06212 3841 None 89 Human Binding pKi = 7.5 7.5 -23 5
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1021/acs.jmedchem.1c00863
15952030 118646 None 0 Human Binding pKi = 7.5 7.5 208 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 332 1 1 2 3.8 O=C(c1c[nH]c2ccccc12)N1CCC2(CC1)OCc1ccccc12 10.1021/jm501745f
CHEMBL3416867 118646 None 0 Human Binding pKi = 7.5 7.5 208 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 332 1 1 2 3.8 O=C(c1c[nH]c2ccccc12)N1CCC2(CC1)OCc1ccccc12 10.1021/jm501745f
17757748 118656 None 0 Human Binding pKi = 7.5 7.5 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 395 1 2 3 4.5 O=C1Nc2ccccc2C2(CCN(C(=O)c3c[nH]c4cc(Cl)ccc34)CC2)O1 10.1021/jm501745f
CHEMBL3416877 118656 None 0 Human Binding pKi = 7.5 7.5 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 395 1 2 3 4.5 O=C1Nc2ccccc2C2(CCN(C(=O)c3c[nH]c4cc(Cl)ccc34)CC2)O1 10.1021/jm501745f
114904 2952 None 56 Rat Binding pKi = 7.5 7.5 7 7
Displacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissue
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm901812z
2196 2952 None 56 Rat Binding pKi = 7.5 7.5 7 7
Displacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissue
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm901812z
CHEMBL296908 2952 None 56 Rat Binding pKi = 7.5 7.5 7 7
Displacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissue
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm901812z
10304617 206225 None 0 Rat Binding pKi = 7.5 7.5 -32 4
Binding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liverBinding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liver
ChEMBL 625 8 0 6 7.9 Cc1cccc(OCc2ccc(C(=O)N3CCC(N4CCCCC4)CC3)cc2)c1-n1c(C)nnc1-c1ccc(-c2ccccc2)cc1 10.1021/jm010544r
CHEMBL86667 206225 None 0 Rat Binding pKi = 7.5 7.5 -32 4
Binding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liverBinding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liver
ChEMBL 625 8 0 6 7.9 Cc1cccc(OCc2ccc(C(=O)N3CCC(N4CCCCC4)CC3)cc2)c1-n1c(C)nnc1-c1ccc(-c2ccccc2)cc1 10.1021/jm010544r
2252 2228 None 48 Human Binding pKi = 5.5 5.5 -851 5
Binding affinity towards human Vasopressin V1a receptor by using functional assayBinding affinity towards human Vasopressin V1a receptor by using functional assay
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(99)00181-x
6918320 2228 None 48 Human Binding pKi = 5.5 5.5 -851 5
Binding affinity towards human Vasopressin V1a receptor by using functional assayBinding affinity towards human Vasopressin V1a receptor by using functional assay
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(99)00181-x
CHEMBL24781 2228 None 48 Human Binding pKi = 5.5 5.5 -851 5
Binding affinity towards human Vasopressin V1a receptor by using functional assayBinding affinity towards human Vasopressin V1a receptor by using functional assay
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(99)00181-x
2252 2228 None 48 Human Binding pKi = 5.5 5.5 -851 5
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human plateletsBinding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm00023a002
6918320 2228 None 48 Human Binding pKi = 5.5 5.5 -851 5
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human plateletsBinding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm00023a002
CHEMBL24781 2228 None 48 Human Binding pKi = 5.5 5.5 -851 5
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human plateletsBinding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm00023a002
2252 2228 None 48 Human Binding pKi = 5.5 5.5 -851 5
Displacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissue
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm901812z
6918320 2228 None 48 Human Binding pKi = 5.5 5.5 -851 5
Displacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissue
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm901812z
CHEMBL24781 2228 None 48 Human Binding pKi = 5.5 5.5 -851 5
Displacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissue
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm901812z
2253 2229 None 20 Human Binding pKi = 5.5 5.5 -4168 6
Displacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissue
ChEMBL 586 7 0 7 4.4 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)Cc1ccc[n+](c1C)[O-] 10.1021/jm901812z
5311202 2229 None 20 Human Binding pKi = 5.5 5.5 -4168 6
Displacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissue
ChEMBL 586 7 0 7 4.4 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)Cc1ccc[n+](c1C)[O-] 10.1021/jm901812z
CHEMBL306645 2229 None 20 Human Binding pKi = 5.5 5.5 -4168 6
Displacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissue
ChEMBL 586 7 0 7 4.4 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)Cc1ccc[n+](c1C)[O-] 10.1021/jm901812z
135475964 72874 None 0 Human Binding pKi = 5.5 5.5 -53 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 467 9 2 6 3.4 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C/c2ccccc2O)c2ccc(C)cc2)cc1 10.1021/jm050645f
CHEMBL200329 72874 None 0 Human Binding pKi = 5.5 5.5 -53 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 467 9 2 6 3.4 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C/c2ccccc2O)c2ccc(C)cc2)cc1 10.1021/jm050645f
999998 140629 None 11 Human Binding pKi = 6.5 6.5 1 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 420 5 0 3 3.8 Cc1ccc(N(CC(=O)N2CCc3ccccc3C2)S(=O)(=O)c2ccccc2)cc1 10.1021/jm050645f
CHEMBL381433 140629 None 11 Human Binding pKi = 6.5 6.5 1 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 420 5 0 3 3.8 Cc1ccc(N(CC(=O)N2CCc3ccccc3C2)S(=O)(=O)c2ccccc2)cc1 10.1021/jm050645f
44428548 92294 None 0 Human Binding pKi = 7.5 7.5 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 793 14 1 6 6.3 O=C(NCc1cccc(C(F)(F)F)c1)[C@@H](CCC(=O)N1CCN(CCc2ccccc2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL242728 92294 None 0 Human Binding pKi = 7.5 7.5 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 793 14 1 6 6.3 O=C(NCc1cccc(C(F)(F)F)c1)[C@@H](CCC(=O)N1CCN(CCc2ccccc2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
45483237 198761 None 0 Human Binding pKi = 7.5 7.5 2 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 8 4.3 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCc3ccsc3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL583082 198761 None 0 Human Binding pKi = 7.5 7.5 2 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 8 4.3 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCc3ccsc3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
46890261 6683 None 0 Human Binding pKi = 7.5 7.5 -3 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 562 3 0 2 9.6 CC1(C)C[C@@H]2C[C@@](C)(CN2C(=O)c2ccc(-c3ccc(-c4cccc5cccnc45)c(Cl)c3Cl)cc2Cl)C1 10.1016/j.bmcl.2010.04.068
CHEMBL1083479 6683 None 0 Human Binding pKi = 7.5 7.5 -3 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 562 3 0 2 9.6 CC1(C)C[C@@H]2C[C@@](C)(CN2C(=O)c2ccc(-c3ccc(-c4cccc5cccnc45)c(Cl)c3Cl)cc2Cl)C1 10.1016/j.bmcl.2010.04.068
54580291 61897 None 0 Human Binding pKi = 7.5 7.5 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 507 7 2 3 4.7 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)C(Cc1ccc(Cl)cc1)NC(=O)Cc1cccc(Cl)c1Cl)C2 10.1016/j.bmcl.2011.02.096
CHEMBL1774011 61897 None 0 Human Binding pKi = 7.5 7.5 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 507 7 2 3 4.7 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)C(Cc1ccc(Cl)cc1)NC(=O)Cc1cccc(Cl)c1Cl)C2 10.1016/j.bmcl.2011.02.096
135413563 122928 None 25 Human Binding pKi = 6.5 6.5 -1 2
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/jm901084f
CHEMBL360648 122928 None 25 Human Binding pKi = 6.5 6.5 -1 2
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/jm901084f
52947354 16993 None 12 Human Binding pKi = 6.5 6.5 -3 3
Displacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 338 4 1 4 2.9 CO/N=C1/C[C@@H](CO)N(C(=O)c2ccc(-c3ccccc3C)cc2)C1 10.1021/jm901812z
CHEMBL1254025 16993 None 12 Human Binding pKi = 6.5 6.5 -3 3
Displacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 338 4 1 4 2.9 CO/N=C1/C[C@@H](CO)N(C(=O)c2ccc(-c3ccccc3C)cc2)C1 10.1021/jm901812z
16109446 136603 None 0 Rat Binding pKi = 5.5 5.5 -8709 4
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 983 15 11 14 -2.7 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL373968 136603 None 0 Rat Binding pKi = 5.5 5.5 -8709 4
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 983 15 11 14 -2.7 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
145959434 162124 None 0 Human Binding pKi = 5.5 5.5 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 566 8 1 8 5.0 COc1cc(CN2CCN(c3cccc(CCC(=O)N4Cc5cnn(C)c5Nc5ccccc54)c3)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
CHEMBL4161507 162124 None 0 Human Binding pKi = 5.5 5.5 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 566 8 1 8 5.0 COc1cc(CN2CCN(c3cccc(CCC(=O)N4Cc5cnn(C)c5Nc5ccccc54)c3)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
44314342 103084 None 0 Rat Binding pKi = 6.5 6.5 6 2
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 604 7 1 5 6.9 Cc1occc1C(=O)Nc1ccc(C(=O)N(C)c2ccccc2-c2ccc(C(=O)N3CCC(N4CCCCC4)CC3)cc2)cc1 10.1016/s0960-894x(01)00723-5
CHEMBL307487 103084 None 0 Rat Binding pKi = 6.5 6.5 6 2
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 604 7 1 5 6.9 Cc1occc1C(=O)Nc1ccc(C(=O)N(C)c2ccccc2-c2ccc(C(=O)N3CCC(N4CCCCC4)CC3)cc2)cc1 10.1016/s0960-894x(01)00723-5
54583264 61881 None 0 Human Binding pKi = 6.5 6.5 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 424 7 2 4 2.9 CNC(=O)[C@H](Cc1ccc(Cl)cc1)NS(=O)(=O)c1c(C)cc(OC)c(C)c1C 10.1016/j.bmcl.2011.02.096
CHEMBL1773999 61881 None 0 Human Binding pKi = 6.5 6.5 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 424 7 2 4 2.9 CNC(=O)[C@H](Cc1ccc(Cl)cc1)NS(=O)(=O)c1c(C)cc(OC)c(C)c1C 10.1016/j.bmcl.2011.02.096
145978570 163817 None 0 Human Binding pKi = 7.5 7.5 2 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 331 2 0 3 4.2 Cc1ccn(-c2ccc(C(=O)N3CCCCc4ccccc43)cc2)n1 10.1021/acs.jmedchem.8b00697
CHEMBL4206233 163817 None 0 Human Binding pKi = 7.5 7.5 2 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 331 2 0 3 4.2 Cc1ccn(-c2ccc(C(=O)N3CCCCc4ccccc43)cc2)n1 10.1021/acs.jmedchem.8b00697
CHEMBL5085869 214994 None 0 Human Binding pKi = 7.5 7.5 - 1
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL None None None Cc1ccc2c(c1)-n1c(nnc1[C@H]1CC[C@H](Oc3ccccn3)CC1)CC(O)C2 10.1021/acs.jmedchem.1c00863
2042 2981 None 58 Human Binding pKi = 7.5 7.5 -29 8
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL None None None None 10.1016/j.bmcl.2008.11.064
2174 2981 None 58 Human Binding pKi = 7.5 7.5 -29 8
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL None None None None 10.1016/j.bmcl.2008.11.064
2176 2981 None 58 Human Binding pKi = 7.5 7.5 -29 8
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL None None None None 10.1016/j.bmcl.2008.11.064
439302 2981 None 58 Human Binding pKi = 7.5 7.5 -29 8
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL None None None None 10.1016/j.bmcl.2008.11.064
CHEMBL395429 2981 None 58 Human Binding pKi = 7.5 7.5 -29 8
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL None None None None 10.1016/j.bmcl.2008.11.064
DB00107 2981 None 58 Human Binding pKi = 7.5 7.5 -29 8
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL None None None None 10.1016/j.bmcl.2008.11.064
44325695 168004 None 0 Human Binding pKi = 5.5 5.5 -1230 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 567 5 1 5 6.1 COc1cccc(-c2ccccc2C(=O)Nc2ccc(C(=O)N3C[C@H]4COCCN4Cc4ccccc43)c(Cl)c2)c1 10.1016/j.bmcl.2004.03.083
CHEMBL432043 168004 None 0 Human Binding pKi = 5.5 5.5 -1230 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 567 5 1 5 6.1 COc1cccc(-c2ccccc2C(=O)Nc2ccc(C(=O)N3C[C@H]4COCCN4Cc4ccccc43)c(Cl)c2)c1 10.1016/j.bmcl.2004.03.083
3537 4002 None 22 Human Binding pKi = 6.5 6.5 -9 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
5311500 4002 None 22 Human Binding pKi = 6.5 6.5 -9 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
CHEMBL363910 4002 None 22 Human Binding pKi = 6.5 6.5 -9 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
3537 4002 None 22 Human Binding pKi = 6.5 6.5 -9 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/jm901084f
5311500 4002 None 22 Human Binding pKi = 6.5 6.5 -9 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/jm901084f
CHEMBL363910 4002 None 22 Human Binding pKi = 6.5 6.5 -9 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/jm901084f
114904 2952 None 56 Human Binding pKi = 6.5 6.5 -301 7
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/np50112a001
2196 2952 None 56 Human Binding pKi = 6.5 6.5 -301 7
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/np50112a001
CHEMBL296908 2952 None 56 Human Binding pKi = 6.5 6.5 -301 7
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/np50112a001
46890486 7029 None 0 Human Binding pKi = 7.4 7.4 28 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 361 2 0 1 6.0 Cc1ccccc1-c1ccc(C(=O)N2C[C@@]3(C)C[C@@H]2CC(C)(C)C3)cc1C 10.1016/j.bmcl.2010.04.068
CHEMBL1084824 7029 None 0 Human Binding pKi = 7.4 7.4 28 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 361 2 0 1 6.0 Cc1ccccc1-c1ccc(C(=O)N2C[C@@]3(C)C[C@@H]2CC(C)(C)C3)cc1C 10.1016/j.bmcl.2010.04.068
CHEMBL2369834 209697 None 0 Human Binding pKi = 7.4 7.4 -2 4
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL None None None NCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
CHEMBL2369842 209705 None 0 Human Binding pKi = 7.4 7.4 -2 4
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL None None None NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
44361406 35012 None 0 Human Binding pKi = 4.4 4.4 -1174 5
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets.Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets.
ChEMBL 451 7 1 5 3.4 CC(=O)NCCCOc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)cc1 10.1021/jm00023a002
CHEMBL143304 35012 None 0 Human Binding pKi = 4.4 4.4 -1174 5
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets.Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets.
ChEMBL 451 7 1 5 3.4 CC(=O)NCCCOc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)cc1 10.1021/jm00023a002
135520373 79068 None 0 Human Binding pKi = 5.4 5.4 -56 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 513 8 2 7 2.8 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccncc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113202 79068 None 0 Human Binding pKi = 5.4 5.4 -56 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 513 8 2 7 2.8 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccncc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
45483320 198219 None 0 Human Binding pKi = 5.4 5.4 -2 2
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 543 7 1 5 5.1 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(NCc2cccs2)CC1 10.1016/j.bmcl.2009.09.050
CHEMBL575359 198219 None 0 Human Binding pKi = 5.4 5.4 -2 2
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 543 7 1 5 5.1 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(NCc2cccs2)CC1 10.1016/j.bmcl.2009.09.050
118734334 118595 None 0 Human Binding pKi = 7.4 7.4 10 2
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 416 3 1 3 5.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCSc3cccc(C)c32)cc1 10.1021/acs.jmedchem.5b00289
CHEMBL3416767 118595 None 0 Human Binding pKi = 7.4 7.4 10 2
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 416 3 1 3 5.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCSc3cccc(C)c32)cc1 10.1021/acs.jmedchem.5b00289
135916059 201087 None 0 Human Binding pKi = 7.4 7.4 -5 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 513 4 2 5 6.6 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1NC(=O)c1ccccc1-c1ccccc1 10.1021/jm901084f
CHEMBL602872 201087 None 0 Human Binding pKi = 7.4 7.4 -5 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 513 4 2 5 6.6 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1NC(=O)c1ccccc1-c1ccccc1 10.1021/jm901084f
2241 2216 None 1 Rat Binding pKi = 6.4 6.4 -117 4
Binding affinity towards rat liver V1a receptor was determined using [3H]arginine vasopressin as radioligandBinding affinity towards rat liver V1a receptor was determined using [3H]arginine vasopressin as radioligand
ChEMBL None None None None 10.1021/jm00099a019
9810632 2216 None 1 Rat Binding pKi = 6.4 6.4 -117 4
Binding affinity towards rat liver V1a receptor was determined using [3H]arginine vasopressin as radioligandBinding affinity towards rat liver V1a receptor was determined using [3H]arginine vasopressin as radioligand
ChEMBL None None None None 10.1021/jm00099a019
CHEMBL127686 2216 None 1 Rat Binding pKi = 6.4 6.4 -117 4
Binding affinity towards rat liver V1a receptor was determined using [3H]arginine vasopressin as radioligandBinding affinity towards rat liver V1a receptor was determined using [3H]arginine vasopressin as radioligand
ChEMBL None None None None 10.1021/jm00099a019
45483204 197885 None 0 Rat Binding pKi = 5.4 5.4 -40 5
Displacement of [3H]Arg8-vasopressin from rat vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from rat vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL1204126 197885 None 0 Rat Binding pKi = 5.4 5.4 -40 5
Displacement of [3H]Arg8-vasopressin from rat vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from rat vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL1204403 197885 None 0 Rat Binding pKi = 5.4 5.4 -40 5
Displacement of [3H]Arg8-vasopressin from rat vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from rat vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL572709 197885 None 0 Rat Binding pKi = 5.4 5.4 -40 5
Displacement of [3H]Arg8-vasopressin from rat vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from rat vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
135461099 79082 None 0 Human Binding pKi = 5.4 5.4 -177 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 506 9 2 6 3.5 CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm050645f
CHEMBL2113216 79082 None 0 Human Binding pKi = 5.4 5.4 -177 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 506 9 2 6 3.5 CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm050645f
44520857 179460 None 0 Human Binding pKi = 7.4 7.4 -3 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 562 5 2 6 5.2 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4cccc(N)n4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
CHEMBL474072 179460 None 0 Human Binding pKi = 7.4 7.4 -3 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 562 5 2 6 5.2 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4cccc(N)n4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
44321415 112313 None 0 Human Binding pKi = 7.4 7.4 269 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 467 8 0 6 4.9 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCN1CCN(C)CC1 10.1021/jm010544r
CHEMBL329209 112313 None 0 Human Binding pKi = 7.4 7.4 269 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 467 8 0 6 4.9 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCN1CCN(C)CC1 10.1021/jm010544r
46890288 7423 None 0 Human Binding pKi = 7.4 7.4 1 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 528 3 0 2 8.9 CC1(C)C[C@@H]2C[C@@](C)(CN2C(=O)c2ccc(-c3ccc(-c4cccc5cccnc45)cc3Cl)cc2Cl)C1 10.1016/j.bmcl.2010.04.068
CHEMBL1086574 7423 None 0 Human Binding pKi = 7.4 7.4 1 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 528 3 0 2 8.9 CC1(C)C[C@@H]2C[C@@](C)(CN2C(=O)c2ccc(-c3ccc(-c4cccc5cccnc45)cc3Cl)cc2Cl)C1 10.1016/j.bmcl.2010.04.068
46890708 6726 None 0 Human Binding pKi = 7.4 7.4 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 453 3 0 3 7.3 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1cccc2c1oc1ccccc12 10.1016/j.bmcl.2010.04.068
CHEMBL1083704 6726 None 0 Human Binding pKi = 7.4 7.4 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 453 3 0 3 7.3 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1cccc2c1oc1ccccc12 10.1016/j.bmcl.2010.04.068
54580293 61904 None 0 Rat Binding pKi = 6.4 6.4 -53 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 453 7 2 3 3.7 Cc1ccc(CC(=O)N[C@H](Cc2ccc(Cl)cc2)C(=O)N[C@@H]2C[C@@H]3CC[C@H](C2)N3C)cc1 10.1016/j.bmcl.2011.02.096
CHEMBL1774019 61904 None 0 Rat Binding pKi = 6.4 6.4 -53 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 453 7 2 3 3.7 Cc1ccc(CC(=O)N[C@H](Cc2ccc(Cl)cc2)C(=O)N[C@@H]2C[C@@H]3CC[C@H](C2)N3C)cc1 10.1016/j.bmcl.2011.02.096
44419030 161612 None 19 Rat Binding pKi = 5.4 5.4 -23988 4
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1025 18 11 14 -1.5 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL412972 161612 None 19 Rat Binding pKi = 5.4 5.4 -23988 4
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1025 18 11 14 -1.5 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
44361403 33843 None 1 Human Binding pKi = 4.4 4.4 -1584 5
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human plateletsBinding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets
ChEMBL 491 5 0 5 4.1 CC(=O)N1CCCC(COc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2)C1 10.1021/jm00023a002
CHEMBL142324 33843 None 1 Human Binding pKi = 4.4 4.4 -1584 5
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human plateletsBinding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets
ChEMBL 491 5 0 5 4.1 CC(=O)N1CCCC(COc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2)C1 10.1021/jm00023a002
54582318 61184 None 0 Human Binding pKi = 6.4 6.4 -102 4
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL 1210 29 12 15 1.7 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
CHEMBL1765668 61184 None 0 Human Binding pKi = 6.4 6.4 -102 4
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL 1210 29 12 15 1.7 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
11257380 178612 None 0 Human Binding pKi = 6.4 6.4 -64 2
Displacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uMDisplacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uM
ChEMBL 376 4 0 7 3.6 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1021/jm901812z
CHEMBL467378 178612 None 0 Human Binding pKi = 6.4 6.4 -64 2
Displacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uMDisplacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uM
ChEMBL 376 4 0 7 3.6 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1021/jm901812z
25001616 118651 None 0 Human Binding pKi = 7.4 7.4 123 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 367 1 1 3 3.9 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)OCc1ncccc12 10.1021/jm501745f
CHEMBL3416872 118651 None 0 Human Binding pKi = 7.4 7.4 123 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 367 1 1 3 3.9 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)OCc1ncccc12 10.1021/jm501745f
59657596 118664 None 31 Mouse Binding pKi = 7.4 7.4 -16 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 437 4 0 4 4.5 CN(C)CCn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1021/jm501745f
CHEMBL3416885 118664 None 31 Mouse Binding pKi = 7.4 7.4 -16 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 437 4 0 4 4.5 CN(C)CCn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1021/jm501745f
44520850 199862 None 0 Human Binding pKi = 7.4 7.4 -2 2
Displacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation countingDisplacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation counting
ChEMBL 537 5 2 4 4.7 C[C@@H]1CCN(c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCCO)c4ccccc43)c(C(F)(F)F)c2)C1 10.1016/j.bmc.2009.10.038
CHEMBL594488 199862 None 0 Human Binding pKi = 7.4 7.4 -2 2
Displacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation countingDisplacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation counting
ChEMBL 537 5 2 4 4.7 C[C@@H]1CCN(c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCCO)c4ccccc43)c(C(F)(F)F)c2)C1 10.1016/j.bmc.2009.10.038
10929819 106942 None 0 Human Binding pKi = 7.4 7.4 371 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 565 15 0 6 7.7 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCCCCCCCN1CCN(C)CC1 10.1021/jm010544r
CHEMBL314908 106942 None 0 Human Binding pKi = 7.4 7.4 371 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 565 15 0 6 7.7 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCCCCCCCN1CCN(C)CC1 10.1021/jm010544r
54584253 61899 None 0 Human Binding pKi = 7.4 7.4 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 507 7 2 3 4.7 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)C(Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1Cl)C2 10.1016/j.bmcl.2011.02.096
CHEMBL1774013 61899 None 0 Human Binding pKi = 7.4 7.4 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 507 7 2 3 4.7 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)C(Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)cc1Cl)C2 10.1016/j.bmcl.2011.02.096
56663273 64064 None 0 Rat Binding pKi = 7.4 7.4 -28 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 448 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)NC1CCCCC1O 10.1016/j.bmcl.2011.05.092
CHEMBL1807281 64064 None 0 Rat Binding pKi = 7.4 7.4 -28 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 448 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)NC1CCCCC1O 10.1016/j.bmcl.2011.05.092
118734426 118644 None 0 Human Binding pKi = 5.4 5.4 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 452 4 1 4 4.8 Cc1c(C(=O)N2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1C(=O)c1ccccc1 10.1021/jm501745f
CHEMBL3416865 118644 None 0 Human Binding pKi = 5.4 5.4 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 452 4 1 4 4.8 Cc1c(C(=O)N2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1C(=O)c1ccccc1 10.1021/jm501745f
45483239 197890 None 0 Human Binding pKi = 6.4 6.4 -2 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 631 11 1 7 4.3 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCc3ccc(F)cc3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL572760 197890 None 0 Human Binding pKi = 6.4 6.4 -2 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 631 11 1 7 4.3 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCc3ccc(F)cc3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
135475778 79076 None 0 Human Binding pKi = 5.4 5.4 -223 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 540 10 2 6 4.2 CCCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113210 79076 None 0 Human Binding pKi = 5.4 5.4 -223 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 540 10 2 6 4.2 CCCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
44279590 110342 None 0 Human Binding pKi = 5.4 5.4 -1000 2
Compound was tested for its ability to displace vasopressin from human Vasopressin V1a receptorCompound was tested for its ability to displace vasopressin from human Vasopressin V1a receptor
ChEMBL 609 6 1 8 4.1 O=C(Cn1cnc(C(F)(F)F)cc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL32404 110342 None 0 Human Binding pKi = 5.4 5.4 -1000 2
Compound was tested for its ability to displace vasopressin from human Vasopressin V1a receptorCompound was tested for its ability to displace vasopressin from human Vasopressin V1a receptor
ChEMBL 609 6 1 8 4.1 O=C(Cn1cnc(C(F)(F)F)cc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
15951937 118641 None 0 Human Binding pKi = 8.4 8.4 251 3
Antagonist activity at human vasopressin 1a receptorAntagonist activity at human vasopressin 1a receptor
ChEMBL 366 1 1 2 4.5 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)OCc1ccccc12 10.1021/acs.jmedchem.6b01437
CHEMBL3416861 118641 None 0 Human Binding pKi = 8.4 8.4 251 3
Antagonist activity at human vasopressin 1a receptorAntagonist activity at human vasopressin 1a receptor
ChEMBL 366 1 1 2 4.5 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)OCc1ccccc12 10.1021/acs.jmedchem.6b01437
15951937 118641 None 0 Human Binding pKi = 8.4 8.4 251 3
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 366 1 1 2 4.5 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)OCc1ccccc12 10.1021/jm501745f
CHEMBL3416861 118641 None 0 Human Binding pKi = 8.4 8.4 251 3
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 366 1 1 2 4.5 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)OCc1ccccc12 10.1021/jm501745f
118734429 118663 None 0 Human Binding pKi = 8.4 8.4 2 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 463 2 0 4 5.2 CN1CCC(n2cc(C(=O)N3CCC4(CC3)OCc3ccccc34)c3ccc(Cl)cc32)CC1 10.1021/jm501745f
CHEMBL3416884 118663 None 0 Human Binding pKi = 8.4 8.4 2 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 463 2 0 4 5.2 CN1CCC(n2cc(C(=O)N3CCC4(CC3)OCc3ccccc34)c3ccc(Cl)cc32)CC1 10.1021/jm501745f
162647523 179775 None 0 Human Binding pKi = 8.4 8.4 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 428 2 1 4 2.7 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)CO)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4744606 179775 None 0 Human Binding pKi = 8.4 8.4 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 428 2 1 4 2.7 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)CO)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
162648022 179972 None 0 Human Binding pKi = 8.4 8.4 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 479 3 0 3 5.0 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CCCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4746818 179972 None 0 Human Binding pKi = 8.4 8.4 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 479 3 0 3 5.0 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CCCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
162658540 181101 None 0 Human Binding pKi = 8.4 8.4 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 369 1 0 2 4.3 Cc1ccccc1N1CCN(C(=O)N2CCCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4760164 181101 None 0 Human Binding pKi = 8.4 8.4 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 369 1 0 2 4.3 Cc1ccccc1N1CCN(C(=O)N2CCCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
162665294 182371 None 0 Human Binding pKi = 8.4 8.4 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 383 0 1 3 4.2 O=C(N1CCC2(CC1)OCc1ccccc12)N1CCNc2cc(Cl)ccc21 10.1016/j.bmcl.2020.127416
CHEMBL4785083 182371 None 0 Human Binding pKi = 8.4 8.4 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 383 0 1 3 4.2 O=C(N1CCC2(CC1)OCc1ccccc12)N1CCNc2cc(Cl)ccc21 10.1016/j.bmcl.2020.127416
10278394 206181 None 0 Human Binding pKi = 8.4 8.4 1202 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 495 10 0 6 5.7 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCCN1CCN(C)CC1 10.1021/jm010544r
CHEMBL86384 206181 None 0 Human Binding pKi = 8.4 8.4 1202 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 495 10 0 6 5.7 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCCN1CCN(C)CC1 10.1021/jm010544r
162667594 182525 None 0 Human Binding pKi = 8.4 8.4 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 370 1 1 3 3.8 Cc1ccccc1N1CCN(C(=O)N2CCNc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4787242 182525 None 0 Human Binding pKi = 8.4 8.4 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 370 1 1 3 3.8 Cc1ccccc1N1CCN(C(=O)N2CCNc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
54586172 61909 None 0 Rat Binding pKi = 8.4 8.4 -7 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 485 7 3 3 4.2 O=C(N[C@@H]1C[C@@H]2CC[C@H](C1)N2)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C1(c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.02.096
CHEMBL1774024 61909 None 0 Rat Binding pKi = 8.4 8.4 -7 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 485 7 3 3 4.2 O=C(N[C@@H]1C[C@@H]2CC[C@H](C1)N2)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C1(c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.02.096
56676960 64061 None 0 Human Binding pKi = 8.4 8.4 75 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 448 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)NC1CCCC(O)C1 10.1016/j.bmcl.2011.05.092
CHEMBL1807279 64061 None 0 Human Binding pKi = 8.4 8.4 75 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 448 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)NC1CCCC(O)C1 10.1016/j.bmcl.2011.05.092
53349471 118601 None 0 Human Binding pKi = 8.4 8.4 22 2
Binding affinity to human V1a assessed as inhibition constantBinding affinity to human V1a assessed as inhibition constant
ChEMBL 413 3 1 3 5.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCN(C)c3cccc(C)c32)cc1 10.1016/j.bmcl.2017.11.050
CHEMBL3416774 118601 None 0 Human Binding pKi = 8.4 8.4 22 2
Binding affinity to human V1a assessed as inhibition constantBinding affinity to human V1a assessed as inhibition constant
ChEMBL 413 3 1 3 5.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCN(C)c3cccc(C)c32)cc1 10.1016/j.bmcl.2017.11.050
53349471 118601 None 0 Human Binding pKi = 8.4 8.4 22 2
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 413 3 1 3 5.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCN(C)c3cccc(C)c32)cc1 10.1021/acs.jmedchem.5b00289
CHEMBL3416774 118601 None 0 Human Binding pKi = 8.4 8.4 22 2
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 413 3 1 3 5.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCN(C)c3cccc(C)c32)cc1 10.1021/acs.jmedchem.5b00289
46890614 6671 None 0 Human Binding pKi = 8.4 8.4 416 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 397 3 0 2 6.1 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1ccc(Cl)cc1 10.1016/j.bmcl.2010.04.068
CHEMBL1083443 6671 None 0 Human Binding pKi = 8.4 8.4 416 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 397 3 0 2 6.1 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1ccc(Cl)cc1 10.1016/j.bmcl.2010.04.068
44428545 93291 None 0 Human Binding pKi = 8.4 8.4 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 839 12 1 6 7.5 O=C(NCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@H](CCC(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL245115 93291 None 0 Human Binding pKi = 8.4 8.4 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 839 12 1 6 7.5 O=C(NCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@H](CCC(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
10142915 206418 None 0 Human Binding pKi = 8.4 8.4 549 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 523 12 0 6 6.5 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCCCCN1CCN(C)CC1 10.1021/jm010544r
CHEMBL87887 206418 None 0 Human Binding pKi = 8.4 8.4 549 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 523 12 0 6 6.5 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCCCCN1CCN(C)CC1 10.1021/jm010544r
56663269 64039 None 0 Human Binding pKi = 8.3 8.3 67 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 433 7 3 3 3.1 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)NC1CCNCC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807257 64039 None 0 Human Binding pKi = 8.3 8.3 67 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 433 7 3 3 3.1 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)NC1CCNCC1 10.1016/j.bmcl.2011.05.092
137642420 158058 None 0 Human Binding pKi = 8.3 8.3 11 2
Displacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting methodDisplacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting method
ChEMBL 414 3 2 3 5.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC[C@H](O)c3cccc(C)c32)cc1 10.1021/acs.jmedchem.7b00422
CHEMBL4086079 158058 None 0 Human Binding pKi = 8.3 8.3 11 2
Displacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting methodDisplacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting method
ChEMBL 414 3 2 3 5.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC[C@H](O)c3cccc(C)c32)cc1 10.1021/acs.jmedchem.7b00422
2213 518 None 46 Human Binding pKi = 8.3 8.3 28 5
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL None None None None 10.1016/j.bmcl.2008.11.064
3008 518 None 46 Human Binding pKi = 8.3 8.3 28 5
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL None None None None 10.1016/j.bmcl.2008.11.064
5311010 518 None 46 Human Binding pKi = 8.3 8.3 28 5
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL None None None None 10.1016/j.bmcl.2008.11.064
68613 518 None 46 Human Binding pKi = 8.3 8.3 28 5
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL None None None None 10.1016/j.bmcl.2008.11.064
CHEMBL378642 518 None 46 Human Binding pKi = 8.3 8.3 28 5
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL None None None None 10.1016/j.bmcl.2008.11.064
CHEMBL382301 518 None 46 Human Binding pKi = 8.3 8.3 28 5
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL None None None None 10.1016/j.bmcl.2008.11.064
DB09059 518 None 46 Human Binding pKi = 8.3 8.3 28 5
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL None None None None 10.1016/j.bmcl.2008.11.064
54587187 61898 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 507 7 2 3 4.7 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)C(Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)c(Cl)c1)C2 10.1016/j.bmcl.2011.02.096
CHEMBL1774012 61898 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 507 7 2 3 4.7 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)C(Cc1ccc(Cl)cc1)NC(=O)Cc1ccc(Cl)c(Cl)c1)C2 10.1016/j.bmcl.2011.02.096
56683606 64053 None 0 Rat Binding pKi = 8.3 8.3 -19 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 499 8 2 3 4.6 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)C2(c3ccc(F)cc3)CCC2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807271 64053 None 0 Rat Binding pKi = 8.3 8.3 -19 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 499 8 2 3 4.6 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)C2(c3ccc(F)cc3)CCC2)CC1 10.1016/j.bmcl.2011.05.092
44314552 205048 None 0 Rat Binding pKi = 8.3 8.3 18 2
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 628 12 1 6 6.8 Cc1ccc(N(C)C(=O)c2ccc(NC(=O)c3ccoc3C)cc2)c(OCCCCCC(=O)N2CCC(N3CCCCC3)CC2)c1 10.1016/s0960-894x(01)00723-5
CHEMBL77105 205048 None 0 Rat Binding pKi = 8.3 8.3 18 2
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 628 12 1 6 6.8 Cc1ccc(N(C)C(=O)c2ccc(NC(=O)c3ccoc3C)cc2)c(OCCCCCC(=O)N2CCC(N3CCCCC3)CC2)c1 10.1016/s0960-894x(01)00723-5
162648022 179972 None 0 Human Binding pKi = 7.4 7.4 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 479 3 0 3 5.0 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CCCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4746818 179972 None 0 Human Binding pKi = 7.4 7.4 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 479 3 0 3 5.0 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CCCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
10119966 185386 None 0 Human Binding pKi = 7.4 7.4 -1 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 547 5 1 5 5.6 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4cccnc4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
CHEMBL486064 185386 None 0 Human Binding pKi = 7.4 7.4 -1 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 547 5 1 5 5.6 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4cccnc4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
44520871 192611 None 0 Human Binding pKi = 7.4 7.4 -3 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 513 5 2 5 3.5 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCC(N)=O)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
CHEMBL521597 192611 None 0 Human Binding pKi = 7.4 7.4 -3 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 513 5 2 5 3.5 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCC(N)=O)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
10392505 108590 None 0 Human Binding pKi = 7.4 7.4 -4 2
Inhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cellsInhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 539 3 1 3 6.6 O=C(Nc1ccc(C(=O)N2C[C@@H]3C4CCC(C4)N3Cc3cc(Cl)ccc32)cc1)c1ccccc1C(F)(F)F 10.1016/s0960-894x(02)00649-2
CHEMBL320416 108590 None 0 Human Binding pKi = 7.4 7.4 -4 2
Inhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cellsInhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 539 3 1 3 6.6 O=C(Nc1ccc(C(=O)N2C[C@@H]3C4CCC(C4)N3Cc3cc(Cl)ccc32)cc1)c1ccccc1C(F)(F)F 10.1016/s0960-894x(02)00649-2
46890152 6751 None 0 Human Binding pKi = 7.4 7.4 3 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 457 2 0 2 7.9 CC1(C)C[C@@H]2C[C@@](C)(CN2C(=O)c2ccc(-c3csc4ccccc34)c(Cl)c2Cl)C1 10.1016/j.bmcl.2010.04.068
CHEMBL1083765 6751 None 0 Human Binding pKi = 7.4 7.4 3 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 457 2 0 2 7.9 CC1(C)C[C@@H]2C[C@@](C)(CN2C(=O)c2ccc(-c3csc4ccccc34)c(Cl)c2Cl)C1 10.1016/j.bmcl.2010.04.068
162666950 182481 None 0 Human Binding pKi = 6.4 6.4 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 450 4 0 7 4.3 COC(=O)C12CC1c1cc(Cl)ccc1-n1c2nnc1[C@H]1CC[C@H](Oc2ccccn2)CC1 10.1016/j.bmcl.2020.127417
CHEMBL4786739 182481 None 0 Human Binding pKi = 6.4 6.4 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 450 4 0 7 4.3 COC(=O)C12CC1c1cc(Cl)ccc1-n1c2nnc1[C@H]1CC[C@H](Oc2ccccn2)CC1 10.1016/j.bmcl.2020.127417
137212769 137917 None 0 Human Binding pKi = 6.4 6.4 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader methodDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader method
ChEMBL 518 9 1 8 4.0 COc1cc(CN2CCN(CCCCC(=O)N3Cc4cnn(C)c4Nc4ccccc43)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
CHEMBL3763620 137917 None 0 Human Binding pKi = 6.4 6.4 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader methodDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader method
ChEMBL 518 9 1 8 4.0 COc1cc(CN2CCN(CCCCC(=O)N3Cc4cnn(C)c4Nc4ccccc43)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
59657616 118647 None 0 Mouse Binding pKi = 7.4 7.4 -40 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 506 3 0 5 3.7 CN1CCN(C(=O)Cn2cc(C(=O)N3CCC4(CC3)OCc3ccccc34)c3ccc(Cl)cc32)CC1 10.1021/jm501745f
CHEMBL3416868 118647 None 0 Mouse Binding pKi = 7.4 7.4 -40 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 506 3 0 5 3.7 CN1CCN(C(=O)Cn2cc(C(=O)N3CCC4(CC3)OCc3ccccc34)c3ccc(Cl)cc32)CC1 10.1021/jm501745f
44325766 112557 None 0 Human Binding pKi = 6.4 6.4 -109 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 571 4 1 4 7.0 O=C(Nc1ccc(C(=O)N2CC3CSCCN3Cc3ccccc32)c(Cl)c1)c1ccc(F)cc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL330005 112557 None 0 Human Binding pKi = 6.4 6.4 -109 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 571 4 1 4 7.0 O=C(Nc1ccc(C(=O)N2CC3CSCCN3Cc3ccccc32)c(Cl)c1)c1ccc(F)cc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
167519 189198 None 16 Rat Binding pKi = 4.4 4.4 - 1
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 220 1 1 1 3.4 C=C1[C@H]2CC[C@H](CO)[C@@]23CC[C@H](C3)C1(C)C 10.1021/np50112a001
CHEMBL511334 189198 None 16 Rat Binding pKi = 4.4 4.4 - 1
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 220 1 1 1 3.4 C=C1[C@H]2CC[C@H](CO)[C@@]23CC[C@H](C3)C1(C)C 10.1021/np50112a001
135413562 2203 None 15 Human Binding pKi = 7.4 7.4 -16 5
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm050645f
2194 2203 None 15 Human Binding pKi = 7.4 7.4 -16 5
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm050645f
CHEMBL445816 2203 None 15 Human Binding pKi = 7.4 7.4 -16 5
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm050645f
44325538 112559 None 0 Human Binding pKi = 5.4 5.4 -616 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 553 4 2 5 5.8 O=C(Nc1ccc(C(=O)N2C[C@H]3COCCN3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccc(O)cc1 10.1016/j.bmcl.2004.03.083
CHEMBL330016 112559 None 0 Human Binding pKi = 5.4 5.4 -616 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 553 4 2 5 5.8 O=C(Nc1ccc(C(=O)N2C[C@H]3COCCN3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccc(O)cc1 10.1016/j.bmcl.2004.03.083
44520861 180817 None 0 Human Binding pKi = 7.4 7.4 -12 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 548 5 1 6 5.0 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4cccnn4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
CHEMBL475684 180817 None 0 Human Binding pKi = 7.4 7.4 -12 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 548 5 1 6 5.0 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4cccnn4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
44520863 181854 None 0 Human Binding pKi = 7.4 7.4 -3 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 553 5 1 6 5.7 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4nccs4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
CHEMBL477868 181854 None 0 Human Binding pKi = 7.4 7.4 -3 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 553 5 1 6 5.7 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4nccs4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
44520854 191931 None 0 Human Binding pKi = 7.4 7.4 -2 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 546 5 1 4 6.2 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4ccccc4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
CHEMBL520040 191931 None 0 Human Binding pKi = 7.4 7.4 -2 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 546 5 1 4 6.2 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4ccccc4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
44520852 199706 None 0 Human Binding pKi = 7.4 7.4 -3 2
Displacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation countingDisplacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation counting
ChEMBL 537 5 2 4 4.7 C[C@H]1CCN(c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCCO)c4ccccc43)c(C(F)(F)F)c2)C1 10.1016/j.bmc.2009.10.038
CHEMBL593325 199706 None 0 Human Binding pKi = 7.4 7.4 -3 2
Displacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation countingDisplacement of [3H]vasopressin from human vasopressin V1A receptor expressed in CHO cells by microplate scintillation counting
ChEMBL 537 5 2 4 4.7 C[C@H]1CCN(c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCCO)c4ccccc43)c(C(F)(F)F)c2)C1 10.1016/j.bmc.2009.10.038
CHEMBL2369835 209698 None 0 Human Binding pKi = 6.4 6.4 -2 4
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL None None None NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
135446053 79081 None 1 Human Binding pKi = 6.4 6.4 -21 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 478 7 2 6 2.7 COc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm050645f
CHEMBL2113215 79081 None 1 Human Binding pKi = 6.4 6.4 -21 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 478 7 2 6 2.7 COc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm050645f
44520862 189604 None 0 Human Binding pKi = 7.4 7.4 -3 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 548 5 1 6 5.0 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4ccncn4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
CHEMBL514772 189604 None 0 Human Binding pKi = 7.4 7.4 -3 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 548 5 1 6 5.0 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4ccncn4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
172997 2330 None 57 Human Binding pKi = 7.4 7.4 -64 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2004.03.083
2238 2330 None 57 Human Binding pKi = 7.4 7.4 -64 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2004.03.083
CHEMBL49429 2330 None 57 Human Binding pKi = 7.4 7.4 -64 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2004.03.083
DB06666 2330 None 57 Human Binding pKi = 7.4 7.4 -64 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2004.03.083
44316241 97187 None 0 Human Binding pKi = 7.4 7.4 -190 4
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1053 18 12 14 -2.6 CC(C)C[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm030611c
CHEMBL268306 97187 None 0 Human Binding pKi = 7.4 7.4 -190 4
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1053 18 12 14 -2.6 CC(C)C[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm030611c
162646174 179692 None 0 Human Binding pKi = 6.4 6.4 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 396 1 0 3 3.2 CC(=O)N1CCN(C(=O)N2CCN(c3ccccc3C)CC2)c2ccc(F)cc21 10.1016/j.bmcl.2020.127416
CHEMBL4743673 179692 None 0 Human Binding pKi = 6.4 6.4 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 396 1 0 3 3.2 CC(=O)N1CCN(C(=O)N2CCN(c3ccccc3C)CC2)c2ccc(F)cc21 10.1016/j.bmcl.2020.127416
16109444 161447 None 0 Rat Binding pKi = 5.4 5.4 -5495 5
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1037 16 11 14 -1.3 NCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL412742 161447 None 0 Rat Binding pKi = 5.4 5.4 -5495 5
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1037 16 11 14 -1.3 NCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
46890187 7252 None 0 Human Binding pKi = 6.4 6.4 -3 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 451 2 0 1 7.9 CC1(C)C[C@@H]2C[C@@](C)(CN2C(=O)c2cc(Cl)c(-c3cccc4ccccc34)cc2Cl)C1 10.1016/j.bmcl.2010.04.068
CHEMBL1085851 7252 None 0 Human Binding pKi = 6.4 6.4 -3 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 451 2 0 1 7.9 CC1(C)C[C@@H]2C[C@@](C)(CN2C(=O)c2cc(Cl)c(-c3cccc4ccccc34)cc2Cl)C1 10.1016/j.bmcl.2010.04.068
137212774 138070 None 0 Human Binding pKi = 6.4 6.4 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader methodDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader method
ChEMBL 504 8 3 8 3.8 Cn1ncc2c1Nc1ccccc1N(C(=O)CCCCCN1CCN(Cc3cc(O)cc(O)c3)CC1)C2 10.1016/j.ejmech.2015.11.050
CHEMBL3765525 138070 None 0 Human Binding pKi = 6.4 6.4 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader methodDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader method
ChEMBL 504 8 3 8 3.8 Cn1ncc2c1Nc1ccccc1N(C(=O)CCCCCN1CCN(Cc3cc(O)cc(O)c3)CC1)C2 10.1016/j.ejmech.2015.11.050
44419027 161780 None 6 Rat Binding pKi = 6.4 6.4 -6 3
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1053 19 13 15 -4.4 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2cccnc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL414074 161780 None 6 Rat Binding pKi = 6.4 6.4 -6 3
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1053 19 13 15 -4.4 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2cccnc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
46890488 6897 None 0 Human Binding pKi = 7.3 7.3 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 377 3 0 2 5.7 COc1cc(C(=O)N2C[C@@]3(C)C[C@@H]2CC(C)(C)C3)ccc1-c1ccccc1C 10.1016/j.bmcl.2010.04.068
CHEMBL1084308 6897 None 0 Human Binding pKi = 7.3 7.3 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 377 3 0 2 5.7 COc1cc(C(=O)N2C[C@@]3(C)C[C@@H]2CC(C)(C)C3)ccc1-c1ccccc1C 10.1016/j.bmcl.2010.04.068
45483282 197031 None 0 Human Binding pKi = 5.3 5.3 -3 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 543 9 1 5 5.9 O=S(=O)(c1ccc(Cl)cc1)N1c2ccccc2CCC1CCCN1CCC(NCc2cccs2)CC1 10.1016/j.bmcl.2009.09.050
CHEMBL567176 197031 None 0 Human Binding pKi = 5.3 5.3 -3 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 543 9 1 5 5.9 O=S(=O)(c1ccc(Cl)cc1)N1c2ccccc2CCC1CCCN1CCC(NCc2cccs2)CC1 10.1016/j.bmcl.2009.09.050
44400363 10296 None 0 Human Binding pKi = 6.3 6.3 - 1
Binding affinity against human vasopressin V1a receptor expressed in CHO cellsBinding affinity against human vasopressin V1a receptor expressed in CHO cells
ChEMBL 1533 40 16 17 -2.0 COc1ccc(C[C@@H](NC(=O)C(N)Cc2ccc(C(=O)c3ccccc3)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc(O)c(I)c2)C(N)=O)cc1 10.1021/jm040871+
91936753 10296 None 0 Human Binding pKi = 6.3 6.3 - 1
Binding affinity against human vasopressin V1a receptor expressed in CHO cellsBinding affinity against human vasopressin V1a receptor expressed in CHO cells
ChEMBL 1533 40 16 17 -2.0 COc1ccc(C[C@@H](NC(=O)C(N)Cc2ccc(C(=O)c3ccccc3)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc(O)c(I)c2)C(N)=O)cc1 10.1021/jm040871+
CHEMBL1161782 10296 None 0 Human Binding pKi = 6.3 6.3 - 1
Binding affinity against human vasopressin V1a receptor expressed in CHO cellsBinding affinity against human vasopressin V1a receptor expressed in CHO cells
ChEMBL 1533 40 16 17 -2.0 COc1ccc(C[C@@H](NC(=O)C(N)Cc2ccc(C(=O)c3ccccc3)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc(O)c(I)c2)C(N)=O)cc1 10.1021/jm040871+
CHEMBL2369837 209700 None 0 Human Binding pKi = 6.3 6.3 -257 4
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL None None None NCCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
3537 4002 None 22 Human Binding pKi = 6.3 6.3 -9 3
Binding affinity to V1A receptor (unknown origin)Binding affinity to V1A receptor (unknown origin)
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
5311500 4002 None 22 Human Binding pKi = 6.3 6.3 -9 3
Binding affinity to V1A receptor (unknown origin)Binding affinity to V1A receptor (unknown origin)
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
CHEMBL363910 4002 None 22 Human Binding pKi = 6.3 6.3 -9 3
Binding affinity to V1A receptor (unknown origin)Binding affinity to V1A receptor (unknown origin)
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
137212773 138000 None 0 Human Binding pKi = 6.3 6.3 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader methodDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader method
ChEMBL 490 7 3 8 3.4 Cn1ncc2c1Nc1ccccc1N(C(=O)CCCCN1CCN(Cc3cc(O)cc(O)c3)CC1)C2 10.1016/j.ejmech.2015.11.050
CHEMBL3764572 138000 None 0 Human Binding pKi = 6.3 6.3 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader methodDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader method
ChEMBL 490 7 3 8 3.4 Cn1ncc2c1Nc1ccccc1N(C(=O)CCCCN1CCN(Cc3cc(O)cc(O)c3)CC1)C2 10.1016/j.ejmech.2015.11.050
44520856 189025 None 0 Human Binding pKi = 7.3 7.3 -2 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 577 6 1 6 5.6 COc1cccc(CNC(=O)/C=C2/c3ccccc3N(C(=O)c3ccc(-n4ccc(C)n4)cc3Cl)CCC2(F)F)n1 10.1016/j.bmc.2009.03.001
CHEMBL509183 189025 None 0 Human Binding pKi = 7.3 7.3 -2 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 577 6 1 6 5.6 COc1cccc(CNC(=O)/C=C2/c3ccccc3N(C(=O)c3ccc(-n4ccc(C)n4)cc3Cl)CCC2(F)F)n1 10.1016/j.bmc.2009.03.001
54582310 61900 None 0 Human Binding pKi = 7.3 7.3 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 439 7 2 3 3.4 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccccc1)C2 10.1016/j.bmcl.2011.02.096
CHEMBL1774014 61900 None 0 Human Binding pKi = 7.3 7.3 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 439 7 2 3 3.4 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)Cc1ccccc1)C2 10.1016/j.bmcl.2011.02.096
135466581 79065 None 0 Human Binding pKi = 6.3 6.3 -120 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 512 8 2 6 3.4 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113198 79065 None 0 Human Binding pKi = 6.3 6.3 -120 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 512 8 2 6 3.4 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
118734335 118596 None 0 Human Binding pKi = 7.3 7.3 18 2
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 416 3 1 3 5.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCSc3c(C)cccc32)cc1 10.1021/acs.jmedchem.5b00289
CHEMBL3416768 118596 None 0 Human Binding pKi = 7.3 7.3 18 2
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 416 3 1 3 5.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCSc3c(C)cccc32)cc1 10.1021/acs.jmedchem.5b00289
47177173 164440 None 1 Human Binding pKi = 7.3 7.3 3 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 377 1 0 1 4.3 O=C(c1ccc(I)cc1)N1CCCCc2ccccc21 10.1021/acs.jmedchem.8b00697
CHEMBL4213812 164440 None 1 Human Binding pKi = 7.3 7.3 3 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 377 1 0 1 4.3 O=C(c1ccc(I)cc1)N1CCCCc2ccccc21 10.1021/acs.jmedchem.8b00697
44520858 174416 None 0 Human Binding pKi = 7.3 7.3 -4 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 590 6 1 6 5.7 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4cccc(N(C)C)n4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
CHEMBL455279 174416 None 0 Human Binding pKi = 7.3 7.3 -4 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 590 6 1 6 5.7 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4cccc(N(C)C)n4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
CHEMBL2369836 209699 None 0 Human Binding pKi = 7.3 7.3 -91 4
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL None None None NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
54581268 61890 None 0 Human Binding pKi = 7.3 7.3 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 533 8 2 5 3.9 COc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)N[C@@H]2C[C@@H]3CC[C@H](C2)N3C)c(C)c1C 10.1016/j.bmcl.2011.02.096
CHEMBL1774005 61890 None 0 Human Binding pKi = 7.3 7.3 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 533 8 2 5 3.9 COc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)N[C@@H]2C[C@@H]3CC[C@H](C2)N3C)c(C)c1C 10.1016/j.bmcl.2011.02.096
57520031 73654 None 0 Human Binding pKi = 5.3 5.3 -169 4
Displacement of [3H]-AVP from human V1A receptor after 1.5 hrs by liquid scintillation countingDisplacement of [3H]-AVP from human V1A receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 555 7 0 6 3.0 COc1cc(OC2CCN(S(C)(=O)=O)CC2)ccc1CC(=O)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1016/j.bmc.2012.02.019
CHEMBL2017979 73654 None 0 Human Binding pKi = 5.3 5.3 -169 4
Displacement of [3H]-AVP from human V1A receptor after 1.5 hrs by liquid scintillation countingDisplacement of [3H]-AVP from human V1A receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 555 7 0 6 3.0 COc1cc(OC2CCN(S(C)(=O)=O)CC2)ccc1CC(=O)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1016/j.bmc.2012.02.019
45483242 197897 None 0 Human Binding pKi = 5.3 5.3 -6 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 627 11 1 7 4.7 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NC(C)c3ccccc3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL572835 197897 None 0 Human Binding pKi = 5.3 5.3 -6 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 627 11 1 7 4.7 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NC(C)c3ccccc3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
25001616 118651 None 0 Mouse Binding pKi = 5.3 5.3 -123 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 367 1 1 3 3.9 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)OCc1ncccc12 10.1021/jm501745f
CHEMBL3416872 118651 None 0 Mouse Binding pKi = 5.3 5.3 -123 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 367 1 1 3 3.9 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)OCc1ncccc12 10.1021/jm501745f
45483243 197915 None 0 Human Binding pKi = 6.3 6.3 -5 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 627 12 1 7 4.2 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCCc3ccccc3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL572984 197915 None 0 Human Binding pKi = 6.3 6.3 -5 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 627 12 1 7 4.2 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCCc3ccccc3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
54586390 62372 None 0 Human Binding pKi = 7.3 7.3 -23 2
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 630 8 1 10 2.3 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cnccc3OC)(N3C[C@H](O)C[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
CHEMBL1779402 62372 None 0 Human Binding pKi = 7.3 7.3 -23 2
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 630 8 1 10 2.3 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cnccc3OC)(N3C[C@H](O)C[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
9849525 111424 None 0 Human Binding pKi = 7.3 7.3 -61 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 519 4 1 4 6.2 O=C(Nc1ccc(C(=O)N2CC3CSCCN3Cc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL327365 111424 None 0 Human Binding pKi = 7.3 7.3 -61 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 519 4 1 4 6.2 O=C(Nc1ccc(C(=O)N2CC3CSCCN3Cc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
46890289 7424 None 0 Human Binding pKi = 7.3 7.3 -1 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 558 4 0 3 8.9 COc1cc(-c2cccc3cccnc23)c(Cl)cc1-c1ccc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)c(Cl)c1 10.1016/j.bmcl.2010.04.068
CHEMBL1086575 7424 None 0 Human Binding pKi = 7.3 7.3 -1 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 558 4 0 3 8.9 COc1cc(-c2cccc3cccnc23)c(Cl)cc1-c1ccc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)c(Cl)c1 10.1016/j.bmcl.2010.04.068
44325689 206858 None 0 Human Binding pKi = 6.3 6.3 -44 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 553 4 1 4 6.8 O=C(Nc1ccc(C(=O)N2CC3CSCCN3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL90657 206858 None 0 Human Binding pKi = 6.3 6.3 -44 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 553 4 1 4 6.8 O=C(Nc1ccc(C(=O)N2CC3CSCCN3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
44314081 204965 None 0 Rat Binding pKi = 6.3 6.3 2 2
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 620 8 1 6 7.0 Cc1occc1C(=O)Nc1ccc(C(=O)N(C)c2ccccc2Oc2cccc(C(=O)N3CCC(N4CCCCC4)CC3)c2)cc1 10.1016/s0960-894x(01)00723-5
CHEMBL76498 204965 None 0 Rat Binding pKi = 6.3 6.3 2 2
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 620 8 1 6 7.0 Cc1occc1C(=O)Nc1ccc(C(=O)N(C)c2ccccc2Oc2cccc(C(=O)N3CCC(N4CCCCC4)CC3)c2)cc1 10.1016/s0960-894x(01)00723-5
45483240 198763 None 0 Human Binding pKi = 5.3 5.3 -7 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 643 12 1 8 4.2 COc1ccc(CNC2CCN(S(=O)(=O)CCC3CCc4ccccc4N3S(=O)(=O)c3ccc(OC)cc3OC)CC2)cc1 10.1016/j.bmcl.2009.09.050
CHEMBL583084 198763 None 0 Human Binding pKi = 5.3 5.3 -7 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 643 12 1 8 4.2 COc1ccc(CNC2CCN(S(=O)(=O)CCC3CCc4ccccc4N3S(=O)(=O)c3ccc(OC)cc3OC)CC2)cc1 10.1016/j.bmcl.2009.09.050
135414288 79079 None 0 Human Binding pKi = 5.3 5.3 -79 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 524 6 2 5 4.3 CC(C)(C)c1ccc(S(=O)(=O)N(CC(=O)N/N=C2/C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113213 79079 None 0 Human Binding pKi = 5.3 5.3 -79 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 524 6 2 5 4.3 CC(C)(C)c1ccc(S(=O)(=O)N(CC(=O)N/N=C2/C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
45483255 198295 None 0 Human Binding pKi = 5.3 5.3 -8 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 593 9 1 6 4.9 O=S(=O)(CCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(NCc2cccs2)CC1 10.1016/j.bmcl.2009.09.050
CHEMBL575986 198295 None 0 Human Binding pKi = 5.3 5.3 -8 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 593 9 1 6 4.9 O=S(=O)(CCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(NCc2cccs2)CC1 10.1016/j.bmcl.2009.09.050
392622 56310 None 95 Human Binding pKi = 5.3 5.3 -2 4
DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 nan
CHEMBL163 56310 None 95 Human Binding pKi = 5.3 5.3 -2 4
DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 nan
118734427 118645 None 0 Human Binding pKi = 5.3 5.3 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 488 5 1 5 4.4 Cc1c(C(=O)N2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1S(=O)(=O)c1ccccc1 10.1021/jm501745f
CHEMBL3416866 118645 None 0 Human Binding pKi = 5.3 5.3 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 488 5 1 5 4.4 Cc1c(C(=O)N2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1S(=O)(=O)c1ccccc1 10.1021/jm501745f
24997177 118649 None 0 Human Binding pKi = 8.3 8.3 204 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 367 1 1 3 3.9 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)OCc1cccnc12 10.1021/jm501745f
CHEMBL3416870 118649 None 0 Human Binding pKi = 8.3 8.3 204 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 367 1 1 3 3.9 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)OCc1cccnc12 10.1021/jm501745f
59657599 118652 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 380 1 1 3 4.1 O=C1OC2(CCN(C(=O)c3c[nH]c4cc(Cl)ccc34)CC2)c2ccccc21 10.1021/jm501745f
CHEMBL3416873 118652 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 380 1 1 3 4.1 O=C1OC2(CCN(C(=O)c3c[nH]c4cc(Cl)ccc34)CC2)c2ccccc21 10.1021/jm501745f
162646888 179557 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 437 3 0 3 3.8 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4741743 179557 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 437 3 0 3 3.8 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
162648022 179972 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 479 3 0 3 5.0 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CCCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4746818 179972 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 479 3 0 3 5.0 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CCCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
162651435 180203 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 383 1 0 2 4.7 Cc1ccccc1N1CCN(C(=O)N2CCCCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4749660 180203 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 383 1 0 2 4.7 Cc1ccccc1N1CCN(C(=O)N2CCCCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
162657486 181065 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 480 2 0 3 5.3 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)C3CCCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4759748 181065 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 480 2 0 3 5.3 Cc1ccccc1N1CCN(C(=O)N2CN(C(=O)C3CCCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
162661774 181403 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 439 3 0 3 4.1 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C(C)C)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4763639 181403 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 439 3 0 3 4.1 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C(C)C)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
44428494 93287 None 0 Human Binding pKi = 8.3 8.3 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 779 12 1 6 6.3 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CC(=O)N1CCCN(Cc2ccccc2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL245072 93287 None 0 Human Binding pKi = 8.3 8.3 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 779 12 1 6 6.3 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CC(=O)N1CCCN(Cc2ccccc2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
162664826 182096 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 448 2 0 4 3.1 Cc1ccccc1N1CCN(C(=O)N2CN(S(C)(=O)=O)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4781783 182096 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 448 2 0 4 3.1 Cc1ccccc1N1CCN(C(=O)N2CN(S(C)(=O)=O)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
46890052 6853 None 0 Human Binding pKi = 8.3 8.3 11 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 413 3 0 2 6.6 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1cccc2ccccc12 10.1016/j.bmcl.2010.04.068
CHEMBL1084111 6853 None 0 Human Binding pKi = 8.3 8.3 11 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 413 3 0 2 6.6 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1cccc2ccccc12 10.1016/j.bmcl.2010.04.068
59657596 118664 None 31 Human Binding pKi = 8.3 8.3 16 2
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL 437 4 0 4 4.5 CN(C)CCn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1021/acs.jmedchem.1c00863
CHEMBL3416885 118664 None 31 Human Binding pKi = 8.3 8.3 16 2
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL 437 4 0 4 4.5 CN(C)CCn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1021/acs.jmedchem.1c00863
59657596 118664 None 31 Human Binding pKi = 8.3 8.3 16 2
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 437 4 0 4 4.5 CN(C)CCn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1016/j.bmcl.2020.127416
CHEMBL3416885 118664 None 31 Human Binding pKi = 8.3 8.3 16 2
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 437 4 0 4 4.5 CN(C)CCn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2ccc(Cl)cc21 10.1016/j.bmcl.2020.127416
44428509 142888 None 0 Human Binding pKi = 8.3 8.3 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 780 12 2 6 6.2 NC1CC[N+](Cc2ccccc2)(C(=O)C[C@H](C(=O)NCc2cccc(C(F)(F)F)c2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)CC1 10.1016/j.bmc.2006.12.031
CHEMBL389360 142888 None 0 Human Binding pKi = 8.3 8.3 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 780 12 2 6 6.2 NC1CC[N+](Cc2ccccc2)(C(=O)C[C@H](C(=O)NCc2cccc(C(F)(F)F)c2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)CC1 10.1016/j.bmc.2006.12.031
44361522 121693 None 0 Rat Binding pKi = 8.3 8.3 4 5
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liverBinding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver
ChEMBL 477 4 0 5 3.8 CC(=O)N1CCC(Oc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2)CC1 10.1021/jm00023a002
CHEMBL358793 121693 None 0 Rat Binding pKi = 8.3 8.3 4 5
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liverBinding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver
ChEMBL 477 4 0 5 3.8 CC(=O)N1CCC(Oc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2)CC1 10.1021/jm00023a002
44274761 159630 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1471 34 14 20 1.1 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N(C(=O)c1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21)[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(N)=O 10.1021/jm9804782
91931054 159630 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1471 34 14 20 1.1 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N(C(=O)c1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21)[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(N)=O 10.1021/jm9804782
CHEMBL410353 159630 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cellsDisplacement of [125I]- HO-LVA from human Vasopressin V1a receptor in membranes of CHO cells
ChEMBL 1471 34 14 20 1.1 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N(C(=O)c1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21)[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(N)=O 10.1021/jm9804782
54580269 61885 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 500 9 2 4 4.5 COc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)NCc2ccccc2)c(C)c1C 10.1016/j.bmcl.2011.02.096
CHEMBL1774000 61885 None 0 Human Binding pKi = 8.3 8.3 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 500 9 2 4 4.5 COc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)NCc2ccccc2)c(C)c1C 10.1016/j.bmcl.2011.02.096
44314343 103051 None 0 Rat Binding pKi = 8.2 8.2 134 2
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 650 13 1 7 6.0 CCc1nccn1-c1ccccc1C(=O)Nc1ccc(C(=O)N(C)c2ccc(C)cc2OCCCCCC(=O)N2CCN(C)CC2)cc1 10.1016/s0960-894x(01)00723-5
CHEMBL307269 103051 None 0 Rat Binding pKi = 8.2 8.2 134 2
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 650 13 1 7 6.0 CCc1nccn1-c1ccccc1C(=O)Nc1ccc(C(=O)N(C)c2ccc(C)cc2OCCCCCC(=O)N2CCN(C)CC2)cc1 10.1016/s0960-894x(01)00723-5
46890099 7299 None 0 Human Binding pKi = 8.2 8.2 331 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 414 3 0 3 6.0 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1cnc2ccccc2c1 10.1016/j.bmcl.2010.04.068
CHEMBL1086068 7299 None 0 Human Binding pKi = 8.2 8.2 331 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 414 3 0 3 6.0 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1cnc2ccccc2c1 10.1016/j.bmcl.2010.04.068
11700583 91813 None 0 Human Binding pKi = 8.2 8.2 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 771 12 1 6 6.4 O=C(NCc1cccc(C(F)(F)F)c1)[C@@H](CCC(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL241305 91813 None 0 Human Binding pKi = 8.2 8.2 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 771 12 1 6 6.4 O=C(NCc1cccc(C(F)(F)F)c1)[C@@H](CCC(=O)N1CCN(C2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
53349471 118601 None 0 Human Binding pKi = 8.2 8.2 22 2
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 413 3 1 3 5.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCN(C)c3cccc(C)c32)cc1 10.1021/acs.jmedchem.5b00289
CHEMBL3416774 118601 None 0 Human Binding pKi = 8.2 8.2 22 2
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 413 3 1 3 5.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCN(C)c3cccc(C)c32)cc1 10.1021/acs.jmedchem.5b00289
54584477 62373 None 0 Human Binding pKi = 6.3 6.3 -19 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 631 8 1 11 1.7 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3nccnc3OC)(N3C[C@H](O)C[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
CHEMBL1779403 62373 None 0 Human Binding pKi = 6.3 6.3 -19 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 631 8 1 11 1.7 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3nccnc3OC)(N3C[C@H](O)C[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
46890217 6852 None 0 Human Binding pKi = 5.3 5.3 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 458 3 1 2 6.7 CC(=O)Nc1cccc(-c2cc(Cl)c(C(=O)N3C[C@]4(C)C[C@H]3CC(C)(C)C4)cc2Cl)c1 10.1016/j.bmcl.2010.04.068
CHEMBL1084086 6852 None 0 Human Binding pKi = 5.3 5.3 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 458 3 1 2 6.7 CC(=O)Nc1cccc(-c2cc(Cl)c(C(=O)N3C[C@]4(C)C[C@H]3CC(C)(C)C4)cc2Cl)c1 10.1016/j.bmcl.2010.04.068
46890657 7184 None 0 Human Binding pKi = 5.3 5.3 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 479 4 0 3 7.8 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1c(-c2ccccc2)oc2ccccc12 10.1016/j.bmcl.2010.04.068
CHEMBL1085548 7184 None 0 Human Binding pKi = 5.3 5.3 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 479 4 0 3 7.8 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1c(-c2ccccc2)oc2ccccc12 10.1016/j.bmcl.2010.04.068
47177176 164828 None 1 Human Binding pKi = 6.3 6.3 1 2
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 329 1 0 1 4.4 O=C(c1ccc(Br)cc1)N1CCCCc2ccccc21 10.1021/acs.jmedchem.8b00697
CHEMBL4218739 164828 None 1 Human Binding pKi = 6.3 6.3 1 2
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 329 1 0 1 4.4 O=C(c1ccc(Br)cc1)N1CCCCc2ccccc21 10.1021/acs.jmedchem.8b00697
54581243 61848 None 0 Human Binding pKi = 7.3 7.3 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 640 13 1 6 4.8 COc1cc(C)c(S(=O)(=O)N[C@H](Cc2ccc(Cl)cc2)C(=O)N(CCCN2CCN(C)CC2)Cc2ccccc2)c(C)c1C 10.1016/j.bmcl.2011.02.096
CHEMBL1773858 61848 None 0 Human Binding pKi = 7.3 7.3 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 640 13 1 6 4.8 COc1cc(C)c(S(=O)(=O)N[C@H](Cc2ccc(Cl)cc2)C(=O)N(CCCN2CCN(C)CC2)Cc2ccccc2)c(C)c1C 10.1016/j.bmcl.2011.02.096
46890102 6612 None 0 Human Binding pKi = 7.3 7.3 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 389 4 0 2 5.9 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1/C=C/c1ccccc1 10.1016/j.bmcl.2010.04.068
CHEMBL1083254 6612 None 0 Human Binding pKi = 7.3 7.3 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 389 4 0 2 5.9 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1/C=C/c1ccccc1 10.1016/j.bmcl.2010.04.068
135446051 79070 None 0 Human Binding pKi = 6.3 6.3 -13 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 474 6 2 6 3.1 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1cccs1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
CHEMBL2113204 79070 None 0 Human Binding pKi = 6.3 6.3 -13 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 474 6 2 6 3.1 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1cccs1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
135414531 79074 None 0 Human Binding pKi = 6.3 6.3 -169 3
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 586 13 2 8 3.1 COCCOCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113208 79074 None 0 Human Binding pKi = 6.3 6.3 -169 3
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 586 13 2 8 3.1 COCCOCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
46890154 6849 None 0 Human Binding pKi = 7.3 7.3 3 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 423 2 0 2 7.3 CC1(C)C[C@@H]2C[C@@](C)(CN2C(=O)c2ccc(-c3csc4ccccc34)cc2Cl)C1 10.1016/j.bmcl.2010.04.068
CHEMBL1084070 6849 None 0 Human Binding pKi = 7.3 7.3 3 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 423 2 0 2 7.3 CC1(C)C[C@@H]2C[C@@](C)(CN2C(=O)c2ccc(-c3csc4ccccc34)cc2Cl)C1 10.1016/j.bmcl.2010.04.068
162673440 183152 None 0 Human Binding pKi = 5.3 5.3 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 352 2 1 5 3.6 Clc1ccc2c(c1)nc1[nH]nc(C3CCN(c4ccccn4)CC3)n12 10.1016/j.bmcl.2020.127417
CHEMBL4795303 183152 None 0 Human Binding pKi = 5.3 5.3 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 352 2 1 5 3.6 Clc1ccc2c(c1)nc1[nH]nc(C3CCN(c4ccccn4)CC3)n12 10.1016/j.bmcl.2020.127417
114904 2952 None 56 Human Binding pKi = 4.3 4.3 -301 7
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets.Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets.
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm00023a002
2196 2952 None 56 Human Binding pKi = 4.3 4.3 -301 7
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets.Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets.
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm00023a002
CHEMBL296908 2952 None 56 Human Binding pKi = 4.3 4.3 -301 7
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets.Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets.
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm00023a002
114904 2952 None 56 Human Binding pKi = 4.3 4.3 -301 7
Displacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissue
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm901812z
2196 2952 None 56 Human Binding pKi = 4.3 4.3 -301 7
Displacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissue
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm901812z
CHEMBL296908 2952 None 56 Human Binding pKi = 4.3 4.3 -301 7
Displacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissue
ChEMBL 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 10.1021/jm901812z
44243143 17022 None 0 Human Binding pKi = 6.3 6.3 -9 3
Displacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uMDisplacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uM
ChEMBL 372 5 0 6 4.3 COc1ccc(-n2c(C)nnc2-c2ccc(-c3ccccc3OC)cc2)cn1 10.1021/jm901812z
CHEMBL1254297 17022 None 0 Human Binding pKi = 6.3 6.3 -9 3
Displacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uMDisplacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uM
ChEMBL 372 5 0 6 4.3 COc1ccc(-n2c(C)nnc2-c2ccc(-c3ccccc3OC)cc2)cn1 10.1021/jm901812z
57519947 73648 None 0 Human Binding pKi = 6.3 6.3 -91 5
Displacement of [3H]-AVP from human V1A receptor after 1.5 hrs by liquid scintillation countingDisplacement of [3H]-AVP from human V1A receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 707 9 0 6 4.3 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OC/C=C\I)c2)CC1 10.1016/j.bmc.2012.02.019
CHEMBL2017868 73648 None 0 Human Binding pKi = 6.3 6.3 -91 5
Displacement of [3H]-AVP from human V1A receptor after 1.5 hrs by liquid scintillation countingDisplacement of [3H]-AVP from human V1A receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 707 9 0 6 4.3 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OC/C=C\I)c2)CC1 10.1016/j.bmc.2012.02.019
167519 189198 None 16 Rat Binding pKi = 4.3 4.3 - 1
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane by competitive displacement assayDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane by competitive displacement assay
ChEMBL 220 1 1 1 3.4 C=C1[C@H]2CC[C@H](CO)[C@@]23CC[C@H](C3)C1(C)C 10.1021/np50112a001
CHEMBL511334 189198 None 16 Rat Binding pKi = 4.3 4.3 - 1
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane by competitive displacement assayDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane by competitive displacement assay
ChEMBL 220 1 1 1 3.4 C=C1[C@H]2CC[C@H](CO)[C@@]23CC[C@H](C3)C1(C)C 10.1021/np50112a001
44419039 137394 None 0 Human Binding pKi = 7.3 7.3 -416 8
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1096 20 14 15 -4.6 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
CHEMBL375324 137394 None 0 Human Binding pKi = 7.3 7.3 -416 8
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1096 20 14 15 -4.6 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
54587189 61907 None 0 Rat Binding pKi = 7.3 7.3 -33 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 499 7 2 3 4.5 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C1(c3ccc(Cl)cc3)CC1)C2 10.1016/j.bmcl.2011.02.096
CHEMBL1774022 61907 None 0 Rat Binding pKi = 7.3 7.3 -33 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 499 7 2 3 4.5 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C1(c3ccc(Cl)cc3)CC1)C2 10.1016/j.bmcl.2011.02.096
44579399 187160 None 0 Human Binding pKi = 6.3 6.3 -19 2
Displacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uMDisplacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uM
ChEMBL 368 8 0 7 3.6 CCOCc1nnc(-c2ccc(OCC)c(C)c2)n1-c1ccc(OC)nc1 10.1021/jm901812z
CHEMBL492029 187160 None 0 Human Binding pKi = 6.3 6.3 -19 2
Displacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uMDisplacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uM
ChEMBL 368 8 0 7 3.6 CCOCc1nnc(-c2ccc(OCC)c(C)c2)n1-c1ccc(OC)nc1 10.1021/jm901812z
162645988 179690 None 0 Human Binding pKi = 7.3 7.3 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 380 2 0 5 5.2 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccc(Cl)cc3[C@H]3C[C@@H]43)CC2)no1 10.1016/j.bmcl.2020.127417
CHEMBL4743652 179690 None 0 Human Binding pKi = 7.3 7.3 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 380 2 0 5 5.2 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccc(Cl)cc3[C@H]3C[C@@H]43)CC2)no1 10.1016/j.bmcl.2020.127417
54584476 62370 None 0 Human Binding pKi = 7.3 7.3 -42 4
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 630 8 1 10 2.3 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cccnc3OC)(N3C[C@H](O)C[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
CHEMBL1779400 62370 None 0 Human Binding pKi = 7.3 7.3 -42 4
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 630 8 1 10 2.3 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cccnc3OC)(N3C[C@H](O)C[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
44520864 172635 None 0 Human Binding pKi = 7.3 7.3 -5 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 603 5 1 6 6.8 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4nc5ccccc5s4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
CHEMBL449517 172635 None 0 Human Binding pKi = 7.3 7.3 -5 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 603 5 1 6 6.8 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4nc5ccccc5s4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
10873853 106994 None 0 Human Binding pKi = 7.3 7.3 147 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 438 7 1 5 5.7 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCC1CCNCC1 10.1021/jm010544r
CHEMBL315251 106994 None 0 Human Binding pKi = 7.3 7.3 147 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 438 7 1 5 5.7 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCC1CCNCC1 10.1021/jm010544r
118734336 118598 None 0 Human Binding pKi = 6.3 6.3 1 2
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 418 3 1 3 4.4 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC[S@@+]([O-])c3ccccc32)cc1 10.1021/acs.jmedchem.5b00289
CHEMBL3416770 118598 None 0 Human Binding pKi = 6.3 6.3 1 2
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 418 3 1 3 4.4 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC[S@@+]([O-])c3ccccc32)cc1 10.1021/acs.jmedchem.5b00289
45483203 197889 None 0 Human Binding pKi = 6.3 6.3 -9 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 621 11 1 8 3.4 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCOCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL572754 197889 None 0 Human Binding pKi = 6.3 6.3 -9 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 621 11 1 8 3.4 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCOCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
54580303 63093 None 0 Human Binding pKi = 4.3 4.3 -371 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL 1558 24 17 23 0.3 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)C(O)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc(-c3c4ccc(=N)c(S(=O)(=O)O)c-4oc4c(S(=O)(=O)O)c(N)ccc34)c(C(=O)O)c2)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
CHEMBL1765670 63093 None 0 Human Binding pKi = 4.3 4.3 -371 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL 1558 24 17 23 0.3 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)C(O)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc(-c3c4ccc(=N)c(S(=O)(=O)O)c-4oc4c(S(=O)(=O)O)c(N)ccc34)c(C(=O)O)c2)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
CHEMBL1789152 63093 None 0 Human Binding pKi = 4.3 4.3 -371 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL 1558 24 17 23 0.3 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)C(O)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc(-c3c4ccc(=N)c(S(=O)(=O)O)c-4oc4c(S(=O)(=O)O)c(N)ccc34)c(C(=O)O)c2)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
5306925 164077 None 13 Human Binding pKi = 6.3 6.3 -1 2
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 285 1 0 1 4.3 O=C(c1ccc(Cl)cc1)N1CCCCc2ccccc21 10.1021/acs.jmedchem.8b00697
CHEMBL4209421 164077 None 13 Human Binding pKi = 6.3 6.3 -1 2
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 285 1 0 1 4.3 O=C(c1ccc(Cl)cc1)N1CCCCc2ccccc21 10.1021/acs.jmedchem.8b00697
45483183 198294 None 0 Human Binding pKi = 5.3 5.3 -5 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 607 10 1 6 5.3 O=S(=O)(CCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(NCc2cccs2)CC1 10.1016/j.bmcl.2009.09.050
CHEMBL575972 198294 None 0 Human Binding pKi = 5.3 5.3 -5 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 607 10 1 6 5.3 O=S(=O)(CCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(NCc2cccs2)CC1 10.1016/j.bmcl.2009.09.050
54582290 61878 None 0 Human Binding pKi = 7.3 7.3 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 578 12 1 6 3.6 CCN(CCCN1CCN(C)CC1)C(=O)[C@H](Cc1ccc(Cl)cc1)NS(=O)(=O)c1c(C)cc(OC)c(C)c1C 10.1016/j.bmcl.2011.02.096
CHEMBL1773996 61878 None 0 Human Binding pKi = 7.3 7.3 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 578 12 1 6 3.6 CCN(CCCN1CCN(C)CC1)C(=O)[C@H](Cc1ccc(Cl)cc1)NS(=O)(=O)c1c(C)cc(OC)c(C)c1C 10.1016/j.bmcl.2011.02.096
54585219 61894 None 0 Human Binding pKi = 7.3 7.3 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 473 7 2 3 4.0 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)C(Cc1ccc(Cl)cc1)NC(=O)Cc1cccc(Cl)c1)C2 10.1016/j.bmcl.2011.02.096
CHEMBL1774009 61894 None 0 Human Binding pKi = 7.3 7.3 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 473 7 2 3 4.0 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)C(Cc1ccc(Cl)cc1)NC(=O)Cc1cccc(Cl)c1)C2 10.1016/j.bmcl.2011.02.096
162656367 180888 None 0 Human Binding pKi = 6.3 6.3 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 370 1 1 3 3.8 Cc1ccccc1N1CCN(C(=O)N2CCNc3ccc(Cl)cc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4757593 180888 None 0 Human Binding pKi = 6.3 6.3 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 370 1 1 3 3.8 Cc1ccccc1N1CCN(C(=O)N2CCNc3ccc(Cl)cc32)CC1 10.1016/j.bmcl.2020.127416
73350823 102528 None 0 Human Binding pKi = 5.3 5.3 -371 9
Binding affinity to human V1AR by competitive binding assayBinding affinity to human V1AR by competitive binding assay
ChEMBL 509 8 1 5 3.7 O=C(Cc1ccc(OC2CCNCC2)cc1OCCF)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1016/j.bmcl.2013.07.045
CHEMBL2424668 102528 None 0 Human Binding pKi = 5.3 5.3 -371 9
Binding affinity to human V1AR by competitive binding assayBinding affinity to human V1AR by competitive binding assay
ChEMBL 509 8 1 5 3.7 O=C(Cc1ccc(OC2CCNCC2)cc1OCCF)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1016/j.bmcl.2013.07.045
CHEMBL3040578 102528 None 0 Human Binding pKi = 5.3 5.3 -371 9
Binding affinity to human V1AR by competitive binding assayBinding affinity to human V1AR by competitive binding assay
ChEMBL 509 8 1 5 3.7 O=C(Cc1ccc(OC2CCNCC2)cc1OCCF)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1016/j.bmcl.2013.07.045
56664848 63218 None 0 Human Binding pKi = 7.2 7.2 -199 3
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1322 19 14 20 0.5 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
CHEMBL1790718 63218 None 0 Human Binding pKi = 7.2 7.2 -199 3
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1322 19 14 20 0.5 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
44520860 179618 None 0 Human Binding pKi = 7.2 7.2 -4 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 548 5 1 6 5.0 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4cnccn4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
CHEMBL474274 179618 None 0 Human Binding pKi = 7.2 7.2 -4 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 548 5 1 6 5.0 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4cnccn4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
10208363 72380 None 0 Human Binding pKi = 6.2 6.2 -1 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 523 9 1 6 2.7 CCOc1ccc(S(=O)(=O)N(CC(=O)N2Cc3ccccc3CC2C(N)=O)c2ccc(OC)cc2)cc1 10.1021/jm050645f
CHEMBL198622 72380 None 0 Human Binding pKi = 6.2 6.2 -1 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 523 9 1 6 2.7 CCOc1ccc(S(=O)(=O)N(CC(=O)N2Cc3ccccc3CC2C(N)=O)c2ccc(OC)cc2)cc1 10.1021/jm050645f
162648178 179873 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 380 2 0 5 5.2 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccc(Cl)cc3[C@@H]3C[C@H]43)CC2)no1 10.1016/j.bmcl.2020.127417
CHEMBL4745630 179873 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 380 2 0 5 5.2 Cc1cc([C@H]2CC[C@H](c3nnc4n3-c3ccc(Cl)cc3[C@@H]3C[C@H]43)CC2)no1 10.1016/j.bmcl.2020.127417
145964296 164124 None 0 Human Binding pKi = 6.2 6.2 -1 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 329 2 0 3 4.1 O=C(c1ccc(-c2ncccn2)cc1)N1CCCCc2ccccc21 10.1021/acs.jmedchem.8b00697
CHEMBL4209952 164124 None 0 Human Binding pKi = 6.2 6.2 -1 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 329 2 0 3 4.1 O=C(c1ccc(-c2ncccn2)cc1)N1CCCCc2ccccc21 10.1021/acs.jmedchem.8b00697
56663268 64038 None 0 Rat Binding pKi = 7.2 7.2 -95 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 447 7 3 3 3.5 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)NC1CCCNCC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807256 64038 None 0 Rat Binding pKi = 7.2 7.2 -95 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 447 7 3 3 3.5 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)NC1CCCNCC1 10.1016/j.bmcl.2011.05.092
46890655 7132 None 0 Human Binding pKi = 7.2 7.2 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 455 5 0 3 7.2 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1ccc(Oc2ccccc2)cc1 10.1016/j.bmcl.2010.04.068
CHEMBL1085300 7132 None 0 Human Binding pKi = 7.2 7.2 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 455 5 0 3 7.2 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1ccc(Oc2ccccc2)cc1 10.1016/j.bmcl.2010.04.068
135508167 79056 None 0 Human Binding pKi = 6.2 6.2 -81 3
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 596 10 3 8 2.8 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(NCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
CHEMBL2113177 79056 None 0 Human Binding pKi = 6.2 6.2 -81 3
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 596 10 3 8 2.8 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(NCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
118734428 118655 None 0 Mouse Binding pKi = 5.2 5.2 -245 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 414 1 1 3 3.9 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)c1ccccc1CS2(=O)=O 10.1021/jm501745f
CHEMBL3416876 118655 None 0 Mouse Binding pKi = 5.2 5.2 -245 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 414 1 1 3 3.9 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)c1ccccc1CS2(=O)=O 10.1021/jm501745f
59657691 118654 None 0 Mouse Binding pKi = 5.2 5.2 -218 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 365 1 2 2 4.4 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)CNc1ccccc12 10.1021/jm501745f
CHEMBL3416875 118654 None 0 Mouse Binding pKi = 5.2 5.2 -218 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 365 1 2 2 4.4 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)CNc1ccccc12 10.1021/jm501745f
44520869 186932 None 0 Human Binding pKi = 7.2 7.2 -1 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 527 6 1 5 4.6 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCCN(C)C)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
CHEMBL490049 186932 None 0 Human Binding pKi = 7.2 7.2 -1 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 527 6 1 5 4.6 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCCN(C)C)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
135520202 133587 None 0 Human Binding pKi = 6.2 6.2 -33 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 528 8 2 7 5.1 COc1ccc(S(=O)(=O)N(CC(=O)/N=N/c2c(O)[nH]c3ccccc23)c2ccc(Cl)cc2)cc1OC 10.1021/jm050645f
CHEMBL371223 133587 None 0 Human Binding pKi = 6.2 6.2 -33 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 528 8 2 7 5.1 COc1ccc(S(=O)(=O)N(CC(=O)/N=N/c2c(O)[nH]c3ccccc23)c2ccc(Cl)cc2)cc1OC 10.1021/jm050645f
44428495 142107 None 0 Human Binding pKi = 8.2 8.2 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 785 13 1 6 6.7 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CC(=O)N1CCC(CCN2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL388259 142107 None 0 Human Binding pKi = 8.2 8.2 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 785 13 1 6 6.7 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CC(=O)N1CCC(CCN2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
162647212 179699 None 0 Human Binding pKi = 8.2 8.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 391 1 1 4 3.6 O=C(N1CCN(c2ncccc2Cl)CC1)N1CCNc2cc(Cl)ccc21 10.1016/j.bmcl.2020.127416
CHEMBL4743785 179699 None 0 Human Binding pKi = 8.2 8.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 391 1 1 4 3.6 O=C(N1CCN(c2ncccc2Cl)CC1)N1CCNc2cc(Cl)ccc21 10.1016/j.bmcl.2020.127416
162653495 180492 None 0 Human Binding pKi = 8.2 8.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 465 3 0 3 4.6 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4753130 180492 None 0 Human Binding pKi = 8.2 8.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 465 3 0 3 4.6 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CCCC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
162663957 182151 None 0 Human Binding pKi = 8.2 8.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 412 1 0 3 3.7 CC(=O)N1Cc2cc(Cl)ccc2N(C(=O)N2CCN(c3ccccc3C)CC2)C1 10.1016/j.bmcl.2020.127416
CHEMBL4782389 182151 None 0 Human Binding pKi = 8.2 8.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 412 1 0 3 3.7 CC(=O)N1Cc2cc(Cl)ccc2N(C(=O)N2CCN(c3ccccc3C)CC2)C1 10.1016/j.bmcl.2020.127416
132822145 159540 None 0 Human Binding pKi = 8.2 8.2 26 2
Displacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting methodDisplacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting method
ChEMBL 414 3 2 3 5.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cccc(C)c32)cc1 10.1021/acs.jmedchem.7b00422
CHEMBL4102459 159540 None 0 Human Binding pKi = 8.2 8.2 26 2
Displacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting methodDisplacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting method
ChEMBL 414 3 2 3 5.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cccc(C)c32)cc1 10.1021/acs.jmedchem.7b00422
CHEMBL5078950 214593 None 0 Human Binding pKi = 8.2 8.2 - 1
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL None None None Cc1cccc2c1-n1c(nnc1[C@H]1CC[C@H](Oc3ccccn3)CC1)C[C@@H](O)C2 10.1021/acs.jmedchem.1c00863
44428557 150929 None 0 Human Binding pKi = 8.2 8.2 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 717 12 1 6 5.1 CCCCN1CCN(C(=O)C(C(=O)NCc2cccc(C(F)(F)F)c2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)CC1 10.1016/j.bmc.2006.12.031
CHEMBL395778 150929 None 0 Human Binding pKi = 8.2 8.2 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 717 12 1 6 5.1 CCCCN1CCN(C(=O)C(C(=O)NCc2cccc(C(F)(F)F)c2)N2C(=O)[C@@H](N3C(=O)OC[C@@H]3c3ccccc3)[C@H]2/C=C/c2ccccc2)CC1 10.1016/j.bmc.2006.12.031
132822146 157238 None 0 Human Binding pKi = 8.2 8.2 23 2
Displacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting methodDisplacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting method
ChEMBL 414 3 2 3 5.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3c(C)cccc32)cc1 10.1021/acs.jmedchem.7b00422
CHEMBL4076436 157238 None 0 Human Binding pKi = 8.2 8.2 23 2
Displacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting methodDisplacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting method
ChEMBL 414 3 2 3 5.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3c(C)cccc32)cc1 10.1021/acs.jmedchem.7b00422
44419025 84294 None 0 Rat Binding pKi = 7.2 7.2 -239 8
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL221436 84294 None 0 Rat Binding pKi = 7.2 7.2 -239 8
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
52947410 17012 None 0 Human Binding pKi = 7.2 7.2 -1 2
Displacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uMDisplacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uM
ChEMBL 390 4 0 6 3.9 CO/N=C1/C[C@H](c2nc(C)no2)N(C(=O)c2ccc(-c3ccccc3C)cc2)C1 10.1021/jm901812z
CHEMBL1254210 17012 None 0 Human Binding pKi = 7.2 7.2 -1 2
Displacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uMDisplacement of [3H]vasopressin from human vasopressin V1a receptor expressed in CHO cells at 10 uM
ChEMBL 390 4 0 6 3.9 CO/N=C1/C[C@H](c2nc(C)no2)N(C(=O)c2ccc(-c3ccccc3C)cc2)C1 10.1021/jm901812z
135644174 71805 None 7 Human Binding pKi = 6.2 6.2 8 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 457 7 2 5 3.8 C/C(=N\NC(=O)CN(c1cccc(Cl)c1)S(=O)(=O)c1ccccc1)c1ccccc1O 10.1021/jm050645f
CHEMBL196816 71805 None 7 Human Binding pKi = 6.2 6.2 8 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 457 7 2 5 3.8 C/C(=N\NC(=O)CN(c1cccc(Cl)c1)S(=O)(=O)c1ccccc1)c1ccccc1O 10.1021/jm050645f
2198 3418 None 2 Human Binding pKi = 6.2 6.2 -46 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 537 4 1 4 6.1 Clc1cc(ccc1C(=O)N1C[C@H]2COCCN2Cc2c1cccc2)NC(=O)c1ccccc1c1ccccc1 10.1016/j.bmcl.2004.03.083
9807249 3418 None 2 Human Binding pKi = 6.2 6.2 -46 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 537 4 1 4 6.1 Clc1cc(ccc1C(=O)N1C[C@H]2COCCN2Cc2c1cccc2)NC(=O)c1ccccc1c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL1192593 3418 None 2 Human Binding pKi = 6.2 6.2 -46 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 537 4 1 4 6.1 Clc1cc(ccc1C(=O)N1C[C@H]2COCCN2Cc2c1cccc2)NC(=O)c1ccccc1c1ccccc1 10.1016/j.bmcl.2004.03.083
172997 2330 None 57 Human Binding pKi = 5.2 5.2 -64 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2004.03.083
2238 2330 None 57 Human Binding pKi = 5.2 5.2 -64 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2004.03.083
CHEMBL49429 2330 None 57 Human Binding pKi = 5.2 5.2 -64 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2004.03.083
DB06666 2330 None 57 Human Binding pKi = 5.2 5.2 -64 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2004.03.083
44428491 152084 None 0 Human Binding pKi = 7.2 7.2 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 703 11 2 6 4.9 NCCC1CCCCN1C(=O)C(C(=O)NCc1cccc(C(F)(F)F)c1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL396758 152084 None 0 Human Binding pKi = 7.2 7.2 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 703 11 2 6 4.9 NCCC1CCCCN1C(=O)C(C(=O)NCc1cccc(C(F)(F)F)c1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
44428501 142346 None 0 Human Binding pKi = 5.2 5.2 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 779 13 1 6 6.0 O=C(C[C@@H](C(=O)N1CCN(CCc2ccccc2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1)NCc1cccc(C(F)(F)F)c1 10.1016/j.bmc.2006.12.031
CHEMBL388701 142346 None 0 Human Binding pKi = 5.2 5.2 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 779 13 1 6 6.0 O=C(C[C@@H](C(=O)N1CCN(CCc2ccccc2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1)NCc1cccc(C(F)(F)F)c1 10.1016/j.bmc.2006.12.031
135438362 79073 None 1 Human Binding pKi = 6.2 6.2 -70 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 468 6 2 5 3.0 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccccc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
CHEMBL2113207 79073 None 1 Human Binding pKi = 6.2 6.2 -70 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 468 6 2 5 3.0 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccccc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
135530014 79057 None 0 Human Binding pKi = 6.2 6.2 -151 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 526 9 3 6 2.9 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(CCCO)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
CHEMBL2113179 79057 None 0 Human Binding pKi = 6.2 6.2 -151 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 526 9 3 6 2.9 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(CCCO)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
45483300 198508 None 0 Human Binding pKi = 5.2 5.2 -53 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 559 7 1 6 5.3 O=C(OCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(NCc2cccs2)CC1 10.1016/j.bmcl.2009.09.050
CHEMBL577816 198508 None 0 Human Binding pKi = 5.2 5.2 -53 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 559 7 1 6 5.3 O=C(OCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(NCc2cccs2)CC1 10.1016/j.bmcl.2009.09.050
135530164 79066 None 0 Human Binding pKi = 6.2 6.2 -5 3
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 570 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccncc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113200 79066 None 0 Human Binding pKi = 6.2 6.2 -5 3
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 570 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccncc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
137212772 137938 None 0 Human Binding pKi = 7.2 7.2 12 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader methodDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader method
ChEMBL 609 7 2 8 4.7 COc1cc(CN2CCN(C(=O)NCc3ccc(C(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3C)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
CHEMBL3763951 137938 None 0 Human Binding pKi = 7.2 7.2 12 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader methodDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader method
ChEMBL 609 7 2 8 4.7 COc1cc(CN2CCN(C(=O)NCc3ccc(C(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3C)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
137212772 137938 None 0 Human Binding pKi = 7.2 7.2 12 2
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 609 7 2 8 4.7 COc1cc(CN2CCN(C(=O)NCc3ccc(C(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3C)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
CHEMBL3763951 137938 None 0 Human Binding pKi = 7.2 7.2 12 2
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 609 7 2 8 4.7 COc1cc(CN2CCN(C(=O)NCc3ccc(C(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3C)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
162668040 182516 None 0 Human Binding pKi = 7.2 7.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 371 1 1 4 3.3 C[C@H]1CN(C(=O)N2CCNc3cc(Cl)ccc32)CCN1c1ccccn1 10.1016/j.bmcl.2020.127416
CHEMBL4787124 182516 None 0 Human Binding pKi = 7.2 7.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 371 1 1 4 3.3 C[C@H]1CN(C(=O)N2CCNc3cc(Cl)ccc32)CCN1c1ccccn1 10.1016/j.bmcl.2020.127416
2181 1330 None 42 Human Binding pKi = 7.2 7.2 -28 7
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL None None None None 10.1021/jm030611c
2182 1330 None 42 Human Binding pKi = 7.2 7.2 -28 7
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL None None None None 10.1021/jm030611c
27991 1330 None 42 Human Binding pKi = 7.2 7.2 -28 7
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL None None None None 10.1021/jm030611c
CHEMBL1429 1330 None 42 Human Binding pKi = 7.2 7.2 -28 7
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL None None None None 10.1021/jm030611c
CHEMBL264448 1330 None 42 Human Binding pKi = 7.2 7.2 -28 7
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL None None None None 10.1021/jm030611c
DB00035 1330 None 42 Human Binding pKi = 7.2 7.2 -28 7
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL None None None None 10.1021/jm030611c
46890262 6684 None 0 Human Binding pKi = 7.2 7.2 1 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 562 3 0 2 9.6 CC1(C)C[C@@H]2C[C@@](C)(CN2C(=O)c2ccc(-c3cc(Cl)c(-c4cccc5cccnc45)cc3Cl)cc2Cl)C1 10.1016/j.bmcl.2010.04.068
CHEMBL1083480 6684 None 0 Human Binding pKi = 7.2 7.2 1 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 562 3 0 2 9.6 CC1(C)C[C@@H]2C[C@@](C)(CN2C(=O)c2ccc(-c3cc(Cl)c(-c4cccc5cccnc45)cc3Cl)cc2Cl)C1 10.1016/j.bmcl.2010.04.068
10187283 206211 None 0 Rat Binding pKi = 7.2 7.2 -20 4
Binding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liverBinding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liver
ChEMBL 543 7 0 6 5.9 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCc1ccc(C(=O)N2CCN(C)CC2)cc1 10.1021/jm010544r
CHEMBL86577 206211 None 0 Rat Binding pKi = 7.2 7.2 -20 4
Binding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liverBinding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liver
ChEMBL 543 7 0 6 5.9 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCc1ccc(C(=O)N2CCN(C)CC2)cc1 10.1021/jm010544r
10483105 90678 None 1 Human Binding pKi = 6.2 6.2 -117 4
Binding affinity to human liver V1A receptorBinding affinity to human liver V1A receptor
ChEMBL 568 10 2 7 1.8 CN[C@@H](CCS(C)(=O)=O)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCN(c3ccccc3C)CC1)C2(C)C 10.1016/j.bmcl.2012.10.116
CHEMBL2391300 90678 None 1 Human Binding pKi = 6.2 6.2 -117 4
Binding affinity to human liver V1A receptorBinding affinity to human liver V1A receptor
ChEMBL 568 10 2 7 1.8 CN[C@@H](CCS(C)(=O)=O)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCN(c3ccccc3C)CC1)C2(C)C 10.1016/j.bmcl.2012.10.116
53349364 166687 None 0 Human Binding pKi = 6.2 6.2 8 2
Displacement of [3H] (Arg8)-vasopressin from human vasopressin V1a receptor expressed in CHO cell membranes after 60 minsDisplacement of [3H] (Arg8)-vasopressin from human vasopressin V1a receptor expressed in CHO cell membranes after 60 mins
ChEMBL 427 3 1 3 4.6 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC(=O)N(C)c3cccc(C)c32)cc1 10.1039/C8MD00033F
CHEMBL4282161 166687 None 0 Human Binding pKi = 6.2 6.2 8 2
Displacement of [3H] (Arg8)-vasopressin from human vasopressin V1a receptor expressed in CHO cell membranes after 60 minsDisplacement of [3H] (Arg8)-vasopressin from human vasopressin V1a receptor expressed in CHO cell membranes after 60 mins
ChEMBL 427 3 1 3 4.6 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC(=O)N(C)c3cccc(C)c32)cc1 10.1039/C8MD00033F
44335343 107468 None 0 Human Binding pKi = 6.2 6.2 -1 2
Inhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cellsInhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 519 3 1 3 6.6 O=C(Nc1ccc(C(=O)N2C[C@@H]3C4CCC(CC4)N3Cc3cc(Cl)ccc32)cc1)c1ccccc1Cl 10.1016/s0960-894x(02)00649-2
CHEMBL318392 107468 None 0 Human Binding pKi = 6.2 6.2 -1 2
Inhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cellsInhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 519 3 1 3 6.6 O=C(Nc1ccc(C(=O)N2C[C@@H]3C4CCC(CC4)N3Cc3cc(Cl)ccc32)cc1)c1ccccc1Cl 10.1016/s0960-894x(02)00649-2
44361521 35068 None 0 Human Binding pKi = 4.2 4.2 -29 3
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets.Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets.
ChEMBL 450 7 2 4 2.9 CC(=O)NCCCOc1ccc(C(=O)N2CCC(N3C(=O)NCc4ccccc43)CC2)cc1 10.1021/jm00023a002
CHEMBL143341 35068 None 0 Human Binding pKi = 4.2 4.2 -29 3
Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets.Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets.
ChEMBL 450 7 2 4 2.9 CC(=O)NCCCOc1ccc(C(=O)N2CCC(N3C(=O)NCc4ccccc43)CC2)cc1 10.1021/jm00023a002
71457081 82373 None 0 Human Binding pKi = 6.2 6.2 -218 3
Displacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 mins
ChEMBL 1309 24 5 14 10.2 CCN1/C(=C/C=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)[O-])cc3C2(C)C)C(C)(CCCC(=O)NCCn2cc(CNC(=O)CCC(=O)NC3CCCN(C(=O)c4ccc(NC(=O)c5ccccc5-c5ccccc5)cc4)c4ccccc43)nn2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm3006146
71482251 82373 None 0 Human Binding pKi = 6.2 6.2 -218 3
Displacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 mins
ChEMBL 1309 24 5 14 10.2 CCN1/C(=C/C=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)[O-])cc3C2(C)C)C(C)(CCCC(=O)NCCn2cc(CNC(=O)CCC(=O)NC3CCCN(C(=O)c4ccc(NC(=O)c5ccccc5-c5ccccc5)cc4)c4ccccc43)nn2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm3006146
CHEMBL2172289 82373 None 0 Human Binding pKi = 6.2 6.2 -218 3
Displacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human vasopressin V1a receptor expressed in CHO cells after 30 mins
ChEMBL 1309 24 5 14 10.2 CCN1/C(=C/C=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)[O-])cc3C2(C)C)C(C)(CCCC(=O)NCCn2cc(CNC(=O)CCC(=O)NC3CCCN(C(=O)c4ccc(NC(=O)c5ccccc5-c5ccccc5)cc4)c4ccccc43)nn2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm3006146
145956239 162622 None 0 Human Binding pKi = 5.2 5.2 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 566 8 1 8 5.0 COc1cc(CN2CCN(c3ccc(CCC(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
CHEMBL4169437 162622 None 0 Human Binding pKi = 5.2 5.2 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 566 8 1 8 5.0 COc1cc(CN2CCN(c3ccc(CCC(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
145976648 163841 None 0 Human Binding pKi = 7.2 7.2 1 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 293 3 0 1 4.6 CCCc1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/acs.jmedchem.8b00697
CHEMBL4206482 163841 None 0 Human Binding pKi = 7.2 7.2 1 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 293 3 0 1 4.6 CCCc1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/acs.jmedchem.8b00697
25212177 174827 None 10 Human Binding pKi = 7.2 7.2 -14 4
Binding affinity to vasopressin V1a receptor by filtration assayBinding affinity to vasopressin V1a receptor by filtration assay
ChEMBL 463 7 0 7 3.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cn(C)c(C)n2)cn1 10.1016/j.bmcl.2008.11.018
CHEMBL456263 174827 None 10 Human Binding pKi = 7.2 7.2 -14 4
Binding affinity to vasopressin V1a receptor by filtration assayBinding affinity to vasopressin V1a receptor by filtration assay
ChEMBL 463 7 0 7 3.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cn(C)c(C)n2)cn1 10.1016/j.bmcl.2008.11.018
56676959 64051 None 0 Human Binding pKi = 7.2 7.2 3 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 485 8 2 3 4.2 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(F)cc2)NC(=O)C2(c3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807269 64051 None 0 Human Binding pKi = 7.2 7.2 3 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 485 8 2 3 4.2 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(F)cc2)NC(=O)C2(c3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL2369848 209708 None 0 Human Binding pKi = 7.2 7.2 -13 4
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL None None None NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2cccs2)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
11465834 138420 None 0 Human Binding pKi = 6.2 6.2 -1479 4
Displacement of [3H]vasopressin from human vasopressin V1a receptorDisplacement of [3H]vasopressin from human vasopressin V1a receptor
ChEMBL 483 6 1 3 3.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(F)cc1F 10.1021/jm201287w
CHEMBL377414 138420 None 0 Human Binding pKi = 6.2 6.2 -1479 4
Displacement of [3H]vasopressin from human vasopressin V1a receptorDisplacement of [3H]vasopressin from human vasopressin V1a receptor
ChEMBL 483 6 1 3 3.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(F)cc1F 10.1021/jm201287w
42629368 182663 None 0 Human Binding pKi = 5.2 5.2 -251 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 457 3 1 4 5.0 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)O)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
CHEMBL478902 182663 None 0 Human Binding pKi = 5.2 5.2 -251 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 457 3 1 4 5.0 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)O)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
2239 1076 None 1 Human Binding pKi = 5.2 5.2 -5011 3
Displacement of [3H]vasopressin from human vasopressin V1a receptorDisplacement of [3H]vasopressin from human vasopressin V1a receptor
ChEMBL 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 10.1021/jm901812z
6918854 1076 None 1 Human Binding pKi = 5.2 5.2 -5011 3
Displacement of [3H]vasopressin from human vasopressin V1a receptorDisplacement of [3H]vasopressin from human vasopressin V1a receptor
ChEMBL 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 10.1021/jm901812z
CHEMBL196478 1076 None 1 Human Binding pKi = 5.2 5.2 -5011 3
Displacement of [3H]vasopressin from human vasopressin V1a receptorDisplacement of [3H]vasopressin from human vasopressin V1a receptor
ChEMBL 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 10.1021/jm901812z
46233065 201057 None 0 Human Binding pKi = 6.2 6.2 1 2
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 548 4 2 5 4.1 Cc1cc(C(=O)N2CCCNc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/jm901084f
CHEMBL602671 201057 None 0 Human Binding pKi = 6.2 6.2 1 2
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells
ChEMBL 548 4 2 5 4.1 Cc1cc(C(=O)N2CCCNc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/jm901084f
137212776 137931 None 0 Human Binding pKi = 7.2 7.2 128 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader methodDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader method
ChEMBL 532 10 3 8 4.6 Cn1ncc2c1Nc1ccccc1N(C(=O)CCCCCCCN1CCN(Cc3cc(O)cc(O)c3)CC1)C2 10.1016/j.ejmech.2015.11.050
CHEMBL3763823 137931 None 0 Human Binding pKi = 7.2 7.2 128 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader methodDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cells after 90 mins by microbeta 2 microplate-reader method
ChEMBL 532 10 3 8 4.6 Cn1ncc2c1Nc1ccccc1N(C(=O)CCCCCCCN1CCN(Cc3cc(O)cc(O)c3)CC1)C2 10.1016/j.ejmech.2015.11.050
137212776 137931 None 0 Human Binding pKi = 7.2 7.2 128 2
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 532 10 3 8 4.6 Cn1ncc2c1Nc1ccccc1N(C(=O)CCCCCCCN1CCN(Cc3cc(O)cc(O)c3)CC1)C2 10.1016/j.ejmech.2017.10.059
CHEMBL3763823 137931 None 0 Human Binding pKi = 7.2 7.2 128 2
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 532 10 3 8 4.6 Cn1ncc2c1Nc1ccccc1N(C(=O)CCCCCCCN1CCN(Cc3cc(O)cc(O)c3)CC1)C2 10.1016/j.ejmech.2017.10.059
9807250 78345 None 0 Human Binding pKi = 6.2 6.2 -58 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 537 4 1 4 6.1 O=C(Nc1ccc(C(=O)N2C[C@@H]3COCCN3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL2093899 78345 None 0 Human Binding pKi = 6.2 6.2 -58 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 537 4 1 4 6.1 O=C(Nc1ccc(C(=O)N2C[C@@H]3COCCN3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL2110044 78345 None 0 Human Binding pKi = 6.2 6.2 -58 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 537 4 1 4 6.1 O=C(Nc1ccc(C(=O)N2C[C@@H]3COCCN3Cc3ccccc32)c(Cl)c1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
44325505 207441 None 0 Human Binding pKi = 5.2 5.2 -562 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 555 4 1 4 6.3 O=C(Nc1ccc(C(=O)N2C[C@H]3COCCN3Cc3ccccc32)c(Cl)c1)c1cc(F)ccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL94133 207441 None 0 Human Binding pKi = 5.2 5.2 -562 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 555 4 1 4 6.3 O=C(Nc1ccc(C(=O)N2C[C@H]3COCCN3Cc3ccccc32)c(Cl)c1)c1cc(F)ccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
145959206 162185 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 524 5 3 8 4.0 Cn1ncc2c1Nc1ccccc1N(C(=O)Cc1cccc(N3CCN(Cc4cc(O)cc(O)c4)CC3)c1)C2 10.1016/j.ejmech.2017.10.059
CHEMBL4162565 162185 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 524 5 3 8 4.0 Cn1ncc2c1Nc1ccccc1N(C(=O)Cc1cccc(N3CCN(Cc4cc(O)cc(O)c4)CC3)c1)C2 10.1016/j.ejmech.2017.10.059
46890439 6585 None 1 Human Binding pKi = 7.2 7.2 51 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 347 2 0 1 5.7 Cc1ccccc1-c1ccc(C(=O)N2C[C@@]3(C)C[C@@H]2CC(C)(C)C3)cc1 10.1016/j.bmcl.2010.04.068
CHEMBL1083095 6585 None 1 Human Binding pKi = 7.2 7.2 51 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 347 2 0 1 5.7 Cc1ccccc1-c1ccc(C(=O)N2C[C@@]3(C)C[C@@H]2CC(C)(C)C3)cc1 10.1016/j.bmcl.2010.04.068
135493119 79067 None 0 Human Binding pKi = 7.2 7.2 -58 3
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 569 11 2 7 3.3 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113201 79067 None 0 Human Binding pKi = 7.2 7.2 -58 3
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 569 11 2 7 3.3 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
135438560 135197 None 0 Human Binding pKi = 6.2 6.2 -42 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 487 9 2 6 3.8 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C/c2ccccc2O)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL372122 135197 None 0 Human Binding pKi = 6.2 6.2 -42 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 487 9 2 6 3.8 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C/c2ccccc2O)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
56671721 63223 None 0 Human Binding pKi = 6.2 6.2 -5 2
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1321 15 13 19 3.0 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
CHEMBL1790722 63223 None 0 Human Binding pKi = 6.2 6.2 -5 2
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1321 15 13 19 3.0 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
118734339 118600 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 432 3 1 3 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC[S@@+]([O-])c3c(C)cccc32)cc1 10.1021/acs.jmedchem.5b00289
CHEMBL3416773 118600 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 432 3 1 3 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC[S@@+]([O-])c3c(C)cccc32)cc1 10.1021/acs.jmedchem.5b00289
118734424 118642 None 0 Human Binding pKi = 5.2 5.2 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 345 3 1 2 4.1 O=C(c1cccc2ccccc12)N1CCC(O)(Cc2ccccc2)CC1 10.1021/jm501745f
CHEMBL3416862 118642 None 0 Human Binding pKi = 5.2 5.2 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 345 3 1 2 4.1 O=C(c1cccc2ccccc12)N1CCC(O)(Cc2ccccc2)CC1 10.1021/jm501745f
15952030 118646 None 0 Mouse Binding pKi = 5.2 5.2 -208 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 332 1 1 2 3.8 O=C(c1c[nH]c2ccccc12)N1CCC2(CC1)OCc1ccccc12 10.1021/jm501745f
CHEMBL3416867 118646 None 0 Mouse Binding pKi = 5.2 5.2 -208 2
Displacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from mouse vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 332 1 1 2 3.8 O=C(c1c[nH]c2ccccc12)N1CCC2(CC1)OCc1ccccc12 10.1021/jm501745f
145975166 163791 None 0 Human Binding pKi = 7.2 7.2 2 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 328 2 0 2 4.7 O=C(c1ccc(-c2cccnc2)cc1)N1CCCCc2ccccc21 10.1021/acs.jmedchem.8b00697
CHEMBL4205970 163791 None 0 Human Binding pKi = 7.2 7.2 2 3
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 328 2 0 2 4.7 O=C(c1ccc(-c2cccnc2)cc1)N1CCCCc2ccccc21 10.1021/acs.jmedchem.8b00697
16109448 141598 None 0 Rat Binding pKi = 7.2 7.2 -112 4
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1054 19 14 15 -3.7 N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL385068 141598 None 0 Rat Binding pKi = 7.2 7.2 -112 4
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1054 19 14 15 -3.7 N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
19608069 118594 None 0 Human Binding pKi = 7.2 7.2 -3 2
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 402 3 1 3 5.4 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCSc3ccccc32)cc1 10.1021/acs.jmedchem.5b00289
CHEMBL3416766 118594 None 0 Human Binding pKi = 7.2 7.2 -3 2
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 402 3 1 3 5.4 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCSc3ccccc32)cc1 10.1021/acs.jmedchem.5b00289
145950135 162869 None 0 Human Binding pKi = 5.2 5.2 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 552 7 1 8 4.6 COc1cc(CN2CCN(c3ccccc3CC(=O)N3Cc4cnn(C)c4Nc4ccccc43)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
CHEMBL4173255 162869 None 0 Human Binding pKi = 5.2 5.2 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 552 7 1 8 4.6 COc1cc(CN2CCN(c3ccccc3CC(=O)N3Cc4cnn(C)c4Nc4ccccc43)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
135513039 79071 None 0 Human Binding pKi = 5.2 5.2 -63 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 473 6 2 6 2.5 Cc1ccc(N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)S(=O)(=O)c2ccc(C#N)cc2)cc1 10.1021/jm050645f
CHEMBL2113205 79071 None 0 Human Binding pKi = 5.2 5.2 -63 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 473 6 2 6 2.5 Cc1ccc(N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)S(=O)(=O)c2ccc(C#N)cc2)cc1 10.1021/jm050645f
45483321 198244 None 0 Human Binding pKi = 5.2 5.2 -9 2
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 557 8 1 5 5.5 O=C(CCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(NCc2cccs2)CC1 10.1016/j.bmcl.2009.09.050
CHEMBL575574 198244 None 0 Human Binding pKi = 5.2 5.2 -9 2
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 557 8 1 5 5.5 O=C(CCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(NCc2cccs2)CC1 10.1016/j.bmcl.2009.09.050
145963213 161479 None 0 Human Binding pKi = 7.2 7.2 3 2
Displacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1095 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccccc2CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL4127791 161479 None 0 Human Binding pKi = 7.2 7.2 3 2
Displacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]AVP from human liver vasopressin V1a receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL 1095 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccccc2CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
54584265 61180 None 0 Human Binding pKi = 7.2 7.2 -131 4
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL 1026 18 11 14 -0.9 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
CHEMBL1765663 61180 None 0 Human Binding pKi = 7.2 7.2 -131 4
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL 1026 18 11 14 -0.9 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
56683607 64056 None 0 Rat Binding pKi = 7.2 7.2 -61 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 459 8 2 3 3.7 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)Cc2ccc(F)cc2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807274 64056 None 0 Rat Binding pKi = 7.2 7.2 -61 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 459 8 2 3 3.7 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)Cc2ccc(F)cc2)CC1 10.1016/j.bmcl.2011.05.092
162672471 183039 None 0 Human Binding pKi = 8.2 8.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 384 1 0 3 3.8 Cc1ccccc1N1CCN(C(=O)N2CCN(C)c3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4794001 183039 None 0 Human Binding pKi = 8.2 8.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 384 1 0 3 3.8 Cc1ccccc1N1CCN(C(=O)N2CCN(C)c3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
54580293 61904 None 0 Human Binding pKi = 8.2 8.2 53 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 453 7 2 3 3.7 Cc1ccc(CC(=O)N[C@H](Cc2ccc(Cl)cc2)C(=O)N[C@@H]2C[C@@H]3CC[C@H](C2)N3C)cc1 10.1016/j.bmcl.2011.02.096
CHEMBL1774019 61904 None 0 Human Binding pKi = 8.2 8.2 53 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 453 7 2 3 3.7 Cc1ccc(CC(=O)N[C@H](Cc2ccc(Cl)cc2)C(=O)N[C@@H]2C[C@@H]3CC[C@H](C2)N3C)cc1 10.1016/j.bmcl.2011.02.096
56670126 64046 None 0 Human Binding pKi = 8.2 8.2 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 408 9 3 3 2.8 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)NCCCO 10.1016/j.bmcl.2011.05.092
CHEMBL1807264 64046 None 0 Human Binding pKi = 8.2 8.2 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 408 9 3 3 2.8 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)NCCCO 10.1016/j.bmcl.2011.05.092
56683608 64058 None 0 Human Binding pKi = 8.2 8.2 18 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 446 9 3 3 3.5 O=C(NCCCO)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C1(c2ccc(F)cc2)CCCC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807276 64058 None 0 Human Binding pKi = 8.2 8.2 18 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 446 9 3 3 3.5 O=C(NCCCO)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C1(c2ccc(F)cc2)CCCC1 10.1016/j.bmcl.2011.05.092
46890290 6995 None 0 Human Binding pKi = 8.2 8.2 58 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 544 3 0 2 9.4 CC1(C)C[C@@H]2C[C@@](C)(CN2C(=O)c2ccc(-c3ccc(-c4cccc5cccnc45)c4ccccc34)cc2Cl)C1 10.1016/j.bmcl.2010.04.068
CHEMBL1084717 6995 None 0 Human Binding pKi = 8.2 8.2 58 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 544 3 0 2 9.4 CC1(C)C[C@@H]2C[C@@](C)(CN2C(=O)c2ccc(-c3ccc(-c4cccc5cccnc45)c4ccccc34)cc2Cl)C1 10.1016/j.bmcl.2010.04.068
44313913 204838 None 0 Rat Binding pKi = 8.1 8.1 58 2
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 670 10 1 7 6.2 CCc1nccn1-c1ccccc1C(=O)Nc1ccc(C(=O)N(C)c2ccc(C)cc2OCc2ccc(C(=O)N3CCN(C)CC3)cc2)cc1 10.1016/s0960-894x(01)00723-5
CHEMBL75489 204838 None 0 Rat Binding pKi = 8.1 8.1 58 2
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 670 10 1 7 6.2 CCc1nccn1-c1ccccc1C(=O)Nc1ccc(C(=O)N(C)c2ccc(C)cc2OCc2ccc(C(=O)N3CCN(C)CC3)cc2)cc1 10.1016/s0960-894x(01)00723-5
56675150 63224 None 0 Human Binding pKi = 8.1 8.1 -85 2
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1382 21 14 19 -1.2 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc(C3=C4C=CC(N(C)C)=CC4OC4=CC(=[N+](C)C)C=CC43)c(C(=O)O)c2)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
CHEMBL1790723 63224 None 0 Human Binding pKi = 8.1 8.1 -85 2
Binding affinity for human Vasopressin V1a receptorBinding affinity for human Vasopressin V1a receptor
ChEMBL 1382 21 14 19 -1.2 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc(C3=C4C=CC(N(C)C)=CC4OC4=CC(=[N+](C)C)C=CC43)c(C(=O)O)c2)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
11144861 106992 None 0 Human Binding pKi = 8.1 8.1 954 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 452 8 1 5 6.1 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCC1CCNCC1 10.1021/jm010544r
CHEMBL315232 106992 None 0 Human Binding pKi = 8.1 8.1 954 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 452 8 1 5 6.1 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCC1CCNCC1 10.1021/jm010544r
44428510 158922 None 0 Human Binding pKi = 8.1 8.1 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 785 13 1 6 6.7 O=C(NCc1cccc(C(F)(F)F)c1)[C@@H](CC(=O)N1CCC(CCN2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL409561 158922 None 0 Human Binding pKi = 8.1 8.1 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 785 13 1 6 6.7 O=C(NCc1cccc(C(F)(F)F)c1)[C@@H](CC(=O)N1CCC(CCN2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
1134627 72967 None 10 Human Binding pKi = 7.2 7.2 11 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 444 7 1 4 4.5 COc1ccc(N(CC(=O)Nc2ccc(Cl)cc2C)S(=O)(=O)c2ccccc2)cc1 10.1021/jm050645f
CHEMBL200682 72967 None 10 Human Binding pKi = 7.2 7.2 11 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 444 7 1 4 4.5 COc1ccc(N(CC(=O)Nc2ccc(Cl)cc2C)S(=O)(=O)c2ccccc2)cc1 10.1021/jm050645f
53349364 166687 None 0 Human Binding pKi = 7.2 7.2 8 2
Displacement of [3H] (Arg8)-vasopressin from human vasopressin V1a receptor expressed in CHO cell membranes after 60 minsDisplacement of [3H] (Arg8)-vasopressin from human vasopressin V1a receptor expressed in CHO cell membranes after 60 mins
ChEMBL 427 3 1 3 4.6 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC(=O)N(C)c3cccc(C)c32)cc1 10.1039/C8MD00033F
CHEMBL4282161 166687 None 0 Human Binding pKi = 7.2 7.2 8 2
Displacement of [3H] (Arg8)-vasopressin from human vasopressin V1a receptor expressed in CHO cell membranes after 60 minsDisplacement of [3H] (Arg8)-vasopressin from human vasopressin V1a receptor expressed in CHO cell membranes after 60 mins
ChEMBL 427 3 1 3 4.6 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC(=O)N(C)c3cccc(C)c32)cc1 10.1039/C8MD00033F
162645370 179592 None 0 Human Binding pKi = 7.2 7.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 385 1 1 4 3.6 Cc1cccnc1N1CCN(C(=O)N2CCNc3cc(Cl)ccc32)[C@H](C)C1 10.1016/j.bmcl.2020.127416
CHEMBL4742173 179592 None 0 Human Binding pKi = 7.2 7.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 385 1 1 4 3.6 Cc1cccnc1N1CCN(C(=O)N2CCNc3cc(Cl)ccc32)[C@H](C)C1 10.1016/j.bmcl.2020.127416
162661801 181453 None 0 Human Binding pKi = 7.2 7.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 336 1 1 3 3.2 Cc1ccccc1N1CCN(C(=O)N2CCNc3ccccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4764410 181453 None 0 Human Binding pKi = 7.2 7.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 336 1 1 3 3.2 Cc1ccccc1N1CCN(C(=O)N2CCNc3ccccc32)CC1 10.1016/j.bmcl.2020.127416
162643251 181707 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 394 3 0 7 3.7 COc1nc2cc(Cl)ccc2n2c(C3CCN(c4ccccn4)CC3)nnc12 10.1016/j.bmcl.2020.127417
CHEMBL4776887 181707 None 0 Human Binding pKi = 6.2 6.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 394 3 0 7 3.7 COc1nc2cc(Cl)ccc2n2c(C3CCN(c4ccccn4)CC3)nnc12 10.1016/j.bmcl.2020.127417
44325362 207342 None 0 Human Binding pKi = 6.2 6.2 -354 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 555 4 1 4 6.3 O=C(Nc1ccc(C(=O)N2C[C@H]3COCCN3Cc3ccccc32)c(Cl)c1)c1ccc(F)cc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL93603 207342 None 0 Human Binding pKi = 6.2 6.2 -354 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 555 4 1 4 6.3 O=C(Nc1ccc(C(=O)N2C[C@H]3COCCN3Cc3ccccc32)c(Cl)c1)c1ccc(F)cc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
441243 9834 None 58 Human Binding pKi = 5.2 5.2 -33 8
DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)
ChEMBL 670 12 5 7 3.1 CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1 nan
CHEMBL114 9834 None 58 Human Binding pKi = 5.2 5.2 -33 8
DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)
ChEMBL 670 12 5 7 3.1 CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1 nan
132559160 175519 None 0 Human Binding pKi = 5.2 5.2 - 1
Binding affinity to vasopressin 1A receptor (unknown origin)Binding affinity to vasopressin 1A receptor (unknown origin)
ChEMBL 514 7 2 6 2.0 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccoc2)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccoc2)N(C)C1=O 10.1039/C9MD00050J
CHEMBL4578103 175519 None 0 Human Binding pKi = 5.2 5.2 - 1
Binding affinity to vasopressin 1A receptor (unknown origin)Binding affinity to vasopressin 1A receptor (unknown origin)
ChEMBL 514 7 2 6 2.0 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccoc2)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccoc2)N(C)C1=O 10.1039/C9MD00050J
45483202 198339 None 0 Human Binding pKi = 6.2 6.2 -1 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 577 10 1 7 3.5 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NC3CCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL576341 198339 None 0 Human Binding pKi = 6.2 6.2 -1 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 577 10 1 7 3.5 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NC3CCC3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
162660975 181855 None 0 Human Binding pKi = 7.2 7.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 365 2 0 5 3.8 Clc1ccc2c(c1)CCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
CHEMBL4778700 181855 None 0 Human Binding pKi = 7.2 7.2 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 365 2 0 5 3.8 Clc1ccc2c(c1)CCc1nnc(C3CCN(c4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
44520866 181638 None 0 Human Binding pKi = 7.1 7.1 -2 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 536 5 1 5 5.8 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4ccco4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
CHEMBL477456 181638 None 0 Human Binding pKi = 7.1 7.1 -2 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 536 5 1 5 5.8 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4ccco4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
44520865 189123 None 0 Human Binding pKi = 7.1 7.1 -6 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 586 5 2 5 6.1 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4nc5ccccc5[nH]4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
CHEMBL510500 189123 None 0 Human Binding pKi = 7.1 7.1 -6 2
Displacement of [3H]vasopressin from human V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from human V1a receptor expressed in CHO cells
ChEMBL 586 5 2 5 6.1 Cc1ccn(-c2ccc(C(=O)N3CCC(F)(F)/C(=C\C(=O)NCc4nc5ccccc5[nH]4)c4ccccc43)c(Cl)c2)n1 10.1016/j.bmc.2009.03.001
45483236 198760 None 0 Human Binding pKi = 6.1 6.1 -31 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 8 4.3 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCc3cccs3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL583081 198760 None 0 Human Binding pKi = 6.1 6.1 -31 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 619 11 1 8 4.3 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCc3cccs3)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
135399831 79060 None 0 Human Binding pKi = 6.1 6.1 -457 3
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 597 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)NC(=O)c3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113189 79060 None 0 Human Binding pKi = 6.1 6.1 -457 3
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 597 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)NC(=O)c3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
10587836 119423 None 7 Human Binding pKi = 6.1 6.1 - 1
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 266 1 1 2 3.3 Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/acs.jmedchem.8b00697
CHEMBL344848 119423 None 7 Human Binding pKi = 6.1 6.1 - 1
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 266 1 1 2 3.3 Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/acs.jmedchem.8b00697
54581529 62378 None 0 Human Binding pKi = 7.1 7.1 -288 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 696 10 0 9 4.5 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN4CCCC4)ccc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
CHEMBL1779408 62378 None 0 Human Binding pKi = 7.1 7.1 -288 3
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 696 10 0 9 4.5 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN4CCCC4)ccc3OC)(N3CCC[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1 10.1016/j.bmcl.2011.03.012
9938406 93315 None 1 Human Binding pKi = 6.1 6.1 -1047 6
Binding affinity towards human Vasopressin V1a receptor by using functional assayBinding affinity towards human Vasopressin V1a receptor by using functional assay
ChEMBL 589 7 0 6 4.7 CC(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)c(OCC(F)(F)F)c2)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL24526 93315 None 1 Human Binding pKi = 6.1 6.1 -1047 6
Binding affinity towards human Vasopressin V1a receptor by using functional assayBinding affinity towards human Vasopressin V1a receptor by using functional assay
ChEMBL 589 7 0 6 4.7 CC(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)c(OCC(F)(F)F)c2)CC1 10.1016/s0960-894x(99)00181-x
145971417 164677 None 0 Human Binding pKi = 6.1 6.1 1 2
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 374 3 0 4 4.2 Cc1ccn(-c2ccc(C(=O)N3CCCC(N(C)C)c4ccccc43)cc2)n1 10.1021/acs.jmedchem.8b00697
CHEMBL4216926 164677 None 0 Human Binding pKi = 6.1 6.1 1 2
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 374 3 0 4 4.2 Cc1ccn(-c2ccc(C(=O)N3CCCC(N(C)C)c4ccccc43)cc2)n1 10.1021/acs.jmedchem.8b00697
CHEMBL2369840 209703 None 0 Human Binding pKi = 7.1 7.1 -9 4
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL None None None NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
137648906 157380 None 0 Human Binding pKi = 7.1 7.1 22 2
Displacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting methodDisplacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting method
ChEMBL 414 3 2 3 5.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC[C@@H](O)c3c(C)cccc32)cc1 10.1021/acs.jmedchem.7b00422
CHEMBL4078185 157380 None 0 Human Binding pKi = 7.1 7.1 22 2
Displacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting methodDisplacement of [125I] phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 from human recombinant vasopressin V1a receptor expressed in HEK293 after 2 hrs by liquid scintillation counting method
ChEMBL 414 3 2 3 5.0 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC[C@@H](O)c3c(C)cccc32)cc1 10.1021/acs.jmedchem.7b00422
57520031 73654 None 0 Prairie vole Binding pKi = 7.1 7.1 -2 4
Displacement of [125I]-LVA from prairie vole vasopressin V1A receptor after 72 hrsDisplacement of [125I]-LVA from prairie vole vasopressin V1A receptor after 72 hrs
ChEMBL 555 7 0 6 3.0 COc1cc(OC2CCN(S(C)(=O)=O)CC2)ccc1CC(=O)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1016/j.bmc.2012.02.019
CHEMBL2017979 73654 None 0 Prairie vole Binding pKi = 7.1 7.1 -2 4
Displacement of [125I]-LVA from prairie vole vasopressin V1A receptor after 72 hrsDisplacement of [125I]-LVA from prairie vole vasopressin V1A receptor after 72 hrs
ChEMBL 555 7 0 6 3.0 COc1cc(OC2CCN(S(C)(=O)=O)CC2)ccc1CC(=O)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1016/j.bmc.2012.02.019
53239961 66617 None 0 Rat Binding pKi = 7.1 7.1 2 2
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 491 2 3 5 5.1 Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1 10.1016/s0960-894x(01)00723-5
CHEMBL1794053 66617 None 0 Rat Binding pKi = 7.1 7.1 2 2
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 491 2 3 5 5.1 Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1 10.1016/s0960-894x(01)00723-5
CHEMBL1852697 66617 None 0 Rat Binding pKi = 7.1 7.1 2 2
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 491 2 3 5 5.1 Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1 10.1016/s0960-894x(01)00723-5
70685417 73647 None 0 Human Binding pKi = 6.1 6.1 -467 4
Displacement of [3H]-AVP from human V1A receptor after 1.5 hrs by liquid scintillation countingDisplacement of [3H]-AVP from human V1A receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 707 9 0 6 4.3 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OC/C=C/I)c2)CC1 10.1016/j.bmc.2012.02.019
CHEMBL2017867 73647 None 0 Human Binding pKi = 6.1 6.1 -467 4
Displacement of [3H]-AVP from human V1A receptor after 1.5 hrs by liquid scintillation countingDisplacement of [3H]-AVP from human V1A receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 707 9 0 6 4.3 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OC/C=C/I)c2)CC1 10.1016/j.bmc.2012.02.019
145949926 162868 None 0 Human Binding pKi = 6.1 6.1 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 524 5 3 8 4.0 Cn1ncc2c1Nc1ccccc1N(C(=O)Cc1ccc(N3CCN(Cc4cc(O)cc(O)c4)CC3)cc1)C2 10.1016/j.ejmech.2017.10.059
CHEMBL4173250 162868 None 0 Human Binding pKi = 6.1 6.1 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 524 5 3 8 4.0 Cn1ncc2c1Nc1ccccc1N(C(=O)Cc1ccc(N3CCN(Cc4cc(O)cc(O)c4)CC3)cc1)C2 10.1016/j.ejmech.2017.10.059
16059348 118657 None 1 Human Binding pKi = 8.1 8.1 301 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 394 2 2 3 3.9 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC(n2c(=O)[nH]c3ccccc32)CC1 10.1021/jm501745f
CHEMBL3416878 118657 None 1 Human Binding pKi = 8.1 8.1 301 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 394 2 2 3 3.9 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC(n2c(=O)[nH]c3ccccc32)CC1 10.1021/jm501745f
10144208 107126 None 0 Human Binding pKi = 8.1 8.1 1047 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 557 7 0 6 6.2 Cc1cccc(OCc2ccc(C(=O)N3CCN(C)CC3)cc2)c1-n1c(C)nnc1-c1ccc(-c2ccccc2)cc1 10.1021/jm010544r
CHEMBL316093 107126 None 0 Human Binding pKi = 8.1 8.1 1047 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 557 7 0 6 6.2 Cc1cccc(OCc2ccc(C(=O)N3CCN(C)CC3)cc2)c1-n1c(C)nnc1-c1ccc(-c2ccccc2)cc1 10.1021/jm010544r
11740743 14106 None 0 Human Binding pKi = 8.1 8.1 -1 3
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL 384 3 1 2 5.2 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/jm3006146
CHEMBL119793 14106 None 0 Human Binding pKi = 8.1 8.1 -1 3
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
ChEMBL 384 3 1 2 5.2 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/jm3006146
56680283 64048 None 0 Rat Binding pKi = 8.1 8.1 -44 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 475 8 2 3 4.3 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)Cc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807266 64048 None 0 Rat Binding pKi = 8.1 8.1 -44 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 475 8 2 3 4.3 CN(C)[C@H]1CC[C@H](NC(=O)[C@@H](Cc2ccc(Cl)cc2)NC(=O)Cc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.05.092
44428570 152377 None 0 Human Binding pKi = 8.1 8.1 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 731 13 1 6 6.2 C[C@H](NC(=O)[C@H](CC(=O)N1CCC(CCN2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1)c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL397026 152377 None 0 Human Binding pKi = 8.1 8.1 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 731 13 1 6 6.2 C[C@H](NC(=O)[C@H](CC(=O)N1CCC(CCN2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1)c1ccccc1 10.1016/j.bmc.2006.12.031
44314222 204758 None 0 Rat Binding pKi = 8.1 8.1 8 2
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 560 11 1 6 5.1 Cc1ccc(N(C)C(=O)c2ccc(NC(=O)c3ccoc3C)cc2)c(OCCCCCC(=O)N2CCN(C)CC2)c1 10.1016/s0960-894x(01)00723-5
CHEMBL74593 204758 None 0 Rat Binding pKi = 8.1 8.1 8 2
Evaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligandEvaluated for the binding affinity towards vasopressin (V1A) receptor in rat liver membrane using [3H]AVP as radioligand
ChEMBL 560 11 1 6 5.1 Cc1ccc(N(C)C(=O)c2ccc(NC(=O)c3ccoc3C)cc2)c(OCCCCCC(=O)N2CCN(C)CC2)c1 10.1016/s0960-894x(01)00723-5
CHEMBL5088219 215143 None 0 Human Binding pKi = 8.1 8.1 - 1
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL None None None Cc1cccc2c1CC(O)Cc1nnc([C@H]3CC[C@H](Oc4ccccn4)CC3)n1-2 10.1021/acs.jmedchem.1c00863
CHEMBL2369847 209707 None 0 Human Binding pKi = 7.1 7.1 -8 4
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL None None None NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
162646888 179557 None 0 Human Binding pKi = 7.1 7.1 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 437 3 0 3 3.8 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
CHEMBL4741743 179557 None 0 Human Binding pKi = 7.1 7.1 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 437 3 0 3 3.8 Cc1ccccc1N1CCN(C(=O)C2CN(C(=O)C3CC3)Cc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2020.127416
162663490 181999 None 0 Human Binding pKi = 6.1 6.1 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 394 2 1 6 4.4 CC1(C)Nc2cc(Cl)ccc2-n2c(C3CCN(c4ccccn4)CC3)nnc21 10.1016/j.bmcl.2020.127417
CHEMBL4780533 181999 None 0 Human Binding pKi = 6.1 6.1 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 394 2 1 6 4.4 CC1(C)Nc2cc(Cl)ccc2-n2c(C3CCN(c4ccccn4)CC3)nnc21 10.1016/j.bmcl.2020.127417
9849525 111424 None 0 Human Binding pKi = 5.1 5.1 -61 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 519 4 1 4 6.2 O=C(Nc1ccc(C(=O)N2CC3CSCCN3Cc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL327365 111424 None 0 Human Binding pKi = 5.1 5.1 -61 2
Inhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptorInhibition of 1 nM AVP-induced calcium mobilisation in cells expressing human vasopressin V1a receptor
ChEMBL 519 4 1 4 6.2 O=C(Nc1ccc(C(=O)N2CC3CSCCN3Cc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
24958835 118639 None 0 Human Binding pKi = 7.1 7.1 - 1
Antagonist activity at human vasopressin 1a receptorAntagonist activity at human vasopressin 1a receptor
ChEMBL 387 3 0 3 4.9 CCOc1ccc2ccccc2c1C(=O)N1CCC2(CC1)OCc1ccccc12 10.1021/acs.jmedchem.6b01437
CHEMBL3416859 118639 None 0 Human Binding pKi = 7.1 7.1 - 1
Antagonist activity at human vasopressin 1a receptorAntagonist activity at human vasopressin 1a receptor
ChEMBL 387 3 0 3 4.9 CCOc1ccc2ccccc2c1C(=O)N1CCC2(CC1)OCc1ccccc12 10.1021/acs.jmedchem.6b01437
24958835 118639 None 0 Human Binding pKi = 7.1 7.1 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 387 3 0 3 4.9 CCOc1ccc2ccccc2c1C(=O)N1CCC2(CC1)OCc1ccccc12 10.1021/jm501745f
CHEMBL3416859 118639 None 0 Human Binding pKi = 7.1 7.1 - 1
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 387 3 0 3 4.9 CCOc1ccc2ccccc2c1C(=O)N1CCC2(CC1)OCc1ccccc12 10.1021/jm501745f
2173 2954 None 13 Human Binding pKi = 6.1 6.1 -8 2
Displacement of [3H]-AVP from human V1A receptor expressed in human HeLa cell membranes incubated for 2 hrs by scintillation counting methodDisplacement of [3H]-AVP from human V1A receptor expressed in human HeLa cell membranes incubated for 2 hrs by scintillation counting method
ChEMBL 453 5 1 3 5.4 CC(NC(=O)C[C@H]1CCCN(c2c1cccc2)C(=O)c1ccc(cc1Cl)N1CCCC1)C 10.1021/acs.jmedchem.8b00697
3038506 2954 None 13 Human Binding pKi = 6.1 6.1 -8 2
Displacement of [3H]-AVP from human V1A receptor expressed in human HeLa cell membranes incubated for 2 hrs by scintillation counting methodDisplacement of [3H]-AVP from human V1A receptor expressed in human HeLa cell membranes incubated for 2 hrs by scintillation counting method
ChEMBL 453 5 1 3 5.4 CC(NC(=O)C[C@H]1CCCN(c2c1cccc2)C(=O)c1ccc(cc1Cl)N1CCCC1)C 10.1021/acs.jmedchem.8b00697
CHEMBL332447 2954 None 13 Human Binding pKi = 6.1 6.1 -8 2
Displacement of [3H]-AVP from human V1A receptor expressed in human HeLa cell membranes incubated for 2 hrs by scintillation counting methodDisplacement of [3H]-AVP from human V1A receptor expressed in human HeLa cell membranes incubated for 2 hrs by scintillation counting method
ChEMBL 453 5 1 3 5.4 CC(NC(=O)C[C@H]1CCCN(c2c1cccc2)C(=O)c1ccc(cc1Cl)N1CCCC1)C 10.1021/acs.jmedchem.8b00697
DB05838 2954 None 13 Human Binding pKi = 6.1 6.1 -8 2
Displacement of [3H]-AVP from human V1A receptor expressed in human HeLa cell membranes incubated for 2 hrs by scintillation counting methodDisplacement of [3H]-AVP from human V1A receptor expressed in human HeLa cell membranes incubated for 2 hrs by scintillation counting method
ChEMBL 453 5 1 3 5.4 CC(NC(=O)C[C@H]1CCCN(c2c1cccc2)C(=O)c1ccc(cc1Cl)N1CCCC1)C 10.1021/acs.jmedchem.8b00697
145974527 164758 None 0 Human Binding pKi = 7.1 7.1 -1 2
Displacement of DY647 from SNAP-tagged V1A receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayDisplacement of DY647 from SNAP-tagged V1A receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 491 5 3 6 3.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)NCC(=S)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4217872 164758 None 0 Human Binding pKi = 7.1 7.1 -1 2
Displacement of DY647 from SNAP-tagged V1A receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayDisplacement of DY647 from SNAP-tagged V1A receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 491 5 3 6 3.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)NCC(=S)N(C)C 10.1021/acs.jmedchem.8b00697
26434734 163515 None 8 Human Binding pKi = 7.1 7.1 5 2
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 294 2 0 2 3.7 CN(C)c1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/acs.jmedchem.8b00697
CHEMBL4202525 163515 None 8 Human Binding pKi = 7.1 7.1 5 2
Displacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human V1A receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 294 2 0 2 3.7 CN(C)c1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/acs.jmedchem.8b00697
10414302 112518 None 0 Human Binding pKi = 7.1 7.1 -50 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 519 4 1 4 6.2 O=C(Nc1ccc(C(=O)N2C[C@H]3CSCCN3Cc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
CHEMBL329903 112518 None 0 Human Binding pKi = 7.1 7.1 -50 2
Inhibition of [3H]AVP binding to recombinant human vasopressin V1a receptorInhibition of [3H]AVP binding to recombinant human vasopressin V1a receptor
ChEMBL 519 4 1 4 6.2 O=C(Nc1ccc(C(=O)N2C[C@H]3CSCCN3Cc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.03.083
46890184 6533 None 0 Human Binding pKi = 7.1 7.1 -2 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 453 3 0 3 7.3 COc1cc(-c2csc3ccccc23)c(Cl)cc1C(=O)N1C[C@]2(C)C[C@H]1CC(C)(C)C2 10.1016/j.bmcl.2010.04.068
CHEMBL1082835 6533 None 0 Human Binding pKi = 7.1 7.1 -2 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 453 3 0 3 7.3 COc1cc(-c2csc3ccccc23)c(Cl)cc1C(=O)N1C[C@]2(C)C[C@H]1CC(C)(C)C2 10.1016/j.bmcl.2010.04.068
118734338 118599 None 0 Human Binding pKi = 6.1 6.1 - 1
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 432 3 1 3 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC[S+]([O-])c3c(C)cccc32)cc1 10.1021/acs.jmedchem.5b00289
CHEMBL3416772 118599 None 0 Human Binding pKi = 6.1 6.1 - 1
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 432 3 1 3 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC[S+]([O-])c3c(C)cccc32)cc1 10.1021/acs.jmedchem.5b00289
57519948 73649 None 4 Human Binding pKi = 5.1 5.1 -933 4
Binding affinity to human V1AR by competitive binding assayBinding affinity to human V1AR by competitive binding assay
ChEMBL 587 9 0 6 3.4 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OCCF)c2)CC1 10.1016/j.bmcl.2013.07.045
CHEMBL2017869 73649 None 4 Human Binding pKi = 5.1 5.1 -933 4
Binding affinity to human V1AR by competitive binding assayBinding affinity to human V1AR by competitive binding assay
ChEMBL 587 9 0 6 3.4 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OCCF)c2)CC1 10.1016/j.bmcl.2013.07.045
57519948 73649 None 4 Human Binding pKi = 5.1 5.1 -933 4
Displacement of [3H]-AVP from human V1A receptor after 1.5 hrs by liquid scintillation countingDisplacement of [3H]-AVP from human V1A receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 587 9 0 6 3.4 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OCCF)c2)CC1 10.1016/j.bmc.2012.02.019
CHEMBL2017869 73649 None 4 Human Binding pKi = 5.1 5.1 -933 4
Displacement of [3H]-AVP from human V1A receptor after 1.5 hrs by liquid scintillation countingDisplacement of [3H]-AVP from human V1A receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 587 9 0 6 3.4 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OCCF)c2)CC1 10.1016/j.bmc.2012.02.019
45483323 197909 None 0 Human Binding pKi = 5.1 5.1 -11 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 579 8 1 6 4.5 O=S(=O)(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(NCc2cccs2)CC1 10.1016/j.bmcl.2009.09.050
CHEMBL572921 197909 None 0 Human Binding pKi = 5.1 5.1 -11 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 579 8 1 6 4.5 O=S(=O)(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(NCc2cccs2)CC1 10.1016/j.bmcl.2009.09.050
145971236 163080 None 0 Human Binding pKi = 6.1 6.1 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 538 6 3 8 4.4 Cn1ncc2c1Nc1ccccc1N(C(=O)CCc1cccc(N3CCN(Cc4cc(O)cc(O)c4)CC3)c1)C2 10.1016/j.ejmech.2017.10.059
CHEMBL4176616 163080 None 0 Human Binding pKi = 6.1 6.1 - 1
Displacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assayDisplacement of [3H]-vasopressin from human vasopressin V1a receptor expressed in HEK293 cell membranes after 90 mins by radioligand binding assay
ChEMBL 538 6 3 8 4.4 Cn1ncc2c1Nc1ccccc1N(C(=O)CCc1cccc(N3CCN(Cc4cc(O)cc(O)c4)CC3)c1)C2 10.1016/j.ejmech.2017.10.059
54585227 61185 None 0 Human Binding pKi = 6.1 6.1 -512 4
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL 1042 18 12 15 -1.9 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)C(O)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
CHEMBL1765669 61185 None 0 Human Binding pKi = 6.1 6.1 -512 4
Displacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human vasopressin V1a receptor expressed CHO cells after 60 mins
ChEMBL 1042 18 12 15 -1.9 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)C(O)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
11366713 137220 None 0 Human Binding pKi = 7.1 7.1 -194 8
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1054 19 13 15 -3.9 NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
CHEMBL375096 137220 None 0 Human Binding pKi = 7.1 7.1 -194 8
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1054 19 13 15 -3.9 NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
45483235 198097 None 0 Human Binding pKi = 5.1 5.1 -30 2
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 572 7 1 5 5.2 CN(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)C(=O)N1CCC(NCc2cccs2)CC1 10.1016/j.bmcl.2009.09.050
CHEMBL574450 198097 None 0 Human Binding pKi = 5.1 5.1 -30 2
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 572 7 1 5 5.2 CN(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)C(=O)N1CCC(NCc2cccs2)CC1 10.1016/j.bmcl.2009.09.050
54581298 61892 None 0 Human Binding pKi = 7.1 7.1 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 439 7 2 3 3.4 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)C(Cc1ccc(Cl)cc1)NC(=O)Cc1ccccc1)C2 10.1016/j.bmcl.2011.02.096
CHEMBL1774007 61892 None 0 Human Binding pKi = 7.1 7.1 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 439 7 2 3 3.4 CN1[C@H]2CC[C@@H]1C[C@H](NC(=O)C(Cc1ccc(Cl)cc1)NC(=O)Cc1ccccc1)C2 10.1016/j.bmcl.2011.02.096
56663271 64044 None 0 Human Binding pKi = 7.1 7.1 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 461 10 2 3 3.8 CN(C)CCCNC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C1(c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807262 64044 None 0 Human Binding pKi = 7.1 7.1 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 461 10 2 3 3.8 CN(C)CCCNC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C1(c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.05.092
44335356 5223 None 0 Human Binding pKi = 6.1 6.1 -5 2
Inhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cellsInhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 385 3 2 3 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCNc3ccccc32)cc1 10.1016/s0960-894x(02)00649-2
CHEMBL106229 5223 None 0 Human Binding pKi = 6.1 6.1 -5 2
Inhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cellsInhibition of AVP mediated activation of human vasopressin V1a receptor expressed in HEK293 cells
ChEMBL 385 3 2 3 4.7 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCNc3ccccc32)cc1 10.1016/s0960-894x(02)00649-2
44428533 166469 None 0 Human Binding pKi = 8.1 8.1 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 731 14 2 6 5.6 O=C(CC[C@@H](C(=O)NCc1cccc(C(F)(F)F)c1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1)NCCN1CCCCC1 10.1016/j.bmc.2006.12.031
CHEMBL427816 166469 None 0 Human Binding pKi = 8.1 8.1 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 731 14 2 6 5.6 O=C(CC[C@@H](C(=O)NCc1cccc(C(F)(F)F)c1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1)NCCN1CCCCC1 10.1016/j.bmc.2006.12.031
25001929 118650 None 0 Human Binding pKi = 8.1 8.1 331 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 367 1 1 3 3.9 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)OCc1ccncc12 10.1021/jm501745f
CHEMBL3416871 118650 None 0 Human Binding pKi = 8.1 8.1 331 2
Displacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assayDisplacement of [3H]-vasopressin from human vasopressin 1a receptor expressed in HEK293 cell membranes after 1 hr by scintillation proximity assay
ChEMBL 367 1 1 3 3.9 O=C(c1c[nH]c2cc(Cl)ccc12)N1CCC2(CC1)OCc1ccncc12 10.1021/jm501745f
162664620 182145 None 0 Human Binding pKi = 8.1 8.1 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 380 3 0 5 4.5 Clc1ccc2c(c1)CCc1nnc([C@H]3CC[C@H](Oc4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
CHEMBL4782340 182145 None 0 Human Binding pKi = 8.1 8.1 - 1
Displacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assayDisplacement of [3H]AVP from human V1a receptor expressed in 1132N1 cells assessed as dissociation constant by radioligand binding assay
ChEMBL 380 3 0 5 4.5 Clc1ccc2c(c1)CCc1nnc([C@H]3CC[C@H](Oc4ccccn4)CC3)n1-2 10.1016/j.bmcl.2020.127417
10863737 206628 None 0 Human Binding pKi = 8.0 8.0 1202 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 477 11 0 6 6.7 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCCCn1ccnc1 10.1021/jm010544r
CHEMBL89177 206628 None 0 Human Binding pKi = 8.0 8.0 1202 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 477 11 0 6 6.7 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCCCn1ccnc1 10.1021/jm010544r
10907482 206273 None 0 Human Binding pKi = 8.0 8.0 724 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 523 10 0 6 5.6 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCCC(=O)N1CCN(C)CC1 10.1021/jm010544r
CHEMBL86936 206273 None 0 Human Binding pKi = 8.0 8.0 724 2
Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligandBinding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand
ChEMBL 523 10 0 6 5.6 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCCC(=O)N1CCN(C)CC1 10.1021/jm010544r
56663273 64064 None 0 Human Binding pKi = 8.0 8.0 28 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 448 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)NC1CCCCC1O 10.1016/j.bmcl.2011.05.092
CHEMBL1807281 64064 None 0 Human Binding pKi = 8.0 8.0 28 2
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 448 7 3 3 3.7 O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)NC1CCCCC1O 10.1016/j.bmcl.2011.05.092
57519948 73649 None 4 Prairie vole Binding pKi = 8.0 8.0 1 4
Displacement of [125I]-LVA from prairie vole vasopressin V1A receptor after 72 hrsDisplacement of [125I]-LVA from prairie vole vasopressin V1A receptor after 72 hrs
ChEMBL 587 9 0 6 3.4 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OCCF)c2)CC1 10.1016/j.bmc.2012.02.019
CHEMBL2017869 73649 None 4 Prairie vole Binding pKi = 8.0 8.0 1 4
Displacement of [125I]-LVA from prairie vole vasopressin V1A receptor after 72 hrsDisplacement of [125I]-LVA from prairie vole vasopressin V1A receptor after 72 hrs
ChEMBL 587 9 0 6 3.4 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OCCF)c2)CC1 10.1016/j.bmc.2012.02.019
10303620 206274 None 0 Rat Binding pKi = 8.0 8.0 -9 4
Binding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liverBinding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liver
ChEMBL 577 12 0 6 7.8 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCCCN1CCC(N2CCCCC2)CC1 10.1021/jm010544r
CHEMBL86949 206274 None 0 Rat Binding pKi = 8.0 8.0 -9 4
Binding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liverBinding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liver
ChEMBL 577 12 0 6 7.8 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCCCCCN1CCC(N2CCCCC2)CC1 10.1021/jm010544r
44428535 161254 None 0 Human Binding pKi = 8 8.0 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 799 14 1 6 7.1 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CCC(=O)N1CCC(CCN2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
CHEMBL411960 161254 None 0 Human Binding pKi = 8 8.0 - 1
Binding affinity for human cloned vasopressin V1a receptor expressed in CHO cellsBinding affinity for human cloned vasopressin V1a receptor expressed in CHO cells
ChEMBL 799 14 1 6 7.1 O=C(NCc1cccc(C(F)(F)F)c1)[C@H](CCC(=O)N1CCC(CCN2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1 10.1016/j.bmc.2006.12.031
11366713 137220 None 0 Rat Binding pKi = 6.1 6.1 -1995 8
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1054 19 13 15 -3.9 NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL375096 137220 None 0 Rat Binding pKi = 6.1 6.1 -1995 8
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1054 19 13 15 -3.9 NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
19607875 118597 None 0 Human Binding pKi = 6.0 6.0 -1 2
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 418 3 1 3 4.4 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC[S+]([O-])c3ccccc32)cc1 10.1021/acs.jmedchem.5b00289
CHEMBL3416769 118597 None 0 Human Binding pKi = 6.0 6.0 -1 2
Displacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranesDisplacement of [3H]-(Arg8)-vasopressin from human vasopressin V1a receptor transfected in CHO cell membranes
ChEMBL 418 3 1 3 4.4 Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCC[S+]([O-])c3ccccc32)cc1 10.1021/acs.jmedchem.5b00289
16109437 84302 None 0 Rat Binding pKi = 5.0 5.0 -4786 5
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1065 18 11 14 -0.6 NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL221485 84302 None 0 Rat Binding pKi = 5.0 5.0 -4786 5
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
ChEMBL 1065 18 11 14 -0.6 NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
46890151 7042 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 445 4 0 3 7.1 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1ccc(-c2ccccc2)s1 10.1016/j.bmcl.2010.04.068
CHEMBL1084864 7042 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 445 4 0 3 7.1 COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1ccc(-c2ccccc2)s1 10.1016/j.bmcl.2010.04.068
54587156 61875 None 0 Human Binding pKi = 6.0 6.0 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 532 11 1 4 4.3 CN1CCN(CCCN(Cc2ccccc2)C(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)c2ccccc2)CC1 10.1016/j.bmcl.2011.02.096
CHEMBL1773993 61875 None 0 Human Binding pKi = 6.0 6.0 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 532 11 1 4 4.3 CN1CCN(CCCN(Cc2ccccc2)C(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)c2ccccc2)CC1 10.1016/j.bmcl.2011.02.096
135491819 79058 None 0 Human Binding pKi = 7.0 7.0 -104 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 597 12 4 7 2.4 O=C(CCc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1)NCCCO 10.1021/jm050645f
CHEMBL2113181 79058 None 0 Human Binding pKi = 7.0 7.0 -104 2
Displacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cellsDisplacement of [125I]LVA antagonist from human vasopressin 1a receptor expressed in HEK293-EBNA cells
ChEMBL 597 12 4 7 2.4 O=C(CCc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1)NCCCO 10.1021/jm050645f
2202 2759 None 33 Human Binding pKi = 7.0 7.0 -58 5
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2011.03.012
9895468 2759 None 33 Human Binding pKi = 7.0 7.0 -58 5
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2011.03.012
CHEMBL582857 2759 None 33 Human Binding pKi = 7.0 7.0 -58 5
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2011.03.012
DB12643 2759 None 33 Human Binding pKi = 7.0 7.0 -58 5
Displacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation countingDisplacement of [3H]AVP from human vasopressin V1a receptor expressed in CHO cells by scintillation counting
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2011.03.012
46890260 6934 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 550 4 1 2 8.8 CC(=O)Nc1cccc(-c2ccc(-c3ccc(C(=O)N4C[C@]5(C)C[C@H]4CC(C)(C)C5)c(Cl)c3)c3ccccc23)c1 10.1016/j.bmcl.2010.04.068
CHEMBL1084456 6934 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 550 4 1 2 8.8 CC(=O)Nc1cccc(-c2ccc(-c3ccc(C(=O)N4C[C@]5(C)C[C@H]4CC(C)(C)C5)c(Cl)c3)c3ccccc23)c1 10.1016/j.bmcl.2010.04.068
46890186 7251 None 0 Human Binding pKi = 7.0 7.0 -1 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 451 2 0 1 7.9 CC1(C)C[C@@H]2C[C@@](C)(CN2C(=O)c2ccc(-c3cccc4ccccc34)c(Cl)c2Cl)C1 10.1016/j.bmcl.2010.04.068
CHEMBL1085850 7251 None 0 Human Binding pKi = 7.0 7.0 -1 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 451 2 0 1 7.9 CC1(C)C[C@@H]2C[C@@](C)(CN2C(=O)c2ccc(-c3cccc4ccccc34)c(Cl)c2Cl)C1 10.1016/j.bmcl.2010.04.068
45483324 198268 None 0 Human Binding pKi = 6.0 6.0 -35 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 593 12 1 7 4.0 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCCC(C)C)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
CHEMBL575796 198268 None 0 Human Binding pKi = 6.0 6.0 -35 3
Displacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counterDisplacement of [3H]Arg8-vasopressin from human vasopressin V1a receptor expressed in CHO-K1 cells by Packard Topcount scintillation counter
ChEMBL 593 12 1 7 4.0 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCCC(C)C)CC2)c(OC)c1 10.1016/j.bmcl.2009.09.050
46890214 7094 None 0 Human Binding pKi = 7.0 7.0 1 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 417 2 0 1 7.2 CC1(C)C[C@@H]2C[C@@](C)(CN2C(=O)c2ccc(-c3cccc4ccccc34)cc2Cl)C1 10.1016/j.bmcl.2010.04.068
CHEMBL1085123 7094 None 0 Human Binding pKi = 7.0 7.0 1 2
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
ChEMBL 417 2 0 1 7.2 CC1(C)C[C@@H]2C[C@@](C)(CN2C(=O)c2ccc(-c3cccc4ccccc34)cc2Cl)C1 10.1016/j.bmcl.2010.04.068
54581265 61877 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 550 11 2 6 2.9 COc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)NCCCN2CCN(C)CC2)c(C)c1C 10.1016/j.bmcl.2011.02.096
CHEMBL1773995 61877 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of [3H]AVP from human V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from human V1A receptor expressed in CHO cells
ChEMBL 550 11 2 6 2.9 COc1cc(C)c(S(=O)(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)NCCCN2CCN(C)CC2)c(C)c1C 10.1016/j.bmcl.2011.02.096
CHEMBL5070501 214236 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL None None None Cc1cccc2c1-n1c(nnc1C1CCN(c3ccccc3)CC1)C[C@H](O)C2 10.1021/acs.jmedchem.1c00863
56666700 64047 None 0 Rat Binding pKi = 7.0 7.0 -5 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 434 9 3 3 3.3 O=C(NCCCO)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C1(c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.05.092
CHEMBL1807265 64047 None 0 Rat Binding pKi = 7.0 7.0 -5 2
Displacement of [3H]AVP from rat V1A receptor expressed in CHO cellsDisplacement of [3H]AVP from rat V1A receptor expressed in CHO cells
ChEMBL 434 9 3 3 3.3 O=C(NCCCO)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C1(c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2011.05.092
9797987 118507 None 3 Rat Binding pKi = 5.0 5.0 -9 3
Displacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissue
ChEMBL 339 2 0 2 3.7 Cc1ccc(S(=O)(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm901812z
CHEMBL341490 118507 None 3 Rat Binding pKi = 5.0 5.0 -9 3
Displacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissueDisplacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissue
ChEMBL 339 2 0 2 3.7 Cc1ccc(S(=O)(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm901812z
10461270 3676 None 7 Rat Binding pKi = 7 7.0 -131 5
Displacement of [3H]vasopressin from rat vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from rat vasopressin V1a receptor expressed in CHO cells
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
2201 3676 None 7 Rat Binding pKi = 7 7.0 -131 5
Displacement of [3H]vasopressin from rat vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from rat vasopressin V1a receptor expressed in CHO cells
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
CHEMBL1615640 3676 None 7 Rat Binding pKi = 7 7.0 -131 5
Displacement of [3H]vasopressin from rat vasopressin V1a receptor expressed in CHO cellsDisplacement of [3H]vasopressin from rat vasopressin V1a receptor expressed in CHO cells
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
CHEMBL5070501 214236 None 0 Human Binding pKi = 6 6.0 - 1
Displacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assayDisplacement of [3H]-arginine-vasopressin from human V1A receptor expressed in human 1321N1 cell membranes incubated for 60 mins by radioligand binding assay
ChEMBL None None None Cc1cccc2c1-n1c(nnc1C1CCN(c3ccccc3)CC1)C[C@H](O)C2 10.1021/acs.jmedchem.1c00863
119369 2604 None 74 Rat Binding pIC50 = 8.2 8.2 -31 8
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
Drug Central 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
2197 2604 None 74 Rat Binding pIC50 = 8.2 8.2 -31 8
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
Drug Central 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
4004 2604 None 74 Rat Binding pIC50 = 8.2 8.2 -31 8
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
Drug Central 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
CHEMBL420762 2604 None 74 Rat Binding pIC50 = 8.2 8.2 -31 8
Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liverDisplacement of [3H]AVP from AVP-V1a receptor binding site in rat liver
Drug Central 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
146681949 216075 None 0 Rat Binding pKd = 8.0 8.0 -1 9
Binding potency against V1 receptor in rat liver cellsBinding potency against V1 receptor in rat liver cells
Drug Central 1083 19 14 16 -5.4 C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N None
2171 1615 None 0 Human Binding pKd = 8.1 8.1 - 1
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10866830
2171 1615 None 0 Human Binding pKd = 8.1 8.1 - 1
UnclassifiedUnclassified
Guide to Pharmacology None None None None 11934825
2200 3309 None 46 Human Binding pKd = 8.5 8.5 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 8123034
3482 3309 None 46 Human Binding pKd = 8.5 8.5 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 8123034
60943 3309 None 46 Human Binding pKd = 8.5 8.5 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 8123034
CHEMBL419667 3309 None 46 Human Binding pKd = 8.5 8.5 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 8123034
DB13929 3309 None 46 Human Binding pKd = 8.5 8.5 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 8123034
10615 572 None 32 Human Binding pKd = 8.6 8.6 -501 4
UnclassifiedUnclassified
Guide to Pharmacology 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 31951127
46200932 572 None 32 Human Binding pKd = 8.6 8.6 -501 4
UnclassifiedUnclassified
Guide to Pharmacology 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 31951127
CHEMBL4297183 572 None 32 Human Binding pKd = 8.6 8.6 -501 4
UnclassifiedUnclassified
Guide to Pharmacology 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 31951127
DB14823 572 None 32 Human Binding pKd = 8.6 8.6 -501 4
UnclassifiedUnclassified
Guide to Pharmacology 409 3 0 6 4.4 CN1Cc2cc(Cl)ccc2n2c(C1)nnc2[C@@H]1CC[C@H](CC1)Oc1ccccn1 31951127
2042 2981 None 58 Human Binding pKd None 6.9 6.9 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
2174 2981 None 58 Human Binding pKd None 6.9 6.9 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
2176 2981 None 58 Human Binding pKd None 6.9 6.9 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
439302 2981 None 58 Human Binding pKd None 6.9 6.9 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
CHEMBL395429 2981 None 58 Human Binding pKd None 6.9 6.9 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
DB00107 2981 None 58 Human Binding pKd None 6.9 6.9 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
151171 1163 3H-Oxytocin 50 Rat Binding pKi = 9.6 9.6 1 6
NoneNone
PDSP KiDatabase 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
216322 1163 3H-Oxytocin 50 Rat Binding pKi = 9.6 9.6 1 6
NoneNone
PDSP KiDatabase 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
2203 1163 3H-Oxytocin 50 Rat Binding pKi = 9.6 9.6 1 6
NoneNone
PDSP KiDatabase 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
732 1163 3H-Oxytocin 50 Rat Binding pKi = 9.6 9.6 1 6
NoneNone
PDSP KiDatabase 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
CHEMBL1755 1163 3H-Oxytocin 50 Rat Binding pKi = 9.6 9.6 1 6
NoneNone
PDSP KiDatabase 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
DB00872 1163 3H-Oxytocin 50 Rat Binding pKi = 9.6 9.6 1 6
NoneNone
PDSP KiDatabase 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
None 216076 3H-Oxytocin 0 Rat Binding pKi = 9.5 9.5 50 3
NoneNone
PDSP KiDatabase 1151 20 12 15 -2.3 COC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSC3(CCCCC3)CC(=O)N2)C(=O)N4CCCC4C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N)CC5=CC=CC=C5 None
151171 1163 3H-AVP 50 Rat Binding pKi = 9.3 9.3 1 6
NoneNone
PDSP KiDatabase 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
216322 1163 3H-AVP 50 Rat Binding pKi = 9.3 9.3 1 6
NoneNone
PDSP KiDatabase 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
2203 1163 3H-AVP 50 Rat Binding pKi = 9.3 9.3 1 6
NoneNone
PDSP KiDatabase 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
732 1163 3H-AVP 50 Rat Binding pKi = 9.3 9.3 1 6
NoneNone
PDSP KiDatabase 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
CHEMBL1755 1163 3H-AVP 50 Rat Binding pKi = 9.3 9.3 1 6
NoneNone
PDSP KiDatabase 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
DB00872 1163 3H-AVP 50 Rat Binding pKi = 9.3 9.3 1 6
NoneNone
PDSP KiDatabase 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
146681949 216075 3H-Oxytocin 0 Rat Binding pKi = 9.2 9.2 -1 9
NoneNone
PDSP KiDatabase 1083 19 14 16 -5.4 C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N None
146681949 216075 3H-AVP 0 Human Binding pKi = 9.1 9.1 -1 9
NoneNone
PDSP KiDatabase 1083 19 14 16 -5.4 C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N None
146681949 216075 3H-AVP 0 Rat Binding pKi = 9.0 9.0 -1 9
NoneNone
PDSP KiDatabase 1083 19 14 16 -5.4 C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N None
146681949 216075 3H-AVP 0 Rat Binding pKi = 8.8 8.8 -1 9
NoneNone
PDSP KiDatabase 1083 19 14 16 -5.4 C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N None
None 216076 3H-AVP 0 Rat Binding pKi = 8.8 8.8 50 3
NoneNone
PDSP KiDatabase 1151 20 12 15 -2.3 COC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSC3(CCCCC3)CC(=O)N2)C(=O)N4CCCC4C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N)CC5=CC=CC=C5 None
21830793 91833 3H-8-OH-DPAT 10 Bovine Binding pKi = 5 5.0 -66069 45
NoneNone
PDSP KiDatabase 373 7 0 8 0.6 COc1ccccc1N1CCN(CCCCn2ncc(=O)n(C)c2=O)CC1 None
CHEMBL2413154 91833 3H-8-OH-DPAT 10 Bovine Binding pKi = 5 5.0 -66069 45
NoneNone
PDSP KiDatabase 373 7 0 8 0.6 COc1ccccc1N1CCN(CCCCn2ncc(=O)n(C)c2=O)CC1 None
1973 203481 3H-V1-antagonist 15 Rat Binding pKi = 5 5.0 -3 37
NoneNone
PDSP KiDatabase 462 3 1 7 3.9 Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12 None
CHEMBL1394464 203481 3H-V1-antagonist 15 Rat Binding pKi = 5 5.0 -3 37
NoneNone
PDSP KiDatabase 462 3 1 7 3.9 Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12 None
CHEMBL66089 203481 3H-V1-antagonist 15 Rat Binding pKi = 5 5.0 -3 37
NoneNone
PDSP KiDatabase 462 3 1 7 3.9 Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12 None
4054 205499 3H-VASOPRESSIN 72 Human Binding pKi = 5 5.0 -1 37
NoneNone
PDSP KiDatabase 179 0 1 1 2.7 CC12CC3CC(C)(C1)CC(N)(C3)C2 None
CHEMBL1699 205499 3H-VASOPRESSIN 72 Human Binding pKi = 5 5.0 -1 37
NoneNone
PDSP KiDatabase 179 0 1 1 2.7 CC12CC3CC(C)(C1)CC(N)(C3)C2 None
CHEMBL807 205499 3H-VASOPRESSIN 72 Human Binding pKi = 5 5.0 -1 37
NoneNone
PDSP KiDatabase 179 0 1 1 2.7 CC12CC3CC(C)(C1)CC(N)(C3)C2 None
216237 3841 3H-AVP 89 Human Binding pKi = 7.9 7.9 -23 5
NoneNone
PDSP KiDatabase 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
2226 3841 3H-AVP 89 Human Binding pKi = 7.9 7.9 -23 5
NoneNone
PDSP KiDatabase 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
4110 3841 3H-AVP 89 Human Binding pKi = 7.9 7.9 -23 5
NoneNone
PDSP KiDatabase 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
443894 3841 3H-AVP 89 Human Binding pKi = 7.9 7.9 -23 5
NoneNone
PDSP KiDatabase 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
CHEMBL344159 3841 3H-AVP 89 Human Binding pKi = 7.9 7.9 -23 5
NoneNone
PDSP KiDatabase 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
DB06212 3841 3H-AVP 89 Human Binding pKi = 7.9 7.9 -23 5
NoneNone
PDSP KiDatabase 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
2042 2981 3H-AVP 58 Human Binding pKi = 6.9 6.9 -29 8
NoneNone
PDSP KiDatabase None None None None None
2174 2981 3H-AVP 58 Human Binding pKi = 6.9 6.9 -29 8
NoneNone
PDSP KiDatabase None None None None None
2176 2981 3H-AVP 58 Human Binding pKi = 6.9 6.9 -29 8
NoneNone
PDSP KiDatabase None None None None None
439302 2981 3H-AVP 58 Human Binding pKi = 6.9 6.9 -29 8
NoneNone
PDSP KiDatabase None None None None None
CHEMBL395429 2981 3H-AVP 58 Human Binding pKi = 6.9 6.9 -29 8
NoneNone
PDSP KiDatabase None None None None None
DB00107 2981 3H-AVP 58 Human Binding pKi = 6.9 6.9 -29 8
NoneNone
PDSP KiDatabase None None None None None
114904 2952 3H-Oxytocin 56 Rat Binding pKi = 7.8 7.8 7 7
NoneNone
PDSP KiDatabase 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 None
2196 2952 3H-Oxytocin 56 Rat Binding pKi = 7.8 7.8 7 7
NoneNone
PDSP KiDatabase 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 None
CHEMBL296908 2952 3H-Oxytocin 56 Rat Binding pKi = 7.8 7.8 7 7
NoneNone
PDSP KiDatabase 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 None
119369 2604 3H-AVP 74 Human Binding pKi = 6.8 6.8 -6 8
NoneNone
PDSP KiDatabase 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
2197 2604 3H-AVP 74 Human Binding pKi = 6.8 6.8 -6 8
NoneNone
PDSP KiDatabase 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
4004 2604 3H-AVP 74 Human Binding pKi = 6.8 6.8 -6 8
NoneNone
PDSP KiDatabase 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
CHEMBL420762 2604 3H-AVP 74 Human Binding pKi = 6.8 6.8 -6 8
NoneNone
PDSP KiDatabase 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
119369 2604 3H-AVP 74 Rat Binding pKi = 6.7 6.7 -31 8
NoneNone
PDSP KiDatabase 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
2197 2604 3H-AVP 74 Rat Binding pKi = 6.7 6.7 -31 8
NoneNone
PDSP KiDatabase 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
4004 2604 3H-AVP 74 Rat Binding pKi = 6.7 6.7 -31 8
NoneNone
PDSP KiDatabase 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
CHEMBL420762 2604 3H-AVP 74 Rat Binding pKi = 6.7 6.7 -31 8
NoneNone
PDSP KiDatabase 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
114904 2952 3H-AVP 56 Rat Binding pKi = 7.6 7.6 7 7
NoneNone
PDSP KiDatabase 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 None
2196 2952 3H-AVP 56 Rat Binding pKi = 7.6 7.6 7 7
NoneNone
PDSP KiDatabase 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 None
CHEMBL296908 2952 3H-AVP 56 Rat Binding pKi = 7.6 7.6 7 7
NoneNone
PDSP KiDatabase 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 None
119369 2604 3H-Oxytocin 74 Rat Binding pKi = 6.6 6.6 -31 8
NoneNone
PDSP KiDatabase 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
2197 2604 3H-Oxytocin 74 Rat Binding pKi = 6.6 6.6 -31 8
NoneNone
PDSP KiDatabase 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
4004 2604 3H-Oxytocin 74 Rat Binding pKi = 6.6 6.6 -31 8
NoneNone
PDSP KiDatabase 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
CHEMBL420762 2604 3H-Oxytocin 74 Rat Binding pKi = 6.6 6.6 -31 8
NoneNone
PDSP KiDatabase 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
46783812 216077 3H-AVP 0 Rat Binding pKi = 6.5 6.5 -75 3
NoneNone
PDSP KiDatabase 1182 19 14 16 -6.7 CC(=O)O.C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N.O.O.O None
133612094 216484 3H-AVP 0 Human Binding pKi = 8.5 8.5 4 5
NoneNone
PDSP KiDatabase 993 18 11 15 -3.0 CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)OCC)C(=O)N3CCCC3C(=O)NC(CCCN)C(=O)NCC(=O)N)CC(=O)N)C(C)O None
216237 3841 3H-AVP 89 Rat Binding pKi = 6.5 6.5 -79 5
NoneNone
PDSP KiDatabase 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
2226 3841 3H-AVP 89 Rat Binding pKi = 6.5 6.5 -79 5
NoneNone
PDSP KiDatabase 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
4110 3841 3H-AVP 89 Rat Binding pKi = 6.5 6.5 -79 5
NoneNone
PDSP KiDatabase 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
443894 3841 3H-AVP 89 Rat Binding pKi = 6.5 6.5 -79 5
NoneNone
PDSP KiDatabase 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
CHEMBL344159 3841 3H-AVP 89 Rat Binding pKi = 6.5 6.5 -79 5
NoneNone
PDSP KiDatabase 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
DB06212 3841 3H-AVP 89 Rat Binding pKi = 6.5 6.5 -79 5
NoneNone
PDSP KiDatabase 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
448537 160248 None 89 Human Binding pKi = 8.3 8.3 -45 25
DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)
Drug Central 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 None
CHEMBL411 160248 None 89 Human Binding pKi = 8.3 8.3 -45 25
DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)
Drug Central 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 None
2042 2981 3H-AVP 58 Rat Binding pKi = 7.3 7.3 -31 8
NoneNone
PDSP KiDatabase None None None None None
2174 2981 3H-AVP 58 Rat Binding pKi = 7.3 7.3 -31 8
NoneNone
PDSP KiDatabase None None None None None
2176 2981 3H-AVP 58 Rat Binding pKi = 7.3 7.3 -31 8
NoneNone
PDSP KiDatabase None None None None None
439302 2981 3H-AVP 58 Rat Binding pKi = 7.3 7.3 -31 8
NoneNone
PDSP KiDatabase None None None None None
CHEMBL395429 2981 3H-AVP 58 Rat Binding pKi = 7.3 7.3 -31 8
NoneNone
PDSP KiDatabase None None None None None
DB00107 2981 3H-AVP 58 Rat Binding pKi = 7.3 7.3 -31 8
NoneNone
PDSP KiDatabase None None None None None
441243 9834 None 58 Human Binding pKi = 8.3 8.3 -33 8
DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)
Drug Central 670 12 5 7 3.1 CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1 None
CHEMBL114 9834 None 58 Human Binding pKi = 8.3 8.3 -33 8
DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)
Drug Central 670 12 5 7 3.1 CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1 None
392622 56310 None 95 Human Binding pKi = 8.3 8.3 -2 4
DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)
Drug Central 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 None
CHEMBL163 56310 None 95 Human Binding pKi = 8.3 8.3 -2 4
DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)
Drug Central 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 None
119369 2604 3H-AVP 74 Rat Binding pKi = 6.3 6.3 -31 8
NoneNone
PDSP KiDatabase 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
2197 2604 3H-AVP 74 Rat Binding pKi = 6.3 6.3 -31 8
NoneNone
PDSP KiDatabase 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
4004 2604 3H-AVP 74 Rat Binding pKi = 6.3 6.3 -31 8
NoneNone
PDSP KiDatabase 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
CHEMBL420762 2604 3H-AVP 74 Rat Binding pKi = 6.3 6.3 -31 8
NoneNone
PDSP KiDatabase 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
2042 2981 3H-Oxytocin 58 Rat Binding pKi = 7.2 7.2 -31 8
NoneNone
PDSP KiDatabase None None None None None
2174 2981 3H-Oxytocin 58 Rat Binding pKi = 7.2 7.2 -31 8
NoneNone
PDSP KiDatabase None None None None None
2176 2981 3H-Oxytocin 58 Rat Binding pKi = 7.2 7.2 -31 8
NoneNone
PDSP KiDatabase None None None None None
439302 2981 3H-Oxytocin 58 Rat Binding pKi = 7.2 7.2 -31 8
NoneNone
PDSP KiDatabase None None None None None
CHEMBL395429 2981 3H-Oxytocin 58 Rat Binding pKi = 7.2 7.2 -31 8
NoneNone
PDSP KiDatabase None None None None None
DB00107 2981 3H-Oxytocin 58 Rat Binding pKi = 7.2 7.2 -31 8
NoneNone
PDSP KiDatabase None None None None None
2042 2981 None 58 Rat Binding pKi = 8.2 8.2 -31 8
NoneNone
Drug Central None None None None None
2174 2981 None 58 Rat Binding pKi = 8.2 8.2 -31 8
NoneNone
Drug Central None None None None None
2176 2981 None 58 Rat Binding pKi = 8.2 8.2 -31 8
NoneNone
Drug Central None None None None None
439302 2981 None 58 Rat Binding pKi = 8.2 8.2 -31 8
NoneNone
Drug Central None None None None None
CHEMBL395429 2981 None 58 Rat Binding pKi = 8.2 8.2 -31 8
NoneNone
Drug Central None None None None None
DB00107 2981 None 58 Rat Binding pKi = 8.2 8.2 -31 8
NoneNone
Drug Central None None None None None
216237 3841 None 89 Rat Binding pKi = 8.2 8.2 -79 5
NoneNone
Drug Central 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
2226 3841 None 89 Rat Binding pKi = 8.2 8.2 -79 5
NoneNone
Drug Central 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
4110 3841 None 89 Rat Binding pKi = 8.2 8.2 -79 5
NoneNone
Drug Central 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
443894 3841 None 89 Rat Binding pKi = 8.2 8.2 -79 5
NoneNone
Drug Central 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
CHEMBL344159 3841 None 89 Rat Binding pKi = 8.2 8.2 -79 5
NoneNone
Drug Central 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
DB06212 3841 None 89 Rat Binding pKi = 8.2 8.2 -79 5
NoneNone
Drug Central 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
119369 2604 None 74 Human Binding pKi = 8.2 8.2 -6 8
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
Drug Central 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
2197 2604 None 74 Human Binding pKi = 8.2 8.2 -6 8
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
Drug Central 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
4004 2604 None 74 Human Binding pKi = 8.2 8.2 -6 8
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
Drug Central 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
CHEMBL420762 2604 None 74 Human Binding pKi = 8.2 8.2 -6 8
Binding affinity to vasopressin V1a receptorBinding affinity to vasopressin V1a receptor
Drug Central 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C None
216237 3841 None 89 Human Binding pKi = 8.1 8.1 -23 5
NoneNone
Drug Central 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
2226 3841 None 89 Human Binding pKi = 8.1 8.1 -23 5
NoneNone
Drug Central 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
4110 3841 None 89 Human Binding pKi = 8.1 8.1 -23 5
NoneNone
Drug Central 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
443894 3841 None 89 Human Binding pKi = 8.1 8.1 -23 5
NoneNone
Drug Central 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
CHEMBL344159 3841 None 89 Human Binding pKi = 8.1 8.1 -23 5
NoneNone
Drug Central 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
DB06212 3841 None 89 Human Binding pKi = 8.1 8.1 -23 5
NoneNone
Drug Central 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C None
122172899 217703 None 0 Rat Binding pKi = 8.1 8.1 -1 8
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
Drug Central 1068 19 14 15 -4.1 NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O None
5311065 217703 None 0 Rat Binding pKi = 8.1 8.1 -1 8
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
Drug Central 1068 19 14 15 -4.1 NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O None
CHEMBL1429 217703 None 0 Rat Binding pKi = 8.1 8.1 -1 8
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
Drug Central 1068 19 14 15 -4.1 NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O None
DB00035 217703 None 0 Rat Binding pKi = 8.1 8.1 -1 8
Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membraneDisplacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane
Drug Central 1068 19 14 15 -4.1 NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O None
122172899 217703 None 0 Human Binding pKi = 8.1 8.1 -1 8
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
Drug Central 1068 19 14 15 -4.1 NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O None
5311065 217703 None 0 Human Binding pKi = 8.1 8.1 -1 8
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
Drug Central 1068 19 14 15 -4.1 NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O None
CHEMBL1429 217703 None 0 Human Binding pKi = 8.1 8.1 -1 8
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
Drug Central 1068 19 14 15 -4.1 NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O None
DB00035 217703 None 0 Human Binding pKi = 8.1 8.1 -1 8
Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
Drug Central 1068 19 14 15 -4.1 NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O None
151171 1163 None 50 Rat Binding pKi = 8.0 8.0 1 6
Displacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting methodDisplacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting method
Drug Central 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
216322 1163 None 50 Rat Binding pKi = 8.0 8.0 1 6
Displacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting methodDisplacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting method
Drug Central 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
2203 1163 None 50 Rat Binding pKi = 8.0 8.0 1 6
Displacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting methodDisplacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting method
Drug Central 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
732 1163 None 50 Rat Binding pKi = 8.0 8.0 1 6
Displacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting methodDisplacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting method
Drug Central 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
CHEMBL1755 1163 None 50 Rat Binding pKi = 8.0 8.0 1 6
Displacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting methodDisplacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting method
Drug Central 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
DB00872 1163 None 50 Rat Binding pKi = 8.0 8.0 1 6
Displacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting methodDisplacement of [3H]AVP from V1A receptor in Wistar rat liver membranes incubated for 60 mins by microplate scintillation counting method
Drug Central 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
151171 1163 None 50 Human Binding pKi = 8.0 8.0 -3 6
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
Drug Central 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
216322 1163 None 50 Human Binding pKi = 8.0 8.0 -3 6
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
Drug Central 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
2203 1163 None 50 Human Binding pKi = 8.0 8.0 -3 6
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
Drug Central 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
732 1163 None 50 Human Binding pKi = 8.0 8.0 -3 6
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
Drug Central 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
CHEMBL1755 1163 None 50 Human Binding pKi = 8.0 8.0 -3 6
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
Drug Central 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
DB00872 1163 None 50 Human Binding pKi = 8.0 8.0 -3 6
Displacement [3H]Arg human recombinant Vasopressin V1a receptorDisplacement [3H]Arg human recombinant Vasopressin V1a receptor
Drug Central 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 None
146681949 216075 None 0 Human Binding pKi = 8.0 8.0 -1 9
Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranesInhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranes
Drug Central 1083 19 14 16 -5.4 C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N None
133612094 216484 None 0 Human Binding pKi = 8.0 8.0 4 5
Binding affinity to human vasopressin V1a receptorBinding affinity to human vasopressin V1a receptor
Drug Central 993 18 11 15 -3.0 CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)OCC)C(=O)N3CCCC3C(=O)NC(CCCN)C(=O)NCC(=O)N)CC(=O)N)C(C)O None
10444 2324 None 14 Human Binding pKi = 5.9 5.9 -5 3
Binding affinity determined by a TR-FRET binding assay on HEK cells expressing SNAP-tagged V<sub>1a</sub> receptors using 20 nM fluorescent DY647 and increasing concentration of competitor.Binding affinity determined by a TR-FRET binding assay on HEK cells expressing SNAP-tagged V<sub>1a</sub> receptors using 20 nM fluorescent DY647 and increasing concentration of competitor.
Guide to Pharmacology 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 30199637
139030525 2324 None 14 Human Binding pKi = 5.9 5.9 -5 3
Binding affinity determined by a TR-FRET binding assay on HEK cells expressing SNAP-tagged V<sub>1a</sub> receptors using 20 nM fluorescent DY647 and increasing concentration of competitor.Binding affinity determined by a TR-FRET binding assay on HEK cells expressing SNAP-tagged V<sub>1a</sub> receptors using 20 nM fluorescent DY647 and increasing concentration of competitor.
Guide to Pharmacology 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 30199637
145711714 2324 None 14 Human Binding pKi = 5.9 5.9 -5 3
Binding affinity determined by a TR-FRET binding assay on HEK cells expressing SNAP-tagged V<sub>1a</sub> receptors using 20 nM fluorescent DY647 and increasing concentration of competitor.Binding affinity determined by a TR-FRET binding assay on HEK cells expressing SNAP-tagged V<sub>1a</sub> receptors using 20 nM fluorescent DY647 and increasing concentration of competitor.
Guide to Pharmacology 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 30199637
CHEMBL4204210 2324 None 14 Human Binding pKi = 5.9 5.9 -5 3
Binding affinity determined by a TR-FRET binding assay on HEK cells expressing SNAP-tagged V<sub>1a</sub> receptors using 20 nM fluorescent DY647 and increasing concentration of competitor.Binding affinity determined by a TR-FRET binding assay on HEK cells expressing SNAP-tagged V<sub>1a</sub> receptors using 20 nM fluorescent DY647 and increasing concentration of competitor.
Guide to Pharmacology 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 30199637
2184 1490 None 0 Human Binding pKi = 7.9 7.9 2 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12446593
2184 1490 None 0 Human Binding pKi = 7.9 7.9 2 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 1649739
2184 1490 None 0 Human Binding pKi = 7.9 7.9 2 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
151171 1163 None 50 Human Binding pKi = 8.3 8.3 -3 6
UnclassifiedUnclassified
Guide to Pharmacology 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 9459574
151171 1163 None 50 Human Binding pKi = 8.3 8.3 -3 6
UnclassifiedUnclassified
Guide to Pharmacology 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 9884074
216322 1163 None 50 Human Binding pKi = 8.3 8.3 -3 6
UnclassifiedUnclassified
Guide to Pharmacology 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 9459574
216322 1163 None 50 Human Binding pKi = 8.3 8.3 -3 6
UnclassifiedUnclassified
Guide to Pharmacology 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 9884074
2203 1163 None 50 Human Binding pKi = 8.3 8.3 -3 6
UnclassifiedUnclassified
Guide to Pharmacology 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 9459574
2203 1163 None 50 Human Binding pKi = 8.3 8.3 -3 6
UnclassifiedUnclassified
Guide to Pharmacology 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 9884074
732 1163 None 50 Human Binding pKi = 8.3 8.3 -3 6
UnclassifiedUnclassified
Guide to Pharmacology 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 9459574
732 1163 None 50 Human Binding pKi = 8.3 8.3 -3 6
UnclassifiedUnclassified
Guide to Pharmacology 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 9884074
CHEMBL1755 1163 None 50 Human Binding pKi = 8.3 8.3 -3 6
UnclassifiedUnclassified
Guide to Pharmacology 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 9459574
CHEMBL1755 1163 None 50 Human Binding pKi = 8.3 8.3 -3 6
UnclassifiedUnclassified
Guide to Pharmacology 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 9884074
DB00872 1163 None 50 Human Binding pKi = 8.3 8.3 -3 6
UnclassifiedUnclassified
Guide to Pharmacology 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 9459574
DB00872 1163 None 50 Human Binding pKi = 8.3 8.3 -3 6
UnclassifiedUnclassified
Guide to Pharmacology 498 4 2 3 6.5 Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1 9884074
2169 466 None 0 Human Binding pKi = 8.3 8.3 -12 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
68649 466 None 0 Human Binding pKi = 8.3 8.3 -12 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
2169 466 None 0 Rat Binding pKi = 8.5 8.5 -7 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
68649 466 None 0 Rat Binding pKi = 8.5 8.5 -7 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
2172 2389 None 0 Human Binding pKi = 8.6 8.6 1 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
2959 2389 None 0 Human Binding pKi = 8.6 8.6 1 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
644076 2389 None 0 Human Binding pKi = 8.6 8.6 1 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
CHEMBL1200690 2389 None 0 Human Binding pKi = 8.6 8.6 1 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
DB14642 2389 None 0 Human Binding pKi = 8.6 8.6 1 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
2200 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10519430
2200 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10866830
2200 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 16158071
2200 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 8106369
2200 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 9884074
3482 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10519430
3482 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10866830
3482 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 16158071
3482 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 8106369
3482 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 9884074
60943 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10519430
60943 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10866830
60943 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 16158071
60943 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 8106369
60943 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 9884074
CHEMBL419667 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10519430
CHEMBL419667 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10866830
CHEMBL419667 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 16158071
CHEMBL419667 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 8106369
CHEMBL419667 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 9884074
DB13929 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10519430
DB13929 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 10866830
DB13929 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 16158071
DB13929 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 8106369
DB13929 3309 None 46 Human Binding pKi = 8.7 8.7 1 6
UnclassifiedUnclassified
Guide to Pharmacology 619 7 2 7 3.3 COc1ccc(cc1OC)S(=O)(=O)N1c2ccc(cc2[C@]([C@@H]1C(=O)N1CCC[C@H]1C(=O)N)(O)c1ccccc1Cl)Cl 9884074
2168 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10519430
2168 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10780976
2168 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10866830
2168 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12446593
2168 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15084136
2168 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8106369
2168 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9264324
2168 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
2168 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
2168 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9459574
2168 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9864265
2168 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
2810 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10519430
2810 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10780976
2810 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10866830
2810 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12446593
2810 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15084136
2810 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8106369
2810 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9264324
2810 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
2810 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
2810 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9459574
2810 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9864265
2810 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
644077 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10519430
644077 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10780976
644077 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10866830
644077 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12446593
644077 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15084136
644077 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8106369
644077 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9264324
644077 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
644077 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
644077 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9459574
644077 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9864265
644077 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
CHEMBL373742 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10519430
CHEMBL373742 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10780976
CHEMBL373742 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10866830
CHEMBL373742 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12446593
CHEMBL373742 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15084136
CHEMBL373742 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8106369
CHEMBL373742 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9264324
CHEMBL373742 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
CHEMBL373742 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
CHEMBL373742 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9459574
CHEMBL373742 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9864265
CHEMBL373742 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
DB00067 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10519430
DB00067 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10780976
DB00067 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10866830
DB00067 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12446593
DB00067 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15084136
DB00067 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8106369
DB00067 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9264324
DB00067 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
DB00067 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
DB00067 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9459574
DB00067 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9864265
DB00067 3974 None 38 Human Binding pKi = 8.9 8.9 -5 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
3867 1350 None 0 Human Binding pKi = 9 9.0 - 1
UnclassifiedUnclassified
Guide to Pharmacology None None None None None
8529 3352 None 0 Human Binding pKi = 9 9.0 10000 3
UnclassifiedUnclassified
Guide to Pharmacology 439 4 0 4 3.9 CN(CCN1CC(c2c1cc(Cl)cc2)C(=O)N1CCC2(CC1)OCc1c2cccc1)C 25654260
91827367 3352 None 0 Human Binding pKi = 9 9.0 10000 3
UnclassifiedUnclassified
Guide to Pharmacology 439 4 0 4 3.9 CN(CCN1CC(c2c1cc(Cl)cc2)C(=O)N1CCC2(CC1)OCc1c2cccc1)C 25654260
12262 3675 None 0 Human Binding pKi = 9.5 9.5 - 1
UnclassifiedUnclassified
Guide to Pharmacology 731 13 1 6 6.2 C[C@H](NC(=O)[C@@H](CC(=O)N1CCC(CCN2CCCCC2)CC1)N1[C@H](/C=C/c2ccccc2)[C@H](N2[C@H](COC2=O)c2ccccc2)C1=O)c1ccccc1 17234419
165437864 3675 None 0 Human Binding pKi = 9.5 9.5 - 1
UnclassifiedUnclassified
Guide to Pharmacology 731 13 1 6 6.2 C[C@H](NC(=O)[C@@H](CC(=O)N1CCC(CCN2CCCCC2)CC1)N1[C@H](/C=C/c2ccccc2)[C@H](N2[C@H](COC2=O)c2ccccc2)C1=O)c1ccccc1 17234419
2188 1342 None 0 Rat Binding pKi None 5 5.0 -5011 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 17300166
114904 2952 None 56 Human Binding pKi None 5.1 5.1 -301 7
UnclassifiedUnclassified
Guide to Pharmacology 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 9322919
2196 2952 None 56 Human Binding pKi None 5.1 5.1 -301 7
UnclassifiedUnclassified
Guide to Pharmacology 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 9322919
CHEMBL296908 2952 None 56 Human Binding pKi None 5.1 5.1 -301 7
UnclassifiedUnclassified
Guide to Pharmacology 449 7 1 4 3.2 CC(=O)NCCCOc1ccc(cc1)C(=O)N1CCC(CC1)N1C(=O)CCc2c1cccc2 9322919
2186 1341 None 0 Rat Binding pKi None 5.4 5.4 -5011 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 17300166
2191 1444 None 0 Rat Binding pKi None 5.4 5.4 -25118 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 17300166
2189 1443 None 0 Rat Binding pKi None 5.5 5.5 -7943 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 17300166
2181 1330 None 42 Rat Binding pKi None 5.6 5.6 -645 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
2182 1330 None 42 Rat Binding pKi None 5.6 5.6 -645 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
27991 1330 None 42 Rat Binding pKi None 5.6 5.6 -645 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
CHEMBL1429 1330 None 42 Rat Binding pKi None 5.6 5.6 -645 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
CHEMBL264448 1330 None 42 Rat Binding pKi None 5.6 5.6 -645 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
DB00035 1330 None 42 Rat Binding pKi None 5.6 5.6 -645 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
2170 1331 None 0 Rat Binding pKi None 6.1 6.1 -158 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
2173 2954 None 13 Human Binding pKi None 6.1 6.1 -8 2
UnclassifiedUnclassified
Guide to Pharmacology 453 5 1 3 5.4 CC(NC(=O)C[C@H]1CCCN(c2c1cccc2)C(=O)c1ccc(cc1Cl)N1CCCC1)C 10780976
3038506 2954 None 13 Human Binding pKi None 6.1 6.1 -8 2
UnclassifiedUnclassified
Guide to Pharmacology 453 5 1 3 5.4 CC(NC(=O)C[C@H]1CCCN(c2c1cccc2)C(=O)c1ccc(cc1Cl)N1CCCC1)C 10780976
CHEMBL332447 2954 None 13 Human Binding pKi None 6.1 6.1 -8 2
UnclassifiedUnclassified
Guide to Pharmacology 453 5 1 3 5.4 CC(NC(=O)C[C@H]1CCCN(c2c1cccc2)C(=O)c1ccc(cc1Cl)N1CCCC1)C 10780976
DB05838 2954 None 13 Human Binding pKi None 6.1 6.1 -8 2
UnclassifiedUnclassified
Guide to Pharmacology 453 5 1 3 5.4 CC(NC(=O)C[C@H]1CCCN(c2c1cccc2)C(=O)c1ccc(cc1Cl)N1CCCC1)C 10780976
2042 2981 None 58 Rat Binding pKi None 6.1 6.1 -31 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
2174 2981 None 58 Rat Binding pKi None 6.1 6.1 -31 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
2176 2981 None 58 Rat Binding pKi None 6.1 6.1 -31 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
439302 2981 None 58 Rat Binding pKi None 6.1 6.1 -31 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
CHEMBL395429 2981 None 58 Rat Binding pKi None 6.1 6.1 -31 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
DB00107 2981 None 58 Rat Binding pKi None 6.1 6.1 -31 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
119369 2604 None 74 Rat Binding pKi None 6.3 6.3 -31 8
UnclassifiedUnclassified
Guide to Pharmacology 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 9864265
2197 2604 None 74 Rat Binding pKi None 6.3 6.3 -31 8
UnclassifiedUnclassified
Guide to Pharmacology 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 9864265
4004 2604 None 74 Rat Binding pKi None 6.3 6.3 -31 8
UnclassifiedUnclassified
Guide to Pharmacology 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 9864265
CHEMBL420762 2604 None 74 Rat Binding pKi None 6.3 6.3 -31 8
UnclassifiedUnclassified
Guide to Pharmacology 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 9864265
164712 3104 None 0 Rat Binding pKi None 6.3 6.3 -316 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
2178 3104 None 0 Rat Binding pKi None 6.3 6.3 -316 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
CHEMBL3272682 3104 None 0 Rat Binding pKi None 6.3 6.3 -316 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
158348 3485 None 18 Human Binding pKi None 6.5 6.5 -1318 4
UnclassifiedUnclassified
Guide to Pharmacology 643 10 1 9 3.9 CCOc1ccc2c(c1)[C@@]1(CC[C@H](CC1)OCCN1CCOCC1)C(=O)N2S(=O)(=O)c1ccc(cc1OC)C(=O)NC(C)(C)C 11429400
158348 3485 None 18 Human Binding pKi None 6.5 6.5 -1318 4
UnclassifiedUnclassified
Guide to Pharmacology 643 10 1 9 3.9 CCOc1ccc2c(c1)[C@@]1(CC[C@H](CC1)OCCN1CCOCC1)C(=O)N2S(=O)(=O)c1ccc(cc1OC)C(=O)NC(C)(C)C 9884074
2199 3485 None 18 Human Binding pKi None 6.5 6.5 -1318 4
UnclassifiedUnclassified
Guide to Pharmacology 643 10 1 9 3.9 CCOc1ccc2c(c1)[C@@]1(CC[C@H](CC1)OCCN1CCOCC1)C(=O)N2S(=O)(=O)c1ccc(cc1OC)C(=O)NC(C)(C)C 11429400
2199 3485 None 18 Human Binding pKi None 6.5 6.5 -1318 4
UnclassifiedUnclassified
Guide to Pharmacology 643 10 1 9 3.9 CCOc1ccc2c(c1)[C@@]1(CC[C@H](CC1)OCCN1CCOCC1)C(=O)N2S(=O)(=O)c1ccc(cc1OC)C(=O)NC(C)(C)C 9884074
CHEMBL4283439 3485 None 18 Human Binding pKi None 6.5 6.5 -1318 4
UnclassifiedUnclassified
Guide to Pharmacology 643 10 1 9 3.9 CCOc1ccc2c(c1)[C@@]1(CC[C@H](CC1)OCCN1CCOCC1)C(=O)N2S(=O)(=O)c1ccc(cc1OC)C(=O)NC(C)(C)C 11429400
CHEMBL4283439 3485 None 18 Human Binding pKi None 6.5 6.5 -1318 4
UnclassifiedUnclassified
Guide to Pharmacology 643 10 1 9 3.9 CCOc1ccc2c(c1)[C@@]1(CC[C@H](CC1)OCCN1CCOCC1)C(=O)N2S(=O)(=O)c1ccc(cc1OC)C(=O)NC(C)(C)C 9884074
DB14923 3485 None 18 Human Binding pKi None 6.5 6.5 -1318 4
UnclassifiedUnclassified
Guide to Pharmacology 643 10 1 9 3.9 CCOc1ccc2c(c1)[C@@]1(CC[C@H](CC1)OCCN1CCOCC1)C(=O)N2S(=O)(=O)c1ccc(cc1OC)C(=O)NC(C)(C)C 11429400
DB14923 3485 None 18 Human Binding pKi None 6.5 6.5 -1318 4
UnclassifiedUnclassified
Guide to Pharmacology 643 10 1 9 3.9 CCOc1ccc2c(c1)[C@@]1(CC[C@H](CC1)OCCN1CCOCC1)C(=O)N2S(=O)(=O)c1ccc(cc1OC)C(=O)NC(C)(C)C 9884074
216237 3841 None 89 Rat Binding pKi None 6.5 6.5 -79 5
UnclassifiedUnclassified
Guide to Pharmacology 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 9864265
2226 3841 None 89 Rat Binding pKi None 6.5 6.5 -79 5
UnclassifiedUnclassified
Guide to Pharmacology 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 9864265
4110 3841 None 89 Rat Binding pKi None 6.5 6.5 -79 5
UnclassifiedUnclassified
Guide to Pharmacology 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 9864265
443894 3841 None 89 Rat Binding pKi None 6.5 6.5 -79 5
UnclassifiedUnclassified
Guide to Pharmacology 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 9864265
CHEMBL344159 3841 None 89 Rat Binding pKi None 6.5 6.5 -79 5
UnclassifiedUnclassified
Guide to Pharmacology 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 9864265
DB06212 3841 None 89 Rat Binding pKi None 6.5 6.5 -79 5
UnclassifiedUnclassified
Guide to Pharmacology 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 9864265
2179 3813 None 0 Human Binding pKi None 6.7 6.7 -44 2
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
2179 3813 None 0 Human Binding pKi None 6.7 6.7 -44 2
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
3080871 3813 None 0 Human Binding pKi None 6.7 6.7 -44 2
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
3080871 3813 None 0 Human Binding pKi None 6.7 6.7 -44 2
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
2192 2356 None 28 Human Binding pKi None 6.7 6.7 -7 3
UnclassifiedUnclassified
Guide to Pharmacology 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 12660315
9690136 2356 None 28 Human Binding pKi None 6.7 6.7 -7 3
UnclassifiedUnclassified
Guide to Pharmacology 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 12660315
CHEMBL1254024 2356 None 28 Human Binding pKi None 6.7 6.7 -7 3
UnclassifiedUnclassified
Guide to Pharmacology 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 12660315
10461270 3676 None 7 Human Binding pKi None 6.8 6.8 -199 5
UnclassifiedUnclassified
Guide to Pharmacology 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 14722330
2201 3676 None 7 Human Binding pKi None 6.8 6.8 -199 5
UnclassifiedUnclassified
Guide to Pharmacology 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 14722330
CHEMBL1615640 3676 None 7 Human Binding pKi None 6.8 6.8 -199 5
UnclassifiedUnclassified
Guide to Pharmacology 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 14722330
119369 2604 None 74 Human Binding pKi None 7.0 7.0 -6 8
UnclassifiedUnclassified
Guide to Pharmacology 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 9322919
119369 2604 None 74 Human Binding pKi None 7.0 7.0 -6 8
UnclassifiedUnclassified
Guide to Pharmacology 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 9864265
119369 2604 None 74 Human Binding pKi None 7.0 7.0 -6 8
UnclassifiedUnclassified
Guide to Pharmacology 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 9884074
2197 2604 None 74 Human Binding pKi None 7.0 7.0 -6 8
UnclassifiedUnclassified
Guide to Pharmacology 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 9322919
2197 2604 None 74 Human Binding pKi None 7.0 7.0 -6 8
UnclassifiedUnclassified
Guide to Pharmacology 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 9864265
2197 2604 None 74 Human Binding pKi None 7.0 7.0 -6 8
UnclassifiedUnclassified
Guide to Pharmacology 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 9884074
4004 2604 None 74 Human Binding pKi None 7.0 7.0 -6 8
UnclassifiedUnclassified
Guide to Pharmacology 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 9322919
4004 2604 None 74 Human Binding pKi None 7.0 7.0 -6 8
UnclassifiedUnclassified
Guide to Pharmacology 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 9864265
4004 2604 None 74 Human Binding pKi None 7.0 7.0 -6 8
UnclassifiedUnclassified
Guide to Pharmacology 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 9884074
CHEMBL420762 2604 None 74 Human Binding pKi None 7.0 7.0 -6 8
UnclassifiedUnclassified
Guide to Pharmacology 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 9322919
CHEMBL420762 2604 None 74 Human Binding pKi None 7.0 7.0 -6 8
UnclassifiedUnclassified
Guide to Pharmacology 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 9864265
CHEMBL420762 2604 None 74 Human Binding pKi None 7.0 7.0 -6 8
UnclassifiedUnclassified
Guide to Pharmacology 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 9884074
2202 2759 None 33 Human Binding pKi None 7 7.0 -58 5
UnclassifiedUnclassified
Guide to Pharmacology 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 11861823
9895468 2759 None 33 Human Binding pKi None 7 7.0 -58 5
UnclassifiedUnclassified
Guide to Pharmacology 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 11861823
CHEMBL582857 2759 None 33 Human Binding pKi None 7 7.0 -58 5
UnclassifiedUnclassified
Guide to Pharmacology 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 11861823
DB12643 2759 None 33 Human Binding pKi None 7 7.0 -58 5
UnclassifiedUnclassified
Guide to Pharmacology 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 11861823
2187 1340 None 0 Human Binding pKi None 7.1 7.1 -177 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12446593
2215 1343 None 0 Human Binding pKi None 7.3 7.3 1 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8106369
2215 1343 None 0 Human Binding pKi None 7.3 7.3 1 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
2181 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10780976
2181 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15084136
2181 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9264324
2181 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
2181 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
2181 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
2182 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10780976
2182 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15084136
2182 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9264324
2182 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
2182 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
2182 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
27991 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10780976
27991 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15084136
27991 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9264324
27991 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
27991 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
27991 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
CHEMBL1429 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10780976
CHEMBL1429 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15084136
CHEMBL1429 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9264324
CHEMBL1429 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
CHEMBL1429 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
CHEMBL1429 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
CHEMBL264448 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10780976
CHEMBL264448 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15084136
CHEMBL264448 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9264324
CHEMBL264448 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
CHEMBL264448 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
CHEMBL264448 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
DB00035 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10780976
DB00035 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15084136
DB00035 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9264324
DB00035 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
DB00035 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
DB00035 1330 None 42 Human Binding pKi None 7.4 7.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
2190 1442 None 0 Human Binding pKi None 7.4 7.4 -79 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15084136
135413562 2203 None 15 Human Binding pKi None 7.4 7.4 -16 5
UnclassifiedUnclassified
Guide to Pharmacology 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 16302826
2194 2203 None 15 Human Binding pKi None 7.4 7.4 -16 5
UnclassifiedUnclassified
Guide to Pharmacology 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 16302826
CHEMBL445816 2203 None 15 Human Binding pKi None 7.4 7.4 -16 5
UnclassifiedUnclassified
Guide to Pharmacology 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 16302826
2214 1344 None 0 Human Binding pKi None 7.5 7.5 1 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
171113 3968 None 0 Human Binding pKi None 7.5 7.5 -31 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12446593
2180 3968 None 0 Human Binding pKi None 7.5 7.5 -31 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12446593
CHEMBL3274309 3968 None 0 Human Binding pKi None 7.5 7.5 -31 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12446593
2042 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10519430
2042 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12660315
2042 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8106369
2042 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9264324
2042 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
2042 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
2042 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9459574
2042 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
2174 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10519430
2174 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12660315
2174 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8106369
2174 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9264324
2174 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
2174 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
2174 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9459574
2174 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
2176 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10519430
2176 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12660315
2176 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8106369
2176 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9264324
2176 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
2176 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
2176 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9459574
2176 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
439302 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10519430
439302 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12660315
439302 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8106369
439302 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9264324
439302 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
439302 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
439302 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9459574
439302 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
CHEMBL395429 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10519430
CHEMBL395429 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12660315
CHEMBL395429 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8106369
CHEMBL395429 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9264324
CHEMBL395429 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
CHEMBL395429 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
CHEMBL395429 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9459574
CHEMBL395429 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
DB00107 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10519430
DB00107 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12660315
DB00107 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8106369
DB00107 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9264324
DB00107 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
DB00107 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
DB00107 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9459574
DB00107 2981 None 58 Human Binding pKi None 7.6 7.6 -29 8
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
2198 3418 None 2 Human Binding pKi None 7.6 7.6 -46 2
UnclassifiedUnclassified
Guide to Pharmacology 537 4 1 4 6.1 Clc1cc(ccc1C(=O)N1C[C@H]2COCCN2Cc2c1cccc2)NC(=O)c1ccccc1c1ccccc1 16620295
9807249 3418 None 2 Human Binding pKi None 7.6 7.6 -46 2
UnclassifiedUnclassified
Guide to Pharmacology 537 4 1 4 6.1 Clc1cc(ccc1C(=O)N1C[C@H]2COCCN2Cc2c1cccc2)NC(=O)c1ccccc1c1ccccc1 16620295
CHEMBL1192593 3418 None 2 Human Binding pKi None 7.6 7.6 -46 2
UnclassifiedUnclassified
Guide to Pharmacology 537 4 1 4 6.1 Clc1cc(ccc1C(=O)N1C[C@H]2COCCN2Cc2c1cccc2)NC(=O)c1ccccc1c1ccccc1 16620295
2183 1512 None 0 Human Binding pKi None 7.8 7.8 -11 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12446593
2183 1512 None 0 Human Binding pKi None 7.8 7.8 -11 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
6441676 1512 None 0 Human Binding pKi None 7.8 7.8 -11 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12446593
6441676 1512 None 0 Human Binding pKi None 7.8 7.8 -11 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
216237 3841 None 89 Human Binding pKi None 7.9 7.9 -23 5
UnclassifiedUnclassified
Guide to Pharmacology 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 9864265
2226 3841 None 89 Human Binding pKi None 7.9 7.9 -23 5
UnclassifiedUnclassified
Guide to Pharmacology 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 9864265
4110 3841 None 89 Human Binding pKi None 7.9 7.9 -23 5
UnclassifiedUnclassified
Guide to Pharmacology 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 9864265
443894 3841 None 89 Human Binding pKi None 7.9 7.9 -23 5
UnclassifiedUnclassified
Guide to Pharmacology 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 9864265
CHEMBL344159 3841 None 89 Human Binding pKi None 7.9 7.9 -23 5
UnclassifiedUnclassified
Guide to Pharmacology 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 9864265
DB06212 3841 None 89 Human Binding pKi None 7.9 7.9 -23 5
UnclassifiedUnclassified
Guide to Pharmacology 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 9864265
2222 1352 None 0 Human Binding pKi None 8.1 8.1 794 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
2221 1354 None 0 Human Binding pKi None 8.4 8.4 -17 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15880385
2221 1354 None 0 Human Binding pKi None 8.4 8.4 -17 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
2213 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10519430
2213 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12660315
2213 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 14722330
2213 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15880385
3008 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10519430
3008 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12660315
3008 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 14722330
3008 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15880385
5311010 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10519430
5311010 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12660315
5311010 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 14722330
5311010 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15880385
68613 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10519430
68613 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12660315
68613 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 14722330
68613 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15880385
CHEMBL378642 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10519430
CHEMBL378642 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12660315
CHEMBL378642 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 14722330
CHEMBL378642 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15880385
CHEMBL382301 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10519430
CHEMBL382301 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12660315
CHEMBL382301 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 14722330
CHEMBL382301 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15880385
DB09059 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10519430
DB09059 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12660315
DB09059 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 14722330
DB09059 518 None 46 Human Binding pKi None 8.4 8.4 28 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15880385
2181 1330 None 42 Human Binding pKi None 8.4 8.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12446593
2181 1330 None 42 Human Binding pKi None 8.4 8.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15084136
2182 1330 None 42 Human Binding pKi None 8.4 8.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12446593
2182 1330 None 42 Human Binding pKi None 8.4 8.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15084136
27991 1330 None 42 Human Binding pKi None 8.4 8.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12446593
27991 1330 None 42 Human Binding pKi None 8.4 8.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15084136
CHEMBL1429 1330 None 42 Human Binding pKi None 8.4 8.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12446593
CHEMBL1429 1330 None 42 Human Binding pKi None 8.4 8.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15084136
CHEMBL264448 1330 None 42 Human Binding pKi None 8.4 8.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12446593
CHEMBL264448 1330 None 42 Human Binding pKi None 8.4 8.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15084136
DB00035 1330 None 42 Human Binding pKi None 8.4 8.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12446593
DB00035 1330 None 42 Human Binding pKi None 8.4 8.4 -28 7
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15084136
2168 3974 None 38 Rat Binding pKi None 8.4 8.4 -8 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
2810 3974 None 38 Rat Binding pKi None 8.4 8.4 -8 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
644077 3974 None 38 Rat Binding pKi None 8.4 8.4 -8 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
CHEMBL373742 3974 None 38 Rat Binding pKi None 8.4 8.4 -8 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
DB00067 3974 None 38 Rat Binding pKi None 8.4 8.4 -8 9
UnclassifiedUnclassified
Guide to Pharmacology None None None None 7774575
2209 3088 None 0 Human Binding pKi None 8.6 8.6 281 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8106369
2209 3088 None 0 Human Binding pKi None 8.6 8.6 281 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
2223 1351 None 0 Human Binding pKi None 8.8 8.8 3 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10866830
2223 1351 None 0 Human Binding pKi None 8.8 8.8 3 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9264324
2223 1351 None 0 Human Binding pKi None 8.8 8.8 3 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
2223 1351 None 0 Human Binding pKi None 8.8 8.8 3 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
2223 1351 None 0 Human Binding pKi None 8.8 8.8 3 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9459574
2223 1351 None 0 Human Binding pKi None 8.8 8.8 3 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
6917952 1351 None 0 Human Binding pKi None 8.8 8.8 3 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10866830
6917952 1351 None 0 Human Binding pKi None 8.8 8.8 3 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9264324
6917952 1351 None 0 Human Binding pKi None 8.8 8.8 3 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
6917952 1351 None 0 Human Binding pKi None 8.8 8.8 3 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232
6917952 1351 None 0 Human Binding pKi None 8.8 8.8 3 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9459574
6917952 1351 None 0 Human Binding pKi None 8.8 8.8 3 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
2219 1353 None 0 Human Binding pKi None 8.9 8.9 -1 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 11337500
2208 3087 None 0 Human Binding pKi None 9 9.0 31 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8106369
2208 3087 None 0 Human Binding pKi None 9 9.0 31 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
2216 1348 None 0 Human Binding pKi None 9.1 9.1 1 2
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10866830
122322 1349 None 0 Human Binding pKi None 9.1 9.1 8 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
2217 1349 None 0 Human Binding pKi None 9.1 9.1 8 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
119517 1473 None 0 Human Binding pKi None 9.1 9.1 7 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
2225 1473 None 0 Human Binding pKi None 9.1 9.1 7 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9884074
2210 3089 None 0 Human Binding pKi None 9.1 9.1 12 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
2212 3758 None 0 Human Binding pKi None 9.1 9.1 63 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
2185 1491 None 0 Human Binding pKi None 9.2 9.2 -1 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12446593
2211 3090 None 0 Human Binding pKi None 9.2 9.2 25 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
2205 4121 None 6 Human Binding pKi None 9.2 9.2 -1 5
UnclassifiedUnclassified
Guide to Pharmacology 648 6 1 4 7.2 CN(C1CCN(CC1)C(=O)/C=C\1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1)C 11429400
9810140 4121 None 6 Human Binding pKi None 9.2 9.2 -1 5
UnclassifiedUnclassified
Guide to Pharmacology 648 6 1 4 7.2 CN(C1CCN(CC1)C(=O)/C=C\1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1)C 11429400
CHEMBL307483 4121 None 6 Human Binding pKi None 9.2 9.2 -1 5
UnclassifiedUnclassified
Guide to Pharmacology 648 6 1 4 7.2 CN(C1CCN(CC1)C(=O)/C=C\1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1)C 11429400
2195 2909 None 0 Human Binding pKi None 9.3 9.3 3 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9322919
2204 4115 None 5 Human Binding pKi None 9.5 9.5 229 4
UnclassifiedUnclassified
Guide to Pharmacology 616 5 1 5 6.4 O=C(N1CCC(CC1)N1CCCCC1)/C=C\1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccoc1C 15661579
9917025 4115 None 5 Human Binding pKi None 9.5 9.5 229 4
UnclassifiedUnclassified
Guide to Pharmacology 616 5 1 5 6.4 O=C(N1CCC(CC1)N1CCCCC1)/C=C\1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccoc1C 15661579
CHEMBL3307200 4115 None 5 Human Binding pKi None 9.5 9.5 229 4
UnclassifiedUnclassified
Guide to Pharmacology 616 5 1 5 6.4 O=C(N1CCC(CC1)N1CCCCC1)/C=C\1/c2ccccc2N(CCC1(F)F)C(=O)c1ccc(cc1)NC(=O)c1ccoc1C 15661579
2193 108 None 0 Human Binding pKi None 9.6 9.6 - 1
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9334232